data_1ap7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ap7 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 52.3 t . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.938 0.399 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -53.64 -83.07 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 3.0 p30 -51.92 -29.94 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -37.0 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.787 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 4.9 tp -72.28 -23.84 61.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -65.59 -49.89 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.7 -27.91 68.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.503 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -72.21 -55.07 7.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.347 . . . . 0.0 111.249 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.82 79.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.249 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -32.64 64.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.4 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -71.0 -9.86 58.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.002 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.42 75.89 0.57 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 24' ' ' GLN . 1.2 t70 -144.7 85.56 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.795 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -52.9 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.432 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 mt-30 -70.66 -45.02 65.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.7 mm-40 -72.99 -49.43 29.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.676 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 58' ' ' VAL . 47.2 t -57.92 -29.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 4.8 mmt180 -72.03 -60.86 2.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -69.16 -22.77 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.1 mt -54.44 -66.55 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 35' ' ' VAL . 16.5 mt -72.28 -40.59 67.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.13 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 23.0 m-70 -65.41 -19.62 66.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.306 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -133.0 -66.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' LEU . 2.4 tp10 -58.48 -14.46 7.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.2 mt 46.96 25.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.786 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' CG2' ' CB ' ' A' ' 14' ' ' LEU . 14.7 p -43.96 148.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 144.29 43.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.12 -22.98 21.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.404 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.54 2.53 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -42.25 124.74 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.2 mt -122.01 130.08 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 4.6 p-10 -66.21 -179.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -47.79 -43.34 27.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.89 -65.34 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.52 47.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 13.2 mtpt -116.42 151.08 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.8 p -85.14 162.05 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . . . -53.83 -47.46 70.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.118 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 69' ' ' PRO . 1.1 mp -62.8 -27.59 69.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' NE2' HG22 ' A' ' 71' ' ' VAL . 9.8 tt0 -72.97 -29.26 62.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 46' ' ' THR . 2.9 m -101.63 -26.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -36.65 142.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.797 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 ptt? -102.31 22.69 12.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 4.7 m-85 36.57 31.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -76.94 -77.8 0.77 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.487 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -77.86 121.02 83.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.966 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.47 -45.69 37.9 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.61 2.207 . . . . 0.0 112.159 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 61' ' ' GLU . . . -63.16 -28.69 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.368 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.525 HG23 ' CG2' ' A' ' 26' ' ' VAL . 2.5 t -62.95 -38.57 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.209 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' CB ' HG21 ' A' ' 91' ' ' THR . . . -63.32 -49.77 72.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 53.1 tp -63.15 -33.13 74.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 1.9 mm-40 -62.54 -49.1 76.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 47' ' ' ALA . 5.6 mt -62.96 -56.26 18.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.608 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.36 -25.73 68.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 1.6 tttp -62.84 -29.84 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -73.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.92 62.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.45 153.29 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.165 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -96.6 99.24 5.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.493 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 31.7 Cg_endo -64.31 -15.83 51.75 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -79.7 65.86 4.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG22 ' NE2' ' A' ' 49' ' ' GLN . 28.2 m -126.4 138.11 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.261 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -114.88 102.1 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -89.75 -174.57 0.46 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 51.3 Cg_exo -55.57 -41.65 75.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.85 2.367 . . . . 0.0 112.545 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -62.86 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.328 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.412 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 65.8 m80 -58.14 -51.37 70.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.532 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -66.63 -50.38 63.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.39 -30.44 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.41 -67.11 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.617 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -62.33 -29.55 70.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.812 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 52.2 p -66.99 -54.07 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 111.211 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.457 ' CA ' ' NE2' ' A' ' 121' ' ' HIS . . . 110.38 66.04 0.54 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.121 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -140.66 53.43 1.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 0.0 110.55 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 123' ' ' SER . 20.6 tp -52.23 -19.07 1.8 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -63.52 -72.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.461 HG21 ' CB ' ' A' ' 59' ' ' ALA . 6.3 m -73.15 -24.1 60.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.527 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD21 ' N ' ' A' ' 93' ' ' LYS . 9.7 tt -56.16 -59.79 4.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 127' ' ' PHE . 8.1 ptmt -58.32 -38.0 76.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.133 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -51.73 -61.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.09 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.57 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -74.8 -43.48 54.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.527 ' CG2' HD22 ' A' ' 92' ' ' LEU . 10.7 t -52.54 -42.55 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.512 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.6 mm-40 -73.54 -39.53 64.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.225 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -51.88 66.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 178.77 -26.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.095 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.511 ' CB ' HD11 ' A' ' 95' ' ' LEU . . . -23.82 123.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 112.002 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.49 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 9.8 t0 -56.6 85.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.462 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 10.2 p -98.31 28.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 104' ' ' ALA . 0.2 OUTLIER -120.91 -33.22 3.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -48.11 -177.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.469 HD23 ' HG ' ' A' ' 111' ' ' LEU . 9.3 mt -139.99 175.47 9.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.88 62.03 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 108' ' ' THR . 0.3 OUTLIER 68.45 -75.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 107' ' ' SER . 4.7 p -37.96 -48.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.93 19.72 2.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.512 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.512 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -93.06 118.29 31.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 110.993 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.469 ' HG ' HD23 ' A' ' 105' ' ' LEU . 5.2 mt -65.27 143.8 98.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.646 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.497 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 83.7 Cg_exo -45.2 -26.12 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.606 2.204 . . . . 0.0 112.173 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -72.12 -40.04 66.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.084 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.48 ' O ' HD22 ' A' ' 147' ' ' LEU . 46.0 m170 -53.04 -46.04 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.699 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 0.5 OUTLIER -58.76 -44.19 90.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.671 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.532 ' CB ' HG13 ' A' ' 124' ' ' VAL . . . -60.04 -35.63 75.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.443 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.478 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 97.8 mt -64.45 -43.62 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 12.6 ptt180 -73.26 -10.12 59.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.745 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -59.77 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.08 25.22 7.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.404 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.526 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 9.7 m-70 -63.82 -11.93 31.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.2 t 70.52 -68.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -70.63 -52.86 18.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 116' ' ' ALA . 22.0 t -52.83 -55.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 2.9 t -52.0 -61.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.555 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 5.4 p -58.0 -30.44 66.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 93' ' ' LYS . 27.4 t80 -73.31 -55.39 6.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -63.93 -11.67 30.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.067 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.583 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -57.56 -70.24 0.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 57.9 Cg_endo -71.51 -17.92 29.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.238 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' HG12 ' A' ' 102' ' ' VAL . 29.4 mm-40 -90.56 31.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -152.1 -168.62 3.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.901 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 135' ' ' HIS . 23.5 t0 -77.1 83.78 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 130' ' ' PRO . 5.9 mp -64.97 61.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.976 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 133' ' ' ASP . 19.0 t-160 -175.07 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.438 ' HB3' HD12 ' A' ' 111' ' ' LEU . 79.0 t60 -54.89 155.02 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -140.67 158.29 44.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.512 ' OD1' ' CB ' ' A' ' 110' ' ' SER . 1.9 t70 -64.23 158.7 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.68 -19.69 6.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 110.287 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.459 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -67.87 -46.22 72.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.859 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 125.08 32.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 140' ' ' SER . 0.2 OUTLIER -129.16 146.31 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -115.82 -174.32 0.27 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.593 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 71.7 Cg_exo -48.66 -43.69 33.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.455 HD13 ' HE1' ' A' ' 164' ' ' MET . 0.8 OUTLIER -73.19 -47.91 39.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 17.3 tp10 -57.54 -57.52 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 114' ' ' HIS . 6.6 tp -52.35 -34.31 46.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 157' ' ' MET . . . -63.82 -33.04 74.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.61 -30.18 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.007 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.518 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 3.1 tp-100 -70.4 -80.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.668 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -74.2 71.89 1.71 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -72.54 46.18 1.07 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.321 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -36.79 -32.81 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.393 0.616 . . . . 0.0 110.263 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 3.3 pm0 -179.66 -143.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.689 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.537 ' N ' ' HG2' ' A' ' 154' ' ' GLN . 1.1 m-80 -68.82 57.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.963 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.492 HD22 ' NE2' ' A' ' 154' ' ' GLN . 4.1 mt -71.47 -69.77 0.36 Allowed 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 111.008 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.527 ' CB ' ' HB2' ' A' ' 148' ' ' ALA . 6.8 ptm -52.73 -19.46 2.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.786 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.64 -47.28 41.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.555 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 1.5 mt -62.08 -50.64 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 156' ' ' LEU . 4.1 mp -68.33 -29.99 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 157' ' ' MET . 4.4 tt0 -63.54 -42.91 98.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.24 -47.76 35.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.653 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -71.1 -20.04 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.043 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.455 ' HE1' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.554 ' CG2' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -34.27 -31.12 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.816 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -109.62 -21.08 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 0.0 110.935 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' VAL . 9.5 tpt180 -57.07 -69.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.034 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 3.8 tp -68.65 -20.4 64.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 23.8 t -73.32 -44.32 59.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.01 -33.68 59.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.621 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -71.61 -38.88 70.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.58 62.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.206 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -67.96 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.202 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.1 ptp180 -68.3 -9.33 46.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . 62.0 76.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.27 90.02 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.467 ' HA ' HG13 ' A' ' 26' ' ' VAL . 2.4 p -52.65 -22.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.08 -47.86 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 mm-40 -72.87 -44.7 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.993 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.493 HG11 ' N ' ' A' ' 27' ' ' ARG . 4.8 p -52.64 -41.87 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.018 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.493 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.3 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 5.2 mtt180 -56.0 -21.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' LEU . 10.3 mt -72.42 -68.99 0.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.61 -44.07 78.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.302 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 61.6 m-70 -73.13 -0.94 15.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.277 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -149.26 -76.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.212 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.5 tp10 -42.88 -27.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.978 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER 55.4 59.57 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.554 ' CG1' ' CG2' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -84.23 143.35 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.687 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 2.1 t-80 -76.29 143.56 73.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.766 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 45.1 Cg_endo -68.07 -21.75 42.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 0.0 112.135 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.869 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -91.21 33.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.77 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.507 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -80.93 125.6 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.39 124.2 39.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 2.4 p30 -62.5 -62.21 1.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 30.5 tpt180 -97.87 46.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 26.5 t80 37.48 62.32 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.95 -65.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.385 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 15.3 mtpp -86.91 146.63 26.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.676 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 50' ' ' VAL . 4.2 p -92.73 -177.95 4.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -72.27 -36.0 68.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -32.08 69.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB2' HG22 ' A' ' 71' ' ' VAL . 1.8 tt0 -69.94 -15.31 63.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 46' ' ' THR . 2.6 m -110.25 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.8 ttp -38.08 123.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.562 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -88.87 19.64 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.605 ' CE2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 39.35 30.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.121 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . -71.22 -45.51 48.48 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.121 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.517 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 20.5 m -108.6 134.85 20.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 57.3 Cg_endo -70.6 -37.7 6.84 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.572 2.181 . . . . 0.0 112.29 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.22 83.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 55' ' ' SER . 5.4 m -62.5 -27.99 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 94' ' ' VAL . . . -63.37 -60.36 3.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.8 tm? -63.15 -40.67 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.964 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -62.52 -40.57 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.562 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.86 -63.57 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.496 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 98' ' ' HIS . 23.6 tp -63.58 -14.69 53.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -62.9 -36.01 81.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.051 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HG2' HD11 ' A' ' 30' ' ' LEU . 2.4 mm-40 -68.08 -14.48 63.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.15 34.88 4.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.85 -179.41 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -121.92 93.75 48.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.22 -17.4 11.64 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.734 2.289 . . . . 0.0 112.179 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.719 ' OD1' ' OD1' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -94.65 64.02 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.793 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG21 ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -104.56 146.55 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.569 HG21 ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -164.63 135.56 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.897 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.553 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.54 -177.38 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 29.2 Cg_exo -61.65 -39.53 53.21 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.883 2.389 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.5 m -60.31 -28.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.569 ' CG ' HG21 ' A' ' 77' ' ' THR . 3.2 m80 -62.65 -67.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.81 -43.92 90.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB3' ' CD2' ' A' ' 53' ' ' PHE . . . -52.48 -28.3 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.128 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.71 -56.5 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 115' ' ' LEU . 1.8 mtt180 -73.16 -22.79 60.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.815 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 69.5 p -71.12 -57.06 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.2 67.8 0.5 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 52' ' ' MET . 22.8 m-85 -140.61 52.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.413 . . . . 0.0 110.586 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.482 ' CD2' ' HD3' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -52.36 -30.63 29.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.47 ' HA ' HG22 ' A' ' 94' ' ' VAL . 97.8 m -65.9 -37.4 86.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' CE2' ' A' ' 53' ' ' PHE . 9.6 tp -52.82 -49.46 65.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.334 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.572 ' HD2' ' CE2' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -53.99 -42.15 68.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.504 ' HB ' ' CB ' ' A' ' 59' ' ' ALA . 22.6 t -52.86 -59.09 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.435 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.605 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 2.9 pp -71.3 -41.17 70.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 2.1 t -67.48 -56.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.953 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -52.72 -29.73 28.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.053 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.521 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 4.2 t-80 -60.61 -32.26 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.934 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.33 -5.52 4.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.01 141.13 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.743 0.306 . . . . 0.0 111.044 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.719 ' OD1' ' OD1' ' A' ' 70' ' ' ASN . 19.6 p-10 -52.08 140.17 21.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.06 13.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.465 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.82 8.01 30.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -82.26 136.85 34.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.52 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -106.76 167.34 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 108' ' ' THR . 3.3 p30 -89.59 -169.67 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -20.89 26.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.406 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 1.9 m -90.05 -9.39 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.795 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 71.93 42.28 52.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.441 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 1.342 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 2.7 m -119.15 127.93 53.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -59.95 149.63 72.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 55.1 Cg_exo -51.72 -30.52 37.68 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.13 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 128' ' ' LEU . 14.4 tt -71.0 -32.46 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 32.9 m170 -62.16 -36.19 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -73.28 -42.95 61.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.638 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.543 ' CG1' ' CG1' ' A' ' 125' ' ' VAL . 96.6 mt -59.79 -41.51 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -73.23 -4.05 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 115' ' ' LEU . 1.9 mm-40 -118.07 -46.07 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.5 53.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.099 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.47 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 23.8 m-70 -66.99 84.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.0 t 52.91 -146.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -73.6 4.37 5.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 46.7 t -52.27 -60.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.543 ' CG1' ' CG1' ' A' ' 117' ' ' ILE . 2.4 t -52.75 -36.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.104 0.478 . . . . 0.0 110.506 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.5 t -70.13 -44.96 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.581 ' CE2' ' OE1' ' A' ' 131' ' ' GLU . 20.4 t80 -69.15 -26.78 65.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -73.56 -0.19 14.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.251 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.586 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -73.11 -70.05 0.29 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 39.4 Cg_endo -66.86 -46.81 3.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.795 2.33 . . . . 0.0 112.802 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.581 ' OE1' ' CE2' ' A' ' 127' ' ' PHE . 4.8 pt-20 -51.52 -34.65 37.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.351 . . . . 0.0 110.758 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 9.3 m -108.8 151.06 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.125 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 31.1 p30 -34.8 121.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 164' ' ' MET . 6.9 mt -89.8 27.69 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -167.87 43.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.066 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.125 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -109.85 172.91 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -141.66 125.42 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 1.342 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 1.5 t0 -76.14 152.62 36.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.12 -21.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.74 47.87 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.575 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' A' ' 147' ' ' LEU . 2.9 pp -174.43 139.65 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.165 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -95.41 -175.31 0.45 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 85.0 Cg_exo -47.67 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.802 2.335 . . . . 0.0 112.275 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.77 -36.05 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.526 ' CB ' ' HB2' ' A' ' 142' ' ' LEU . 68.3 mm-40 -61.48 -63.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -52.83 -48.99 66.6 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.063 0.458 . . . . 0.0 109.808 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -54.61 -33.79 61.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.052 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -66.42 -44.73 82.15 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.501 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -67.84 -88.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.932 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 11.3 ttm180 -75.22 58.0 0.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 148' ' ' ALA . . . -73.18 45.53 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.557 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.54 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -39.27 134.86 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 36.68 -152.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.529 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 3.5 p-10 -74.45 50.31 0.41 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.236 -0.186 . . . . 0.0 110.861 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 3.3 mt -66.39 -70.64 0.23 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 111.67 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.535 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 9.1 ptm -52.49 -20.07 2.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -73.62 -52.35 13.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 1.9 mt -57.65 -32.2 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 120.913 0.387 . . . . 0.0 111.009 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.61 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -73.5 -40.84 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.058 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -65.71 -25.71 67.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -54.68 6.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.345 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -71.37 -12.62 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.447 ' HA ' HD11 ' A' ' 134' ' ' LEU . 6.7 mmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 121.144 0.497 . . . . 0.0 110.468 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -41.35 -26.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.688 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 41' ' ' ASN . 30.6 t0 -108.11 31.58 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' VAL . 12.4 ttm180 -117.32 -59.82 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.3 tp -70.87 -24.13 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -64.68 -48.35 75.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.762 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -73.1 -36.32 56.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.4 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.24 -57.37 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.74 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' CA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.13 -22.93 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 8.0 mtp180 -72.84 -27.48 61.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 62.34 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.221 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.1 p-10 -132.11 84.42 2.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 26' ' ' VAL . 6.4 p -52.84 -21.53 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.445 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 46.8 mt-30 -73.5 -49.13 28.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.818 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.221 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 7.0 mp0 -73.47 -41.88 62.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.952 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 3.8 p -52.86 -39.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 1.114 ' HG2' ' OE2' ' A' ' 61' ' ' GLU . 5.2 mtt180 -73.13 -61.46 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.362 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 14.4 mtm-85 -62.04 -25.6 67.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.224 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.5 mt -56.73 -66.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -73.54 -48.73 30.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.775 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 1.1 m-70 -68.95 -10.94 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.963 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -137.42 -66.88 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.72 0.295 . . . . 0.0 111.386 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -54.51 -18.26 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.076 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.8 mt 55.29 61.65 2.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 14' ' ' LEU . 12.0 p -107.31 129.3 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.579 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -56.83 146.6 57.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 18.6 Cg_endo -58.78 -66.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.713 2.276 . . . . 0.0 112.21 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -44.73 -62.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . 34.28 97.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 1.7 mp -92.78 130.82 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.508 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 37.8 p-10 -65.51 -31.67 72.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.92 39.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 43' ' ' PHE . 65.5 t80 54.42 72.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.01 -64.71 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.581 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' HG2' ' A' ' 49' ' ' GLN . 10.8 mmtt -98.32 136.47 38.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.751 0.31 . . . . 0.0 111.052 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 50' ' ' VAL . 33.3 p -89.2 161.72 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.91 -33.68 51.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 51' ' ' MET . 2.0 tp -73.25 -42.23 62.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.462 ' HG2' ' HD3' ' A' ' 45' ' ' LYS . 54.2 tt0 -73.15 -8.71 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.502 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 3.9 m -115.83 -23.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.528 ' HA ' ' CA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.8 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.732 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.523 ' CE ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -124.37 21.12 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.79 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.59 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 1.1 m-85 41.01 29.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.944 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.523 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . -58.38 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.076 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.521 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -73.7 153.33 89.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.432 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.677 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 13.1 Cg_exo -69.96 -42.93 2.79 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.819 2.346 . . . . 0.0 112.303 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.998 ' HB2' ' OE1' ' A' ' 61' ' ' GLU . . . -63.55 -23.72 67.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.926 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' CG2' ' N ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -62.49 -49.45 83.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.36 -47.56 81.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.597 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -63.03 -53.25 56.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.325 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.114 ' OE2' ' HG2' ' A' ' 27' ' ' ARG . 2.2 mt-10 -63.27 -56.86 13.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.928 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -62.67 -50.46 71.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.672 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 6.9 tt -63.4 -42.89 98.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.67 0.271 . . . . 0.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.8 tttp -62.77 -42.05 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -44.49 -29.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 37' ' ' PRO . . . 132.7 59.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.21 167.26 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -108.56 103.67 51.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 37.0 Cg_endo -65.88 -13.55 40.36 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.797 2.331 . . . . 0.0 112.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 101' ' ' ASP . 31.4 m120 -102.61 86.67 2.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 78' ' ' SER . 12.7 m -142.74 132.11 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.99 154.22 34.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.986 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -139.62 -174.26 0.4 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.86 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 55.2 Cg_exo -51.67 -51.24 11.6 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.79 2.327 . . . . 0.0 112.458 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.454 ' CG2' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.83 -44.08 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' NE2' ' HG3' ' A' ' 112' ' ' PRO . 51.4 m80 -62.94 -56.25 18.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.86 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 1.9 p30 -54.77 -48.83 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.59 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -56.28 -57.19 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.12 -50.3 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.849 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -57.16 -40.77 77.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 21.3 p -73.33 -59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.82 73.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.216 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 56.7 m-85 -136.75 49.81 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.567 HD23 ' CG ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -52.39 -35.73 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.056 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.57 -66.43 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.779 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.812 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 63.0 m -71.72 -41.09 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 53' ' ' PHE . 49.7 tp -52.66 -51.24 61.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.502 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 97' ' ' GLU . 28.9 ttmt -52.74 -36.85 58.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.481 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.295 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 24.2 t -57.03 -70.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' A' ' 53' ' ' PHE . 2.6 pp -58.59 -38.51 78.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.56 HG12 ' OE1' ' A' ' 131' ' ' GLU . 2.4 t -64.02 -60.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.682 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.295 ' CD ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.73 -30.81 34.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.863 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.506 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -73.15 -54.56 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.653 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . -164.73 -65.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.287 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . 40.2 -166.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.354 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 14.6 p-10 -135.63 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -100.9 19.14 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.765 ' ND2' ' OD2' ' A' ' 133' ' ' ASP . 15.3 m120 -104.67 -25.18 12.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.55 167.6 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.485 ' HB3' ' N ' ' A' ' 110' ' ' SER . 7.7 mt -136.14 -160.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.91 -154.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.9 m -60.34 -38.79 84.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -88.17 -3.53 58.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 138' ' ' ASP . . . 69.71 46.55 53.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.485 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -107.37 134.8 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.996 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.495 ' HB2' ' ND1' ' A' ' 114' ' ' HIS . 36.9 mt -62.97 151.22 86.37 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 89.3 Cg_exo -46.64 -26.46 4.42 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.626 2.217 . . . . 0.0 112.243 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.493 ' CB ' ' HB3' ' A' ' 128' ' ' LEU . 17.7 tt -71.79 -35.78 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.511 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 21.6 m80 -56.34 -37.96 70.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.755 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 115' ' ' LEU . 1.1 mt -69.09 -51.78 35.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . . . -52.83 -32.07 42.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 147' ' ' LEU . 52.7 mt -60.9 -39.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.57 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CD ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -68.19 -17.35 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.525 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.849 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -92.08 -54.69 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.76 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.26 37.15 7.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -65.63 -10.63 37.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.4 OUTLIER 74.86 -68.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.966 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -49.74 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 116' ' ' ALA . 45.8 t -59.59 -59.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 11.4 t -52.34 -46.52 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.313 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 159' ' ' ILE . 73.4 p -69.45 -33.59 73.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.289 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 1.381 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 17.6 t80 -73.3 -40.01 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -62.17 -12.16 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -66.69 -64.59 2.13 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 18.3 Cg_endo -59.17 -35.63 97.29 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.876 2.384 . . . . 0.0 112.445 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 1.381 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mt-10 -90.5 35.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.508 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 92.6 p -151.59 48.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.765 ' OD2' ' ND2' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 36.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 69.8 mt -55.6 141.09 38.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.499 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 7.7 t-80 84.72 -12.56 0.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 137' ' ' ARG . 74.1 t60 -60.49 169.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -119.32 -169.77 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 4.5 m-20 -145.5 171.26 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.411 ' HB1' ' HA3' ' A' ' 109' ' ' GLY . . . -68.54 -6.44 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 p -114.05 0.87 14.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.21 95.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 147' ' ' LEU . 33.9 mt -120.2 77.4 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.076 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 14.2 p -48.27 161.41 0.38 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 160' ' ' LEU . 75.5 Cg_exo -48.28 -37.5 32.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.747 2.298 . . . . 0.0 112.421 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HG ' ' HG3' ' A' ' 161' ' ' GLN . 2.0 tt -71.06 -41.74 70.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.076 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -66.3 -48.54 70.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.19 -39.79 60.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.039 0.447 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 157' ' ' MET . . . -61.23 -45.69 93.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.204 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.431 ' HB2' ' CE ' ' A' ' 157' ' ' MET . 11.0 tpt180 -57.19 -30.5 64.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.29 -75.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.792 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.545 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 17.1 mmm180 -74.56 70.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.46 51.39 0.09 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.334 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 154' ' ' GLN . . . -52.57 -31.19 34.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.473 0.654 . . . . 0.0 109.831 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.526 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 2.9 pm0 173.27 -146.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.182 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 1.205 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 21.5 m120 -74.91 44.53 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -73.58 -31.45 63.61 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.479 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.544 ' N ' HD11 ' A' ' 156' ' ' LEU . 1.1 ptm -67.34 -29.05 68.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.205 ' OD1' ' O ' ' A' ' 155' ' ' ASN . 5.4 p-10 -74.26 -46.58 40.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.245 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -52.16 -39.83 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.198 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.01 -41.56 61.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.11 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HG3' ' HG ' ' A' ' 145' ' ' LEU . 1.9 mt-30 -61.73 -55.37 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.3 95.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.427 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 159' ' ' ILE . 1.1 m-70 -72.98 -10.86 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.978 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.866 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 13' ' ' ARG . 4.7 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -78.37 -10.57 86.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 2.5 p30 -129.12 24.07 5.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.745 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 5.8 ttt180 -103.89 -67.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.39 -39.99 77.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.696 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 1.1 m -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.68 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.03 -36.4 60.72 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.31 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -68.49 -57.17 6.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.95 64.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -73.04 -27.94 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -73.14 -31.7 64.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 83.69 64.92 1.59 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.406 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.399 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 1.2 p30 -137.12 100.94 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' HA ' HG11 ' A' ' 26' ' ' VAL . 2.5 p -52.7 -23.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -73.31 -49.61 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.399 ' OE1' ' CB ' ' A' ' 22' ' ' ASP . 1.8 mt-10 -73.09 -47.24 46.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 23' ' ' VAL . 4.9 p -52.86 -38.1 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 60.2 mtm180 -73.15 -61.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.192 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.459 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -52.94 -31.8 42.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.251 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.555 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -72.9 -69.08 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 61' ' ' GLU . 10.8 mt -70.69 -42.62 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 4.3 t-80 -73.29 -0.51 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.376 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -150.58 -75.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.717 0.294 . . . . 0.0 111.179 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 2.8 tm-20 -41.18 -27.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 29' ' ' LEU . 9.7 mt 54.79 56.04 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 41.0 t -87.28 130.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -48.41 133.7 13.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.9 Cg_endo -71.61 -18.95 28.63 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.767 2.311 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 57.5 p-10 -87.49 1.73 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -45.91 121.83 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -111.34 127.45 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 6.5 m-80 -64.06 -163.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -2.0 49.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.83 -23.13 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . 96.24 29.35 8.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.447 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -105.45 152.92 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.22 168.16 14.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -61.17 -53.8 52.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' SD ' ' A' ' 51' ' ' MET . 3.6 mt -68.17 -27.99 66.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -73.39 -3.66 28.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 47' ' ' ALA . 28.6 m -133.68 -37.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -36.09 137.72 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.901 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.454 ' CE ' ' HA3' ' A' ' 54' ' ' GLY . 12.4 ptm -93.5 123.62 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CD2' ' CD1' ' A' ' 92' ' ' LEU . 60.9 m-85 -56.96 -16.51 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . -36.31 -40.85 0.45 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.255 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -110.94 127.16 27.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.608 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.486 ' N ' ' OG1' ' A' ' 91' ' ' THR . 60.3 Cg_endo -73.6 -32.28 7.88 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.297 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.789 ' HB2' ' OE2' ' A' ' 61' ' ' GLU . . . -63.0 -39.73 95.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 59' ' ' ALA . 19.1 m -62.38 -30.04 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.065 0.46 . . . . 0.0 110.447 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' N ' HG21 ' A' ' 58' ' ' VAL . . . -64.0 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.502 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 6.2 tt -63.24 -32.12 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.789 ' OE2' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -62.91 -54.54 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 6.2 mt -62.69 -46.1 89.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.654 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -63.29 -49.48 73.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HD3' HD23 ' A' ' 60' ' ' LEU . 5.6 ttpp -63.01 -13.1 31.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.089 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -79.0 -34.47 44.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.86 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.16 44.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.74 -171.63 2.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 m -136.47 114.11 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -26.51 20.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.621 2.214 . . . . 0.0 112.348 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.14 75.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 71' ' ' VAL . 4.0 m -137.25 134.2 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -110.95 113.89 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.536 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -86.68 171.19 10.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.704 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 14.3 Cg_endo -56.92 -41.64 73.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.629 2.219 . . . . 0.0 112.07 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 81' ' ' HIS . 2.9 m -56.39 -43.9 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.486 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 79.7 m80 -54.1 -53.43 53.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.505 ' O ' ' CG2' ' A' ' 86' ' ' THR . 2.9 p30 -70.12 -31.17 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.597 ' CB ' ' CD1' ' A' ' 92' ' ' LEU . . . -66.64 -25.8 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.25 -65.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 1.298 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -59.51 -26.3 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 4.1 p -65.9 -37.62 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.094 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.54 66.28 1.29 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.425 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -140.33 49.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.571 HD23 ' CD2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -53.4 -18.82 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.29 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.715 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.4 -70.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.8 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.63 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 13.8 m -71.21 -31.76 67.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.34 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.609 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 1.1 mp -53.7 -52.01 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.111 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.78 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -51.18 -30.93 18.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 62.1 t -74.3 -58.23 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.201 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' A' ' 53' ' ' PHE . 2.3 pp -74.58 -44.1 52.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -66.13 -29.84 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.78 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.21 -27.28 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -73.51 -50.2 22.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -168.15 -70.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.035 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' VAL . . . 24.4 99.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' ALA . 6.2 p-10 -37.52 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -92.68 -6.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.55 2.44 39.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -74.65 171.51 13.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.1 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 111' ' ' LEU . 56.3 mt -136.35 -168.14 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -171.1 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -52.04 -28.25 16.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -10.71 38.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 72.13 9.83 72.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.623 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -77.62 109.79 11.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.768 HD12 ' OD2' ' A' ' 133' ' ' ASP . 6.3 tp -59.78 142.22 88.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 111' ' ' LEU . 90.8 Cg_exo -40.7 -29.13 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.734 2.29 . . . . 0.0 112.352 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.585 ' CG2' ' CD2' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -73.27 -43.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 43.2 m80 -53.59 -37.11 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 112' ' ' PRO . 6.6 mp -57.54 -57.8 11.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.783 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -52.86 -30.23 32.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.524 HG12 ' CG1' ' A' ' 125' ' ' VAL . 77.9 mt -66.46 -38.08 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.516 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HG2' HD22 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -73.18 -15.85 61.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.298 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 2.6 mp0 -94.69 -52.99 4.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 87.39 18.1 57.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.158 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' SER . 92.8 m-70 -35.82 -69.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.545 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 3.1 t 156.63 -92.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -73.34 -14.1 61.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.749 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 116' ' ' ALA . 69.2 t -68.57 -65.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.524 ' CG1' HG12 ' A' ' 117' ' ' ILE . 2.6 t -52.27 -41.18 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.503 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 93.4 p -72.27 -30.87 65.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 1.352 ' CE1' ' OE2' ' A' ' 131' ' ' GLU . 53.2 t80 -73.24 -53.06 11.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.485 HD21 ' CA ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -59.6 -19.48 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -53.93 -70.58 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 38.8 Cg_endo -66.64 -37.6 21.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.7 2.266 . . . . 0.0 112.412 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 1.352 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 23.8 mp0 -65.94 -21.52 66.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.9 m -114.02 148.77 36.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.113 ' OD2' ' ND1' ' A' ' 136' ' ' HIS . 2.2 p30 -38.33 110.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.71 -10.25 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.47 39.68 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.113 ' ND1' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -106.21 138.71 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.985 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.09 163.21 27.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.451 ' OD2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -96.47 160.89 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.66 -15.76 13.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -34.66 21.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.801 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.95 72.09 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.579 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 20.1 mt -151.92 62.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.496 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -40.93 168.21 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.035 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 136' ' ' HIS . 84.2 Cg_exo -44.34 -51.18 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.621 2.214 . . . . 0.0 112.144 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.456 ' CG ' ' HE2' ' A' ' 164' ' ' MET . 1.0 OUTLIER -68.88 -40.29 79.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.496 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -53.03 -63.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.57 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.452 HD22 ' HG2' ' A' ' 118' ' ' ARG . 13.8 tp -56.61 -41.89 77.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.536 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . . . -53.01 -40.25 63.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.06 -40.58 96.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -68.76 -79.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.93 71.78 1.57 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.528 ' CA ' ' HE2' ' A' ' 157' ' ' MET . . . -72.54 42.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.576 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 156' ' ' LEU . . . -52.26 128.96 26.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 31.38 -154.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 20.6 m120 -76.82 42.82 0.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -72.87 -50.48 23.58 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.198 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.528 ' HE2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -52.24 -30.81 29.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.91 0.386 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.2 OUTLIER -74.17 -49.45 23.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -51.77 -59.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.505 ' CD1' HD11 ' A' ' 156' ' ' LEU . 6.4 mp -57.81 -63.63 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 157' ' ' MET . 1.5 pt20 -52.67 -37.1 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -66.13 -49.03 60.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.17 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -18.64 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.65 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.456 ' HE2' ' CG ' ' A' ' 145' ' ' LEU . 6.5 ttm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 7.1 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 12' ' ' ASP . . . -49.86 126.01 20.53 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.405 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 4.6 t0 87.31 5.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 7.0 tpt180 -73.26 -74.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -73.2 -23.84 60.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -65.46 -48.61 72.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -70.33 -31.33 68.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.606 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.553 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . . . -72.68 -64.66 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.53 65.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' A' ' 52' ' ' MET . . . -71.66 -26.09 62.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HD2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.41 -29.42 62.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' ARG . . . 97.8 70.46 1.0 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.807 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.071 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 1.4 p30 -146.03 79.97 1.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.876 0.369 . . . . 0.0 110.508 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 2.2 p -52.61 -20.1 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -72.68 -47.88 43.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.495 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.071 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.34 -39.39 65.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.21 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.4 p -53.41 -36.22 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.854 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 76.5 mtt-85 -73.32 -55.97 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.572 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -66.94 -18.3 65.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.029 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.804 HD22 ' OE1' ' A' ' 33' ' ' GLU . 2.8 mt -65.54 -65.67 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.509 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.767 HD11 ' CD ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -73.54 -38.18 65.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.75 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -72.46 -33.91 67.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.684 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -113.8 -55.46 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.184 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.804 ' OE1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.03 -6.36 27.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER 43.62 27.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 14' ' ' LEU . 9.2 p -53.09 147.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 136.68 39.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HB2' ' CA ' ' A' ' 67' ' ' ALA . 60.6 Cg_endo -73.08 -11.2 25.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.902 2.402 . . . . 0.0 112.471 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -108.58 7.4 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.54 78.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.068 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.9 mp -64.48 148.05 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.4 -154.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -23.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.6 -35.37 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.17 29.28 3.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HE2' ' OE1' ' A' ' 49' ' ' GLN . 48.0 mtpt -95.12 160.14 14.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.318 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.455 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -84.85 150.44 25.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -65.51 -31.74 72.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 12.7 tp -72.31 -47.55 48.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.516 ' HB3' ' CG2' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -63.08 -18.06 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.745 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' MET . 35.5 m -104.36 -34.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.515 ' HE3' ' CD2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -38.7 162.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.517 ' N ' ' HA ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -103.07 139.25 38.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.574 ' CE2' HD23 ' A' ' 95' ' ' LEU . 19.6 m-85 -84.03 10.29 10.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.84 -54.02 38.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.286 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -99.55 134.86 20.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.653 0.263 . . . . 0.0 110.895 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.843 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 11.2 Cg_exo -71.68 -43.84 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.744 2.296 . . . . 0.0 112.172 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -62.75 -27.22 69.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 55' ' ' SER . 4.5 t -62.87 -45.84 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.88 -56.6 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.228 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.493 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 3.3 tt -63.14 -44.67 94.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.413 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.21 ' OE2' ' O ' ' A' ' 26' ' ' VAL . 1.6 tt0 -62.31 -58.51 7.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.493 ' HA ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -63.4 -46.84 84.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' CD2' ' CE1' ' A' ' 98' ' ' HIS . 10.4 tt -62.91 -31.7 72.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 12.3 mttt -63.0 -44.39 96.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.518 ' CG ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -44.01 -25.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 134.68 -11.78 4.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.457 ' CA ' ' HB2' ' A' ' 37' ' ' PRO . . . -37.16 148.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 71' ' ' VAL . 57.8 m -103.82 116.47 61.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 73.9 Cg_endo -75.88 -29.76 6.6 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.75 2.3 . . . . 0.0 112.432 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -73.62 68.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 49' ' ' GLN . 9.7 m -117.19 155.41 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 77' ' ' THR . 4.8 mp0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -89.54 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.901 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 1.134 ' OG ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 178.92 170.79 0.51 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.676 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 3.3 Cg_endo -46.36 -55.02 4.07 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.857 2.371 . . . . 0.0 112.089 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.576 ' CG2' ' CG1' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.43 -39.75 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.039 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 78' ' ' SER . 34.9 m80 -52.86 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.229 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.511 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.4 OUTLIER -67.11 -36.0 80.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.329 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.569 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -26.58 19.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.462 ' HB1' HD13 ' A' ' 115' ' ' LEU . . . -73.71 -62.52 1.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.776 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.93 -25.65 61.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.915 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 12.9 p -56.12 -23.31 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.656 0.265 . . . . 0.0 111.25 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 67.78 65.47 2.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.204 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -155.4 60.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.617 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 127' ' ' PHE . 1.5 tm? -52.06 -19.65 2.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.076 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.338 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -66.82 -66.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 1.338 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 21.8 m -73.09 -34.54 66.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 93' ' ' LYS . 1.6 tt -52.7 -60.89 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.814 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 1.195 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 12.6 ptpt -52.33 -37.66 56.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.053 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.542 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 53.1 t -55.58 -64.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 53' ' ' PHE . 3.9 pp -71.06 -35.53 71.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.524 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 31.2 t -66.39 -42.31 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.195 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -71.63 -22.02 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.754 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.525 ' CE1' ' CD2' ' A' ' 63' ' ' LEU . 58.3 t-80 -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 145.82 -9.46 1.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.843 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . -34.83 114.36 0.22 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.134 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 9.7 p30 -33.48 91.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.576 ' CG1' ' CG2' ' A' ' 80' ' ' VAL . 2.4 m -98.63 -1.39 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.008 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 9.1 m-20 -116.56 20.35 14.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.11 151.11 29.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.521 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -129.16 -159.93 0.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' THR . 0.1 OUTLIER -150.38 86.78 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.44 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 t -43.07 -26.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.67 32.58 61.43 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.41 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.463 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -97.92 102.36 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.013 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.476 HD12 ' CG ' ' A' ' 133' ' ' ASP . 13.3 mt -53.93 146.86 26.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.537 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 94.4 Cg_exo -43.14 -35.18 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 2.3 tt -73.61 -31.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.328 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 21.3 m170 -52.61 -58.39 6.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.737 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -55.14 -50.87 68.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.522 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.522 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -53.81 -37.04 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.617 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.531 ' CG1' ' CG1' ' A' ' 125' ' ' VAL . 73.6 mt -62.32 -41.28 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.447 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.32 -14.78 62.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.539 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 19.8 mt-10 -102.87 -50.57 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.616 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 74.29 31.04 59.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.581 ' CE1' ' HA3' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -34.12 -46.23 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.687 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 5.1 t 155.83 -109.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.528 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 38.7 m -73.88 -14.86 61.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.678 0.275 . . . . 0.0 110.929 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.456 ' O ' HD22 ' A' ' 128' ' ' LEU . 55.2 t -55.07 -67.05 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.531 ' CG1' ' CG1' ' A' ' 117' ' ' ILE . 2.8 t -52.64 -46.44 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.411 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.582 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 6.4 p -73.14 -23.2 60.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 93' ' ' LYS . 15.6 t80 -73.52 -65.74 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -75.18 26.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -64.24 -56.49 23.29 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 110.669 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 129' ' ' ALA . 73.1 Cg_endo -76.63 -34.71 2.39 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.73 2.287 . . . . 0.0 111.894 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 4.8 mm-40 -54.49 -24.94 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 3.5 m -114.86 146.93 40.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.476 ' CG ' HD12 ' A' ' 111' ' ' LEU . 1.8 p-10 -37.48 105.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 164' ' ' MET . 7.5 mt -83.72 63.98 7.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' HIS . 41.0 t-80 -176.87 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.774 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 56.4 t60 -39.58 161.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.819 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -141.23 156.34 45.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.463 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 2.5 t0 -60.92 153.83 23.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.6 -16.89 11.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.626 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -48.99 28.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 131.3 54.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.579 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 20.7 mt -152.3 125.89 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.468 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -100.68 178.35 1.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.751 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 88.9 Cg_exo -46.93 -57.33 2.36 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.766 2.31 . . . . 0.0 112.361 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -71.13 -36.87 72.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.27 -53.09 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.5 OUTLIER -52.47 -40.1 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.538 ' HB2' ' CA ' ' A' ' 157' ' ' MET . . . -59.67 -40.57 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -36.05 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.062 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.7 tp-100 -67.43 -76.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.76 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.528 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 1.5 mpt_? -74.25 70.15 1.62 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -69.79 49.67 0.66 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.019 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 154' ' ' GLN . . . -43.96 -27.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 0.0 110.178 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.514 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER 168.96 -132.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.441 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.542 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 44.1 m-20 -75.46 42.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.96 -0.463 . . . . 0.0 111.602 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.514 ' HG ' ' NE2' ' A' ' 154' ' ' GLN . 3.6 mt -62.56 -69.16 0.27 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.771 0.319 . . . . 0.0 111.437 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.538 ' CA ' ' HB2' ' A' ' 148' ' ' ALA . 10.0 ptm -52.36 -21.82 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.073 ' OD1' HG13 ' A' ' 159' ' ' ILE . 31.9 p30 -73.93 -51.04 17.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.418 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.073 HG13 ' OD1' ' A' ' 158' ' ' ASP . 1.5 mt -61.71 -24.12 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.375 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.04 -34.24 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -31.46 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.92 18.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -70.12 -16.25 63.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.483 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 8.5 mtp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.039 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 8.2 p . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -61.98 -57.3 17.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.47 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 53.2 p30 -85.56 13.52 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -82.33 -66.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' CD2' ' O ' ' A' ' 36' ' ' HIS . 2.5 tp -72.15 -44.44 63.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -56.78 -32.52 65.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.829 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -72.69 -46.38 31.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.469 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.59 38.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.65 79.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.3 -22.75 61.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.202 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -73.14 -43.23 61.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.62 70.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.542 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p30 -139.0 103.65 4.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.494 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.04 -23.01 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.55 -51.45 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 60.0 mm-40 -68.49 -44.77 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.201 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 12.8 p -52.68 -49.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 70.5 mtt-85 -69.79 -54.57 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 8.7 mtm180 -61.31 -24.13 66.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -73.24 -71.48 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.54 -43.77 59.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -71.75 -1.85 15.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.517 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -147.5 -75.56 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 1.333 ' OE1' ' CG2' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -47.46 -23.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.4 mt 56.04 37.71 29.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 1.333 ' CG2' ' OE1' ' A' ' 33' ' ' GLU . 1.6 t -66.16 140.59 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.997 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -60.69 139.92 93.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.8 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HG3' ' N ' ' A' ' 66' ' ' GLY . 33.0 Cg_endo -64.25 -18.58 63.81 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.729 2.286 . . . . 0.0 112.113 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.997 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 16.7 p-10 -87.94 -81.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.882 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 40.39 95.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 3.6 mp -91.21 131.87 36.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.985 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p30 -65.78 169.75 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.76 -38.98 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.67 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.27 28.11 2.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 2.9 mttp -98.87 157.02 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 1.1 p -85.03 150.64 24.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -62.17 -35.29 78.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.509 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 8.6 tp -71.46 -43.91 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.022 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HB2' ' OG1' ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.1 -5.31 26.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 46' ' ' THR . 15.9 m -125.78 -17.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.577 ' HE3' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -51.28 151.83 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.181 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -92.36 130.24 38.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.896 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CZ ' ' HE3' ' A' ' 51' ' ' MET . 10.3 m-85 -85.5 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.506 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -89.04 -39.13 6.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.908 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 91' ' ' THR . 1.8 t -114.88 135.4 22.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.247 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.73 -34.26 19.2 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.649 2.233 . . . . 0.0 112.062 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.16 -28.0 69.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.529 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 2.7 t -63.44 -50.78 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 91' ' ' THR . . . -63.23 -50.41 70.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.806 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.512 ' CD2' ' HG3' ' A' ' 64' ' ' LYS . 9.7 tt -63.24 -38.01 89.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 1.3 mp0 -62.92 -56.23 19.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.249 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 4.4 mp -62.73 -46.89 85.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -63.07 -40.24 97.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HG3' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -62.94 -32.99 74.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.03 -57.54 5.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.445 ' N ' ' HG3' ' A' ' 37' ' ' PRO . . . 163.89 36.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 37' ' ' PRO . . . -97.14 106.09 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.968 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -63.34 119.67 55.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 29.2 Cg_endo -63.21 -15.62 49.32 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.727 2.284 . . . . 0.0 112.224 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.551 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 37.1 m-80 -95.22 93.56 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.35 159.12 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.474 HG21 ' CB ' ' A' ' 81' ' ' HIS . 34.9 m -128.61 137.51 51.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.805 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.82 179.23 1.16 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.572 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 42.2 Cg_exo -56.06 -32.68 87.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.824 2.349 . . . . 0.0 112.307 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 96' ' ' VAL . 9.6 t -68.25 -28.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.474 ' CB ' HG21 ' A' ' 77' ' ' THR . 35.6 m80 -63.44 -67.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' A' ' 53' ' ' PHE . 2.5 p30 -53.01 -48.65 67.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -19.33 3.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 81' ' ' HIS . . . -72.52 -65.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.328 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HD3' HD11 ' A' ' 115' ' ' LEU . 11.3 mtm180 -73.07 -37.72 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 60.2 p -54.33 -17.75 3.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 67.02 66.76 2.24 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.006 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 22.7 m-85 -135.62 49.38 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 123' ' ' SER . 19.9 tp -55.11 -15.28 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.781 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -74.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.67 0.271 . . . . 0.0 110.729 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 59' ' ' ALA . 24.8 m -69.8 -33.44 72.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.376 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 2.3 tt -53.28 -46.36 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -56.39 -37.19 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.216 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.783 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 74.2 t -52.84 -63.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.734 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.66 -36.47 67.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 111.152 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.514 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 3.8 t -68.99 -46.54 78.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.29 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.783 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 10.6 pm0 -59.04 -33.77 71.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.054 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -39.28 93.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.21 36.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' PRO . . . -63.63 -177.74 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -75.32 74.52 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.416 HG12 HG11 ' A' ' 96' ' ' VAL . 13.0 m -91.78 19.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -130.71 5.37 4.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.23 155.49 22.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -129.11 144.37 51.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -84.77 -176.68 6.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.21 -53.29 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.8 p -61.31 -24.3 66.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 84.35 -10.32 61.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.73 117.99 3.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD2' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -56.35 130.64 75.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 82.9 Cg_exo -44.11 -31.67 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.54 ' CD1' ' N ' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -73.52 -42.72 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.574 ' CE1' ' OD2' ' A' ' 138' ' ' ASP . 9.5 m80 -52.91 -27.36 18.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.513 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.85 -53.03 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.523 ' CB ' HG11 ' A' ' 125' ' ' VAL . . . -52.64 -43.17 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 110.352 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.451 HG21 HD12 ' A' ' 156' ' ' LEU . 50.5 mt -57.57 -42.32 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.782 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -71.11 -15.66 62.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -90.64 -55.39 3.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.639 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.67 12.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.526 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.468 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 97.1 m-70 -56.01 -18.15 8.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.79 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 71.75 -63.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.522 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 12.1 m -69.55 -38.97 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.069 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 39.7 t -73.39 -54.91 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 126' ' ' SER . 3.5 m -52.8 -47.03 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 5.6 t -71.53 -34.15 69.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 1.194 ' CD2' ' OE1' ' A' ' 131' ' ' GLU . 45.1 t80 -73.36 -39.6 65.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -67.36 -25.66 66.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 113' ' ' ILE . . . -56.93 -62.12 5.72 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.498 ' CD ' ' O ' ' A' ' 126' ' ' SER . 44.2 Cg_endo -68.15 -48.83 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.79 2.327 . . . . 0.0 112.62 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 1.194 ' OE1' ' CD2' ' A' ' 127' ' ' PHE . 0.5 OUTLIER -58.07 -29.51 65.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.732 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.2 m -107.77 154.46 21.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.935 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.5 p-10 -41.76 113.85 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 129' ' ' ALA . 8.1 mt -85.08 43.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.976 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.05 33.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.422 ' HB3' HD12 ' A' ' 111' ' ' LEU . 50.8 t60 -107.18 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -126.31 -156.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER 177.15 155.59 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.574 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -37.7 -30.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.508 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -60.42 -44.87 95.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.869 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 84.28 25.52 43.5 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.469 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -133.51 80.44 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.371 . . . . 0.0 111.015 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 1.6 p -42.48 169.12 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 91.0 Cg_exo -43.66 -44.76 11.15 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.289 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.405 ' O ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -72.84 -42.92 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.498 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.496 ' HB3' ' CA ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -52.52 -64.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.427 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 114' ' ' HIS . 0.3 OUTLIER -52.72 -34.96 54.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -60.82 -31.31 70.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -45.02 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.491 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -69.85 -89.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.171 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.533 ' N ' ' CG ' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -75.62 51.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.085 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -61.74 -9.18 18.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.136 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 156' ' ' LEU . . . 47.38 -86.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -125.47 -136.79 0.27 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 1.229 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 12.5 p30 -74.37 14.37 0.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.153 -0.342 . . . . 0.0 111.267 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.566 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 0.2 OUTLIER -51.82 -45.68 64.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.67 0.272 . . . . 0.0 111.331 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 3.3 ptm -57.09 -30.15 64.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.37 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD2' ' HB2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -73.55 -47.12 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.931 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -52.0 -49.3 38.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.515 ' CD1' ' O ' ' A' ' 156' ' ' LEU . 5.3 mp -73.46 -26.74 61.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -64.46 -63.8 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.08 -31.59 79.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.646 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 1.2 m-70 -66.24 -39.57 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.954 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.468 ' HA ' HD12 ' A' ' 134' ' ' LEU . 2.6 ptm . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 13' ' ' ARG . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -54.57 -44.44 78.61 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.12 5.33 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -78.87 -62.5 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 ' HB1' ' A' ' 47' ' ' ALA . 2.8 tm? -71.17 -33.22 69.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.514 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 25.4 t -67.79 -50.12 58.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -57.1 -26.97 56.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.205 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.23 -67.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.021 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.472 ' HB2' ' CG ' ' A' ' 51' ' ' MET . . . -53.04 -54.58 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . . . -53.43 -29.16 33.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 18.0 mtt180 -73.92 -37.62 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . 93.64 66.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.577 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.688 ' OD1' ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -138.66 97.13 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.831 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' HG11 ' A' ' 26' ' ' VAL . 2.3 p -57.29 -18.43 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.0 -46.47 43.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.3 -34.41 65.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.8 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 1.1 p -52.57 -48.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.744 0.307 . . . . 0.0 111.212 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.99 -56.33 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.64 -48.14 66.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.445 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 52.7 mt -52.72 -55.84 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.214 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 61' ' ' GLU . 84.5 mt -73.95 -55.8 5.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.17 4.0 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -146.19 -70.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 1.25 ' OE1' HG21 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.79 -16.47 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.5 mt 45.37 45.01 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.671 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 1.25 HG21 ' OE1' ' A' ' 33' ' ' GLU . 2.8 t -72.29 153.74 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 1.016 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 1.3 t-80 -63.59 138.12 97.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.6 Cg_endo -71.23 -37.7 5.61 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 1.016 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -92.26 31.35 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.076 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -65.71 118.44 9.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -120.3 125.02 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -60.95 -178.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -41.59 -46.1 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -48.15 -62.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.02 24.09 1.9 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.61 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -109.39 163.17 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.755 0.312 . . . . 0.0 110.714 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 49' ' ' GLN . 17.0 p -84.87 152.14 23.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -52.92 -26.09 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' CD2' ' CE ' ' A' ' 51' ' ' MET . 7.0 mt -73.26 -41.82 63.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HG3' ' OG1' ' A' ' 46' ' ' THR . 0.0 OUTLIER -73.17 -7.48 51.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.228 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 24.2 m -136.05 24.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.585 ' CE ' ' CD2' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -70.59 -177.95 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 0.0 110.708 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 1.1 ttp -114.31 -11.09 12.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.618 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 12.1 m-85 50.35 21.0 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.88 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.48 -55.2 7.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.69 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 2.4 t -100.41 137.91 20.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 0.0 110.198 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 40.8 Cg_endo -67.87 -50.29 0.88 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.34 -18.72 63.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.166 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.53 ' CG2' ' HB3' ' A' ' 55' ' ' SER . 2.1 t -63.06 -55.62 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.25 -37.87 88.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 25.0 tp -63.19 -51.33 66.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 13.7 mm-40 -62.75 -53.66 50.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.505 ' HG ' ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -62.63 -51.84 65.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.179 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -63.94 -50.5 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.958 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.575 ' N ' ' CD1' ' A' ' 63' ' ' LEU . 7.2 tttt -65.24 56.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.052 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LEU . 6.7 tp60 -154.42 -39.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.046 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.47 38.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.769 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 63' ' ' LEU . . . -100.13 -0.07 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.121 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.473 ' O ' ' CG1' ' A' ' 71' ' ' VAL . 2.8 m 43.88 83.02 0.22 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.979 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.48 -30.35 15.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.766 2.311 . . . . 0.0 112.238 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 91.8 m-20 -79.51 75.15 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 68' ' ' SER . 20.3 m -116.58 150.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.76 43.67 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -53.14 160.77 1.49 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.997 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.93 -32.51 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.0 2.467 . . . . 0.0 111.888 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 112' ' ' PRO . 0.5 OUTLIER -52.83 -45.33 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.902 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.498 ' NE2' ' O ' ' A' ' 105' ' ' LEU . 39.8 m80 -73.12 -38.72 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.1 OUTLIER -69.71 -67.42 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.319 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -52.64 -19.18 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 80' ' ' VAL . . . -72.8 -63.02 1.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.42 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 1.048 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 15.6 ptt85 -70.17 -18.26 63.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.392 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 82.6 p -68.07 -51.94 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.207 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.01 67.52 0.41 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -152.95 57.32 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.538 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.553 HD12 ' CG ' ' A' ' 127' ' ' PHE . 24.7 tp -58.65 -13.66 6.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.407 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -67.61 -73.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 53' ' ' PHE . 19.4 m -68.95 -35.86 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.524 ' HG ' ' CG2' ' A' ' 96' ' ' VAL . 29.9 tp -52.69 -49.44 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.449 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 127' ' ' PHE . 2.6 ttmt -52.66 -44.67 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.842 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.4 t -53.26 -59.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.132 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -72.58 -39.64 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.524 ' CG2' ' HG ' ' A' ' 92' ' ' LEU . 20.4 t -67.0 -43.85 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.4 pt-20 -68.33 -43.1 78.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -55.17 -23.87 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.14 50.57 0.3 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.577 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 96' ' ' VAL . . . -85.76 56.32 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 111.141 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 5.5 t0 37.32 52.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.83 -0.95 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.239 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 36.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -117.09 -178.61 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.516 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 26.0 mt -125.17 -152.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 110' ' ' SER . 2.0 p30 -145.29 -163.25 1.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.761 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 m -54.12 -28.96 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.34 28.61 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' A' ' 139' ' ' ALA . . . 42.91 40.11 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.542 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 40.7 m -113.51 133.84 55.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 136' ' ' HIS . 0.3 OUTLIER -68.97 162.83 61.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 80' ' ' VAL . 52.6 Cg_exo -55.35 -25.67 48.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.825 2.35 . . . . 0.0 112.073 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 128' ' ' LEU . 2.5 tp -70.82 -33.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.516 ' CE1' ' HB3' ' A' ' 138' ' ' ASP . 15.6 m170 -70.47 -30.22 66.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.633 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.88 -54.1 15.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 1.351 ' CA ' ' OE2' ' A' ' 119' ' ' GLU . . . -52.6 -37.53 58.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.519 ' N ' HG13 ' A' ' 125' ' ' VAL . 76.4 mt -56.62 -36.92 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -66.04 -33.52 75.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.002 0.43 . . . . 0.0 110.53 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.351 ' OE2' ' CA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -82.4 -53.64 5.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.804 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.95 27.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.84 ' CD2' ' OE1' ' A' ' 119' ' ' GLU . 94.4 m-70 -47.69 -23.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 80.23 -62.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 89' ' ' LEU . 7.9 m -70.17 -33.11 71.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.509 HG13 ' CB ' ' A' ' 116' ' ' ALA . 24.1 t -73.73 -57.01 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.002 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 117' ' ' ILE . 2.2 m -52.57 -60.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.532 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 10.2 t -54.99 -29.02 56.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 110.854 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 26.0 t80 -73.22 -53.92 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -63.38 -11.83 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.581 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -59.69 -69.54 0.53 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.204 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.581 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 56.5 Cg_endo -70.2 -31.86 17.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 5.4 mm-40 -61.9 -13.86 28.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.425 ' HB3' HD21 ' A' ' 111' ' ' LEU . 10.0 m -121.75 143.57 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.801 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 p30 -39.24 98.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 164' ' ' MET . 20.2 mt -67.17 66.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.017 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -177.77 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.552 ' CD2' HD12 ' A' ' 111' ' ' LEU . 1.5 p-80 -53.58 179.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.25 -165.51 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -128.9 178.08 6.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.055 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.462 ' CB ' ' HA3' ' A' ' 109' ' ' GLY . . . -71.0 -8.66 54.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.6 p -105.96 -9.66 16.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' A' ' 142' ' ' LEU . . . 72.73 59.07 4.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.503 ' CD2' ' O ' ' A' ' 141' ' ' GLY . 62.0 mt -154.61 86.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -71.28 -174.18 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.891 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 87.1 Cg_exo -47.43 -61.5 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.659 2.24 . . . . 0.0 112.473 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.466 ' HB2' ' HE2' ' A' ' 164' ' ' MET . 6.6 tp -63.81 -32.59 74.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.506 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -67.29 -70.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 114' ' ' HIS . 11.4 tp -52.75 -45.62 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.424 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.505 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -55.45 -38.23 68.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -65.75 -41.78 91.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.109 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -64.06 -78.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.883 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 4.7 mtp180 -74.05 58.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.09 54.09 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.695 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -34.61 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 0.0 110.851 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 173.83 -114.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.376 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.538 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.5 m-20 -74.31 5.55 4.44 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.198 -0.314 . . . . 0.0 111.594 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 125' ' ' VAL . 1.0 OUTLIER -51.15 -59.33 4.3 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.708 0.289 . . . . 0.0 111.298 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -52.26 -32.08 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -55.57 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -51.9 -35.2 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.678 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.91 -33.6 64.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.43 -51.13 18.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.257 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.56 97.3 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 126' ' ' SER . 3.0 m-70 -61.14 -30.13 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.692 0.282 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.523 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 2.7 mtt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.864 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -65.82 -40.05 95.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.698 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -101.43 40.65 1.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.562 ' NH1' ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -112.44 -71.48 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.807 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD21 ' CD2' ' A' ' 30' ' ' LEU . 26.4 tp -70.92 -26.81 63.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 1.2 t -61.35 -40.8 95.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.63 -35.08 59.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.533 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -66.91 -62.77 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 62' ' ' LEU . . . -54.09 -43.55 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -72.43 -22.42 61.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mtt180 -73.09 -36.19 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.892 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 97.41 63.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p30 -142.29 91.66 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 23' ' ' VAL . 13.2 p -52.75 -21.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.517 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 62.7 mt-30 -72.44 -47.35 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.517 ' OE2' ' HB2' ' A' ' 24' ' ' GLN . 1.5 mp0 -68.67 -41.02 79.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.499 HG13 ' CD ' ' A' ' 61' ' ' GLU . 55.5 t -53.87 -53.38 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 69.7 mtt180 -61.5 -60.13 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.9 mmt-85 -54.92 -29.27 55.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.584 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.52 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 17.7 mt -73.42 -72.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 41.1 mt -73.48 -43.11 60.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.513 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -72.6 -11.93 60.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.285 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.41 -78.16 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' OE2' ' NH1' ' A' ' 13' ' ' ARG . 1.4 tm-20 -39.94 -28.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.034 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LEU . 3.7 mt 62.71 46.21 5.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG22 HD21 ' A' ' 29' ' ' LEU . 25.0 t -77.87 155.23 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 134.77 65.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 65' ' ' GLN . 69.3 Cg_endo -74.58 -6.91 18.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.81 2.34 . . . . 0.0 112.248 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -103.03 13.58 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -57.08 127.67 33.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.9 OUTLIER -120.65 130.07 53.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -52.2 -55.94 17.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.69 -52.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -35.47 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.85 30.16 1.17 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -98.2 151.81 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 p -94.51 154.96 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 15' ' ' SER . . . -58.39 -26.46 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.035 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.0 mt -71.99 -42.7 66.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.451 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.3 tm0? -60.07 -53.6 55.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 7.2 m -64.5 -23.32 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.2 ttp -39.18 154.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.512 ' CE ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -116.24 21.44 13.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 0.7 OUTLIER 36.21 34.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . -71.0 -81.84 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.383 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 56.5 m -86.28 119.74 71.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 1.336 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 81.8 Cg_exo -43.99 -39.61 11.28 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 1.122 ' O ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.29 -22.32 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.451 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.521 HG23 ' CG2' ' A' ' 26' ' ' VAL . 37.3 t -63.05 -54.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -63.1 -32.93 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.03 -42.69 99.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.037 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.499 ' CD ' HG13 ' A' ' 26' ' ' VAL . 1.2 mt-10 -63.1 -51.49 66.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.207 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 18' ' ' ALA . 5.8 mp -62.5 -46.2 89.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -62.91 -56.17 19.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.731 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -63.21 -11.71 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.1 mm-40 -81.56 -35.11 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.16 22.85 2.07 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.592 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 48' ' ' LEU . . . -81.29 154.46 26.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.051 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -108.16 98.94 29.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -68.41 -10.31 28.61 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.652 2.235 . . . . 0.0 112.239 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.59 56.93 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 m -125.92 158.82 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.872 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.784 HG22 ' OD2' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -128.76 112.37 14.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.846 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -82.08 -177.84 1.05 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.783 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 52.3 Cg_exo -54.07 -46.32 34.42 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.318 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 m -52.98 -39.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.506 ' NE2' ' O ' ' A' ' 104' ' ' ALA . 73.0 m80 -53.4 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.783 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 5.0 p30 -53.11 -44.52 67.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -55.83 -48.29 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.39 92.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.505 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -73.24 -33.13 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.7 p -73.45 -78.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.76 68.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 35.8 m-85 -139.27 51.49 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.591 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 16.0 tp -52.5 -18.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.286 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.336 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -73.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.568 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 1.124 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -73.39 -30.29 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 2.5 tt -59.08 -34.83 72.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.049 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.561 ' HE2' ' CD1' ' A' ' 127' ' ' PHE . 4.0 mttt -67.73 -53.18 29.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 2.7 m -52.71 -48.17 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.37 -51.37 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.518 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 55.1 t -67.37 -51.12 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.844 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.905 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 5.0 pm0 -52.58 -30.47 31.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.814 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.497 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER -73.08 -36.34 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.23 65.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.64 18.97 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.024 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 61.7 72.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.446 HG23 ' OE1' ' A' ' 131' ' ' GLU . 4.1 m -89.17 13.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.048 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.69 38.87 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.506 ' O ' ' NE2' ' A' ' 81' ' ' HIS . . . -136.08 131.82 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.272 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -100.4 -176.88 3.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.882 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.872 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 0.9 OUTLIER -99.42 40.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER 76.73 12.51 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 110' ' ' SER . 8.7 t -115.9 8.83 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 61.75 14.84 45.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB2' HG22 ' A' ' 108' ' ' THR . 34.1 m -98.67 91.91 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 1.054 HD23 ' OD1' ' A' ' 133' ' ' ASP . 35.0 mt -51.52 146.17 13.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 85.1 Cg_exo -47.41 -39.73 28.44 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.726 2.284 . . . . 0.0 112.55 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -61.41 -32.35 53.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.893 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.555 ' CG ' ' OD1' ' A' ' 138' ' ' ASP . 15.9 m170 -66.7 -29.83 69.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -47.38 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 125' ' ' VAL . . . -52.73 -45.12 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.33 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 89.4 mt -53.18 -39.46 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HD2' ' CD ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -61.96 -20.81 64.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.015 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -112.37 -42.0 3.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.528 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.59 84.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.99 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 10.9 m-70 -38.49 102.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' HIS . 3.0 m 35.63 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.999 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.39 10.36 1.33 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 59.4 t -56.09 -53.93 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.008 0.432 . . . . 0.0 110.229 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -52.64 -41.37 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.608 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 15.7 p -66.69 -34.76 78.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.561 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 14.3 t80 -72.86 -48.56 36.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.418 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.501 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.538 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -55.09 -66.48 0.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 66.6 Cg_endo -75.21 -52.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.656 2.237 . . . . 0.0 112.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -49.15 -23.74 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.541 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 128' ' ' LEU . 9.3 t -93.83 -153.54 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.054 ' OD1' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.41 56.33 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.874 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.94 88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 17.6 t60 155.42 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.466 ' O ' HG21 ' A' ' 143' ' ' THR . 13.6 t60 -65.27 164.04 14.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.507 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -134.6 127.45 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.555 ' OD1' ' CG ' ' A' ' 114' ' ' HIS . 1.1 m-20 -50.2 155.27 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.19 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 110.318 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -67.53 -48.73 66.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 116.58 57.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.554 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.457 ' HA ' ' CD ' ' A' ' 146' ' ' GLU . 1.1 mt -144.65 104.21 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.144 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -66.11 171.5 3.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 82.5 Cg_exo -43.6 -43.0 11.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.534 2.156 . . . . 0.0 112.021 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.26 -34.62 65.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.144 ' OE1' ' N ' ' A' ' 143' ' ' THR . 5.4 mt-10 -61.84 -61.77 2.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.53 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.7 OUTLIER -52.7 -36.52 57.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.54 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.524 ' O ' ' CA ' ' A' ' 152' ' ' GLY . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.283 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -73.17 -45.41 56.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -73.11 -92.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.244 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' HD2' ' A' ' 118' ' ' ARG . 16.2 mtt-85 -76.56 45.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -53.29 -17.89 6.24 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.49 ' HB2' ' NE2' ' A' ' 154' ' ' GLN . . . 64.18 -64.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -154.4 -138.37 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.019 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 10.4 m120 -74.16 9.85 1.46 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.226 -0.296 . . . . 0.0 111.391 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.536 ' CD1' ' C ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -51.82 -34.87 42.21 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.846 0.355 . . . . 0.0 111.281 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.499 ' CB ' ' HB2' ' A' ' 148' ' ' ALA . 2.5 ppp? -52.44 -28.39 19.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.059 0.457 . . . . 0.0 110.081 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.06 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 3.4 p30 -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.06 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -51.65 -44.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.291 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.525 ' CD1' HG12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -73.56 -16.08 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 111.035 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -55.08 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.33 -43.4 96.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' LEU . 2.1 m-70 -70.31 -11.79 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.524 ' CG1' ' CG2' ' A' ' 35' ' ' VAL . 36.5 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.865 0.364 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -48.58 -21.72 2.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.569 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 29.4 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.78 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 1.7 ttm105 -109.82 -74.94 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CB ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -70.92 -35.18 72.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.427 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.24 -40.55 82.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.598 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -73.13 -40.42 50.53 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -67.79 -47.05 70.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 62' ' ' LEU . . . -52.82 -41.71 64.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -18.6 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 1.7 mtt180 -73.17 -28.06 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.72 65.03 1.96 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.615 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.115 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -133.12 92.46 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.635 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 10.7 p -52.58 -20.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.412 ' N ' HG11 ' A' ' 23' ' ' VAL . 1.1 mm-40 -73.81 -56.33 5.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.938 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.115 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.48 -30.26 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.629 -179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 2.4 p -52.85 -45.36 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.744 0.306 . . . . 0.0 111.407 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -73.56 -46.35 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 4.7 mmm180 -53.51 -32.71 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HB3' HG13 ' A' ' 35' ' ' VAL . 10.4 mt -73.42 -72.39 0.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.417 ' HG ' ' CG1' ' A' ' 35' ' ' VAL . 5.5 mt -73.4 -45.71 53.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.686 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -70.06 -13.39 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.691 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -134.05 -75.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.199 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.78 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 2.5 tt0 -43.99 -25.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.2 mp 72.46 13.08 5.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.4 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG23 ' CB ' ' A' ' 14' ' ' LEU . 3.3 p -44.75 158.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.407 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -94.81 141.27 23.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.52 -23.27 27.53 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.744 2.296 . . . . 0.0 112.201 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.71 37.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.547 ' HB3' ' CD2' ' A' ' 36' ' ' HIS . . . -79.01 127.55 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 6.3 mp -122.55 133.66 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 111.454 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -62.57 -168.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' CD ' ' C ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -70.32 -4.98 24.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -98.95 -69.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.413 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . 146.74 67.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 19.1 mtpt -142.41 146.65 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.6 p -84.54 152.61 23.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' CB ' HD22 ' A' ' 62' ' ' LEU . . . -52.75 -54.89 27.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD13 ' CE ' ' A' ' 51' ' ' MET . 7.3 tp -53.05 -30.53 36.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.639 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.436 ' HB2' HG22 ' A' ' 71' ' ' VAL . 3.3 tt0 -73.2 -34.61 66.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -91.42 -25.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.512 ' CE ' HD13 ' A' ' 48' ' ' LEU . 1.4 mtp -36.35 137.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 3.6 ptt? -96.42 10.11 39.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 4.4 m-85 47.38 23.54 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -62.43 -56.02 24.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.312 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -98.04 146.15 31.01 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.788 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 1.228 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.3 Cg_endo -79.67 -42.15 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.834 2.356 . . . . 0.0 112.555 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.14 72.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 55' ' ' SER . 11.4 m -62.64 -30.79 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -62.94 -43.16 99.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.986 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -63.31 -34.53 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.217 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -63.04 -67.89 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 47' ' ' ALA . 6.3 mp -62.32 -35.41 78.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.088 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 7.6 tp -62.95 -63.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.444 ' HB2' HD12 ' A' ' 60' ' ' LEU . 5.1 ttmm -62.93 -17.3 61.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -60.22 -52.86 63.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.63 -13.49 2.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.05 98.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.322 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.16 121.57 2.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.95 -21.45 24.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.733 2.289 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.202 ' CA ' ' OD2' ' A' ' 101' ' ' ASP . 1.4 m120 -81.47 86.11 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' VAL . 27.2 m -135.74 133.61 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.31 129.51 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.36 171.52 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.853 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 50.8 Cg_exo -53.86 -32.14 65.7 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.767 2.311 . . . . 0.0 112.336 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.487 ' CG1' ' CB ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -64.31 -36.53 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -64.47 -47.93 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.853 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.9 p30 -60.3 -51.66 68.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.635 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -51.97 -29.61 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -73.33 -65.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.477 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.489 ' NE ' ' HB3' ' A' ' 115' ' ' LEU . 7.2 mtp180 -64.68 -29.41 70.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 61.6 p -73.29 0.3 12.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.549 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 52.76 80.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.098 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.474 ' O ' HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -154.12 60.48 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.856 0.36 . . . . 0.0 110.433 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 3.2 tm? -52.15 -19.05 1.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.267 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.228 ' OD1' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -56.2 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.382 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -73.4 -8.92 57.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.127 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . 5.6 mp -73.0 -64.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HA ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -57.06 -24.03 50.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.77 -82.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.09 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -76.11 -44.83 36.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.079 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.523 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 94.3 t -67.77 -3.3 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.201 ' HA ' ' OE2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -73.1 -43.23 62.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -64.57 -37.77 88.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 101' ' ' ASP . . . 146.96 -49.97 0.61 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.487 ' CB ' ' CG1' ' A' ' 80' ' ' VAL . . . 36.21 31.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.202 ' OD2' ' CA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 71.52 56.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.45 HG23 ' HA2' ' A' ' 99' ' ' GLY . 5.0 m -79.95 1.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -116.0 40.67 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.956 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.51 166.93 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.64 160.61 41.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 3.5 p30 -84.83 79.06 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 1.1 p 84.13 -54.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER -174.38 32.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.765 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . -76.83 -3.35 79.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.542 ' OG ' ' CG ' ' A' ' 114' ' ' HIS . 0.6 OUTLIER 85.4 159.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.3 OUTLIER -45.18 158.86 0.29 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 50.9 Cg_exo -53.86 -38.47 85.78 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.645 2.23 . . . . 0.0 112.223 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -58.33 -41.43 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.542 ' CG ' ' OG ' ' A' ' 110' ' ' SER . 57.3 m80 -52.96 -31.73 42.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.681 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' HB3' ' NE ' ' A' ' 85' ' ' ARG . 12.6 mt -73.17 -53.77 10.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 1.355 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -54.25 -33.09 57.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.342 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 147' ' ' LEU . 81.8 mt -61.41 -40.51 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -64.38 -21.35 66.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.355 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 1.9 mp0 -94.7 -51.65 4.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.84 22.79 35.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.514 ' O ' ' CB ' ' A' ' 122' ' ' SER . 99.0 m-70 -46.41 -24.85 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER 84.97 -60.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.836 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -73.1 -42.16 63.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.046 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.474 HG11 ' CB ' ' A' ' 116' ' ' ALA . 49.0 t -67.08 -60.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.514 HG21 ' CB ' ' A' ' 116' ' ' ALA . 2.7 t -52.69 -57.14 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 88.8 p -52.73 -37.15 58.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 92' ' ' LEU . 51.6 t80 -71.91 -55.1 8.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -62.41 -19.33 63.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.579 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -52.98 -69.51 0.33 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 55.0 Cg_endo -69.6 -25.32 29.44 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 1.201 ' OE2' ' HA ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -89.55 36.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -169.7 134.88 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.818 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.266 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 2.9 p-10 -35.74 97.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 129' ' ' ALA . 2.8 mp -72.91 56.36 0.42 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.03 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 -39.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.138 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.266 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -56.83 142.67 40.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.019 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 167.88 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -75.14 166.89 22.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.48 -21.92 2.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.324 0.583 . . . . 0.0 110.141 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -59.0 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.91 40.8 0.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.253 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 2.4 mt -122.91 125.22 44.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -98.11 -174.53 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 72.8 Cg_exo -49.31 -56.84 2.77 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.694 2.263 . . . . 0.0 112.401 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 149' ' ' ARG . 13.8 tp -69.31 -40.38 77.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.046 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.08 -65.7 0.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.93 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.488 ' CD2' HG23 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -53.12 -39.45 63.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 160' ' ' LEU . . . -73.13 -27.3 61.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.7 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -68.55 -47.64 66.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.97 -74.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.968 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -74.55 56.56 0.69 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.02 55.4 0.8 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.139 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.512 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -31.44 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.99 0.424 . . . . 0.0 110.979 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.561 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 174.43 -114.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.42 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 1.266 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 8.0 m-80 -75.35 6.92 3.95 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.291 -0.255 . . . . 0.0 111.438 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 159' ' ' ILE . 1.3 mt -51.11 -64.39 0.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.445 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.474 ' CE ' HD13 ' A' ' 145' ' ' LEU . 4.3 ptm -52.89 -29.26 27.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.266 ' OD2' ' HA ' ' A' ' 155' ' ' ASN . 0.4 OUTLIER -74.59 -51.52 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.01 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -51.68 -42.35 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.22 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -74.63 -44.83 48.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.187 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 164' ' ' MET . 4.0 mt-30 -53.61 -50.56 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.286 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.22 98.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.523 ' CD2' ' HG3' ' A' ' 130' ' ' PRO . 2.0 m-70 -73.23 -7.1 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.861 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 39' ' ' ALA . . . -47.24 -34.74 8.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.35 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.776 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.66 28.28 7.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.754 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -94.56 -56.56 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' CD1' HD12 ' A' ' 30' ' ' LEU . 37.9 tp -72.72 -40.78 65.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.1 t -57.67 -34.6 69.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.14 -53.74 7.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.574 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -72.69 -39.77 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.151 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -67.44 -50.32 59.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -68.77 -12.03 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 20.7 mtt180 -67.89 -43.51 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.64 59.41 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.066 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 10.7 p-10 -138.55 95.1 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG2' ' HB1' ' A' ' 57' ' ' ALA . 2.9 p -53.9 -18.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.024 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 9.2 mt-30 -72.98 -54.57 8.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.01 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.066 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.04 -36.42 66.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.342 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.087 HG11 ' OE1' ' A' ' 61' ' ' GLU . 2.7 p -52.82 -42.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.397 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 1.089 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 23.6 mtp180 -70.91 -50.54 33.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.065 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 2.4 mtm180 -67.4 -12.0 59.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.502 ' CD1' HD13 ' A' ' 14' ' ' LEU . 8.7 mt -73.55 -70.4 0.37 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.35 -45.27 56.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.66 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 3.1 m-70 -72.42 -12.38 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.61 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 1.8 mtt-85 -134.18 -78.98 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.997 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -37.84 -30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.74 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.9 mt 61.56 45.02 8.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 10' ' ' VAL . 60.4 t -92.89 110.7 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.652 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -46.93 125.09 8.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' A' ' 65' ' ' GLN . 52.3 Cg_exo -54.66 -34.77 84.88 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.749 2.299 . . . . 0.0 112.377 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.652 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 16.3 p-10 -57.38 -21.69 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . . . -33.39 108.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.345 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 38' ' ' ASP . 4.2 mp -102.35 133.44 47.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.988 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.524 ' OD1' ' CB ' ' A' ' 43' ' ' PHE . 8.5 p30 -72.67 159.15 34.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' ASN . 3.8 ptm180 -35.12 -43.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 t80 -56.8 -49.13 76.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 119.22 35.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.21 157.09 25.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.785 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 147.5 25.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -58.03 -28.83 64.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 68' ' ' SER . 12.8 tp -70.79 -47.95 56.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 44.5 tt0 -60.65 -24.95 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 6.1 m -106.03 -14.2 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 2.2 ttp -42.34 145.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -85.53 134.88 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.777 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.618 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 14.1 m-85 -87.75 -7.27 57.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 88' ' ' PHE . . . -50.02 -41.04 36.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.028 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.528 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 47.0 m -108.78 127.56 27.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 91' ' ' THR . 58.8 Cg_endo -71.87 -34.0 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.682 2.255 . . . . 0.0 112.211 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 23' ' ' VAL . . . -63.14 -35.09 79.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 55' ' ' SER . 4.0 m -62.57 -32.1 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.609 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' N ' HG21 ' A' ' 58' ' ' VAL . . . -63.63 -64.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.902 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.516 HD22 ' CD ' ' A' ' 64' ' ' LYS . 7.3 tt -63.4 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.089 ' OE2' ' HA ' ' A' ' 27' ' ' ARG . 6.7 mt-10 -62.41 -70.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' HG3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.75 -36.53 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 18.4 tp -63.03 -37.87 88.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.516 ' CD ' HD22 ' A' ' 60' ' ' LEU . 1.9 mtpp -63.32 -48.87 76.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HB3' ' CG ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -36.68 -35.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.38 42.61 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.33 28.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.482 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 2.1 m -47.85 112.09 2.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HG2' ' OD1' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -63.52 -21.19 70.7 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.728 2.285 . . . . 0.0 112.175 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -100.37 82.56 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 8.0 m -116.1 142.32 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.402 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 4.2 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.402 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -110.3 71.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -70.15 169.04 14.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.907 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.522 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 17.9 Cg_endo -60.4 -32.26 93.67 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.738 2.292 . . . . 0.0 111.799 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 78' ' ' SER . 32.1 m -57.49 -42.53 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.243 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -53.65 -67.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.522 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -54.14 -27.44 33.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -68.94 -16.25 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . . . -73.18 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.37 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.535 ' CG ' ' HB3' ' A' ' 115' ' ' LEU . 61.0 mtm180 -63.73 -29.7 70.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 75.0 p -67.87 -6.53 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.228 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.94 74.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.174 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.559 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 8.3 m-85 -145.2 53.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.565 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.572 HD13 ' CG ' ' A' ' 127' ' ' PHE . 13.9 tp -52.78 -21.12 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.158 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.488 ' CG ' ' HG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -60.12 -73.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.488 ' HG1' ' CG ' ' A' ' 90' ' ' ASP . 24.1 m -73.21 -28.16 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 93' ' ' LYS . 1.8 tt -60.72 -61.31 2.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 1.289 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -52.7 -30.28 31.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.274 ' CA ' ' OE2' ' A' ' 97' ' ' GLU . 16.2 t -61.0 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.301 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.583 HD22 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -71.01 -26.76 63.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.018 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.516 HG11 ' CG1' ' A' ' 102' ' ' VAL . 6.9 t -73.22 -56.05 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.8 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.289 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -52.81 -35.45 57.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.232 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.439 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.87 -32.01 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.968 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.44 62.38 0.31 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.61 43.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 54.2 60.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.516 ' CG1' HG11 ' A' ' 96' ' ' VAL . 5.4 m -70.07 -10.77 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -105.48 42.76 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -105.31 168.41 9.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 60.4 mt -145.72 135.18 23.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.609 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.828 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.51 47.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER 80.03 -54.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 p -48.76 -37.7 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.72 0.57 49.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.441 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 89.1 p -79.09 100.16 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 7.0 mt -56.38 149.78 36.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 79.7 Cg_exo -48.21 -28.98 11.89 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.617 2.211 . . . . 0.0 112.151 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -73.45 -29.58 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.201 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 138' ' ' ASP . 50.3 m80 -62.76 -30.8 71.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 1.124 ' O ' ' OE2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -66.02 -56.51 11.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.975 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.17 -37.78 62.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.168 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 113' ' ' ILE . 71.5 mt -58.71 -43.13 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.465 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -64.73 -15.28 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.472 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.124 ' OE2' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -93.7 -56.12 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 156' ' ' LEU . . . 94.79 24.27 18.23 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.106 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.562 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 82.3 m-70 -55.14 -157.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.624 0.25 . . . . 0.0 110.693 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -102.24 -95.96 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.455 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 29.8 t -73.05 -19.22 61.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.325 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.562 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -56.71 -69.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.048 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 18.0 t -52.12 -46.32 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.594 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 4.9 p -66.67 -32.69 74.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.783 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 86.6 t80 -73.03 -43.47 62.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HB3' ' CB ' ' A' ' 113' ' ' ILE . 0.4 OUTLIER -65.42 -11.22 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.073 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -67.69 -62.51 3.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 129' ' ' ALA . 27.0 Cg_endo -61.75 -52.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.845 2.363 . . . . 0.0 112.352 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.783 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 3.9 mt-10 -51.88 -25.74 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.7 m -108.46 137.29 46.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.262 ' OD1' ' HB3' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -35.64 103.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 11.1 mt -61.4 134.14 56.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.937 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 1.9 t-160 86.17 14.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.262 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 4.6 p-80 -64.33 168.95 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.87 166.04 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -140.65 148.64 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.664 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -41.38 -28.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.17 0.51 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -34.35 73.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.782 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 93.22 45.07 3.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -153.71 158.05 40.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 111.037 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -108.59 167.97 8.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HG3' ' NE2' ' A' ' 136' ' ' HIS . 99.3 Cg_exo -40.59 -50.19 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.827 2.352 . . . . 0.0 112.524 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.503 HD13 ' CG ' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -62.25 -43.77 98.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -56.01 -64.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.511 ' CD1' HG23 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.72 -39.25 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.703 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.517 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -69.3 -27.7 65.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.621 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -70.73 -54.35 12.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.617 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -59.69 -67.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.01 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.81 59.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.57 52.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.925 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.538 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -37.79 -31.22 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.159 0.504 . . . . 0.0 110.15 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 170.35 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.823 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.539 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 1.3 p30 -76.54 13.16 1.03 Allowed 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.111 -0.368 . . . . 0.0 111.646 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.544 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 2.5 mt -51.56 -66.65 0.35 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.5 ptm -52.88 -20.81 3.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.69 -63.97 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.489 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.594 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -52.81 -27.71 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 0.0 110.81 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.535 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.32 -40.89 64.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.503 ' CG ' HD13 ' A' ' 145' ' ' LEU . 3.1 mt-30 -72.95 -40.53 65.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.005 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.68 37.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 -46.64 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.011 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 160' ' ' LEU . 3.7 ttp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.441 HG22 HG11 ' A' ' 35' ' ' VAL . 22.5 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' ALA . . . -38.99 -32.65 0.19 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.574 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 18.8 t0 -117.74 28.08 8.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 111.032 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -96.63 -62.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.802 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' C ' ' CD1' ' A' ' 14' ' ' LEU . 1.7 tm? -71.86 -42.39 66.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 39' ' ' ALA . 18.7 m -57.16 -36.23 70.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -67.12 -52.1 34.48 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.362 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.79 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -60.17 -51.21 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 111.026 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.59 69.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.59 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 2.3 mmm180 -73.56 0.11 13.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.216 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.542 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 50.49 66.25 2.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.631 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.882 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.2 p-10 -132.79 95.23 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 110.819 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.55 -22.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.717 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . 4.2 mm100 -73.05 -59.0 2.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.848 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.882 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.28 -17.84 61.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.142 HG11 ' CD ' ' A' ' 61' ' ' GLU . 3.1 t -65.36 -67.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.2 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.931 ' CA ' ' OE2' ' A' ' 61' ' ' GLU . 3.9 ptt-85 -73.17 -38.15 66.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.897 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -61.87 -27.55 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.797 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.272 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 12.0 mt -73.69 -62.08 1.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 0.0 111.981 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 2.3 mt -65.56 -53.24 44.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -72.98 -3.35 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -138.36 -78.71 0.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.038 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 1.272 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 1.1 tt0 -41.43 -27.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' LEU . 41.6 tp 65.67 73.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 36' ' ' HIS . 80.1 t -122.5 159.74 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.056 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.454 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -74.64 145.06 81.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 65' ' ' GLN . 38.2 Cg_endo -66.86 -29.49 41.62 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.722 2.282 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -82.52 -67.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' O ' ' OG ' ' A' ' 15' ' ' SER . . . 35.84 87.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 5.2 mp -92.54 140.18 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -67.72 88.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER 86.78 19.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 t80 65.84 52.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -135.99 -73.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 7.7 mtpt -86.13 148.86 25.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.455 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 1.1 p -87.09 150.14 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HA ' ' OG ' ' A' ' 15' ' ' SER . . . -52.89 -36.61 59.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.934 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 HD22 ' CE ' ' A' ' 51' ' ' MET . 2.1 mt -73.28 -26.75 61.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.73 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 47' ' ' ALA . 15.8 m -93.11 -18.8 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.746 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.522 ' CE ' HD22 ' A' ' 48' ' ' LEU . 1.3 tmm? -44.2 145.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.542 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.68 12.9 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.853 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 7.3 m-85 56.29 -80.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.66 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 31.94 -93.71 0.01 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.677 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.483 ' CB ' HG12 ' A' ' 58' ' ' VAL . 1.8 m -67.71 130.56 92.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.483 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.507 ' N ' ' OG1' ' A' ' 91' ' ' THR . 56.1 Cg_endo -71.0 -27.9 19.96 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.715 2.276 . . . . 0.0 111.828 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' C ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.38 -36.37 83.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.01 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.542 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.47 -34.18 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.573 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . . . -62.7 -58.04 8.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 64' ' ' LYS . 6.7 tt -63.27 -33.03 74.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.794 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.142 ' CD ' HG11 ' A' ' 26' ' ' VAL . 8.1 mt-10 -63.03 -60.26 3.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 5.6 mp -62.81 -46.91 85.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.17 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -63.16 -58.77 6.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' CB ' HD22 ' A' ' 60' ' ' LEU . 7.2 tmtt? -62.92 -23.79 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.131 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.518 ' HG2' ' CD2' ' A' ' 30' ' ' LEU . 24.8 tp60 -74.4 -20.02 60.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.999 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.53 50.35 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.04 159.81 21.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -126.21 120.44 23.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.986 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 71' ' ' VAL . 70.0 Cg_endo -74.68 -17.67 20.23 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.78 60.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' SER . 4.3 m -134.89 126.67 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HB3' ' N ' ' A' ' 77' ' ' THR . 2.7 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.471 ' N ' ' HB3' ' A' ' 72' ' ' GLN . 17.2 m -137.8 100.69 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.99 173.45 3.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 26.3 Cg_exo -62.68 -34.04 75.2 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.835 2.357 . . . . 0.0 112.116 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 78' ' ' SER . 0.9 OUTLIER -54.98 -38.43 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -59.66 -65.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.989 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.933 ' OD1' ' C ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -57.99 -37.36 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.286 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.689 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -52.9 -42.97 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.248 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.64 -55.81 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.781 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -61.62 -27.68 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.781 HG22 ' OD1' ' A' ' 82' ' ' ASP . 21.4 p -70.8 -70.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.55 64.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 18.7 m-85 -136.26 49.75 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 127' ' ' PHE . 2.7 tm? -52.28 -45.78 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.498 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -66.2 0.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.863 0.363 . . . . 0.0 110.8 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 56' ' ' PRO . 18.0 m -65.33 -44.58 87.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 22.6 tp -52.71 -48.76 66.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -52.13 -32.29 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -74.45 -55.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.556 ' N ' ' CG1' ' A' ' 94' ' ' VAL . 3.8 pp -74.33 -47.8 32.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.679 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.514 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -59.4 -36.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.552 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.787 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.87 -28.39 62.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -55.97 -37.42 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 160.08 -19.81 0.24 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.669 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 99' ' ' GLY . . . -33.63 115.16 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.2 p30 -48.8 113.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 131' ' ' GLU . 6.1 m -106.24 26.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.41 -35.93 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.74 145.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.486 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -123.64 -151.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -140.67 -77.17 0.31 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -57.85 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 1.128 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -63.41 -12.42 30.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.695 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.53 17.49 77.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.451 ' HB3' HD22 ' A' ' 115' ' ' LEU . 1.4 t -77.38 123.15 26.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.534 HD23 ' OD1' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -70.96 157.79 89.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.817 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.432 ' HD2' ' HG ' ' A' ' 111' ' ' LEU . 71.5 Cg_exo -48.74 -38.54 37.45 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.616 2.211 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -69.88 -40.97 79.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.086 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.535 ' CE1' ' HA ' ' A' ' 137' ' ' ARG . 22.0 m80 -52.66 -37.87 59.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.637 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 110' ' ' SER . 9.9 mt -72.84 -50.02 26.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.529 ' CB ' HG11 ' A' ' 124' ' ' VAL . . . -52.95 -37.1 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.526 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 95.0 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -72.99 -9.87 59.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.772 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.781 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -91.93 -57.94 2.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.674 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.28 41.49 3.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.861 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 9.8 m-70 -82.22 -1.75 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.87 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m 65.86 -81.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.7 OUTLIER -54.83 -52.74 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.981 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 116' ' ' ALA . 51.6 t -55.31 -60.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.345 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 3.8 t -52.13 -60.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.372 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.46 -27.55 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.64 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 11.7 t80 -73.64 -51.4 16.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.95 -7.49 22.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.258 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.584 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -58.41 -69.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.265 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 56.3 Cg_endo -70.49 -28.69 21.42 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.72 2.28 . . . . 0.0 112.487 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.503 ' OE2' ' CZ ' ' A' ' 127' ' ' PHE . 3.3 mm-40 -68.01 -18.14 64.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.497 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 3.8 m -116.88 157.8 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.71 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -44.19 113.96 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.471 ' CD1' ' HA ' ' A' ' 164' ' ' MET . 6.4 mt -85.48 43.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.73 30.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -138.53 155.83 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.535 ' HA ' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -130.13 -172.65 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 1.128 ' OD1' ' O ' ' A' ' 108' ' ' THR . 1.5 t70 -82.97 -174.68 5.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.747 ' H ' ' CG ' ' A' ' 138' ' ' ASP . . . -77.94 -4.99 49.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.042 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -46.75 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.761 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.457 ' O ' HD22 ' A' ' 142' ' ' LEU . . . 124.66 80.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.621 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 141' ' ' GLY . 28.5 mt -161.92 107.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.2 p -77.44 150.44 79.7 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.801 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.462 ' HB3' HD12 ' A' ' 113' ' ' ILE . 82.1 Cg_exo -45.43 -31.56 6.87 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.604 2.203 . . . . 0.0 112.206 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.527 ' C ' ' OE1' ' A' ' 146' ' ' GLU . 0.4 OUTLIER -73.32 -47.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.94 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.047 ' OE1' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.34 -50.92 63.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.209 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.59 -26.93 14.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.391 . . . . 0.0 110.677 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.518 ' HB3' ' N ' ' A' ' 157' ' ' MET . . . -73.67 -23.71 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -49.22 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -60.92 -72.79 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.477 ' CG ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -73.18 60.98 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.81 47.92 0.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.085 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -36.92 -57.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.441 0.638 . . . . 0.0 110.052 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -145.37 -146.51 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.548 179.031 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 1.087 ' HB2' ' CG ' ' A' ' 158' ' ' ASP . 17.6 p30 -73.36 53.63 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 160' ' ' LEU . 6.3 mt -65.14 -66.29 0.56 Allowed 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.574 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.518 ' N ' ' HB3' ' A' ' 148' ' ' ALA . 2.7 ppp? -51.44 -20.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.087 ' CG ' ' HB2' ' A' ' 155' ' ' ASN . 7.9 p-10 -73.72 -42.42 61.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.025 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.518 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.7 OUTLIER -72.47 -40.24 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 156' ' ' LEU . 5.4 mp -73.12 -40.17 65.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -63.51 -47.33 82.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.78 -44.32 92.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.38 -12.29 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.471 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 6.9 mtp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 35' ' ' VAL . 66.6 t . . . . . 0 N--CA 1.465 0.313 0 CA-C-O 120.853 0.358 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.51 ' N ' ' HB3' ' A' ' 39' ' ' ALA . . . -65.94 -9.52 47.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.687 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -117.85 18.46 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tpt85 -122.62 -53.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.01 -43.72 70.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.754 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.99 -31.41 63.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.87 -53.33 8.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.398 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -57.57 -58.76 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB3' HD21 ' A' ' 62' ' ' LEU . . . -54.02 -40.96 67.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.48 -28.48 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.438 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 1.375 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -73.6 0.66 12.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.249 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.454 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . 50.73 78.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.375 ' OD2' ' CG ' ' A' ' 20' ' ' ARG . 2.6 p30 -152.63 97.15 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.598 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 2.1 p -52.83 -25.18 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.66 -49.99 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.004 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.544 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -73.25 -39.75 65.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.57 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 27' ' ' ARG . 8.8 p -52.42 -42.15 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 67.1 mtp85 -72.91 -50.75 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 3.5 mmp_? -52.61 -30.63 32.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.753 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.484 HD21 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -73.64 -74.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.172 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 62' ' ' LEU . 3.5 mt -74.31 -42.91 58.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -67.54 -4.56 11.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 9.4 tpt180 -149.51 -77.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.646 0.26 . . . . 0.0 111.311 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.987 ' OE1' HG23 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -41.69 -26.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 32' ' ' ARG . 3.6 tp 66.27 83.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.987 HG23 ' OE1' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -111.84 134.92 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.26 129.56 88.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.689 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' HG3' ' A' ' 65' ' ' GLN . 49.1 Cg_endo -69.17 -15.67 39.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.745 2.297 . . . . 0.0 112.239 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 6.7 t0 -83.57 -28.47 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.962 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 11' ' ' GLY . . . -43.52 157.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.495 ' N ' HD11 ' A' ' 40' ' ' LEU . 2.9 mp -143.34 142.47 31.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.263 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 22.3 p30 -71.4 169.38 15.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -39.85 -34.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.833 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -62.05 -52.92 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' HD21 ' A' ' 40' ' ' LEU . . . 118.45 33.44 1.21 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 10.9 mtpt -109.99 170.83 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -98.94 166.58 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 50' ' ' VAL . . . -58.32 -46.37 86.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.79 -34.26 77.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.5 tp60 -73.43 -45.75 52.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 15' ' ' SER . 15.7 m -72.97 -39.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.657 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 53' ' ' PHE . 2.7 ppp? -35.26 148.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.038 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 54' ' ' GLY . 2.5 ptm -111.14 22.79 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.159 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.896 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 56.3 m-85 50.19 -87.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.347 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 34.46 -94.35 0.01 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.413 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 91' ' ' THR . 0.2 OUTLIER -53.54 156.26 4.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 1.033 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 93.8 Cg_endo -89.17 -52.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.961 2.441 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG2' ' A' ' 23' ' ' VAL . . . -62.99 -23.15 67.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 55' ' ' SER . 4.9 p -62.32 -45.46 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.12 -48.89 76.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -62.48 -48.88 77.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.18 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -62.67 -58.07 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.76 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.504 ' CD2' ' HB3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.86 -49.68 73.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -63.11 -44.36 95.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 111.214 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 10.5 ttpp -62.74 -31.0 71.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HG3' ' HD3' ' A' ' 37' ' ' PRO . 31.6 tp60 -45.66 -29.42 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.1 -19.14 2.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.422 ' HB2' HD21 ' A' ' 48' ' ' LEU . . . -56.41 152.46 11.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.0 m -105.99 126.66 30.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.979 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HA ' ' HG ' ' A' ' 48' ' ' LEU . 44.4 Cg_endo -68.57 -4.29 12.78 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.737 2.291 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -98.4 64.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.88 125.7 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.08 83.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.467 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 1.7 m -84.71 166.95 29.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 1.348 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 79.5 Cg_exo -47.81 -33.79 20.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 81' ' ' HIS . 0.5 OUTLIER -54.8 -42.15 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.014 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.571 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 15.7 m80 -70.07 -48.41 57.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.032 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 1.348 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.3 p30 -55.79 -50.45 70.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.259 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.66 -48.77 66.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 128' ' ' LEU . . . -64.14 -49.93 70.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.234 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -37.9 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 58.5 p -67.82 -27.44 66.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.06 73.6 1.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.34 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -153.64 58.4 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.631 ' CD1' ' CG ' ' A' ' 127' ' ' PHE . 61.7 tp -53.87 -16.7 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.673 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.033 ' OD2' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.78 -74.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.803 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -73.65 -33.25 64.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 2.0 tt -52.38 -56.91 11.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 1.215 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -56.64 -34.27 67.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 91' ' ' THR . 54.7 t -56.29 -62.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.642 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.43 -32.61 64.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 19.8 t -70.81 -46.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.215 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -56.08 -32.38 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.967 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.57 63.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.11 -68.47 0.44 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 96' ' ' VAL . . . 43.62 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -111.8 64.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 111' ' ' LEU . 6.7 m -79.88 5.88 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.29 24.85 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -119.82 128.4 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.471 HD22 ' HG ' ' A' ' 111' ' ' LEU . 7.1 mt -85.49 162.38 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.669 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -88.39 -84.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 t -131.61 -45.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.03 7.27 11.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 70.77 10.75 68.2 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.554 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.442 ' O ' HD22 ' A' ' 115' ' ' LEU . 73.6 p -78.89 92.46 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 111.044 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.471 ' HG ' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -36.24 146.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 99.2 Cg_exo -43.08 -28.44 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.409 2.073 . . . . 0.0 112.113 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.519 ' CA ' HD21 ' A' ' 128' ' ' LEU . 1.9 tp -73.4 -35.34 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.56 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 56.6 m80 -57.68 -43.73 85.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 110' ' ' SER . 0.8 OUTLIER -58.75 -42.97 90.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.476 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 125' ' ' VAL . . . -54.59 -48.9 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.569 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.511 ' N ' HG12 ' A' ' 125' ' ' VAL . 93.8 mt -56.0 -40.83 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' CD ' ' A' ' 151' ' ' ARG . 3.0 mmt85 -62.41 -21.44 65.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.32 -54.87 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 116.26 -6.61 19.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.519 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 98.2 m-70 -51.1 85.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' GLY . 18.0 p -38.88 -38.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 124' ' ' VAL . 1.9 p -73.17 -63.89 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.494 ' N ' ' OG ' ' A' ' 123' ' ' SER . 39.3 t -55.54 -57.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.361 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 117' ' ' ILE . 3.6 t -51.93 -54.09 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 44.0 t -63.74 -31.7 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.406 . . . . 0.0 111.11 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.631 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 71.3 t80 -73.1 -47.59 43.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -67.89 -8.96 40.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.489 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -66.29 -64.0 2.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 43.7 Cg_endo -67.88 -46.29 2.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 4.2 mm-40 -51.59 -47.09 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 134' ' ' LEU . 27.8 m -77.67 132.26 38.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' ND1' ' A' ' 136' ' ' HIS . 1.2 m-20 -36.14 96.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 6.7 mt -56.08 146.77 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.2 t-160 87.64 -21.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 133' ' ' ASP . 2.0 p-80 -42.85 167.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.015 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -122.27 -172.62 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.56 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -130.0 159.17 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -10.6 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 p -109.27 -24.04 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.786 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.11 28.92 3.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.633 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 1.419 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 34.4 mt -102.77 -179.35 3.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -169.8 177.01 1.16 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 75.6 Cg_exo -49.93 -58.76 1.52 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.641 2.228 . . . . 0.0 112.119 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.419 ' OE1' ' CD2' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -54.84 -59.63 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.54 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.476 HD11 ' CD2' ' A' ' 114' ' ' HIS . 0.9 OUTLIER -52.88 -51.86 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.411 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -52.8 -36.21 57.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.135 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -31.24 72.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -79.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.131 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 156' ' ' LEU . 4.5 mtt85 -74.06 75.08 1.73 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.84 55.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.082 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 154' ' ' GLN . . . -59.32 -18.68 40.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 1.229 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 7.5 tp-100 102.76 -85.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.858 0.724 . . . . 0.0 112.834 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.983 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -54.99 -42.87 72.98 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 153' ' ' ALA . 1.7 pt? -51.87 -53.84 36.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.524 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 10.2 ptm -60.28 -36.3 77.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD1' ' O ' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -73.55 -25.2 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.716 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 18.8 mt -73.28 -42.06 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.238 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -73.48 -53.55 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.718 -179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 162' ' ' GLY . 1.0 OUTLIER -52.37 -25.29 9.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.906 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 161' ' ' GLN . . . -73.31 -54.79 6.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.291 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.14 -49.23 29.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.474 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 2.6 tmm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.85 0.357 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -53.64 -71.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 1.271 ' OD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -49.86 -22.48 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 1.158 ' HG2' ' OE2' ' A' ' 33' ' ' GLU . 1.9 tpt180 -61.91 -65.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -71.73 -45.42 61.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -35.93 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.93 -49.47 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.456 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.36 -43.96 75.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.64 -50.86 22.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.32 80.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -19.59 62.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.441 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . 69.66 60.23 5.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.464 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.749 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 3.6 p30 -125.77 92.88 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 10.3 p -52.75 -20.71 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.842 ' C ' ' OE1' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -74.0 -53.9 9.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.264 ' OE1' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -73.39 -33.43 65.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.82 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 2.7 p -52.78 -50.8 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 0.0 111.306 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.634 ' CB ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.21 -50.52 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.163 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 8.2 ttt180 -56.41 -25.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.005 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.501 HD21 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.36 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CD2' ' NE2' ' A' ' 65' ' ' GLN . 3.5 mt -73.67 -40.15 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' CB ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -72.64 -1.59 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.321 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -144.73 -70.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.743 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 1.158 ' OE2' ' HG2' ' A' ' 13' ' ' ARG . 1.2 tt0 -61.67 -15.1 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 47.44 76.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.937 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 14' ' ' LEU . 6.7 t -100.4 159.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -88.27 142.44 31.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.971 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HD3' ' NE2' ' A' ' 65' ' ' GLN . 11.6 Cg_endo -54.77 -39.95 87.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.072 2.515 . . . . 0.0 112.296 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 59.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -107.68 121.37 44.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.99 170.74 9.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 1.271 ' CB ' ' OD1' ' A' ' 12' ' ' ASP . 15.9 p30 -124.41 -170.79 2.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.57 -30.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HB2' ' OD1' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -69.02 -52.12 31.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.93 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.16 18.39 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 40' ' ' LEU . 15.0 mttp -102.47 167.66 9.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.429 ' O ' HG11 ' A' ' 50' ' ' VAL . 28.1 p -85.12 162.79 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -54.75 -44.44 73.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 62' ' ' LEU . 5.1 tp -63.76 -51.19 66.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.043 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -54.34 -70.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 46' ' ' THR . 7.8 p -56.69 -23.99 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -36.6 132.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.441 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 3.4 ptt? -93.48 13.64 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.611 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER 43.72 26.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.888 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . -59.86 -67.91 1.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 91' ' ' THR . 0.4 OUTLIER -93.24 141.85 24.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 0.0 110.516 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 52.2 Cg_endo -68.55 -43.2 4.24 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.636 2.224 . . . . 0.0 111.975 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.2 -32.73 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.697 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 26' ' ' VAL . 3.3 t -62.48 -31.88 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 121.145 0.498 . . . . 0.0 109.79 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.528 ' CB ' HG22 ' A' ' 94' ' ' VAL . . . -63.63 -64.03 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.177 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HA ' HD11 ' A' ' 60' ' ' LEU . 44.4 tp -63.14 -28.86 70.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.274 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -63.02 -71.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -63.35 -27.46 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.504 HD23 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -62.78 -62.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -19.03 63.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.511 ' NE2' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -48.07 -24.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.95 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.15 0.39 5.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.57 -173.89 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.46 130.45 9.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -14.19 35.33 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.764 2.309 . . . . 0.0 112.373 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.57 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 23.5 m120 -82.36 74.8 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 28.4 m -130.08 138.21 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.007 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 1.29 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.889 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 5.7 m -101.77 69.57 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.543 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -73.38 170.89 12.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 10.2 Cg_endo -53.67 -40.5 79.31 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.835 2.356 . . . . 0.0 112.321 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.44 HG11 HG23 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.26 -25.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.577 ' CD2' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -70.97 -67.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.663 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 43.8 p30 -60.66 -26.35 67.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.25 -52.79 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB3' ' HB1' ' A' ' 116' ' ' ALA . . . -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.273 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -72.81 -29.05 62.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 12.1 p -69.41 -6.1 27.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.41 74.97 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.39 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -161.11 59.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' A' ' 127' ' ' PHE . 2.1 tm? -53.6 -28.93 35.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.609 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -58.75 -67.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.694 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.609 ' OG1' ' OD1' ' A' ' 90' ' ' ASP . 17.5 m -70.66 -23.39 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 93' ' ' LYS . 1.7 tt -72.83 -42.87 63.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 1.305 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 6.6 ptpt -67.87 -32.44 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.67 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.338 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 1.3 m -64.9 -54.35 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.491 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.553 HD22 ' CD2' ' A' ' 53' ' ' PHE . 1.5 pp -74.01 -33.39 63.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.519 ' CG1' HG12 ' A' ' 102' ' ' VAL . 42.3 t -73.04 -53.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.254 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.338 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 1.2 pm0 -52.72 -31.6 38.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.889 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.504 ' CD2' HD23 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -57.65 -19.43 26.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.3 6.71 5.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 95' ' ' LEU . . . -50.16 132.5 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 2.9 p30 -43.94 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.519 HG12 ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -99.06 22.55 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.144 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.29 14.29 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.721 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -89.82 161.65 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.512 ' CD2' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -141.64 -179.69 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 1.29 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 1.7 m-20 -121.11 -155.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -57.83 7.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -33.45 73.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.017 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.39 66.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.503 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.3 113.76 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -59.67 150.1 68.47 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 98.8 Cg_exo -42.71 -31.85 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.829 2.353 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.528 ' HA ' ' CD2' ' A' ' 128' ' ' LEU . 3.3 tp -72.37 -39.32 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.11 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 36.3 m80 -61.38 -35.18 76.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 81' ' ' HIS . 5.1 mp -69.1 -50.49 47.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.619 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB1' ' CD2' ' A' ' 128' ' ' LEU . . . -54.18 -37.45 64.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.527 ' N ' HG12 ' A' ' 125' ' ' VAL . 94.5 mt -62.23 -43.76 98.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.299 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 11.9 mtp180 -61.48 -16.22 45.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.313 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 3.7 mt-10 -105.3 -49.81 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 81.07 29.48 41.39 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.116 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.59 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 68.6 m-70 -51.5 -169.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 121' ' ' HIS . 91.6 p -57.56 -130.69 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.729 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 1.54 9.76 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.223 -0.298 . . . . 0.0 111.441 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.59 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -54.39 -68.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.852 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 116' ' ' ALA . 2.7 t -52.18 -32.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.578 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 13.8 t -73.53 -56.87 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.787 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 1.097 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 5.0 t80 -67.97 -47.06 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.762 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.725 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -66.4 -7.5 19.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.877 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -73.12 -60.7 1.71 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.37 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.498 ' CD ' ' O ' ' A' ' 126' ' ' SER . 18.4 Cg_endo -59.45 -64.27 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.831 2.354 . . . . 0.0 112.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 1.097 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -43.8 -26.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.507 ' OG ' ' CD2' ' A' ' 111' ' ' LEU . 6.0 t -89.5 133.86 34.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.657 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 3.2 p-10 -38.05 93.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.657 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 132' ' ' SER . 6.6 mt -63.88 69.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER 178.34 -42.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.017 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.657 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.8 OUTLIER -54.06 154.41 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.91 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.523 ' HD3' ' NE2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -140.91 -148.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.783 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.447 ' N ' ' HD2' ' A' ' 137' ' ' ARG . 0.7 OUTLIER -160.91 -162.72 0.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.65 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.33 -22.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.172 0.511 . . . . 0.0 110.612 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -62.38 -52.68 62.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.89 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.36 20.73 58.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.525 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.4 mt -106.6 -105.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.551 0.175 . . . . 0.0 110.807 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.253 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER 160.52 167.83 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.8 0.333 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 3.8 Cg_endo -47.41 -57.56 2.25 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 123.022 2.481 . . . . 0.0 112.088 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.474 ' CD1' ' HG2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -66.12 -44.75 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.253 ' CD ' ' OG1' ' A' ' 143' ' ' THR . 4.0 mp0 -55.53 -51.12 68.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.531 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.504 ' HG ' ' NH2' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -53.04 -43.34 66.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 110.171 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 157' ' ' MET . . . -52.85 -36.42 58.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -35.61 78.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.627 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -74.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.248 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.471 ' O ' HD22 ' A' ' 156' ' ' LEU . 10.8 mmm180 -73.97 70.59 1.51 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.29 52.0 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.909 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 154' ' ' GLN . . . -57.17 -16.6 8.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.513 0.196 . . . . 0.0 110.535 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 7.0 tp-100 101.79 -59.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.659 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.468 ' CB ' HD13 ' A' ' 159' ' ' ILE . 4.8 m-20 -72.6 -54.73 8.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.0 111.512 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.576 HD11 ' N ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -53.05 -16.78 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.946 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.576 ' N ' HD11 ' A' ' 156' ' ' LEU . 14.4 mtp -74.74 -60.37 2.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.858 0.361 . . . . 0.0 111.603 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.071 -179.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.578 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 60.0 mt -52.74 -55.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.673 0.273 . . . . 0.0 111.366 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -73.64 -31.12 63.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.34 -179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 145' ' ' LEU . 1.3 mm-40 -62.94 -42.64 99.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -36.14 57.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.403 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -70.18 -31.73 69.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' CG2' HG21 ' A' ' 35' ' ' VAL . 13.1 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.917 0.389 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.534 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -46.47 -57.59 6.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.444 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -84.21 54.68 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -127.86 -66.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 37' ' ' PRO . 29.0 tp -67.23 -33.92 76.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.008 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.477 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -61.89 -39.18 91.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -31.63 75.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.9 -59.67 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 111.153 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.51 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -54.28 -48.62 71.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -64.24 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -72.61 -37.65 68.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . 98.85 73.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.37 83.78 1.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.3 p -52.65 -22.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -74.11 -49.67 22.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' O ' HD21 ' A' ' 29' ' ' LEU . 55.8 mm-40 -73.84 -27.3 61.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.845 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -52.76 -51.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.53 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.559 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.2 mtm180 -73.28 -43.09 61.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 19.7 mmt180 -63.5 -34.21 77.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -53.47 -71.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -69.68 -49.36 54.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.012 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -66.72 -25.83 66.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.93 -58.66 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.555 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.3 tp10 -67.35 -7.14 22.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.06 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER 42.46 28.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.7 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -66.76 148.85 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.435 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 1.5 m-70 -67.62 131.03 92.97 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.98 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 57.5 Cg_endo -71.07 -22.42 26.19 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.852 2.368 . . . . 0.0 112.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -99.55 18.68 17.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -62.18 107.59 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.3 mp -89.82 145.22 25.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 54.2 p30 -80.93 -171.37 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -70.56 58.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -172.52 -43.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.58 60.14 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.594 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -141.08 145.64 36.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -85.57 155.9 20.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -55.27 -24.24 27.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.9 -49.65 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 78' ' ' SER . 1.8 tp-100 -63.88 -28.29 69.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 28.9 m -96.23 -14.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.515 ' HE2' ' CD2' ' A' ' 95' ' ' LEU . 1.2 ttp -44.64 154.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -109.72 23.51 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 83' ' ' ALA . 5.2 m-85 35.84 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -72.39 -85.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.314 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.1 m -77.91 120.31 80.79 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.37 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.1 -43.48 48.05 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.472 2.115 . . . . 0.0 112.08 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.61 -28.51 69.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' SER . 3.2 t -62.27 -41.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB3' ' CG2' ' A' ' 91' ' ' THR . . . -63.65 -50.18 70.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.641 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.5 tp -63.14 -40.19 96.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.712 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -63.04 -43.24 99.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.51 HD13 ' CB ' ' A' ' 18' ' ' ALA . 6.0 mt -62.81 -56.92 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' A' ' 69' ' ' PRO . 5.8 mt -63.12 -31.31 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 4.2 mmtt -63.36 -46.27 87.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -56.57 -27.2 57.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.969 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.39 47.88 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.436 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.25 123.58 49.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.903 0.382 . . . . 0.0 111.039 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 124.86 83.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 59.3 Cg_endo -72.42 -38.61 3.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.727 2.285 . . . . 0.0 112.302 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.01 101.48 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 11.6 m -139.41 132.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.405 ' HG3' ' C ' ' A' ' 71' ' ' VAL . 49.5 mt-30 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.3 m -124.97 144.79 50.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.516 ' HA ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -144.41 177.97 1.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 77.6 Cg_exo -49.61 -47.56 22.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.656 2.238 . . . . 0.0 112.288 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.57 -38.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -59.31 -70.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.204 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.03 -33.31 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 53' ' ' PHE . . . -52.81 -52.44 56.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.41 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 124' ' ' VAL . . . -64.97 -46.56 80.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.441 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -72.21 -24.36 61.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.355 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 11.5 p -73.11 -73.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.124 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 126.75 63.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.997 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -148.38 57.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.56 HD23 ' CG ' ' A' ' 127' ' ' PHE . 2.7 tm? -52.11 -19.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 4.5 m-20 -60.36 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 2.4 m -73.37 -27.55 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.51 HD22 ' CG2' ' A' ' 96' ' ' VAL . 3.1 tt -56.54 -57.52 11.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.988 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -54.07 -32.22 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.807 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 23.7 t -57.71 -65.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.515 ' CD2' ' HE2' ' A' ' 51' ' ' MET . 1.6 pp -70.41 -29.33 65.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.429 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 92' ' ' LEU . 23.5 t -72.55 -40.31 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.807 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 4.5 pm0 -72.82 -25.75 61.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -61.07 -62.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -176.74 -30.35 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.868 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 69' ' ' PRO . . . -31.8 118.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.351 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.23 119.27 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 131' ' ' GLU . 5.3 p -110.84 20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -136.62 27.88 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.92 130.99 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.622 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -97.49 162.61 13.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.091 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 51.9 p-10 -85.31 53.07 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 106' ' ' ASP . 8.4 t 80.42 -62.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.414 ' OG1' ' OG ' ' A' ' 110' ' ' SER . 34.4 p -42.04 -28.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.003 0.43 . . . . 0.0 110.048 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 88.45 31.69 13.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.57 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.524 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -101.8 96.87 7.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 10.6 tp -34.89 135.35 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' HD11 ' A' ' 105' ' ' LEU . 83.9 Cg_exo -45.92 -29.25 5.76 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.734 2.29 . . . . 0.0 112.452 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG23 ' CD2' ' A' ' 111' ' ' LEU . 4.5 tt -73.06 -35.7 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -52.84 -37.66 60.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -68.64 -46.55 68.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.615 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.522 ' CB ' HG11 ' A' ' 125' ' ' VAL . . . -56.29 -41.64 76.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.257 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.534 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 85.5 mt -57.64 -38.04 62.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.595 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 2.3 mtp180 -66.22 -17.44 64.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -98.95 -50.94 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.76 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.406 ' HA2' HD21 ' A' ' 156' ' ' LEU . . . 86.84 40.96 6.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 123' ' ' SER . 23.9 m-70 -72.95 -3.04 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.722 0.296 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER 63.0 -70.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.791 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 121' ' ' HIS . 32.5 m -55.98 -41.61 75.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 84' ' ' ALA . 51.9 t -73.19 -61.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.28 -51.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.56 ' CB ' ' CB ' ' A' ' 159' ' ' ILE . 83.7 p -56.57 -42.68 79.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.04 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.568 ' CZ ' ' HG3' ' A' ' 131' ' ' GLU . 72.8 t80 -73.41 -37.61 65.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -71.97 -2.64 18.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.28 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.594 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -69.19 -71.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.226 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 37.5 Cg_endo -66.96 -57.63 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.614 2.21 . . . . 0.0 112.336 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 6.6 mm-40 -39.63 -37.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 102' ' ' VAL . 9.7 m -96.38 133.4 40.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.786 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.305 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -36.51 107.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.549 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.467 HD23 ' HG2' ' A' ' 164' ' ' MET . 31.0 mt -72.89 -1.31 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.268 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.05 24.09 13.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.305 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 4.4 t60 -107.27 171.1 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER -159.94 157.38 28.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 141' ' ' GLY . 6.7 t0 -77.57 157.89 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.486 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.7 -27.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 109.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -40.64 62.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.657 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 114.11 35.85 1.44 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.39 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 67.8 mt -93.92 -167.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.524 ' CG2' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -178.35 165.28 1.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 143' ' ' THR . 99.4 Cg_exo -42.61 -56.83 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.619 2.213 . . . . 0.0 111.886 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.452 ' HB2' ' HE3' ' A' ' 164' ' ' MET . 6.3 mt -72.03 -42.74 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.482 ' HB3' ' N ' ' A' ' 143' ' ' THR . 3.6 tp10 -55.56 -69.78 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 150' ' ' GLN . 21.9 tp -52.73 -38.17 60.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 109.914 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 157' ' ' MET . . . -54.14 -44.63 71.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.036 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.473 ' N ' ' SD ' ' A' ' 157' ' ' MET . 1.9 tpm_? -58.57 -23.36 58.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 1.4 tt0 -71.9 -75.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' HD13 ' A' ' 156' ' ' LEU . 5.6 mmm180 -74.06 74.43 1.72 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.88 55.81 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.582 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 154' ' ' GLN . . . -69.88 -13.26 62.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.756 0.313 . . . . 0.0 110.748 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 8.2 tp-100 88.39 -37.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.536 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -72.51 -64.89 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.252 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -52.01 -55.02 23.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.291 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.476 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . 34.5 mmm -50.98 -28.19 9.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 154' ' ' GLN . 30.9 t0 -75.31 -71.04 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.708 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.56 ' CB ' ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -53.05 -40.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.232 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 156' ' ' LEU . 6.5 mp -73.68 -14.75 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -73.37 -61.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.38 -48.69 50.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.301 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 19.4 m-70 -53.93 -18.96 3.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.467 ' HG2' HD23 ' A' ' 134' ' ' LEU . 6.9 mmm . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.769 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG1' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -81.9 -60.91 2.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.521 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -10.77 26.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -98.66 -70.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.8 OUTLIER -72.22 -61.36 1.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 5.1 t -55.81 -25.8 43.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.18 -50.69 11.73 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.745 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.51 -47.42 48.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 111.223 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -52.87 -39.67 62.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.024 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.34 -41.45 63.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.304 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -62.63 -22.14 66.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.68 59.47 3.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.898 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.253 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 16.5 t0 -109.29 90.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.643 0.259 . . . . 0.0 110.374 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 3.4 p -51.92 -23.53 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.151 0.5 . . . . 0.0 110.255 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.14 -59.58 2.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.8 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.253 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 11.0 mm-40 -73.96 -28.19 61.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.613 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 3.7 p -52.41 -51.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.816 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 19.6 mtp180 -74.48 -51.25 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -52.75 -36.74 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.11 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 9.2 mt -73.16 -74.33 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.685 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.49 HD12 ' CG ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.16 -42.19 63.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -73.08 -1.68 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.27 -64.74 0.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 111.121 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.955 ' OE2' ' CG1' ' A' ' 35' ' ' VAL . 2.2 tt0 -62.51 -11.35 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tp 54.22 73.25 0.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.955 ' CG1' ' OE2' ' A' ' 33' ' ' GLU . 2.0 m -101.29 153.92 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' OD2' ' A' ' 38' ' ' ASP . 1.8 t-80 -74.83 126.6 88.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.55 1.03 7.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.786 2.324 . . . . 0.0 112.357 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 1.1 p-10 -111.86 53.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.33 177.21 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 3.8 mp -142.19 -173.87 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' PHE . 17.8 p-10 -150.9 166.7 29.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -35.17 -31.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -68.33 -47.63 67.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 110.13 16.12 10.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 11.5 mtpt -101.83 169.02 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.15 168.52 13.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -60.4 -55.01 38.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.42 -36.64 84.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -52.87 -66.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 51' ' ' MET . 7.1 p -70.09 -25.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.529 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -35.7 107.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 20' ' ' ARG . 2.8 ptt? -66.27 137.28 56.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.637 ' CE2' ' CD2' ' A' ' 95' ' ' LEU . 11.6 m-85 -82.64 47.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.36 -64.36 1.46 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 5.2 m -98.36 111.52 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 1.026 ' CG ' ' OD1' ' A' ' 90' ' ' ASP . 76.1 Cg_exo -48.67 -23.5 5.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.449 2.1 . . . . 0.0 111.834 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' CB ' ' CG2' ' A' ' 23' ' ' VAL . . . -64.41 -43.45 94.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.112 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 55' ' ' SER . 2.1 p -61.94 -36.9 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.87 0.367 . . . . 0.0 110.549 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -63.8 -51.32 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.8 tt -63.29 -46.45 86.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.942 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' HG ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -62.56 -47.4 84.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.439 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD1' ' HG3' ' A' ' 51' ' ' MET . 11.9 mt -62.73 -58.97 5.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -28.16 69.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.389 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 18.0 ttpt -62.77 -17.78 61.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.774 0.321 . . . . 0.0 111.084 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.49 ' CG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -77.34 -67.49 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.15 37.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.54 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 48' ' ' LEU . . . -79.52 -160.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 111.089 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 71' ' ' VAL . 32.1 m -123.7 124.1 26.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 74.2 Cg_endo -75.16 -17.23 19.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.783 2.322 . . . . 0.0 112.366 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -114.17 77.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 68' ' ' SER . 5.0 m -117.85 152.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.832 ' HA3' ' OD2' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.438 HG21 ' OD1' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -164.7 105.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.52 170.62 6.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.736 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 76.9 Cg_exo -49.66 -40.45 46.71 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.593 2.196 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 81' ' ' HIS . 7.6 m -59.05 -34.0 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.485 ' N ' HG21 ' A' ' 80' ' ' VAL . 62.0 m80 -69.8 -62.36 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.1 OUTLIER -53.1 -48.15 68.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.05 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.33 -27.71 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.49 -62.42 1.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.43 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HG3' ' A' ' 119' ' ' GLU . 16.4 mtp180 -73.07 -28.13 62.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 75.8 p -69.82 -5.58 26.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.147 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 50.28 76.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.528 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 11.7 m-85 -150.4 56.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.54 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.473 ' O ' ' HD2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -52.56 -22.95 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.188 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.026 ' OD1' ' CG ' ' A' ' 56' ' ' PRO . 3.6 t70 -62.29 -74.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 110.647 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 43.2 m -70.71 -19.81 62.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.501 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.523 HD22 ' CG2' ' A' ' 96' ' ' VAL . 2.8 tt -68.61 -55.3 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.511 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.688 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.6 -30.01 62.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.966 ' O ' ' OE2' ' A' ' 97' ' ' GLU . 78.8 t -59.98 -62.46 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.12 -28.78 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.471 . . . . 0.0 110.148 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.523 ' CG2' HD22 ' A' ' 92' ' ' LEU . 16.4 t -73.33 -44.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.966 ' OE2' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -68.1 -28.42 67.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.742 ' CG ' ' OE2' ' A' ' 97' ' ' GLU . 19.0 m-70 -60.06 -29.63 68.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.48 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 102' ' ' VAL . . . -95.81 143.56 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 111.108 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.1 84.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.49 HG13 ' CG1' ' A' ' 96' ' ' VAL . 11.7 m -88.66 11.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 0.0 OUTLIER -124.16 37.92 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.441 ' C ' ' CD2' ' A' ' 105' ' ' LEU . . . -107.9 145.01 34.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.121 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -121.51 146.5 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.832 ' OD2' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -155.25 -53.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.426 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -48.16 -52.98 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.5 OUTLIER -163.08 57.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 108' ' ' THR . . . 36.49 52.62 1.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.432 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 111' ' ' LEU . 48.0 m -134.49 110.9 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.97 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.457 HD11 ' CD2' ' A' ' 136' ' ' HIS . 8.8 tp -35.01 140.53 0.29 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 88.1 Cg_exo -46.69 -32.26 11.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.767 2.311 . . . . 0.0 112.194 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 1.6 tt -66.69 -37.44 79.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.506 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 73.8 m80 -59.3 -35.56 73.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -53.07 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.415 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.72 -41.4 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 110.055 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.529 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 88.2 mt -52.81 -42.5 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.333 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -16.22 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.579 ' HB3' ' CD2' ' A' ' 121' ' ' HIS . 3.8 mm-40 -86.46 -59.58 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.694 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.29 -0.35 14.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.603 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.579 ' CD2' ' HB3' ' A' ' 119' ' ' GLU . 77.9 m-70 -61.44 73.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m -34.53 -33.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.57 -48.76 30.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' HIS . 12.4 t -73.07 -50.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.411 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.07 -52.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.547 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.1 t -69.04 -34.98 76.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.229 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.446 ' HB3' HD22 ' A' ' 89' ' ' LEU . 67.7 t80 -72.94 -35.83 67.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.088 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.457 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.28 -0.23 13.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.273 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.569 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -66.2 -69.41 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.306 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 41.5 Cg_endo -68.56 -57.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.633 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.487 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 24.0 mm-40 -39.28 -31.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.006 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.465 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 1.3 t -109.01 136.3 48.77 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.3 p30 -35.37 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 129' ' ' ALA . 12.6 mt -70.71 75.3 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER 173.14 -33.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.457 ' CD2' HD11 ' A' ' 111' ' ' LEU . 6.7 t60 -38.61 161.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -140.51 147.65 39.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.88 ' OD2' ' HB3' ' A' ' 140' ' ' SER . 0.3 OUTLIER -85.32 159.84 19.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.685 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 109.891 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.88 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . 0.1 OUTLIER -71.52 -56.1 6.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.833 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.51 12.62 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.701 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 2.7 mt -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.534 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.4 OUTLIER -74.22 -178.67 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 75.0 Cg_exo -49.92 -49.87 14.87 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.837 2.358 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -67.99 -42.41 80.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.738 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.647 ' OE1' ' OE1' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -52.93 -60.16 3.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.037 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 150' ' ' GLN . 0.4 OUTLIER -52.84 -29.83 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.682 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . . . -72.63 -24.08 61.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 146' ' ' GLU . 7.4 tmm_? -65.85 -51.03 62.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.647 ' OE1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.17 -71.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -74.18 58.3 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.29 52.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.433 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -31.05 -48.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -173.81 -109.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.535 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.3 m-80 -74.71 4.97 5.41 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.227 -0.295 . . . . 0.0 111.434 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.488 ' O ' HD21 ' A' ' 160' ' ' LEU . 1.6 mt -51.2 -59.34 4.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.704 0.288 . . . . 0.0 111.33 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.2 -32.17 35.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.916 0.389 . . . . 0.0 110.637 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.33 -57.77 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.787 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.15 -32.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -179.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.4 -59.88 2.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 145' ' ' LEU . 6.3 pt20 -65.45 -14.91 61.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.05 -55.43 6.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.96 -14.09 61.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.1 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.479 ' HE2' ' CD1' ' A' ' 145' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.774 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.53 HG13 ' CB ' ' A' ' 39' ' ' ALA . 9.2 t . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.717 0.294 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -33.2 -56.43 0.55 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.25 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -73.42 -24.14 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 111.252 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -72.56 -68.74 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.187 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.561 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 3.0 tm? -68.07 -54.83 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 1.0 OUTLIER -61.12 -38.6 86.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.122 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -62.16 -61.08 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.673 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 29' ' ' LEU . . . -57.55 -41.58 81.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.02 75.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.89 61.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 4.1 mtp85 -68.59 -30.71 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.487 ' CA ' ' HG2' ' A' ' 52' ' ' MET . . . 84.46 33.06 20.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.464 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.343 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 p-10 -104.64 100.18 9.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.2 p -54.72 -17.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.817 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 16.8 mt-30 -74.25 -53.39 9.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.269 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.343 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.32 -34.64 65.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.025 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.535 HG22 ' CB ' ' A' ' 58' ' ' VAL . 9.9 p -52.56 -50.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -72.52 -48.1 43.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 111.038 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.87 -27.44 65.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 17' ' ' ALA . 26.8 mt -74.43 -71.85 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.023 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' A' ' 62' ' ' LEU . 82.9 mt -63.3 -67.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -64.9 -4.88 4.97 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -129.43 -70.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.459 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 1.186 ' OE1' ' CG2' ' A' ' 35' ' ' VAL . 4.4 tt0 -51.86 -20.49 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt 59.12 53.51 5.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 1.186 ' CG2' ' OE1' ' A' ' 33' ' ' GLU . 48.5 t -86.02 137.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.179 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.6 t-80 -55.41 143.56 56.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 36.9 Cg_endo -65.22 -33.77 47.87 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.78 2.32 . . . . 0.0 112.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -96.42 31.59 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' CB ' HG13 ' A' ' 10' ' ' VAL . . . -79.43 61.19 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.366 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 5.0 mp -55.76 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -84.26 46.06 1.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 2.0 tmt_? 84.7 -11.69 0.78 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER 155.74 50.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.791 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -143.12 -102.47 0.42 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.979 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 14.3 mttt -95.07 154.69 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 0.0 111.229 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.474 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -84.39 142.93 29.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.989 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 14' ' ' LEU . . . -52.84 -22.62 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD21 ' SD ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -73.29 -67.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -52.96 -37.76 61.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 28.7 m -78.43 -19.21 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.292 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.492 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.61 143.22 51.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.487 ' HG2' ' CA ' ' A' ' 21' ' ' GLY . 4.1 ppp? -78.04 116.69 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.641 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 36.7 m-85 -70.32 57.93 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -50.66 0.21 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.521 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 49.6 m -82.3 127.07 72.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.544 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 55.4 Cg_endo -70.2 -37.34 8.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.631 2.22 . . . . 0.0 112.317 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' OE2' ' A' ' 61' ' ' GLU . . . -63.31 -39.28 94.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.315 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.535 ' CB ' HG22 ' A' ' 26' ' ' VAL . 4.1 m -62.96 -31.33 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.523 ' N ' HG21 ' A' ' 58' ' ' VAL . . . -63.45 -59.89 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 7.0 tt -63.26 -37.87 88.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.505 ' OE2' ' HB2' ' A' ' 57' ' ' ALA . 5.3 mp0 -62.75 -62.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' HA ' ' CD1' ' A' ' 30' ' ' LEU . 3.4 mt -62.82 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 4.9 tp -63.33 -50.88 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.6 ttpp -62.83 -36.87 84.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.92 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.484 ' CG ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -37.55 -60.55 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.853 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.95 -23.94 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.2 146.23 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.038 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.14 119.68 62.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.52 -19.64 37.03 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.106 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.03 70.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 78' ' ' SER . 23.4 m -124.2 145.76 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 1.193 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.607 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -112.38 75.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 110.926 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.843 ' OG ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -43.84 170.06 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.684 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 8.9 Cg_endo -50.6 -32.73 36.55 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.933 2.422 . . . . 0.0 112.38 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -63.75 -52.94 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.411 ' N ' HG13 ' A' ' 80' ' ' VAL . 33.4 m80 -53.01 -54.1 40.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -60.76 -50.91 71.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.076 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.581 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.83 -30.1 31.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -68.95 0.41 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -60.09 -18.62 48.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.311 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 83' ' ' ALA . 7.8 p -73.33 -27.84 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.074 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.49 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 75.1 76.18 0.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.147 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 70.2 m-85 -156.19 61.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 127' ' ' PHE . 6.3 mt -52.51 -18.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.596 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.044 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.28 -70.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 1.044 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 t -65.5 -35.94 82.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.9 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.505 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -52.89 -51.96 59.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.7 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.746 ' O ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.86 -38.01 61.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.536 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' CA ' ' OE1' ' A' ' 97' ' ' GLU . 87.9 t -75.27 -64.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.309 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 96' ' ' VAL . 4.6 pp -73.69 -52.53 12.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.563 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -52.55 -26.58 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.746 ' OE1' ' O ' ' A' ' 93' ' ' LYS . 3.0 pm0 -72.13 -29.79 64.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -67.11 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.21 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -67.47 63.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.138 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 1.1 p-10 39.96 69.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -90.74 21.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 35.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -119.45 -178.54 3.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.194 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -150.09 165.24 33.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 1.193 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 2.4 t0 -84.76 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.25 -44.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -16.94 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 138' ' ' ASP . . . 72.34 52.81 9.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.382 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.65 105.48 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.557 ' N ' ' ND1' ' A' ' 114' ' ' HIS . 8.2 mt -43.82 158.22 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 67.3 Cg_exo -51.26 -43.54 48.38 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.284 . . . . 0.0 112.283 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -55.83 -40.22 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.557 ' ND1' ' N ' ' A' ' 111' ' ' LEU . 33.4 m170 -54.95 -43.86 73.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 11.3 mt -63.01 -56.0 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 125' ' ' VAL . . . -52.87 -32.23 43.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.504 ' N ' HG12 ' A' ' 125' ' ' VAL . 46.9 mt -65.35 -41.28 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.604 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 0.8 OUTLIER -70.57 -18.29 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.602 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 1.6 mt-10 -87.56 -56.62 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.59 28.77 9.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.604 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 21.3 m-70 -60.04 -15.03 19.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.341 . . . . 0.0 110.547 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER 77.93 -75.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.981 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.521 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.65 -48.38 75.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 42.5 t -58.22 -60.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 116' ' ' ALA . 2.2 t -52.24 -40.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.473 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 1.9 t -72.18 -23.82 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CE2' ' OE2' ' A' ' 131' ' ' GLU . 7.0 t80 -73.59 -48.14 35.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -69.63 -5.26 23.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -53.03 -70.33 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.185 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 73.9 Cg_endo -75.04 -43.4 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.696 2.264 . . . . 0.0 112.399 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.635 ' OE2' ' CE2' ' A' ' 127' ' ' PHE . 1.6 mt-10 -50.55 -33.51 22.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.707 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 132' ' ' SER . 1.2 m-20 -35.6 120.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 6.5 mt -87.64 19.79 3.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.38 -44.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.461 ' HB3' HD12 ' A' ' 111' ' ' LEU . 3.1 t60 -55.7 157.1 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.473 ' HB3' HG21 ' A' ' 143' ' ' THR . 0.0 OUTLIER -138.42 166.91 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.649 ' CG ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -80.97 153.21 27.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.44 -21.9 1.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -44.19 85.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.423 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 107.87 53.65 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.577 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.423 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 10.1 mt -149.94 104.76 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.71 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -72.95 177.62 1.83 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.697 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.463 ' O ' HD13 ' A' ' 160' ' ' LEU . 87.0 Cg_exo -46.55 -57.89 2.0 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.7 -28.81 70.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.71 ' OE2' ' OG1' ' A' ' 143' ' ' THR . 0.4 OUTLIER -72.75 -65.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.34 -39.34 60.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.146 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.543 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -60.63 -37.43 81.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.23 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.62 84.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.613 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -65.1 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.364 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -75.14 57.82 0.87 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.53 52.01 0.86 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.071 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -35.55 -32.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -178.86 -123.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.461 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 1.349 ' CB ' ' OD2' ' A' ' 158' ' ' ASP . 3.4 m-20 -75.97 29.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.065 0.393 . . . . 0.0 111.963 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.469 ' HA ' HD11 ' A' ' 159' ' ' ILE . 1.5 mt -54.25 -72.02 0.07 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 110.971 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.543 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 8.7 ptm -53.95 -21.27 7.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.349 ' OD2' ' CB ' ' A' ' 155' ' ' ASN . 8.6 p-10 -73.95 -54.42 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.098 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 1.176 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 2.0 mt -53.13 -37.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.8 -27.9 61.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -52.9 -54.18 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.46 91.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.516 ' O ' ' CD1' ' A' ' 134' ' ' LEU . 42.8 m-70 -68.81 -37.7 79.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.822 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.434 ' HA ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.423 ' HB ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.786 0.326 . . . . 0.0 111.227 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' CA ' ' CB ' ' A' ' 39' ' ' ALA . . . -52.06 -20.3 6.41 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.389 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 p30 -92.78 -8.83 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 0.0 110.863 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -98.65 -51.95 3.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 37' ' ' PRO . 9.0 tp -64.06 -33.84 76.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -62.39 -41.87 98.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -70.87 -49.23 29.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . . . -58.2 -47.86 82.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.351 . . . . 0.0 111.074 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -69.91 -43.44 71.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.74 -23.64 59.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 3.0 mmt180 -73.9 -12.3 60.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.535 ' HA2' ' CE ' ' A' ' 52' ' ' MET . . . 66.83 80.61 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.68 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 11.4 t0 -147.51 88.49 1.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.302 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' HG11 ' A' ' 26' ' ' VAL . 6.3 p -52.18 -29.18 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -52.27 11.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.77 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -74.12 -27.85 61.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.737 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.642 HG12 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.56 -47.21 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.312 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 1.266 ' NE ' ' OE2' ' A' ' 61' ' ' GLU . 6.2 mtt180 -73.64 -34.38 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.073 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 2.6 mmm-85 -52.4 -27.54 16.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.258 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 17' ' ' ALA . 1.4 mt -73.05 -68.42 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -63.99 -53.62 47.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.006 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -59.29 -16.51 22.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 2.3 mmp_? -135.21 -73.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -47.45 -23.44 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 59.36 16.05 4.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.791 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.482 ' CG1' ' CD1' ' A' ' 30' ' ' LEU . 13.8 p -46.36 154.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.94 121.49 66.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 30.8 Cg_endo -63.47 -9.69 18.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.763 2.309 . . . . 0.0 112.154 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.93 21.15 18.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.517 ' CB ' ' CA ' ' A' ' 11' ' ' GLY . . . -97.79 143.71 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -119.93 160.15 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 15' ' ' SER . 1.1 m-20 -71.24 -159.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -4.99 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.05 -44.56 6.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.85 38.55 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' N ' ' HB3' ' A' ' 40' ' ' LEU . 7.1 mtpt -117.7 143.76 45.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.829 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.468 ' OG1' ' CG ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -85.06 156.69 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -57.63 -36.18 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.468 ' HG ' HD13 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -61.33 -36.53 80.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.468 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 1.3 mt-30 -73.05 -55.83 5.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -59.4 -19.03 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.256 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -43.62 148.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.759 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.93 23.39 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.105 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER 33.15 57.91 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.467 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -108.46 -72.16 0.75 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.312 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.48 ' OG ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -84.54 121.54 74.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.751 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.71 -45.0 44.27 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.574 2.183 . . . . 0.0 111.859 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.3 -31.3 72.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.518 ' CG2' ' HB ' ' A' ' 26' ' ' VAL . 2.2 t -62.12 -47.88 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.027 0.441 . . . . 0.0 110.009 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.74 -49.79 71.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 2.4 tt -63.08 -43.3 98.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.548 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.266 ' OE2' ' NE ' ' A' ' 27' ' ' ARG . 7.4 tt0 -62.74 -61.23 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.414 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.09 -37.59 87.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 39.4 tp -63.42 -52.65 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.117 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -62.62 -34.0 76.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.017 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 1.3 tp-100 -46.24 -25.32 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.29 3.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.593 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.31 148.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG11 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.01 123.05 44.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.26 -14.77 28.53 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.772 2.314 . . . . 0.0 112.235 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.9 57.21 4.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 13.9 m -103.2 175.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 m -82.21 65.67 7.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 110.72 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -58.79 171.14 0.69 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.521 ' HD3' ' CG2' ' A' ' 71' ' ' VAL . 78.1 Cg_exo -49.99 -44.27 38.04 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.772 2.315 . . . . 0.0 112.134 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' CG ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -52.56 -41.04 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.318 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 78' ' ' SER . 6.0 m80 -52.83 -66.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.515 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -62.58 -30.76 71.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.639 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -53.55 -39.21 64.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.331 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.76 -50.17 38.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.542 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB3' ' OE2' ' A' ' 119' ' ' GLU . 13.4 mtt180 -72.97 -26.88 61.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 32.6 p -70.76 -3.43 18.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.301 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 43.83 76.17 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.13 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -158.98 61.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD1' ' CD2' ' A' ' 127' ' ' PHE . 62.5 tp -52.42 -19.63 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.138 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -63.13 -71.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.713 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.546 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -73.15 -20.74 60.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 92' ' ' LEU . 1.7 tt -72.95 -42.51 63.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.34 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 97' ' ' GLU . 38.8 ttmt -65.71 -36.94 85.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.447 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.769 ' HA ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -55.82 -58.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.078 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.6 pp -73.07 -34.44 66.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 38.8 t -72.32 -49.31 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.769 ' CD ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -58.77 -32.97 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -30.91 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.35 -0.58 7.55 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -42.99 167.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.113 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.07 88.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.45 HG11 HG23 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -89.35 13.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.6 9.81 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.07 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.08 141.63 58.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 111' ' ' LEU . 6.7 mt -121.67 150.54 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.065 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' OG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -84.98 -48.87 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 106' ' ' ASP . 0.6 OUTLIER -175.25 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 2.26 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 52.8 18.97 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.353 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.575 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -48.27 -50.37 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.541 0.21 . . . . 0.0 111.132 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' SER . 6.2 tp 92.49 127.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.724 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.552 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 84.7 Cg_exo -44.38 -46.11 12.06 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.854 2.369 . . . . 0.0 112.589 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.519 ' N ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -63.38 -31.39 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.153 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 110' ' ' SER . 8.9 m80 -70.03 -34.17 72.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 1.2 mt -63.5 -52.96 59.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -53.56 -36.02 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.582 ' CG1' ' CG1' ' A' ' 125' ' ' VAL . 83.6 mt -61.5 -41.52 90.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -68.91 -12.6 61.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.587 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.544 ' CB ' ' CD2' ' A' ' 121' ' ' HIS . 2.6 mt-10 -91.76 -57.81 2.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.736 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.92 -11.88 10.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.796 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.544 ' CD2' ' CB ' ' A' ' 119' ' ' GLU . 30.7 m-70 -57.22 78.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 126' ' ' SER . 11.8 p -37.72 -45.02 0.76 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.2 p -56.94 -51.27 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.255 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 45.3 t -72.9 -58.85 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.452 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.582 ' CG1' ' CG1' ' A' ' 117' ' ' ILE . 2.4 t -52.04 -40.94 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.321 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' SER . 77.3 p -67.09 -36.87 82.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.111 0.481 . . . . 0.0 110.799 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 68.1 t80 -73.7 -44.51 56.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -70.44 -10.79 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.082 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.574 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -53.31 -69.09 0.37 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 72.0 Cg_endo -74.5 -50.07 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.772 2.315 . . . . 0.0 112.58 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -39.27 -44.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.429 ' HB2' HD12 ' A' ' 128' ' ' LEU . 8.1 t -90.77 134.2 34.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.411 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -40.14 101.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 130' ' ' PRO . 5.2 mp -62.68 -36.77 83.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -63.53 -33.91 76.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.066 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.411 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 12.0 t60 -50.35 155.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -114.14 149.66 35.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.996 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.57 ' HB2' ' CD2' ' A' ' 114' ' ' HIS . 12.4 t70 -66.34 -9.32 32.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 138' ' ' ASP . . . 82.41 -5.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -14.01 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.33 48.3 0.88 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 94.3 mt -151.62 93.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 111.057 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.529 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.82 179.65 0.75 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 73.3 Cg_exo -49.33 -49.41 15.6 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.763 2.309 . . . . 0.0 112.575 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.478 HD23 ' HG2' ' A' ' 161' ' ' GLN . 3.8 mt -73.28 -34.98 66.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 143' ' ' THR . 15.4 mm-40 -52.78 -62.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.512 ' CD1' HD12 ' A' ' 142' ' ' LEU . 2.7 tp -54.71 -48.35 72.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.41 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -57.17 -36.8 71.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.337 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.451 ' HD2' ' HE2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -70.19 -43.69 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.002 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.511 ' HG2' ' N ' ' A' ' 151' ' ' ARG . 10.2 tt0 -71.9 -86.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.976 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.511 ' N ' ' HG2' ' A' ' 150' ' ' GLN . 37.5 mtt-85 -74.7 53.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.549 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -52.07 -20.61 6.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 154' ' ' GLN . . . 34.43 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.597 ' CG ' ' O ' ' A' ' 153' ' ' ALA . 4.6 pp0? 125.95 -154.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.506 ' C ' ' NE2' ' A' ' 154' ' ' GLN . 2.2 t30 -74.41 46.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.408 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.54 ' N ' ' NE2' ' A' ' 154' ' ' GLN . 11.3 mt -69.91 -50.32 43.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.526 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 10.5 ptm -52.13 -26.18 10.68 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.944 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -74.4 -58.61 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.819 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.529 ' CD1' HD21 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -51.91 -38.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.346 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.607 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.23 -23.79 59.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.025 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.478 ' HG2' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.26 -47.26 44.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.07 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.16 53.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 53.3 m-70 -72.12 -8.34 54.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.486 ' CG ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.37 24.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -11.22 28.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.807 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -86.61 -65.26 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 35' ' ' VAL . 2.2 tm? -71.44 -65.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -56.97 -30.97 64.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.43 -63.77 2.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -64.75 -44.51 89.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.077 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -52.62 -51.5 59.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -65.1 -38.24 90.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -70.42 -7.91 46.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 23' ' ' VAL . . . 114.94 -66.28 0.28 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.901 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.083 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 26.89 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.0 111.822 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 55' ' ' SER . 12.6 p -51.66 -35.64 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.21 -42.87 59.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.083 ' OE1' ' HA ' ' A' ' 22' ' ' ASP . 2.7 mp0 -74.43 -25.94 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.302 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.328 HG12 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.31 -40.06 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 60.9 mtt180 -73.99 -48.28 31.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 9.8 mtt180 -66.2 -29.31 69.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 33' ' ' GLU . 6.7 mt -55.31 -67.46 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.507 HD21 ' N ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -73.63 -52.97 11.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.922 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 41.0 m-70 -67.62 -4.73 12.74 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -142.28 -57.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.689 0.281 . . . . 0.0 111.345 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.807 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.92 -4.52 20.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.165 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 39.88 32.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.977 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 14' ' ' LEU . 9.7 p -59.15 166.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 135.5 21.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 56.5 Cg_endo -70.84 -10.04 26.92 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.65 50.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.796 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.6 116.33 32.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -97.54 165.04 12.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.47 46.03 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.85 21.95 5.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.434 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.8 -9.16 8.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.12 20.96 43.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 3.5 mtpt -113.94 143.9 43.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 50' ' ' VAL . 64.7 p -89.3 174.31 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.501 ' CB ' HD13 ' A' ' 14' ' ' LEU . . . -58.48 -38.28 77.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.062 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 69' ' ' PRO . 5.7 mt -73.44 -33.08 64.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.26 -1.39 17.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.481 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -129.78 -46.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.352 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.542 ' HE1' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -36.71 140.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -88.35 146.9 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.091 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 95' ' ' LEU . 1.9 m-85 -87.5 21.72 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -73.06 -40.1 51.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 2.6 m -109.58 120.03 46.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 0.0 110.819 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 1.169 ' HG3' ' OD1' ' A' ' 90' ' ' ASP . 32.1 Cg_exo -58.83 -42.23 54.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.677 2.251 . . . . 0.0 112.168 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.15 70.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 2.3 t -62.98 -48.61 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -63.51 -40.93 98.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 1.8 tm? -63.01 -47.97 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.681 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.328 ' OE1' HG12 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.28 -48.4 78.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.8 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 51' ' ' MET . 8.2 mt -62.87 -54.38 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 95' ' ' LEU . 1.3 tt -63.08 -43.29 98.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.1 ttmm -62.93 -26.15 68.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 35' ' ' VAL . 34.8 tt0 -62.11 -14.67 39.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.7 62.93 1.02 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.69 170.98 8.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -106.96 99.5 26.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HB3' HD12 ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.71 -9.18 23.57 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.689 2.259 . . . . 0.0 112.161 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.506 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.99 63.78 8.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 78' ' ' SER . 16.1 m -117.89 126.99 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.744 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 10.4 mt-30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.463 ' O ' ' OG1' ' A' ' 77' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 76' ' ' GLY . 2.1 m 179.91 139.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.818 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -117.51 179.62 0.79 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.145 0.498 . . . . 0.0 110.982 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 1.178 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 77.1 Cg_exo -48.53 -51.04 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 111.765 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.539 ' CG2' HG23 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.14 -48.76 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.316 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.52 ' N ' HG11 ' A' ' 80' ' ' VAL . 24.0 m80 -52.75 -61.37 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.94 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 1.178 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 10.5 p30 -57.77 -53.69 55.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.665 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -52.25 -38.82 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.459 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.11 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -73.49 -27.42 61.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 27.8 p -71.32 -41.57 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.76 70.71 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.003 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -145.25 53.61 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.648 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.503 HD12 ' CB ' ' A' ' 127' ' ' PHE . 9.2 tp -52.47 -20.63 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.169 ' OD1' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -63.53 -71.8 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.422 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.645 ' N ' ' CG ' ' A' ' 90' ' ' ASP . 6.5 m -73.12 -22.24 60.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.176 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 53' ' ' PHE . 64.8 tp -70.29 -44.22 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 1.259 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 20.3 ttpp -60.63 -44.74 96.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.834 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.969 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.93 -53.33 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.583 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.55 -42.47 61.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.539 HG23 ' CG2' ' A' ' 80' ' ' VAL . 3.2 t -63.69 -52.48 56.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.259 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -55.5 -29.16 58.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.53 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 6.3 t60 -73.08 -56.21 5.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.54 33.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.815 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . -69.41 120.31 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.324 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.8 p-10 -35.81 92.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -107.1 14.17 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.127 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -143.53 38.47 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.08 122.37 26.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -119.16 146.0 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.744 ' OD2' ' HB3' ' A' ' 72' ' ' GLN . 7.3 p30 -155.22 141.03 18.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.1 m 49.39 26.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -163.85 -40.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 1.174 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 68.68 10.79 61.51 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 1.428 ' HA ' ' CG ' ' A' ' 138' ' ' ASP . 2.6 t -104.02 129.45 51.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.564 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 32.5 mt -65.83 147.51 98.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HG3' ' CE1' ' A' ' 81' ' ' HIS . 74.4 Cg_exo -50.44 -29.53 24.43 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.681 2.254 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 128' ' ' LEU . 2.9 tt -69.8 -38.31 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.819 ' ND1' ' OD2' ' A' ' 138' ' ' ASP . 36.4 m80 -53.32 -38.95 63.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.444 HD21 ' NH2' ' A' ' 118' ' ' ARG . 1.4 mt -65.96 -57.61 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.625 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.53 ' O ' ' CG2' ' A' ' 125' ' ' VAL . . . -52.95 -28.67 24.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.42 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.52 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 4.7 mm -65.42 -39.73 86.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.86 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.444 ' NH2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -71.48 -18.25 62.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.526 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 121' ' ' HIS . 4.1 mm-40 -90.87 -54.78 3.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.2 45.76 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.009 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.581 ' CB ' HG21 ' A' ' 124' ' ' VAL . 99.0 m-70 -76.96 3.77 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.698 0.285 . . . . 0.0 111.205 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 40.5 t 71.09 -92.94 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.785 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -52.64 -56.51 14.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.358 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.581 HG21 ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -52.19 -62.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.944 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 116' ' ' ALA . 4.5 t -52.31 -43.83 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.522 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.2 t -72.63 -30.49 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 123' ' ' SER . 63.3 t80 -73.8 -42.12 61.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.065 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.7 -6.99 17.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.336 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.565 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -64.13 -68.94 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 41.2 Cg_endo -67.27 -36.75 20.01 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 2.25 . . . . 0.0 112.353 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 102' ' ' VAL . 8.7 mm-40 -62.33 -22.31 65.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.98 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 128' ' ' LEU . 51.8 m -112.84 147.6 36.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -35.47 111.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 164' ' ' MET . 5.8 mt -79.35 64.46 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.0 p-80 164.72 -36.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . 68.6 t60 -48.62 143.76 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.47 ' HG3' HG21 ' A' ' 143' ' ' THR . 3.4 ttm180 -101.32 177.66 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 1.428 ' CG ' ' HA ' ' A' ' 110' ' ' SER . 1.3 t0 -121.26 156.48 32.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -22.25 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.183 0.516 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.53 ' HB3' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -73.88 -58.73 3.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.724 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 1.18 ' O ' ' OE2' ' A' ' 146' ' ' GLU . . . 124.84 43.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.852 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 140' ' ' SER . 0.2 OUTLIER -153.45 114.42 4.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.568 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -82.78 -174.35 0.52 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 86.9 Cg_exo -44.87 -52.12 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.448 2.098 . . . . 0.0 112.072 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 161' ' ' GLN . 10.2 mt -73.35 -36.79 66.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.18 ' OE2' ' O ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -63.9 -64.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.951 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -52.37 -46.19 66.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.491 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 157' ' ' MET . . . -55.97 -32.96 64.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.19 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.35 -68.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.649 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.76 66.18 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 153' ' ' ALA . . . -64.46 50.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.587 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 154' ' ' GLN . . . -60.56 -142.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.41 -149.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 1.071 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 71.4 m-20 -74.64 44.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.565 ' HB3' ' NE2' ' A' ' 154' ' ' GLN . 2.5 pt? -69.16 -52.9 23.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.555 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER -56.37 -33.62 65.89 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.144 0.497 . . . . 0.0 110.076 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 1.071 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 15.4 p-10 -74.23 -40.0 62.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 10.6 mt -52.69 -49.86 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.76 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.78 -33.11 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.968 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.451 ' HG3' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -52.7 -51.41 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.947 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.35 63.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -48.8 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.484 ' HA ' HD12 ' A' ' 134' ' ' LEU . 1.5 tpp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 35' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.825 0.345 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -60.85 -81.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 11.0 t0 -59.93 -14.54 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -63.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 1.7 tm? -73.13 -54.67 7.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.034 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.457 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 5.5 p -57.72 -30.32 65.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -70.76 -46.12 48.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.5 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.86 -55.89 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.267 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.4 69.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 52' ' ' MET . . . -68.03 -26.83 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.226 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -73.29 -26.58 61.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.441 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 88.1 66.5 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 1.069 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 13.4 p-10 -137.15 94.46 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' HG11 ' A' ' 26' ' ' VAL . 7.3 p -53.07 -20.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.169 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -74.18 -51.87 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.08 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.069 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -73.24 -32.98 65.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.818 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 2.3 p -52.69 -49.58 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 111.09 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 29.7 mtt180 -73.64 -48.88 29.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.279 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.5 mmp_? -52.85 -30.23 32.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.17 -73.99 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.525 ' CD1' HD22 ' A' ' 62' ' ' LEU . 1.7 mt -73.59 -42.7 61.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.484 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.11 -3.23 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.37 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -143.02 -75.46 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.815 ' OE1' ' HB ' ' A' ' 35' ' ' VAL . 14.1 tt0 -46.93 -23.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt 62.01 29.92 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.815 ' HB ' ' OE1' ' A' ' 33' ' ' GLU . 2.7 p -58.92 137.15 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.434 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -69.03 145.88 96.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 40.0 Cg_endo -67.33 -11.03 30.69 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.211 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 29.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . . . -97.9 94.81 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.282 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.519 ' CD1' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -102.86 147.87 26.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.685 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 24.5 p30 -44.99 -26.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.0 0.429 . . . . 0.0 110.285 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -146.02 -71.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.534 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 177.89 66.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.933 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.29 -73.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.971 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 30.1 mttm -84.87 152.92 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 111.336 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.519 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 74.5 p -101.52 176.71 5.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' CB ' HD23 ' A' ' 62' ' ' LEU . . . -57.14 -35.74 69.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 62' ' ' LEU . 3.5 tp -72.83 -47.86 42.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 77' ' ' THR . 2.0 tm0? -65.52 -9.56 27.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 46' ' ' THR . 32.8 m -136.31 26.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.1 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.525 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 1.1 tmm? -86.86 149.88 24.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.512 ' N ' ' HG2' ' A' ' 51' ' ' MET . 0.9 OUTLIER -87.87 86.6 7.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.381 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB1' ' A' ' 83' ' ' ALA . 53.4 m-85 -35.14 -30.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -28.79 -55.32 0.15 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.148 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.454 ' HB3' HG22 ' A' ' 58' ' ' VAL . 1.3 t -90.94 130.94 38.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 91' ' ' THR . 61.0 Cg_endo -73.22 -42.97 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.761 2.307 . . . . 0.0 112.043 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -62.8 -29.01 70.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.521 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.52 ' CG2' HG22 ' A' ' 26' ' ' VAL . 2.5 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.879 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' HG22 ' A' ' 91' ' ' THR . . . -63.21 -52.95 60.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.61 -38.45 91.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.024 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -62.84 -49.35 75.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 HD22 ' CD1' ' A' ' 30' ' ' LEU . 13.0 mt -62.77 -50.29 71.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.842 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 ' HG3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -62.91 -23.02 67.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.671 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 11.9 tttt -63.05 -20.4 65.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.79 -57.22 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.89 50.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.515 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . . . -83.56 -13.78 53.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.9 95.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.455 ' HG3' HD12 ' A' ' 63' ' ' LEU . 74.6 Cg_exo -48.19 -41.47 34.37 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.85 ' ND2' ' OD1' ' A' ' 101' ' ' ASP . 3.5 m120 -71.16 84.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 49' ' ' GLN . 4.7 m -136.45 131.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.9 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 1.279 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . 2.6 m -115.9 119.21 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.6 p -104.96 -176.02 0.41 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 40.5 Cg_exo -56.22 -42.98 60.59 Favored 'Trans proline' 0 CA--C 1.527 0.128 0 C-N-CA 122.814 2.342 . . . . 0.0 112.058 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.67 -29.95 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.476 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.582 ' ND1' ' OD2' ' A' ' 106' ' ' ASP . 9.4 m170 -72.08 -68.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.0 OUTLIER -61.25 -25.98 67.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.207 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB1' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.49 -53.76 53.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.563 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.97 -38.14 66.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.568 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 1.081 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 6.5 tpt180 -72.15 -24.04 61.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.215 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 5.5 p -73.07 -73.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 132.7 63.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.324 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 22.8 m-85 -155.06 59.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.635 ' CD1' ' CG ' ' A' ' 127' ' ' PHE . 37.6 tp -52.21 -29.32 22.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.235 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 1.108 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -53.19 -67.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.459 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 1.108 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 47.7 m -72.24 -42.16 65.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.519 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 1.2 tt -52.37 -48.68 65.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.492 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 127' ' ' PHE . 6.2 ttpp -55.39 -26.08 39.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.877 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.229 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 18.1 t -73.54 -70.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.542 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -63.91 -27.33 69.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.534 -179.375 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 95' ' ' LEU . 41.3 t -73.88 -56.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.759 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 1.229 ' OE2' ' HA ' ' A' ' 94' ' ' VAL . 17.3 pm0 -56.29 -35.39 67.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.516 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 10.6 t-160 -60.65 -68.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . 179.19 61.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.523 ' C ' ' OD1' ' A' ' 101' ' ' ASP . . . -105.76 26.5 9.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.85 ' OD1' ' ND2' ' A' ' 70' ' ' ASN . 1.1 p-10 47.87 82.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.456 HG12 HG12 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -88.02 15.51 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 65.3 m-20 -131.89 27.33 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -101.7 162.03 13.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 74.2 mt -125.13 150.27 47.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 1.279 ' OD2' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -100.34 -169.55 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.8 m -48.29 -46.14 35.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -33.33 75.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 84.03 31.17 26.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.569 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.3 m -105.73 119.98 40.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 9.3 tp -54.53 138.09 60.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 104' ' ' ALA . 94.4 Cg_exo -43.37 -27.01 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.796 2.33 . . . . 0.0 112.366 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.525 ' HB ' ' CD2' ' A' ' 128' ' ' LEU . 0.3 OUTLIER -73.23 -42.77 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.797 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 31.3 m80 -52.91 -32.51 45.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.286 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 118' ' ' ARG . 0.5 OUTLIER -73.11 -48.66 33.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.361 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 125' ' ' VAL . . . -61.74 -32.95 73.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 147' ' ' LEU . 80.2 mt -66.55 -42.2 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.691 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.6 -16.91 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.081 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -86.67 -57.84 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.415 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 110.23 -0.69 29.72 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.531 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 15.2 m-70 -57.68 78.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.592 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -34.36 -48.59 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.466 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -62.45 -48.33 80.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 121' ' ' HIS . 47.5 t -69.57 -60.17 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 116' ' ' ALA . 2.4 t -51.87 -44.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.158 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.559 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 60.6 p -71.87 -29.35 64.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.169 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 27.3 t80 -73.22 -66.4 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.525 ' CD2' ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -65.73 -8.76 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.58 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -52.22 -71.1 0.22 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 57.4 Cg_endo -70.88 -33.0 13.0 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 128' ' ' LEU . 30.9 mm-40 -54.59 -20.4 7.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.283 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.447 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 p -105.81 -171.25 1.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' HIS . 4.1 p30 -94.5 84.63 4.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.992 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -57.59 75.3 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.222 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 p-80 174.98 -39.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -47.89 173.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -129.88 174.32 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -131.25 166.97 20.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.6 -20.18 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -52.38 55.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.44 11.2 6.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 1.445 ' HB3' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -132.72 160.72 35.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.522 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -112.99 -178.39 0.52 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 84.3 Cg_exo -44.91 -59.75 1.04 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.634 2.223 . . . . 0.0 112.138 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.44 HD23 ' CG ' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -58.4 -46.74 85.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.633 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.445 ' CD ' ' HB3' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.78 -62.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.478 ' HG ' ' CD1' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -52.87 -43.61 66.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 157' ' ' MET . . . -52.64 -43.46 65.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.375 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -61.04 -36.15 78.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.753 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.486 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -69.74 -80.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.572 179.032 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.36 61.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.6 52.29 0.88 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.79 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -32.7 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.452 . . . . 0.0 110.723 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER 172.53 -119.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.29 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.78 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 2.0 m-20 -74.06 4.73 5.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.135 -0.353 . . . . 0.0 111.692 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 0.1 OUTLIER -52.66 -51.84 58.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.524 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 2.4 ppp? -53.2 -34.7 58.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.78 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 3.1 p30 -73.67 -43.58 59.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.559 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 15.5 mt -52.74 -44.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.369 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 160' ' ' LEU . 1.3 mt -73.29 -35.51 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.336 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.44 ' CG ' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -67.41 -37.89 83.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.01 44.98 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.389 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -73.26 -9.8 59.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 13' ' ' ARG . 3.9 p . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.779 0.323 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.524 ' N ' ' HB3' ' A' ' 39' ' ' ALA . . . -40.24 -60.48 1.96 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.386 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 29.4 p30 -56.51 -17.39 8.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.754 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.536 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.1 tpm_? -98.59 -64.25 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.756 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' VAL . 2.8 tm? -69.22 -61.71 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -55.94 -28.29 56.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.64 -49.05 39.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.188 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -73.03 -40.3 65.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.12 65.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.287 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 52' ' ' MET . . . -73.1 -37.58 66.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -73.43 -8.13 54.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' HA2' ' CE ' ' A' ' 52' ' ' MET . . . 124.89 -66.56 0.53 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.179 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 33.54 38.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.39 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 2.3 p -52.66 -49.88 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -75.14 -32.62 61.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.811 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.494 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -73.24 -37.39 66.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.577 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 1.194 HG12 ' OE1' ' A' ' 61' ' ' GLU . 2.4 p -52.39 -35.08 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -71.29 -51.63 23.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.97 -36.72 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.095 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.877 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 20.2 mt -52.96 -61.86 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.1 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.508 HD22 ' CG2' ' A' ' 35' ' ' VAL . 10.3 mt -73.45 -49.19 28.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.823 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.869 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 20.2 m-70 -70.14 -19.33 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.861 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -126.05 -78.91 0.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 1.232 ' OE2' HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -39.87 -28.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.1 mt 62.38 31.03 17.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.525 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 1.232 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -54.44 152.07 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.336 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.69 124.6 69.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.83 -11.34 29.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.694 2.262 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 6.3 p30 -90.97 -8.61 48.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.524 ' HB3' ' N ' ' A' ' 11' ' ' GLY . . . -43.67 136.96 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 43' ' ' PHE . 6.4 mt -129.81 108.92 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -40.45 -44.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.989 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -135.77 35.18 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 49.25 48.08 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.27 -45.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.445 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.05 147.39 46.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -86.09 166.62 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.27 25.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -73.12 -43.86 61.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HG2' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.74 -20.63 65.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.434 HG21 ' N ' ' A' ' 51' ' ' MET . 18.7 m -104.73 -34.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.456 ' HG3' HD13 ' A' ' 62' ' ' LEU . 2.0 ttp -42.12 134.81 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.482 ' CE ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -86.74 134.44 33.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.591 ' CE2' HD22 ' A' ' 95' ' ' LEU . 10.8 m-85 -78.37 52.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.633 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -106.29 -59.55 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.108 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -86.76 114.3 57.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 110.302 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.493 ' N ' HG22 ' A' ' 91' ' ' THR . 9.2 Cg_endo -53.64 -42.29 67.18 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.562 2.175 . . . . 0.0 112.145 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.24 -33.36 75.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 2.2 t -63.06 -39.93 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -63.04 -59.83 4.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 19.6 tp -63.23 -41.2 99.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.535 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 1.194 ' OE1' HG12 ' A' ' 26' ' ' VAL . 10.6 mt-10 -62.88 -45.84 90.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.501 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 3.2 mt -62.83 -57.1 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 4.4 pp -63.51 -25.82 68.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.339 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -63.14 -46.9 85.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 30' ' ' LEU . 1.8 mm100 -51.36 -43.85 61.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.65 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.46 159.91 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.92 110.8 36.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.988 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.435 ' HB3' HD12 ' A' ' 48' ' ' LEU . 77.7 Cg_endo -77.59 7.72 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.787 2.325 . . . . 0.0 112.423 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 1.081 ' OD1' ' OD2' ' A' ' 101' ' ' ASP . 43.4 m-80 -89.48 26.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' SER . 8.3 m -107.5 139.08 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.045 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -156.85 103.68 2.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 p -70.51 -174.29 0.25 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.962 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 62.9 Cg_exo -50.64 -50.9 12.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.774 2.316 . . . . 0.0 112.533 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 15.3 m -59.34 -43.81 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.373 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 44.1 m170 -61.45 -34.47 75.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.043 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.962 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.74 -51.09 20.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.568 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -70.05 -11.98 61.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.39 -43.83 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.406 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.995 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 2.0 mmt180 -61.51 -58.42 8.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.231 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -72.48 -22.55 61.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' CA ' ' CG2' ' A' ' 124' ' ' VAL . . . 105.14 -62.83 0.33 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 16.9 m-85 30.97 37.1 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 110.259 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.631 ' CD2' ' CD2' ' A' ' 127' ' ' PHE . 2.2 tm? -51.73 -41.87 61.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.512 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.641 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.0 -62.96 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.828 0.347 . . . . 0.0 110.877 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -72.01 -46.33 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 14.6 tp -52.4 -43.03 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 109.916 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 97' ' ' GLU . 1.9 ttpp -53.52 -37.92 63.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.486 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 42.9 t -57.08 -60.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.107 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -73.18 -33.41 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.533 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 4.6 t -73.12 -45.33 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 93' ' ' LYS . 0.9 OUTLIER -58.24 -32.44 68.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.773 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -73.13 -50.38 23.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -166.44 -69.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.298 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.533 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . 30.13 82.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.777 0.322 . . . . 0.0 111.559 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.081 ' OD2' ' OD1' ' A' ' 70' ' ' ASN . 2.1 p-10 -39.84 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 100' ' ' ALA . 12.9 m -84.24 11.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.38 -25.94 20.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 105' ' ' LEU . . . -50.9 157.45 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.481 ' CD2' HD22 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -143.29 161.39 38.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.814 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.82 -90.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.005 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.84 -38.57 2.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 -1.89 25.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 62.57 23.29 64.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 139.79 30.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' A' ' 114' ' ' HIS . 11.4 mt -68.34 162.76 58.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 102' ' ' VAL . 76.4 Cg_exo -50.23 -34.26 39.16 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -61.46 -44.06 97.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.98 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.561 ' CE1' ' HG ' ' A' ' 111' ' ' LEU . 1.9 m80 -53.07 -44.38 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.875 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -67.64 -48.95 65.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.539 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 1.196 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.21 -43.31 67.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 156' ' ' LEU . 46.0 mt -54.86 -40.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.654 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -41.7 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.473 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.196 ' OE1' ' CA ' ' A' ' 116' ' ' ALA . 2.2 mp0 -72.53 -55.58 6.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.8 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.18 52.01 2.46 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 0.5 OUTLIER -81.43 -7.14 59.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.996 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -71.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -66.63 -35.53 80.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.519 ' CG2' ' CA ' ' A' ' 87' ' ' GLY . 42.9 t -74.01 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.087 0.47 . . . . 0.0 110.606 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 116' ' ' ALA . 4.2 m -53.3 -45.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.335 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.481 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 15.8 p -71.92 -28.85 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.784 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 19.0 t80 -73.49 -44.33 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.521 ' CD1' ' OG ' ' A' ' 132' ' ' SER . 0.2 OUTLIER -67.41 -11.51 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.153 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.537 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -56.41 -67.46 0.79 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.283 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 29.6 Cg_endo -64.16 -62.07 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.617 2.212 . . . . 0.0 112.452 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.784 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -37.59 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 17.4 m -98.41 129.4 45.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 1.181 ' OD1' ' HB2' ' A' ' 136' ' ' HIS . 0.1 OUTLIER -36.0 95.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 132' ' ' SER . 4.0 mt -60.19 151.03 28.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 74.52 13.79 3.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.181 ' HB2' ' OD1' ' A' ' 133' ' ' ASP . 63.1 t60 -103.83 168.95 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -127.2 -160.34 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.12 -171.63 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.41 -9.59 26.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -39.6 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.26 68.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.8 mt -156.91 133.3 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 1.196 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 80.9 p -96.51 159.12 32.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 6.0 Cg_exo -38.61 -48.8 2.59 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.15 2.566 . . . . 0.0 112.184 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.98 -40.58 87.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.792 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 1.196 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 1.1 mp0 -52.99 -68.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' ' 150' ' ' GLN . 8.4 tp -52.66 -29.01 24.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 157' ' ' MET . . . -73.17 -15.22 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.459 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 1.4 ttt180 -73.26 -48.46 34.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.46 -90.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.885 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -75.88 50.65 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -74.21 44.26 1.34 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.829 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.553 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -34.46 150.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 40.44 -161.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.89 ' CA ' ' OD1' ' A' ' 158' ' ' ASP . 1.1 t-20 -74.61 43.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.207 -0.308 . . . . 0.0 111.543 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.513 ' CD1' HG21 ' A' ' 117' ' ' ILE . 2.2 mt -59.43 -55.95 28.15 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 110.966 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.469 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -51.66 -44.04 62.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.89 ' OD1' ' CA ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -74.5 -35.08 63.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.267 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.511 HG21 ' CD2' ' A' ' 160' ' ' LEU . 11.0 mt -53.16 -52.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.158 0.504 . . . . 0.0 110.456 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.51 -24.54 59.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.256 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -64.46 -41.72 96.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.164 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.48 -53.51 8.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 15.2 m-70 -60.87 -40.24 92.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.881 0.372 . . . . 0.0 110.88 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.417 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.994 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 t -113.64 144.45 42.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.757 0.313 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.2 mtt 55.27 74.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -11.61 13.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.05 106.81 12.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -124.58 124.46 42.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 18.6 tt0 -134.67 47.75 2.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' GLY . 12.6 p -114.91 -26.15 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.025 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.3 t -44.05 -36.87 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.558 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 52.3 t -92.04 -18.22 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.863 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -53.64 -83.07 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 3.0 p30 -51.92 -29.94 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -37.0 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.787 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 4.9 tp -72.28 -23.84 61.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -65.59 -49.89 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.7 -27.91 68.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.503 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -72.21 -55.07 7.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.347 . . . . 0.0 111.249 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.82 79.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.249 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -32.64 64.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.4 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -71.0 -9.86 58.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.002 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.42 75.89 0.57 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 24' ' ' GLN . 1.2 t70 -144.7 85.56 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.795 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -52.9 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.432 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 mt-30 -70.66 -45.02 65.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.7 mm-40 -72.99 -49.43 29.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.676 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 58' ' ' VAL . 47.2 t -57.92 -29.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 4.8 mmt180 -72.03 -60.86 2.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -69.16 -22.77 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.1 mt -54.44 -66.55 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 35' ' ' VAL . 16.5 mt -72.28 -40.59 67.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.13 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 23.0 m-70 -65.41 -19.62 66.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.306 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -133.0 -66.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' LEU . 2.4 tp10 -58.48 -14.46 7.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.2 mt 46.96 25.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.786 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' CG2' ' CB ' ' A' ' 14' ' ' LEU . 14.7 p -43.96 148.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 144.29 43.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.12 -22.98 21.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.404 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.54 2.53 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -42.25 124.74 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.2 mt -122.01 130.08 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 4.6 p-10 -66.21 -179.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -47.79 -43.34 27.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.89 -65.34 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.52 47.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 13.2 mtpt -116.42 151.08 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.8 p -85.14 162.05 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . . . -53.83 -47.46 70.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.118 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 69' ' ' PRO . 1.1 mp -62.8 -27.59 69.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' NE2' HG22 ' A' ' 71' ' ' VAL . 9.8 tt0 -72.97 -29.26 62.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 46' ' ' THR . 2.9 m -101.63 -26.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -36.65 142.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.797 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 ptt? -102.31 22.69 12.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 4.7 m-85 36.57 31.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -76.94 -77.8 0.77 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.487 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -77.86 121.02 83.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.966 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.47 -45.69 37.9 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.61 2.207 . . . . 0.0 112.159 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 61' ' ' GLU . . . -63.16 -28.69 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.368 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 HG23 ' CG2' ' A' ' 26' ' ' VAL . 2.5 t -62.95 -38.57 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.209 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' CB ' HG21 ' A' ' 91' ' ' THR . . . -63.32 -49.77 72.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 53.1 tp -63.15 -33.13 74.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 1.9 mm-40 -62.54 -49.1 76.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 47' ' ' ALA . 5.6 mt -62.96 -56.26 18.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.608 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.36 -25.73 68.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 1.6 tttp -62.84 -29.84 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -73.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.92 62.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.45 153.29 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.165 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -96.6 99.24 5.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.493 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 31.7 Cg_endo -64.31 -15.83 51.75 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -79.7 65.86 4.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG22 ' NE2' ' A' ' 49' ' ' GLN . 28.2 m -126.4 138.11 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.261 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.44 146.53 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 2.9 p30 -153.06 142.99 22.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 73' ' ' ASP . . . 40.88 97.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 76' ' ' GLY . 7.4 t 73.68 30.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 75' ' ' SER . . . 37.18 62.83 0.84 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -114.88 102.1 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -89.75 -174.57 0.46 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 51.3 Cg_exo -55.57 -41.65 75.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.85 2.367 . . . . 0.0 112.545 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -62.86 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.328 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.412 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 65.8 m80 -58.14 -51.37 70.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.532 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -66.63 -50.38 63.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.39 -30.44 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.41 -67.11 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.617 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -62.33 -29.55 70.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.812 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 52.2 p -66.99 -54.07 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 111.211 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.457 ' CA ' ' NE2' ' A' ' 121' ' ' HIS . . . 110.38 66.04 0.54 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.121 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -140.66 53.43 1.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 0.0 110.55 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 123' ' ' SER . 20.6 tp -52.23 -19.07 1.8 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -63.52 -72.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.461 HG21 ' CB ' ' A' ' 59' ' ' ALA . 6.3 m -73.15 -24.1 60.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.527 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD21 ' N ' ' A' ' 93' ' ' LYS . 9.7 tt -56.16 -59.79 4.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 127' ' ' PHE . 8.1 ptmt -58.32 -38.0 76.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.133 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -51.73 -61.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.09 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -74.8 -43.48 54.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.527 ' CG2' HD22 ' A' ' 92' ' ' LEU . 10.7 t -52.54 -42.55 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.512 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.6 mm-40 -73.54 -39.53 64.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.225 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -51.88 66.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 178.77 -26.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.095 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.511 ' CB ' HD11 ' A' ' 95' ' ' LEU . . . -23.82 123.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 112.002 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.49 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 9.8 t0 -56.6 85.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 102' ' ' VAL . 10.2 p -98.31 28.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 104' ' ' ALA . 0.2 OUTLIER -120.91 -33.22 3.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -48.11 -177.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.469 HD23 ' HG ' ' A' ' 111' ' ' LEU . 9.3 mt -139.99 175.47 9.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.88 62.03 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 108' ' ' THR . 0.3 OUTLIER 68.45 -75.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 107' ' ' SER . 4.7 p -37.96 -48.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.93 19.72 2.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.512 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.512 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -93.06 118.29 31.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 110.993 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.469 ' HG ' HD23 ' A' ' 105' ' ' LEU . 5.2 mt -65.27 143.8 98.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.646 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.497 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 83.7 Cg_exo -45.2 -26.12 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.606 2.204 . . . . 0.0 112.173 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -72.12 -40.04 66.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.084 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.48 ' O ' HD22 ' A' ' 147' ' ' LEU . 46.0 m170 -53.04 -46.04 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.699 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' A' ' 118' ' ' ARG . 0.5 OUTLIER -58.76 -44.19 90.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.671 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.532 ' CB ' HG13 ' A' ' 124' ' ' VAL . . . -60.04 -35.63 75.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.443 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.478 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 97.8 mt -64.45 -43.62 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 12.6 ptt180 -73.26 -10.12 59.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.745 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -59.77 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.08 25.22 7.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.404 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.526 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 9.7 m-70 -63.82 -11.93 31.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.2 t 70.52 -68.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -70.63 -52.86 18.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 116' ' ' ALA . 22.0 t -52.83 -55.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 2.9 t -52.0 -61.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.555 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 5.4 p -58.0 -30.44 66.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 93' ' ' LYS . 27.4 t80 -73.31 -55.39 6.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -63.93 -11.67 30.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.067 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.583 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -57.56 -70.24 0.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 57.9 Cg_endo -71.51 -17.92 29.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.238 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' HG12 ' A' ' 102' ' ' VAL . 29.4 mm-40 -90.56 31.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -152.1 -168.62 3.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.901 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 135' ' ' HIS . 23.5 t0 -77.1 83.78 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 130' ' ' PRO . 5.9 mp -64.97 61.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.976 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.464 ' N ' ' O ' ' A' ' 133' ' ' ASP . 19.0 t-160 -175.07 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.438 ' HB3' HD12 ' A' ' 111' ' ' LEU . 79.0 t60 -54.89 155.02 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -140.67 158.29 44.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.512 ' OD1' ' CB ' ' A' ' 110' ' ' SER . 1.9 t70 -64.23 158.7 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.68 -19.69 6.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 110.287 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.459 ' HB3' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -67.87 -46.22 72.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.859 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 125.08 32.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 140' ' ' SER . 0.2 OUTLIER -129.16 146.31 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -115.82 -174.32 0.27 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.593 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 71.7 Cg_exo -48.66 -43.69 33.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.455 HD13 ' HE1' ' A' ' 164' ' ' MET . 0.8 OUTLIER -73.19 -47.91 39.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 17.3 tp10 -57.54 -57.52 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 114' ' ' HIS . 6.6 tp -52.35 -34.31 46.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 157' ' ' MET . . . -63.82 -33.04 74.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.61 -30.18 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.007 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.518 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 3.1 tp-100 -70.4 -80.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.668 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -74.2 71.89 1.71 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -72.54 46.18 1.07 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.321 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -36.79 -32.81 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.393 0.616 . . . . 0.0 110.263 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 3.3 pm0 -179.66 -143.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.689 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.537 ' N ' ' HG2' ' A' ' 154' ' ' GLN . 1.1 m-80 -68.82 57.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.963 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.492 HD22 ' NE2' ' A' ' 154' ' ' GLN . 4.1 mt -71.47 -69.77 0.36 Allowed 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 111.008 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.527 ' CB ' ' HB2' ' A' ' 148' ' ' ALA . 6.8 ptm -52.73 -19.46 2.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.786 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.64 -47.28 41.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.555 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 1.5 mt -62.08 -50.64 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 156' ' ' LEU . 4.1 mp -68.33 -29.99 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 157' ' ' MET . 4.4 tt0 -63.54 -42.91 98.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.24 -47.76 35.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.653 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -71.1 -20.04 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.043 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.455 ' HE1' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -45.71 -70.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.519 ' O ' ' CD1' ' A' ' 166' ' ' ILE . 0.6 OUTLIER 169.12 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 165' ' ' MET . 0.6 OUTLIER 35.38 77.67 0.37 Allowed Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.088 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.77 7.4 4.29 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.813 2.342 . . . . 0.0 112.423 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.941 -179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t -132.38 102.19 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -124.02 37.89 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.81 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt -76.77 -24.03 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mt 56.25 -172.49 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.704 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' C ' ' CG ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -138.88 52.92 1.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' CG ' ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER 44.36 71.44 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 9' ' ' CYS . 54.1 t -126.19 -85.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' N ' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER 60.03 -83.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.554 ' CG2' ' CG1' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -93.53 -13.51 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -34.27 -31.12 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.816 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -109.62 -21.08 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 0.0 110.935 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' VAL . 9.5 tpt180 -57.07 -69.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.034 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 3.8 tp -68.65 -20.4 64.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 23.8 t -73.32 -44.32 59.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.01 -33.68 59.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.621 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -71.61 -38.88 70.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.58 62.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.206 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -67.96 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.202 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.1 ptp180 -68.3 -9.33 46.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . 62.0 76.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.27 90.02 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' HA ' HG13 ' A' ' 26' ' ' VAL . 2.4 p -52.65 -22.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.08 -47.86 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 mm-40 -72.87 -44.7 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.993 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.493 HG11 ' N ' ' A' ' 27' ' ' ARG . 4.8 p -52.64 -41.87 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.018 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.493 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.3 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 5.2 mtt180 -56.0 -21.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' LEU . 10.3 mt -72.42 -68.99 0.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.61 -44.07 78.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.302 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 61.6 m-70 -73.13 -0.94 15.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.277 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -149.26 -76.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.212 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.5 tp10 -42.88 -27.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.978 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER 55.4 59.57 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.554 ' CG1' ' CG2' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -84.23 143.35 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.687 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 2.1 t-80 -76.29 143.56 73.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.766 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 45.1 Cg_endo -68.07 -21.75 42.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 0.0 112.135 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.869 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -91.21 33.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.77 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.507 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -80.93 125.6 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.39 124.2 39.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 2.4 p30 -62.5 -62.21 1.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 30.5 tpt180 -97.87 46.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 26.5 t80 37.48 62.32 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.95 -65.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.385 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 15.3 mtpp -86.91 146.63 26.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.676 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 50' ' ' VAL . 4.2 p -92.73 -177.95 4.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -72.27 -36.0 68.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -32.08 69.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HB2' HG22 ' A' ' 71' ' ' VAL . 1.8 tt0 -69.94 -15.31 63.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 46' ' ' THR . 2.6 m -110.25 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.8 ttp -38.08 123.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.562 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -88.87 19.64 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.605 ' CE2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER 39.35 30.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.121 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . -71.22 -45.51 48.48 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.121 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.517 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 20.5 m -108.6 134.85 20.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 57.3 Cg_endo -70.6 -37.7 6.84 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.572 2.181 . . . . 0.0 112.29 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.22 83.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 55' ' ' SER . 5.4 m -62.5 -27.99 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 94' ' ' VAL . . . -63.37 -60.36 3.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.8 tm? -63.15 -40.67 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.964 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -62.52 -40.57 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.562 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.86 -63.57 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.496 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 98' ' ' HIS . 23.6 tp -63.58 -14.69 53.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -62.9 -36.01 81.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.051 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.461 ' HG2' HD11 ' A' ' 30' ' ' LEU . 2.4 mm-40 -68.08 -14.48 63.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.15 34.88 4.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.85 -179.41 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -121.92 93.75 48.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.22 -17.4 11.64 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.734 2.289 . . . . 0.0 112.179 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.719 ' OD1' ' OD1' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -94.65 64.02 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.793 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG21 ' HD3' ' A' ' 79' ' ' PRO . 2.7 m -104.56 146.55 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -142.79 143.68 32.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.7 p-10 -109.41 -170.3 1.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.75 68.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER 177.48 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.49 77.3 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.569 HG21 ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -164.63 135.56 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.897 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.553 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.54 -177.38 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 29.2 Cg_exo -61.65 -39.53 53.21 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.883 2.389 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.5 m -60.31 -28.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.569 ' CG ' HG21 ' A' ' 77' ' ' THR . 3.2 m80 -62.65 -67.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.81 -43.92 90.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB3' ' CD2' ' A' ' 53' ' ' PHE . . . -52.48 -28.3 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.128 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.71 -56.5 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 115' ' ' LEU . 1.8 mtt180 -73.16 -22.79 60.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.815 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 69.5 p -71.12 -57.06 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.2 67.8 0.5 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 52' ' ' MET . 22.8 m-85 -140.61 52.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.413 . . . . 0.0 110.586 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' CD2' ' HD3' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -52.36 -30.63 29.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.47 ' HA ' HG22 ' A' ' 94' ' ' VAL . 97.8 m -65.9 -37.4 86.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' CE2' ' A' ' 53' ' ' PHE . 9.6 tp -52.82 -49.46 65.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.334 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.572 ' HD2' ' CE2' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -53.99 -42.15 68.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.504 ' HB ' ' CB ' ' A' ' 59' ' ' ALA . 22.6 t -52.86 -59.09 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.435 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.605 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 2.9 pp -71.3 -41.17 70.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 2.1 t -67.48 -56.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.953 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -52.72 -29.73 28.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.053 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.521 ' N ' ' HG3' ' A' ' 97' ' ' GLU . 4.2 t-80 -60.61 -32.26 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.934 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.33 -5.52 4.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.01 141.13 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.743 0.306 . . . . 0.0 111.044 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.719 ' OD1' ' OD1' ' A' ' 70' ' ' ASN . 19.6 p-10 -52.08 140.17 21.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.06 13.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.465 ' HA ' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.82 8.01 30.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -82.26 136.85 34.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.52 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -106.76 167.34 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 108' ' ' THR . 3.3 p30 -89.59 -169.67 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -20.89 26.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.406 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 1.9 m -90.05 -9.39 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.795 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 71.93 42.28 52.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.441 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 1.342 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 2.7 m -119.15 127.93 53.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -59.95 149.63 72.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 55.1 Cg_exo -51.72 -30.52 37.68 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.13 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 128' ' ' LEU . 14.4 tt -71.0 -32.46 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 32.9 m170 -62.16 -36.19 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -73.28 -42.95 61.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.638 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.543 ' CG1' ' CG1' ' A' ' 125' ' ' VAL . 96.6 mt -59.79 -41.51 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -73.23 -4.05 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 115' ' ' LEU . 1.9 mm-40 -118.07 -46.07 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.5 53.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.099 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.47 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 23.8 m-70 -66.99 84.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.0 t 52.91 -146.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -73.6 4.37 5.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 46.7 t -52.27 -60.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.543 ' CG1' ' CG1' ' A' ' 117' ' ' ILE . 2.4 t -52.75 -36.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.104 0.478 . . . . 0.0 110.506 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.534 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.5 t -70.13 -44.96 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.581 ' CE2' ' OE1' ' A' ' 131' ' ' GLU . 20.4 t80 -69.15 -26.78 65.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -73.56 -0.19 14.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.251 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.586 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -73.11 -70.05 0.29 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 39.4 Cg_endo -66.86 -46.81 3.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.795 2.33 . . . . 0.0 112.802 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.581 ' OE1' ' CE2' ' A' ' 127' ' ' PHE . 4.8 pt-20 -51.52 -34.65 37.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.351 . . . . 0.0 110.758 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 9.3 m -108.8 151.06 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.125 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 31.1 p30 -34.8 121.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 164' ' ' MET . 6.9 mt -89.8 27.69 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -167.87 43.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.066 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.125 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -109.85 172.91 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 mtm-85 -141.66 125.42 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.986 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 1.342 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 1.5 t0 -76.14 152.62 36.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.12 -21.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.74 47.87 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.575 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' A' ' 147' ' ' LEU . 2.9 pp -174.43 139.65 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.165 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -95.41 -175.31 0.45 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 85.0 Cg_exo -47.67 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.802 2.335 . . . . 0.0 112.275 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.77 -36.05 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.526 ' CB ' ' HB2' ' A' ' 142' ' ' LEU . 68.3 mm-40 -61.48 -63.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -52.83 -48.99 66.6 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.063 0.458 . . . . 0.0 109.808 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -54.61 -33.79 61.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.052 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -66.42 -44.73 82.15 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.501 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -67.84 -88.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.932 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 11.3 ttm180 -75.22 58.0 0.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 148' ' ' ALA . . . -73.18 45.53 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.557 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.54 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -39.27 134.86 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 36.68 -152.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.529 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 3.5 p-10 -74.45 50.31 0.41 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.236 -0.186 . . . . 0.0 110.861 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 3.3 mt -66.39 -70.64 0.23 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 111.67 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.535 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 9.1 ptm -52.49 -20.07 2.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -73.62 -52.35 13.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.534 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 1.9 mt -57.65 -32.2 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 120.913 0.387 . . . . 0.0 111.009 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.61 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -73.5 -40.84 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.058 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -65.71 -25.71 67.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -54.68 6.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.345 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -71.37 -12.62 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.452 ' O ' HG12 ' A' ' 166' ' ' ILE . 6.7 mmm -78.09 116.16 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.18 -155.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.995 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.519 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 35.4 pt 38.87 58.19 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 166' ' ' ILE . 42.6 Cg_exo -56.64 83.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.719 2.279 . . . . 0.0 112.279 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 10.3 mmt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.895 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 1' ' ' GLY . 0.4 OUTLIER 37.12 80.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.4 -33.25 15.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.53 126.59 46.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.73 69.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.806 ' OE2' ' N ' ' A' ' 9' ' ' CYS . 4.4 tm-20 -151.4 152.25 32.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -145.57 21.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' VAL . 53.1 t -125.13 -93.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.806 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 98.4 m 48.69 -85.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -72.09 -30.2 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.468 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -41.35 -26.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.688 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 41' ' ' ASN . 30.6 t0 -108.11 31.58 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' VAL . 12.4 ttm180 -117.32 -59.82 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.3 tp -70.87 -24.13 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -64.68 -48.35 75.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.762 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -73.1 -36.32 56.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.4 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.24 -57.37 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.74 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' CA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.13 -22.93 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 8.0 mtp180 -72.84 -27.48 61.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 62.34 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.221 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.1 p-10 -132.11 84.42 2.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 26' ' ' VAL . 6.4 p -52.84 -21.53 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.445 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 46.8 mt-30 -73.5 -49.13 28.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.818 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.221 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 7.0 mp0 -73.47 -41.88 62.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.952 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 3.8 p -52.86 -39.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 1.114 ' HG2' ' OE2' ' A' ' 61' ' ' GLU . 5.2 mtt180 -73.13 -61.46 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.362 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 14.4 mtm-85 -62.04 -25.6 67.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.224 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.5 mt -56.73 -66.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' CD2' ' HG3' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -73.54 -48.73 30.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.775 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 1.1 m-70 -68.95 -10.94 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.963 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -137.42 -66.88 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.72 0.295 . . . . 0.0 111.386 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -54.51 -18.26 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.076 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.8 mt 55.29 61.65 2.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 14' ' ' LEU . 12.0 p -107.31 129.3 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.579 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -56.83 146.6 57.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 18.6 Cg_endo -58.78 -66.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.713 2.276 . . . . 0.0 112.21 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -44.73 -62.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . 34.28 97.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 1.7 mp -92.78 130.82 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.508 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 37.8 p-10 -65.51 -31.67 72.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.92 39.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 43' ' ' PHE . 65.5 t80 54.42 72.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.01 -64.71 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.581 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' HG2' ' A' ' 49' ' ' GLN . 10.8 mmtt -98.32 136.47 38.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.751 0.31 . . . . 0.0 111.052 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 50' ' ' VAL . 33.3 p -89.2 161.72 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.91 -33.68 51.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 51' ' ' MET . 2.0 tp -73.25 -42.23 62.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.983 ' NE2' ' OD2' ' A' ' 73' ' ' ASP . 54.2 tt0 -73.15 -8.71 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.502 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 3.9 m -115.83 -23.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.528 ' HA ' ' CA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.8 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.732 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.523 ' CE ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -124.37 21.12 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.79 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.59 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 1.1 m-85 41.01 29.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.944 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . -58.38 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.076 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.521 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -73.7 153.33 89.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.432 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.677 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 13.1 Cg_exo -69.96 -42.93 2.79 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.819 2.346 . . . . 0.0 112.303 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.998 ' HB2' ' OE1' ' A' ' 61' ' ' GLU . . . -63.55 -23.72 67.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.926 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' CG2' ' N ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -62.49 -49.45 83.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.36 -47.56 81.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.597 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -63.03 -53.25 56.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.325 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.114 ' OE2' ' HG2' ' A' ' 27' ' ' ARG . 2.2 mt-10 -63.27 -56.86 13.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.928 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -62.67 -50.46 71.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.672 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 6.9 tt -63.4 -42.89 98.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.67 0.271 . . . . 0.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.8 tttp -62.77 -42.05 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.53 ' HG3' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -44.49 -29.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 37' ' ' PRO . . . 132.7 59.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.21 167.26 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -108.56 103.67 51.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.474 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 37.0 Cg_endo -65.88 -13.55 40.36 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.797 2.331 . . . . 0.0 112.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 101' ' ' ASP . 31.4 m120 -102.61 86.67 2.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 78' ' ' SER . 12.7 m -142.74 132.11 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.0 OUTLIER -149.6 146.44 27.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.983 ' OD2' ' NE2' ' A' ' 49' ' ' GLN . 2.7 p30 -151.1 -170.49 3.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 61.38 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' ASP . 1.4 p -133.62 -66.93 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.04 78.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.99 154.22 34.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.986 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -139.62 -174.26 0.4 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.86 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 55.2 Cg_exo -51.67 -51.24 11.6 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.79 2.327 . . . . 0.0 112.458 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.454 ' CG2' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.83 -44.08 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' NE2' ' HG3' ' A' ' 112' ' ' PRO . 51.4 m80 -62.94 -56.25 18.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.86 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 1.9 p30 -54.77 -48.83 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -56.28 -57.19 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.12 -50.3 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.849 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -57.16 -40.77 77.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 88' ' ' PHE . 21.3 p -73.33 -59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.82 73.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.216 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 56.7 m-85 -136.75 49.81 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.567 HD23 ' CG ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -52.39 -35.73 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.056 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.57 -66.43 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.779 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.812 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 63.0 m -71.72 -41.09 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 53' ' ' PHE . 49.7 tp -52.66 -51.24 61.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.502 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 97' ' ' GLU . 28.9 ttmt -52.74 -36.85 58.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.481 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.295 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 24.2 t -57.03 -70.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' A' ' 53' ' ' PHE . 2.6 pp -58.59 -38.51 78.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.56 HG12 ' OE1' ' A' ' 131' ' ' GLU . 2.4 t -64.02 -60.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.682 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.295 ' CD ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.73 -30.81 34.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.863 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.506 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -73.15 -54.56 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.653 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . -164.73 -65.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.287 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . 40.2 -166.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.354 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 14.6 p-10 -135.63 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -100.9 19.14 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.765 ' ND2' ' OD2' ' A' ' 133' ' ' ASP . 15.3 m120 -104.67 -25.18 12.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.55 167.6 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.485 ' HB3' ' N ' ' A' ' 110' ' ' SER . 7.7 mt -136.14 -160.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.91 -154.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.9 m -60.34 -38.79 84.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -88.17 -3.53 58.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 138' ' ' ASP . . . 69.71 46.55 53.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.485 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -107.37 134.8 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.996 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.495 ' HB2' ' ND1' ' A' ' 114' ' ' HIS . 36.9 mt -62.97 151.22 86.37 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 89.3 Cg_exo -46.64 -26.46 4.42 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.626 2.217 . . . . 0.0 112.243 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.493 ' CB ' ' HB3' ' A' ' 128' ' ' LEU . 17.7 tt -71.79 -35.78 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.511 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 21.6 m80 -56.34 -37.96 70.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.755 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 115' ' ' LEU . 1.1 mt -69.09 -51.78 35.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . . . -52.83 -32.07 42.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 147' ' ' LEU . 52.7 mt -60.9 -39.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.57 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CD ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -68.19 -17.35 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.525 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.849 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -92.08 -54.69 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.76 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.26 37.15 7.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -65.63 -10.63 37.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.4 OUTLIER 74.86 -68.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.966 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -49.74 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 116' ' ' ALA . 45.8 t -59.59 -59.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 11.4 t -52.34 -46.52 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.313 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 159' ' ' ILE . 73.4 p -69.45 -33.59 73.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.289 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 1.381 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 17.6 t80 -73.3 -40.01 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -62.17 -12.16 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -66.69 -64.59 2.13 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 18.3 Cg_endo -59.17 -35.63 97.29 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.876 2.384 . . . . 0.0 112.445 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 1.381 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mt-10 -90.5 35.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.508 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 92.6 p -151.59 48.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.765 ' OD2' ' ND2' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 36.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 69.8 mt -55.6 141.09 38.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.499 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 7.7 t-80 84.72 -12.56 0.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 137' ' ' ARG . 74.1 t60 -60.49 169.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -119.32 -169.77 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 4.5 m-20 -145.5 171.26 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.411 ' HB1' ' HA3' ' A' ' 109' ' ' GLY . . . -68.54 -6.44 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 p -114.05 0.87 14.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.21 95.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 147' ' ' LEU . 33.9 mt -120.2 77.4 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.076 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 14.2 p -48.27 161.41 0.38 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 160' ' ' LEU . 75.5 Cg_exo -48.28 -37.5 32.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.747 2.298 . . . . 0.0 112.421 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HG ' ' HG3' ' A' ' 161' ' ' GLN . 2.0 tt -71.06 -41.74 70.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.076 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -66.3 -48.54 70.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.19 -39.79 60.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.039 0.447 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 157' ' ' MET . . . -61.23 -45.69 93.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.204 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.431 ' HB2' ' CE ' ' A' ' 157' ' ' MET . 11.0 tpt180 -57.19 -30.5 64.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.29 -75.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.792 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.545 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 17.1 mmm180 -74.56 70.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.46 51.39 0.09 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.334 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 154' ' ' GLN . . . -52.57 -31.19 34.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.473 0.654 . . . . 0.0 109.831 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.526 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 2.9 pm0 173.27 -146.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.182 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 1.205 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 21.5 m120 -74.91 44.53 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -73.58 -31.45 63.61 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.479 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.544 ' N ' HD11 ' A' ' 156' ' ' LEU . 1.1 ptm -67.34 -29.05 68.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.205 ' OD1' ' O ' ' A' ' 155' ' ' ASN . 5.4 p-10 -74.26 -46.58 40.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.245 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -52.16 -39.83 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.198 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.01 -41.56 61.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.11 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HG3' ' HG ' ' A' ' 145' ' ' LEU . 1.9 mt-30 -61.73 -55.37 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.3 95.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.427 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 159' ' ' ILE . 1.1 m-70 -72.98 -10.86 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.978 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 ttm -90.82 -176.36 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 ttp -130.94 28.3 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 166' ' ' ILE . 9.9 pt -53.12 113.29 4.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.16 -10.36 17.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.896 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 t -148.73 -57.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 mtm -98.48 112.1 24.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER 170.12 44.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.567 ' C ' ' OE1' ' A' ' 7' ' ' GLU . 1.8 mt -88.55 115.33 25.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.669 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 1.2 mm-40 -112.33 -27.4 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.692 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER 41.71 68.9 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.744 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' GLY . 2.2 p -134.08 -57.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.2 m 41.95 -91.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 13' ' ' ARG . 4.7 p -94.57 25.04 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -78.37 -10.57 86.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 2.5 p30 -129.12 24.07 5.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.745 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 5.8 ttt180 -103.89 -67.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HB2' ' CB ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.39 -39.99 77.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.696 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.428 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 1.1 m -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.68 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.03 -36.4 60.72 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.31 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -68.49 -57.17 6.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.95 64.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -73.04 -27.94 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -73.14 -31.7 64.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 83.69 64.92 1.59 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.406 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.399 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 1.2 p30 -137.12 100.94 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' HA ' HG11 ' A' ' 26' ' ' VAL . 2.5 p -52.7 -23.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -73.31 -49.61 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.399 ' OE1' ' CB ' ' A' ' 22' ' ' ASP . 1.8 mt-10 -73.09 -47.24 46.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 23' ' ' VAL . 4.9 p -52.86 -38.1 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 60.2 mtm180 -73.15 -61.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.192 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.459 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -52.94 -31.8 42.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.251 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.555 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -72.9 -69.08 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 61' ' ' GLU . 10.8 mt -70.69 -42.62 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 4.3 t-80 -73.29 -0.51 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.376 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -150.58 -75.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.717 0.294 . . . . 0.0 111.179 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 2.8 tm-20 -41.18 -27.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 29' ' ' LEU . 9.7 mt 54.79 56.04 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . 41.0 t -87.28 130.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -48.41 133.7 13.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.9 Cg_endo -71.61 -18.95 28.63 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.767 2.311 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 57.5 p-10 -87.49 1.73 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -45.91 121.83 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -111.34 127.45 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 6.5 m-80 -64.06 -163.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -2.0 49.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.83 -23.13 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . 96.24 29.35 8.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.447 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -105.45 152.92 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.22 168.16 14.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . . . -61.17 -53.8 52.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' O ' ' SD ' ' A' ' 51' ' ' MET . 3.6 mt -68.17 -27.99 66.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -73.39 -3.66 28.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 47' ' ' ALA . 28.6 m -133.68 -37.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -36.09 137.72 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.901 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.454 ' CE ' ' HA3' ' A' ' 54' ' ' GLY . 12.4 ptm -93.5 123.62 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CD2' ' CD1' ' A' ' 92' ' ' LEU . 60.9 m-85 -56.96 -16.51 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . -36.31 -40.85 0.45 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.255 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -110.94 127.16 27.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.608 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.486 ' N ' ' OG1' ' A' ' 91' ' ' THR . 60.3 Cg_endo -73.6 -32.28 7.88 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.297 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.789 ' HB2' ' OE2' ' A' ' 61' ' ' GLU . . . -63.0 -39.73 95.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 59' ' ' ALA . 19.1 m -62.38 -30.04 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.065 0.46 . . . . 0.0 110.447 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' N ' HG21 ' A' ' 58' ' ' VAL . . . -64.0 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.502 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 6.2 tt -63.24 -32.12 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.789 ' OE2' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -62.91 -54.54 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 6.2 mt -62.69 -46.1 89.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.654 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -63.29 -49.48 73.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HD3' HD23 ' A' ' 60' ' ' LEU . 5.6 ttpp -63.01 -13.1 31.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.089 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -79.0 -34.47 44.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.86 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.16 44.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.74 -171.63 2.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 m -136.47 114.11 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -26.51 20.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.621 2.214 . . . . 0.0 112.348 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.14 75.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 71' ' ' VAL . 4.0 m -137.25 134.2 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -131.34 167.54 19.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.48 -71.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 75' ' ' SER . . . -41.04 -29.87 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 1.1 t 162.92 -28.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.2 37.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -110.95 113.89 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.536 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -86.68 171.19 10.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.704 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 14.3 Cg_endo -56.92 -41.64 73.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.629 2.219 . . . . 0.0 112.07 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 81' ' ' HIS . 2.9 m -56.39 -43.9 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.486 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 79.7 m80 -54.1 -53.43 53.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.505 ' O ' ' CG2' ' A' ' 86' ' ' THR . 2.9 p30 -70.12 -31.17 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.597 ' CB ' ' CD1' ' A' ' 92' ' ' LEU . . . -66.64 -25.8 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.25 -65.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 1.298 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -59.51 -26.3 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 4.1 p -65.9 -37.62 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.094 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.54 66.28 1.29 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.425 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -140.33 49.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.571 HD23 ' CD2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -53.4 -18.82 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.29 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.715 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.4 -70.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.8 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.63 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 13.8 m -71.21 -31.76 67.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.34 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.609 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 1.1 mp -53.7 -52.01 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.111 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.78 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -51.18 -30.93 18.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 62.1 t -74.3 -58.23 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.201 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' A' ' 53' ' ' PHE . 2.3 pp -74.58 -44.1 52.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -66.13 -29.84 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.78 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.21 -27.28 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -73.51 -50.2 22.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -168.15 -70.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.035 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' VAL . . . 24.4 99.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' ALA . 6.2 p-10 -37.52 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -92.68 -6.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HA ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.55 2.44 39.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -74.65 171.51 13.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.1 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 111' ' ' LEU . 56.3 mt -136.35 -168.14 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -171.1 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -52.04 -28.25 16.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -10.71 38.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 72.13 9.83 72.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.623 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -77.62 109.79 11.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.768 HD12 ' OD2' ' A' ' 133' ' ' ASP . 6.3 tp -59.78 142.22 88.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 111' ' ' LEU . 90.8 Cg_exo -40.7 -29.13 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.734 2.29 . . . . 0.0 112.352 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.585 ' CG2' ' CD2' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -73.27 -43.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 43.2 m80 -53.59 -37.11 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 112' ' ' PRO . 6.6 mp -57.54 -57.8 11.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.783 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -52.86 -30.23 32.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.524 HG12 ' CG1' ' A' ' 125' ' ' VAL . 77.9 mt -66.46 -38.08 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.516 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HG2' HD22 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -73.18 -15.85 61.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.298 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 2.6 mp0 -94.69 -52.99 4.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 87.39 18.1 57.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.158 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' SER . 92.8 m-70 -35.82 -69.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.545 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 3.1 t 156.63 -92.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -73.34 -14.1 61.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.749 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 116' ' ' ALA . 69.2 t -68.57 -65.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.524 ' CG1' HG12 ' A' ' 117' ' ' ILE . 2.6 t -52.27 -41.18 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.503 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 93.4 p -72.27 -30.87 65.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 1.352 ' CE1' ' OE2' ' A' ' 131' ' ' GLU . 53.2 t80 -73.24 -53.06 11.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.485 HD21 ' CA ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -59.6 -19.48 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -53.93 -70.58 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 38.8 Cg_endo -66.64 -37.6 21.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.7 2.266 . . . . 0.0 112.412 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 1.352 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 23.8 mp0 -65.94 -21.52 66.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.9 m -114.02 148.77 36.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.113 ' OD2' ' ND1' ' A' ' 136' ' ' HIS . 2.2 p30 -38.33 110.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.71 -10.25 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.47 39.68 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.113 ' ND1' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -106.21 138.71 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.985 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.09 163.21 27.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.451 ' OD2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -96.47 160.89 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.66 -15.76 13.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -34.66 21.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.801 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.95 72.09 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.579 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 20.1 mt -151.92 62.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.496 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -40.93 168.21 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.035 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 136' ' ' HIS . 84.2 Cg_exo -44.34 -51.18 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.621 2.214 . . . . 0.0 112.144 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.456 ' CG ' ' HE2' ' A' ' 164' ' ' MET . 1.0 OUTLIER -68.88 -40.29 79.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.496 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -53.03 -63.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.57 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.452 HD22 ' HG2' ' A' ' 118' ' ' ARG . 13.8 tp -56.61 -41.89 77.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.536 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . . . -53.01 -40.25 63.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.06 -40.58 96.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -68.76 -79.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.93 71.78 1.57 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' CA ' ' HE2' ' A' ' 157' ' ' MET . . . -72.54 42.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.576 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 156' ' ' LEU . . . -52.26 128.96 26.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 31.38 -154.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 20.6 m120 -76.82 42.82 0.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -72.87 -50.48 23.58 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.198 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.528 ' HE2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -52.24 -30.81 29.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.91 0.386 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.2 OUTLIER -74.17 -49.45 23.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -51.77 -59.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.505 ' CD1' HD11 ' A' ' 156' ' ' LEU . 6.4 mp -57.81 -63.63 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 157' ' ' MET . 1.5 pt20 -52.67 -37.1 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -66.13 -49.03 60.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.17 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -18.64 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.65 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.456 ' HE2' ' CG ' ' A' ' 145' ' ' LEU . 6.5 ttm -75.94 -165.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.407 ' HE2' ' HD3' ' A' ' 167' ' ' PRO . 7.9 tpt -150.03 67.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.522 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.6 OUTLIER -143.44 47.84 0.86 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 166' ' ' ILE . 58.5 Cg_endo -71.97 170.71 18.23 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.666 2.244 . . . . 0.0 112.296 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.943 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.97 -65.41 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.46 48.59 21.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -134.55 16.75 3.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LEU . 13.2 tp 56.32 119.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.88 107.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.95 106.6 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.6 -9.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.213 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -43.9 -41.03 4.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 7.1 p -95.91 -13.47 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 12' ' ' ASP . . . -49.86 126.01 20.53 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.405 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 4.6 t0 87.31 5.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 7.0 tpt180 -73.26 -74.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -73.2 -23.84 60.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -65.46 -48.61 72.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -70.33 -31.33 68.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.606 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.553 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . . . -72.68 -64.66 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.53 65.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' A' ' 52' ' ' MET . . . -71.66 -26.09 62.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HD2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.41 -29.42 62.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' ARG . . . 97.8 70.46 1.0 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.807 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.071 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 1.4 p30 -146.03 79.97 1.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.876 0.369 . . . . 0.0 110.508 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 2.2 p -52.61 -20.1 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -72.68 -47.88 43.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.495 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.071 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.34 -39.39 65.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.21 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.4 p -53.41 -36.22 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.854 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 76.5 mtt-85 -73.32 -55.97 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.572 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -66.94 -18.3 65.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.029 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.804 HD22 ' OE1' ' A' ' 33' ' ' GLU . 2.8 mt -65.54 -65.67 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.509 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.767 HD11 ' CD ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -73.54 -38.18 65.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.75 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -72.46 -33.91 67.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.684 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -113.8 -55.46 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.184 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.804 ' OE1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.03 -6.36 27.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER 43.62 27.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 14' ' ' LEU . 9.2 p -53.09 147.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 136.68 39.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HB2' ' CA ' ' A' ' 67' ' ' ALA . 60.6 Cg_endo -73.08 -11.2 25.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.902 2.402 . . . . 0.0 112.471 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -108.58 7.4 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.54 78.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.068 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.9 mp -64.48 148.05 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.4 -154.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -23.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.6 -35.37 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.17 29.28 3.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HE2' ' OE1' ' A' ' 49' ' ' GLN . 48.0 mtpt -95.12 160.14 14.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.318 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.455 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -84.85 150.44 25.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -65.51 -31.74 72.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 12.7 tp -72.31 -47.55 48.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.516 ' HB3' ' CG2' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -63.08 -18.06 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.745 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' MET . 35.5 m -104.36 -34.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.515 ' HE3' ' CD2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -38.7 162.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.517 ' N ' ' HA ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -103.07 139.25 38.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.574 ' CE2' HD23 ' A' ' 95' ' ' LEU . 19.6 m-85 -84.03 10.29 10.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.84 -54.02 38.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.286 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -99.55 134.86 20.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.653 0.263 . . . . 0.0 110.895 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.843 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 11.2 Cg_exo -71.68 -43.84 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.744 2.296 . . . . 0.0 112.172 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -62.75 -27.22 69.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 55' ' ' SER . 4.5 t -62.87 -45.84 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.88 -56.6 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.228 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.493 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 3.3 tt -63.14 -44.67 94.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.413 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.21 ' OE2' ' O ' ' A' ' 26' ' ' VAL . 1.6 tt0 -62.31 -58.51 7.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.493 ' HA ' ' CD1' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -63.4 -46.84 84.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' CD2' ' CE1' ' A' ' 98' ' ' HIS . 10.4 tt -62.91 -31.7 72.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 12.3 mttt -63.0 -44.39 96.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.518 ' CG ' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -44.01 -25.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 134.68 -11.78 4.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.457 ' CA ' ' HB2' ' A' ' 37' ' ' PRO . . . -37.16 148.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 71' ' ' VAL . 57.8 m -103.82 116.47 61.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 73.9 Cg_endo -75.88 -29.76 6.6 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.75 2.3 . . . . 0.0 112.432 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -73.62 68.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 49' ' ' GLN . 9.7 m -117.19 155.41 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 77' ' ' THR . 4.8 mp0 -147.93 145.57 28.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 75' ' ' SER . 5.7 p-10 -120.4 100.9 7.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 48.75 -89.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 73' ' ' ASP . 3.4 m -39.32 -57.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.16 46.24 0.17 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -89.54 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.901 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 1.134 ' OG ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 178.92 170.79 0.51 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.676 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 3.3 Cg_endo -46.36 -55.02 4.07 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.857 2.371 . . . . 0.0 112.089 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.576 ' CG2' ' CG1' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.43 -39.75 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.039 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 78' ' ' SER . 34.9 m80 -52.86 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.229 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.511 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.4 OUTLIER -67.11 -36.0 80.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.329 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.569 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -26.58 19.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.462 ' HB1' HD13 ' A' ' 115' ' ' LEU . . . -73.71 -62.52 1.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.776 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.93 -25.65 61.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.915 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 12.9 p -56.12 -23.31 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.656 0.265 . . . . 0.0 111.25 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 67.78 65.47 2.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.204 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -155.4 60.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.617 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 127' ' ' PHE . 1.5 tm? -52.06 -19.65 2.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.076 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.338 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -66.82 -66.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 1.338 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 21.8 m -73.09 -34.54 66.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 93' ' ' LYS . 1.6 tt -52.7 -60.89 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.814 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 1.195 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 12.6 ptpt -52.33 -37.66 56.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.053 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.542 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 53.1 t -55.58 -64.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 53' ' ' PHE . 3.9 pp -71.06 -35.53 71.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.524 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 31.2 t -66.39 -42.31 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.195 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -71.63 -22.02 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.754 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.525 ' CE1' ' CD2' ' A' ' 63' ' ' LEU . 58.3 t-80 -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 145.82 -9.46 1.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.843 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . -34.83 114.36 0.22 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.134 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 9.7 p30 -33.48 91.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.576 ' CG1' ' CG2' ' A' ' 80' ' ' VAL . 2.4 m -98.63 -1.39 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.008 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 9.1 m-20 -116.56 20.35 14.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.11 151.11 29.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.521 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -129.16 -159.93 0.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' THR . 0.1 OUTLIER -150.38 86.78 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.44 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 106' ' ' ASP . 1.3 t -43.07 -26.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.67 32.58 61.43 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.41 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.463 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -97.92 102.36 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.013 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.476 HD12 ' CG ' ' A' ' 133' ' ' ASP . 13.3 mt -53.93 146.86 26.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.537 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 94.4 Cg_exo -43.14 -35.18 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 2.3 tt -73.61 -31.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.328 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 21.3 m170 -52.61 -58.39 6.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.737 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -55.14 -50.87 68.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.522 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.522 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -53.81 -37.04 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.617 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.531 ' CG1' ' CG1' ' A' ' 125' ' ' VAL . 73.6 mt -62.32 -41.28 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.447 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.32 -14.78 62.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.539 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 19.8 mt-10 -102.87 -50.57 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.616 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 74.29 31.04 59.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.581 ' CE1' ' HA3' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -34.12 -46.23 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.687 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 5.1 t 155.83 -109.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.528 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 38.7 m -73.88 -14.86 61.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.678 0.275 . . . . 0.0 110.929 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 ' O ' HD22 ' A' ' 128' ' ' LEU . 55.2 t -55.07 -67.05 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.531 ' CG1' ' CG1' ' A' ' 117' ' ' ILE . 2.8 t -52.64 -46.44 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.411 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.582 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 6.4 p -73.14 -23.2 60.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 93' ' ' LYS . 15.6 t80 -73.52 -65.74 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 113' ' ' ILE . 0.5 OUTLIER -75.18 26.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -64.24 -56.49 23.29 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 110.669 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 129' ' ' ALA . 73.1 Cg_endo -76.63 -34.71 2.39 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.73 2.287 . . . . 0.0 111.894 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 4.8 mm-40 -54.49 -24.94 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 3.5 m -114.86 146.93 40.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.476 ' CG ' HD12 ' A' ' 111' ' ' LEU . 1.8 p-10 -37.48 105.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 164' ' ' MET . 7.5 mt -83.72 63.98 7.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' HIS . 41.0 t-80 -176.87 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.774 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 56.4 t60 -39.58 161.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.819 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.449 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -141.23 156.34 45.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.463 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 2.5 t0 -60.92 153.83 23.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.6 -16.89 11.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.626 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -48.99 28.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 131.3 54.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.579 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 20.7 mt -152.3 125.89 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.468 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -100.68 178.35 1.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.751 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 88.9 Cg_exo -46.93 -57.33 2.36 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.766 2.31 . . . . 0.0 112.361 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -71.13 -36.87 72.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.27 -53.09 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.5 OUTLIER -52.47 -40.1 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.538 ' HB2' ' CA ' ' A' ' 157' ' ' MET . . . -59.67 -40.57 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -36.05 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.062 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.528 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.7 tp-100 -67.43 -76.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.76 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.528 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 1.5 mpt_? -74.25 70.15 1.62 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -69.79 49.67 0.66 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.019 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 154' ' ' GLN . . . -43.96 -27.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 0.0 110.178 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.514 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER 168.96 -132.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.441 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.542 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 44.1 m-20 -75.46 42.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.96 -0.463 . . . . 0.0 111.602 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.514 ' HG ' ' NE2' ' A' ' 154' ' ' GLN . 3.6 mt -62.56 -69.16 0.27 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.771 0.319 . . . . 0.0 111.437 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.538 ' CA ' ' HB2' ' A' ' 148' ' ' ALA . 10.0 ptm -52.36 -21.82 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.073 ' OD1' HG13 ' A' ' 159' ' ' ILE . 31.9 p30 -73.93 -51.04 17.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.418 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.073 HG13 ' OD1' ' A' ' 158' ' ' ASP . 1.5 mt -61.71 -24.12 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.375 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.04 -34.24 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -31.46 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.92 18.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -70.12 -16.25 63.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.483 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 8.5 mtp -77.36 169.94 17.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 8.2 ttt -140.24 136.8 33.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.2 tt -153.85 115.28 2.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.157 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -51.11 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 0.0 112.254 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 31.7 mtp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.857 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.415 -0.274 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.89 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.757 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 1' ' ' GLY . 1.2 mtp -92.88 74.75 4.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 pp -102.32 132.89 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.793 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 160.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.914 ' OE1' ' HA ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -65.14 79.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.977 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -106.72 -11.05 15.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.048 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 10' ' ' VAL . 77.5 t 42.72 -89.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.209 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' GLU . 14.4 t 59.1 -79.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 8' ' ' VAL . 8.2 p -86.29 -6.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -61.98 -57.3 17.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.47 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 53.2 p30 -85.56 13.52 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -82.33 -66.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' CD2' ' O ' ' A' ' 36' ' ' HIS . 2.5 tp -72.15 -44.44 63.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -56.78 -32.52 65.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.829 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -72.69 -46.38 31.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.469 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.59 38.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.65 79.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.3 -22.75 61.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.202 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -73.14 -43.23 61.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.62 70.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.542 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p30 -139.0 103.65 4.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.494 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.04 -23.01 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.55 -51.45 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 60.0 mm-40 -68.49 -44.77 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.201 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 12.8 p -52.68 -49.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 70.5 mtt-85 -69.79 -54.57 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 8.7 mtm180 -61.31 -24.13 66.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -73.24 -71.48 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -73.54 -43.77 59.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -71.75 -1.85 15.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.517 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -147.5 -75.56 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.333 ' OE1' ' CG2' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -47.46 -23.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.4 mt 56.04 37.71 29.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 1.333 ' CG2' ' OE1' ' A' ' 33' ' ' GLU . 1.6 t -66.16 140.59 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.997 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -60.69 139.92 93.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.8 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HG3' ' N ' ' A' ' 66' ' ' GLY . 33.0 Cg_endo -64.25 -18.58 63.81 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.729 2.286 . . . . 0.0 112.113 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.997 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 16.7 p-10 -87.94 -81.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.882 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 40.39 95.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 3.6 mp -91.21 131.87 36.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.985 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p30 -65.78 169.75 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.76 -38.98 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.67 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.27 28.11 2.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 2.9 mttp -98.87 157.02 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 1.1 p -85.03 150.64 24.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -62.17 -35.29 78.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.509 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 8.6 tp -71.46 -43.91 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.022 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.012 ' NE2' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -70.1 -5.31 26.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 46' ' ' THR . 15.9 m -125.78 -17.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.577 ' HE3' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -51.28 151.83 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.181 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -92.36 130.24 38.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.896 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CZ ' ' HE3' ' A' ' 51' ' ' MET . 10.3 m-85 -85.5 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.506 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -89.04 -39.13 6.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.908 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 91' ' ' THR . 1.8 t -114.88 135.4 22.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.247 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.73 -34.26 19.2 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.649 2.233 . . . . 0.0 112.062 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.16 -28.0 69.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 2.7 t -63.44 -50.78 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 91' ' ' THR . . . -63.23 -50.41 70.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.806 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.512 ' CD2' ' HG3' ' A' ' 64' ' ' LYS . 9.7 tt -63.24 -38.01 89.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 1.3 mp0 -62.92 -56.23 19.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.249 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 4.4 mp -62.73 -46.89 85.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -63.07 -40.24 97.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HG3' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -62.94 -32.99 74.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.03 -57.54 5.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' N ' ' HG3' ' A' ' 37' ' ' PRO . . . 163.89 36.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 37' ' ' PRO . . . -97.14 106.09 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.968 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -63.34 119.67 55.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.509 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 29.2 Cg_endo -63.21 -15.62 49.32 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.727 2.284 . . . . 0.0 112.224 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.551 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 37.1 m-80 -95.22 93.56 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.35 159.12 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -151.79 -174.17 4.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 1.012 ' OD2' ' NE2' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -140.1 77.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 73' ' ' ASP . . . 35.74 62.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.023 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -172.51 -66.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . 138.69 38.32 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.474 HG21 ' CB ' ' A' ' 81' ' ' HIS . 34.9 m -128.61 137.51 51.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.805 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.82 179.23 1.16 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.572 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 42.2 Cg_exo -56.06 -32.68 87.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.824 2.349 . . . . 0.0 112.307 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.457 HG23 HG23 ' A' ' 96' ' ' VAL . 9.6 t -68.25 -28.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.474 ' CB ' HG21 ' A' ' 77' ' ' THR . 35.6 m80 -63.44 -67.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' A' ' 53' ' ' PHE . 2.5 p30 -53.01 -48.65 67.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -19.33 3.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 81' ' ' HIS . . . -72.52 -65.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.328 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HD3' HD11 ' A' ' 115' ' ' LEU . 11.3 mtm180 -73.07 -37.72 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 60.2 p -54.33 -17.75 3.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 67.02 66.76 2.24 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.006 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 22.7 m-85 -135.62 49.38 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 123' ' ' SER . 19.9 tp -55.11 -15.28 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.781 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -74.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.67 0.271 . . . . 0.0 110.729 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 59' ' ' ALA . 24.8 m -69.8 -33.44 72.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.376 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 2.3 tt -53.28 -46.36 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -56.39 -37.19 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.216 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.783 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 74.2 t -52.84 -63.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.734 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.66 -36.47 67.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 111.152 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.514 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 3.8 t -68.99 -46.54 78.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.29 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.783 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 10.6 pm0 -59.04 -33.77 71.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.054 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -39.28 93.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.21 36.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' PRO . . . -63.63 -177.74 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -75.32 74.52 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.416 HG12 HG11 ' A' ' 96' ' ' VAL . 13.0 m -91.78 19.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -130.71 5.37 4.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.23 155.49 22.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -129.11 144.37 51.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -84.77 -176.68 6.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.21 -53.29 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.8 p -61.31 -24.3 66.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 84.35 -10.32 61.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.73 117.99 3.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.526 ' CD2' ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -56.35 130.64 75.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 82.9 Cg_exo -44.11 -31.67 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.54 ' CD1' ' N ' ' A' ' 129' ' ' ALA . 0.5 OUTLIER -73.52 -42.72 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.574 ' CE1' ' OD2' ' A' ' 138' ' ' ASP . 9.5 m80 -52.91 -27.36 18.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.513 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.85 -53.03 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' CB ' HG11 ' A' ' 125' ' ' VAL . . . -52.64 -43.17 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 110.352 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.451 HG21 HD12 ' A' ' 156' ' ' LEU . 50.5 mt -57.57 -42.32 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.782 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -71.11 -15.66 62.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -90.64 -55.39 3.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.639 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.67 12.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.526 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.468 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 97.1 m-70 -56.01 -18.15 8.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.79 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.8 m 71.75 -63.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.522 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 12.1 m -69.55 -38.97 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.069 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 39.7 t -73.39 -54.91 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 126' ' ' SER . 3.5 m -52.8 -47.03 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 5.6 t -71.53 -34.15 69.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 1.194 ' CD2' ' OE1' ' A' ' 131' ' ' GLU . 45.1 t80 -73.36 -39.6 65.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -67.36 -25.66 66.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 113' ' ' ILE . . . -56.93 -62.12 5.72 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.498 ' CD ' ' O ' ' A' ' 126' ' ' SER . 44.2 Cg_endo -68.15 -48.83 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.79 2.327 . . . . 0.0 112.62 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 1.194 ' OE1' ' CD2' ' A' ' 127' ' ' PHE . 0.5 OUTLIER -58.07 -29.51 65.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.732 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.2 m -107.77 154.46 21.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.935 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.5 p-10 -41.76 113.85 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 129' ' ' ALA . 8.1 mt -85.08 43.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.976 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.05 33.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.422 ' HB3' HD12 ' A' ' 111' ' ' LEU . 50.8 t60 -107.18 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -126.31 -156.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER 177.15 155.59 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.574 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -37.7 -30.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.508 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -60.42 -44.87 95.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.869 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 84.28 25.52 43.5 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.469 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -133.51 80.44 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.371 . . . . 0.0 111.015 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 1.6 p -42.48 169.12 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 91.0 Cg_exo -43.66 -44.76 11.15 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.289 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.405 ' O ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -72.84 -42.92 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.498 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.496 ' HB3' ' CA ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -52.52 -64.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.427 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 114' ' ' HIS . 0.3 OUTLIER -52.72 -34.96 54.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -60.82 -31.31 70.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -45.02 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.491 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -69.85 -89.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.171 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.533 ' N ' ' CG ' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -75.62 51.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.085 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -61.74 -9.18 18.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.136 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 156' ' ' LEU . . . 47.38 -86.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -125.47 -136.79 0.27 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 1.229 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 12.5 p30 -74.37 14.37 0.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.153 -0.342 . . . . 0.0 111.267 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.566 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 0.2 OUTLIER -51.82 -45.68 64.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.67 0.272 . . . . 0.0 111.331 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 3.3 ptm -57.09 -30.15 64.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.37 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD2' ' HB2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -73.55 -47.12 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.931 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -52.0 -49.3 38.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.515 ' CD1' ' O ' ' A' ' 156' ' ' LEU . 5.3 mp -73.46 -26.74 61.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -64.46 -63.8 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.08 -31.59 79.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.646 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 1.2 m-70 -66.24 -39.57 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.954 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.468 ' HA ' HD12 ' A' ' 134' ' ' LEU . 2.6 ptm -63.97 -174.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 92.78 3.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.433 ' O ' HG21 ' A' ' 166' ' ' ILE . 13.1 mt -153.99 90.97 3.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.401 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.7 90.08 1.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.765 2.31 . . . . 0.0 112.352 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 38.0 mtm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.62 107.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 97.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.92 -52.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.18 106.81 15.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.69 65.55 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.764 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.49 56.4 2.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.024 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 11' ' ' GLY . 16.2 m -143.54 13.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 10' ' ' VAL . 12.7 m -50.6 97.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.453 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CB ' ' O ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER 92.79 -6.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.881 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -54.57 -44.44 78.61 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.12 5.33 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -78.87 -62.5 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 ' HB1' ' A' ' 47' ' ' ALA . 2.8 tm? -71.17 -33.22 69.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.514 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 25.4 t -67.79 -50.12 58.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -57.1 -26.97 56.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.205 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.23 -67.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.021 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.472 ' HB2' ' CG ' ' A' ' 51' ' ' MET . . . -53.04 -54.58 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 50' ' ' VAL . . . -53.43 -29.16 33.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 18.0 mtt180 -73.92 -37.62 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . 93.64 66.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.577 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.688 ' OD1' ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -138.66 97.13 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.831 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' O ' HG11 ' A' ' 26' ' ' VAL . 2.3 p -57.29 -18.43 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.0 -46.47 43.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.3 -34.41 65.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.8 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 1.1 p -52.57 -48.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.744 0.307 . . . . 0.0 111.212 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.99 -56.33 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.64 -48.14 66.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.445 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 52.7 mt -52.72 -55.84 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.214 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 61' ' ' GLU . 84.5 mt -73.95 -55.8 5.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.17 4.0 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -146.19 -70.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.25 ' OE1' HG21 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.79 -16.47 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.5 mt 45.37 45.01 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.671 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 1.25 HG21 ' OE1' ' A' ' 33' ' ' GLU . 2.8 t -72.29 153.74 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 1.016 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 1.3 t-80 -63.59 138.12 97.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.6 Cg_endo -71.23 -37.7 5.61 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 1.016 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -92.26 31.35 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.076 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -65.71 118.44 9.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -120.3 125.02 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -60.95 -178.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -41.59 -46.1 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -48.15 -62.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.02 24.09 1.9 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.61 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -109.39 163.17 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.755 0.312 . . . . 0.0 110.714 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 49' ' ' GLN . 17.0 p -84.87 152.14 23.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -52.92 -26.09 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' CD2' ' CE ' ' A' ' 51' ' ' MET . 7.0 mt -73.26 -41.82 63.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HG3' ' OG1' ' A' ' 46' ' ' THR . 0.0 OUTLIER -73.17 -7.48 51.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.228 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 24.2 m -136.05 24.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.585 ' CE ' ' CD2' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -70.59 -177.95 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 0.0 110.708 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 1.1 ttp -114.31 -11.09 12.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.618 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 12.1 m-85 50.35 21.0 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.88 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.48 -55.2 7.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.69 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 2.4 t -100.41 137.91 20.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 0.0 110.198 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 40.8 Cg_endo -67.87 -50.29 0.88 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.34 -18.72 63.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.166 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.53 ' CG2' ' HB3' ' A' ' 55' ' ' SER . 2.1 t -63.06 -55.62 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.25 -37.87 88.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 25.0 tp -63.19 -51.33 66.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 13.7 mm-40 -62.75 -53.66 50.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.505 ' HG ' ' N ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -62.63 -51.84 65.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.179 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -63.94 -50.5 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.958 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.575 ' N ' ' CD1' ' A' ' 63' ' ' LEU . 7.2 tttt -65.24 56.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.052 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LEU . 6.7 tp60 -154.42 -39.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.046 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.47 38.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.769 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 63' ' ' LEU . . . -100.13 -0.07 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.121 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.473 ' O ' ' CG1' ' A' ' 71' ' ' VAL . 2.8 m 43.88 83.02 0.22 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.979 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.48 -30.35 15.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.766 2.311 . . . . 0.0 112.238 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 91.8 m-20 -79.51 75.15 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 68' ' ' SER . 20.3 m -116.58 150.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -142.82 134.7 26.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -103.58 128.1 50.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 41.21 -91.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 73' ' ' ASP . 72.4 m -78.84 -85.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.09 64.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.534 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.76 43.67 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -53.14 160.77 1.49 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.997 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.93 -32.51 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.0 2.467 . . . . 0.0 111.888 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 112' ' ' PRO . 0.5 OUTLIER -52.83 -45.33 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.902 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.498 ' NE2' ' O ' ' A' ' 105' ' ' LEU . 39.8 m80 -73.12 -38.72 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.1 OUTLIER -69.71 -67.42 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.319 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -52.64 -19.18 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 80' ' ' VAL . . . -72.8 -63.02 1.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.42 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 1.048 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 15.6 ptt85 -70.17 -18.26 63.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.392 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 82.6 p -68.07 -51.94 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.207 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.01 67.52 0.41 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -152.95 57.32 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.538 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.553 HD12 ' CG ' ' A' ' 127' ' ' PHE . 24.7 tp -58.65 -13.66 6.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.407 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -67.61 -73.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 53' ' ' PHE . 19.4 m -68.95 -35.86 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.524 ' HG ' ' CG2' ' A' ' 96' ' ' VAL . 29.9 tp -52.69 -49.44 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.449 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 127' ' ' PHE . 2.6 ttmt -52.66 -44.67 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.842 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.4 t -53.26 -59.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.132 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -72.58 -39.64 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.524 ' CG2' ' HG ' ' A' ' 92' ' ' LEU . 20.4 t -67.0 -43.85 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.4 pt-20 -68.33 -43.1 78.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -55.17 -23.87 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.14 50.57 0.3 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.577 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 96' ' ' VAL . . . -85.76 56.32 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 111.141 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 5.5 t0 37.32 52.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.83 -0.95 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.239 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 36.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -117.09 -178.61 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 26.0 mt -125.17 -152.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 110' ' ' SER . 2.0 p30 -145.29 -163.25 1.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.761 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 m -54.12 -28.96 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.34 28.61 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' A' ' 139' ' ' ALA . . . 42.91 40.11 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.542 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 40.7 m -113.51 133.84 55.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 136' ' ' HIS . 0.3 OUTLIER -68.97 162.83 61.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 80' ' ' VAL . 52.6 Cg_exo -55.35 -25.67 48.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.825 2.35 . . . . 0.0 112.073 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.463 ' HA ' ' HB3' ' A' ' 128' ' ' LEU . 2.5 tp -70.82 -33.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.516 ' CE1' ' HB3' ' A' ' 138' ' ' ASP . 15.6 m170 -70.47 -30.22 66.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.633 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.88 -54.1 15.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 1.351 ' CA ' ' OE2' ' A' ' 119' ' ' GLU . . . -52.6 -37.53 58.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.519 ' N ' HG13 ' A' ' 125' ' ' VAL . 76.4 mt -56.62 -36.92 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.407 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -66.04 -33.52 75.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.002 0.43 . . . . 0.0 110.53 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.351 ' OE2' ' CA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -82.4 -53.64 5.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.804 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.95 27.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.84 ' CD2' ' OE1' ' A' ' 119' ' ' GLU . 94.4 m-70 -47.69 -23.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 80.23 -62.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.401 ' HB3' HD21 ' A' ' 89' ' ' LEU . 7.9 m -70.17 -33.11 71.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.509 HG13 ' CB ' ' A' ' 116' ' ' ALA . 24.1 t -73.73 -57.01 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.002 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 117' ' ' ILE . 2.2 m -52.57 -60.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.532 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 10.2 t -54.99 -29.02 56.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 110.854 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 26.0 t80 -73.22 -53.92 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -63.38 -11.83 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.581 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -59.69 -69.54 0.53 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.204 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.581 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 56.5 Cg_endo -70.2 -31.86 17.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 5.4 mm-40 -61.9 -13.86 28.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.425 ' HB3' HD21 ' A' ' 111' ' ' LEU . 10.0 m -121.75 143.57 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.801 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 p30 -39.24 98.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 164' ' ' MET . 20.2 mt -67.17 66.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.017 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -177.77 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.552 ' CD2' HD12 ' A' ' 111' ' ' LEU . 1.5 p-80 -53.58 179.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.25 -165.51 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -128.9 178.08 6.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.055 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.462 ' CB ' ' HA3' ' A' ' 109' ' ' GLY . . . -71.0 -8.66 54.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.6 p -105.96 -9.66 16.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' A' ' 142' ' ' LEU . . . 72.73 59.07 4.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.503 ' CD2' ' O ' ' A' ' 141' ' ' GLY . 62.0 mt -154.61 86.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -71.28 -174.18 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.891 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 87.1 Cg_exo -47.43 -61.5 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.659 2.24 . . . . 0.0 112.473 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.466 ' HB2' ' HE2' ' A' ' 164' ' ' MET . 6.6 tp -63.81 -32.59 74.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.506 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -67.29 -70.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 114' ' ' HIS . 11.4 tp -52.75 -45.62 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.424 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.505 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -55.45 -38.23 68.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -65.75 -41.78 91.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.109 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -64.06 -78.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.883 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 4.7 mtp180 -74.05 58.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.09 54.09 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.695 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -34.61 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 0.0 110.851 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.504 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 173.83 -114.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.376 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.538 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.5 m-20 -74.31 5.55 4.44 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.198 -0.314 . . . . 0.0 111.594 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 125' ' ' VAL . 1.0 OUTLIER -51.15 -59.33 4.3 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.708 0.289 . . . . 0.0 111.298 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -52.26 -32.08 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -55.57 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -51.9 -35.2 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.678 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.91 -33.6 64.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -73.43 -51.13 18.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.257 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.56 97.3 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 126' ' ' SER . 3.0 m-70 -61.14 -30.13 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.692 0.282 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.523 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 2.7 mtt -45.49 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 164' ' ' MET . 11.7 ttt 159.35 -26.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.996 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 165' ' ' MET . 53.8 mt 35.31 98.3 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.465 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 168' ' ' MET . 60.0 Cg_endo -73.11 155.08 52.49 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.804 2.336 . . . . 0.0 112.371 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.42 ' CB ' ' O ' ' A' ' 167' ' ' PRO . 3.4 ptm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.803 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.29 72.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' GLY . 1.1 ttp -175.37 138.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.73 26.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.6 mt -136.53 144.77 44.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.052 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.776 ' CD ' ' HG ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -125.46 159.91 30.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 1.154 ' OE1' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -131.35 171.79 12.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.029 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.154 HG11 ' OE1' ' A' ' 7' ' ' GLU . 12.3 p 39.05 29.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.275 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.776 ' HG ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -51.28 116.57 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.319 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 9' ' ' CYS . 16.9 m 47.28 24.6 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -65.82 -40.05 95.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.698 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -101.43 40.65 1.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.562 ' NH1' ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -112.44 -71.48 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.807 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD21 ' CD2' ' A' ' 30' ' ' LEU . 26.4 tp -70.92 -26.81 63.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 1.2 t -61.35 -40.8 95.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.63 -35.08 59.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.533 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -66.91 -62.77 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 62' ' ' LEU . . . -54.09 -43.55 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -72.43 -22.42 61.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mtt180 -73.09 -36.19 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.892 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 97.41 63.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p30 -142.29 91.66 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 23' ' ' VAL . 13.2 p -52.75 -21.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.517 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 62.7 mt-30 -72.44 -47.35 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.517 ' OE2' ' HB2' ' A' ' 24' ' ' GLN . 1.5 mp0 -68.67 -41.02 79.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.499 HG13 ' CD ' ' A' ' 61' ' ' GLU . 55.5 t -53.87 -53.38 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 69.7 mtt180 -61.5 -60.13 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.9 mmt-85 -54.92 -29.27 55.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.584 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.52 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 17.7 mt -73.42 -72.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 41.1 mt -73.48 -43.11 60.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.513 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -72.6 -11.93 60.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.285 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.41 -78.16 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' OE2' ' NH1' ' A' ' 13' ' ' ARG . 1.4 tm-20 -39.94 -28.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.034 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LEU . 3.7 mt 62.71 46.21 5.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG22 HD21 ' A' ' 29' ' ' LEU . 25.0 t -77.87 155.23 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 134.77 65.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 65' ' ' GLN . 69.3 Cg_endo -74.58 -6.91 18.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.81 2.34 . . . . 0.0 112.248 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -103.03 13.58 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -57.08 127.67 33.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -120.65 130.07 53.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -52.2 -55.94 17.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.69 -52.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -35.47 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.85 30.16 1.17 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -98.2 151.81 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 p -94.51 154.96 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 15' ' ' SER . . . -58.39 -26.46 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.035 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.0 mt -71.99 -42.7 66.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.451 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.3 tm0? -60.07 -53.6 55.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 7.2 m -64.5 -23.32 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.2 ttp -39.18 154.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.512 ' CE ' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -116.24 21.44 13.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 0.7 OUTLIER 36.21 34.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . -71.0 -81.84 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.383 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 56.5 m -86.28 119.74 71.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 1.336 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 81.8 Cg_exo -43.99 -39.61 11.28 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 1.122 ' O ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.29 -22.32 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.451 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.521 HG23 ' CG2' ' A' ' 26' ' ' VAL . 37.3 t -63.05 -54.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -63.1 -32.93 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.03 -42.69 99.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.037 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.499 ' CD ' HG13 ' A' ' 26' ' ' VAL . 1.2 mt-10 -63.1 -51.49 66.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.207 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 18' ' ' ALA . 5.8 mp -62.5 -46.2 89.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -62.91 -56.17 19.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.731 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -63.21 -11.71 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.1 mm-40 -81.56 -35.11 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.16 22.85 2.07 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.592 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 48' ' ' LEU . . . -81.29 154.46 26.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.051 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -108.16 98.94 29.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -68.41 -10.31 28.61 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.652 2.235 . . . . 0.0 112.239 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.59 56.93 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 m -125.92 158.82 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -132.94 149.69 52.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -132.32 142.05 49.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 73' ' ' ASP . . . 81.03 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.88 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -126.84 -77.15 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.872 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . -162.94 54.83 0.29 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.784 HG22 ' OD2' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -128.76 112.37 14.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.846 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -82.08 -177.84 1.05 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.783 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 52.3 Cg_exo -54.07 -46.32 34.42 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.318 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 m -52.98 -39.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.506 ' NE2' ' O ' ' A' ' 104' ' ' ALA . 73.0 m80 -53.4 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.783 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 5.0 p30 -53.11 -44.52 67.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -55.83 -48.29 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.39 92.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.505 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -73.24 -33.13 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.7 p -73.45 -78.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.76 68.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 35.8 m-85 -139.27 51.49 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.591 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 16.0 tp -52.5 -18.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.286 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.336 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -73.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.568 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 1.124 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -73.39 -30.29 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 2.5 tt -59.08 -34.83 72.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.049 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.561 ' HE2' ' CD1' ' A' ' 127' ' ' PHE . 4.0 mttt -67.73 -53.18 29.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 2.7 m -52.71 -48.17 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.453 HD23 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.37 -51.37 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.518 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 55.1 t -67.37 -51.12 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.844 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.905 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 5.0 pm0 -52.58 -30.47 31.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.814 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.497 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER -73.08 -36.34 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.23 65.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.64 18.97 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.024 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 61.7 72.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.446 HG23 ' OE1' ' A' ' 131' ' ' GLU . 4.1 m -89.17 13.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.048 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.69 38.87 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.506 ' O ' ' NE2' ' A' ' 81' ' ' HIS . . . -136.08 131.82 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.272 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -100.4 -176.88 3.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.882 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.88 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 0.9 OUTLIER -99.42 40.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER 76.73 12.51 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.402 HG22 ' HB2' ' A' ' 110' ' ' SER . 8.7 t -115.9 8.83 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.897 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 61.75 14.84 45.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.402 ' HB2' HG22 ' A' ' 108' ' ' THR . 34.1 m -98.67 91.91 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 1.054 HD23 ' OD1' ' A' ' 133' ' ' ASP . 35.0 mt -51.52 146.17 13.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 85.1 Cg_exo -47.41 -39.73 28.44 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.726 2.284 . . . . 0.0 112.55 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -61.41 -32.35 53.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.893 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.555 ' CG ' ' OD1' ' A' ' 138' ' ' ASP . 15.9 m170 -66.7 -29.83 69.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -47.38 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 125' ' ' VAL . . . -52.73 -45.12 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.33 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 89.4 mt -53.18 -39.46 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HD2' ' CD ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -61.96 -20.81 64.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.015 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -112.37 -42.0 3.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.528 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.59 84.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.99 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 10.9 m-70 -38.49 102.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' HIS . 3.0 m 35.63 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.999 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.39 10.36 1.33 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 59.4 t -56.09 -53.93 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.008 0.432 . . . . 0.0 110.229 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -52.64 -41.37 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.608 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 15.7 p -66.69 -34.76 78.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.561 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 14.3 t80 -72.86 -48.56 36.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.418 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.519 ' CD1' ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.501 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.538 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -55.09 -66.48 0.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 66.6 Cg_endo -75.21 -52.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.656 2.237 . . . . 0.0 112.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' OE1' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -49.15 -23.74 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.541 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 128' ' ' LEU . 9.3 t -93.83 -153.54 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.054 ' OD1' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.41 56.33 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.874 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.94 88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 17.6 t60 155.42 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.466 ' O ' HG21 ' A' ' 143' ' ' THR . 13.6 t60 -65.27 164.04 14.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.507 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -134.6 127.45 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.555 ' OD1' ' CG ' ' A' ' 114' ' ' HIS . 1.1 m-20 -50.2 155.27 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.19 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 110.318 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -67.53 -48.73 66.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 116.58 57.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.554 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.457 ' HA ' ' CD ' ' A' ' 146' ' ' GLU . 1.1 mt -144.65 104.21 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.144 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -66.11 171.5 3.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 82.5 Cg_exo -43.6 -43.0 11.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.534 2.156 . . . . 0.0 112.021 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.26 -34.62 65.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.144 ' OE1' ' N ' ' A' ' 143' ' ' THR . 5.4 mt-10 -61.84 -61.77 2.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.53 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.7 OUTLIER -52.7 -36.52 57.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.54 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.524 ' O ' ' CA ' ' A' ' 152' ' ' GLY . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.283 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -73.17 -45.41 56.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -73.11 -92.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.244 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.529 ' CD ' ' HD2' ' A' ' 118' ' ' ARG . 16.2 mtt-85 -76.56 45.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -53.29 -17.89 6.24 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.49 ' HB2' ' NE2' ' A' ' 154' ' ' GLN . . . 64.18 -64.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -154.4 -138.37 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.019 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 10.4 m120 -74.16 9.85 1.46 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.226 -0.296 . . . . 0.0 111.391 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.536 ' CD1' ' C ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -51.82 -34.87 42.21 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.846 0.355 . . . . 0.0 111.281 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.499 ' CB ' ' HB2' ' A' ' 148' ' ' ALA . 2.5 ppp? -52.44 -28.39 19.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.059 0.457 . . . . 0.0 110.081 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.06 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 3.4 p30 -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.06 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -51.65 -44.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.291 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.525 ' CD1' HG12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -73.56 -16.08 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 111.035 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -55.08 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.33 -43.4 96.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' LEU . 2.1 m-70 -70.31 -11.79 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -168.87 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.457 ' O ' HG13 ' A' ' 166' ' ' ILE . 1.6 mmm -126.71 -2.53 6.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 165' ' ' MET . 1.3 pt 35.39 56.01 2.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.11 -0.11 8.64 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.837 2.358 . . . . 0.0 112.273 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.966 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 3' ' ' MET . 57.8 p -119.41 41.85 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 74.28 -74.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 59.7 177.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' OE1' ' A' ' 6' ' ' GLU . 11.2 mt -131.93 160.32 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' OE1' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -119.47 46.09 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.046 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 63.39 36.42 11.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 9' ' ' CYS . 85.3 t -82.56 -12.79 12.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' C ' ' O ' ' A' ' 8' ' ' VAL . 42.2 t -35.33 -37.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.524 ' CG1' ' CG2' ' A' ' 35' ' ' VAL . 36.5 t -110.07 -19.03 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -48.58 -21.72 2.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.569 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 29.4 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.78 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 1.7 ttm105 -109.82 -74.94 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CB ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -70.92 -35.18 72.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.427 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -58.24 -40.55 82.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.598 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -73.13 -40.42 50.53 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -67.79 -47.05 70.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 62' ' ' LEU . . . -52.82 -41.71 64.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -18.6 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 1.7 mtt180 -73.17 -28.06 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.72 65.03 1.96 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.615 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.115 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -133.12 92.46 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.635 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 10.7 p -52.58 -20.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.412 ' N ' HG11 ' A' ' 23' ' ' VAL . 1.1 mm-40 -73.81 -56.33 5.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.938 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.115 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.48 -30.26 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.629 -179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 2.4 p -52.85 -45.36 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.744 0.306 . . . . 0.0 111.407 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -73.56 -46.35 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 4.7 mmm180 -53.51 -32.71 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HB3' HG13 ' A' ' 35' ' ' VAL . 10.4 mt -73.42 -72.39 0.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' HG ' ' CG1' ' A' ' 35' ' ' VAL . 5.5 mt -73.4 -45.71 53.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.686 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -70.06 -13.39 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.691 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -134.05 -75.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.199 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.78 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 2.5 tt0 -43.99 -25.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.2 mp 72.46 13.08 5.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.4 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG23 ' CB ' ' A' ' 14' ' ' LEU . 3.3 p -44.75 158.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.407 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -94.81 141.27 23.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.52 -23.27 27.53 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.744 2.296 . . . . 0.0 112.201 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.71 37.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.547 ' HB3' ' CD2' ' A' ' 36' ' ' HIS . . . -79.01 127.55 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 6.3 mp -122.55 133.66 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 111.454 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -62.57 -168.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' CD ' ' C ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -70.32 -4.98 24.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -98.95 -69.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.413 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . 146.74 67.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 19.1 mtpt -142.41 146.65 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.6 p -84.54 152.61 23.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' CB ' HD22 ' A' ' 62' ' ' LEU . . . -52.75 -54.89 27.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD13 ' CE ' ' A' ' 51' ' ' MET . 7.3 tp -53.05 -30.53 36.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.639 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.436 ' HB2' HG22 ' A' ' 71' ' ' VAL . 3.3 tt0 -73.2 -34.61 66.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -91.42 -25.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.512 ' CE ' HD13 ' A' ' 48' ' ' LEU . 1.4 mtp -36.35 137.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 3.6 ptt? -96.42 10.11 39.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 4.4 m-85 47.38 23.54 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -62.43 -56.02 24.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.312 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.465 ' O ' HG21 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -98.04 146.15 31.01 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.788 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 1.228 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.3 Cg_endo -79.67 -42.15 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.834 2.356 . . . . 0.0 112.555 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.14 72.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 55' ' ' SER . 11.4 m -62.64 -30.79 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -62.94 -43.16 99.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.986 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -63.31 -34.53 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.217 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -63.04 -67.89 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 47' ' ' ALA . 6.3 mp -62.32 -35.41 78.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.088 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 7.6 tp -62.95 -63.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.444 ' HB2' HD12 ' A' ' 60' ' ' LEU . 5.1 ttmm -62.93 -17.3 61.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -60.22 -52.86 63.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.63 -13.49 2.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.05 98.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.322 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.16 121.57 2.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.95 -21.45 24.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.733 2.289 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.202 ' CA ' ' OD2' ' A' ' 101' ' ' ASP . 1.4 m120 -81.47 86.11 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 71' ' ' VAL . 27.2 m -135.74 133.61 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -139.62 157.8 45.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -126.23 98.21 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 57.25 -80.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ASP . 5.6 m -38.44 -55.0 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.24 33.18 1.84 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.31 129.51 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.36 171.52 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.853 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 50.8 Cg_exo -53.86 -32.14 65.7 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.767 2.311 . . . . 0.0 112.336 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.487 ' CG1' ' CB ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -64.31 -36.53 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -64.47 -47.93 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.853 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.9 p30 -60.3 -51.66 68.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.635 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -51.97 -29.61 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 124' ' ' VAL . . . -73.33 -65.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.477 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.489 ' NE ' ' HB3' ' A' ' 115' ' ' LEU . 7.2 mtp180 -64.68 -29.41 70.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 61.6 p -73.29 0.3 12.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.549 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 52.76 80.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.098 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.474 ' O ' HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -154.12 60.48 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.856 0.36 . . . . 0.0 110.433 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 3.2 tm? -52.15 -19.05 1.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.267 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.228 ' OD1' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -56.2 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.382 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -73.4 -8.92 57.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.127 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . 5.6 mp -73.0 -64.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.605 ' HA ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -57.06 -24.03 50.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.77 -82.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.09 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -76.11 -44.83 36.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.079 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.523 ' N ' ' HG ' ' A' ' 95' ' ' LEU . 94.3 t -67.77 -3.3 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.201 ' HA ' ' OE2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -73.1 -43.23 62.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -64.57 -37.77 88.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 101' ' ' ASP . . . 146.96 -49.97 0.61 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.487 ' CB ' ' CG1' ' A' ' 80' ' ' VAL . . . 36.21 31.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.202 ' OD2' ' CA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 71.52 56.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.45 HG23 ' HA2' ' A' ' 99' ' ' GLY . 5.0 m -79.95 1.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -116.0 40.67 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.956 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.51 166.93 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -154.64 160.61 41.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 3.5 p30 -84.83 79.06 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 1.1 p 84.13 -54.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER -174.38 32.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.765 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . -76.83 -3.35 79.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.542 ' OG ' ' CG ' ' A' ' 114' ' ' HIS . 0.6 OUTLIER 85.4 159.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.3 OUTLIER -45.18 158.86 0.29 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 50.9 Cg_exo -53.86 -38.47 85.78 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.645 2.23 . . . . 0.0 112.223 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -58.33 -41.43 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.542 ' CG ' ' OG ' ' A' ' 110' ' ' SER . 57.3 m80 -52.96 -31.73 42.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.681 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' HB3' ' NE ' ' A' ' 85' ' ' ARG . 12.6 mt -73.17 -53.77 10.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 1.355 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -54.25 -33.09 57.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.342 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 147' ' ' LEU . 81.8 mt -61.41 -40.51 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -64.38 -21.35 66.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.355 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 1.9 mp0 -94.7 -51.65 4.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.84 22.79 35.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.514 ' O ' ' CB ' ' A' ' 122' ' ' SER . 99.0 m-70 -46.41 -24.85 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER 84.97 -60.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.836 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -73.1 -42.16 63.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.046 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.474 HG11 ' CB ' ' A' ' 116' ' ' ALA . 49.0 t -67.08 -60.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.514 HG21 ' CB ' ' A' ' 116' ' ' ALA . 2.7 t -52.69 -57.14 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 88.8 p -52.73 -37.15 58.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 92' ' ' LEU . 51.6 t80 -71.91 -55.1 8.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -62.41 -19.33 63.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.579 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -52.98 -69.51 0.33 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 55.0 Cg_endo -69.6 -25.32 29.44 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 1.201 ' OE2' ' HA ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -89.55 36.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -169.7 134.88 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.818 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.266 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 2.9 p-10 -35.74 97.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 129' ' ' ALA . 2.8 mp -72.91 56.36 0.42 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.03 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 -39.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.138 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.266 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -56.83 142.67 40.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.019 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 167.88 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -75.14 166.89 22.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.48 -21.92 2.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.324 0.583 . . . . 0.0 110.141 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -59.0 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.91 40.8 0.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.253 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 2.4 mt -122.91 125.22 44.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -98.11 -174.53 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 72.8 Cg_exo -49.31 -56.84 2.77 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.694 2.263 . . . . 0.0 112.401 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 149' ' ' ARG . 13.8 tp -69.31 -40.38 77.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.046 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.08 -65.7 0.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.93 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.488 ' CD2' HG23 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -53.12 -39.45 63.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 160' ' ' LEU . . . -73.13 -27.3 61.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.7 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -68.55 -47.64 66.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.97 -74.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.968 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -74.55 56.56 0.69 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.02 55.4 0.8 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.139 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.512 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -31.44 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.99 0.424 . . . . 0.0 110.979 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.561 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 174.43 -114.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.42 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 1.266 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 8.0 m-80 -75.35 6.92 3.95 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.291 -0.255 . . . . 0.0 111.438 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 159' ' ' ILE . 1.3 mt -51.11 -64.39 0.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.445 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.474 ' CE ' HD13 ' A' ' 145' ' ' LEU . 4.3 ptm -52.89 -29.26 27.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.266 ' OD2' ' HA ' ' A' ' 155' ' ' ASN . 0.4 OUTLIER -74.59 -51.52 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.01 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -51.68 -42.35 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.22 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -74.63 -44.83 48.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.187 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 164' ' ' MET . 4.0 mt-30 -53.61 -50.56 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.286 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.22 98.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.523 ' CD2' ' HG3' ' A' ' 130' ' ' PRO . 2.0 m-70 -73.23 -7.1 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -64.38 169.85 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.861 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.22 91.32 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -151.21 78.87 7.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.67 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.809 2.339 . . . . 0.0 112.357 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 3' ' ' MET . 5.8 p -140.28 94.37 2.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.421 ' CB ' ' O ' ' A' ' 2' ' ' SER . 5.9 ttt 77.37 91.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.76 100.38 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.011 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.67 70.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.608 ' C ' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -152.76 99.17 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.989 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 2.1 tm-20 -122.06 74.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 HG13 ' OE2' ' A' ' 6' ' ' GLU . 14.2 p -126.04 10.93 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.547 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 3.6 p -46.32 102.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.806 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER 80.62 -6.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 8' ' ' VAL . . . -47.24 -34.74 8.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.35 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.776 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.66 28.28 7.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.754 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -94.56 -56.56 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' CD1' HD12 ' A' ' 30' ' ' LEU . 37.9 tp -72.72 -40.78 65.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.1 t -57.67 -34.6 69.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.14 -53.74 7.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.574 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -72.69 -39.77 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.151 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -67.44 -50.32 59.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -68.77 -12.03 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 20.7 mtt180 -67.89 -43.51 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.64 59.41 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.066 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 10.7 p-10 -138.55 95.1 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG2' ' HB1' ' A' ' 57' ' ' ALA . 2.9 p -53.9 -18.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.024 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 9.2 mt-30 -72.98 -54.57 8.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.01 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.066 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.04 -36.42 66.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.342 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.087 HG11 ' OE1' ' A' ' 61' ' ' GLU . 2.7 p -52.82 -42.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.397 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 1.089 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 23.6 mtp180 -70.91 -50.54 33.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.065 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 2.4 mtm180 -67.4 -12.0 59.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.502 ' CD1' HD13 ' A' ' 14' ' ' LEU . 8.7 mt -73.55 -70.4 0.37 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.35 -45.27 56.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.66 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 3.1 m-70 -72.42 -12.38 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.61 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 1.8 mtt-85 -134.18 -78.98 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.997 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -37.84 -30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.74 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.9 mt 61.56 45.02 8.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 10' ' ' VAL . 60.4 t -92.89 110.7 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.652 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -46.93 125.09 8.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.531 ' CG ' ' HB3' ' A' ' 65' ' ' GLN . 52.3 Cg_exo -54.66 -34.77 84.88 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.749 2.299 . . . . 0.0 112.377 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.652 ' OD1' ' HB3' ' A' ' 36' ' ' HIS . 16.3 p-10 -57.38 -21.69 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . . . -33.39 108.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.345 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 38' ' ' ASP . 4.2 mp -102.35 133.44 47.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.988 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.524 ' OD1' ' CB ' ' A' ' 43' ' ' PHE . 8.5 p30 -72.67 159.15 34.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' ASN . 3.8 ptm180 -35.12 -43.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 t80 -56.8 -49.13 76.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 119.22 35.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' NZ ' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -116.21 157.09 25.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.785 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.32 147.5 25.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -58.03 -28.83 64.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 68' ' ' SER . 12.8 tp -70.79 -47.95 56.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 44.5 tt0 -60.65 -24.95 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 6.1 m -106.03 -14.2 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 2.2 ttp -42.34 145.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -85.53 134.88 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.777 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.618 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 14.1 m-85 -87.75 -7.27 57.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 88' ' ' PHE . . . -50.02 -41.04 36.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.028 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.528 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 47.0 m -108.78 127.56 27.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 91' ' ' THR . 58.8 Cg_endo -71.87 -34.0 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.682 2.255 . . . . 0.0 112.211 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 23' ' ' VAL . . . -63.14 -35.09 79.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 55' ' ' SER . 4.0 m -62.57 -32.1 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.609 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' N ' HG21 ' A' ' 58' ' ' VAL . . . -63.63 -64.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.902 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.516 HD22 ' CD ' ' A' ' 64' ' ' LYS . 7.3 tt -63.4 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.089 ' OE2' ' HA ' ' A' ' 27' ' ' ARG . 6.7 mt-10 -62.41 -70.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' HG3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.75 -36.53 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 18.4 tp -63.03 -37.87 88.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.516 ' CD ' HD22 ' A' ' 60' ' ' LEU . 1.9 mtpp -63.32 -48.87 76.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.531 ' HB3' ' CG ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -36.68 -35.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.38 42.61 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.33 28.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.482 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 2.1 m -47.85 112.09 2.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HG2' ' OD1' ' A' ' 70' ' ' ASN . 30.0 Cg_endo -63.52 -21.19 70.7 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.728 2.285 . . . . 0.0 112.175 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -100.37 82.56 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 8.0 m -116.1 142.32 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.402 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 4.2 mt-30 -136.24 160.69 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' OD2' ' NZ ' ' A' ' 45' ' ' LYS . 3.5 m-20 -89.46 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.89 5.95 7.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.7 m -145.46 -70.83 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.814 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.402 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . 172.78 58.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.7 m -110.3 71.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -70.15 169.04 14.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.907 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.522 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 17.9 Cg_endo -60.4 -32.26 93.67 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.738 2.292 . . . . 0.0 111.799 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 78' ' ' SER . 32.1 m -57.49 -42.53 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.243 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -53.65 -67.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.522 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -54.14 -27.44 33.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -68.94 -16.25 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . . . -73.18 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.37 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.535 ' CG ' ' HB3' ' A' ' 115' ' ' LEU . 61.0 mtm180 -63.73 -29.7 70.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 75.0 p -67.87 -6.53 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.228 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.94 74.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.174 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.559 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 8.3 m-85 -145.2 53.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.565 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.572 HD13 ' CG ' ' A' ' 127' ' ' PHE . 13.9 tp -52.78 -21.12 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.158 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.488 ' CG ' ' HG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -60.12 -73.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.488 ' HG1' ' CG ' ' A' ' 90' ' ' ASP . 24.1 m -73.21 -28.16 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 93' ' ' LYS . 1.8 tt -60.72 -61.31 2.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 1.289 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -52.7 -30.28 31.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.274 ' CA ' ' OE2' ' A' ' 97' ' ' GLU . 16.2 t -61.0 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.301 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.583 HD22 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -71.01 -26.76 63.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.018 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.516 HG11 ' CG1' ' A' ' 102' ' ' VAL . 6.9 t -73.22 -56.05 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.8 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.289 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -52.81 -35.45 57.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.232 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.439 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.87 -32.01 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.968 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.44 62.38 0.31 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.61 43.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 54.2 60.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.516 ' CG1' HG11 ' A' ' 96' ' ' VAL . 5.4 m -70.07 -10.77 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -105.48 42.76 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -105.31 168.41 9.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 60.4 mt -145.72 135.18 23.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.609 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.828 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.51 47.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER 80.03 -54.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 p -48.76 -37.7 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 102.72 0.57 49.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.441 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 89.1 p -79.09 100.16 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 7.0 mt -56.38 149.78 36.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 79.7 Cg_exo -48.21 -28.98 11.89 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.617 2.211 . . . . 0.0 112.151 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -73.45 -29.58 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.201 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 138' ' ' ASP . 50.3 m80 -62.76 -30.8 71.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 1.124 ' O ' ' OE2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -66.02 -56.51 11.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.975 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.17 -37.78 62.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.168 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 113' ' ' ILE . 71.5 mt -58.71 -43.13 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.465 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -64.73 -15.28 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.472 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.124 ' OE2' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -93.7 -56.12 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 156' ' ' LEU . . . 94.79 24.27 18.23 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.106 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 82.3 m-70 -55.14 -157.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.624 0.25 . . . . 0.0 110.693 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -102.24 -95.96 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.455 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 29.8 t -73.05 -19.22 61.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.325 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.562 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -56.71 -69.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.048 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 18.0 t -52.12 -46.32 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.594 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 4.9 p -66.67 -32.69 74.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.783 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 86.6 t80 -73.03 -43.47 62.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HB3' ' CB ' ' A' ' 113' ' ' ILE . 0.4 OUTLIER -65.42 -11.22 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.073 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -67.69 -62.51 3.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 129' ' ' ALA . 27.0 Cg_endo -61.75 -52.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.845 2.363 . . . . 0.0 112.352 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.783 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 3.9 mt-10 -51.88 -25.74 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.7 m -108.46 137.29 46.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.262 ' OD1' ' HB3' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -35.64 103.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 11.1 mt -61.4 134.14 56.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.937 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 1.9 t-160 86.17 14.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.262 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 4.6 p-80 -64.33 168.95 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.87 166.04 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -140.65 148.64 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.664 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -41.38 -28.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.17 0.51 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -34.35 73.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.782 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 93.22 45.07 3.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -153.71 158.05 40.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 111.037 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -108.59 167.97 8.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.443 ' HG3' ' NE2' ' A' ' 136' ' ' HIS . 99.3 Cg_exo -40.59 -50.19 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.827 2.352 . . . . 0.0 112.524 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.503 HD13 ' CG ' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -62.25 -43.77 98.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -56.01 -64.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.511 ' CD1' HG23 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.72 -39.25 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.703 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.517 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -69.3 -27.7 65.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.621 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -70.73 -54.35 12.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.617 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -59.69 -67.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.01 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.81 59.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.57 52.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.925 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.538 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -37.79 -31.22 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.159 0.504 . . . . 0.0 110.15 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER 170.35 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.823 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.539 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 1.3 p30 -76.54 13.16 1.03 Allowed 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.111 -0.368 . . . . 0.0 111.646 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.544 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 2.5 mt -51.56 -66.65 0.35 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.5 ptm -52.88 -20.81 3.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.69 -63.97 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.489 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.594 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -52.81 -27.71 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 0.0 110.81 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.535 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.32 -40.89 64.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.503 ' CG ' HD13 ' A' ' 145' ' ' LEU . 3.1 mt-30 -72.95 -40.53 65.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.005 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.68 37.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 -46.64 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.011 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 160' ' ' LEU . 3.7 ttp -73.8 100.19 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.11 107.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.411 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 3.4 tt -155.55 62.7 3.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 166' ' ' ILE . 50.1 Cg_exo -53.62 141.92 62.16 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.685 2.257 . . . . 0.0 112.27 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.966 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.117 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -113.53 134.08 54.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 tpp -165.09 -59.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.15 52.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.26 39.47 3.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HG2' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -116.18 -29.83 6.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.938 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.99 ' HA ' ' OE1' ' A' ' 7' ' ' GLU . 0.7 OUTLIER 58.68 32.55 22.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 93.0 t 69.0 7.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.178 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -33.73 -38.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.24 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.441 HG22 HG11 ' A' ' 35' ' ' VAL . 22.5 m -131.14 3.96 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.324 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' ALA . . . -38.99 -32.65 0.19 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.574 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 18.8 t0 -117.74 28.08 8.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 111.032 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -96.63 -62.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.802 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' C ' ' CD1' ' A' ' 14' ' ' LEU . 1.7 tm? -71.86 -42.39 66.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 39' ' ' ALA . 18.7 m -57.16 -36.23 70.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -67.12 -52.1 34.48 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.362 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.79 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -60.17 -51.21 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 111.026 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.59 69.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.59 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 2.3 mmm180 -73.56 0.11 13.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.216 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.542 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 50.49 66.25 2.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.631 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.882 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.2 p-10 -132.79 95.23 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 110.819 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.55 -22.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.717 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . 4.2 mm100 -73.05 -59.0 2.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.848 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.882 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.28 -17.84 61.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.142 HG11 ' CD ' ' A' ' 61' ' ' GLU . 3.1 t -65.36 -67.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.2 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.931 ' CA ' ' OE2' ' A' ' 61' ' ' GLU . 3.9 ptt-85 -73.17 -38.15 66.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.897 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.581 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -61.87 -27.55 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.797 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.272 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 12.0 mt -73.69 -62.08 1.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 0.0 111.981 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 2.3 mt -65.56 -53.24 44.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -72.98 -3.35 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -138.36 -78.71 0.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.038 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.272 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 1.1 tt0 -41.43 -27.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' LEU . 41.6 tp 65.67 73.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 36' ' ' HIS . 80.1 t -122.5 159.74 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.056 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.454 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -74.64 145.06 81.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 65' ' ' GLN . 38.2 Cg_endo -66.86 -29.49 41.62 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.722 2.282 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -82.52 -67.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' O ' ' OG ' ' A' ' 15' ' ' SER . . . 35.84 87.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 5.2 mp -92.54 140.18 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -67.72 88.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER 86.78 19.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 t80 65.84 52.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -135.99 -73.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 7.7 mtpt -86.13 148.86 25.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.455 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 1.1 p -87.09 150.14 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HA ' ' OG ' ' A' ' 15' ' ' SER . . . -52.89 -36.61 59.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.934 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 HD22 ' CE ' ' A' ' 51' ' ' MET . 2.1 mt -73.28 -26.75 61.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.73 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.989 ' CG ' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 47' ' ' ALA . 15.8 m -93.11 -18.8 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.746 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.522 ' CE ' HD22 ' A' ' 48' ' ' LEU . 1.3 tmm? -44.2 145.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.542 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.68 12.9 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.853 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 7.3 m-85 56.29 -80.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.66 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 31.94 -93.71 0.01 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.677 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.483 ' CB ' HG12 ' A' ' 58' ' ' VAL . 1.8 m -67.71 130.56 92.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.483 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.507 ' N ' ' OG1' ' A' ' 91' ' ' THR . 56.1 Cg_endo -71.0 -27.9 19.96 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.715 2.276 . . . . 0.0 111.828 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' C ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.38 -36.37 83.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.01 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.542 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.47 -34.18 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' CB ' ' CG1' ' A' ' 94' ' ' VAL . . . -62.7 -58.04 8.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 64' ' ' LYS . 6.7 tt -63.27 -33.03 74.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.794 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.142 ' CD ' HG11 ' A' ' 26' ' ' VAL . 8.1 mt-10 -63.03 -60.26 3.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 5.6 mp -62.81 -46.91 85.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.17 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -63.16 -58.77 6.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' CB ' HD22 ' A' ' 60' ' ' LEU . 7.2 tmtt? -62.92 -23.79 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.131 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.518 ' HG2' ' CD2' ' A' ' 30' ' ' LEU . 24.8 tp60 -74.4 -20.02 60.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.999 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.53 50.35 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.04 159.81 21.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -126.21 120.44 23.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.986 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 71' ' ' VAL . 70.0 Cg_endo -74.68 -17.67 20.23 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.78 60.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 78' ' ' SER . 4.3 m -134.89 126.67 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HB3' ' N ' ' A' ' 77' ' ' THR . 2.7 mt-30 -127.33 133.32 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.989 ' OD2' ' CG ' ' A' ' 49' ' ' GLN . 2.1 p30 -125.08 -36.88 2.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.23 68.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.091 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.7 p 54.94 19.73 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.07 55.28 0.6 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.471 ' N ' ' HB3' ' A' ' 72' ' ' GLN . 17.2 m -137.8 100.69 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.99 173.45 3.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 26.3 Cg_exo -62.68 -34.04 75.2 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.835 2.357 . . . . 0.0 112.116 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 78' ' ' SER . 0.9 OUTLIER -54.98 -38.43 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -59.66 -65.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.989 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.933 ' OD1' ' C ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -57.99 -37.36 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.286 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.689 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -52.9 -42.97 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.248 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.64 -55.81 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.781 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -61.62 -27.68 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.781 HG22 ' OD1' ' A' ' 82' ' ' ASP . 21.4 p -70.8 -70.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.55 64.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 18.7 m-85 -136.26 49.75 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.64 ' CD2' ' CD2' ' A' ' 127' ' ' PHE . 2.7 tm? -52.28 -45.78 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.498 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -66.2 0.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.863 0.363 . . . . 0.0 110.8 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 56' ' ' PRO . 18.0 m -65.33 -44.58 87.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 22.6 tp -52.71 -48.76 66.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -52.13 -32.29 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -74.45 -55.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.556 ' N ' ' CG1' ' A' ' 94' ' ' VAL . 3.8 pp -74.33 -47.8 32.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.679 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.514 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -59.4 -36.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.552 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.787 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.87 -28.39 62.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -55.97 -37.42 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 160.08 -19.81 0.24 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.669 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 99' ' ' GLY . . . -33.63 115.16 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.2 p30 -48.8 113.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 131' ' ' GLU . 6.1 m -106.24 26.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.41 -35.93 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.74 145.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.486 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -123.64 -151.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -140.67 -77.17 0.31 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -57.85 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 1.128 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -63.41 -12.42 30.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.695 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.53 17.49 77.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.451 ' HB3' HD22 ' A' ' 115' ' ' LEU . 1.4 t -77.38 123.15 26.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.534 HD23 ' OD1' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -70.96 157.79 89.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.817 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.432 ' HD2' ' HG ' ' A' ' 111' ' ' LEU . 71.5 Cg_exo -48.74 -38.54 37.45 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.616 2.211 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -69.88 -40.97 79.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.086 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.535 ' CE1' ' HA ' ' A' ' 137' ' ' ARG . 22.0 m80 -52.66 -37.87 59.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.637 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 110' ' ' SER . 9.9 mt -72.84 -50.02 26.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.529 ' CB ' HG11 ' A' ' 124' ' ' VAL . . . -52.95 -37.1 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.526 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 95.0 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.477 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -72.99 -9.87 59.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.772 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.781 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -91.93 -57.94 2.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.674 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.28 41.49 3.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.861 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 9.8 m-70 -82.22 -1.75 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.87 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m 65.86 -81.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.7 OUTLIER -54.83 -52.74 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.981 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 116' ' ' ALA . 51.6 t -55.31 -60.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.345 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 3.8 t -52.13 -60.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.372 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.46 -27.55 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.64 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 11.7 t80 -73.64 -51.4 16.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.95 -7.49 22.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.258 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.584 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -58.41 -69.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.265 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 56.3 Cg_endo -70.49 -28.69 21.42 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.72 2.28 . . . . 0.0 112.487 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.503 ' OE2' ' CZ ' ' A' ' 127' ' ' PHE . 3.3 mm-40 -68.01 -18.14 64.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.497 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 3.8 m -116.88 157.8 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.71 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -44.19 113.96 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.471 ' CD1' ' HA ' ' A' ' 164' ' ' MET . 6.4 mt -85.48 43.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.73 30.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -138.53 155.83 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.535 ' HA ' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -130.13 -172.65 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 1.128 ' OD1' ' O ' ' A' ' 108' ' ' THR . 1.5 t70 -82.97 -174.68 5.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.747 ' H ' ' CG ' ' A' ' 138' ' ' ASP . . . -77.94 -4.99 49.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.042 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -46.75 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.761 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.457 ' O ' HD22 ' A' ' 142' ' ' LEU . . . 124.66 80.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.621 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 141' ' ' GLY . 28.5 mt -161.92 107.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.2 p -77.44 150.44 79.7 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.801 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.462 ' HB3' HD12 ' A' ' 113' ' ' ILE . 82.1 Cg_exo -45.43 -31.56 6.87 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.604 2.203 . . . . 0.0 112.206 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.527 ' C ' ' OE1' ' A' ' 146' ' ' GLU . 0.4 OUTLIER -73.32 -47.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.94 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.047 ' OE1' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.34 -50.92 63.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.209 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.59 -26.93 14.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.391 . . . . 0.0 110.677 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.518 ' HB3' ' N ' ' A' ' 157' ' ' MET . . . -73.67 -23.71 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -49.22 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -60.92 -72.79 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.477 ' CG ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -73.18 60.98 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.81 47.92 0.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.085 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -36.92 -57.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.441 0.638 . . . . 0.0 110.052 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -145.37 -146.51 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.548 179.031 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 1.087 ' HB2' ' CG ' ' A' ' 158' ' ' ASP . 17.6 p30 -73.36 53.63 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 160' ' ' LEU . 6.3 mt -65.14 -66.29 0.56 Allowed 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.574 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.518 ' N ' ' HB3' ' A' ' 148' ' ' ALA . 2.7 ppp? -51.44 -20.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.087 ' CG ' ' HB2' ' A' ' 155' ' ' ASN . 7.9 p-10 -73.72 -42.42 61.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.025 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.518 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.7 OUTLIER -72.47 -40.24 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 156' ' ' LEU . 5.4 mp -73.12 -40.17 65.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -63.51 -47.33 82.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.78 -44.32 92.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.38 -12.29 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.471 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 6.9 mtp -72.7 -53.18 12.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.466 ' O ' ' N ' ' A' ' 167' ' ' PRO . 3.4 ttp 75.35 37.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 168' ' ' MET . 0.9 OUTLIER -34.6 93.01 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.276 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' MET . 32.5 Cg_exo -57.88 75.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.238 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -79.84 -13.26 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.467 ' CE ' ' HG3' ' A' ' 42' ' ' ARG . 1.6 ttm -82.67 143.5 30.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.954 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.02 -55.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.78 -175.49 4.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 1.158 ' OE1' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.64 47.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.709 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.99 -26.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.158 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 54.7 t -48.98 -67.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.778 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER 35.44 90.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.546 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.577 ' CB ' ' O ' ' A' ' 9' ' ' CYS . 66.6 t 105.92 -39.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.931 0.77 . . . . 0.0 110.851 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.51 ' N ' ' HB3' ' A' ' 39' ' ' ALA . . . -65.94 -9.52 47.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.687 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -117.85 18.46 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tpt85 -122.62 -53.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.01 -43.72 70.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.754 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.99 -31.41 63.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.87 -53.33 8.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.398 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -57.57 -58.76 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB3' HD21 ' A' ' 62' ' ' LEU . . . -54.02 -40.96 67.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.48 -28.48 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.438 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.375 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -73.6 0.66 12.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.249 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . 50.73 78.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.375 ' OD2' ' CG ' ' A' ' 20' ' ' ARG . 2.6 p30 -152.63 97.15 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.598 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 2.1 p -52.83 -25.18 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.66 -49.99 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.004 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.544 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -73.25 -39.75 65.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.57 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.501 HG11 ' N ' ' A' ' 27' ' ' ARG . 8.8 p -52.42 -42.15 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 67.1 mtp85 -72.91 -50.75 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 3.5 mmp_? -52.61 -30.63 32.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.753 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.484 HD21 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -73.64 -74.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.172 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 62' ' ' LEU . 3.5 mt -74.31 -42.91 58.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -67.54 -4.56 11.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 9.4 tpt180 -149.51 -77.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.646 0.26 . . . . 0.0 111.311 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.987 ' OE1' HG23 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -41.69 -26.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 32' ' ' ARG . 3.6 tp 66.27 83.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.987 HG23 ' OE1' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -111.84 134.92 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.26 129.56 88.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.689 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' HG3' ' A' ' 65' ' ' GLN . 49.1 Cg_endo -69.17 -15.67 39.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.745 2.297 . . . . 0.0 112.239 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 6.7 t0 -83.57 -28.47 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.962 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB3' ' N ' ' A' ' 11' ' ' GLY . . . -43.52 157.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.495 ' N ' HD11 ' A' ' 40' ' ' LEU . 2.9 mp -143.34 142.47 31.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.263 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 22.3 p30 -71.4 169.38 15.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' HG3' ' CE ' ' A' ' 3' ' ' MET . 3.0 tmt_? -39.85 -34.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -62.05 -52.92 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' HD21 ' A' ' 40' ' ' LEU . . . 118.45 33.44 1.21 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 10.9 mtpt -109.99 170.83 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -98.94 166.58 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 50' ' ' VAL . . . -58.32 -46.37 86.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.79 -34.26 77.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.848 ' NE2' ' CG ' ' A' ' 73' ' ' ASP . 1.5 tp60 -73.43 -45.75 52.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 15' ' ' SER . 15.7 m -72.97 -39.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.657 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 53' ' ' PHE . 2.7 ppp? -35.26 148.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.038 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 54' ' ' GLY . 2.5 ptm -111.14 22.79 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.159 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.896 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 56.3 m-85 50.19 -87.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.347 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 34.46 -94.35 0.01 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.413 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 91' ' ' THR . 0.2 OUTLIER -53.54 156.26 4.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 1.033 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 93.8 Cg_endo -89.17 -52.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.961 2.441 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG2' ' A' ' 23' ' ' VAL . . . -62.99 -23.15 67.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 55' ' ' SER . 4.9 p -62.32 -45.46 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.12 -48.89 76.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -62.48 -48.88 77.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.18 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -62.67 -58.07 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.76 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.504 ' CD2' ' HB3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.86 -49.68 73.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -63.11 -44.36 95.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 111.214 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 10.5 ttpp -62.74 -31.0 71.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HG3' ' HD3' ' A' ' 37' ' ' PRO . 31.6 tp60 -45.66 -29.42 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.1 -19.14 2.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.422 ' HB2' HD21 ' A' ' 48' ' ' LEU . . . -56.41 152.46 11.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.0 m -105.99 126.66 30.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.979 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HA ' ' HG ' ' A' ' 48' ' ' LEU . 44.4 Cg_endo -68.57 -4.29 12.78 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.737 2.291 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -98.4 64.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.88 125.7 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -104.76 144.31 31.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.848 ' CG ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -123.37 122.03 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 47.94 -91.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -72.44 -87.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . -175.93 45.33 0.12 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.541 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.08 83.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.467 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 1.7 m -84.71 166.95 29.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 1.348 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 79.5 Cg_exo -47.81 -33.79 20.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.474 HG11 ' N ' ' A' ' 81' ' ' HIS . 0.5 OUTLIER -54.8 -42.15 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.014 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.571 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 15.7 m80 -70.07 -48.41 57.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.032 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 1.348 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.3 p30 -55.79 -50.45 70.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.259 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.66 -48.77 66.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 128' ' ' LEU . . . -64.14 -49.93 70.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.234 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -37.9 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 58.5 p -67.82 -27.44 66.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.06 73.6 1.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.34 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -153.64 58.4 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.631 ' CD1' ' CG ' ' A' ' 127' ' ' PHE . 61.7 tp -53.87 -16.7 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.673 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.033 ' OD2' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.78 -74.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.803 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -73.65 -33.25 64.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 2.0 tt -52.38 -56.91 11.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 1.215 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -56.64 -34.27 67.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 91' ' ' THR . 54.7 t -56.29 -62.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.642 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.43 -32.61 64.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 19.8 t -70.81 -46.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.215 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -56.08 -32.38 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.967 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.57 63.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.11 -68.47 0.44 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 96' ' ' VAL . . . 43.62 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -111.8 64.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 111' ' ' LEU . 6.7 m -79.88 5.88 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.29 24.85 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -119.82 128.4 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.471 HD22 ' HG ' ' A' ' 111' ' ' LEU . 7.1 mt -85.49 162.38 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.669 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -88.39 -84.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 t -131.61 -45.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.03 7.27 11.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 70.77 10.75 68.2 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.554 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.442 ' O ' HD22 ' A' ' 115' ' ' LEU . 73.6 p -78.89 92.46 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 111.044 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.471 ' HG ' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -36.24 146.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.524 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 99.2 Cg_exo -43.08 -28.44 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.409 2.073 . . . . 0.0 112.113 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.519 ' CA ' HD21 ' A' ' 128' ' ' LEU . 1.9 tp -73.4 -35.34 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.56 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 56.6 m80 -57.68 -43.73 85.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 110' ' ' SER . 0.8 OUTLIER -58.75 -42.97 90.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.476 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 125' ' ' VAL . . . -54.59 -48.9 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.569 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.511 ' N ' HG12 ' A' ' 125' ' ' VAL . 93.8 mt -56.0 -40.83 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' CD ' ' A' ' 151' ' ' ARG . 3.0 mmt85 -62.41 -21.44 65.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.32 -54.87 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 116.26 -6.61 19.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.519 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 98.2 m-70 -51.1 85.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' GLY . 18.0 p -38.88 -38.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 124' ' ' VAL . 1.9 p -73.17 -63.89 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.494 ' N ' ' OG ' ' A' ' 123' ' ' SER . 39.3 t -55.54 -57.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.361 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 117' ' ' ILE . 3.6 t -51.93 -54.09 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 44.0 t -63.74 -31.7 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.406 . . . . 0.0 111.11 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.631 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 71.3 t80 -73.1 -47.59 43.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -67.89 -8.96 40.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.489 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -66.29 -64.0 2.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 43.7 Cg_endo -67.88 -46.29 2.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 4.2 mm-40 -51.59 -47.09 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 134' ' ' LEU . 27.8 m -77.67 132.26 38.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' ND1' ' A' ' 136' ' ' HIS . 1.2 m-20 -36.14 96.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 6.7 mt -56.08 146.77 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.2 t-160 87.64 -21.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 133' ' ' ASP . 2.0 p-80 -42.85 167.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.015 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -122.27 -172.62 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.56 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -130.0 159.17 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -10.6 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 p -109.27 -24.04 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.786 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.11 28.92 3.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.633 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 1.419 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 34.4 mt -102.77 -179.35 3.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -169.8 177.01 1.16 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 75.6 Cg_exo -49.93 -58.76 1.52 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.641 2.228 . . . . 0.0 112.119 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.419 ' OE1' ' CD2' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -54.84 -59.63 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.54 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.476 HD11 ' CD2' ' A' ' 114' ' ' HIS . 0.9 OUTLIER -52.88 -51.86 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.411 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -52.8 -36.21 57.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.135 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -31.24 72.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -79.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.131 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 156' ' ' LEU . 4.5 mtt85 -74.06 75.08 1.73 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.84 55.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.082 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.586 ' O ' ' CB ' ' A' ' 154' ' ' GLN . . . -59.32 -18.68 40.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 1.229 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 7.5 tp-100 102.76 -85.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.858 0.724 . . . . 0.0 112.834 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.983 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -54.99 -42.87 72.98 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 153' ' ' ALA . 1.7 pt? -51.87 -53.84 36.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.524 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 10.2 ptm -60.28 -36.3 77.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD1' ' O ' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -73.55 -25.2 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.716 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 18.8 mt -73.28 -42.06 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.238 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -73.48 -53.55 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.718 -179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 162' ' ' GLY . 1.0 OUTLIER -52.37 -25.29 9.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.906 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 161' ' ' GLN . . . -73.31 -54.79 6.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.291 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.14 -49.23 29.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.474 ' HA ' ' CD1' ' A' ' 134' ' ' LEU . 2.6 tmm? -38.3 -64.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.7 ttm 57.23 -164.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.638 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.2 mm -136.91 108.71 9.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 168' ' ' MET . 50.3 Cg_endo -69.8 179.43 3.73 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.815 2.343 . . . . 0.0 112.307 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 167' ' ' PRO . 3.6 ptt? . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 57.9 m 65.82 -80.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.2 69.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -100.19 111.76 24.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.77 ' O ' ' OE1' ' A' ' 6' ' ' GLU . 7.3 tp -164.21 48.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.77 ' OE1' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.98 81.47 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.24 12.76 23.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.458 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 19.5 m -117.24 35.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.036 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 8' ' ' VAL . 1.2 p -35.31 -42.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.18 -9.96 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' HA2' ' CB ' ' A' ' 39' ' ' ALA . . . -53.64 -71.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 1.271 ' OD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -49.86 -22.48 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 1.158 ' HG2' ' OE2' ' A' ' 33' ' ' GLU . 1.9 tpt180 -61.91 -65.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -71.73 -45.42 61.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -35.93 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.93 -49.47 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.456 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.36 -43.96 75.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.64 -50.86 22.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.32 80.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -19.59 62.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.441 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . 69.66 60.23 5.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.464 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.749 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 3.6 p30 -125.77 92.88 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 10.3 p -52.75 -20.71 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.842 ' C ' ' OE1' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -74.0 -53.9 9.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.264 ' OE1' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -73.39 -33.43 65.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.82 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 2.7 p -52.78 -50.8 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 0.0 111.306 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.634 ' CB ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.21 -50.52 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.163 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 8.2 ttt180 -56.41 -25.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.005 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.501 HD21 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.36 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.5 ' CD2' ' NE2' ' A' ' 65' ' ' GLN . 3.5 mt -73.67 -40.15 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' CB ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -72.64 -1.59 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.321 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -144.73 -70.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.743 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.158 ' OE2' ' HG2' ' A' ' 13' ' ' ARG . 1.2 tt0 -61.67 -15.1 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 47.44 76.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.937 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 14' ' ' LEU . 6.7 t -100.4 159.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -88.27 142.44 31.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.971 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HD3' ' NE2' ' A' ' 65' ' ' GLN . 11.6 Cg_endo -54.77 -39.95 87.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.072 2.515 . . . . 0.0 112.296 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 59.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -107.68 121.37 44.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.99 170.74 9.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 1.271 ' CB ' ' OD1' ' A' ' 12' ' ' ASP . 15.9 p30 -124.41 -170.79 2.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.57 -30.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HB2' ' OD1' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -69.02 -52.12 31.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.93 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.16 18.39 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 40' ' ' LEU . 15.0 mttp -102.47 167.66 9.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.429 ' O ' HG11 ' A' ' 50' ' ' VAL . 28.1 p -85.12 162.79 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -54.75 -44.44 73.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 62' ' ' LEU . 5.1 tp -63.76 -51.19 66.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.043 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' NE2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tt0 -54.34 -70.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 46' ' ' THR . 7.8 p -56.69 -23.99 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -36.6 132.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.441 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 3.4 ptt? -93.48 13.64 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.611 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER 43.72 26.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.888 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . -59.86 -67.91 1.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 91' ' ' THR . 0.4 OUTLIER -93.24 141.85 24.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 0.0 110.516 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 52.2 Cg_endo -68.55 -43.2 4.24 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.636 2.224 . . . . 0.0 111.975 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.2 -32.73 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.697 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 26' ' ' VAL . 3.3 t -62.48 -31.88 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 121.145 0.498 . . . . 0.0 109.79 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.528 ' CB ' HG22 ' A' ' 94' ' ' VAL . . . -63.63 -64.03 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.177 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HA ' HD11 ' A' ' 60' ' ' LEU . 44.4 tp -63.14 -28.86 70.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.274 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -63.02 -71.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -63.35 -27.46 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.504 HD23 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -62.78 -62.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -19.03 63.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' NE2' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -48.07 -24.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.95 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.15 0.39 5.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.57 -173.89 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.46 130.45 9.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -14.19 35.33 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.764 2.309 . . . . 0.0 112.373 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.57 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 23.5 m120 -82.36 74.8 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.509 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 28.4 m -130.08 138.21 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.007 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -144.43 157.58 44.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -144.88 -77.62 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 85.23 6.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.44 -56.16 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 1.29 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 172.83 56.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.889 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 5.7 m -101.77 69.57 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.543 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -73.38 170.89 12.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 10.2 Cg_endo -53.67 -40.5 79.31 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.835 2.356 . . . . 0.0 112.321 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.44 HG11 HG23 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.26 -25.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.577 ' CD2' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -70.97 -67.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.663 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 43.8 p30 -60.66 -26.35 67.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -55.25 -52.79 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB3' ' HB1' ' A' ' 116' ' ' ALA . . . -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.273 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -72.81 -29.05 62.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 12.1 p -69.41 -6.1 27.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.41 74.97 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.39 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -161.11 59.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' A' ' 127' ' ' PHE . 2.1 tm? -53.6 -28.93 35.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.609 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -58.75 -67.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.694 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.609 ' OG1' ' OD1' ' A' ' 90' ' ' ASP . 17.5 m -70.66 -23.39 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 93' ' ' LYS . 1.7 tt -72.83 -42.87 63.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 1.305 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 6.6 ptpt -67.87 -32.44 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.67 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.338 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 1.3 m -64.9 -54.35 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.491 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.553 HD22 ' CD2' ' A' ' 53' ' ' PHE . 1.5 pp -74.01 -33.39 63.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.519 ' CG1' HG12 ' A' ' 102' ' ' VAL . 42.3 t -73.04 -53.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.254 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.338 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 1.2 pm0 -52.72 -31.6 38.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.889 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.504 ' CD2' HD23 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -57.65 -19.43 26.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.3 6.71 5.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 95' ' ' LEU . . . -50.16 132.5 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 2.9 p30 -43.94 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.519 HG12 ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -99.06 22.55 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.144 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.29 14.29 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.721 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -89.82 161.65 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.512 ' CD2' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -141.64 -179.69 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 1.29 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 1.7 m-20 -121.11 -155.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -57.83 7.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -33.45 73.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.017 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.39 66.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.503 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.3 113.76 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -59.67 150.1 68.47 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 98.8 Cg_exo -42.71 -31.85 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.829 2.353 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.528 ' HA ' ' CD2' ' A' ' 128' ' ' LEU . 3.3 tp -72.37 -39.32 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.11 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 36.3 m80 -61.38 -35.18 76.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.577 HD23 ' CD2' ' A' ' 81' ' ' HIS . 5.1 mp -69.1 -50.49 47.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.619 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB1' ' CD2' ' A' ' 128' ' ' LEU . . . -54.18 -37.45 64.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.527 ' N ' HG12 ' A' ' 125' ' ' VAL . 94.5 mt -62.23 -43.76 98.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.299 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 11.9 mtp180 -61.48 -16.22 45.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.313 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 3.7 mt-10 -105.3 -49.81 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 81.07 29.48 41.39 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.116 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.59 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 68.6 m-70 -51.5 -169.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 121' ' ' HIS . 91.6 p -57.56 -130.69 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.729 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 1.54 9.76 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.223 -0.298 . . . . 0.0 111.441 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.59 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -54.39 -68.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.852 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 116' ' ' ALA . 2.7 t -52.18 -32.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.578 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 13.8 t -73.53 -56.87 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.787 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 1.097 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 5.0 t80 -67.97 -47.06 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.762 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.725 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -66.4 -7.5 19.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.877 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -73.12 -60.7 1.71 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.37 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.498 ' CD ' ' O ' ' A' ' 126' ' ' SER . 18.4 Cg_endo -59.45 -64.27 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.831 2.354 . . . . 0.0 112.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 1.097 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -43.8 -26.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.507 ' OG ' ' CD2' ' A' ' 111' ' ' LEU . 6.0 t -89.5 133.86 34.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.657 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 3.2 p-10 -38.05 93.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.657 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 132' ' ' SER . 6.6 mt -63.88 69.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER 178.34 -42.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.017 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.657 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.8 OUTLIER -54.06 154.41 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.91 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.523 ' HD3' ' NE2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -140.91 -148.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.783 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.447 ' N ' ' HD2' ' A' ' 137' ' ' ARG . 0.7 OUTLIER -160.91 -162.72 0.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.65 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.33 -22.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.172 0.511 . . . . 0.0 110.612 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -62.38 -52.68 62.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.89 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.36 20.73 58.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.525 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.4 mt -106.6 -105.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.551 0.175 . . . . 0.0 110.807 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.253 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER 160.52 167.83 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.8 0.333 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 3.8 Cg_endo -47.41 -57.56 2.25 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 123.022 2.481 . . . . 0.0 112.088 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.474 ' CD1' ' HG2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -66.12 -44.75 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.253 ' CD ' ' OG1' ' A' ' 143' ' ' THR . 4.0 mp0 -55.53 -51.12 68.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.531 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.504 ' HG ' ' NH2' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -53.04 -43.34 66.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 110.171 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 157' ' ' MET . . . -52.85 -36.42 58.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -35.61 78.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.627 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -74.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.248 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.471 ' O ' HD22 ' A' ' 156' ' ' LEU . 10.8 mmm180 -73.97 70.59 1.51 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.29 52.0 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.909 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.585 ' O ' ' CB ' ' A' ' 154' ' ' GLN . . . -57.17 -16.6 8.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.513 0.196 . . . . 0.0 110.535 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 7.0 tp-100 101.79 -59.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.659 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.468 ' CB ' HD13 ' A' ' 159' ' ' ILE . 4.8 m-20 -72.6 -54.73 8.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.0 111.512 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.576 HD11 ' N ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -53.05 -16.78 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.946 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.576 ' N ' HD11 ' A' ' 156' ' ' LEU . 14.4 mtp -74.74 -60.37 2.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.858 0.361 . . . . 0.0 111.603 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.071 -179.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.578 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 60.0 mt -52.74 -55.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.673 0.273 . . . . 0.0 111.366 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -73.64 -31.12 63.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.34 -179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 145' ' ' LEU . 1.3 mm-40 -62.94 -42.64 99.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -36.14 57.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.403 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -70.18 -31.73 69.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.57 87.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.18 168.52 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -136.44 105.59 9.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.949 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.54 108.05 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.958 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -126.3 104.73 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.81 56.81 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.8 -51.32 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tp 65.53 165.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 1.204 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER 63.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.904 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 1.204 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 0.1 OUTLIER 172.97 101.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.885 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.01 HG12 ' OE2' ' A' ' 6' ' ' GLU . 15.6 m -119.27 -11.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.202 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 8' ' ' VAL . 20.7 p -36.38 -38.54 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.695 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' CG2' HG21 ' A' ' 35' ' ' VAL . 13.1 p -107.33 -17.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -46.47 -57.59 6.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.444 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -84.21 54.68 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -127.86 -66.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 37' ' ' PRO . 29.0 tp -67.23 -33.92 76.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.008 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.477 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -61.89 -39.18 91.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -31.63 75.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.9 -59.67 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 111.153 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.51 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -54.28 -48.62 71.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -64.24 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -72.61 -37.65 68.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA3' ' HE1' ' A' ' 52' ' ' MET . . . 98.85 73.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.37 83.78 1.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.3 p -52.65 -22.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -74.11 -49.67 22.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' O ' HD21 ' A' ' 29' ' ' LEU . 55.8 mm-40 -73.84 -27.3 61.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.845 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -52.76 -51.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.53 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.559 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.2 mtm180 -73.28 -43.09 61.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 19.7 mmt180 -63.5 -34.21 77.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -53.47 -71.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -69.68 -49.36 54.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.012 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -66.72 -25.83 66.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.93 -58.66 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.555 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.3 tp10 -67.35 -7.14 22.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.06 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER 42.46 28.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.7 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -66.76 148.85 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.435 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 1.5 m-70 -67.62 131.03 92.97 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.98 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 57.5 Cg_endo -71.07 -22.42 26.19 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.852 2.368 . . . . 0.0 112.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -99.55 18.68 17.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -62.18 107.59 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.3 mp -89.82 145.22 25.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 54.2 p30 -80.93 -171.37 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -70.56 58.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -172.52 -43.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.58 60.14 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.594 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -141.08 145.64 36.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -85.57 155.9 20.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -55.27 -24.24 27.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.9 -49.65 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 78' ' ' SER . 1.8 tp-100 -63.88 -28.29 69.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 28.9 m -96.23 -14.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.515 ' HE2' ' CD2' ' A' ' 95' ' ' LEU . 1.2 ttp -44.64 154.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -109.72 23.51 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 83' ' ' ALA . 5.2 m-85 35.84 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -72.39 -85.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.314 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.1 m -77.91 120.31 80.79 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.37 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.1 -43.48 48.05 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.472 2.115 . . . . 0.0 112.08 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.61 -28.51 69.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' SER . 3.2 t -62.27 -41.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB3' ' CG2' ' A' ' 91' ' ' THR . . . -63.65 -50.18 70.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.641 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.5 tp -63.14 -40.19 96.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.712 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -63.04 -43.24 99.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.51 HD13 ' CB ' ' A' ' 18' ' ' ALA . 6.0 mt -62.81 -56.92 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' A' ' 69' ' ' PRO . 5.8 mt -63.12 -31.31 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 4.2 mmtt -63.36 -46.27 87.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -56.57 -27.2 57.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.969 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.39 47.88 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.436 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.25 123.58 49.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.903 0.382 . . . . 0.0 111.039 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 124.86 83.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.463 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 59.3 Cg_endo -72.42 -38.61 3.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.727 2.285 . . . . 0.0 112.302 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.01 101.48 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 11.6 m -139.41 132.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.405 ' HG3' ' C ' ' A' ' 71' ' ' VAL . 49.5 mt-30 -144.85 131.86 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -138.8 -44.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 75' ' ' SER . . . -104.55 115.33 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' GLY . 0.9 OUTLIER 36.38 63.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . 35.53 66.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.602 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.3 m -124.97 144.79 50.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.516 ' HA ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -144.41 177.97 1.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 77.6 Cg_exo -49.61 -47.56 22.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.656 2.238 . . . . 0.0 112.288 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.57 -38.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -59.31 -70.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.204 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.03 -33.31 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 53' ' ' PHE . . . -52.81 -52.44 56.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.41 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 124' ' ' VAL . . . -64.97 -46.56 80.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.441 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -72.21 -24.36 61.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.355 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 11.5 p -73.11 -73.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.124 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 126.75 63.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.997 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -148.38 57.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.56 HD23 ' CG ' ' A' ' 127' ' ' PHE . 2.7 tm? -52.11 -19.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 4.5 m-20 -60.36 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.46 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 2.4 m -73.37 -27.55 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.51 HD22 ' CG2' ' A' ' 96' ' ' VAL . 3.1 tt -56.54 -57.52 11.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.988 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -54.07 -32.22 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.807 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 23.7 t -57.71 -65.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.515 ' CD2' ' HE2' ' A' ' 51' ' ' MET . 1.6 pp -70.41 -29.33 65.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.429 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.51 ' CG2' HD22 ' A' ' 92' ' ' LEU . 23.5 t -72.55 -40.31 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.807 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 4.5 pm0 -72.82 -25.75 61.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -61.07 -62.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -176.74 -30.35 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.868 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 69' ' ' PRO . . . -31.8 118.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.351 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.23 119.27 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 131' ' ' GLU . 5.3 p -110.84 20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -136.62 27.88 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.92 130.99 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.622 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -97.49 162.61 13.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.091 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 51.9 p-10 -85.31 53.07 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 106' ' ' ASP . 8.4 t 80.42 -62.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.414 ' OG1' ' OG ' ' A' ' 110' ' ' SER . 34.4 p -42.04 -28.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.003 0.43 . . . . 0.0 110.048 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 88.45 31.69 13.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.57 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.524 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -101.8 96.87 7.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 10.6 tp -34.89 135.35 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' HD11 ' A' ' 105' ' ' LEU . 83.9 Cg_exo -45.92 -29.25 5.76 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.734 2.29 . . . . 0.0 112.452 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG23 ' CD2' ' A' ' 111' ' ' LEU . 4.5 tt -73.06 -35.7 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -52.84 -37.66 60.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -68.64 -46.55 68.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.615 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.522 ' CB ' HG11 ' A' ' 125' ' ' VAL . . . -56.29 -41.64 76.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.257 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.534 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 85.5 mt -57.64 -38.04 62.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.595 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 2.3 mtp180 -66.22 -17.44 64.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -98.95 -50.94 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.76 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.406 ' HA2' HD21 ' A' ' 156' ' ' LEU . . . 86.84 40.96 6.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 123' ' ' SER . 23.9 m-70 -72.95 -3.04 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.722 0.296 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER 63.0 -70.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.791 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 121' ' ' HIS . 32.5 m -55.98 -41.61 75.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 84' ' ' ALA . 51.9 t -73.19 -61.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.28 -51.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.56 ' CB ' ' CB ' ' A' ' 159' ' ' ILE . 83.7 p -56.57 -42.68 79.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.04 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.568 ' CZ ' ' HG3' ' A' ' 131' ' ' GLU . 72.8 t80 -73.41 -37.61 65.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -71.97 -2.64 18.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.28 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.594 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -69.19 -71.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.226 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 37.5 Cg_endo -66.96 -57.63 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.614 2.21 . . . . 0.0 112.336 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.568 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 6.6 mm-40 -39.63 -37.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 102' ' ' VAL . 9.7 m -96.38 133.4 40.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.786 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.305 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -36.51 107.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.549 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.467 HD23 ' HG2' ' A' ' 164' ' ' MET . 31.0 mt -72.89 -1.31 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.268 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.05 24.09 13.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.305 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 4.4 t60 -107.27 171.1 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER -159.94 157.38 28.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 141' ' ' GLY . 6.7 t0 -77.57 157.89 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.486 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.7 -27.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 109.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -40.64 62.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.657 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 114.11 35.85 1.44 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.39 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 67.8 mt -93.92 -167.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.524 ' CG2' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -178.35 165.28 1.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 143' ' ' THR . 99.4 Cg_exo -42.61 -56.83 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.619 2.213 . . . . 0.0 111.886 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.452 ' HB2' ' HE3' ' A' ' 164' ' ' MET . 6.3 mt -72.03 -42.74 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.482 ' HB3' ' N ' ' A' ' 143' ' ' THR . 3.6 tp10 -55.56 -69.78 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 150' ' ' GLN . 21.9 tp -52.73 -38.17 60.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 109.914 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 157' ' ' MET . . . -54.14 -44.63 71.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.036 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.473 ' N ' ' SD ' ' A' ' 157' ' ' MET . 1.9 tpm_? -58.57 -23.36 58.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 1.4 tt0 -71.9 -75.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' HD13 ' A' ' 156' ' ' LEU . 5.6 mmm180 -74.06 74.43 1.72 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.88 55.81 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.582 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 154' ' ' GLN . . . -69.88 -13.26 62.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.756 0.313 . . . . 0.0 110.748 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 8.2 tp-100 88.39 -37.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.536 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -72.51 -64.89 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.252 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -52.01 -55.02 23.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.291 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.476 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . 34.5 mmm -50.98 -28.19 9.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 154' ' ' GLN . 30.9 t0 -75.31 -71.04 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.708 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.56 ' CB ' ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -53.05 -40.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.232 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 156' ' ' LEU . 6.5 mp -73.68 -14.75 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -73.37 -61.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.38 -48.69 50.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.301 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 19.4 m-70 -53.93 -18.96 3.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.467 ' HG2' HD23 ' A' ' 134' ' ' LEU . 6.9 mmm -94.74 133.51 38.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -78.08 73.69 4.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 166' ' ' ILE . 0.6 OUTLIER -34.45 93.47 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.462 ' N ' ' O ' ' A' ' 165' ' ' MET . 50.7 Cg_exo -54.01 113.31 1.27 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.72 2.28 . . . . 0.0 112.232 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.3 mtt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.85 144.21 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mmm -118.53 -8.11 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.45 155.85 25.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.265 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 19.7 mt -106.08 -159.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.827 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.98 52.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.876 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 1.265 ' OE2' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.86 16.41 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.489 HG13 ' CA ' ' A' ' 41' ' ' ASN . 33.7 m -103.3 -30.83 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 8' ' ' VAL . 1.3 m 58.09 130.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.791 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.534 ' CG1' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER 52.13 20.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -81.9 -60.91 2.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.521 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -10.77 26.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -98.66 -70.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.8 OUTLIER -72.22 -61.36 1.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 5.1 t -55.81 -25.8 43.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.18 -50.69 11.73 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.745 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.51 -47.42 48.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 111.223 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -52.87 -39.67 62.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.024 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.34 -41.45 63.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.304 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -62.63 -22.14 66.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.68 59.47 3.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.898 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.253 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 16.5 t0 -109.29 90.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.643 0.259 . . . . 0.0 110.374 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 3.4 p -51.92 -23.53 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.151 0.5 . . . . 0.0 110.255 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.14 -59.58 2.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.8 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.253 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 11.0 mm-40 -73.96 -28.19 61.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.613 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 3.7 p -52.41 -51.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.816 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 19.6 mtp180 -74.48 -51.25 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -52.75 -36.74 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.11 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 9.2 mt -73.16 -74.33 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.685 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.49 HD12 ' CG ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -73.16 -42.19 63.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -73.08 -1.68 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.27 -64.74 0.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 111.121 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.955 ' OE2' ' CG1' ' A' ' 35' ' ' VAL . 2.2 tt0 -62.51 -11.35 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tp 54.22 73.25 0.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.955 ' CG1' ' OE2' ' A' ' 33' ' ' GLU . 2.0 m -101.29 153.92 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' OD2' ' A' ' 38' ' ' ASP . 1.8 t-80 -74.83 126.6 88.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.55 1.03 7.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.786 2.324 . . . . 0.0 112.357 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 1.1 p-10 -111.86 53.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.33 177.21 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 3.8 mp -142.19 -173.87 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' PHE . 17.8 p-10 -150.9 166.7 29.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -35.17 -31.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -68.33 -47.63 67.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 110.13 16.12 10.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 11.5 mtpt -101.83 169.02 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.15 168.52 13.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -60.4 -55.01 38.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.42 -36.64 84.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -52.87 -66.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 51' ' ' MET . 7.1 p -70.09 -25.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.529 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -35.7 107.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 20' ' ' ARG . 2.8 ptt? -66.27 137.28 56.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.637 ' CE2' ' CD2' ' A' ' 95' ' ' LEU . 11.6 m-85 -82.64 47.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.36 -64.36 1.46 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.135 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.552 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 5.2 m -98.36 111.52 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 1.026 ' CG ' ' OD1' ' A' ' 90' ' ' ASP . 76.1 Cg_exo -48.67 -23.5 5.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.449 2.1 . . . . 0.0 111.834 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' CB ' ' CG2' ' A' ' 23' ' ' VAL . . . -64.41 -43.45 94.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.112 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 55' ' ' SER . 2.1 p -61.94 -36.9 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.87 0.367 . . . . 0.0 110.549 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -63.8 -51.32 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.8 tt -63.29 -46.45 86.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.942 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' HG ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -62.56 -47.4 84.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.439 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD1' ' HG3' ' A' ' 51' ' ' MET . 11.9 mt -62.73 -58.97 5.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -28.16 69.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.389 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 18.0 ttpt -62.77 -17.78 61.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.774 0.321 . . . . 0.0 111.084 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.49 ' CG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -77.34 -67.49 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.15 37.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.54 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 48' ' ' LEU . . . -79.52 -160.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 111.089 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 71' ' ' VAL . 32.1 m -123.7 124.1 26.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 74.2 Cg_endo -75.16 -17.23 19.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.783 2.322 . . . . 0.0 112.366 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -114.17 77.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 68' ' ' SER . 5.0 m -117.85 152.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -134.62 160.32 38.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.742 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -117.25 67.38 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 73' ' ' ASP . . . 36.17 41.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.0 m -151.46 -43.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.832 ' HA3' ' OD2' ' A' ' 106' ' ' ASP . . . 111.95 67.57 0.53 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.45 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.438 HG21 ' OD1' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -164.7 105.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.52 170.62 6.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.736 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 76.9 Cg_exo -49.66 -40.45 46.71 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.593 2.196 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 81' ' ' HIS . 7.6 m -59.05 -34.0 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.485 ' N ' HG21 ' A' ' 80' ' ' VAL . 62.0 m80 -69.8 -62.36 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.1 OUTLIER -53.1 -48.15 68.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.05 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.33 -27.71 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.49 -62.42 1.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.43 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HG3' ' A' ' 119' ' ' GLU . 16.4 mtp180 -73.07 -28.13 62.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 75.8 p -69.82 -5.58 26.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.147 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 50.28 76.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.528 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 11.7 m-85 -150.4 56.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.54 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.473 ' O ' ' HD2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -52.56 -22.95 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.188 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.026 ' OD1' ' CG ' ' A' ' 56' ' ' PRO . 3.6 t70 -62.29 -74.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 110.647 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 43.2 m -70.71 -19.81 62.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.501 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.523 HD22 ' CG2' ' A' ' 96' ' ' VAL . 2.8 tt -68.61 -55.3 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.511 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.688 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.6 -30.01 62.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.966 ' O ' ' OE2' ' A' ' 97' ' ' GLU . 78.8 t -59.98 -62.46 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.12 -28.78 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.471 . . . . 0.0 110.148 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.523 ' CG2' HD22 ' A' ' 92' ' ' LEU . 16.4 t -73.33 -44.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.966 ' OE2' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -68.1 -28.42 67.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.742 ' CG ' ' OE2' ' A' ' 97' ' ' GLU . 19.0 m-70 -60.06 -29.63 68.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.48 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 102' ' ' VAL . . . -95.81 143.56 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 111.108 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.1 84.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.49 HG13 ' CG1' ' A' ' 96' ' ' VAL . 11.7 m -88.66 11.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 0.0 OUTLIER -124.16 37.92 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.441 ' C ' ' CD2' ' A' ' 105' ' ' LEU . . . -107.9 145.01 34.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.121 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -121.51 146.5 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.832 ' OD2' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -155.25 -53.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.426 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -48.16 -52.98 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.5 OUTLIER -163.08 57.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 108' ' ' THR . . . 36.49 52.62 1.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.432 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 111' ' ' LEU . 48.0 m -134.49 110.9 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.97 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.457 HD11 ' CD2' ' A' ' 136' ' ' HIS . 8.8 tp -35.01 140.53 0.29 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 88.1 Cg_exo -46.69 -32.26 11.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.767 2.311 . . . . 0.0 112.194 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 1.6 tt -66.69 -37.44 79.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.506 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 73.8 m80 -59.3 -35.56 73.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -53.07 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.415 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.72 -41.4 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 110.055 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.529 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 88.2 mt -52.81 -42.5 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.333 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -16.22 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.579 ' HB3' ' CD2' ' A' ' 121' ' ' HIS . 3.8 mm-40 -86.46 -59.58 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.694 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.29 -0.35 14.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.603 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.579 ' CD2' ' HB3' ' A' ' 119' ' ' GLU . 77.9 m-70 -61.44 73.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m -34.53 -33.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.57 -48.76 30.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' HIS . 12.4 t -73.07 -50.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.411 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.07 -52.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.547 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.1 t -69.04 -34.98 76.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.229 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.446 ' HB3' HD22 ' A' ' 89' ' ' LEU . 67.7 t80 -72.94 -35.83 67.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.088 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.457 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.28 -0.23 13.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.273 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.569 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -66.2 -69.41 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.306 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 41.5 Cg_endo -68.56 -57.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.633 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.487 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 24.0 mm-40 -39.28 -31.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.006 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.465 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 1.3 t -109.01 136.3 48.77 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.3 p30 -35.37 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 129' ' ' ALA . 12.6 mt -70.71 75.3 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER 173.14 -33.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.457 ' CD2' HD11 ' A' ' 111' ' ' LEU . 6.7 t60 -38.61 161.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -140.51 147.65 39.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.88 ' OD2' ' HB3' ' A' ' 140' ' ' SER . 0.3 OUTLIER -85.32 159.84 19.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.685 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 109.891 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.88 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . 0.1 OUTLIER -71.52 -56.1 6.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.833 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.51 12.62 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.701 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 2.7 mt -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.534 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.4 OUTLIER -74.22 -178.67 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 75.0 Cg_exo -49.92 -49.87 14.87 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.837 2.358 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -67.99 -42.41 80.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.738 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.647 ' OE1' ' OE1' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -52.93 -60.16 3.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.037 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 150' ' ' GLN . 0.4 OUTLIER -52.84 -29.83 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.682 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 160' ' ' LEU . . . -72.63 -24.08 61.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 146' ' ' GLU . 7.4 tmm_? -65.85 -51.03 62.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.647 ' OE1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.17 -71.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -74.18 58.3 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.29 52.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.433 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -31.05 -48.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -173.81 -109.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.535 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.3 m-80 -74.71 4.97 5.41 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.227 -0.295 . . . . 0.0 111.434 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.488 ' O ' HD21 ' A' ' 160' ' ' LEU . 1.6 mt -51.2 -59.34 4.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.704 0.288 . . . . 0.0 111.33 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.2 -32.17 35.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.916 0.389 . . . . 0.0 110.637 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.33 -57.77 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.787 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.15 -32.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -179.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.4 -59.88 2.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 145' ' ' LEU . 6.3 pt20 -65.45 -14.91 61.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.05 -55.43 6.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.96 -14.09 61.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.1 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.479 ' HE2' ' CD1' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -42.47 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.774 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.445 ' O ' ' C ' ' A' ' 166' ' ' ILE . 1.1 mtp 171.52 -36.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.996 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 167' ' ' PRO . 26.8 mm 32.07 89.26 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 166' ' ' ILE . 52.8 Cg_exo -54.66 -148.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 0.0 112.274 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.88 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.3 p -62.56 72.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.841 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 1' ' ' GLY . 2.1 mtm -96.67 17.77 15.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tp -101.92 48.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.8 OUTLIER -100.78 168.27 9.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.853 ' HB3' ' OD2' ' A' ' 12' ' ' ASP . 1.3 mt-10 -45.6 131.12 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -109.23 41.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' HA3' ' A' ' 11' ' ' GLY . 2.6 p -108.16 -17.28 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 50.9 m 67.39 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.389 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.53 HG13 ' CB ' ' A' ' 39' ' ' ALA . 9.2 t -72.07 -57.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.603 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' A' ' 8' ' ' VAL . . . -33.2 -56.43 0.55 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.25 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.853 ' OD2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -73.42 -24.14 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 111.252 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -72.56 -68.74 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.187 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.561 ' CD1' ' CB ' ' A' ' 47' ' ' ALA . 3.0 tm? -68.07 -54.83 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 1.0 OUTLIER -61.12 -38.6 86.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.122 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -62.16 -61.08 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.673 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 29' ' ' LEU . . . -57.55 -41.58 81.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.02 75.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.89 61.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 4.1 mtp85 -68.59 -30.71 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.487 ' CA ' ' HG2' ' A' ' 52' ' ' MET . . . 84.46 33.06 20.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.464 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.343 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 p-10 -104.64 100.18 9.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.2 p -54.72 -17.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.817 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 16.8 mt-30 -74.25 -53.39 9.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.269 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.343 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.32 -34.64 65.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.025 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.535 HG22 ' CB ' ' A' ' 58' ' ' VAL . 9.9 p -52.56 -50.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -72.52 -48.1 43.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 111.038 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.87 -27.44 65.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 17' ' ' ALA . 26.8 mt -74.43 -71.85 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.023 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.512 ' CD1' ' HA ' ' A' ' 62' ' ' LEU . 82.9 mt -63.3 -67.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -64.9 -4.88 4.97 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -129.43 -70.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.459 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.186 ' OE1' ' CG2' ' A' ' 35' ' ' VAL . 4.4 tt0 -51.86 -20.49 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt 59.12 53.51 5.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 1.186 ' CG2' ' OE1' ' A' ' 33' ' ' GLU . 48.5 t -86.02 137.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.179 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.6 t-80 -55.41 143.56 56.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 36.9 Cg_endo -65.22 -33.77 47.87 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.78 2.32 . . . . 0.0 112.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -96.42 31.59 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' CB ' HG13 ' A' ' 10' ' ' VAL . . . -79.43 61.19 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.366 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 45' ' ' LYS . 5.0 mp -55.76 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -84.26 46.06 1.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 2.0 tmt_? 84.7 -11.69 0.78 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER 155.74 50.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.791 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 40' ' ' LEU . . . -143.12 -102.47 0.42 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.979 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 14.3 mttt -95.07 154.69 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 0.0 111.229 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.474 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -84.39 142.93 29.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.989 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 14' ' ' LEU . . . -52.84 -22.62 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD21 ' SD ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -73.29 -67.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -52.96 -37.76 61.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 28.7 m -78.43 -19.21 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.292 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.492 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.61 143.22 51.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.487 ' HG2' ' CA ' ' A' ' 21' ' ' GLY . 4.1 ppp? -78.04 116.69 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.641 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CE2' ' HB1' ' A' ' 83' ' ' ALA . 36.7 m-85 -70.32 57.93 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -50.66 0.21 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.521 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 49.6 m -82.3 127.07 72.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.544 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 55.4 Cg_endo -70.2 -37.34 8.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.631 2.22 . . . . 0.0 112.317 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' OE2' ' A' ' 61' ' ' GLU . . . -63.31 -39.28 94.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.315 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.535 ' CB ' HG22 ' A' ' 26' ' ' VAL . 4.1 m -62.96 -31.33 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.523 ' N ' HG21 ' A' ' 58' ' ' VAL . . . -63.45 -59.89 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 7.0 tt -63.26 -37.87 88.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.505 ' OE2' ' HB2' ' A' ' 57' ' ' ALA . 5.3 mp0 -62.75 -62.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' HA ' ' CD1' ' A' ' 30' ' ' LEU . 3.4 mt -62.82 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 4.9 tp -63.33 -50.88 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.6 ttpp -62.83 -36.87 84.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.92 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.484 ' CG ' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -37.55 -60.55 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.853 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.95 -23.94 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.2 146.23 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.038 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.14 119.68 62.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.52 -19.64 37.03 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.106 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.03 70.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 78' ' ' SER . 23.4 m -124.2 145.76 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -134.4 133.35 40.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.669 ' CG ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -100.12 -169.95 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.669 ' N ' ' CG ' ' A' ' 73' ' ' ASP . . . -35.75 -71.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.063 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.038 ' O ' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -59.15 -34.89 72.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 1.193 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 92.29 48.16 3.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.607 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -112.38 75.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 110.926 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.843 ' OG ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -43.84 170.06 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.684 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 8.9 Cg_endo -50.6 -32.73 36.55 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.933 2.422 . . . . 0.0 112.38 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -63.75 -52.94 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.411 ' N ' HG13 ' A' ' 80' ' ' VAL . 33.4 m80 -53.01 -54.1 40.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -60.76 -50.91 71.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.076 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.581 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -52.83 -30.1 31.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -68.95 0.41 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -60.09 -18.62 48.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.311 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 83' ' ' ALA . 7.8 p -73.33 -27.84 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.074 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.49 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 75.1 76.18 0.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.147 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 70.2 m-85 -156.19 61.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 127' ' ' PHE . 6.3 mt -52.51 -18.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.596 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.044 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.28 -70.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 1.044 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 t -65.5 -35.94 82.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.9 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.505 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -52.89 -51.96 59.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.7 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.746 ' O ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.86 -38.01 61.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.536 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' CA ' ' OE1' ' A' ' 97' ' ' GLU . 87.9 t -75.27 -64.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.309 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 96' ' ' VAL . 4.6 pp -73.69 -52.53 12.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.563 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -52.55 -26.58 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.746 ' OE1' ' O ' ' A' ' 93' ' ' LYS . 3.0 pm0 -72.13 -29.79 64.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -67.11 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.21 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -67.47 63.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.138 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 1.1 p-10 39.96 69.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -90.74 21.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 35.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -119.45 -178.54 3.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.194 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -150.09 165.24 33.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 1.193 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 2.4 t0 -84.76 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.25 -44.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -16.94 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 138' ' ' ASP . . . 72.34 52.81 9.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.382 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.65 105.48 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.557 ' N ' ' ND1' ' A' ' 114' ' ' HIS . 8.2 mt -43.82 158.22 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 67.3 Cg_exo -51.26 -43.54 48.38 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.284 . . . . 0.0 112.283 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -55.83 -40.22 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.557 ' ND1' ' N ' ' A' ' 111' ' ' LEU . 33.4 m170 -54.95 -43.86 73.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 11.3 mt -63.01 -56.0 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 125' ' ' VAL . . . -52.87 -32.23 43.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.504 ' N ' HG12 ' A' ' 125' ' ' VAL . 46.9 mt -65.35 -41.28 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.604 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.461 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 0.8 OUTLIER -70.57 -18.29 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.602 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 1.6 mt-10 -87.56 -56.62 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.59 28.77 9.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.604 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 21.3 m-70 -60.04 -15.03 19.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.341 . . . . 0.0 110.547 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER 77.93 -75.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.981 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.521 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.65 -48.38 75.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 42.5 t -58.22 -60.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 116' ' ' ALA . 2.2 t -52.24 -40.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.473 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 1.9 t -72.18 -23.82 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CE2' ' OE2' ' A' ' 131' ' ' GLU . 7.0 t80 -73.59 -48.14 35.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -69.63 -5.26 23.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -53.03 -70.33 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.185 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 73.9 Cg_endo -75.04 -43.4 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.696 2.264 . . . . 0.0 112.399 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.635 ' OE2' ' CE2' ' A' ' 127' ' ' PHE . 1.6 mt-10 -50.55 -33.51 22.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.707 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 132' ' ' SER . 1.2 m-20 -35.6 120.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 163' ' ' HIS . 6.5 mt -87.64 19.79 3.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.38 -44.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.461 ' HB3' HD12 ' A' ' 111' ' ' LEU . 3.1 t60 -55.7 157.1 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.473 ' HB3' HG21 ' A' ' 143' ' ' THR . 0.0 OUTLIER -138.42 166.91 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.649 ' CG ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -80.97 153.21 27.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.44 -21.9 1.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -44.19 85.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.423 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 107.87 53.65 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.577 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.423 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 10.1 mt -149.94 104.76 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.71 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -72.95 177.62 1.83 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.697 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.463 ' O ' HD13 ' A' ' 160' ' ' LEU . 87.0 Cg_exo -46.55 -57.89 2.0 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.7 -28.81 70.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.71 ' OE2' ' OG1' ' A' ' 143' ' ' THR . 0.4 OUTLIER -72.75 -65.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.34 -39.34 60.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.146 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.543 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -60.63 -37.43 81.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.23 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.62 84.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.613 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -65.1 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.364 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -75.14 57.82 0.87 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.53 52.01 0.86 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.071 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -35.55 -32.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -178.86 -123.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.461 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 1.349 ' CB ' ' OD2' ' A' ' 158' ' ' ASP . 3.4 m-20 -75.97 29.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.065 0.393 . . . . 0.0 111.963 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.469 ' HA ' HD11 ' A' ' 159' ' ' ILE . 1.5 mt -54.25 -72.02 0.07 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 110.971 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.543 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 8.7 ptm -53.95 -21.27 7.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.349 ' OD2' ' CB ' ' A' ' 155' ' ' ASN . 8.6 p-10 -73.95 -54.42 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.098 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 1.176 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 2.0 mt -53.13 -37.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.8 -27.9 61.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -52.9 -54.18 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.46 91.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.516 ' O ' ' CD1' ' A' ' 134' ' ' LEU . 42.8 m-70 -68.81 -37.7 79.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.822 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.434 ' HA ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.18 -176.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -151.18 153.56 35.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.079 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.498 ' N ' HD11 ' A' ' 166' ' ' ILE . 0.0 OUTLIER -117.68 123.69 29.52 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.005 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.27 -14.18 11.57 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 0.0 112.585 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -172.05 150.53 2.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.83 134.12 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -176.34 81.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.9 tp -151.0 22.58 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.89 97.73 5.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 53.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 41' ' ' ASN . 9.8 p -132.96 -37.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.309 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.43 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . 5.4 p -39.12 -31.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.211 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.423 ' HB ' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -87.58 -51.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.227 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' CA ' ' CB ' ' A' ' 39' ' ' ALA . . . -52.06 -20.3 6.41 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.389 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' OD2' ' HA ' ' A' ' 9' ' ' CYS . 1.2 p30 -92.78 -8.83 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 0.0 110.863 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -98.65 -51.95 3.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 37' ' ' PRO . 9.0 tp -64.06 -33.84 76.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -62.39 -41.87 98.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -70.87 -49.23 29.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . . . -58.2 -47.86 82.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.351 . . . . 0.0 111.074 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -69.91 -43.44 71.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.74 -23.64 59.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 3.0 mmt180 -73.9 -12.3 60.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.535 ' HA2' ' CE ' ' A' ' 52' ' ' MET . . . 66.83 80.61 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.68 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 11.4 t0 -147.51 88.49 1.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.302 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' O ' HG11 ' A' ' 26' ' ' VAL . 6.3 p -52.18 -29.18 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -52.27 11.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.77 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -74.12 -27.85 61.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.737 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.642 HG12 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.56 -47.21 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.312 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 1.266 ' NE ' ' OE2' ' A' ' 61' ' ' GLU . 6.2 mtt180 -73.64 -34.38 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.073 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 2.6 mmm-85 -52.4 -27.54 16.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.258 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 17' ' ' ALA . 1.4 mt -73.05 -68.42 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -63.99 -53.62 47.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.006 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -59.29 -16.51 22.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 2.3 mmp_? -135.21 -73.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -47.45 -23.44 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 59.36 16.05 4.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.791 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.482 ' CG1' ' CD1' ' A' ' 30' ' ' LEU . 13.8 p -46.36 154.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.94 121.49 66.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 30.8 Cg_endo -63.47 -9.69 18.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.763 2.309 . . . . 0.0 112.154 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.93 21.15 18.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.517 ' CB ' ' CA ' ' A' ' 11' ' ' GLY . . . -97.79 143.71 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -119.93 160.15 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 15' ' ' SER . 1.1 m-20 -71.24 -159.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -4.99 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.05 -44.56 6.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.85 38.55 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' N ' ' HB3' ' A' ' 40' ' ' LEU . 7.1 mtpt -117.7 143.76 45.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.829 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.468 ' OG1' ' CG ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -85.06 156.69 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -57.63 -36.18 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.468 ' HG ' HD13 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -61.33 -36.53 80.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.468 ' CG ' ' OG1' ' A' ' 46' ' ' THR . 1.3 mt-30 -73.05 -55.83 5.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -59.4 -19.03 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.256 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -43.62 148.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.759 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.93 23.39 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.105 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CE2' ' CB ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER 33.15 57.91 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.467 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -108.46 -72.16 0.75 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.312 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.48 ' OG ' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -84.54 121.54 74.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.751 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.71 -45.0 44.27 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.574 2.183 . . . . 0.0 111.859 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.3 -31.3 72.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.518 ' CG2' ' HB ' ' A' ' 26' ' ' VAL . 2.2 t -62.12 -47.88 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.027 0.441 . . . . 0.0 110.009 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.74 -49.79 71.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 ' CD2' ' C ' ' A' ' 60' ' ' LEU . 2.4 tt -63.08 -43.3 98.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.548 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.266 ' OE2' ' NE ' ' A' ' 27' ' ' ARG . 7.4 tt0 -62.74 -61.23 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.414 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.09 -37.59 87.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 39.4 tp -63.42 -52.65 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.117 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -62.62 -34.0 76.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.017 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 1.3 tp-100 -46.24 -25.32 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.29 3.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.593 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.31 148.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG11 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.01 123.05 44.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.26 -14.77 28.53 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.772 2.314 . . . . 0.0 112.235 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.9 57.21 4.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 13.9 m -103.2 175.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -153.59 129.97 10.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -104.14 124.12 48.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.43 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -116.37 -65.46 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.41 23.57 0.36 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.541 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 m -82.21 65.67 7.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 110.72 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -58.79 171.14 0.69 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.521 ' HD3' ' CG2' ' A' ' 71' ' ' VAL . 78.1 Cg_exo -49.99 -44.27 38.04 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.772 2.315 . . . . 0.0 112.134 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' ' CG ' ' A' ' 112' ' ' PRO . 0.4 OUTLIER -52.56 -41.04 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.318 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 78' ' ' SER . 6.0 m80 -52.83 -66.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.515 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -62.58 -30.76 71.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.639 ' CB ' ' CE2' ' A' ' 53' ' ' PHE . . . -53.55 -39.21 64.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.331 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.76 -50.17 38.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.542 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB3' ' OE2' ' A' ' 119' ' ' GLU . 13.4 mtt180 -72.97 -26.88 61.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 32.6 p -70.76 -3.43 18.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.301 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 43.83 76.17 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.13 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -158.98 61.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD1' ' CD2' ' A' ' 127' ' ' PHE . 62.5 tp -52.42 -19.63 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.138 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -63.13 -71.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.713 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.546 ' HA ' ' CG2' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -73.15 -20.74 60.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 92' ' ' LEU . 1.7 tt -72.95 -42.51 63.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.34 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 97' ' ' GLU . 38.8 ttmt -65.71 -36.94 85.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.447 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.769 ' HA ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -55.82 -58.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.078 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.6 pp -73.07 -34.44 66.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.073 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 38.8 t -72.32 -49.31 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.769 ' CD ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -58.77 -32.97 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -30.91 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.35 -0.58 7.55 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -42.99 167.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.113 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.07 88.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.45 HG11 HG23 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -89.35 13.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.6 9.81 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.07 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.08 141.63 58.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.529 HD23 ' CD1' ' A' ' 111' ' ' LEU . 6.7 mt -121.67 150.54 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.065 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' OG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -84.98 -48.87 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 106' ' ' ASP . 0.6 OUTLIER -175.25 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 2.26 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 52.8 18.97 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.353 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.575 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -48.27 -50.37 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.541 0.21 . . . . 0.0 111.132 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.565 ' CB ' ' O ' ' A' ' 110' ' ' SER . 6.2 tp 92.49 127.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.724 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.552 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 84.7 Cg_exo -44.38 -46.11 12.06 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.854 2.369 . . . . 0.0 112.589 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.519 ' N ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -63.38 -31.39 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.153 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 110' ' ' SER . 8.9 m80 -70.03 -34.17 72.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 1.2 mt -63.5 -52.96 59.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -53.56 -36.02 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.582 ' CG1' ' CG1' ' A' ' 125' ' ' VAL . 83.6 mt -61.5 -41.52 90.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -68.91 -12.6 61.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.587 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.544 ' CB ' ' CD2' ' A' ' 121' ' ' HIS . 2.6 mt-10 -91.76 -57.81 2.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.736 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.92 -11.88 10.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.796 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.544 ' CD2' ' CB ' ' A' ' 119' ' ' GLU . 30.7 m-70 -57.22 78.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 126' ' ' SER . 11.8 p -37.72 -45.02 0.76 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.2 p -56.94 -51.27 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.255 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 45.3 t -72.9 -58.85 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.452 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.582 ' CG1' ' CG1' ' A' ' 117' ' ' ILE . 2.4 t -52.04 -40.94 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.321 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 122' ' ' SER . 77.3 p -67.09 -36.87 82.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.111 0.481 . . . . 0.0 110.799 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 68.1 t80 -73.7 -44.51 56.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -70.44 -10.79 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.082 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.574 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -53.31 -69.09 0.37 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 72.0 Cg_endo -74.5 -50.07 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.772 2.315 . . . . 0.0 112.58 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -39.27 -44.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.429 ' HB2' HD12 ' A' ' 128' ' ' LEU . 8.1 t -90.77 134.2 34.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.411 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -40.14 101.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 130' ' ' PRO . 5.2 mp -62.68 -36.77 83.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -63.53 -33.91 76.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.066 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.411 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 12.0 t60 -50.35 155.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -114.14 149.66 35.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.996 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.57 ' HB2' ' CD2' ' A' ' 114' ' ' HIS . 12.4 t70 -66.34 -9.32 32.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 138' ' ' ASP . . . 82.41 -5.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -14.01 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.33 48.3 0.88 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 94.3 mt -151.62 93.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 111.057 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.529 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.82 179.65 0.75 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 73.3 Cg_exo -49.33 -49.41 15.6 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.763 2.309 . . . . 0.0 112.575 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.478 HD23 ' HG2' ' A' ' 161' ' ' GLN . 3.8 mt -73.28 -34.98 66.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.529 ' HB2' ' N ' ' A' ' 143' ' ' THR . 15.4 mm-40 -52.78 -62.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.512 ' CD1' HD12 ' A' ' 142' ' ' LEU . 2.7 tp -54.71 -48.35 72.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.41 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 157' ' ' MET . . . -57.17 -36.8 71.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.337 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.451 ' HD2' ' HE2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -70.19 -43.69 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.002 179.309 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.511 ' HG2' ' N ' ' A' ' 151' ' ' ARG . 10.2 tt0 -71.9 -86.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.976 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.511 ' N ' ' HG2' ' A' ' 150' ' ' GLN . 37.5 mtt-85 -74.7 53.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.549 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -52.07 -20.61 6.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 154' ' ' GLN . . . 34.43 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.597 ' CG ' ' O ' ' A' ' 153' ' ' ALA . 4.6 pp0? 125.95 -154.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.506 ' C ' ' NE2' ' A' ' 154' ' ' GLN . 2.2 t30 -74.41 46.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.408 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.54 ' N ' ' NE2' ' A' ' 154' ' ' GLN . 11.3 mt -69.91 -50.32 43.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.526 ' HA ' ' CB ' ' A' ' 148' ' ' ALA . 10.5 ptm -52.13 -26.18 10.68 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.944 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -74.4 -58.61 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.819 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.529 ' CD1' HD21 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -51.91 -38.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.346 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.607 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.23 -23.79 59.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.025 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.478 ' HG2' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.26 -47.26 44.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.07 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.16 53.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 53.3 m-70 -72.12 -8.34 54.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.486 ' CG ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -77.93 150.11 34.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.967 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.1 ptp -128.11 144.69 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.62 69.77 59.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.433 ' C ' ' HG2' ' A' ' 168' ' ' MET . 40.1 Cg_exo -56.65 -176.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.773 2.315 . . . . 0.0 112.227 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.433 ' HG2' ' C ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.746 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m -100.71 120.05 39.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.3 ttm -82.7 59.35 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.83 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.05 146.38 25.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 49.79 57.16 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.41 -88.25 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 49.56 29.38 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 31.3 m -152.1 -40.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 33.6 t 71.91 -58.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.058 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.25 14.27 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -60.78 -56.37 24.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -11.22 28.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.807 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -86.61 -65.26 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 35' ' ' VAL . 2.2 tm? -71.44 -65.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -56.97 -30.97 64.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.43 -63.77 2.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -64.75 -44.51 89.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.077 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -52.62 -51.5 59.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -65.1 -38.24 90.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -70.42 -7.91 46.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 23' ' ' VAL . . . 114.94 -66.28 0.28 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.901 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.083 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 26.89 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.0 111.822 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 55' ' ' SER . 12.6 p -51.66 -35.64 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.21 -42.87 59.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.083 ' OE1' ' HA ' ' A' ' 22' ' ' ASP . 2.7 mp0 -74.43 -25.94 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.302 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.328 HG12 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.31 -40.06 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 60.9 mtt180 -73.99 -48.28 31.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 9.8 mtt180 -66.2 -29.31 69.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 33' ' ' GLU . 6.7 mt -55.31 -67.46 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.507 HD21 ' N ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -73.63 -52.97 11.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.922 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 41.0 m-70 -67.62 -4.73 12.74 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -142.28 -57.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.689 0.281 . . . . 0.0 111.345 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.807 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.92 -4.52 20.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.165 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 39.88 32.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.977 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 14' ' ' LEU . 9.7 p -59.15 166.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 135.5 21.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 56.5 Cg_endo -70.84 -10.04 26.92 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.65 50.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.796 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.6 116.33 32.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -97.54 165.04 12.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.47 46.03 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.85 21.95 5.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.434 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.8 -9.16 8.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.12 20.96 43.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 3.5 mtpt -113.94 143.9 43.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 50' ' ' VAL . 64.7 p -89.3 174.31 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.501 ' CB ' HD13 ' A' ' 14' ' ' LEU . . . -58.48 -38.28 77.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.062 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 69' ' ' PRO . 5.7 mt -73.44 -33.08 64.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.26 -1.39 17.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.481 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -129.78 -46.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.352 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.542 ' HE1' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -36.71 140.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -88.35 146.9 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.091 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 95' ' ' LEU . 1.9 m-85 -87.5 21.72 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -73.06 -40.1 51.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 2.6 m -109.58 120.03 46.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 0.0 110.819 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 1.169 ' HG3' ' OD1' ' A' ' 90' ' ' ASP . 32.1 Cg_exo -58.83 -42.23 54.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.677 2.251 . . . . 0.0 112.168 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.15 70.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 2.3 t -62.98 -48.61 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -63.51 -40.93 98.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 1.8 tm? -63.01 -47.97 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.681 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.328 ' OE1' HG12 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.28 -48.4 78.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.8 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 51' ' ' MET . 8.2 mt -62.87 -54.38 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 95' ' ' LEU . 1.3 tt -63.08 -43.29 98.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.1 ttmm -62.93 -26.15 68.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 35' ' ' VAL . 34.8 tt0 -62.11 -14.67 39.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.7 62.93 1.02 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.69 170.98 8.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.422 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -106.96 99.5 26.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HB3' HD12 ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.71 -9.18 23.57 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.689 2.259 . . . . 0.0 112.161 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.506 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.99 63.78 8.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 78' ' ' SER . 16.1 m -117.89 126.99 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.744 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 10.4 mt-30 -104.03 142.0 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -88.0 -179.89 6.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.21 -8.24 29.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.36 16.82 16.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.85 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.463 ' O ' ' OG1' ' A' ' 77' ' ' THR . . . 60.84 85.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 76' ' ' GLY . 2.1 m 179.91 139.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.818 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -117.51 179.62 0.79 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.145 0.498 . . . . 0.0 110.982 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 1.178 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 77.1 Cg_exo -48.53 -51.04 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 111.765 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.539 ' CG2' HG23 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.14 -48.76 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.316 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.52 ' N ' HG11 ' A' ' 80' ' ' VAL . 24.0 m80 -52.75 -61.37 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.94 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 1.178 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 10.5 p30 -57.77 -53.69 55.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.665 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -52.25 -38.82 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.459 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.11 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -73.49 -27.42 61.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 27.8 p -71.32 -41.57 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.76 70.71 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.003 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -145.25 53.61 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.648 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.503 HD12 ' CB ' ' A' ' 127' ' ' PHE . 9.2 tp -52.47 -20.63 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.169 ' OD1' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -63.53 -71.8 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.422 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.645 ' N ' ' CG ' ' A' ' 90' ' ' ASP . 6.5 m -73.12 -22.24 60.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.176 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 53' ' ' PHE . 64.8 tp -70.29 -44.22 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 1.259 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 20.3 ttpp -60.63 -44.74 96.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.834 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.969 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.93 -53.33 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.583 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.55 -42.47 61.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.539 HG23 ' CG2' ' A' ' 80' ' ' VAL . 3.2 t -63.69 -52.48 56.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.259 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -55.5 -29.16 58.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.53 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 6.3 t60 -73.08 -56.21 5.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.54 33.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.815 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . -69.41 120.31 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.324 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.8 p-10 -35.81 92.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -107.1 14.17 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.127 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -143.53 38.47 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.08 122.37 26.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -119.16 146.0 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.744 ' OD2' ' HB3' ' A' ' 72' ' ' GLN . 7.3 p30 -155.22 141.03 18.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 71.1 m 49.39 26.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -163.85 -40.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 1.174 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 68.68 10.79 61.51 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 1.428 ' HA ' ' CG ' ' A' ' 138' ' ' ASP . 2.6 t -104.02 129.45 51.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 32.5 mt -65.83 147.51 98.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.448 ' HG3' ' CE1' ' A' ' 81' ' ' HIS . 74.4 Cg_exo -50.44 -29.53 24.43 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.681 2.254 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 128' ' ' LEU . 2.9 tt -69.8 -38.31 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.819 ' ND1' ' OD2' ' A' ' 138' ' ' ASP . 36.4 m80 -53.32 -38.95 63.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.444 HD21 ' NH2' ' A' ' 118' ' ' ARG . 1.4 mt -65.96 -57.61 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.625 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.53 ' O ' ' CG2' ' A' ' 125' ' ' VAL . . . -52.95 -28.67 24.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.42 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.52 ' HA ' ' CG1' ' A' ' 125' ' ' VAL . 4.7 mm -65.42 -39.73 86.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.86 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.444 ' NH2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -71.48 -18.25 62.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.526 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 121' ' ' HIS . 4.1 mm-40 -90.87 -54.78 3.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.2 45.76 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.009 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.581 ' CB ' HG21 ' A' ' 124' ' ' VAL . 99.0 m-70 -76.96 3.77 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.698 0.285 . . . . 0.0 111.205 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 40.5 t 71.09 -92.94 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.785 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -52.64 -56.51 14.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.358 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.581 HG21 ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -52.19 -62.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.944 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 116' ' ' ALA . 4.5 t -52.31 -43.83 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.522 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.2 t -72.63 -30.49 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 123' ' ' SER . 63.3 t80 -73.8 -42.12 61.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.065 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.7 -6.99 17.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.336 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.565 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -64.13 -68.94 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 41.2 Cg_endo -67.27 -36.75 20.01 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 2.25 . . . . 0.0 112.353 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 102' ' ' VAL . 8.7 mm-40 -62.33 -22.31 65.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.98 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 128' ' ' LEU . 51.8 m -112.84 147.6 36.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -35.47 111.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 164' ' ' MET . 5.8 mt -79.35 64.46 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.0 p-80 164.72 -36.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . 68.6 t60 -48.62 143.76 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' HG3' HG21 ' A' ' 143' ' ' THR . 3.4 ttm180 -101.32 177.66 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 1.428 ' CG ' ' HA ' ' A' ' 110' ' ' SER . 1.3 t0 -121.26 156.48 32.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -22.25 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.183 0.516 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.53 ' HB3' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -73.88 -58.73 3.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.724 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 1.18 ' O ' ' OE2' ' A' ' 146' ' ' GLU . . . 124.84 43.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.852 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 140' ' ' SER . 0.2 OUTLIER -153.45 114.42 4.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.568 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -82.78 -174.35 0.52 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 86.9 Cg_exo -44.87 -52.12 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.448 2.098 . . . . 0.0 112.072 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 161' ' ' GLN . 10.2 mt -73.35 -36.79 66.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.18 ' OE2' ' O ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -63.9 -64.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.951 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -52.37 -46.19 66.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.491 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 157' ' ' MET . . . -55.97 -32.96 64.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.19 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.35 -68.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.649 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.76 66.18 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 153' ' ' ALA . . . -64.46 50.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.587 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 154' ' ' GLN . . . -60.56 -142.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.41 -149.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 1.071 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 71.4 m-20 -74.64 44.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.565 ' HB3' ' NE2' ' A' ' 154' ' ' GLN . 2.5 pt? -69.16 -52.9 23.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.555 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER -56.37 -33.62 65.89 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.144 0.497 . . . . 0.0 110.076 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.071 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 15.4 p-10 -74.23 -40.0 62.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 10.6 mt -52.69 -49.86 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.76 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.78 -33.11 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.968 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.451 ' HG3' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -52.7 -51.41 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.947 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.35 63.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -48.8 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.484 ' HA ' HD12 ' A' ' 134' ' ' LEU . 1.5 tpp -60.09 -28.65 68.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.4 tpt 63.48 139.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.4 mp -143.56 98.02 5.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.73 146.04 5.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.732 2.288 . . . . 0.0 112.418 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.7 mtt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.848 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -161.4 -64.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.03 106.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -54.65 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.21 -153.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.988 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 1.333 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 62.06 153.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 1.333 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 22.0 mm-40 -132.25 37.26 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.212 HG22 ' OE2' ' A' ' 6' ' ' GLU . 42.7 t -106.53 49.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.02 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -80.67 98.46 7.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER 82.62 9.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.013 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -60.85 -81.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 11.0 t0 -59.93 -14.54 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -63.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 1.7 tm? -73.13 -54.67 7.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.034 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.457 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 5.5 p -57.72 -30.32 65.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -70.76 -46.12 48.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.5 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.86 -55.89 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.267 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.4 69.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 52' ' ' MET . . . -68.03 -26.83 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.226 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -73.29 -26.58 61.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.441 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 88.1 66.5 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 1.069 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 13.4 p-10 -137.15 94.46 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' HG11 ' A' ' 26' ' ' VAL . 7.3 p -53.07 -20.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.169 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -74.18 -51.87 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.08 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.069 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -73.24 -32.98 65.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.818 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 27' ' ' ARG . 2.3 p -52.69 -49.58 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 111.09 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 29.7 mtt180 -73.64 -48.88 29.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.279 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.5 mmp_? -52.85 -30.23 32.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.17 -73.99 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' CD1' HD22 ' A' ' 62' ' ' LEU . 1.7 mt -73.59 -42.7 61.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.484 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.11 -3.23 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.37 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -143.02 -75.46 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.815 ' OE1' ' HB ' ' A' ' 35' ' ' VAL . 14.1 tt0 -46.93 -23.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.7 mt 62.01 29.92 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.815 ' HB ' ' OE1' ' A' ' 33' ' ' GLU . 2.7 p -58.92 137.15 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.434 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -69.03 145.88 96.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 40.0 Cg_endo -67.33 -11.03 30.69 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.211 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 29.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 10' ' ' VAL . . . -97.9 94.81 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.282 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.519 ' CD1' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -102.86 147.87 26.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.685 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 24.5 p30 -44.99 -26.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.0 0.429 . . . . 0.0 110.285 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.468 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -146.02 -71.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.534 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 177.89 66.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.933 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.29 -73.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.971 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 40' ' ' LEU . 30.1 mttm -84.87 152.92 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 111.336 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.519 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 74.5 p -101.52 176.71 5.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' CB ' HD23 ' A' ' 62' ' ' LEU . . . -57.14 -35.74 69.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 62' ' ' LEU . 3.5 tp -72.83 -47.86 42.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 77' ' ' THR . 2.0 tm0? -65.52 -9.56 27.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 46' ' ' THR . 32.8 m -136.31 26.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.1 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.525 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 1.1 tmm? -86.86 149.88 24.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.512 ' N ' ' HG2' ' A' ' 51' ' ' MET . 0.9 OUTLIER -87.87 86.6 7.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.381 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' ' HB1' ' A' ' 83' ' ' ALA . 53.4 m-85 -35.14 -30.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -28.79 -55.32 0.15 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.148 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.454 ' HB3' HG22 ' A' ' 58' ' ' VAL . 1.3 t -90.94 130.94 38.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 91' ' ' THR . 61.0 Cg_endo -73.22 -42.97 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.761 2.307 . . . . 0.0 112.043 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -62.8 -29.01 70.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.521 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.52 ' CG2' HG22 ' A' ' 26' ' ' VAL . 2.5 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.879 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' HG22 ' A' ' 91' ' ' THR . . . -63.21 -52.95 60.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -63.61 -38.45 91.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.024 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -62.84 -49.35 75.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 HD22 ' CD1' ' A' ' 30' ' ' LEU . 13.0 mt -62.77 -50.29 71.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.842 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 ' HG3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -62.91 -23.02 67.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.671 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 11.9 tttt -63.05 -20.4 65.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.79 -57.22 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.89 50.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.515 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . . . -83.56 -13.78 53.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.9 95.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.455 ' HG3' HD12 ' A' ' 63' ' ' LEU . 74.6 Cg_exo -48.19 -41.47 34.37 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.85 ' ND2' ' OD1' ' A' ' 101' ' ' ASP . 3.5 m120 -71.16 84.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 49' ' ' GLN . 4.7 m -136.45 131.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -140.36 163.34 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -127.52 -166.77 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.813 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.54 -22.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 15.5 p -84.58 -29.86 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.9 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 79.0 28.17 54.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 1.279 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . 2.6 m -115.9 119.21 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.6 p -104.96 -176.02 0.41 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 40.5 Cg_exo -56.22 -42.98 60.59 Favored 'Trans proline' 0 CA--C 1.527 0.128 0 C-N-CA 122.814 2.342 . . . . 0.0 112.058 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.67 -29.95 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.476 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.582 ' ND1' ' OD2' ' A' ' 106' ' ' ASP . 9.4 m170 -72.08 -68.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.0 OUTLIER -61.25 -25.98 67.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.207 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB1' ' CZ ' ' A' ' 53' ' ' PHE . . . -56.49 -53.76 53.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.563 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.97 -38.14 66.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.568 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 1.081 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 6.5 tpt180 -72.15 -24.04 61.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.215 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 82' ' ' ASP . 5.5 p -73.07 -73.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 132.7 63.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.324 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 22.8 m-85 -155.06 59.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.635 ' CD1' ' CG ' ' A' ' 127' ' ' PHE . 37.6 tp -52.21 -29.32 22.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.235 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 1.108 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -53.19 -67.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.459 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 1.108 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 47.7 m -72.24 -42.16 65.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.519 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 1.2 tt -52.37 -48.68 65.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.492 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 127' ' ' PHE . 6.2 ttpp -55.39 -26.08 39.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.877 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.229 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 18.1 t -73.54 -70.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.542 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -63.91 -27.33 69.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.534 -179.375 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.528 ' N ' HD23 ' A' ' 95' ' ' LEU . 41.3 t -73.88 -56.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.759 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 1.229 ' OE2' ' HA ' ' A' ' 94' ' ' VAL . 17.3 pm0 -56.29 -35.39 67.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.516 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 10.6 t-160 -60.65 -68.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . 179.19 61.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.523 ' C ' ' OD1' ' A' ' 101' ' ' ASP . . . -105.76 26.5 9.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.85 ' OD1' ' ND2' ' A' ' 70' ' ' ASN . 1.1 p-10 47.87 82.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.456 HG12 HG12 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -88.02 15.51 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 65.3 m-20 -131.89 27.33 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -101.7 162.03 13.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 111' ' ' LEU . 74.2 mt -125.13 150.27 47.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 1.279 ' OD2' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -100.34 -169.55 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 75' ' ' SER . 61.8 m -48.29 -46.14 35.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -33.33 75.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 84.03 31.17 26.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.569 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.3 m -105.73 119.98 40.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 9.3 tp -54.53 138.09 60.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 104' ' ' ALA . 94.4 Cg_exo -43.37 -27.01 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.796 2.33 . . . . 0.0 112.366 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.525 ' HB ' ' CD2' ' A' ' 128' ' ' LEU . 0.3 OUTLIER -73.23 -42.77 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.797 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 31.3 m80 -52.91 -32.51 45.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.286 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 118' ' ' ARG . 0.5 OUTLIER -73.11 -48.66 33.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.361 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 125' ' ' VAL . . . -61.74 -32.95 73.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 147' ' ' LEU . 80.2 mt -66.55 -42.2 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.691 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.6 -16.91 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.081 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -86.67 -57.84 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.415 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 110.23 -0.69 29.72 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.531 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 15.2 m-70 -57.68 78.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.592 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -34.36 -48.59 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.466 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -62.45 -48.33 80.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 121' ' ' HIS . 47.5 t -69.57 -60.17 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 116' ' ' ALA . 2.4 t -51.87 -44.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.158 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.559 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 60.6 p -71.87 -29.35 64.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.169 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 27.3 t80 -73.22 -66.4 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.525 ' CD2' ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -65.73 -8.76 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.58 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -52.22 -71.1 0.22 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 57.4 Cg_endo -70.88 -33.0 13.0 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 128' ' ' LEU . 30.9 mm-40 -54.59 -20.4 7.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.283 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.447 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 p -105.81 -171.25 1.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' HIS . 4.1 p30 -94.5 84.63 4.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.992 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -57.59 75.3 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.222 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 p-80 174.98 -39.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -47.89 173.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -129.88 174.32 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -131.25 166.97 20.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.6 -20.18 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -52.38 55.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.44 11.2 6.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 1.445 ' HB3' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -132.72 160.72 35.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.522 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -112.99 -178.39 0.52 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.522 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 84.3 Cg_exo -44.91 -59.75 1.04 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.634 2.223 . . . . 0.0 112.138 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.44 HD23 ' CG ' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -58.4 -46.74 85.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.633 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.445 ' CD ' ' HB3' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.78 -62.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.478 ' HG ' ' CD1' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -52.87 -43.61 66.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 157' ' ' MET . . . -52.64 -43.46 65.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.375 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -61.04 -36.15 78.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.753 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.486 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -69.74 -80.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.572 179.032 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.36 61.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.6 52.29 0.88 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.79 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -32.7 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.452 . . . . 0.0 110.723 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER 172.53 -119.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.29 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.78 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 2.0 m-20 -74.06 4.73 5.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.135 -0.353 . . . . 0.0 111.692 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 0.1 OUTLIER -52.66 -51.84 58.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.524 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 2.4 ppp? -53.2 -34.7 58.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.78 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 3.1 p30 -73.67 -43.58 59.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.559 ' CG2' ' CB ' ' A' ' 126' ' ' SER . 15.5 mt -52.74 -44.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.369 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 160' ' ' LEU . 1.3 mt -73.29 -35.51 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.336 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.44 ' CG ' HD23 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -67.41 -37.89 83.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.01 44.98 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.389 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -73.26 -9.8 59.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.08 97.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 tpt -75.67 125.22 28.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.7 mt -101.86 122.83 45.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.99 129.45 24.81 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.71 2.274 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.888 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.9 m -122.06 63.91 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -157.89 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.7 109.25 1.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 tp -177.81 53.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.431 ' O ' HG11 ' A' ' 8' ' ' VAL . 1.6 tt0 -110.83 -42.74 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 39.15 36.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.444 HG23 ' HA3' ' A' ' 11' ' ' GLY . 12.7 p -178.81 139.74 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.34 -68.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 13' ' ' ARG . 3.9 p -123.89 -6.45 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.288 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.524 ' N ' ' HB3' ' A' ' 39' ' ' ALA . . . -40.24 -60.48 1.96 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.386 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 29.4 p30 -56.51 -17.39 8.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.754 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.536 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.1 tpm_? -98.59 -64.25 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.756 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' VAL . 2.8 tm? -69.22 -61.71 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -55.94 -28.29 56.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.64 -49.05 39.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.188 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -73.03 -40.3 65.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.12 65.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.287 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 52' ' ' MET . . . -73.1 -37.58 66.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -73.43 -8.13 54.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' HA2' ' CE ' ' A' ' 52' ' ' MET . . . 124.89 -66.56 0.53 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.179 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 33.54 38.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.39 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 2.3 p -52.66 -49.88 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -75.14 -32.62 61.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.811 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.494 ' OE1' ' HG ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -73.24 -37.39 66.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.577 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 1.194 HG12 ' OE1' ' A' ' 61' ' ' GLU . 2.4 p -52.39 -35.08 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -71.29 -51.63 23.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.97 -36.72 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.095 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.877 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 20.2 mt -52.96 -61.86 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.1 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.508 HD22 ' CG2' ' A' ' 35' ' ' VAL . 10.3 mt -73.45 -49.19 28.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.823 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.869 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 20.2 m-70 -70.14 -19.33 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.861 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -126.05 -78.91 0.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.232 ' OE2' HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -39.87 -28.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.1 mt 62.38 31.03 17.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.525 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 1.232 HG11 ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -54.44 152.07 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.336 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.69 124.6 69.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.83 -11.34 29.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.694 2.262 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 6.3 p30 -90.97 -8.61 48.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.524 ' HB3' ' N ' ' A' ' 11' ' ' GLY . . . -43.67 136.96 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 43' ' ' PHE . 6.4 mt -129.81 108.92 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -40.45 -44.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.989 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -135.77 35.18 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 49.25 48.08 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.27 -45.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.445 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.05 147.39 46.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -86.09 166.62 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.27 25.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -73.12 -43.86 61.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.071 ' CD ' ' OD1' ' A' ' 73' ' ' ASP . 0.3 OUTLIER -62.74 -20.63 65.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.434 HG21 ' N ' ' A' ' 51' ' ' MET . 18.7 m -104.73 -34.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.456 ' HG3' HD13 ' A' ' 62' ' ' LEU . 2.0 ttp -42.12 134.81 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.482 ' CE ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -86.74 134.44 33.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.591 ' CE2' HD22 ' A' ' 95' ' ' LEU . 10.8 m-85 -78.37 52.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.633 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -106.29 -59.55 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.108 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -86.76 114.3 57.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 110.302 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.493 ' N ' HG22 ' A' ' 91' ' ' THR . 9.2 Cg_endo -53.64 -42.29 67.18 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.562 2.175 . . . . 0.0 112.145 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.24 -33.36 75.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 2.2 t -63.06 -39.93 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.468 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -63.04 -59.83 4.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 19.6 tp -63.23 -41.2 99.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.535 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 1.194 ' OE1' HG12 ' A' ' 26' ' ' VAL . 10.6 mt-10 -62.88 -45.84 90.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.501 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 58' ' ' VAL . 3.2 mt -62.83 -57.1 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 4.4 pp -63.51 -25.82 68.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.339 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -63.14 -46.9 85.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 30' ' ' LEU . 1.8 mm100 -51.36 -43.85 61.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.65 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.46 159.91 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.92 110.8 36.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.988 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.435 ' HB3' HD12 ' A' ' 48' ' ' LEU . 77.7 Cg_endo -77.59 7.72 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.787 2.325 . . . . 0.0 112.423 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 1.081 ' OD1' ' OD2' ' A' ' 101' ' ' ASP . 43.4 m-80 -89.48 26.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' SER . 8.3 m -107.5 139.08 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.045 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.51 153.12 37.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 1.071 ' OD1' ' CD ' ' A' ' 49' ' ' GLN . 2.5 p-10 -155.0 -175.17 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.836 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 68.08 -62.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.14 33.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.42 65.89 1.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.558 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -156.85 103.68 2.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 p -70.51 -174.29 0.25 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.962 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 62.9 Cg_exo -50.64 -50.9 12.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.774 2.316 . . . . 0.0 112.533 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 15.3 m -59.34 -43.81 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.373 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 44.1 m170 -61.45 -34.47 75.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.043 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.962 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.74 -51.09 20.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.568 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -70.05 -11.98 61.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.39 -43.83 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.406 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.995 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 2.0 mmt180 -61.51 -58.42 8.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.231 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -72.48 -22.55 61.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' CA ' ' CG2' ' A' ' 124' ' ' VAL . . . 105.14 -62.83 0.33 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 16.9 m-85 30.97 37.1 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 110.259 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.631 ' CD2' ' CD2' ' A' ' 127' ' ' PHE . 2.2 tm? -51.73 -41.87 61.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.512 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.641 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.0 -62.96 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.828 0.347 . . . . 0.0 110.877 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -72.01 -46.33 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 14.6 tp -52.4 -43.03 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 109.916 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 97' ' ' GLU . 1.9 ttpp -53.52 -37.92 63.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.486 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 42.9 t -57.08 -60.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.107 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -73.18 -33.41 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.533 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . 4.6 t -73.12 -45.33 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 93' ' ' LYS . 0.9 OUTLIER -58.24 -32.44 68.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.773 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -73.13 -50.38 23.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -166.44 -69.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.298 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.533 ' CB ' ' HA ' ' A' ' 96' ' ' VAL . . . 30.13 82.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.777 0.322 . . . . 0.0 111.559 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.081 ' OD2' ' OD1' ' A' ' 70' ' ' ASN . 2.1 p-10 -39.84 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 100' ' ' ALA . 12.9 m -84.24 11.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.38 -25.94 20.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 105' ' ' LEU . . . -50.9 157.45 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.481 ' CD2' HD22 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -143.29 161.39 38.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.814 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.82 -90.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.005 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.84 -38.57 2.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 -1.89 25.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 62.57 23.29 64.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 139.79 30.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' A' ' 114' ' ' HIS . 11.4 mt -68.34 162.76 58.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 102' ' ' VAL . 76.4 Cg_exo -50.23 -34.26 39.16 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -61.46 -44.06 97.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.98 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.561 ' CE1' ' HG ' ' A' ' 111' ' ' LEU . 1.9 m80 -53.07 -44.38 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.875 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -67.64 -48.95 65.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.539 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 1.196 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.21 -43.31 67.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 156' ' ' LEU . 46.0 mt -54.86 -40.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.654 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -41.7 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.473 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.196 ' OE1' ' CA ' ' A' ' 116' ' ' ALA . 2.2 mp0 -72.53 -55.58 6.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.8 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.18 52.01 2.46 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 0.5 OUTLIER -81.43 -7.14 59.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.996 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -71.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -66.63 -35.53 80.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.519 ' CG2' ' CA ' ' A' ' 87' ' ' GLY . 42.9 t -74.01 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.087 0.47 . . . . 0.0 110.606 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 116' ' ' ALA . 4.2 m -53.3 -45.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.335 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.481 ' CB ' ' CG2' ' A' ' 159' ' ' ILE . 15.8 p -71.92 -28.85 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.784 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 19.0 t80 -73.49 -44.33 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.521 ' CD1' ' OG ' ' A' ' 132' ' ' SER . 0.2 OUTLIER -67.41 -11.51 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.153 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.537 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . . . -56.41 -67.46 0.79 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.283 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 129' ' ' ALA . 29.6 Cg_endo -64.16 -62.07 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.617 2.212 . . . . 0.0 112.452 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.784 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -37.59 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 17.4 m -98.41 129.4 45.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 1.181 ' OD1' ' HB2' ' A' ' 136' ' ' HIS . 0.1 OUTLIER -36.0 95.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 132' ' ' SER . 4.0 mt -60.19 151.03 28.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 74.52 13.79 3.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.181 ' HB2' ' OD1' ' A' ' 133' ' ' ASP . 63.1 t60 -103.83 168.95 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -127.2 -160.34 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.12 -171.63 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.41 -9.59 26.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -39.6 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.26 68.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.8 mt -156.91 133.3 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.075 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 1.196 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 80.9 p -96.51 159.12 32.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 6.0 Cg_exo -38.61 -48.8 2.59 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.15 2.566 . . . . 0.0 112.184 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.1 mt -66.98 -40.58 87.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.792 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.196 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 1.1 mp0 -52.99 -68.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' A' ' 150' ' ' GLN . 8.4 tp -52.66 -29.01 24.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 157' ' ' MET . . . -73.17 -15.22 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.459 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 1.4 ttt180 -73.26 -48.46 34.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.46 -90.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.885 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -75.88 50.65 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -74.21 44.26 1.34 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.829 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.553 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -34.46 150.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 40.44 -161.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.89 ' CA ' ' OD1' ' A' ' 158' ' ' ASP . 1.1 t-20 -74.61 43.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.207 -0.308 . . . . 0.0 111.543 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.513 ' CD1' HG21 ' A' ' 117' ' ' ILE . 2.2 mt -59.43 -55.95 28.15 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 110.966 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.469 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -51.66 -44.04 62.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.89 ' OD1' ' CA ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -74.5 -35.08 63.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.267 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.511 HG21 ' CD2' ' A' ' 160' ' ' LEU . 11.0 mt -53.16 -52.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.158 0.504 . . . . 0.0 110.456 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.51 -24.54 59.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.256 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -64.46 -41.72 96.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.164 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.48 -53.51 8.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 15.2 m-70 -60.87 -40.24 92.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.881 0.372 . . . . 0.0 110.88 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.417 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -67.99 75.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.994 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 33.0 mtm -94.6 111.04 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 82.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.58 -66.57 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.677 2.252 . . . . 0.0 112.301 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 35' ' ' VAL . 52.3 t . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.938 0.399 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.699 ' O ' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -83.07 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 3.0 p30 -51.92 -29.94 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -37.0 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.787 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.963 ' CB ' HG21 ' A' ' 35' ' ' VAL . 4.9 tp -72.28 -23.84 61.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -65.59 -49.89 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.7 -27.91 68.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.503 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -72.21 -55.07 7.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.347 . . . . 0.0 111.249 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.82 79.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.249 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -32.64 64.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.4 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.0 -9.86 58.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.002 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.406 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 70.42 75.89 0.57 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 24' ' ' GLN . 1.2 t70 -144.7 85.56 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.795 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -52.9 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 mt-30 -70.66 -45.02 65.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.7 mm-40 -72.99 -49.43 29.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.676 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 58' ' ' VAL . 47.2 t -57.92 -29.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 4.8 mmt180 -72.03 -60.86 2.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -69.16 -22.77 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.1 mt -54.44 -66.55 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 65' ' ' GLN . 16.5 mt -72.28 -40.59 67.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.13 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 23.0 m-70 -65.41 -19.62 66.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.306 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -133.0 -66.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' LEU . 2.4 tp10 -58.48 -14.46 7.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.2 mt 46.96 25.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.786 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.963 HG21 ' CB ' ' A' ' 14' ' ' LEU . 14.7 p -43.96 148.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 144.29 43.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.608 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 58.7 Cg_endo -72.12 -22.98 21.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.404 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.54 2.53 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 11' ' ' GLY . . . -42.25 124.74 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.2 mt -122.01 130.08 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 4.6 p-10 -66.21 -179.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -47.79 -43.34 27.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.89 -65.34 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.52 47.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HB3' HE21 ' A' ' 49' ' ' GLN . 13.2 mtpt -116.42 151.08 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.8 p -85.14 162.05 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . . . -53.83 -47.46 70.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.118 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 69' ' ' PRO . 1.1 mp -62.8 -27.59 69.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.486 HE21 ' HB3' ' A' ' 45' ' ' LYS . 6.6 tt0 -72.97 -29.26 62.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' THR . 2.9 m -101.63 -26.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -36.65 142.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.797 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 ptt? -102.31 22.69 12.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.994 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.7 m-85 36.57 31.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -76.94 -77.8 0.77 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.502 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -77.86 121.02 83.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.966 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.47 -45.69 37.9 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.61 2.207 . . . . 0.0 112.159 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 61' ' ' GLU . . . -63.16 -28.69 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.368 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HA ' HG11 ' A' ' 26' ' ' VAL . 2.5 t -62.95 -38.57 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.209 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -63.32 -49.77 72.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 53.1 tp -63.15 -33.13 74.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 1.9 mm-40 -62.54 -49.1 76.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 14' ' ' LEU . 5.6 mt -62.96 -56.26 18.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.608 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' ALA . 1.1 mt -63.36 -25.73 68.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 1.6 tttp -62.84 -29.84 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.751 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -76.87 -73.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.92 62.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -107.45 153.29 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.165 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -96.6 99.24 5.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 31.7 Cg_endo -64.31 -15.83 51.75 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -79.7 65.86 4.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 68' ' ' SER . 28.2 m -126.4 138.11 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.261 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -114.88 102.1 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -89.75 -174.57 0.46 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 51.3 Cg_exo -55.57 -41.65 75.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.85 2.367 . . . . 0.0 112.545 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.899 HG21 ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -62.86 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.328 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 65.8 m80 -58.14 -51.37 70.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.753 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -66.63 -50.38 63.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.39 -30.44 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.41 -67.11 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.617 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -62.33 -29.55 70.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.812 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 82' ' ' ASP . 52.2 p -66.99 -54.07 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 111.211 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 110.38 66.04 0.54 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.121 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -140.66 53.43 1.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 0.0 110.55 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.983 HD22 ' HB2' ' A' ' 123' ' ' SER . 20.6 tp -52.23 -19.07 1.8 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -63.52 -72.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.819 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 6.3 m -73.15 -24.1 60.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.527 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.568 ' CD2' HG21 ' A' ' 96' ' ' VAL . 9.7 tt -56.16 -59.79 4.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 127' ' ' PHE . 8.1 ptmt -58.32 -38.0 76.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.133 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.765 HG11 ' HB3' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -51.73 -61.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.09 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.994 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -74.8 -43.48 54.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.873 HG22 HG12 ' A' ' 80' ' ' VAL . 10.7 t -52.54 -42.55 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.512 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.6 mm-40 -73.54 -39.53 64.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.225 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -51.88 66.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 178.77 -26.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.095 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -23.82 123.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 112.002 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.899 ' O ' HG21 ' A' ' 80' ' ' VAL . 9.8 t0 -56.6 85.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 102' ' ' VAL . 10.2 p -98.31 28.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 104' ' ' ALA . 0.2 OUTLIER -120.91 -33.22 3.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -48.11 -177.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 111' ' ' LEU . 9.3 mt -139.99 175.47 9.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.88 62.03 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 108' ' ' THR . 0.3 OUTLIER 68.45 -75.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 107' ' ' SER . 4.7 p -37.96 -48.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 122.93 19.72 2.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.512 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.512 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -93.06 118.29 31.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 110.993 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.945 HD11 ' HB3' ' A' ' 136' ' ' HIS . 5.2 mt -65.27 143.8 98.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.646 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 83.7 Cg_exo -45.2 -26.12 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.606 2.204 . . . . 0.0 112.173 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -72.12 -40.04 66.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.084 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -53.04 -46.04 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -58.76 -44.19 90.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.671 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.739 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -60.04 -35.63 75.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.443 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.577 ' HB ' HD23 ' A' ' 147' ' ' LEU . 97.8 mt -64.45 -43.62 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 115' ' ' LEU . 12.6 ptt180 -73.26 -10.12 59.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.745 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -59.77 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.08 25.22 7.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.404 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 9.7 m-70 -63.82 -11.93 31.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 23.2 t 70.52 -68.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.983 ' HB2' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -70.63 -52.86 18.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.745 ' HA ' HD13 ' A' ' 89' ' ' LEU . 22.0 t -52.83 -55.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.9 t -52.0 -61.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 159' ' ' ILE . 5.4 p -58.0 -30.44 66.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.7 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.4 t80 -73.31 -55.39 6.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -63.93 -11.67 30.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.067 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.923 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -57.56 -70.24 0.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.929 ' HA ' HD11 ' A' ' 134' ' ' LEU . 57.9 Cg_endo -71.51 -17.92 29.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.238 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 29.4 mm-40 -90.56 31.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -152.1 -168.62 3.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.901 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 135' ' ' HIS . 23.5 t0 -77.1 83.78 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.9 mp -64.97 61.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.976 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 133' ' ' ASP . 19.0 t-160 -175.07 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.945 ' HB3' HD11 ' A' ' 111' ' ' LEU . 79.0 t60 -54.89 155.02 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -140.67 158.29 44.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.512 ' OD1' ' CB ' ' A' ' 110' ' ' SER . 1.9 t70 -64.23 158.7 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.68 -19.69 6.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 110.287 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -46.22 72.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.859 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 125.08 32.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -129.16 146.31 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -115.82 -174.32 0.27 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.593 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 71.7 Cg_exo -48.66 -43.69 33.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -73.19 -47.91 39.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 17.3 tp10 -57.54 -57.52 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.577 HD23 ' HB ' ' A' ' 117' ' ' ILE . 6.6 tp -52.35 -34.31 46.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -63.82 -33.04 74.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.61 -30.18 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.007 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 3.1 tp-100 -70.4 -80.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.668 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.9 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.2 71.89 1.71 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.589 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -72.54 46.18 1.07 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.321 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -36.79 -32.81 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.393 0.616 . . . . 0.0 110.263 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 3.3 pm0 -179.66 -143.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.689 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' GLN . 1.1 m-80 -68.82 57.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.963 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 151' ' ' ARG . 4.1 mt -71.47 -69.77 0.36 Allowed 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 111.008 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.687 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 6.8 ptm -52.73 -19.46 2.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.786 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.64 -47.28 41.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 126' ' ' SER . 1.5 mt -62.08 -50.64 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.747 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -68.33 -29.99 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.541 ' HB2' HD21 ' A' ' 145' ' ' LEU . 4.4 tt0 -63.54 -42.91 98.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.24 -47.76 35.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.653 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -71.1 -20.04 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.043 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.503 ' HA ' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -34.27 -31.12 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.816 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -109.62 -21.08 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 0.0 110.935 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' VAL . 9.5 tpt180 -57.07 -69.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.034 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.86 HD11 ' CD2' ' A' ' 62' ' ' LEU . 3.8 tp -68.65 -20.4 64.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 23.8 t -73.32 -44.32 59.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.01 -33.68 59.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.621 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.611 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -71.61 -38.88 70.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -72.84 -43.58 62.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.206 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -67.96 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.202 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.1 ptp180 -68.3 -9.33 46.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.27 90.02 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 27' ' ' ARG . 2.4 p -52.65 -22.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.08 -47.86 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 mm-40 -72.87 -44.7 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.993 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.8 p -52.64 -41.87 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.018 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD3' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.3 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 5.2 mtt180 -56.0 -21.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.616 HD22 HG21 ' A' ' 35' ' ' VAL . 10.3 mt -72.42 -68.99 0.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.61 -44.07 78.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.302 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 61.6 m-70 -73.13 -0.94 15.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.277 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -149.26 -76.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.212 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 35' ' ' VAL . 14.5 tp10 -42.88 -27.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.978 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER 55.4 59.57 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.23 143.35 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.687 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 2.1 t-80 -76.29 143.56 73.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.766 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 45.1 Cg_endo -68.07 -21.75 42.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 0.0 112.135 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.869 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -91.21 33.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.77 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -80.93 125.6 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.39 124.2 39.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -62.5 -62.21 1.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 30.5 tpt180 -97.87 46.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 26.5 t80 37.48 62.32 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.95 -65.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.385 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 15.3 mtpp -86.91 146.63 26.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.676 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.2 p -92.73 -177.95 4.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -72.27 -36.0 68.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -32.08 69.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' HE3' ' A' ' 45' ' ' LYS . 1.8 tt0 -69.94 -15.31 63.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 46' ' ' THR . 2.6 m -110.25 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.522 ' SD ' HD12 ' A' ' 62' ' ' LEU . 21.8 ttp -38.08 123.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.681 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -88.87 19.64 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.995 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER 39.35 30.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.121 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.22 -45.51 48.48 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.121 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 1.018 ' O ' HG22 ' A' ' 58' ' ' VAL . 20.5 m -108.6 134.85 20.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.6 -37.7 6.84 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.572 2.181 . . . . 0.0 112.29 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.42 -36.22 83.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.353 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.018 HG22 ' O ' ' A' ' 55' ' ' SER . 5.4 m -62.5 -27.99 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' A' ' 91' ' ' THR . . . -63.37 -60.36 3.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 60' ' ' LEU . 1.8 tm? -63.15 -40.67 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.964 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -62.52 -40.57 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.562 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 18' ' ' ALA . 7.1 mt -63.86 -63.57 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.496 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.593 HD23 ' CD2' ' A' ' 98' ' ' HIS . 23.6 tp -63.58 -14.69 53.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -62.9 -36.01 81.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.051 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 37' ' ' PRO . 2.4 mm-40 -68.08 -14.48 63.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.15 34.88 4.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.85 -179.41 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.596 ' O ' HG13 ' A' ' 71' ' ' VAL . 14.4 t -121.92 93.75 48.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.514 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 52.2 Cg_exo -54.22 -17.4 11.64 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.734 2.289 . . . . 0.0 112.179 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.719 ' OD1' ' OD1' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -94.65 64.02 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.793 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 68' ' ' SER . 2.7 m -104.56 146.55 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.457 HG22 ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -164.63 135.56 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.897 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.553 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.54 -177.38 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 29.2 Cg_exo -61.65 -39.53 53.21 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.883 2.389 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.5 m -60.31 -28.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 78' ' ' SER . 3.2 m80 -62.65 -67.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.889 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.81 -43.92 90.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.806 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -52.48 -28.3 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.128 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.71 -56.5 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.535 ' NE ' HD13 ' A' ' 115' ' ' LEU . 1.8 mtt180 -73.16 -22.79 60.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.815 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 82' ' ' ASP . 69.5 p -71.12 -57.06 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.2 67.8 0.5 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 52' ' ' MET . 22.8 m-85 -140.61 52.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.413 . . . . 0.0 110.586 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.874 ' HG ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -52.36 -30.63 29.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.8 m -65.9 -37.4 86.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 83' ' ' ALA . 9.6 tp -52.82 -49.46 65.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.334 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.756 ' CE ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -53.99 -42.15 68.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 59' ' ' ALA . 22.6 t -52.86 -59.09 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.435 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.995 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.9 pp -71.3 -41.17 70.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 2.1 t -67.48 -56.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.953 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -52.72 -29.73 28.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.053 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.593 ' CD2' HD23 ' A' ' 63' ' ' LEU . 4.2 t-80 -60.61 -32.26 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.934 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.33 -5.52 4.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -46.01 141.13 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.743 0.306 . . . . 0.0 111.044 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.719 ' OD1' ' OD1' ' A' ' 70' ' ' ASN . 19.6 p-10 -52.08 140.17 21.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.06 13.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.587 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.82 8.01 30.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -82.26 136.85 34.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -106.76 167.34 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.59 -169.67 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -20.89 26.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 1.9 m -90.05 -9.39 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.795 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 71.93 42.28 52.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.441 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 1.342 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 2.7 m -119.15 127.93 53.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.047 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -59.95 149.63 72.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 1.047 ' HD2' HD23 ' A' ' 111' ' ' LEU . 55.1 Cg_exo -51.72 -30.52 37.68 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.13 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 111' ' ' LEU . 14.4 tt -71.0 -32.46 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 138' ' ' ASP . 32.9 m170 -62.16 -36.19 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -73.28 -42.95 61.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.638 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.772 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.657 ' HA ' HG11 ' A' ' 125' ' ' VAL . 96.6 mt -59.79 -41.51 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -73.23 -4.05 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 115' ' ' LEU . 1.9 mm-40 -118.07 -46.07 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.5 53.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.099 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 23.8 m-70 -66.99 84.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.0 t 52.91 -146.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -73.6 4.37 5.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.874 HG22 ' HG ' ' A' ' 89' ' ' LEU . 46.7 t -52.27 -60.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.772 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.4 t -52.75 -36.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.104 0.478 . . . . 0.0 110.506 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.802 ' HB2' HG21 ' A' ' 159' ' ' ILE . 2.5 t -70.13 -44.96 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.607 ' CD2' HD21 ' A' ' 89' ' ' LEU . 20.4 t80 -69.15 -26.78 65.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -73.56 -0.19 14.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.251 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -73.11 -70.05 0.29 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 39.4 Cg_endo -66.86 -46.81 3.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.795 2.33 . . . . 0.0 112.802 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.581 ' OE1' ' CE2' ' A' ' 127' ' ' PHE . 4.8 pt-20 -51.52 -34.65 37.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.351 . . . . 0.0 110.758 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 9.3 m -108.8 151.06 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.137 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 31.1 p30 -34.8 121.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.9 mt -89.8 27.69 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -167.87 43.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.066 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 1.137 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -109.85 172.91 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.801 ' HG3' HG22 ' A' ' 143' ' ' THR . 8.5 mtm-85 -141.66 125.42 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.986 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 1.342 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 1.5 t0 -76.14 152.62 36.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 108' ' ' THR . . . -51.12 -21.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.74 47.87 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.575 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' CD1' ' HG ' ' A' ' 147' ' ' LEU . 2.9 pp -174.43 139.65 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.165 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.801 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -95.41 -175.31 0.45 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 85.0 Cg_exo -47.67 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.802 2.335 . . . . 0.0 112.275 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.77 -36.05 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 142' ' ' LEU . 68.3 mm-40 -61.48 -63.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.83 -48.99 66.6 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.063 0.458 . . . . 0.0 109.808 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 160' ' ' LEU . . . -54.61 -33.79 61.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.052 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -66.42 -44.73 82.15 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -67.84 -88.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.932 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 11.3 ttm180 -75.22 58.0 0.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 148' ' ' ALA . . . -73.18 45.53 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.557 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 156' ' ' LEU . . . -39.27 134.86 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 36.68 -152.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.529 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 3.5 p-10 -74.45 50.31 0.41 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.236 -0.186 . . . . 0.0 110.861 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 159' ' ' ILE . 3.3 mt -66.39 -70.64 0.23 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 111.67 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.745 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 9.1 ptm -52.49 -20.07 2.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -73.62 -52.35 13.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 126' ' ' SER . 1.9 mt -57.65 -32.2 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 120.913 0.387 . . . . 0.0 111.009 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -73.5 -40.84 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.058 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -65.71 -25.71 67.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -54.68 6.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.345 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -71.37 -12.62 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.72 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.7 mmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 121.144 0.497 . . . . 0.0 110.468 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.548 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -41.35 -26.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.688 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' ASN . 30.6 t0 -108.11 31.58 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' VAL . 12.4 ttm180 -117.32 -59.82 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.628 ' HB2' HG11 ' A' ' 35' ' ' VAL . 12.3 tp -70.87 -24.13 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -64.68 -48.35 75.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.762 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -73.1 -36.32 56.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.4 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.24 -57.37 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.74 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' MET . . . -73.13 -22.93 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 8.0 mtp180 -72.84 -27.48 61.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 62.34 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.225 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.1 p-10 -132.11 84.42 2.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.4 p -52.84 -21.53 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 46.8 mt-30 -73.5 -49.13 28.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.818 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.225 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 7.0 mp0 -73.47 -41.88 62.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.952 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.8 p -52.86 -39.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 1.138 ' HG2' ' OE2' ' A' ' 61' ' ' GLU . 5.2 mtt180 -73.13 -61.46 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.362 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 14.4 mtm-85 -62.04 -25.6 67.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.224 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.574 HD11 ' CB ' ' A' ' 17' ' ' ALA . 9.5 mt -56.73 -66.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.883 HD22 ' HG3' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -73.54 -48.73 30.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.775 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 1.1 m-70 -68.95 -10.94 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.963 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -137.42 -66.88 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.72 0.295 . . . . 0.0 111.386 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -54.51 -18.26 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.076 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 34' ' ' LEU . 4.8 mt 55.29 61.65 2.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 14' ' ' LEU . 12.0 p -107.31 129.3 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.586 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 1.5 t60 -56.83 146.6 57.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 18.6 Cg_endo -58.78 -66.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.713 2.276 . . . . 0.0 112.21 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -44.73 -62.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . 34.28 97.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 46' ' ' THR . 1.7 mp -92.78 130.82 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 37.8 p-10 -65.51 -31.67 72.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.92 39.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 65.5 t80 54.42 72.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.01 -64.71 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.581 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HB3' HG13 ' A' ' 50' ' ' VAL . 10.8 mmtt -98.32 136.47 38.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.751 0.31 . . . . 0.0 111.052 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 50' ' ' VAL . 33.3 p -89.2 161.72 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.91 -33.68 51.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' CD1' HD11 ' A' ' 62' ' ' LEU . 2.0 tp -73.25 -42.23 62.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.471 ' HG2' ' HD3' ' A' ' 45' ' ' LYS . 54.2 tt0 -73.15 -8.71 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 46' ' ' THR . 3.9 m -115.83 -23.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.574 ' HA ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.8 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.732 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.575 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -124.37 21.12 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.79 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.917 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.1 m-85 41.01 29.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.944 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -58.38 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.076 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.544 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -73.7 153.33 89.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.432 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.691 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 13.1 Cg_exo -69.96 -42.93 2.79 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.819 2.346 . . . . 0.0 112.303 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -63.55 -23.72 67.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.926 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.831 ' HA ' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.49 -49.45 83.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.36 -47.56 81.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.597 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.667 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -63.03 -53.25 56.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.325 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.138 ' OE2' ' HG2' ' A' ' 27' ' ' ARG . 2.2 mt-10 -63.27 -56.86 13.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.928 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.67 -50.46 71.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.672 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 6.9 tt -63.4 -42.89 98.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.67 0.271 . . . . 0.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.8 tttp -62.77 -42.05 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.883 ' HG3' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -44.49 -29.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.546 ' CA ' ' HG3' ' A' ' 37' ' ' PRO . . . 132.7 59.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -107.21 167.26 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -108.56 103.67 51.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 37.0 Cg_endo -65.88 -13.55 40.36 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.797 2.331 . . . . 0.0 112.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -102.61 86.67 2.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.879 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' SER . 12.7 m -142.74 132.11 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.99 154.22 34.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.986 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -139.62 -174.26 0.4 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.947 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 55.2 Cg_exo -51.67 -51.24 11.6 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.79 2.327 . . . . 0.0 112.458 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -52.83 -44.08 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' NE2' ' HG3' ' A' ' 112' ' ' PRO . 51.4 m80 -62.94 -56.25 18.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.007 ' O ' HG23 ' A' ' 86' ' ' THR . 1.9 p30 -54.77 -48.83 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.845 ' CB ' HD13 ' A' ' 92' ' ' LEU . . . -56.28 -57.19 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.12 -50.3 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.86 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -57.16 -40.77 77.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.3 p -73.33 -59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.82 73.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.216 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 56.7 m-85 -136.75 49.81 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -52.39 -35.73 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.056 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.57 -66.43 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.779 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.812 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 63.0 m -71.72 -41.09 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.845 HD13 ' CB ' ' A' ' 83' ' ' ALA . 49.7 tp -52.66 -51.24 61.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.502 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 97' ' ' GLU . 28.9 ttmt -52.74 -36.85 58.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.481 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.295 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 24.2 t -57.03 -70.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.917 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -58.59 -38.51 78.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.819 HG11 ' OE1' ' A' ' 131' ' ' GLU . 2.4 t -64.02 -60.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.682 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.295 ' CD ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.73 -30.81 34.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.863 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.506 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -73.15 -54.56 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.653 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . -164.73 -65.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.287 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 40.2 -166.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.354 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.446 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 14.6 p-10 -135.63 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.689 HG13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -100.9 19.14 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.765 ' ND2' ' OD2' ' A' ' 133' ' ' ASP . 15.3 m120 -104.67 -25.18 12.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -67.55 167.6 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 109' ' ' GLY . 7.7 mt -136.14 -160.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 107' ' ' SER . 4.1 m-20 -122.91 -154.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 106' ' ' ASP . 18.9 m -60.34 -38.79 84.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -88.17 -3.53 58.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 69.71 46.55 53.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.499 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -107.37 134.8 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.996 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.501 ' HB2' ' ND1' ' A' ' 114' ' ' HIS . 36.9 mt -62.97 151.22 86.37 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.825 ' HB2' HD11 ' A' ' 128' ' ' LEU . 89.3 Cg_exo -46.64 -26.46 4.42 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.626 2.217 . . . . 0.0 112.243 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 129' ' ' ALA . 17.7 tt -71.79 -35.78 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.844 ' HA ' HD12 ' A' ' 117' ' ' ILE . 21.6 m80 -56.34 -37.96 70.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.755 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.1 mt -69.09 -51.78 35.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.604 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -52.83 -32.07 42.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 147' ' ' LEU . 52.7 mt -60.9 -39.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.57 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.43 ' CD ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -68.19 -17.35 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.525 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.86 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -92.08 -54.69 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.76 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.26 37.15 7.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -65.63 -10.63 37.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.86 -68.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.08 -49.74 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.59 -59.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 116' ' ' ALA . 11.4 t -52.34 -46.52 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.313 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.733 ' HB3' HG21 ' A' ' 159' ' ' ILE . 73.4 p -69.45 -33.59 73.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.289 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 1.381 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 17.6 t80 -73.3 -40.01 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -62.17 -12.16 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -66.69 -64.59 2.13 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.706 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 Cg_endo -59.17 -35.63 97.29 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.876 2.384 . . . . 0.0 112.445 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.381 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mt-10 -90.5 35.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.508 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 92.6 p -151.59 48.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.765 ' OD2' ' ND2' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 36.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.765 HD22 ' HG3' ' A' ' 164' ' ' MET . 69.8 mt -55.6 141.09 38.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.499 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 7.7 t-80 84.72 -12.56 0.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 41.3 t-80 -60.49 169.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -169.77 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 4.5 m-20 -145.5 171.26 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.524 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . . . -68.54 -6.44 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 p -114.05 0.87 14.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.21 95.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.492 ' HB3' HD23 ' A' ' 147' ' ' LEU . 33.9 mt -120.2 77.4 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.076 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 14.2 p -48.27 161.41 0.38 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.711 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.5 Cg_exo -48.28 -37.5 32.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.747 2.298 . . . . 0.0 112.421 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' HD23 ' A' ' 145' ' ' LEU . 2.0 tt -71.06 -41.74 70.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.076 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -66.3 -48.54 70.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.19 -39.79 60.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.039 0.447 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.926 ' HB1' HD13 ' A' ' 156' ' ' LEU . . . -61.23 -45.69 93.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.204 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.437 ' HB2' ' CE ' ' A' ' 157' ' ' MET . 11.0 tpt180 -57.19 -30.5 64.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.29 -75.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.792 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 1.078 ' O ' HD21 ' A' ' 156' ' ' LEU . 17.1 mmm180 -74.56 70.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.46 51.39 0.09 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.334 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -52.57 -31.19 34.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.473 0.654 . . . . 0.0 109.831 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.536 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 2.9 pm0 173.27 -146.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.182 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 1.205 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 21.5 m120 -74.91 44.53 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.078 HD21 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -73.58 -31.45 63.61 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.479 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.677 ' H ' HD12 ' A' ' 156' ' ' LEU . 1.1 ptm -67.34 -29.05 68.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.205 ' OD1' ' O ' ' A' ' 155' ' ' ASN . 5.4 p-10 -74.26 -46.58 40.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.245 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.16 -39.83 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.198 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.01 -41.56 61.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.11 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG3' ' HG ' ' A' ' 145' ' ' LEU . 1.9 mt-30 -61.73 -55.37 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.3 95.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.427 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 159' ' ' ILE . 1.1 m-70 -72.98 -10.86 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.978 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.765 ' HG3' HD22 ' A' ' 134' ' ' LEU . 3.1 ttm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 35' ' ' VAL . 4.7 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.751 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -78.37 -10.57 86.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 2.5 p30 -129.12 24.07 5.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.745 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 5.8 ttt180 -103.89 -67.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.82 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -69.39 -39.99 77.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.696 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.633 ' N ' HD13 ' A' ' 14' ' ' LEU . 1.1 m -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.68 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.03 -36.4 60.72 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.31 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -68.49 -57.17 6.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.95 64.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -27.94 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -73.14 -31.7 64.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 83.69 64.92 1.59 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.406 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.399 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 1.2 p30 -137.12 100.94 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 26' ' ' VAL . 2.5 p -52.7 -23.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -73.31 -49.61 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.399 ' OE1' ' CB ' ' A' ' 22' ' ' ASP . 1.8 mt-10 -73.09 -47.24 46.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.9 p -52.86 -38.1 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 60.2 mtm180 -73.15 -61.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.192 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -52.94 -31.8 42.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.251 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -72.9 -69.08 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 10.8 mt -70.69 -42.62 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 4.3 t-80 -73.29 -0.51 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.376 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -150.58 -75.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.717 0.294 . . . . 0.0 111.179 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.745 ' OE1' HD23 ' A' ' 29' ' ' LEU . 2.8 tm-20 -41.18 -27.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 34' ' ' LEU . 9.7 mt 54.79 56.04 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 14' ' ' LEU . 41.0 t -87.28 130.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -48.41 133.7 13.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.9 Cg_endo -71.61 -18.95 28.63 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.767 2.311 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.821 ' O ' HD12 ' A' ' 40' ' ' LEU . 57.5 p-10 -87.49 1.73 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -45.91 121.83 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -111.34 127.45 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 6.5 m-80 -64.06 -163.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.401 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -81.79 -2.0 49.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.83 -23.13 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.744 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 96.24 29.35 8.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.447 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HB3' HG13 ' A' ' 50' ' ' VAL . 22.6 mttp -105.45 152.92 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.22 168.16 14.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -61.17 -53.8 52.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 51' ' ' MET . 3.6 mt -68.17 -27.99 66.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HB2' HG21 ' A' ' 71' ' ' VAL . 7.4 tt0 -73.39 -3.66 28.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 46' ' ' THR . 28.6 m -133.68 -37.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -36.09 137.72 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.901 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.504 ' HE2' ' HA3' ' A' ' 54' ' ' GLY . 12.4 ptm -93.5 123.62 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.059 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 60.9 m-85 -56.96 -16.51 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -36.31 -40.85 0.45 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.255 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.922 ' O ' HG22 ' A' ' 58' ' ' VAL . 19.3 m -110.94 127.16 27.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.608 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.3 Cg_endo -73.6 -32.28 7.88 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.297 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.93 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.0 -39.73 95.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 55' ' ' SER . 19.1 m -62.38 -30.04 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.065 0.46 . . . . 0.0 110.447 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -64.0 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 6.2 tt -63.24 -32.12 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.93 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -62.91 -54.54 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -62.69 -46.1 89.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.654 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 63' ' ' LEU . 2.5 mt -63.29 -49.48 73.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 60' ' ' LEU . 5.6 ttpp -63.01 -13.1 31.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.089 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -79.0 -34.47 44.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.86 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.16 44.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.74 -171.63 2.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 m -136.47 114.11 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -26.51 20.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.621 2.214 . . . . 0.0 112.348 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.14 75.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 49' ' ' GLN . 4.0 m -137.25 134.2 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.406 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 11.0 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -110.95 113.89 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -86.68 171.19 10.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.704 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 14.3 Cg_endo -56.92 -41.64 73.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.629 2.219 . . . . 0.0 112.07 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 2.9 m -56.39 -43.9 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 79.7 m80 -54.1 -53.43 53.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 86' ' ' THR . 2.9 p30 -70.12 -31.17 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.154 ' CB ' HD11 ' A' ' 92' ' ' LEU . . . -66.64 -25.8 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.25 -65.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.29 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -59.51 -26.3 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 82' ' ' ASP . 4.1 p -65.9 -37.62 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.094 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.54 66.28 1.29 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.425 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -140.33 49.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.97 HD21 ' CD2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -53.4 -18.82 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.29 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.715 ' C ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.4 -70.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.8 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.63 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 13.8 m -71.21 -31.76 67.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.34 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.154 HD11 ' CB ' ' A' ' 83' ' ' ALA . 1.1 mp -53.7 -52.01 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.111 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.901 ' HD3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -51.18 -30.93 18.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 62.1 t -74.3 -58.23 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.201 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.827 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 2.3 pp -74.58 -44.1 52.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.13 -29.84 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.21 -27.28 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -73.51 -50.2 22.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -168.15 -70.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.035 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . 24.4 99.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' ALA . 6.2 p-10 -37.52 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -92.68 -6.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.647 ' HA ' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.55 2.44 39.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -74.65 171.51 13.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.1 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 111' ' ' LEU . 56.3 mt -136.35 -168.14 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -171.1 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -52.04 -28.25 16.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -10.71 38.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.629 ' O ' HD22 ' A' ' 105' ' ' LEU . . . 72.13 9.83 72.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.623 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.462 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -77.62 109.79 11.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.136 HD23 ' CG2' ' A' ' 113' ' ' ILE . 6.3 tp -59.78 142.22 88.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.715 ' HA ' HD13 ' A' ' 115' ' ' LEU . 90.8 Cg_exo -40.7 -29.13 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.734 2.29 . . . . 0.0 112.352 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 1.136 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -73.27 -43.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 43.2 m80 -53.59 -37.11 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.715 HD13 ' HA ' ' A' ' 112' ' ' PRO . 6.6 mp -57.54 -57.8 11.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.783 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -52.86 -30.23 32.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.824 ' HB ' HD23 ' A' ' 147' ' ' LEU . 77.9 mt -66.46 -38.08 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.516 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HG2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -73.18 -15.85 61.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 1.29 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 2.6 mp0 -94.69 -52.99 4.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 87.39 18.1 57.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.158 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' SER . 92.8 m-70 -35.82 -69.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.545 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 3.1 t 156.63 -92.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.576 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -73.34 -14.1 61.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.749 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.621 HG12 ' CB ' ' A' ' 116' ' ' ALA . 69.2 t -68.57 -65.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.685 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.6 t -52.27 -41.18 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.646 ' CB ' HG21 ' A' ' 159' ' ' ILE . 93.4 p -72.27 -30.87 65.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 1.352 ' CE1' ' OE2' ' A' ' 131' ' ' GLU . 53.2 t80 -73.24 -53.06 11.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.6 -19.48 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.83 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.93 -70.58 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.83 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 38.8 Cg_endo -66.64 -37.6 21.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.7 2.266 . . . . 0.0 112.412 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.352 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 23.8 mp0 -65.94 -21.52 66.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.716 ' HB3' HD21 ' A' ' 111' ' ' LEU . 6.9 m -114.02 148.77 36.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.113 ' OD2' ' ND1' ' A' ' 136' ' ' HIS . 2.2 p30 -38.33 110.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -65.71 -10.25 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.47 39.68 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 1.113 ' ND1' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -106.21 138.71 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.985 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -130.09 163.21 27.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -96.47 160.89 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.66 -15.76 13.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -34.66 21.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.801 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.95 72.09 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.579 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 20.1 mt -151.92 62.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -40.93 168.21 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.035 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 143' ' ' THR . 84.2 Cg_exo -44.34 -51.18 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.621 2.214 . . . . 0.0 112.144 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.88 -40.29 79.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -53.03 -63.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.57 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.8 tp -56.61 -41.89 77.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.536 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -53.01 -40.25 63.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.06 -40.58 96.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -68.76 -79.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.93 71.78 1.57 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.448 ' HA2' ' SD ' ' A' ' 157' ' ' MET . . . -72.54 42.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.576 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.973 ' HB1' ' OE1' ' A' ' 154' ' ' GLN . . . -52.26 128.96 26.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.973 ' OE1' ' HB1' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 31.38 -154.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 20.6 m120 -76.82 42.82 0.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.776 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -72.87 -50.48 23.58 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.198 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.752 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.24 -30.81 29.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.91 0.386 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.2 OUTLIER -74.17 -49.45 23.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.646 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.1 OUTLIER -51.77 -59.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 156' ' ' LEU . 6.4 mp -57.81 -63.63 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 157' ' ' MET . 1.5 pt20 -52.67 -37.1 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -66.13 -49.03 60.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.17 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -18.64 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.65 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.486 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.5 ttm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 7.1 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 12' ' ' ASP . . . -49.86 126.01 20.53 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.405 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 4.6 t0 87.31 5.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 7.0 tpt180 -73.26 -74.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.839 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -73.2 -23.84 60.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -65.46 -48.61 72.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -70.33 -31.33 68.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.606 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -72.68 -64.66 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.53 65.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HA ' ' N ' ' A' ' 52' ' ' MET . . . -71.66 -26.09 62.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -73.41 -29.42 62.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' ARG . . . 97.8 70.46 1.0 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.807 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.085 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 1.4 p30 -146.03 79.97 1.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.876 0.369 . . . . 0.0 110.508 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.2 p -52.61 -20.1 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -72.68 -47.88 43.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.495 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.085 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.34 -39.39 65.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.21 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.4 p -53.41 -36.22 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.874 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 76.5 mtt-85 -73.32 -55.97 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.572 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -66.94 -18.3 65.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.029 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.706 HD12 ' CD ' ' A' ' 25' ' ' GLU . 2.8 mt -65.54 -65.67 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.509 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.762 HD12 ' CD ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -73.54 -38.18 65.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.75 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -72.46 -33.91 67.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.684 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HG3' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -113.8 -55.46 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.184 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.583 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.03 -6.36 27.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER 43.62 27.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.839 HG11 ' HB2' ' A' ' 14' ' ' LEU . 9.2 p -53.09 147.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 136.68 39.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 60.6 Cg_endo -73.08 -11.2 25.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.902 2.402 . . . . 0.0 112.471 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -108.58 7.4 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.54 78.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.068 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.9 mp -64.48 148.05 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.4 -154.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -23.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.6 -35.37 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.17 29.28 3.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HE2' ' OE1' ' A' ' 49' ' ' GLN . 48.0 mtpt -95.12 160.14 14.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.318 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -84.85 150.44 25.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.475 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -65.51 -31.74 72.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 69' ' ' PRO . 12.7 tp -72.31 -47.55 48.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 1.016 ' HB3' HG21 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -63.08 -18.06 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.745 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 46' ' ' THR . 35.5 m -104.36 -34.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -38.7 162.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -103.07 139.25 38.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.957 ' CD2' HD21 ' A' ' 95' ' ' LEU . 19.6 m-85 -84.03 10.29 10.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.84 -54.02 38.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.286 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -99.55 134.86 20.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.653 0.263 . . . . 0.0 110.895 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.859 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 11.2 Cg_exo -71.68 -43.84 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.744 2.296 . . . . 0.0 112.172 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -62.75 -27.22 69.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 55' ' ' SER . 4.5 t -62.87 -45.84 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.88 -56.6 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.228 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 60' ' ' LEU . 3.3 tt -63.14 -44.67 94.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.413 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.21 ' OE2' ' O ' ' A' ' 26' ' ' VAL . 1.6 tt0 -62.31 -58.51 7.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.721 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.4 -46.84 84.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.96 HD21 ' CE1' ' A' ' 98' ' ' HIS . 10.4 tt -62.91 -31.7 72.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 12.3 mttt -63.0 -44.39 96.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.633 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -44.01 -25.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 134.68 -11.78 4.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -37.16 148.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 71' ' ' VAL . 57.8 m -103.82 116.47 61.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.936 ' HA ' HD23 ' A' ' 48' ' ' LEU . 73.9 Cg_endo -75.88 -29.76 6.6 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.75 2.3 . . . . 0.0 112.432 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 101' ' ' ASP . 1.7 m-20 -73.62 68.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 49' ' ' GLN . 9.7 m -117.19 155.41 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' THR . 4.8 mp0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -89.54 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.901 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 1.134 ' OG ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 178.92 170.79 0.51 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.676 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 3.3 Cg_endo -46.36 -55.02 4.07 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.857 2.371 . . . . 0.0 112.089 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.01 ' CG2' HG12 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.43 -39.75 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.039 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 78' ' ' SER . 34.9 m80 -52.86 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.229 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER -67.11 -36.0 80.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.329 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -26.58 19.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -73.71 -62.52 1.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.776 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.93 -25.65 61.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.915 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.9 p -56.12 -23.31 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.656 0.265 . . . . 0.0 111.25 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.603 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 67.78 65.47 2.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.204 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -155.4 60.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.617 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' CG ' ' A' ' 127' ' ' PHE . 1.5 tm? -52.06 -19.65 2.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.076 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.338 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -66.82 -66.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.338 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 21.8 m -73.09 -34.54 66.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.6 tt -52.7 -60.89 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.814 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 1.195 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 12.6 ptpt -52.33 -37.66 56.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.053 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 53.1 t -55.58 -64.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.957 HD21 ' CD2' ' A' ' 53' ' ' PHE . 3.9 pp -71.06 -35.53 71.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.932 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 31.2 t -66.39 -42.31 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.195 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -71.63 -22.02 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.754 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 63' ' ' LEU . 58.3 t-80 -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 145.82 -9.46 1.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.843 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -34.83 114.36 0.22 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 1.134 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 9.7 p30 -33.48 91.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.01 HG12 ' CG2' ' A' ' 80' ' ' VAL . 2.4 m -98.63 -1.39 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.008 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 9.1 m-20 -116.56 20.35 14.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.11 151.11 29.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -129.16 -159.93 0.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -150.38 86.78 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.44 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 106' ' ' ASP . 1.3 t -43.07 -26.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.67 32.58 61.43 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.41 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.463 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -97.92 102.36 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.013 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.404 HD11 ' CG ' ' A' ' 133' ' ' ASP . 13.3 mt -53.93 146.86 26.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' A' ' 80' ' ' VAL . 94.4 Cg_exo -43.14 -35.18 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.3 tt -73.61 -31.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.328 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 21.3 m170 -52.61 -58.39 6.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.737 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.14 -50.87 68.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.522 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -53.81 -37.04 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.617 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.819 HG21 ' HB3' ' A' ' 147' ' ' LEU . 73.6 mt -62.32 -41.28 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.447 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.32 -14.78 62.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.539 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 19.8 mt-10 -102.87 -50.57 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.616 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 74.29 31.04 59.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.603 ' CE1' ' HA3' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -34.12 -46.23 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.687 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 5.1 t 155.83 -109.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.528 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 38.7 m -73.88 -14.86 61.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.678 0.275 . . . . 0.0 110.929 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.74 ' O ' HD23 ' A' ' 128' ' ' LEU . 55.2 t -55.07 -67.05 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.8 t -52.64 -46.44 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.411 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.748 ' CB ' HG21 ' A' ' 159' ' ' ILE . 6.4 p -73.14 -23.2 60.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.713 ' CG ' HD21 ' A' ' 89' ' ' LEU . 15.6 t80 -73.52 -65.74 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -75.18 26.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -64.24 -56.49 23.29 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 110.669 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.1 Cg_endo -76.63 -34.71 2.39 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.73 2.287 . . . . 0.0 111.894 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 4.8 mm-40 -54.49 -24.94 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 3.5 m -114.86 146.93 40.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.404 ' CG ' HD11 ' A' ' 111' ' ' LEU . 1.8 p-10 -37.48 105.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 164' ' ' MET . 7.5 mt -83.72 63.98 7.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' HIS . 41.0 t-80 -176.87 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.783 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 56.4 t60 -39.58 161.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.819 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.656 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -141.23 156.34 45.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.463 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 2.5 t0 -60.92 153.83 23.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.6 -16.89 11.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.626 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -48.99 28.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 131.3 54.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.579 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 20.7 mt -152.3 125.89 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.656 HG22 ' CG ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -100.68 178.35 1.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.751 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 88.9 Cg_exo -46.93 -57.33 2.36 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.766 2.31 . . . . 0.0 112.361 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.586 ' HA ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -71.13 -36.87 72.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.27 -53.09 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -52.47 -40.1 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -59.67 -40.57 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -36.05 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.062 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.7 tp-100 -67.43 -76.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.76 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.654 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.5 mpt_? -74.25 70.15 1.62 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -69.79 49.67 0.66 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.019 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -43.96 -27.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 0.0 110.178 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.528 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER 168.96 -132.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.441 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.542 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 44.1 m-20 -75.46 42.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.96 -0.463 . . . . 0.0 111.602 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 151' ' ' ARG . 3.6 mt -62.56 -69.16 0.27 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.771 0.319 . . . . 0.0 111.437 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.64 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 10.0 ptm -52.36 -21.82 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.067 ' OD1' HG13 ' A' ' 159' ' ' ILE . 31.9 p30 -73.93 -51.04 17.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.418 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.067 HG13 ' OD1' ' A' ' 158' ' ' ASP . 1.5 mt -61.71 -24.12 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.375 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.974 HD11 ' HB2' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -73.04 -34.24 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.494 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -70.64 -31.46 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.92 18.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -70.12 -16.25 63.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.781 ' HG2' HD13 ' A' ' 134' ' ' LEU . 8.5 mtp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.039 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.432 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 8.2 p . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -61.98 -57.3 17.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.47 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 53.2 p30 -85.56 13.52 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -82.33 -66.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.914 HD23 ' O ' ' A' ' 36' ' ' HIS . 2.5 tp -72.15 -44.44 63.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -56.78 -32.52 65.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.829 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -72.69 -46.38 31.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.469 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.59 38.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.65 79.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.3 -22.75 61.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.202 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -73.14 -43.23 61.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.62 70.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p30 -139.0 103.65 4.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.501 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.04 -23.01 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.55 -51.45 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 60.0 mm-40 -68.49 -44.77 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.201 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 58' ' ' VAL . 12.8 p -52.68 -49.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HG13 ' A' ' 26' ' ' VAL . 70.5 mtt-85 -69.79 -54.57 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 8.7 mtm180 -61.31 -24.13 66.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.24 -71.48 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 61' ' ' GLU . 11.0 mt -73.54 -43.77 59.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -71.75 -1.85 15.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.517 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -147.5 -75.56 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 1.35 ' CD ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -47.46 -23.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.4 mt 56.04 37.71 29.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.35 HG22 ' CD ' ' A' ' 33' ' ' GLU . 1.6 t -66.16 140.59 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.997 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -60.69 139.92 93.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.8 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 66' ' ' GLY . 33.0 Cg_endo -64.25 -18.58 63.81 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.729 2.286 . . . . 0.0 112.113 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.997 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 16.7 p-10 -87.94 -81.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.863 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 40.39 95.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 3.6 mp -91.21 131.87 36.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.985 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p30 -65.78 169.75 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.76 -38.98 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.67 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.27 28.11 2.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 2.9 mttp -98.87 157.02 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.979 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.1 p -85.03 150.64 24.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -62.17 -35.29 78.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 8.6 tp -71.46 -43.91 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.022 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HG3' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -70.1 -5.31 26.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 46' ' ' THR . 15.9 m -125.78 -17.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.663 ' HE1' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -51.28 151.83 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.181 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -92.36 130.24 38.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.896 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.704 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 10.3 m-85 -85.5 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.506 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -89.04 -39.13 6.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.908 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' ' 91' ' ' THR . 1.8 t -114.88 135.4 22.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.247 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.73 -34.26 19.2 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.649 2.233 . . . . 0.0 112.062 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.16 -28.0 69.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.778 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.7 t -63.44 -50.78 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.23 -50.41 70.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.806 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 64' ' ' LYS . 9.7 tt -63.24 -38.01 89.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.719 ' HB3' HD12 ' A' ' 30' ' ' LEU . 1.3 mp0 -62.92 -56.23 19.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.249 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 58' ' ' VAL . 4.4 mp -62.73 -46.89 85.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -63.07 -40.24 97.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -62.94 -32.99 74.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 30' ' ' LEU . 2.9 mm-40 -69.03 -57.54 5.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 37' ' ' PRO . . . 163.89 36.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -97.14 106.09 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.968 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -63.34 119.67 55.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 29.2 Cg_endo -63.21 -15.62 49.32 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.727 2.284 . . . . 0.0 112.224 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 37.1 m-80 -95.22 93.56 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 49' ' ' GLN . 28.3 m -148.35 159.12 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' THR . 28.1 mp0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.468 HG23 ' CB ' ' A' ' 81' ' ' HIS . 34.9 m -128.61 137.51 51.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.805 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.82 179.23 1.16 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HB3' ' HE1' ' A' ' 51' ' ' MET . 42.2 Cg_exo -56.06 -32.68 87.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.824 2.349 . . . . 0.0 112.307 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 96' ' ' VAL . 9.6 t -68.25 -28.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 35.6 m80 -63.44 -67.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 86' ' ' THR . 2.5 p30 -53.01 -48.65 67.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -19.33 3.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 81' ' ' HIS . . . -72.52 -65.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.328 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -73.07 -37.72 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 82' ' ' ASP . 60.2 p -54.33 -17.75 3.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 67.02 66.76 2.24 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.006 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 22.7 m-85 -135.62 49.38 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 123' ' ' SER . 19.9 tp -55.11 -15.28 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.781 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -74.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.67 0.271 . . . . 0.0 110.729 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 59' ' ' ALA . 24.8 m -69.8 -33.44 72.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.376 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 92' ' ' LEU . 2.3 tt -53.28 -46.36 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -56.39 -37.19 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.216 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.783 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 74.2 t -52.84 -63.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.734 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.66 -36.47 67.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 111.152 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.785 ' CG2' HG22 ' A' ' 80' ' ' VAL . 3.8 t -68.99 -46.54 78.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.29 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.783 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 10.6 pm0 -59.04 -33.77 71.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.054 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -39.28 93.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.21 36.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.63 -177.74 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -75.32 74.52 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.547 HG12 HG11 ' A' ' 80' ' ' VAL . 13.0 m -91.78 19.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -130.71 5.37 4.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.23 155.49 22.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.587 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -129.11 144.37 51.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -84.77 -176.68 6.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.21 -53.29 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.8 p -61.31 -24.3 66.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 84.35 -10.32 61.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.73 117.99 3.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -56.35 130.64 75.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.98 ' HD2' HD23 ' A' ' 111' ' ' LEU . 82.9 Cg_exo -44.11 -31.67 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -73.52 -42.72 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.574 ' CE1' ' OD2' ' A' ' 138' ' ' ASP . 9.5 m80 -52.91 -27.36 18.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -69.85 -53.03 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.884 ' C ' HG12 ' A' ' 125' ' ' VAL . . . -52.64 -43.17 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 110.352 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 147' ' ' LEU . 50.5 mt -57.57 -42.32 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.782 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -71.11 -15.66 62.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -90.64 -55.39 3.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.639 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.67 12.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.526 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 97.1 m-70 -56.01 -18.15 8.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.79 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 126' ' ' SER . 3.8 m 71.75 -63.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.689 ' CB ' HD22 ' A' ' 89' ' ' LEU . 12.1 m -69.55 -38.97 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.069 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.812 HG12 HD12 ' A' ' 128' ' ' LEU . 39.7 t -73.39 -54.91 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.884 HG12 ' C ' ' A' ' 116' ' ' ALA . 3.5 m -52.8 -47.03 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 159' ' ' ILE . 5.6 t -71.53 -34.15 69.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 1.194 ' CD2' ' OE1' ' A' ' 131' ' ' GLU . 45.1 t80 -73.36 -39.6 65.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -67.36 -25.66 66.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.764 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.93 -62.12 5.72 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 44.2 Cg_endo -68.15 -48.83 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.79 2.327 . . . . 0.0 112.62 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.194 ' OE1' ' CD2' ' A' ' 127' ' ' PHE . 0.5 OUTLIER -58.07 -29.51 65.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.732 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.512 ' OG ' HD23 ' A' ' 128' ' ' LEU . 1.2 m -107.77 154.46 21.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.935 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 3.5 p-10 -41.76 113.85 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.867 HD13 ' HA ' ' A' ' 164' ' ' MET . 8.1 mt -85.08 43.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.976 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.05 33.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.463 ' HB3' HD11 ' A' ' 111' ' ' LEU . 20.4 t-80 -107.18 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -126.31 -156.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER 177.15 155.59 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.574 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -37.7 -30.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.508 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -60.42 -44.87 95.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.869 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 84.28 25.52 43.5 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.469 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -133.51 80.44 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.371 . . . . 0.0 111.015 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 1.6 p -42.48 169.12 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 91.0 Cg_exo -43.66 -44.76 11.15 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.289 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.84 -42.92 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.498 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.511 ' HB3' ' CA ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -52.52 -64.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.427 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.571 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.72 -34.96 54.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -60.82 -31.31 70.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -45.02 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.491 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -69.85 -89.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.171 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.533 ' N ' ' CG ' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -75.62 51.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.085 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -61.74 -9.18 18.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.136 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 47.38 -86.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -125.47 -136.79 0.27 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 1.229 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 12.5 p30 -74.37 14.37 0.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.153 -0.342 . . . . 0.0 111.267 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.725 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.82 -45.68 64.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.67 0.272 . . . . 0.0 111.331 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.912 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 3.3 ptm -57.09 -30.15 64.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.37 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD2' ' HB2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -73.55 -47.12 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.931 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.1 OUTLIER -52.0 -49.3 38.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 156' ' ' LEU . 5.3 mp -73.46 -26.74 61.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -64.46 -63.8 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.08 -31.59 79.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.646 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 1.2 m-70 -66.24 -39.57 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.954 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.867 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 ptm . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.461 HG22 HG13 ' A' ' 35' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -54.57 -44.44 78.61 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.12 5.33 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -78.87 -62.5 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 14' ' ' LEU . 2.8 tm? -71.17 -33.22 69.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 25.4 t -67.79 -50.12 58.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -57.1 -26.97 56.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.205 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.23 -67.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.021 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.579 ' HB1' ' CG ' ' A' ' 51' ' ' MET . . . -53.04 -54.58 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -53.43 -29.16 33.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 18.0 mtt180 -73.92 -37.62 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 93.64 66.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.577 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.688 ' OD1' ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -138.66 97.13 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.831 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.3 p -57.29 -18.43 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.0 -46.47 43.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.3 -34.41 65.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.8 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.881 HG21 ' HA ' ' A' ' 58' ' ' VAL . 1.1 p -52.57 -48.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.744 0.307 . . . . 0.0 111.212 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.99 -56.33 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.64 -48.14 66.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.445 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 52.7 mt -52.72 -55.84 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.214 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HA ' ' A' ' 62' ' ' LEU . 84.5 mt -73.95 -55.8 5.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.17 4.0 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -146.19 -70.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 1.259 ' OE1' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.79 -16.47 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.5 mt 45.37 45.01 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.671 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.259 HG22 ' OE1' ' A' ' 33' ' ' GLU . 2.8 t -72.29 153.74 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 1.016 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 1.3 t-80 -63.59 138.12 97.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.6 Cg_endo -71.23 -37.7 5.61 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 1.016 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -92.26 31.35 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.076 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -65.71 118.44 9.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.002 HD23 ' C ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -120.3 125.02 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -60.95 -178.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -41.59 -46.1 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -48.15 -62.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.02 24.09 1.9 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.61 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 1.002 ' C ' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -109.39 163.17 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.755 0.312 . . . . 0.0 110.714 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.629 ' N ' HD23 ' A' ' 40' ' ' LEU . 17.0 p -84.87 152.14 23.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -52.92 -26.09 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.677 HD23 ' HE2' ' A' ' 51' ' ' MET . 7.0 mt -73.26 -41.82 63.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HG3' ' OG1' ' A' ' 46' ' ' THR . 2.6 mt-30 -73.17 -7.48 51.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.228 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 24.2 m -136.05 24.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.677 ' HE2' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -70.59 -177.95 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 0.0 110.708 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 1.1 ttp -114.31 -11.09 12.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.934 ' CE2' HD21 ' A' ' 95' ' ' LEU . 12.1 m-85 50.35 21.0 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.88 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.48 -55.2 7.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.69 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 2.4 t -100.41 137.91 20.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 0.0 110.198 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 40.8 Cg_endo -67.87 -50.29 0.88 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.34 -18.72 63.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.166 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.881 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 t -63.06 -55.62 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.25 -37.87 88.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' HG11 ' A' ' 94' ' ' VAL . 25.0 tp -63.19 -51.33 66.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 13.7 mm-40 -62.75 -53.66 50.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.966 ' HA ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.63 -51.84 65.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.179 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -63.94 -50.5 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.958 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.852 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.2 tttt -65.24 56.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.052 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 63' ' ' LEU . 6.7 tp60 -154.42 -39.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.046 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 37' ' ' PRO . . . 154.47 38.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.769 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.13 -0.07 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.121 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.785 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.8 m 43.88 83.02 0.22 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.979 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.48 -30.35 15.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.766 2.311 . . . . 0.0 112.238 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 91.8 m-20 -79.51 75.15 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 68' ' ' SER . 20.3 m -116.58 150.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.76 43.67 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -53.14 160.77 1.49 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.997 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 2.8 Cg_endo -46.93 -32.51 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.0 2.467 . . . . 0.0 111.888 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.83 -45.33 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.902 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.498 ' NE2' ' O ' ' A' ' 105' ' ' LEU . 39.8 m80 -73.12 -38.72 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.008 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -69.71 -67.42 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.319 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.895 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -52.64 -19.18 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 80' ' ' VAL . . . -72.8 -63.02 1.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.42 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.061 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 15.6 ptt85 -70.17 -18.26 63.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.392 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 1.008 HG23 ' O ' ' A' ' 82' ' ' ASP . 82.6 p -68.07 -51.94 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.207 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.01 67.52 0.41 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -152.95 57.32 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.538 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.7 tp -58.65 -13.66 6.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.407 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -67.61 -73.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 53' ' ' PHE . 19.4 m -68.95 -35.86 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 83' ' ' ALA . 29.9 tp -52.69 -49.44 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.449 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HG3' ' CE1' ' A' ' 127' ' ' PHE . 2.6 ttmt -52.66 -44.67 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.842 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 60' ' ' LEU . 1.4 t -53.26 -59.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.132 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.934 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -72.58 -39.64 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 80' ' ' VAL . 20.4 t -67.0 -43.85 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.4 pt-20 -68.33 -43.1 78.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -55.17 -23.87 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.14 50.57 0.3 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.577 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . -85.76 56.32 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 111.141 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 5.5 t0 37.32 52.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.83 -0.95 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.239 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 36.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.47 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -117.09 -178.61 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 111' ' ' LEU . 26.0 mt -125.17 -152.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 110' ' ' SER . 2.0 p30 -145.29 -163.25 1.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.761 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 m -54.12 -28.96 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.34 28.61 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 42.91 40.11 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.542 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 40.7 m -113.51 133.84 55.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.97 162.83 61.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HG3' ' CG1' ' A' ' 80' ' ' VAL . 52.6 Cg_exo -55.35 -25.67 48.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.825 2.35 . . . . 0.0 112.073 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 128' ' ' LEU . 2.5 tp -70.82 -33.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.62 ' HB3' HD22 ' A' ' 147' ' ' LEU . 15.6 m170 -70.47 -30.22 66.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.633 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.88 -54.1 15.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.351 ' CA ' ' OE2' ' A' ' 119' ' ' GLU . . . -52.6 -37.53 58.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HA ' HG11 ' A' ' 125' ' ' VAL . 76.4 mt -56.62 -36.92 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -66.04 -33.52 75.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.002 0.43 . . . . 0.0 110.53 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 1.351 ' OE2' ' CA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -82.4 -53.64 5.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.804 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.95 27.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.655 ' ND1' ' OE1' ' A' ' 119' ' ' GLU . 46.5 m80 -47.69 -23.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 80.23 -62.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.9 m -70.17 -33.11 71.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 121' ' ' HIS . 24.1 t -73.73 -57.01 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.002 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 117' ' ' ILE . 2.2 m -52.57 -60.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.664 ' H ' HG23 ' A' ' 125' ' ' VAL . 10.2 t -54.99 -29.02 56.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 110.854 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.602 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 26.0 t80 -73.22 -53.92 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -63.38 -11.83 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -59.69 -69.54 0.53 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.204 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.5 Cg_endo -70.2 -31.86 17.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 5.4 mm-40 -61.9 -13.86 28.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 111' ' ' LEU . 10.0 m -121.75 143.57 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.801 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 3.4 p30 -39.24 98.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.002 HD13 ' HA ' ' A' ' 164' ' ' MET . 20.2 mt -67.17 66.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.017 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.2 t60 -177.77 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.488 ' CD2' HD13 ' A' ' 111' ' ' LEU . 1.5 p-80 -53.58 179.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HG3' ' C ' ' A' ' 136' ' ' HIS . 0.6 OUTLIER -137.25 -165.51 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -128.9 178.08 6.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.055 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.533 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . . . -71.0 -8.66 54.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.6 p -105.96 -9.66 16.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.733 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 72.73 59.07 4.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 141' ' ' GLY . 62.0 mt -154.61 86.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -71.28 -174.18 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.891 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 87.1 Cg_exo -47.43 -61.5 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.659 2.24 . . . . 0.0 112.473 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 145' ' ' LEU . 6.6 tp -63.81 -32.59 74.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.522 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -67.29 -70.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 114' ' ' HIS . 11.4 tp -52.75 -45.62 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.424 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . . . -55.45 -38.23 68.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -65.75 -41.78 91.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.109 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -64.06 -78.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.883 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 4.7 mtp180 -74.05 58.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.09 54.09 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.695 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -34.61 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 0.0 110.851 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER 173.83 -114.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.376 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.538 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.5 m-20 -74.31 5.55 4.44 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.198 -0.314 . . . . 0.0 111.594 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -51.15 -59.33 4.3 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.708 0.289 . . . . 0.0 111.298 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.497 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.3 ppp? -52.26 -32.08 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -55.57 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.9 -35.2 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.678 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.614 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.91 -33.6 64.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.43 -51.13 18.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.257 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.56 97.3 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 126' ' ' SER . 3.0 m-70 -61.14 -30.13 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.692 0.282 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . 1.002 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.7 mtt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.864 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.436 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 16.9 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -65.82 -40.05 95.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.698 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -101.43 40.65 1.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.562 ' NH1' ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -112.44 -71.48 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.807 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.916 HD22 HD21 ' A' ' 30' ' ' LEU . 26.4 tp -70.92 -26.81 63.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.2 t -61.35 -40.8 95.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.63 -35.08 59.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.533 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -66.91 -62.77 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.55 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -72.43 -22.42 61.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mtt180 -73.09 -36.19 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.892 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 97.41 63.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p30 -142.29 91.66 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 57' ' ' ALA . 13.2 p -52.75 -21.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.528 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 62.7 mt-30 -72.44 -47.35 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.5 mp0 -68.67 -41.02 79.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.297 HG12 ' CD ' ' A' ' 61' ' ' GLU . 55.5 t -53.87 -53.38 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 69.7 mtt180 -61.5 -60.13 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.9 mmt-85 -54.92 -29.27 55.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.584 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.546 HD13 HD12 ' A' ' 14' ' ' LEU . 17.7 mt -73.42 -72.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.96 HD12 ' HB3' ' A' ' 61' ' ' GLU . 41.1 mt -73.48 -43.11 60.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.513 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -72.6 -11.93 60.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.285 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.41 -78.16 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' OE2' ' NH1' ' A' ' 13' ' ' ARG . 1.4 tm-20 -39.94 -28.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.034 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LEU . 3.7 mt 62.71 46.21 5.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 33' ' ' GLU . 25.0 t -77.87 155.23 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.423 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -77.51 134.77 65.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.907 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 69.3 Cg_endo -74.58 -6.91 18.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.81 2.34 . . . . 0.0 112.248 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -103.03 13.58 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -57.08 127.67 33.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.9 OUTLIER -120.65 130.07 53.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -52.2 -55.94 17.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.69 -52.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -35.47 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.85 30.16 1.17 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -98.2 151.81 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 p -94.51 154.96 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.39 -26.46 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.035 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 69' ' ' PRO . 3.0 mt -71.99 -42.7 66.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.3 tm0? -60.07 -53.6 55.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG21 ' OG ' ' A' ' 15' ' ' SER . 7.2 m -64.5 -23.32 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.765 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 ttp -39.18 154.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.541 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -116.24 21.44 13.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.832 ' CD2' HD21 ' A' ' 95' ' ' LEU . 0.7 OUTLIER 36.21 34.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.0 -81.84 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.383 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 58' ' ' VAL . 56.5 m -86.28 119.74 71.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 1.333 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 81.8 Cg_exo -43.99 -39.61 11.28 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.122 ' O ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.29 -22.32 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.451 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG21 ' A' ' 26' ' ' VAL . 37.3 t -63.05 -54.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.1 -32.93 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.03 -42.69 99.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.037 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.297 ' CD ' HG12 ' A' ' 26' ' ' VAL . 1.2 mt-10 -63.1 -51.49 66.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.207 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.5 -46.2 89.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.346 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -62.91 -56.17 19.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.731 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -63.21 -11.71 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.702 ' HG3' HD22 ' A' ' 30' ' ' LEU . 1.1 mm-40 -81.56 -35.11 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.16 22.85 2.07 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.592 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -81.29 154.46 26.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.051 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -108.16 98.94 29.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HB3' HD13 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -68.41 -10.31 28.61 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.652 2.235 . . . . 0.0 112.239 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.59 56.93 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 68' ' ' SER . 12.7 m -125.92 158.82 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.872 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.837 HG23 ' OD2' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -128.76 112.37 14.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.846 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -82.08 -177.84 1.05 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.783 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 52.3 Cg_exo -54.07 -46.32 34.42 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.318 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 96' ' ' VAL . 2.4 m -52.98 -39.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.67 ' CD2' HG22 ' A' ' 77' ' ' THR . 73.0 m80 -53.4 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.783 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 5.0 p30 -53.11 -44.52 67.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.786 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.83 -48.29 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.39 92.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.505 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -73.24 -33.13 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 82' ' ' ASP . 41.7 p -73.45 -78.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.76 68.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.478 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 35.8 m-85 -139.27 51.49 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.591 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 92' ' ' LEU . 16.0 tp -52.5 -18.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.286 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.333 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -73.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.568 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.124 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -73.39 -30.29 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 92' ' ' LEU . 2.5 tt -59.08 -34.83 72.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.049 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HE2' ' CD1' ' A' ' 127' ' ' PHE . 4.0 mttt -67.73 -53.18 29.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 2.7 m -52.71 -48.17 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 53' ' ' PHE . 1.2 pp -73.37 -51.37 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.518 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.838 HG13 HG11 ' A' ' 102' ' ' VAL . 55.1 t -67.37 -51.12 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.844 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.905 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 5.0 pm0 -52.58 -30.47 31.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.814 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.479 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER -73.08 -36.34 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.23 65.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -91.64 18.97 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 61.7 72.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.838 HG11 HG13 ' A' ' 96' ' ' VAL . 4.1 m -89.17 13.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.048 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.69 38.87 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.542 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -136.08 131.82 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.272 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.903 HD13 ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -100.4 -176.88 3.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.882 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.872 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 0.9 OUTLIER -99.42 40.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER 76.73 12.51 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.7 t -115.9 8.83 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.897 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 61.75 14.84 45.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.1 m -98.67 91.91 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 136' ' ' HIS . 35.0 mt -51.52 146.17 13.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 85.1 Cg_exo -47.41 -39.73 28.44 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.726 2.284 . . . . 0.0 112.55 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -61.41 -32.35 53.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.893 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.58 ' O ' HD13 ' A' ' 147' ' ' LEU . 15.9 m170 -66.7 -29.83 69.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.13 -47.38 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.484 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.73 -45.12 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.33 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.857 HG21 ' HB3' ' A' ' 147' ' ' LEU . 89.4 mt -53.18 -39.46 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.548 ' HD2' ' CD ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -61.96 -20.81 64.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.015 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -112.37 -42.0 3.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.528 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.424 ' HA3' HE22 ' A' ' 154' ' ' GLN . . . 79.47 11.59 84.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.99 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 10.9 m-70 -38.49 102.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' HIS . 3.0 m 35.63 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.999 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.39 10.36 1.33 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 59.4 t -56.09 -53.93 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.008 0.432 . . . . 0.0 110.229 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -52.64 -41.37 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.608 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.569 ' CB ' HG21 ' A' ' 159' ' ' ILE . 15.7 p -66.69 -34.76 78.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.584 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 14.3 t80 -72.86 -48.56 36.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.418 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.501 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.946 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -55.09 -66.48 0.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.946 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 66.6 Cg_endo -75.21 -52.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.656 2.237 . . . . 0.0 112.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -23.74 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.541 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 128' ' ' LEU . 9.3 t -93.83 -153.54 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.688 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.41 56.33 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.874 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.94 88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.629 ' O ' HG22 ' A' ' 143' ' ' THR . 5.4 t-80 155.42 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 111' ' ' LEU . 13.6 t60 -65.27 164.04 14.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.962 ' CG ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -134.6 127.45 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.555 ' OD1' ' CG ' ' A' ' 114' ' ' HIS . 1.1 m-20 -50.2 155.27 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.19 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 110.318 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -67.53 -48.73 66.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 116.58 57.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.554 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 146' ' ' GLU . 1.1 mt -144.65 104.21 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.144 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -66.11 171.5 3.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 82.5 Cg_exo -43.6 -43.0 11.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.534 2.156 . . . . 0.0 112.021 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.26 -34.62 65.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.144 ' OE1' ' N ' ' A' ' 143' ' ' THR . 5.4 mt-10 -61.84 -61.77 2.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -52.7 -36.52 57.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.54 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.283 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -73.17 -45.41 56.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -73.11 -92.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.244 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.548 ' CD ' ' HD2' ' A' ' 118' ' ' ARG . 16.2 mtt-85 -76.56 45.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -53.29 -17.89 6.24 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.761 ' HB3' HD23 ' A' ' 156' ' ' LEU . . . 64.18 -64.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.646 ' NE2' ' HB1' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -154.4 -138.37 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.019 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 10.4 m120 -74.16 9.85 1.46 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.226 -0.296 . . . . 0.0 111.391 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.804 HD12 ' C ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -51.82 -34.87 42.21 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.846 0.355 . . . . 0.0 111.281 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.666 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.5 ppp? -52.44 -28.39 19.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.059 0.457 . . . . 0.0 110.081 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.06 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 3.4 p30 -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.06 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -51.65 -44.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.291 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.56 -16.08 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 111.035 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -55.08 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.33 -43.4 96.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' LEU . 2.1 m-70 -70.31 -11.79 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 35' ' ' VAL . 36.5 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.865 0.364 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.515 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -48.58 -21.72 2.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.569 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 29.4 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 1.7 ttm105 -109.82 -74.94 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.019 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.92 -35.18 72.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -58.24 -40.55 82.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.598 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -73.13 -40.42 50.53 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -67.79 -47.05 70.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.457 ' CB ' HD21 ' A' ' 62' ' ' LEU . . . -52.82 -41.71 64.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -18.6 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 1.7 mtt180 -73.17 -28.06 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.72 65.03 1.96 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.615 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.131 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -133.12 92.46 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.635 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 57' ' ' ALA . 10.7 p -52.58 -20.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -73.81 -56.33 5.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.938 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.131 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.48 -30.26 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.629 -179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 58' ' ' VAL . 2.4 p -52.85 -45.36 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.744 0.306 . . . . 0.0 111.407 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -73.56 -46.35 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 4.7 mmm180 -53.51 -32.71 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD12 ' OE1' ' A' ' 25' ' ' GLU . 10.4 mt -73.42 -72.39 0.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.833 HD22 ' HG2' ' A' ' 65' ' ' GLN . 5.5 mt -73.4 -45.71 53.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.686 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -70.06 -13.39 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.691 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -134.05 -75.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.199 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.806 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 2.5 tt0 -43.99 -25.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.2 mp 72.46 13.08 5.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.4 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' A' ' 14' ' ' LEU . 3.3 p -44.75 158.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.407 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -94.81 141.27 23.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.83 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 55.9 Cg_endo -70.52 -23.27 27.53 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.744 2.296 . . . . 0.0 112.201 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.71 37.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.695 ' HA ' ' CE1' ' A' ' 36' ' ' HIS . . . -79.01 127.55 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 38' ' ' ASP . 6.3 mp -122.55 133.66 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 111.454 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -62.57 -168.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' CD ' ' C ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -70.32 -4.98 24.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -98.95 -69.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 146.74 67.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 19.1 mtpt -142.41 146.65 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.6 p -84.54 152.61 23.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.75 -54.89 27.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 69' ' ' PRO . 7.3 tp -53.05 -30.53 36.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.639 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.3 tt0 -73.2 -34.61 66.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -91.42 -25.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' HD12 ' A' ' 48' ' ' LEU . 1.4 mtp -36.35 137.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 3.6 ptt? -96.42 10.11 39.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.032 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.4 m-85 47.38 23.54 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.43 -56.02 24.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.312 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -98.04 146.15 31.01 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.788 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 1.239 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.3 Cg_endo -79.67 -42.15 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.834 2.356 . . . . 0.0 112.555 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -31.14 72.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 55' ' ' SER . 11.4 m -62.64 -30.79 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -62.94 -43.16 99.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.986 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.66 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -63.31 -34.53 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.217 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -63.04 -67.89 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 62' ' ' LEU . 6.3 mp -62.32 -35.41 78.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.088 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 7.6 tp -62.95 -63.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -62.93 -17.3 61.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.833 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.22 -52.86 63.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.63 -13.49 2.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -60.05 98.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.322 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.16 121.57 2.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.676 ' HA ' HD23 ' A' ' 48' ' ' LEU . 59.5 Cg_endo -71.95 -21.45 24.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.733 2.289 . . . . 0.0 112.326 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.202 ' CA ' ' OD2' ' A' ' 101' ' ' ASP . 1.4 m120 -81.47 86.11 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.74 133.61 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.31 129.51 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -111.36 171.52 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 50.8 Cg_exo -53.86 -32.14 65.7 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.767 2.311 . . . . 0.0 112.336 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -64.31 -36.53 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.447 ' ND1' HG23 ' A' ' 80' ' ' VAL . 3.3 m80 -64.47 -47.93 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.914 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.9 p30 -60.3 -51.66 68.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -51.97 -29.61 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' HG11 ' A' ' 124' ' ' VAL . . . -73.33 -65.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.477 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' NE ' ' HB3' ' A' ' 115' ' ' LEU . 7.2 mtp180 -64.68 -29.41 70.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 82' ' ' ASP . 61.6 p -73.29 0.3 12.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.549 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.468 ' HA2' HG21 ' A' ' 124' ' ' VAL . . . 52.76 80.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.098 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.51 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -154.12 60.48 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.856 0.36 . . . . 0.0 110.433 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.908 ' O ' HD13 ' A' ' 89' ' ' LEU . 3.2 tm? -52.15 -19.05 1.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.267 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.239 ' OD1' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -56.2 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.382 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.848 HG22 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.4 -8.92 57.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.127 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.701 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mp -73.0 -64.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -57.06 -24.03 50.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 95' ' ' LEU . 38.0 t -76.77 -82.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.09 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.032 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -76.11 -44.83 36.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.079 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 80' ' ' VAL . 94.3 t -67.77 -3.3 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.227 ' HA ' ' OE2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -73.1 -43.23 62.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -64.57 -37.77 88.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.841 ' O ' HG13 ' A' ' 102' ' ' VAL . . . 146.96 -49.97 0.61 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . 36.21 31.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 1.202 ' OD2' ' CA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 71.52 56.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 99' ' ' GLY . 5.0 m -79.95 1.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -116.0 40.67 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.956 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.825 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -125.51 166.93 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -154.64 160.61 41.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 3.5 p30 -84.83 79.06 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 108' ' ' THR . 1.1 p 84.13 -54.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER -174.38 32.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.765 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . -76.83 -3.35 79.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.775 ' C ' HD22 ' A' ' 105' ' ' LEU . 0.6 OUTLIER 85.4 159.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -45.18 158.86 0.29 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.544 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 50.9 Cg_exo -53.86 -38.47 85.78 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.645 2.23 . . . . 0.0 112.223 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -58.33 -41.43 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.542 ' CG ' ' OG ' ' A' ' 110' ' ' SER . 57.3 m80 -52.96 -31.73 42.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.681 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.498 ' HB3' ' NE ' ' A' ' 85' ' ' ARG . 12.6 mt -73.17 -53.77 10.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.361 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -54.25 -33.09 57.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.342 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.992 HG21 ' HB3' ' A' ' 147' ' ' LEU . 81.8 mt -61.41 -40.51 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -64.38 -21.35 66.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 1.361 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 1.9 mp0 -94.7 -51.65 4.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.84 22.79 35.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.514 ' O ' ' CB ' ' A' ' 122' ' ' SER . 61.2 m80 -46.41 -24.85 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER 84.97 -60.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.836 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -73.1 -42.16 63.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.046 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 116' ' ' ALA . 49.0 t -67.08 -60.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.684 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.7 t -52.69 -57.14 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.633 ' CB ' HG21 ' A' ' 159' ' ' ILE . 88.8 p -52.73 -37.15 58.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 92' ' ' LEU . 51.6 t80 -71.91 -55.1 8.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -62.41 -19.33 63.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.898 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -52.98 -69.51 0.33 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.925 ' HA ' HD11 ' A' ' 134' ' ' LEU . 55.0 Cg_endo -69.6 -25.32 29.44 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.227 ' OE2' ' HA ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -89.55 36.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -169.7 134.88 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.818 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.286 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 2.9 p-10 -35.74 97.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.925 HD11 ' HA ' ' A' ' 130' ' ' PRO . 2.8 mp -72.91 56.36 0.42 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.03 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 -39.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.138 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 1.286 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -56.83 142.67 40.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.019 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 167.88 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -75.14 166.89 22.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 108' ' ' THR . . . -51.48 -21.92 2.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.324 0.583 . . . . 0.0 110.141 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -59.0 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.91 40.8 0.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.253 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 2.4 mt -122.91 125.22 44.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -98.11 -174.53 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 72.8 Cg_exo -49.31 -56.84 2.77 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.694 2.263 . . . . 0.0 112.401 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.697 HD13 ' HG3' ' A' ' 161' ' ' GLN . 13.8 tp -69.31 -40.38 77.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.046 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.08 -65.7 0.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.93 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.992 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -53.12 -39.45 63.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.13 -27.3 61.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.7 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -68.55 -47.64 66.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.97 -74.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.968 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -74.55 56.56 0.69 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.02 55.4 0.8 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.139 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.851 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -31.44 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.99 0.424 . . . . 0.0 110.979 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.851 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 174.43 -114.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.42 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 1.265 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 8.0 m-80 -75.35 6.92 3.95 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.291 -0.255 . . . . 0.0 111.438 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 156' ' ' LEU . 1.3 mt -51.11 -64.39 0.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.445 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.588 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 4.3 ptm -52.89 -29.26 27.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.265 ' OD2' ' HA ' ' A' ' 155' ' ' ASN . 0.4 OUTLIER -74.59 -51.52 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.01 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.68 -42.35 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.22 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.858 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -74.63 -44.83 48.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.187 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.697 ' HG3' HD13 ' A' ' 145' ' ' LEU . 4.0 mt-30 -53.61 -50.56 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.286 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.22 98.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' HB3' ' A' ' 130' ' ' PRO . 2.0 m-70 -73.23 -7.1 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.679 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.861 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -47.24 -34.74 8.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.35 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.776 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.66 28.28 7.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.754 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -94.56 -56.56 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HD13 ' A' ' 29' ' ' LEU . 37.9 tp -72.72 -40.78 65.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -57.67 -34.6 69.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.14 -53.74 7.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.574 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.69 -39.77 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.151 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -67.44 -50.32 59.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' SER . . . -68.77 -12.03 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 20.7 mtt180 -67.89 -43.51 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.64 59.41 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.066 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 10.7 p-10 -138.55 95.1 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.9 p -53.9 -18.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.024 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 9.2 mt-30 -72.98 -54.57 8.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.01 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.066 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.04 -36.42 66.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.342 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.109 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.7 p -52.82 -42.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.397 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 1.086 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 23.6 mtp180 -70.91 -50.54 33.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.065 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 2.4 mtm180 -67.4 -12.0 59.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.962 HD13 HD12 ' A' ' 14' ' ' LEU . 8.7 mt -73.55 -70.4 0.37 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.35 -45.27 56.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.66 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 3.1 m-70 -72.42 -12.38 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.61 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 1.8 mtt-85 -134.18 -78.98 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.997 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -37.84 -30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.74 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.9 mt 61.56 45.02 8.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 33' ' ' GLU . 60.4 t -92.89 110.7 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.653 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -46.93 125.09 8.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CG ' ' HB3' ' A' ' 65' ' ' GLN . 52.3 Cg_exo -54.66 -34.77 84.88 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.749 2.299 . . . . 0.0 112.377 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 40' ' ' LEU . 16.3 p-10 -57.38 -21.69 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -33.39 108.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.345 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 38' ' ' ASP . 4.2 mp -102.35 133.44 47.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.988 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.524 ' OD1' ' CB ' ' A' ' 43' ' ' PHE . 8.5 p30 -72.67 159.15 34.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' ASN . 3.8 ptm180 -35.12 -43.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 t80 -56.8 -49.13 76.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 119.22 35.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.21 157.09 25.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.785 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -87.32 147.5 25.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -58.03 -28.83 64.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 69' ' ' PRO . 12.8 tp -70.79 -47.95 56.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.74 ' HB2' HG21 ' A' ' 71' ' ' VAL . 44.5 tt0 -60.65 -24.95 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' THR . 6.1 m -106.03 -14.2 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.738 ' HG3' HD23 ' A' ' 62' ' ' LEU . 2.2 ttp -42.34 145.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -85.53 134.88 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.777 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.1 ' CE2' HD21 ' A' ' 95' ' ' LEU . 14.1 m-85 -87.75 -7.27 57.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CE1' ' A' ' 88' ' ' PHE . . . -50.02 -41.04 36.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.028 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.978 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.0 m -108.78 127.56 27.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 91' ' ' THR . 58.8 Cg_endo -71.87 -34.0 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.682 2.255 . . . . 0.0 112.211 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -35.09 79.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 55' ' ' SER . 4.0 m -62.57 -32.1 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.609 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.902 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.874 HD21 ' HD2' ' A' ' 64' ' ' LYS . 7.3 tt -63.4 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.109 ' OE1' HG13 ' A' ' 26' ' ' VAL . 6.7 mt-10 -62.41 -70.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.75 -36.53 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 69' ' ' PRO . 18.4 tp -63.03 -37.87 88.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.874 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 mtpp -63.32 -48.87 76.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HB3' ' CG ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -36.68 -35.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.38 42.61 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.33 28.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.1 m -47.85 112.09 2.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.863 ' HA ' HD21 ' A' ' 48' ' ' LEU . 30.0 Cg_endo -63.52 -21.19 70.7 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.728 2.285 . . . . 0.0 112.175 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -100.37 82.56 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 49' ' ' GLN . 8.0 m -116.1 142.32 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 4.2 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 106' ' ' ASP . 4.7 m -110.3 71.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.15 169.04 14.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.907 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.522 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 17.9 Cg_endo -60.4 -32.26 93.67 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.738 2.292 . . . . 0.0 111.799 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 32.1 m -57.49 -42.53 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.243 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.552 ' O ' HD12 ' A' ' 115' ' ' LEU . 8.5 m80 -53.65 -67.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.857 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -54.14 -27.44 33.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.909 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -68.94 -16.25 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -73.18 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.37 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.553 ' CG ' ' HB3' ' A' ' 115' ' ' LEU . 61.0 mtm180 -63.73 -29.7 70.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.0 p -67.87 -6.53 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.228 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.94 74.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.174 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 8.3 m-85 -145.2 53.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.565 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.648 HD11 ' CG ' ' A' ' 127' ' ' PHE . 13.9 tp -52.78 -21.12 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.158 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.585 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -60.12 -73.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.835 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 24.1 m -73.21 -28.16 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.8 tt -60.72 -61.31 2.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 1.289 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -52.7 -30.28 31.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.274 ' CA ' ' OE2' ' A' ' 97' ' ' GLU . 16.2 t -61.0 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.301 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.1 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -71.01 -26.76 63.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.018 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.796 HG13 HG11 ' A' ' 102' ' ' VAL . 6.9 t -73.22 -56.05 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.8 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.289 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -52.81 -35.45 57.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.232 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.87 -32.01 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.968 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.44 62.38 0.31 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . -96.61 43.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 111.139 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 54.2 60.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 96' ' ' VAL . 5.4 m -70.07 -10.77 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -105.48 42.76 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -105.31 168.41 9.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.966 HD21 ' HG ' ' A' ' 111' ' ' LEU . 60.4 mt -145.72 135.18 23.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.609 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.828 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.51 47.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER 80.03 -54.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 p -48.76 -37.7 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.665 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 102.72 0.57 49.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 89.1 p -79.09 100.16 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.966 ' HG ' HD21 ' A' ' 105' ' ' LEU . 7.0 mt -56.38 149.78 36.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.504 ' C ' HD12 ' A' ' 128' ' ' LEU . 79.7 Cg_exo -48.21 -28.98 11.89 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.617 2.211 . . . . 0.0 112.151 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.821 HG21 ' CE1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.45 -29.58 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.201 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 138' ' ' ASP . 50.3 m80 -62.76 -30.8 71.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.124 ' O ' ' OE2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -66.02 -56.51 11.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.976 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.17 -37.78 62.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.168 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 113' ' ' ILE . 71.5 mt -58.71 -43.13 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.465 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -64.73 -15.28 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.472 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 1.124 ' OE2' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -93.7 -56.12 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 94.79 24.27 18.23 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.106 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.562 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 82.3 m-70 -55.14 -157.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.624 0.25 . . . . 0.0 110.693 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -102.24 -95.96 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.455 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 29.8 t -73.05 -19.22 61.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.325 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.562 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -56.71 -69.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.048 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 156' ' ' LEU . 18.0 t -52.12 -46.32 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.883 ' CB ' HG21 ' A' ' 159' ' ' ILE . 4.9 p -66.67 -32.69 74.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.783 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 86.6 t80 -73.03 -43.47 62.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.4 OUTLIER -65.42 -11.22 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.073 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.673 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -67.69 -62.51 3.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.673 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 27.0 Cg_endo -61.75 -52.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.845 2.363 . . . . 0.0 112.352 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.783 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 3.9 mt-10 -51.88 -25.74 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.7 m -108.46 137.29 46.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.268 ' OD1' ' HB3' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -35.64 103.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.81 HD13 ' HA ' ' A' ' 164' ' ' MET . 11.1 mt -61.4 134.14 56.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.937 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 1.9 t-160 86.17 14.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 1.268 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 4.6 p-80 -64.33 168.95 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.87 166.04 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -140.65 148.64 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.664 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -41.38 -28.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.17 0.51 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -34.35 73.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.782 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 93.22 45.07 3.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -153.71 158.05 40.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 111.037 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -108.59 167.97 8.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.565 ' C ' HD12 ' A' ' 160' ' ' LEU . 99.3 Cg_exo -40.59 -50.19 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.827 2.352 . . . . 0.0 112.524 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.866 HD11 ' CG ' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -62.25 -43.77 98.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -56.01 -64.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.72 -39.25 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.703 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.539 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -69.3 -27.7 65.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.621 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -70.73 -54.35 12.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.617 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -59.69 -67.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.01 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 153' ' ' ALA . 6.1 ttt180 -73.81 59.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.57 52.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.925 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.876 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -37.79 -31.22 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.159 0.504 . . . . 0.0 110.15 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.876 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 170.35 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.823 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.545 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.3 p30 -76.54 13.16 1.03 Allowed 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.111 -0.368 . . . . 0.0 111.646 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mt -51.56 -66.65 0.35 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.5 ptm -52.88 -20.81 3.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.69 -63.97 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.489 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.883 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -52.81 -27.71 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 0.0 110.81 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.32 -40.89 64.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.866 ' CG ' HD11 ' A' ' 145' ' ' LEU . 3.1 mt-30 -72.95 -40.53 65.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.005 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.68 37.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 -46.64 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.011 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.81 ' HA ' HD13 ' A' ' 134' ' ' LEU . 3.7 ttp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.579 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 22.5 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' ALA . . . -38.99 -32.65 0.19 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.574 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 18.8 t0 -117.74 28.08 8.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 111.032 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -96.63 -62.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.802 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -71.86 -42.39 66.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.7 m -57.16 -36.23 70.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -67.12 -52.1 34.48 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.362 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.79 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -60.17 -51.21 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 111.026 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.59 69.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.59 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 2.3 mmm180 -73.56 0.11 13.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.216 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.557 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 50.49 66.25 2.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.631 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.2 p-10 -132.79 95.23 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 110.819 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.1 p -52.55 -22.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.73 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . 4.2 mm100 -73.05 -59.0 2.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.848 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.872 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.28 -17.84 61.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.155 HG12 ' CD ' ' A' ' 61' ' ' GLU . 3.1 t -65.36 -67.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.2 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.931 ' CA ' ' OE2' ' A' ' 61' ' ' GLU . 3.9 ptt-85 -73.17 -38.15 66.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.897 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.594 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -61.87 -27.55 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.797 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.272 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 12.0 mt -73.69 -62.08 1.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 0.0 111.981 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 65' ' ' GLN . 2.3 mt -65.56 -53.24 44.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -72.98 -3.35 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -138.36 -78.71 0.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.038 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 1.272 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 1.1 tt0 -41.43 -27.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' LEU . 41.6 tp 65.67 73.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 36' ' ' HIS . 80.1 t -122.5 159.74 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.056 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.543 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -74.64 145.06 81.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB3' ' CG ' ' A' ' 65' ' ' GLN . 38.2 Cg_endo -66.86 -29.49 41.62 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.722 2.282 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.671 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -82.52 -67.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 10' ' ' VAL . . . 35.84 87.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 45' ' ' LYS . 5.2 mp -92.54 140.18 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 1.4 m120 -67.72 88.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER 86.78 19.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t80 65.84 52.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.99 -73.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.499 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.7 mtpt -86.13 148.86 25.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 71' ' ' VAL . 1.1 p -87.09 150.14 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -52.89 -36.61 59.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.934 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 2.1 mt -73.28 -26.75 61.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.73 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 15' ' ' SER . 15.8 m -93.11 -18.8 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.746 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 1.3 tmm? -44.2 145.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.557 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.68 12.9 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.853 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 7.3 m-85 56.29 -80.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.66 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 31.94 -93.71 0.01 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.677 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.8 m -67.71 130.56 92.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.483 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 56.1 Cg_endo -71.0 -27.9 19.96 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.715 2.276 . . . . 0.0 111.828 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' C ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.38 -36.37 83.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.01 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.041 HG12 HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.47 -34.18 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -62.7 -58.04 8.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 60' ' ' LEU . 6.7 tt -63.27 -33.03 74.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.794 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.155 ' CD ' HG12 ' A' ' 26' ' ' VAL . 8.1 mt-10 -63.03 -60.26 3.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 5.6 mp -62.81 -46.91 85.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.17 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -63.16 -58.77 6.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 7.2 tmtt? -62.92 -23.79 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.131 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HG2' HD22 ' A' ' 30' ' ' LEU . 24.8 tp60 -74.4 -20.02 60.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.999 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 37' ' ' PRO . . . 120.53 50.35 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.04 159.81 21.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -126.21 120.44 23.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.986 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' VAL . 70.0 Cg_endo -74.68 -17.67 20.23 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.78 60.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 69' ' ' PRO . 4.3 m -134.89 126.67 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' N ' ' A' ' 77' ' ' THR . 2.7 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.488 ' N ' ' HB3' ' A' ' 72' ' ' GLN . 17.2 m -137.8 100.69 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -68.99 173.45 3.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 -34.04 75.2 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.835 2.357 . . . . 0.0 112.116 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -54.98 -38.43 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -59.66 -65.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.989 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.933 ' C ' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -57.99 -37.36 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.286 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.9 -42.97 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.248 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.64 -55.81 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.795 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -61.62 -27.68 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.4 p -70.8 -70.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.55 64.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 18.7 m-85 -136.26 49.75 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 89' ' ' LEU . 2.7 tm? -52.28 -45.78 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.498 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -66.2 0.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.863 0.363 . . . . 0.0 110.8 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 56' ' ' PRO . 18.0 m -65.33 -44.58 87.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' HB1' ' A' ' 83' ' ' ALA . 22.6 tp -52.71 -48.76 66.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.778 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -52.13 -32.29 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.811 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -74.45 -55.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.94 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 3.8 pp -74.33 -47.8 32.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.679 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.912 HG23 HG12 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -59.4 -36.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.552 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.778 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.87 -28.39 62.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -55.97 -37.42 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 160.08 -19.81 0.24 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.669 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -33.63 115.16 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.607 ' O ' HG21 ' A' ' 80' ' ' VAL . 1.2 p30 -48.8 113.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 100' ' ' ALA . 6.1 m -106.24 26.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' HA ' ' HG ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -123.41 -35.93 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.74 145.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.931 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.64 -151.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -140.67 -77.17 0.31 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -57.85 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 1.128 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -63.41 -12.42 30.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.695 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.821 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 72.53 17.49 77.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 138' ' ' ASP . 1.4 t -77.38 123.15 26.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.931 HD12 HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -70.96 157.79 89.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.817 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HB2' HD11 ' A' ' 128' ' ' LEU . 71.5 Cg_exo -48.74 -38.54 37.45 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.616 2.211 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HB ' HD12 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.88 -40.97 79.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.086 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' ARG . 22.0 m80 -52.66 -37.87 59.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.637 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 118' ' ' ARG . 9.9 mt -72.84 -50.02 26.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -37.1 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.936 HG21 ' HB3' ' A' ' 147' ' ' LEU . 95.0 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -72.99 -9.87 59.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.772 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.795 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -91.93 -57.94 2.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.674 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.28 41.49 3.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.861 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 9.8 m-70 -82.22 -1.75 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.87 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m 65.86 -81.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.54 ' CB ' ' HG ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -54.83 -52.74 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.981 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 116' ' ' ALA . 51.6 t -55.31 -60.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.345 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 116' ' ' ALA . 3.8 t -52.13 -60.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.372 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.682 ' CB ' HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.46 -27.55 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.64 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 11.7 t80 -73.64 -51.4 16.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HB ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.95 -7.49 22.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.258 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.891 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -58.41 -69.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.265 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.891 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.3 Cg_endo -70.49 -28.69 21.42 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.72 2.28 . . . . 0.0 112.487 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 102' ' ' VAL . 3.3 mm-40 -68.01 -18.14 64.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.497 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 3.8 m -116.88 157.8 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.71 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -44.19 113.96 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.4 mt -85.48 43.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.73 30.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -138.53 155.83 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.543 ' HA ' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -130.13 -172.65 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 1.128 ' OD1' ' O ' ' A' ' 108' ' ' THR . 1.5 t70 -82.97 -174.68 5.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' ' CG ' ' A' ' 138' ' ' ASP . . . -77.94 -4.99 49.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.042 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -46.75 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.761 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . 124.66 80.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.621 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 141' ' ' GLY . 28.5 mt -161.92 107.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.2 p -77.44 150.44 79.7 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.801 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.704 ' O ' HD22 ' A' ' 160' ' ' LEU . 82.1 Cg_exo -45.43 -31.56 6.87 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.604 2.203 . . . . 0.0 112.206 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.771 HD12 ' CE ' ' A' ' 164' ' ' MET . 0.4 OUTLIER -73.32 -47.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.94 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.047 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.34 -50.92 63.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.209 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.936 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.59 -26.93 14.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.391 . . . . 0.0 110.677 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -73.67 -23.71 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -49.22 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -60.92 -72.79 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -73.18 60.98 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.81 47.92 0.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.085 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -36.92 -57.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.441 0.638 . . . . 0.0 110.052 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.426 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -145.37 -146.51 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.548 179.031 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 1.103 ' HB2' ' CG ' ' A' ' 158' ' ' ASP . 17.6 p30 -73.36 53.63 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.848 ' HA ' HD12 ' A' ' 159' ' ' ILE . 6.3 mt -65.14 -66.29 0.56 Allowed 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.574 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 2.7 ppp? -51.44 -20.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.103 ' CG ' ' HB2' ' A' ' 155' ' ' ASN . 7.9 p-10 -73.72 -42.42 61.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.025 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.47 -40.24 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 144' ' ' PRO . 5.4 mp -73.12 -40.17 65.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -63.51 -47.33 82.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.78 -44.32 92.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.38 -12.29 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.909 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.9 mtp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.97 HG13 HG12 ' A' ' 35' ' ' VAL . 66.6 t . . . . . 0 N--CA 1.465 0.313 0 CA-C-O 120.853 0.358 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.742 ' CA ' ' HB1' ' A' ' 39' ' ' ALA . . . -65.94 -9.52 47.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.687 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -117.85 18.46 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tpt85 -122.62 -53.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.2 tp -70.01 -43.72 70.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.754 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.705 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.99 -31.41 63.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.87 -53.33 8.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.398 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -57.57 -58.76 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.96 67.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.48 -28.48 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.438 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 1.375 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -73.6 0.66 12.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.249 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 50.73 78.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.375 ' OD2' ' CG ' ' A' ' 20' ' ' ARG . 2.6 p30 -152.63 97.15 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.598 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.927 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.1 p -52.83 -25.18 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.66 -49.99 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.004 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -73.25 -39.75 65.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.57 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 58' ' ' VAL . 8.8 p -52.42 -42.15 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 67.1 mtp85 -72.91 -50.75 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 3.5 mmp_? -52.61 -30.63 32.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.753 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.64 -74.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.172 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' HG2' ' A' ' 65' ' ' GLN . 3.5 mt -74.31 -42.91 58.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -67.54 -4.56 11.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.015 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 9.4 tpt180 -149.51 -77.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.646 0.26 . . . . 0.0 111.311 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.852 ' OE1' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -41.69 -26.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 34' ' ' LEU . 3.6 tp 66.27 83.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.97 HG12 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -111.84 134.92 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.529 ' H ' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -71.26 129.56 88.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.689 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HG3' ' A' ' 65' ' ' GLN . 49.1 Cg_endo -69.17 -15.67 39.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.745 2.297 . . . . 0.0 112.239 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 6.7 t0 -83.57 -28.47 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.962 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.742 ' HB1' ' CA ' ' A' ' 11' ' ' GLY . . . -43.52 157.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.489 ' N ' ' HA3' ' A' ' 11' ' ' GLY . 2.9 mp -143.34 142.47 31.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.263 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 22.3 p30 -71.4 169.38 15.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -39.85 -34.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.833 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -62.05 -52.92 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.45 33.44 1.21 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 10.9 mtpt -109.99 170.83 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.789 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 p -98.94 166.58 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -58.32 -46.37 86.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -64.79 -34.26 77.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.5 tp60 -73.43 -45.75 52.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 46' ' ' THR . 15.7 m -72.97 -39.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.657 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 53' ' ' PHE . 2.7 ppp? -35.26 148.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.038 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 54' ' ' GLY . 2.5 ptm -111.14 22.79 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.159 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.13 ' CE2' HD21 ' A' ' 95' ' ' LEU . 56.3 m-85 50.19 -87.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.347 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 34.46 -94.35 0.01 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.413 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.622 ' C ' HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -53.54 156.26 4.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 1.041 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 93.8 Cg_endo -89.17 -52.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.961 2.441 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.927 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -62.99 -23.15 67.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.773 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.9 p -62.32 -45.46 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.12 -48.89 76.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -62.48 -48.88 77.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.18 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -62.67 -58.07 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.76 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.86 -49.68 73.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD12 ' C ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -63.11 -44.36 95.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 111.214 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.64 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.5 ttpp -62.74 -31.0 71.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.756 ' HG2' HD22 ' A' ' 30' ' ' LEU . 31.6 tp60 -45.66 -29.42 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.1 -19.14 2.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.41 152.46 11.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 13.0 m -105.99 126.66 30.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.979 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HA ' ' HG ' ' A' ' 48' ' ' LEU . 44.4 Cg_endo -68.57 -4.29 12.78 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.737 2.291 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -98.4 64.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' SER . 31.4 m -116.88 125.7 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.08 83.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 1.7 m -84.71 166.95 29.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 1.263 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 79.5 Cg_exo -47.81 -33.79 20.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 81' ' ' HIS . 0.5 OUTLIER -54.8 -42.15 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.014 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.571 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 15.7 m80 -70.07 -48.41 57.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.032 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.263 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.3 p30 -55.79 -50.45 70.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.259 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.66 -48.77 66.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 128' ' ' LEU . . . -64.14 -49.93 70.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.234 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -37.9 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ASP . 58.5 p -67.82 -27.44 66.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.06 73.6 1.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.34 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -153.64 58.4 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.821 HD11 ' CG ' ' A' ' 127' ' ' PHE . 61.7 tp -53.87 -16.7 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.673 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.041 ' OD2' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.78 -74.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.803 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -73.65 -33.25 64.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 92' ' ' LEU . 2.0 tt -52.38 -56.91 11.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 1.215 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -56.64 -34.27 67.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 91' ' ' THR . 54.7 t -56.29 -62.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.13 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.43 -32.61 64.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 19.8 t -70.81 -46.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.215 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -56.08 -32.38 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.967 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.57 63.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.11 -68.47 0.44 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 69' ' ' PRO . . . 43.62 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -111.8 64.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.469 ' CG1' HG13 ' A' ' 96' ' ' VAL . 6.7 m -79.88 5.88 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.29 24.85 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -119.82 128.4 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.556 HD13 ' CA ' ' A' ' 109' ' ' GLY . 7.1 mt -85.49 162.38 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.669 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -88.39 -84.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 t -131.61 -45.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.03 7.27 11.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 70.77 10.75 68.2 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.554 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' A' ' 138' ' ' ASP . 73.6 p -78.89 92.46 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 111.044 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.72 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -36.24 146.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD23 ' A' ' 111' ' ' LEU . 99.2 Cg_exo -43.08 -28.44 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.409 2.073 . . . . 0.0 112.113 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.683 ' N ' HD22 ' A' ' 128' ' ' LEU . 1.9 tp -73.4 -35.34 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.56 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 56.6 m80 -57.68 -43.73 85.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -58.75 -42.97 90.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.476 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.647 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -54.59 -48.9 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.569 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 147' ' ' LEU . 93.8 mt -56.0 -40.83 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HE ' HD21 ' A' ' 147' ' ' LEU . 3.0 mmt85 -62.41 -21.44 65.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.32 -54.87 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 116.26 -6.61 19.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.519 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.679 ' O ' HG23 ' A' ' 125' ' ' VAL . 65.6 m80 -51.1 85.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' GLY . 18.0 p -38.88 -38.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 124' ' ' VAL . 1.9 p -73.17 -63.89 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 39.3 t -55.54 -57.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.361 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 121' ' ' HIS . 3.6 t -51.93 -54.09 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.961 ' HB2' HG21 ' A' ' 159' ' ' ILE . 44.0 t -63.74 -31.7 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.406 . . . . 0.0 111.11 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.821 ' CG ' HD11 ' A' ' 89' ' ' LEU . 71.3 t80 -73.1 -47.59 43.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -67.89 -8.96 40.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.29 -64.0 2.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 43.7 Cg_endo -67.88 -46.29 2.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 131' ' ' GLU . 4.2 mm-40 -51.59 -47.09 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.506 ' HB3' HD22 ' A' ' 111' ' ' LEU . 27.8 m -77.67 132.26 38.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' ND1' ' A' ' 136' ' ' HIS . 1.2 m-20 -36.14 96.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.772 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.7 mt -56.08 146.77 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.2 t-160 87.64 -21.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.672 ' CG ' HD13 ' A' ' 111' ' ' LEU . 2.0 p-80 -42.85 167.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.015 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -122.27 -172.62 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.56 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -130.0 159.17 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -10.6 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 p -109.27 -24.04 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.786 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.11 28.92 3.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.633 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.419 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 34.4 mt -102.77 -179.35 3.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -169.8 177.01 1.16 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.6 Cg_exo -49.93 -58.76 1.52 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.641 2.228 . . . . 0.0 112.119 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 161' ' ' GLN . 2.2 mt -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.419 ' OE1' ' CD2' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -54.84 -59.63 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.54 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -52.88 -51.86 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.411 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.8 -36.21 57.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.135 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.438 HH12 HD22 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -63.3 -31.24 72.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -79.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.131 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.59 ' O ' HD11 ' A' ' 156' ' ' LEU . 4.5 mtt85 -74.06 75.08 1.73 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.84 55.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.082 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 1.017 ' HB3' HD22 ' A' ' 156' ' ' LEU . . . -59.32 -18.68 40.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 1.229 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 43.1 tp60 102.76 -85.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.858 0.724 . . . . 0.0 112.834 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.986 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 0.7 OUTLIER -54.99 -42.87 72.98 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 153' ' ' ALA . 1.7 pt? -51.87 -53.84 36.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.573 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.2 ptm -60.28 -36.3 77.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD1' ' O ' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -73.55 -25.2 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.716 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.961 HG21 ' HB2' ' A' ' 126' ' ' SER . 18.8 mt -73.28 -42.06 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.238 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.847 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -73.48 -53.55 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.718 -179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.654 ' HB3' HD21 ' A' ' 145' ' ' LEU . 1.0 OUTLIER -52.37 -25.29 9.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.906 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 161' ' ' GLN . . . -73.31 -54.79 6.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.291 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.14 -49.23 29.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.772 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 tmm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.85 0.357 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.615 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -71.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 1.271 ' OD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -49.86 -22.48 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 1.171 ' HG2' ' OE2' ' A' ' 33' ' ' GLU . 1.9 tpt180 -61.91 -65.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -71.73 -45.42 61.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -35.93 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.93 -49.47 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.456 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.36 -43.96 75.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.64 -50.86 22.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.32 80.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -19.59 62.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 69.66 60.23 5.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.464 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.753 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 3.6 p30 -125.77 92.88 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 10.3 p -52.75 -20.71 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.842 ' C ' ' OE1' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -74.0 -53.9 9.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.264 ' OE1' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -73.39 -33.43 65.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.82 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.7 p -52.78 -50.8 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 0.0 111.306 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.634 ' CB ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.21 -50.52 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.163 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 8.2 ttt180 -56.41 -25.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.005 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.36 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.81 HD22 ' CD ' ' A' ' 65' ' ' GLN . 3.5 mt -73.67 -40.15 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' CB ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -72.64 -1.59 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.321 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -144.73 -70.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.743 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 1.171 ' OE2' ' HG2' ' A' ' 13' ' ' ARG . 1.2 tt0 -61.67 -15.1 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 47.44 76.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.937 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 14' ' ' LEU . 6.7 t -100.4 159.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -88.27 142.44 31.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.971 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 11.6 Cg_endo -54.77 -39.95 87.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.072 2.515 . . . . 0.0 112.296 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 59.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -107.68 121.37 44.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.856 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.99 170.74 9.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 1.271 ' CB ' ' OD1' ' A' ' 12' ' ' ASP . 15.9 p30 -124.41 -170.79 2.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.57 -30.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -69.02 -52.12 31.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.93 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.76 ' O ' HD23 ' A' ' 40' ' ' LEU . . . 108.16 18.39 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 40' ' ' LEU . 15.0 mttp -102.47 167.66 9.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.775 ' O ' HG12 ' A' ' 50' ' ' VAL . 28.1 p -85.12 162.79 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -54.75 -44.44 73.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.664 ' CD1' HD11 ' A' ' 62' ' ' LEU . 5.1 tp -63.76 -51.19 66.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.043 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -54.34 -70.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 46' ' ' THR . 7.8 p -56.69 -23.99 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.919 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -36.6 132.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 3.4 ptt? -93.48 13.64 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.911 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.8 OUTLIER 43.72 26.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.888 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.86 -67.91 1.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.18 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 91' ' ' THR . 0.4 OUTLIER -93.24 141.85 24.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 0.0 110.516 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.473 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 52.2 Cg_endo -68.55 -43.2 4.24 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.636 2.224 . . . . 0.0 111.975 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.2 -32.73 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.697 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.745 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.3 t -62.48 -31.88 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 121.145 0.498 . . . . 0.0 109.79 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.857 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.03 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.177 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.14 -28.86 70.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.274 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -63.02 -71.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -63.35 -27.46 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -62.78 -62.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -19.03 63.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.81 ' CD ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.07 -24.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.95 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.15 0.39 5.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.57 -173.89 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.46 130.45 9.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -14.19 35.33 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.764 2.309 . . . . 0.0 112.373 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 23.5 m120 -82.36 74.8 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 28.4 m -130.08 138.21 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.007 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 1.29 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.889 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 5.7 m -101.77 69.57 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -73.38 170.89 12.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 10.2 Cg_endo -53.67 -40.5 79.31 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.835 2.356 . . . . 0.0 112.321 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.26 -25.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -67.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.766 ' O ' HG23 ' A' ' 86' ' ' THR . 43.8 p30 -60.66 -26.35 67.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.893 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.25 -52.79 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.273 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -72.81 -29.05 62.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.766 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.1 p -69.41 -6.1 27.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.41 74.97 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.39 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -161.11 59.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' CG ' ' A' ' 127' ' ' PHE . 2.1 tm? -53.6 -28.93 35.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.75 -67.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.694 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.857 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 17.5 m -70.66 -23.39 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.764 HD23 ' C ' ' A' ' 92' ' ' LEU . 1.7 tt -72.83 -42.87 63.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 1.305 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 6.6 ptpt -67.87 -32.44 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.67 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.338 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 1.3 m -64.9 -54.35 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.491 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.5 pp -74.01 -33.39 63.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.808 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 42.3 t -73.04 -53.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.254 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.338 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 1.2 pm0 -52.72 -31.6 38.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.889 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.443 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -57.65 -19.43 26.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.3 6.71 5.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -50.16 132.5 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 2.9 p30 -43.94 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -99.06 22.55 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.144 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.614 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -128.29 14.29 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.721 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.64 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -89.82 161.65 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -141.64 -179.69 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 1.29 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 1.7 m-20 -121.11 -155.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -57.83 7.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -33.45 73.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.017 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.39 66.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.503 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.54 ' O ' HD11 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -61.3 113.76 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.67 150.1 68.47 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.732 ' HD2' HD23 ' A' ' 111' ' ' LEU . 98.8 Cg_exo -42.71 -31.85 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.829 2.353 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.79 ' HA ' HD21 ' A' ' 128' ' ' LEU . 3.3 tp -72.37 -39.32 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.11 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 36.3 m80 -61.38 -35.18 76.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 115' ' ' LEU . 5.1 mp -69.1 -50.49 47.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.619 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -54.18 -37.45 64.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 147' ' ' LEU . 94.5 mt -62.23 -43.76 98.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.299 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 11.9 mtp180 -61.48 -16.22 45.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.313 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 3.7 mt-10 -105.3 -49.81 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 81.07 29.48 41.39 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.116 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.601 ' CB ' HG21 ' A' ' 124' ' ' VAL . 51.5 m80 -51.5 -169.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 121' ' ' HIS . 91.6 p -57.56 -130.69 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.729 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 1.54 9.76 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.223 -0.298 . . . . 0.0 111.441 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -54.39 -68.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.852 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.7 t -52.18 -32.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.786 ' HB2' HG21 ' A' ' 159' ' ' ILE . 13.8 t -73.53 -56.87 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.787 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 1.097 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 5.0 t80 -67.97 -47.06 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.762 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -66.4 -7.5 19.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.877 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -73.12 -60.7 1.71 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.37 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.4 Cg_endo -59.45 -64.27 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.831 2.354 . . . . 0.0 112.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.097 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -43.8 -26.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.594 ' OG ' HD22 ' A' ' 111' ' ' LEU . 6.0 t -89.5 133.86 34.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.661 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 3.2 p-10 -38.05 93.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.657 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.6 mt -63.88 69.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER 178.34 -42.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.017 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.661 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 1.8 t-160 -54.06 154.41 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HD3' ' NE2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -140.91 -148.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.783 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.457 ' N ' ' HD2' ' A' ' 137' ' ' ARG . 0.7 OUTLIER -160.91 -162.72 0.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.65 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.33 -22.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.172 0.511 . . . . 0.0 110.612 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -62.38 -52.68 62.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.89 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.36 20.73 58.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.748 ' O ' HG23 ' A' ' 143' ' ' THR . 1.4 mt -106.6 -105.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.551 0.175 . . . . 0.0 110.807 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.253 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER 160.52 167.83 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.8 0.333 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 3.8 Cg_endo -47.41 -57.56 2.25 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 123.022 2.481 . . . . 0.0 112.088 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -66.12 -44.75 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.253 ' CD ' ' OG1' ' A' ' 143' ' ' THR . 4.0 mp0 -55.53 -51.12 68.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.531 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.691 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -53.04 -43.34 66.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 110.171 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.834 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.85 -36.42 58.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -35.61 78.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.627 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -74.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.248 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.719 ' O ' HD21 ' A' ' 156' ' ' LEU . 10.8 mmm180 -73.97 70.59 1.51 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.29 52.0 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.909 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.905 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -57.17 -16.6 8.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.513 0.196 . . . . 0.0 110.535 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 36.5 tp60 101.79 -59.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.659 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.494 ' C ' HD12 ' A' ' 159' ' ' ILE . 4.8 m-20 -72.6 -54.73 8.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.0 111.512 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.905 ' HG ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -53.05 -16.78 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.946 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.834 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 14.4 mtp -74.74 -60.37 2.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.858 0.361 . . . . 0.0 111.603 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.616 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.071 -179.122 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.786 HG21 ' HB2' ' A' ' 126' ' ' SER . 60.0 mt -52.74 -55.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.673 0.273 . . . . 0.0 111.366 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.8 OUTLIER -73.64 -31.12 63.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.34 -179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.845 ' HG2' HD13 ' A' ' 145' ' ' LEU . 1.3 mm-40 -62.94 -42.64 99.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -36.14 57.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.403 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -70.18 -31.73 69.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.502 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 35' ' ' VAL . 13.1 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.917 0.389 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -46.47 -57.59 6.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.444 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -84.21 54.68 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -127.86 -66.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 29' ' ' LEU . 29.0 tp -67.23 -33.92 76.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.008 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -61.89 -39.18 91.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -31.63 75.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.9 -59.67 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 111.153 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . . . -54.28 -48.62 71.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 50' ' ' VAL . . . -64.24 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -72.61 -37.65 68.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.85 73.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.37 83.78 1.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -52.65 -22.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -74.11 -49.67 22.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.565 ' O ' HD23 ' A' ' 29' ' ' LEU . 55.8 mm-40 -73.84 -27.3 61.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.845 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.686 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -52.76 -51.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.53 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.559 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.2 mtm180 -73.28 -43.09 61.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 19.7 mmt180 -63.5 -34.21 77.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -53.47 -71.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -69.68 -49.36 54.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.012 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -66.72 -25.83 66.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.93 -58.66 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.555 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.3 tp10 -67.35 -7.14 22.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.06 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER 42.46 28.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.7 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -66.76 148.85 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -67.62 131.03 92.97 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.98 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 57.5 Cg_endo -71.07 -22.42 26.19 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.852 2.368 . . . . 0.0 112.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -99.55 18.68 17.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -62.18 107.59 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.3 mp -89.82 145.22 25.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 54.2 p30 -80.93 -171.37 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -70.56 58.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -172.52 -43.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.58 60.14 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.594 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -141.08 145.64 36.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 50' ' ' VAL . 20.9 p -85.57 155.9 20.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -55.27 -24.24 27.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 69' ' ' PRO . 3.8 mt -72.9 -49.65 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 49' ' ' GLN . 10.6 tp60 -63.88 -28.29 69.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 19' ' ' ALA . 28.9 m -96.23 -14.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HE1' ' CD2' ' A' ' 95' ' ' LEU . 1.2 ttp -44.64 154.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -109.72 23.51 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.73 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 35.84 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -72.39 -85.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.314 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.1 m -77.91 120.31 80.79 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.37 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.791 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.9 Cg_exo -51.1 -43.48 48.05 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.472 2.115 . . . . 0.0 112.08 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.61 -28.51 69.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.644 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.2 t -62.27 -41.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.647 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.65 -50.18 70.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.641 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.5 tp -63.14 -40.19 96.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.712 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -63.04 -43.24 99.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 62' ' ' LEU . 6.0 mt -62.81 -56.92 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 69' ' ' PRO . 5.8 mt -63.12 -31.31 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 4.2 mmtt -63.36 -46.27 87.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -56.57 -27.2 57.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.969 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.39 47.88 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.436 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -109.25 123.58 49.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.903 0.382 . . . . 0.0 111.039 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 124.86 83.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.692 ' HB3' HD21 ' A' ' 63' ' ' LEU . 59.3 Cg_endo -72.42 -38.61 3.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.727 2.285 . . . . 0.0 112.302 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.01 101.48 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 11.6 m -139.41 132.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' HG3' ' C ' ' A' ' 71' ' ' VAL . 49.5 mt-30 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.3 m -124.97 144.79 50.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -144.41 177.97 1.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 77.6 Cg_exo -49.61 -47.56 22.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.656 2.238 . . . . 0.0 112.288 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.69 HG23 HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.57 -38.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -59.31 -70.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.204 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.03 -33.31 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.81 -52.44 56.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.41 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -64.97 -46.56 80.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.441 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -72.21 -24.36 61.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.355 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 82' ' ' ASP . 11.5 p -73.11 -73.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.124 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 126.75 63.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.997 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -148.38 57.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 89' ' ' LEU . 2.7 tm? -52.11 -19.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 4.5 m-20 -60.36 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 56' ' ' PRO . 2.4 m -73.37 -27.55 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 92' ' ' LEU . 3.1 tt -56.54 -57.52 11.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.988 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.65 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.07 -32.22 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.807 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 23.7 t -57.71 -65.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.6 pp -70.41 -29.33 65.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.429 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 80' ' ' VAL . 23.5 t -72.55 -40.31 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.807 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 4.5 pm0 -72.82 -25.75 61.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -61.07 -62.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -176.74 -30.35 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.868 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 99' ' ' GLY . . . -31.8 118.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.351 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.23 119.27 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 131' ' ' GLU . 5.3 p -110.84 20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -136.62 27.88 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.634 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -107.92 130.99 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.064 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -97.49 162.61 13.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.091 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 51.9 p-10 -85.31 53.07 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 106' ' ' ASP . 8.4 t 80.42 -62.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -42.04 -28.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.003 0.43 . . . . 0.0 110.048 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 88.45 31.69 13.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.57 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.542 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -101.8 96.87 7.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 105' ' ' LEU . 10.6 tp -34.89 135.35 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -45.92 -29.25 5.76 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.734 2.29 . . . . 0.0 112.452 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' C ' ' A' ' 128' ' ' LEU . 4.5 tt -73.06 -35.7 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -52.84 -37.66 60.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -68.64 -46.55 68.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.615 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.668 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . . . -56.29 -41.64 76.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.257 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.757 ' HA ' HG11 ' A' ' 125' ' ' VAL . 85.5 mt -57.64 -38.04 62.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.595 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 2.3 mtp180 -66.22 -17.44 64.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -98.95 -50.94 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.76 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.84 40.96 6.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 123' ' ' SER . 23.9 m-70 -72.95 -3.04 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.722 0.296 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER 63.0 -70.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.791 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 121' ' ' HIS . 32.5 m -55.98 -41.61 75.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 84' ' ' ALA . 51.9 t -73.19 -61.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.757 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.28 -51.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.732 ' CB ' HG21 ' A' ' 159' ' ' ILE . 83.7 p -56.57 -42.68 79.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.04 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.653 ' CG ' HD21 ' A' ' 89' ' ' LEU . 72.8 t80 -73.41 -37.61 65.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.853 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -71.97 -2.64 18.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.28 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.849 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -69.19 -71.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.226 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.849 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 37.5 Cg_endo -66.96 -57.63 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.614 2.21 . . . . 0.0 112.336 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 6.6 mm-40 -39.63 -37.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.483 ' OG ' HD13 ' A' ' 128' ' ' LEU . 9.7 m -96.38 133.4 40.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.786 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.32 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -36.51 107.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.549 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 164' ' ' MET . 31.0 mt -72.89 -1.31 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.268 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.05 24.09 13.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 1.32 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 4.4 t60 -107.27 171.1 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.785 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -159.94 157.38 28.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 141' ' ' GLY . 6.7 t0 -77.57 157.89 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.486 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.7 -27.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 109.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -40.64 62.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.657 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 114.11 35.85 1.44 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.39 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 147' ' ' LEU . 67.8 mt -93.92 -167.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -178.35 165.28 1.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 143' ' ' THR . 99.4 Cg_exo -42.61 -56.83 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.619 2.213 . . . . 0.0 111.886 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 161' ' ' GLN . 6.3 mt -72.03 -42.74 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 142' ' ' LEU . 3.6 tp10 -55.56 -69.78 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 142' ' ' LEU . 21.9 tp -52.73 -38.17 60.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 109.914 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 144' ' ' PRO . . . -54.14 -44.63 71.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.036 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.473 ' N ' ' SD ' ' A' ' 157' ' ' MET . 1.9 tpm_? -58.57 -23.36 58.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 1.4 tt0 -71.9 -75.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.87 ' O ' HD11 ' A' ' 156' ' ' LEU . 5.6 mmm180 -74.06 74.43 1.72 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.88 55.81 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.582 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 155' ' ' ASN . . . -69.88 -13.26 62.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.756 0.313 . . . . 0.0 110.748 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 8.2 tp-100 88.39 -37.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.98 ' OD1' HD23 ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.51 -64.89 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.252 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.98 HD23 ' OD1' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -52.01 -55.02 23.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.291 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 34.5 mmm -50.98 -28.19 9.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 154' ' ' GLN . 30.9 t0 -75.31 -71.04 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.708 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.732 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -53.05 -40.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.232 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 156' ' ' LEU . 6.5 mp -73.68 -14.75 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.725 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.37 -61.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.38 -48.69 50.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.301 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -53.93 -18.96 3.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 134' ' ' LEU . 6.9 mmm . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.769 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -81.9 -60.91 2.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.521 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -10.77 26.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -98.66 -70.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -72.22 -61.36 1.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.1 t -55.81 -25.8 43.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.18 -50.69 11.73 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.745 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.51 -47.42 48.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 111.223 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.918 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.87 -39.67 62.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.024 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.34 -41.45 63.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.304 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' CD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.63 -22.14 66.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.68 59.47 3.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.898 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.247 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 16.5 t0 -109.29 90.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.643 0.259 . . . . 0.0 110.374 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' CB ' ' A' ' 57' ' ' ALA . 3.4 p -51.92 -23.53 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.151 0.5 . . . . 0.0 110.255 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.14 -59.58 2.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.8 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.247 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 11.0 mm-40 -73.96 -28.19 61.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.613 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.972 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.7 p -52.41 -51.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.816 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.561 ' N ' HG13 ' A' ' 26' ' ' VAL . 19.6 mtp180 -74.48 -51.25 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -52.75 -36.74 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.11 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 9.2 mt -73.16 -74.33 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.685 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.808 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.16 -42.19 63.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -73.08 -1.68 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.27 -64.74 0.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 111.121 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.955 ' OE2' ' CG1' ' A' ' 35' ' ' VAL . 2.2 tt0 -62.51 -11.35 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tp 54.22 73.25 0.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.955 ' CG1' ' OE2' ' A' ' 33' ' ' GLU . 2.0 m -101.29 153.92 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' OD2' ' A' ' 38' ' ' ASP . 1.8 t-80 -74.83 126.6 88.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.55 1.03 7.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.786 2.324 . . . . 0.0 112.357 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 1.1 p-10 -111.86 53.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.33 177.21 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 3.8 mp -142.19 -173.87 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' PHE . 17.8 p-10 -150.9 166.7 29.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -35.17 -31.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -68.33 -47.63 67.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 110.13 16.12 10.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 11.5 mtpt -101.83 169.02 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.15 168.52 13.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -60.4 -55.01 38.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.42 -36.64 84.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 77' ' ' THR . 41.2 tp60 -52.87 -66.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 46' ' ' THR . 7.1 p -70.09 -25.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.749 ' HG3' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -35.7 107.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 20' ' ' ARG . 2.8 ptt? -66.27 137.28 56.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.108 ' CE2' HD21 ' A' ' 95' ' ' LEU . 11.6 m-85 -82.64 47.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -86.36 -64.36 1.46 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.135 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.907 ' O ' HG12 ' A' ' 58' ' ' VAL . 5.2 m -98.36 111.52 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 1.026 ' CG ' ' OD1' ' A' ' 90' ' ' ASP . 76.1 Cg_exo -48.67 -23.5 5.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.449 2.1 . . . . 0.0 111.834 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.823 ' CB ' HG23 ' A' ' 23' ' ' VAL . . . -64.41 -43.45 94.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.112 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.972 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 p -61.94 -36.9 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.87 0.367 . . . . 0.0 110.549 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.8 -51.32 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.8 tt -63.29 -46.45 86.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.942 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE2' ' HG ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -62.56 -47.4 84.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.439 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.918 HD11 ' HB1' ' A' ' 18' ' ' ALA . 11.9 mt -62.73 -58.97 5.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -28.16 69.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.389 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 18.0 ttpt -62.77 -17.78 61.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.774 0.321 . . . . 0.0 111.084 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.731 ' HG2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -77.34 -67.49 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.15 37.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.54 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.52 -160.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 71' ' ' VAL . 32.1 m -123.7 124.1 26.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 74.2 Cg_endo -75.16 -17.23 19.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.783 2.322 . . . . 0.0 112.366 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -114.17 77.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' SER . 5.0 m -117.85 152.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.821 ' HA3' ' OD2' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -164.7 105.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.52 170.62 6.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.736 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 76.9 Cg_exo -49.66 -40.45 46.71 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.593 2.196 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 101' ' ' ASP . 7.6 m -59.05 -34.0 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -69.8 -62.36 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.76 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -53.1 -48.15 68.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.05 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.33 -27.71 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HA ' HG11 ' A' ' 124' ' ' VAL . . . -71.49 -62.42 1.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HA ' ' HG3' ' A' ' 119' ' ' GLU . 16.4 mtp180 -73.07 -28.13 62.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.8 p -69.82 -5.58 26.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.147 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 50.28 76.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.528 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 11.7 m-85 -150.4 56.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.54 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -52.56 -22.95 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.188 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.026 ' OD1' ' CG ' ' A' ' 56' ' ' PRO . 3.6 t70 -62.29 -74.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 110.647 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 43.2 m -70.71 -19.81 62.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.501 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 89' ' ' LEU . 2.8 tt -68.61 -55.3 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.511 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.6 -30.01 62.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.966 ' O ' ' OE2' ' A' ' 97' ' ' GLU . 78.8 t -59.98 -62.46 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.108 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.12 -28.78 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.471 . . . . 0.0 110.148 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.889 HG13 HG11 ' A' ' 102' ' ' VAL . 16.4 t -73.33 -44.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.966 ' OE2' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -68.1 -28.42 67.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.742 ' CG ' ' OE2' ' A' ' 97' ' ' GLU . 12.3 m170 -60.06 -29.63 68.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.48 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.705 ' O ' HG13 ' A' ' 102' ' ' VAL . . . -95.81 143.56 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 111.108 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.465 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -56.1 84.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.889 HG11 HG13 ' A' ' 96' ' ' VAL . 11.7 m -88.66 11.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.557 ' OD1' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.16 37.92 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.962 ' C ' HD23 ' A' ' 105' ' ' LEU . . . -107.9 145.01 34.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.121 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -121.51 146.5 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.821 ' OD2' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -155.25 -53.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -48.16 -52.98 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.08 57.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 108' ' ' THR . . . 36.49 52.62 1.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.432 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 111' ' ' LEU . 48.0 m -134.49 110.9 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.97 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 136' ' ' HIS . 8.8 tp -35.01 140.53 0.29 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 88.1 Cg_exo -46.69 -32.26 11.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.767 2.311 . . . . 0.0 112.194 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 128' ' ' LEU . 1.6 tt -66.69 -37.44 79.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.553 ' HA ' HD12 ' A' ' 117' ' ' ILE . 73.8 m80 -59.3 -35.56 73.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -64.29 -53.07 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.415 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.72 -41.4 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 110.055 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.627 ' HA ' HG11 ' A' ' 125' ' ' VAL . 88.2 mt -52.81 -42.5 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.333 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -16.22 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 121' ' ' HIS . 3.8 mm-40 -86.46 -59.58 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.694 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.29 -0.35 14.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.603 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.887 ' O ' HG22 ' A' ' 125' ' ' VAL . 77.9 m-70 -61.44 73.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m -34.53 -33.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.57 -48.76 30.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.569 ' HA ' HD23 ' A' ' 89' ' ' LEU . 12.4 t -73.07 -50.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.411 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.887 HG22 ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -52.07 -52.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.548 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.1 t -69.04 -34.98 76.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.229 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.79 ' CD2' HD21 ' A' ' 89' ' ' LEU . 67.7 t80 -72.94 -35.83 67.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.088 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.28 -0.23 13.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.273 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.2 -69.41 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.306 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.5 Cg_endo -68.56 -57.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.633 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.487 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 24.0 mm-40 -39.28 -31.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.006 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 1.3 t -109.01 136.3 48.77 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 111' ' ' LEU . 1.3 p30 -35.37 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 164' ' ' MET . 12.6 mt -70.71 75.3 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER 173.14 -33.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.68 ' HB3' HD22 ' A' ' 111' ' ' LEU . 6.7 t60 -38.61 161.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 143' ' ' THR . 30.3 mtt180 -140.51 147.65 39.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.888 ' OD2' ' HB3' ' A' ' 140' ' ' SER . 0.3 OUTLIER -85.32 159.84 19.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.685 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 109.891 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.888 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . 0.1 OUTLIER -71.52 -56.1 6.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.833 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.51 12.62 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.701 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 2.7 mt -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.584 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -74.22 -178.67 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.695 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.0 Cg_exo -49.92 -49.87 14.87 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.837 2.358 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -67.99 -42.41 80.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.738 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.647 ' OE1' ' OE1' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -52.93 -60.16 3.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.037 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.84 -29.83 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.682 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 157' ' ' MET . . . -72.63 -24.08 61.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 146' ' ' GLU . 7.4 tmm_? -65.85 -51.03 62.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.647 ' OE1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.17 -71.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -74.18 58.3 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.29 52.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.433 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -31.05 -48.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -173.81 -109.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.535 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.3 m-80 -74.71 4.97 5.41 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.227 -0.295 . . . . 0.0 111.434 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 160' ' ' LEU . 1.6 mt -51.2 -59.34 4.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.704 0.288 . . . . 0.0 111.33 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.2 -32.17 35.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.916 0.389 . . . . 0.0 110.637 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.33 -57.77 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.787 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.15 -32.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -179.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.4 -59.88 2.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' HD11 ' A' ' 145' ' ' LEU . 6.3 pt20 -65.45 -14.91 61.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.05 -55.43 6.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.96 -14.09 61.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.1 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.639 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.774 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.774 HG12 ' HB1' ' A' ' 39' ' ' ALA . 9.2 t . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.717 0.294 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -33.2 -56.43 0.55 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.25 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -73.42 -24.14 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 111.252 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -72.56 -68.74 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.187 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.951 ' HB2' HG11 ' A' ' 35' ' ' VAL . 3.0 tm? -68.07 -54.83 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -61.12 -38.6 86.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.122 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -62.16 -61.08 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.673 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.818 ' HB3' HD11 ' A' ' 29' ' ' LEU . . . -57.55 -41.58 81.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.02 75.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.89 61.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 4.1 mtp85 -68.59 -30.71 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' CA ' ' HG2' ' A' ' 52' ' ' MET . . . 84.46 33.06 20.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.464 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.334 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 p-10 -104.64 100.18 9.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.2 p -54.72 -17.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.817 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 16.8 mt-30 -74.25 -53.39 9.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.269 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.334 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.32 -34.64 65.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.025 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.909 HG21 ' HA ' ' A' ' 58' ' ' VAL . 9.9 p -52.56 -50.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' N ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -72.52 -48.1 43.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 111.038 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.87 -27.44 65.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 17' ' ' ALA . 26.8 mt -74.43 -71.85 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.023 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.011 HD22 ' CG ' ' A' ' 65' ' ' GLN . 82.9 mt -63.3 -67.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -64.9 -4.88 4.97 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -129.43 -70.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.459 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 1.206 ' OE1' HG22 ' A' ' 35' ' ' VAL . 4.4 tt0 -51.86 -20.49 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 34' ' ' LEU . 1.4 mt 59.12 53.51 5.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.206 HG22 ' OE1' ' A' ' 33' ' ' GLU . 48.5 t -86.02 137.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.179 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.6 t-80 -55.41 143.56 56.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 36.9 Cg_endo -65.22 -33.77 47.87 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.78 2.32 . . . . 0.0 112.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.887 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -96.42 31.59 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB1' HG12 ' A' ' 10' ' ' VAL . . . -79.43 61.19 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.366 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 38' ' ' ASP . 5.0 mp -55.76 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -84.26 46.06 1.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 2.0 tmt_? 84.7 -11.69 0.78 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER 155.74 50.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.791 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -143.12 -102.47 0.42 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.979 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HB3' HG13 ' A' ' 50' ' ' VAL . 14.3 mttt -95.07 154.69 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 0.0 111.229 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.859 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.39 142.93 29.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.989 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 14' ' ' LEU . . . -52.84 -22.62 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' SD ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -73.29 -67.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -52.96 -37.76 61.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 46' ' ' THR . 28.7 m -78.43 -19.21 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.292 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.796 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.61 143.22 51.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.498 ' HG2' ' CA ' ' A' ' 21' ' ' GLY . 4.1 ppp? -78.04 116.69 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.641 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 36.7 m-85 -70.32 57.93 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -50.66 0.21 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.6 m -82.3 127.07 72.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 55.4 Cg_endo -70.2 -37.34 8.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.631 2.22 . . . . 0.0 112.317 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.851 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.31 -39.28 94.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.315 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.909 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.1 m -62.96 -31.33 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.831 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -63.45 -59.89 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.671 HD23 ' C ' ' A' ' 60' ' ' LEU . 7.0 tt -63.26 -37.87 88.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.851 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 5.3 mp0 -62.75 -62.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 14' ' ' LEU . 3.4 mt -62.82 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 69' ' ' PRO . 4.9 tp -63.33 -50.88 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.6 ttpp -62.83 -36.87 84.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.92 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 1.011 ' CG ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -37.55 -60.55 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.853 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.95 -23.94 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.2 146.23 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.038 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.14 119.68 62.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 63' ' ' LEU . 53.1 Cg_endo -69.52 -19.64 37.03 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.03 70.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' SER . 23.4 m -124.2 145.76 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 1.193 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.886 HG22 ' HB3' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -112.38 75.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 110.926 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.843 ' OG ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -43.84 170.06 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.763 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 8.9 Cg_endo -50.6 -32.73 36.55 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.933 2.422 . . . . 0.0 112.38 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG22 ' CG2' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -63.75 -52.94 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.886 ' HB3' HG22 ' A' ' 77' ' ' THR . 33.4 m80 -53.01 -54.1 40.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.763 ' OD1' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -60.76 -50.91 71.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.076 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -52.83 -30.1 31.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -68.95 0.41 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -60.09 -18.62 48.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.311 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.8 p -73.33 -27.84 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.074 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.49 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 75.1 76.18 0.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.147 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 70.2 m-85 -156.19 61.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 123' ' ' SER . 6.3 mt -52.51 -18.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.596 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.044 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.28 -70.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.044 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 t -65.5 -35.94 82.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.9 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.998 HD23 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -52.89 -51.96 59.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.7 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.746 ' O ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.86 -38.01 61.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.536 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' CA ' ' OE1' ' A' ' 97' ' ' GLU . 87.9 t -75.27 -64.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.309 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.937 HD12 ' N ' ' A' ' 96' ' ' VAL . 4.6 pp -73.69 -52.53 12.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.998 HG11 HD23 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -52.55 -26.58 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.746 ' OE1' ' O ' ' A' ' 93' ' ' LYS . 3.0 pm0 -72.13 -29.79 64.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -67.11 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.21 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -67.47 63.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 1.138 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 1.1 p-10 39.96 69.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.565 HG12 HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -90.74 21.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 35.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -119.45 -178.54 3.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -150.09 165.24 33.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 1.193 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 2.4 t0 -84.76 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.25 -44.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -16.94 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 138' ' ' ASP . . . 72.34 52.81 9.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.382 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.65 105.48 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HA ' HD23 ' A' ' 105' ' ' LEU . 8.2 mt -43.82 158.22 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 67.3 Cg_exo -51.26 -43.54 48.38 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.284 . . . . 0.0 112.283 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -55.83 -40.22 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.676 ' HA ' HD12 ' A' ' 117' ' ' ILE . 33.4 m170 -54.95 -43.86 73.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 11.3 mt -63.01 -56.0 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.87 -32.23 43.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.928 HG21 ' HB3' ' A' ' 147' ' ' LEU . 46.9 mt -65.35 -41.28 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.604 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 0.8 OUTLIER -70.57 -18.29 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.602 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 1.6 mt-10 -87.56 -56.62 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.59 28.77 9.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.604 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 21.3 m-70 -60.04 -15.03 19.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.341 . . . . 0.0 110.547 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER 77.93 -75.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.981 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.716 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.65 -48.38 75.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 42.5 t -58.22 -60.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.2 t -52.24 -40.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.756 ' HB2' HG21 ' A' ' 159' ' ' ILE . 1.9 t -72.18 -23.82 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CE2' ' OE2' ' A' ' 131' ' ' GLU . 7.0 t80 -73.59 -48.14 35.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -69.63 -5.26 23.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.03 -70.33 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.185 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.9 Cg_endo -75.04 -43.4 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.696 2.264 . . . . 0.0 112.399 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.635 ' OE2' ' CE2' ' A' ' 127' ' ' PHE . 1.6 mt-10 -50.55 -33.51 22.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.707 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 132' ' ' SER . 1.2 m-20 -35.6 120.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.884 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.5 mt -87.64 19.79 3.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.38 -44.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.557 ' HB3' HD11 ' A' ' 111' ' ' LEU . 3.1 t60 -55.7 157.1 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.42 166.91 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.649 ' CG ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -80.97 153.21 27.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.44 -21.9 1.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -44.19 85.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 107.87 53.65 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.577 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 10.1 mt -149.94 104.76 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.71 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -72.95 177.62 1.83 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.697 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 87.0 Cg_exo -46.55 -57.89 2.0 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.7 -28.81 70.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.71 ' OE2' ' OG1' ' A' ' 143' ' ' THR . 0.4 OUTLIER -72.75 -65.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.34 -39.34 60.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.146 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -60.63 -37.43 81.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.23 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.62 84.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.613 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -65.1 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.364 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.766 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -75.14 57.82 0.87 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.53 52.01 0.86 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.071 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -35.55 -32.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.587 HE22 HD11 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -178.86 -123.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.461 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 1.349 ' CB ' ' OD2' ' A' ' 158' ' ' ASP . 3.4 m-20 -75.97 29.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.065 0.393 . . . . 0.0 111.963 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 151' ' ' ARG . 1.5 mt -54.25 -72.02 0.07 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 110.971 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.722 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 8.7 ptm -53.95 -21.27 7.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.349 ' OD2' ' CB ' ' A' ' 155' ' ' ASN . 8.6 p-10 -73.95 -54.42 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.098 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.176 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 2.0 mt -53.13 -37.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.815 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.8 -27.9 61.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -52.9 -54.18 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.46 91.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.516 ' O ' ' CD1' ' A' ' 134' ' ' LEU . 42.8 m-70 -68.81 -37.7 79.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.822 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.884 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.786 0.326 . . . . 0.0 111.227 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.577 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -52.06 -20.3 6.41 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.389 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 p30 -92.78 -8.83 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 0.0 110.863 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -98.65 -51.95 3.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB2' HG21 ' A' ' 35' ' ' VAL . 9.0 tp -64.06 -33.84 76.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.608 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -62.39 -41.87 98.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -70.87 -49.23 29.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.823 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -58.2 -47.86 82.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.351 . . . . 0.0 111.074 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.44 71.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.74 -23.64 59.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 3.0 mmt180 -73.9 -12.3 60.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.606 ' HA2' ' HE2' ' A' ' 52' ' ' MET . . . 66.83 80.61 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.68 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 11.4 t0 -147.51 88.49 1.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.302 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.688 HG23 ' HB3' ' A' ' 57' ' ' ALA . 6.3 p -52.18 -29.18 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -52.27 11.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.77 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -74.12 -27.85 61.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.737 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 58' ' ' VAL . 1.8 p -52.56 -47.21 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.312 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 1.266 ' NE ' ' OE2' ' A' ' 61' ' ' GLU . 6.2 mtt180 -73.64 -34.38 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.073 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 2.6 mmm-85 -52.4 -27.54 16.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.258 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.823 HD11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 mt -73.05 -68.42 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -63.99 -53.62 47.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.006 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -59.29 -16.51 22.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 2.3 mmp_? -135.21 -73.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -47.45 -23.44 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 59.36 16.05 4.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.791 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' LEU . 13.8 p -46.36 154.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -91.94 121.49 66.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 30.8 Cg_endo -63.47 -9.69 18.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.763 2.309 . . . . 0.0 112.154 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.93 21.15 18.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' N ' ' A' ' 11' ' ' GLY . . . -97.79 143.71 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.78 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -119.93 160.15 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 15' ' ' SER . 1.1 m-20 -71.24 -159.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -4.99 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.05 -44.56 6.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.624 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 120.85 38.55 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' N ' ' HB3' ' A' ' 40' ' ' LEU . 7.1 mtpt -117.7 143.76 45.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.829 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -85.06 156.69 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -57.63 -36.18 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.761 HD11 HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -61.33 -36.53 80.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.785 ' HG2' HG21 ' A' ' 71' ' ' VAL . 1.3 mt-30 -73.05 -55.83 5.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -59.4 -19.03 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.256 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.676 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -43.62 148.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.759 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.606 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.93 23.39 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.105 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 1.035 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 0.9 OUTLIER 33.15 57.91 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.467 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -108.46 -72.16 0.75 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.312 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -84.54 121.54 74.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.751 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.71 -45.0 44.27 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.574 2.183 . . . . 0.0 111.859 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.3 -31.3 72.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 26' ' ' VAL . 2.2 t -62.12 -47.88 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.027 0.441 . . . . 0.0 110.009 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.74 -49.79 71.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.822 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.4 tt -63.08 -43.3 98.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.548 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.266 ' OE2' ' NE ' ' A' ' 27' ' ' ARG . 7.4 tt0 -62.74 -61.23 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.414 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.09 -37.59 87.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 48' ' ' LEU . 39.4 tp -63.42 -52.65 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.117 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -62.62 -34.0 76.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.017 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 1.3 tp-100 -46.24 -25.32 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.29 3.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.593 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -39.31 148.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.01 123.05 44.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.26 -14.77 28.53 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.772 2.314 . . . . 0.0 112.235 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.9 57.21 4.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.785 HG21 ' HG2' ' A' ' 49' ' ' GLN . 13.9 m -103.2 175.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 m -82.21 65.67 7.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 110.72 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -58.79 171.14 0.69 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD3' ' CG2' ' A' ' 71' ' ' VAL . 78.1 Cg_exo -49.99 -44.27 38.04 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.772 2.315 . . . . 0.0 112.134 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.56 -41.04 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.318 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.618 ' HD2' HD11 ' A' ' 115' ' ' LEU . 6.0 m80 -52.83 -66.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.795 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -62.58 -30.76 71.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.55 -39.21 64.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.331 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.76 -50.17 38.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.542 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 115' ' ' LEU . 13.4 mtt180 -72.97 -26.88 61.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 82' ' ' ASP . 32.6 p -70.76 -3.43 18.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.301 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 43.83 76.17 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.13 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -158.98 61.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD1' ' CD2' ' A' ' 127' ' ' PHE . 62.5 tp -52.42 -19.63 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.138 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -63.13 -71.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.713 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.885 HG22 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -73.15 -20.74 60.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 92' ' ' LEU . 1.7 tt -72.95 -42.51 63.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.34 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 38.8 ttmt -65.71 -36.94 85.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.447 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.76 ' HA ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -55.82 -58.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.078 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.676 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.6 pp -73.07 -34.44 66.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.073 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 80' ' ' VAL . 38.8 t -72.32 -49.31 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.76 ' CD ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -58.77 -32.97 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -30.91 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.35 -0.58 7.55 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 102' ' ' VAL . . . -42.99 167.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.113 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.07 88.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.818 ' HA ' HG21 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -89.35 13.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.6 9.81 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.07 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -65.08 141.63 58.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.886 HD13 ' HA2' ' A' ' 109' ' ' GLY . 6.7 mt -121.67 150.54 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.065 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' OG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -84.98 -48.87 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 106' ' ' ASP . 0.6 OUTLIER -175.25 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 2.26 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.886 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 52.8 18.97 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.353 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.575 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -48.27 -50.37 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.541 0.21 . . . . 0.0 111.132 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 105' ' ' LEU . 6.2 tp 92.49 127.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.724 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.552 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 84.7 Cg_exo -44.38 -46.11 12.06 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.854 2.369 . . . . 0.0 112.589 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.38 -31.39 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.153 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.601 ' CD2' HD22 ' A' ' 147' ' ' LEU . 8.9 m80 -70.03 -34.17 72.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 81' ' ' HIS . 1.2 mt -63.5 -52.96 59.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -53.56 -36.02 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.682 HG21 ' HB3' ' A' ' 147' ' ' LEU . 83.6 mt -61.5 -41.52 90.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -68.91 -12.6 61.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.587 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.544 ' CB ' ' CD2' ' A' ' 121' ' ' HIS . 2.6 mt-10 -91.76 -57.81 2.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.736 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.92 -11.88 10.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.796 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 125' ' ' VAL . 30.7 m-70 -57.22 78.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 126' ' ' SER . 11.8 p -37.72 -45.02 0.76 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.2 p -56.94 -51.27 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.255 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 45.3 t -72.9 -58.85 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.452 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.4 t -52.04 -40.94 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.321 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.586 ' HB3' HG21 ' A' ' 159' ' ' ILE . 77.3 p -67.09 -36.87 82.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.111 0.481 . . . . 0.0 110.799 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 68.1 t80 -73.7 -44.51 56.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -70.44 -10.79 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.082 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.31 -69.09 0.37 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 1.016 ' HA ' HD11 ' A' ' 134' ' ' LEU . 72.0 Cg_endo -74.5 -50.07 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.772 2.315 . . . . 0.0 112.58 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -39.27 -44.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD13 ' A' ' 128' ' ' LEU . 8.1 t -90.77 134.2 34.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.432 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -40.14 101.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.016 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.2 mp -62.68 -36.77 83.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -63.53 -33.91 76.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.066 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 1.432 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 12.0 t60 -50.35 155.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -114.14 149.66 35.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.996 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.669 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 t70 -66.34 -9.32 32.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' ASP . . . 82.41 -5.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -14.01 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 108.33 48.3 0.88 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.478 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 147' ' ' LEU . 94.3 mt -151.62 93.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 111.057 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.82 179.65 0.75 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 73.3 Cg_exo -49.33 -49.41 15.6 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.763 2.309 . . . . 0.0 112.575 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.8 mt -73.28 -34.98 66.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 143' ' ' THR . 15.4 mm-40 -52.78 -62.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.682 ' HB3' HG21 ' A' ' 117' ' ' ILE . 2.7 tp -54.71 -48.35 72.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.41 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -57.17 -36.8 71.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.337 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -43.69 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.002 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 151' ' ' ARG . 10.2 tt0 -71.9 -86.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.976 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.504 ' N ' ' HG2' ' A' ' 150' ' ' GLN . 37.5 mtt-85 -74.7 53.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.549 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -52.07 -20.61 6.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 154' ' ' GLN . . . 34.43 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.597 ' CG ' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 125.95 -154.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.499 ' N ' ' CD ' ' A' ' 154' ' ' GLN . 2.2 t30 -74.41 46.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.408 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 159' ' ' ILE . 11.3 mt -69.91 -50.32 43.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.726 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.5 ptm -52.13 -26.18 10.68 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.944 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -74.4 -58.61 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.819 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.036 HD11 HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -51.91 -38.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.346 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.676 ' HG ' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -74.23 -23.79 59.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.025 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.26 -47.26 44.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.07 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.16 53.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -72.12 -8.34 54.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.486 ' CG ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 35' ' ' VAL . 7.7 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.37 24.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -11.22 28.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.815 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -86.61 -65.26 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.061 HD23 HG11 ' A' ' 35' ' ' VAL . 2.2 tm? -71.44 -65.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -56.97 -30.97 64.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.43 -63.77 2.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -64.75 -44.51 89.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.077 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -52.62 -51.5 59.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -65.1 -38.24 90.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -70.42 -7.91 46.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 23' ' ' VAL . . . 114.94 -66.28 0.28 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.901 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.107 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 26.89 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.0 111.822 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 26' ' ' VAL . 12.6 p -51.66 -35.64 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.21 -42.87 59.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.107 ' OE1' ' HA ' ' A' ' 22' ' ' ASP . 2.7 mp0 -74.43 -25.94 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.302 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.177 HG13 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.31 -40.06 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 60.9 mtt180 -73.99 -48.28 31.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 9.8 mtt180 -66.2 -29.31 69.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.573 HD11 ' OD2' ' A' ' 22' ' ' ASP . 6.7 mt -55.31 -67.46 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -73.63 -52.97 11.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.922 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 41.0 m-70 -67.62 -4.73 12.74 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -142.28 -57.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.689 0.281 . . . . 0.0 111.345 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.815 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.92 -4.52 20.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.165 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 39.88 32.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.977 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.061 HG11 HD23 ' A' ' 14' ' ' LEU . 9.7 p -59.15 166.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -98.72 135.5 21.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HB3' ' NE2' ' A' ' 65' ' ' GLN . 56.5 Cg_endo -70.84 -10.04 26.92 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.65 50.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.796 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.6 116.33 32.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -97.54 165.04 12.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.47 46.03 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.85 21.95 5.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.8 -9.16 8.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.12 20.96 43.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 3.5 mtpt -113.94 143.9 43.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 50' ' ' VAL . 64.7 p -89.3 174.31 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 14' ' ' LEU . . . -58.48 -38.28 77.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.062 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.506 HD23 ' HG2' ' A' ' 51' ' ' MET . 5.7 mt -73.44 -33.08 64.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.26 -1.39 17.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.481 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -129.78 -46.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.352 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -36.71 140.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.464 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -88.35 146.9 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.091 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.877 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.9 m-85 -87.5 21.72 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -73.06 -40.1 51.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 2.6 m -109.58 120.03 46.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 0.0 110.819 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 1.177 ' HG3' ' OD1' ' A' ' 90' ' ' ASP . 32.1 Cg_exo -58.83 -42.23 54.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.677 2.251 . . . . 0.0 112.168 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.15 70.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.044 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.3 t -62.98 -48.61 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.51 -40.93 98.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 1.8 tm? -63.01 -47.97 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.681 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.177 ' OE1' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.28 -48.4 78.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.8 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 51' ' ' MET . 8.2 mt -62.87 -54.38 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 95' ' ' LEU . 1.3 tt -63.08 -43.29 98.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.1 ttmm -62.93 -26.15 68.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.483 ' NE2' ' HB3' ' A' ' 37' ' ' PRO . 5.5 tt0 -62.11 -14.67 39.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.7 62.93 1.02 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.69 170.98 8.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.96 99.5 26.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.71 -9.18 23.57 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.689 2.259 . . . . 0.0 112.161 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.518 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -86.99 63.78 8.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 78' ' ' SER . 16.1 m -117.89 126.99 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.751 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 10.4 mt-30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 81' ' ' HIS . 2.1 m 179.91 139.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.818 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -117.51 179.62 0.79 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.145 0.498 . . . . 0.0 110.982 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 1.178 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 77.1 Cg_exo -48.53 -51.04 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 111.765 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.595 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.14 -48.76 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.316 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.71 ' HB2' HG23 ' A' ' 77' ' ' THR . 24.0 m80 -52.75 -61.37 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.94 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.178 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 10.5 p30 -57.77 -53.69 55.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.75 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -52.25 -38.82 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.459 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.11 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -73.49 -27.42 61.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 1.077 HG23 ' O ' ' A' ' 82' ' ' ASP . 27.8 p -71.32 -41.57 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.76 70.71 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.003 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -145.25 53.61 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.648 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 123' ' ' SER . 9.2 tp -52.47 -20.63 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.177 ' OD1' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -63.53 -71.8 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.422 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.707 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 m -73.12 -22.24 60.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.176 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.755 HD12 HD11 ' A' ' 95' ' ' LEU . 64.8 tp -70.29 -44.22 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 1.259 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 20.3 ttpp -60.63 -44.74 96.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.834 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.98 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.93 -53.33 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.55 -42.47 61.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.84 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 3.2 t -63.69 -52.48 56.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.259 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -55.5 -29.16 58.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.53 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 6.3 t60 -73.08 -56.21 5.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.54 33.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.815 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -69.41 120.31 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.324 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.8 p-10 -35.81 92.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.1 14.17 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.127 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -143.53 38.47 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.08 122.37 26.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.694 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -119.16 146.0 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.751 ' OD2' ' HB3' ' A' ' 72' ' ' GLN . 7.3 p30 -155.22 141.03 18.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 108' ' ' THR . 71.1 m 49.39 26.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.85 -40.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 1.174 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 68.68 10.79 61.51 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 1.429 ' HA ' ' CG ' ' A' ' 138' ' ' ASP . 2.6 t -104.02 129.45 51.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' HD21 ' A' ' 105' ' ' LEU . 32.5 mt -65.83 147.51 98.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HB2' HD11 ' A' ' 128' ' ' LEU . 74.4 Cg_exo -50.44 -29.53 24.43 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.681 2.254 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.9 tt -69.8 -38.31 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.819 ' ND1' ' OD2' ' A' ' 138' ' ' ASP . 36.4 m80 -53.32 -38.95 63.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.4 mt -65.96 -57.61 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.625 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -28.67 24.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.42 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.579 HD13 ' CG1' ' A' ' 125' ' ' VAL . 4.7 mm -65.42 -39.73 86.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.86 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -18.25 62.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.526 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 121' ' ' HIS . 4.1 mm-40 -90.87 -54.78 3.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.2 45.76 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.009 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.643 ' CB ' HG23 ' A' ' 124' ' ' VAL . 99.0 m-70 -76.96 3.77 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.698 0.285 . . . . 0.0 111.205 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 40.5 t 71.09 -92.94 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.785 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.64 ' HB3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -52.64 -56.51 14.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.358 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.643 HG23 ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -52.19 -62.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.944 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 4.5 t -52.31 -43.83 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 1.023 ' HB2' HG21 ' A' ' 159' ' ' ILE . 16.2 t -72.63 -30.49 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 123' ' ' SER . 63.3 t80 -73.8 -42.12 61.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.065 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -66.7 -6.99 17.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.336 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.832 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -64.13 -68.94 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.2 Cg_endo -67.27 -36.75 20.01 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 2.25 . . . . 0.0 112.353 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.33 -22.31 65.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 133' ' ' ASP . 51.8 m -112.84 147.6 36.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -35.47 111.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -79.35 64.46 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.0 p-80 164.72 -36.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . 68.6 t60 -48.62 143.76 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.823 ' HG3' HG22 ' A' ' 143' ' ' THR . 3.4 ttm180 -101.32 177.66 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 1.429 ' CG ' ' HA ' ' A' ' 110' ' ' SER . 1.3 t0 -121.26 156.48 32.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -22.25 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.183 0.516 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -73.88 -58.73 3.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.724 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 1.18 ' O ' ' OE2' ' A' ' 146' ' ' GLU . . . 124.84 43.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.852 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.45 114.42 4.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.823 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -82.78 -174.35 0.52 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 86.9 Cg_exo -44.87 -52.12 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.448 2.098 . . . . 0.0 112.072 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 145' ' ' LEU . 10.2 mt -73.35 -36.79 66.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.18 ' OE2' ' O ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -63.9 -64.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.951 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.708 HD12 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -52.37 -46.19 66.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.491 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -55.97 -32.96 64.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.19 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.35 -68.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.649 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.885 ' O ' HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.76 66.18 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 153' ' ' ALA . . . -64.46 50.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.587 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -60.56 -142.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 0.5 OUTLIER -60.41 -149.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 1.071 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 71.4 m-20 -74.64 44.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.984 ' HA ' HD12 ' A' ' 159' ' ' ILE . 2.5 pt? -69.16 -52.9 23.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.571 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER -56.37 -33.62 65.89 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.144 0.497 . . . . 0.0 110.076 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 1.071 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 15.4 p-10 -74.23 -40.0 62.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 126' ' ' SER . 10.6 mt -52.69 -49.86 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.76 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.836 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.78 -33.11 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.968 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -51.41 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.947 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.35 63.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -48.8 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.434 ' HA ' HD13 ' A' ' 134' ' ' LEU . 1.5 tpp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.646 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.825 0.345 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -60.85 -81.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 11.0 t0 -59.93 -14.54 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -63.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.84 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.7 tm? -73.13 -54.67 7.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.034 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.564 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.5 p -57.72 -30.32 65.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -70.76 -46.12 48.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.5 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.86 -55.89 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.267 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.4 69.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -68.03 -26.83 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.226 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -73.29 -26.58 61.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 88.1 66.5 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.069 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 13.4 p-10 -137.15 94.46 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -53.07 -20.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.169 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -74.18 -51.87 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.08 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.069 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -73.24 -32.98 65.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.818 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.872 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.3 p -52.69 -49.58 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 111.09 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 29.7 mtt180 -73.64 -48.88 29.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.279 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.5 mmp_? -52.85 -30.23 32.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.17 -73.99 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.946 HD11 HD23 ' A' ' 62' ' ' LEU . 1.7 mt -73.59 -42.7 61.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.484 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.11 -3.23 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.37 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -143.02 -75.46 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.825 ' OE1' ' HB ' ' A' ' 35' ' ' VAL . 14.1 tt0 -46.93 -23.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 34' ' ' LEU . 10.7 mt 62.01 29.92 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.825 ' HB ' ' OE1' ' A' ' 33' ' ' GLU . 2.7 p -58.92 137.15 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -69.03 145.88 96.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 40.0 Cg_endo -67.33 -11.03 30.69 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.211 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 29.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.74 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -97.9 94.81 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.282 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -102.86 147.87 26.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.685 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 24.5 p30 -44.99 -26.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.0 0.429 . . . . 0.0 110.285 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -146.02 -71.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.534 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 177.89 66.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.933 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.29 -73.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.971 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 40' ' ' LEU . 30.1 mttm -84.87 152.92 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 111.336 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.985 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.5 p -101.52 176.71 5.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 14' ' ' LEU . . . -57.14 -35.74 69.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 69' ' ' PRO . 3.5 tp -72.83 -47.86 42.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' CG ' HG23 ' A' ' 71' ' ' VAL . 2.0 tm0? -65.52 -9.56 27.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 46' ' ' THR . 32.8 m -136.31 26.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.1 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 1.1 tmm? -86.86 149.88 24.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.9 OUTLIER -87.87 86.6 7.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.381 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 53.4 m-85 -35.14 -30.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -28.79 -55.32 0.15 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.148 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -90.94 130.94 38.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HA ' HG23 ' A' ' 91' ' ' THR . 61.0 Cg_endo -73.22 -42.97 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.761 2.307 . . . . 0.0 112.043 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -62.8 -29.01 70.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.521 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.872 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.5 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.879 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.21 -52.95 60.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.584 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -63.61 -38.45 91.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.024 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -62.84 -49.35 75.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.946 HD23 HD11 ' A' ' 30' ' ' LEU . 13.0 mt -62.77 -50.29 71.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.842 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' CG ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -62.91 -23.02 67.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.671 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 11.9 tttt -63.05 -20.4 65.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.79 -57.22 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.89 50.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.515 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.56 -13.78 53.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.9 OUTLIER 62.9 95.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CG ' HD21 ' A' ' 63' ' ' LEU . 74.6 Cg_exo -48.19 -41.47 34.37 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.85 ' ND2' ' OD1' ' A' ' 101' ' ' ASP . 3.5 m120 -71.16 84.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG23 ' CG ' ' A' ' 49' ' ' GLN . 4.7 m -136.45 131.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . 29.2 mt-30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.9 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 1.291 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . 2.6 m -115.9 119.21 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.6 p -104.96 -176.02 0.41 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 40.5 Cg_exo -56.22 -42.98 60.59 Favored 'Trans proline' 0 CA--C 1.527 0.128 0 C-N-CA 122.814 2.342 . . . . 0.0 112.058 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.523 HG23 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.67 -29.95 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.476 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.582 ' ND1' ' OD2' ' A' ' 106' ' ' ASP . 9.4 m170 -72.08 -68.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -61.25 -25.98 67.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.207 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.815 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -56.49 -53.76 53.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.563 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.97 -38.14 66.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.568 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.087 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 6.5 tpt180 -72.15 -24.04 61.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.215 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 82' ' ' ASP . 5.5 p -73.07 -73.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 132.7 63.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.324 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 22.8 m-85 -155.06 59.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.718 HD11 ' CG ' ' A' ' 127' ' ' PHE . 37.6 tp -52.21 -29.32 22.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.235 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 1.108 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -53.19 -67.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.459 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.108 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 47.7 m -72.24 -42.16 65.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 83' ' ' ALA . 1.2 tt -52.37 -48.68 65.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.492 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 92' ' ' LEU . 6.2 ttpp -55.39 -26.08 39.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.877 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.21 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 18.1 t -73.54 -70.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.542 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.986 HD22 ' N ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -63.91 -27.33 69.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.534 -179.375 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.986 ' N ' HD22 ' A' ' 95' ' ' LEU . 41.3 t -73.88 -56.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.759 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.21 ' OE2' ' HA ' ' A' ' 94' ' ' VAL . 17.3 pm0 -56.29 -35.39 67.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.502 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 10.6 t-160 -60.65 -68.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . 179.19 61.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -105.76 26.5 9.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.85 ' OD1' ' ND2' ' A' ' 70' ' ' ASN . 1.1 p-10 47.87 82.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 15.51 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 65.3 m-20 -131.89 27.33 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -101.7 162.03 13.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.555 HD21 ' CD1' ' A' ' 111' ' ' LEU . 74.2 mt -125.13 150.27 47.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 1.291 ' OD2' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -100.34 -169.55 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.8 m -48.29 -46.14 35.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -33.33 75.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 84.03 31.17 26.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.569 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.3 m -105.73 119.98 40.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.627 HD21 ' OD1' ' A' ' 133' ' ' ASP . 9.3 tp -54.53 138.09 60.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 104' ' ' ALA . 94.4 Cg_exo -43.37 -27.01 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.796 2.33 . . . . 0.0 112.366 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.872 ' HB ' HD21 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -73.23 -42.77 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.797 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 31.3 m80 -52.91 -32.51 45.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.286 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.11 -48.66 33.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.361 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -61.74 -32.95 73.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.92 HG21 ' HB3' ' A' ' 147' ' ' LEU . 80.2 mt -66.55 -42.2 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.691 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.6 -16.91 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 1.087 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -86.67 -57.84 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.415 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 110.23 -0.69 29.72 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.54 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 15.2 m-70 -57.68 78.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.592 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -34.36 -48.59 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -62.45 -48.33 80.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 121' ' ' HIS . 47.5 t -69.57 -60.17 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 2.4 t -51.87 -44.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.158 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.846 ' CB ' HG21 ' A' ' 159' ' ' ILE . 60.6 p -71.87 -29.35 64.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.169 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.3 t80 -73.22 -66.4 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.994 HD22 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.73 -8.76 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.947 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -52.22 -71.1 0.22 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 57.4 Cg_endo -70.88 -33.0 13.0 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 128' ' ' LEU . 30.9 mm-40 -54.59 -20.4 7.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.283 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 p -105.81 -171.25 1.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.627 ' OD1' HD21 ' A' ' 111' ' ' LEU . 4.1 p30 -94.5 84.63 4.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.992 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -57.59 75.3 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.222 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 p-80 174.98 -39.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -47.89 173.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -129.88 174.32 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.467 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -131.25 166.97 20.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.6 -20.18 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -52.38 55.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.44 11.2 6.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.443 ' HB3' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -132.72 160.72 35.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.531 ' CB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -112.99 -178.39 0.52 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 84.3 Cg_exo -44.91 -59.75 1.04 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.634 2.223 . . . . 0.0 112.138 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -58.4 -46.74 85.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.633 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.443 ' CD ' ' HB3' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.78 -62.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.92 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.87 -43.61 66.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.805 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.64 -43.46 65.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.375 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -61.04 -36.15 78.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.753 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.486 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -69.74 -80.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.572 179.032 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.36 61.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.674 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.6 52.29 0.88 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.79 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.548 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -32.7 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.452 . . . . 0.0 110.723 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.548 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.6 OUTLIER 172.53 -119.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.29 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.764 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 2.0 m-20 -74.06 4.73 5.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.135 -0.353 . . . . 0.0 111.692 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.995 ' HA ' HD12 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -52.66 -51.84 58.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.805 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.4 ppp? -53.2 -34.7 58.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.764 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 3.1 p30 -73.67 -43.58 59.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.995 HD12 ' HA ' ' A' ' 156' ' ' LEU . 15.5 mt -52.74 -44.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.369 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 160' ' ' LEU . 1.3 mt -73.29 -35.51 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.336 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -67.41 -37.89 83.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.01 44.98 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.389 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -73.26 -9.8 59.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.649 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.086 HG21 HG12 ' A' ' 35' ' ' VAL . 3.9 p . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.779 0.323 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.736 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -40.24 -60.48 1.96 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.386 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 29.4 p30 -56.51 -17.39 8.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.754 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.1 tpm_? -98.59 -64.25 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.756 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 62' ' ' LEU . 2.8 tm? -69.22 -61.71 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.484 ' OG ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.94 -28.29 56.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.64 -49.05 39.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.188 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 22' ' ' ASP . . . -73.03 -40.3 65.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.43 -45.12 65.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.287 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -73.1 -37.58 66.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -73.43 -8.13 54.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 58' ' ' VAL . . . 124.89 -66.56 0.53 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.179 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.608 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 0.3 OUTLIER 33.54 38.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.39 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.687 ' HA ' HG23 ' A' ' 58' ' ' VAL . 2.3 p -52.66 -49.88 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.656 ' HG3' HG13 ' A' ' 23' ' ' VAL . 15.0 mt-30 -75.14 -32.62 61.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.811 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.24 -37.39 66.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.577 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.291 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.4 p -52.39 -35.08 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -71.29 -51.63 23.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.97 -36.72 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.095 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' OE1' ' A' ' 33' ' ' GLU . 20.2 mt -52.96 -61.86 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.1 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.75 HD23 HG23 ' A' ' 35' ' ' VAL . 10.3 mt -73.45 -49.19 28.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.823 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.869 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 20.2 m-70 -70.14 -19.33 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.861 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -126.05 -78.91 0.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 1.172 ' OE2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -39.87 -28.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.1 mt 62.38 31.03 17.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.525 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.172 HG13 ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -54.44 152.07 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.336 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.69 124.6 69.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.83 -11.34 29.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.694 2.262 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 6.3 p30 -90.97 -8.61 48.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.843 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -43.67 136.96 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 45' ' ' LYS . 6.4 mt -129.81 108.92 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -40.45 -44.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.989 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -135.77 35.18 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 49.25 48.08 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.27 -45.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.445 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.941 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.05 147.39 46.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -86.09 166.62 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.27 25.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -73.12 -43.86 61.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.731 ' HG2' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.74 -20.63 65.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG21 ' OG ' ' A' ' 15' ' ' SER . 18.7 m -104.73 -34.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' LEU . 2.0 ttp -42.12 134.81 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.502 ' CE ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -86.74 134.44 33.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.839 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 10.8 m-85 -78.37 52.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.633 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -106.29 -59.55 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.108 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -86.76 114.3 57.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 110.302 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' HG11 ' A' ' 94' ' ' VAL . 9.2 Cg_endo -53.64 -42.29 67.18 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.562 2.175 . . . . 0.0 112.145 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.24 -33.36 75.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.2 t -63.06 -39.93 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -63.04 -59.83 4.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 19.6 tp -63.23 -41.2 99.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.535 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 1.291 ' OE1' HG13 ' A' ' 26' ' ' VAL . 10.6 mt-10 -62.88 -45.84 90.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.501 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.886 HD11 ' HB1' ' A' ' 18' ' ' ALA . 3.2 mt -62.83 -57.1 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 64' ' ' LYS . 4.4 pp -63.51 -25.82 68.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.339 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.66 ' N ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -63.14 -46.9 85.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 30' ' ' LEU . 1.8 mm100 -51.36 -43.85 61.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.65 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -89.46 159.91 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.978 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.92 110.8 36.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.988 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 77.7 Cg_endo -77.59 7.72 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.787 2.325 . . . . 0.0 112.423 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.081 ' OD1' ' OD2' ' A' ' 101' ' ' ASP . 43.4 m-80 -89.48 26.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.731 HG23 ' HG2' ' A' ' 49' ' ' GLN . 8.3 m -107.5 139.08 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.045 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 76' ' ' GLY . 2.3 p -156.85 103.68 2.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.77 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 p -70.51 -174.29 0.25 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 1.036 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 62.9 Cg_exo -50.64 -50.9 12.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.774 2.316 . . . . 0.0 112.533 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.947 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 15.3 m -59.34 -43.81 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.373 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.438 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 44.1 m170 -61.45 -34.47 75.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.043 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.036 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.74 -51.09 20.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -70.05 -11.98 61.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.39 -43.83 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.406 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 1.007 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 2.0 mmt180 -61.51 -58.42 8.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.231 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -72.48 -22.55 61.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.817 ' CA ' HG21 ' A' ' 124' ' ' VAL . . . 105.14 -62.83 0.33 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 16.9 m-85 30.97 37.1 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 110.259 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.2 tm? -51.73 -41.87 61.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.512 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.641 ' C ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.0 -62.96 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.828 0.347 . . . . 0.0 110.877 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -72.01 -46.33 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.921 HD13 ' HB3' ' A' ' 83' ' ' ALA . 14.6 tp -52.4 -43.03 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 109.916 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.567 ' HE2' HD11 ' A' ' 89' ' ' LEU . 1.9 ttpp -53.52 -37.92 63.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.486 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' 56' ' ' PRO . 42.9 t -57.08 -60.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.107 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -73.18 -33.41 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.842 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 4.6 t -73.12 -45.33 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 93' ' ' LYS . 0.9 OUTLIER -58.24 -32.44 68.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.773 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.455 ' ND1' HD13 ' A' ' 63' ' ' LEU . 4.3 t-160 -73.13 -50.38 23.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -166.44 -69.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.298 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.947 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . 30.13 82.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.777 0.322 . . . . 0.0 111.559 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 1.081 ' OD2' ' OD1' ' A' ' 70' ' ' ASN . 2.1 p-10 -39.84 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 112' ' ' PRO . 12.9 m -84.24 11.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.38 -25.94 20.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -50.9 157.45 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.791 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -143.29 161.39 38.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.814 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.82 -90.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.005 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.84 -38.57 2.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 -1.89 25.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 62.57 23.29 64.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 139.79 30.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.791 HD23 ' CD2' ' A' ' 105' ' ' LEU . 11.4 mt -68.34 162.76 58.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 102' ' ' VAL . 76.4 Cg_exo -50.23 -34.26 39.16 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.559 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -61.46 -44.06 97.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.98 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CE1' ' HG ' ' A' ' 111' ' ' LEU . 1.9 m80 -53.07 -44.38 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.875 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -67.64 -48.95 65.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.539 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.206 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.21 -43.31 67.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.712 HG23 HD13 ' A' ' 156' ' ' LEU . 46.0 mt -54.86 -40.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.654 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -62.67 -41.7 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.473 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 1.206 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 2.2 mp0 -72.53 -55.58 6.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.8 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.18 52.01 2.46 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.565 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -81.43 -7.14 59.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.996 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -71.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -66.63 -35.53 80.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.817 HG21 ' CA ' ' A' ' 87' ' ' GLY . 42.9 t -74.01 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.087 0.47 . . . . 0.0 110.606 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 156' ' ' LEU . 4.2 m -53.3 -45.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.335 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.545 ' HB3' HG21 ' A' ' 159' ' ' ILE . 15.8 p -71.92 -28.85 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.784 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 19.0 t80 -73.49 -44.33 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.521 ' CD1' ' OG ' ' A' ' 132' ' ' SER . 0.2 OUTLIER -67.41 -11.51 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.153 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.41 -67.46 0.79 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.283 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 29.6 Cg_endo -64.16 -62.07 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.617 2.212 . . . . 0.0 112.452 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.784 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -37.59 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 17.4 m -98.41 129.4 45.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 1.179 ' OD1' ' HB2' ' A' ' 136' ' ' HIS . 0.1 OUTLIER -36.0 95.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 134' ' ' LEU . 4.0 mt -60.19 151.03 28.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 74.52 13.79 3.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 1.179 ' HB2' ' OD1' ' A' ' 133' ' ' ASP . 20.2 t-80 -103.83 168.95 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -127.2 -160.34 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.12 -171.63 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.41 -9.59 26.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -39.6 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 104.26 68.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 141' ' ' GLY . 93.8 mt -156.91 133.3 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.196 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 80.9 p -96.51 159.12 32.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 6.0 Cg_exo -38.61 -48.8 2.59 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.15 2.566 . . . . 0.0 112.184 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.1 mt -66.98 -40.58 87.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.196 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 1.1 mp0 -52.99 -68.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' GLN . 8.4 tp -52.66 -29.01 24.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.17 -15.22 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.471 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 1.4 ttt180 -73.26 -48.46 34.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.46 -90.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.885 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -75.88 50.65 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -74.21 44.26 1.34 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.829 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' LEU . . . -34.46 150.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.617 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 40.44 -161.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.89 ' CA ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -74.61 43.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.207 -0.308 . . . . 0.0 111.543 179.228 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 125' ' ' VAL . 2.2 mt -59.43 -55.95 28.15 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 110.966 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -51.66 -44.04 62.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.89 ' OD1' ' CA ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -74.5 -35.08 63.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.267 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.852 HG22 HD23 ' A' ' 160' ' ' LEU . 11.0 mt -53.16 -52.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.158 0.504 . . . . 0.0 110.456 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.872 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.51 -24.54 59.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.256 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -64.46 -41.72 96.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.164 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.48 -53.51 8.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 15.2 m-70 -60.87 -40.24 92.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.881 0.372 . . . . 0.0 110.88 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.417 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.994 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 t -113.64 144.45 42.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.757 0.313 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.2 mtt 55.27 74.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -11.61 13.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -119.05 106.81 12.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -124.58 124.46 42.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' O ' ' CG ' ' A' ' 7' ' ' GLU . 18.6 tt0 -134.67 47.75 2.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 40' ' ' LEU . 12.6 p -114.91 -26.15 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.025 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.3 t -44.05 -36.87 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.558 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 35' ' ' VAL . 52.3 t -92.04 -18.22 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.863 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.699 ' O ' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -83.07 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 3.0 p30 -51.92 -29.94 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -37.0 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.787 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.963 ' CB ' HG21 ' A' ' 35' ' ' VAL . 4.9 tp -72.28 -23.84 61.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -65.59 -49.89 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.7 -27.91 68.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.503 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -72.21 -55.07 7.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.347 . . . . 0.0 111.249 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.82 79.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.249 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -32.64 64.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.4 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.0 -9.86 58.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.002 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.406 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 70.42 75.89 0.57 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 24' ' ' GLN . 1.2 t70 -144.7 85.56 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.795 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -52.9 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 mt-30 -70.66 -45.02 65.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.7 mm-40 -72.99 -49.43 29.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.676 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 58' ' ' VAL . 47.2 t -57.92 -29.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 4.8 mmt180 -72.03 -60.86 2.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -69.16 -22.77 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.1 mt -54.44 -66.55 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 65' ' ' GLN . 16.5 mt -72.28 -40.59 67.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.13 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 23.0 m-70 -65.41 -19.62 66.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.306 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -133.0 -66.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' LEU . 2.4 tp10 -58.48 -14.46 7.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.2 mt 46.96 25.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.786 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.963 HG21 ' CB ' ' A' ' 14' ' ' LEU . 14.7 p -43.96 148.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 144.29 43.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.608 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 58.7 Cg_endo -72.12 -22.98 21.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.404 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.54 2.53 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 11' ' ' GLY . . . -42.25 124.74 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.2 mt -122.01 130.08 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 4.6 p-10 -66.21 -179.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -47.79 -43.34 27.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.89 -65.34 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.52 47.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 13.2 mtpt -116.42 151.08 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.8 p -85.14 162.05 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . . . -53.83 -47.46 70.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.118 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 69' ' ' PRO . 1.1 mp -62.8 -27.59 69.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.578 HE21 HG23 ' A' ' 71' ' ' VAL . 9.8 tt0 -72.97 -29.26 62.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' THR . 2.9 m -101.63 -26.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -36.65 142.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.797 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 ptt? -102.31 22.69 12.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.994 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.7 m-85 36.57 31.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -76.94 -77.8 0.77 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.502 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -77.86 121.02 83.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.966 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.47 -45.69 37.9 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.61 2.207 . . . . 0.0 112.159 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 61' ' ' GLU . . . -63.16 -28.69 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.368 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HA ' HG11 ' A' ' 26' ' ' VAL . 2.5 t -62.95 -38.57 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.209 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -63.32 -49.77 72.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 53.1 tp -63.15 -33.13 74.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 1.9 mm-40 -62.54 -49.1 76.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 14' ' ' LEU . 5.6 mt -62.96 -56.26 18.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.608 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' ALA . 1.1 mt -63.36 -25.73 68.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 1.6 tttp -62.84 -29.84 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.751 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -76.87 -73.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.92 62.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -107.45 153.29 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.165 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -96.6 99.24 5.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 31.7 Cg_endo -64.31 -15.83 51.75 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -79.7 65.86 4.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.578 HG23 HE21 ' A' ' 49' ' ' GLN . 28.2 m -126.4 138.11 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.261 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.44 146.53 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 2.9 p30 -153.06 142.99 22.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 73' ' ' ASP . . . 40.88 97.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 76' ' ' GLY . 7.4 t 73.68 30.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 75' ' ' SER . . . 37.18 62.83 0.84 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -114.88 102.1 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -89.75 -174.57 0.46 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 51.3 Cg_exo -55.57 -41.65 75.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.85 2.367 . . . . 0.0 112.545 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.899 HG21 ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -62.86 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.328 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 65.8 m80 -58.14 -51.37 70.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.753 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -66.63 -50.38 63.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.39 -30.44 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.41 -67.11 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.617 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -62.33 -29.55 70.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.812 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 82' ' ' ASP . 52.2 p -66.99 -54.07 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 111.211 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 110.38 66.04 0.54 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.121 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -140.66 53.43 1.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 0.0 110.55 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.983 HD22 ' HB2' ' A' ' 123' ' ' SER . 20.6 tp -52.23 -19.07 1.8 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -63.52 -72.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.819 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 6.3 m -73.15 -24.1 60.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.527 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.568 ' CD2' HG21 ' A' ' 96' ' ' VAL . 9.7 tt -56.16 -59.79 4.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 127' ' ' PHE . 8.1 ptmt -58.32 -38.0 76.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.133 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.765 HG11 ' HB3' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -51.73 -61.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.09 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.994 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -74.8 -43.48 54.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.873 HG22 HG12 ' A' ' 80' ' ' VAL . 10.7 t -52.54 -42.55 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.512 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.6 mm-40 -73.54 -39.53 64.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.225 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -51.88 66.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 178.77 -26.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.095 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -23.82 123.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 112.002 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.899 ' O ' HG21 ' A' ' 80' ' ' VAL . 9.8 t0 -56.6 85.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 102' ' ' VAL . 10.2 p -98.31 28.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 104' ' ' ALA . 0.2 OUTLIER -120.91 -33.22 3.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -48.11 -177.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 111' ' ' LEU . 9.3 mt -139.99 175.47 9.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.88 62.03 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 108' ' ' THR . 0.3 OUTLIER 68.45 -75.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 107' ' ' SER . 4.7 p -37.96 -48.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 122.93 19.72 2.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.512 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.512 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -93.06 118.29 31.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 110.993 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.945 HD11 ' HB3' ' A' ' 136' ' ' HIS . 5.2 mt -65.27 143.8 98.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.646 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 83.7 Cg_exo -45.2 -26.12 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.606 2.204 . . . . 0.0 112.173 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -72.12 -40.04 66.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.084 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -53.04 -46.04 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -58.76 -44.19 90.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.671 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.739 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -60.04 -35.63 75.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.443 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.577 ' HB ' HD23 ' A' ' 147' ' ' LEU . 97.8 mt -64.45 -43.62 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 115' ' ' LEU . 12.6 ptt180 -73.26 -10.12 59.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.745 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -59.77 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.08 25.22 7.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.404 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 9.7 m-70 -63.82 -11.93 31.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 23.2 t 70.52 -68.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.983 ' HB2' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -70.63 -52.86 18.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.745 ' HA ' HD13 ' A' ' 89' ' ' LEU . 22.0 t -52.83 -55.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.9 t -52.0 -61.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 159' ' ' ILE . 5.4 p -58.0 -30.44 66.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.7 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.4 t80 -73.31 -55.39 6.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -63.93 -11.67 30.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.067 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.923 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -57.56 -70.24 0.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.929 ' HA ' HD11 ' A' ' 134' ' ' LEU . 57.9 Cg_endo -71.51 -17.92 29.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.238 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 29.4 mm-40 -90.56 31.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -152.1 -168.62 3.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.901 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 135' ' ' HIS . 23.5 t0 -77.1 83.78 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.9 mp -64.97 61.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.976 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 133' ' ' ASP . 19.0 t-160 -175.07 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.945 ' HB3' HD11 ' A' ' 111' ' ' LEU . 79.0 t60 -54.89 155.02 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -140.67 158.29 44.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.512 ' OD1' ' CB ' ' A' ' 110' ' ' SER . 1.9 t70 -64.23 158.7 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.68 -19.69 6.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 110.287 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -46.22 72.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.859 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 125.08 32.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -129.16 146.31 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -115.82 -174.32 0.27 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.593 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 71.7 Cg_exo -48.66 -43.69 33.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -73.19 -47.91 39.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 17.3 tp10 -57.54 -57.52 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.577 HD23 ' HB ' ' A' ' 117' ' ' ILE . 6.6 tp -52.35 -34.31 46.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -63.82 -33.04 74.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.61 -30.18 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.007 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 3.1 tp-100 -70.4 -80.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.668 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.9 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.2 71.89 1.71 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -72.54 46.18 1.07 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.321 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -36.79 -32.81 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.393 0.616 . . . . 0.0 110.263 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 3.3 pm0 -179.66 -143.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.689 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' GLN . 1.1 m-80 -68.82 57.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.963 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 151' ' ' ARG . 4.1 mt -71.47 -69.77 0.36 Allowed 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 111.008 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.687 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 6.8 ptm -52.73 -19.46 2.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.786 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.64 -47.28 41.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 126' ' ' SER . 1.5 mt -62.08 -50.64 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.747 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -68.33 -29.99 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.541 ' HB2' HD21 ' A' ' 145' ' ' LEU . 4.4 tt0 -63.54 -42.91 98.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.24 -47.76 35.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.653 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -71.1 -20.04 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.043 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.503 ' HA ' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -45.71 -70.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . 1.054 ' O ' HD12 ' A' ' 166' ' ' ILE . 0.6 OUTLIER 169.12 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 1.054 HD12 ' O ' ' A' ' 165' ' ' MET . 0.6 OUTLIER 35.38 77.67 0.37 Allowed Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.088 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.77 7.4 4.29 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.813 2.342 . . . . 0.0 112.423 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.941 -179.942 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t -132.38 102.19 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -124.02 37.89 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.81 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt -76.77 -24.03 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mt 56.25 -172.49 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.704 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' C ' ' CG ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -138.88 52.92 1.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' CG ' ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER 44.36 71.44 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 9' ' ' CYS . 54.1 t -126.19 -85.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.516 ' N ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER 60.03 -83.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -93.53 -13.51 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -34.27 -31.12 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.816 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -109.62 -21.08 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 0.0 110.935 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' VAL . 9.5 tpt180 -57.07 -69.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.034 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD11 ' CD2' ' A' ' 62' ' ' LEU . 3.8 tp -68.65 -20.4 64.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 23.8 t -73.32 -44.32 59.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.01 -33.68 59.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.621 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.611 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -71.61 -38.88 70.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -72.84 -43.58 62.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.206 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -67.96 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.202 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.1 ptp180 -68.3 -9.33 46.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.27 90.02 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 27' ' ' ARG . 2.4 p -52.65 -22.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.08 -47.86 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 mm-40 -72.87 -44.7 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.993 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.8 p -52.64 -41.87 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.018 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD3' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.3 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 5.2 mtt180 -56.0 -21.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.616 HD22 HG21 ' A' ' 35' ' ' VAL . 10.3 mt -72.42 -68.99 0.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.61 -44.07 78.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.302 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 61.6 m-70 -73.13 -0.94 15.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.277 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -149.26 -76.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.212 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 35' ' ' VAL . 14.5 tp10 -42.88 -27.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.978 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER 55.4 59.57 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.23 143.35 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.687 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 2.1 t-80 -76.29 143.56 73.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.766 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 45.1 Cg_endo -68.07 -21.75 42.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 0.0 112.135 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.869 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -91.21 33.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.77 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -80.93 125.6 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.39 124.2 39.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -62.5 -62.21 1.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 30.5 tpt180 -97.87 46.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 26.5 t80 37.48 62.32 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.95 -65.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.385 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 15.3 mtpp -86.91 146.63 26.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.676 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.2 p -92.73 -177.95 4.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -72.27 -36.0 68.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -32.08 69.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' HE3' ' A' ' 45' ' ' LYS . 1.8 tt0 -69.94 -15.31 63.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 46' ' ' THR . 2.6 m -110.25 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.522 ' SD ' HD12 ' A' ' 62' ' ' LEU . 21.8 ttp -38.08 123.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.681 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -88.87 19.64 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.995 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER 39.35 30.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.121 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.22 -45.51 48.48 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.121 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 1.018 ' O ' HG22 ' A' ' 58' ' ' VAL . 20.5 m -108.6 134.85 20.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.6 -37.7 6.84 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.572 2.181 . . . . 0.0 112.29 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.42 -36.22 83.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.353 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.018 HG22 ' O ' ' A' ' 55' ' ' SER . 5.4 m -62.5 -27.99 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' A' ' 91' ' ' THR . . . -63.37 -60.36 3.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.618 ' C ' HD13 ' A' ' 60' ' ' LEU . 1.8 tm? -63.15 -40.67 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.964 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -62.52 -40.57 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.562 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 18' ' ' ALA . 7.1 mt -63.86 -63.57 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.496 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.593 HD23 ' CD2' ' A' ' 98' ' ' HIS . 23.6 tp -63.58 -14.69 53.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -62.9 -36.01 81.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.051 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 37' ' ' PRO . 2.4 mm-40 -68.08 -14.48 63.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.15 34.88 4.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.85 -179.41 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.596 ' O ' HG13 ' A' ' 71' ' ' VAL . 14.4 t -121.92 93.75 48.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.514 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 52.2 Cg_exo -54.22 -17.4 11.64 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.734 2.289 . . . . 0.0 112.179 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.719 ' OD1' ' OD1' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -94.65 64.02 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.793 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 68' ' ' SER . 2.7 m -104.56 146.55 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -142.79 143.68 32.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.7 p-10 -109.41 -170.3 1.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.75 68.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER 177.48 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.49 77.3 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.457 HG22 ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -164.63 135.56 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.897 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.553 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.54 -177.38 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 29.2 Cg_exo -61.65 -39.53 53.21 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.883 2.389 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.5 m -60.31 -28.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 78' ' ' SER . 3.2 m80 -62.65 -67.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.889 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.81 -43.92 90.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.806 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -52.48 -28.3 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.128 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.71 -56.5 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.535 ' NE ' HD13 ' A' ' 115' ' ' LEU . 1.8 mtt180 -73.16 -22.79 60.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.815 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 82' ' ' ASP . 69.5 p -71.12 -57.06 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.2 67.8 0.5 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 52' ' ' MET . 22.8 m-85 -140.61 52.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.413 . . . . 0.0 110.586 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.874 ' HG ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -52.36 -30.63 29.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.8 m -65.9 -37.4 86.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 83' ' ' ALA . 9.6 tp -52.82 -49.46 65.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.334 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.756 ' CE ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -53.99 -42.15 68.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 59' ' ' ALA . 22.6 t -52.86 -59.09 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.435 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.995 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.9 pp -71.3 -41.17 70.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 2.1 t -67.48 -56.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.953 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -52.72 -29.73 28.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.053 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.593 ' CD2' HD23 ' A' ' 63' ' ' LEU . 4.2 t-80 -60.61 -32.26 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.934 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.33 -5.52 4.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -46.01 141.13 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.743 0.306 . . . . 0.0 111.044 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.719 ' OD1' ' OD1' ' A' ' 70' ' ' ASN . 19.6 p-10 -52.08 140.17 21.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.06 13.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.587 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.82 8.01 30.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -82.26 136.85 34.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -106.76 167.34 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.59 -169.67 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -20.89 26.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 1.9 m -90.05 -9.39 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.795 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 71.93 42.28 52.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.441 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 1.342 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 2.7 m -119.15 127.93 53.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.047 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -59.95 149.63 72.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 1.047 ' HD2' HD23 ' A' ' 111' ' ' LEU . 55.1 Cg_exo -51.72 -30.52 37.68 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.13 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 111' ' ' LEU . 14.4 tt -71.0 -32.46 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 138' ' ' ASP . 32.9 m170 -62.16 -36.19 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -73.28 -42.95 61.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.638 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.772 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.657 ' HA ' HG11 ' A' ' 125' ' ' VAL . 96.6 mt -59.79 -41.51 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -73.23 -4.05 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 115' ' ' LEU . 1.9 mm-40 -118.07 -46.07 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.5 53.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.099 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 23.8 m-70 -66.99 84.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.0 t 52.91 -146.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -73.6 4.37 5.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.874 HG22 ' HG ' ' A' ' 89' ' ' LEU . 46.7 t -52.27 -60.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.772 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.4 t -52.75 -36.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.104 0.478 . . . . 0.0 110.506 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.802 ' HB2' HG21 ' A' ' 159' ' ' ILE . 2.5 t -70.13 -44.96 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.607 ' CD2' HD21 ' A' ' 89' ' ' LEU . 20.4 t80 -69.15 -26.78 65.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -73.56 -0.19 14.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.251 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -73.11 -70.05 0.29 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 39.4 Cg_endo -66.86 -46.81 3.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.795 2.33 . . . . 0.0 112.802 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.581 ' OE1' ' CE2' ' A' ' 127' ' ' PHE . 4.8 pt-20 -51.52 -34.65 37.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.351 . . . . 0.0 110.758 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 9.3 m -108.8 151.06 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.137 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 31.1 p30 -34.8 121.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.9 mt -89.8 27.69 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -167.87 43.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.066 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.137 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -109.85 172.91 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.801 ' HG3' HG22 ' A' ' 143' ' ' THR . 8.5 mtm-85 -141.66 125.42 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.986 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 1.342 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 1.5 t0 -76.14 152.62 36.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 108' ' ' THR . . . -51.12 -21.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.74 47.87 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.575 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' CD1' ' HG ' ' A' ' 147' ' ' LEU . 2.9 pp -174.43 139.65 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.165 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.801 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -95.41 -175.31 0.45 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 85.0 Cg_exo -47.67 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.802 2.335 . . . . 0.0 112.275 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.77 -36.05 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 142' ' ' LEU . 68.3 mm-40 -61.48 -63.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.83 -48.99 66.6 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.063 0.458 . . . . 0.0 109.808 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 160' ' ' LEU . . . -54.61 -33.79 61.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.052 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -66.42 -44.73 82.15 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -67.84 -88.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.932 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 11.3 ttm180 -75.22 58.0 0.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 148' ' ' ALA . . . -73.18 45.53 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.557 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 156' ' ' LEU . . . -39.27 134.86 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 36.68 -152.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.529 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 3.5 p-10 -74.45 50.31 0.41 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.236 -0.186 . . . . 0.0 110.861 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 159' ' ' ILE . 3.3 mt -66.39 -70.64 0.23 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 111.67 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.745 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 9.1 ptm -52.49 -20.07 2.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -73.62 -52.35 13.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 126' ' ' SER . 1.9 mt -57.65 -32.2 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 120.913 0.387 . . . . 0.0 111.009 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -73.5 -40.84 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.058 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -65.71 -25.71 67.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -54.68 6.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.345 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -71.37 -12.62 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.72 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.7 mmm -78.09 116.16 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.18 -155.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.995 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.526 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 35.4 pt 38.87 58.19 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 166' ' ' ILE . 42.6 Cg_exo -56.64 83.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.719 2.279 . . . . 0.0 112.279 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 10.3 mmt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.895 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 1' ' ' GLY . 0.4 OUTLIER 37.12 80.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.4 -33.25 15.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.53 126.59 46.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.73 69.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.806 ' OE2' ' N ' ' A' ' 9' ' ' CYS . 4.4 tm-20 -151.4 152.25 32.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -145.57 21.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 9' ' ' CYS . 53.1 t -125.13 -93.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.806 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 98.4 m 48.69 -85.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -72.09 -30.2 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.468 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.548 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -41.35 -26.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.688 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' ASN . 30.6 t0 -108.11 31.58 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' VAL . 12.4 ttm180 -117.32 -59.82 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.628 ' HB2' HG11 ' A' ' 35' ' ' VAL . 12.3 tp -70.87 -24.13 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -64.68 -48.35 75.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.762 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -73.1 -36.32 56.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.4 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.24 -57.37 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.74 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' MET . . . -73.13 -22.93 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 8.0 mtp180 -72.84 -27.48 61.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 62.34 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.225 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.1 p-10 -132.11 84.42 2.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.4 p -52.84 -21.53 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 46.8 mt-30 -73.5 -49.13 28.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.818 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.225 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 7.0 mp0 -73.47 -41.88 62.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.952 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.8 p -52.86 -39.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 1.138 ' HG2' ' OE2' ' A' ' 61' ' ' GLU . 5.2 mtt180 -73.13 -61.46 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.362 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 14.4 mtm-85 -62.04 -25.6 67.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.224 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.574 HD11 ' CB ' ' A' ' 17' ' ' ALA . 9.5 mt -56.73 -66.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.883 HD22 ' HG3' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -73.54 -48.73 30.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.775 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 1.1 m-70 -68.95 -10.94 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.963 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -137.42 -66.88 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.72 0.295 . . . . 0.0 111.386 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -54.51 -18.26 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.076 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 34' ' ' LEU . 4.8 mt 55.29 61.65 2.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 14' ' ' LEU . 12.0 p -107.31 129.3 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.586 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 1.5 t60 -56.83 146.6 57.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 18.6 Cg_endo -58.78 -66.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.713 2.276 . . . . 0.0 112.21 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -44.73 -62.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . 34.28 97.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 46' ' ' THR . 1.7 mp -92.78 130.82 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 37.8 p-10 -65.51 -31.67 72.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.92 39.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 65.5 t80 54.42 72.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.01 -64.71 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.581 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HB3' HG13 ' A' ' 50' ' ' VAL . 10.8 mmtt -98.32 136.47 38.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.751 0.31 . . . . 0.0 111.052 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 50' ' ' VAL . 33.3 p -89.2 161.72 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.91 -33.68 51.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' CD1' HD11 ' A' ' 62' ' ' LEU . 2.0 tp -73.25 -42.23 62.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.983 ' NE2' ' OD2' ' A' ' 73' ' ' ASP . 54.2 tt0 -73.15 -8.71 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 46' ' ' THR . 3.9 m -115.83 -23.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.574 ' HA ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.8 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.732 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.575 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -124.37 21.12 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.79 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.917 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.1 m-85 41.01 29.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.944 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -58.38 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.076 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.544 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -73.7 153.33 89.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.432 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.691 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 13.1 Cg_exo -69.96 -42.93 2.79 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.819 2.346 . . . . 0.0 112.303 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -63.55 -23.72 67.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.926 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.831 ' HA ' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.49 -49.45 83.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.36 -47.56 81.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.597 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.667 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -63.03 -53.25 56.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.325 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.138 ' OE2' ' HG2' ' A' ' 27' ' ' ARG . 2.2 mt-10 -63.27 -56.86 13.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.928 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.67 -50.46 71.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.672 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 6.9 tt -63.4 -42.89 98.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.67 0.271 . . . . 0.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.8 tttp -62.77 -42.05 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.883 ' HG3' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -44.49 -29.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.546 ' CA ' ' HG3' ' A' ' 37' ' ' PRO . . . 132.7 59.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -107.21 167.26 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -108.56 103.67 51.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 37.0 Cg_endo -65.88 -13.55 40.36 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.797 2.331 . . . . 0.0 112.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -102.61 86.67 2.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.879 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' SER . 12.7 m -142.74 132.11 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.0 OUTLIER -149.6 146.44 27.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.983 ' OD2' ' NE2' ' A' ' 49' ' ' GLN . 2.7 p30 -151.1 -170.49 3.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 61.38 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 73' ' ' ASP . 1.4 p -133.62 -66.93 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.04 78.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.99 154.22 34.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.986 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -139.62 -174.26 0.4 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.947 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 55.2 Cg_exo -51.67 -51.24 11.6 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.79 2.327 . . . . 0.0 112.458 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -52.83 -44.08 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' NE2' ' HG3' ' A' ' 112' ' ' PRO . 51.4 m80 -62.94 -56.25 18.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.007 ' O ' HG23 ' A' ' 86' ' ' THR . 1.9 p30 -54.77 -48.83 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.845 ' CB ' HD13 ' A' ' 92' ' ' LEU . . . -56.28 -57.19 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.12 -50.3 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.86 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -57.16 -40.77 77.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.3 p -73.33 -59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.82 73.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.216 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 56.7 m-85 -136.75 49.81 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -52.39 -35.73 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.056 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.57 -66.43 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.779 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.812 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 63.0 m -71.72 -41.09 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.845 HD13 ' CB ' ' A' ' 83' ' ' ALA . 49.7 tp -52.66 -51.24 61.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.502 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 97' ' ' GLU . 28.9 ttmt -52.74 -36.85 58.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.481 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.295 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 24.2 t -57.03 -70.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.917 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -58.59 -38.51 78.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.819 HG11 ' OE1' ' A' ' 131' ' ' GLU . 2.4 t -64.02 -60.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.682 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.295 ' CD ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.73 -30.81 34.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.863 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.506 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -73.15 -54.56 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.653 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . -164.73 -65.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.287 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 40.2 -166.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.354 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.446 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 14.6 p-10 -135.63 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.689 HG13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -100.9 19.14 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.765 ' ND2' ' OD2' ' A' ' 133' ' ' ASP . 15.3 m120 -104.67 -25.18 12.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -67.55 167.6 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 109' ' ' GLY . 7.7 mt -136.14 -160.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 107' ' ' SER . 4.1 m-20 -122.91 -154.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 106' ' ' ASP . 18.9 m -60.34 -38.79 84.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -88.17 -3.53 58.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 69.71 46.55 53.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.499 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -107.37 134.8 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.996 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.501 ' HB2' ' ND1' ' A' ' 114' ' ' HIS . 36.9 mt -62.97 151.22 86.37 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.825 ' HB2' HD11 ' A' ' 128' ' ' LEU . 89.3 Cg_exo -46.64 -26.46 4.42 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.626 2.217 . . . . 0.0 112.243 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 129' ' ' ALA . 17.7 tt -71.79 -35.78 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.844 ' HA ' HD12 ' A' ' 117' ' ' ILE . 21.6 m80 -56.34 -37.96 70.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.755 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.1 mt -69.09 -51.78 35.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.604 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -52.83 -32.07 42.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 147' ' ' LEU . 52.7 mt -60.9 -39.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.57 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.43 ' CD ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -68.19 -17.35 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.525 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.86 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -92.08 -54.69 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.76 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.26 37.15 7.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -65.63 -10.63 37.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.86 -68.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.08 -49.74 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.59 -59.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 116' ' ' ALA . 11.4 t -52.34 -46.52 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.313 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.733 ' HB3' HG21 ' A' ' 159' ' ' ILE . 73.4 p -69.45 -33.59 73.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.289 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 1.381 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 17.6 t80 -73.3 -40.01 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -62.17 -12.16 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -66.69 -64.59 2.13 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.706 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 Cg_endo -59.17 -35.63 97.29 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.876 2.384 . . . . 0.0 112.445 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.381 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mt-10 -90.5 35.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.508 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 92.6 p -151.59 48.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.765 ' OD2' ' ND2' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 36.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.765 HD22 ' HG3' ' A' ' 164' ' ' MET . 69.8 mt -55.6 141.09 38.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.499 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 7.7 t-80 84.72 -12.56 0.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 41.3 t-80 -60.49 169.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 -169.77 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 4.5 m-20 -145.5 171.26 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.524 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . . . -68.54 -6.44 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 p -114.05 0.87 14.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.21 95.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.492 ' HB3' HD23 ' A' ' 147' ' ' LEU . 33.9 mt -120.2 77.4 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.076 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 14.2 p -48.27 161.41 0.38 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.711 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.5 Cg_exo -48.28 -37.5 32.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.747 2.298 . . . . 0.0 112.421 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.563 ' O ' HD23 ' A' ' 145' ' ' LEU . 2.0 tt -71.06 -41.74 70.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.076 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -66.3 -48.54 70.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.19 -39.79 60.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.039 0.447 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.926 ' HB1' HD13 ' A' ' 156' ' ' LEU . . . -61.23 -45.69 93.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.204 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.437 ' HB2' ' CE ' ' A' ' 157' ' ' MET . 11.0 tpt180 -57.19 -30.5 64.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.29 -75.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.792 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 1.078 ' O ' HD21 ' A' ' 156' ' ' LEU . 17.1 mmm180 -74.56 70.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.46 51.39 0.09 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.334 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -52.57 -31.19 34.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.473 0.654 . . . . 0.0 109.831 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.536 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 2.9 pm0 173.27 -146.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.182 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 1.205 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 21.5 m120 -74.91 44.53 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.078 HD21 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -73.58 -31.45 63.61 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.479 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.677 ' H ' HD12 ' A' ' 156' ' ' LEU . 1.1 ptm -67.34 -29.05 68.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.205 ' OD1' ' O ' ' A' ' 155' ' ' ASN . 5.4 p-10 -74.26 -46.58 40.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.245 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.16 -39.83 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.198 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.01 -41.56 61.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.11 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG3' ' HG ' ' A' ' 145' ' ' LEU . 1.9 mt-30 -61.73 -55.37 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.3 95.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.427 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 159' ' ' ILE . 1.1 m-70 -72.98 -10.86 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.978 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.765 ' HG3' HD22 ' A' ' 134' ' ' LEU . 3.1 ttm -90.82 -176.36 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.866 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 ttp -130.94 28.3 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 166' ' ' ILE . 9.9 pt -53.12 113.29 4.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.16 -10.36 17.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.896 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 t -148.73 -57.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 mtm -98.48 112.1 24.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 170.12 44.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.567 ' C ' ' OE1' ' A' ' 7' ' ' GLU . 1.8 mt -88.55 115.33 25.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.669 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 1.2 mm-40 -112.33 -27.4 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.692 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER 41.71 68.9 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.744 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG13 ' H ' ' A' ' 9' ' ' CYS . 2.2 p -134.08 -57.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.611 ' H ' HG13 ' A' ' 8' ' ' VAL . 55.2 m 41.95 -91.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 35' ' ' VAL . 4.7 p -94.57 25.04 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.751 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -78.37 -10.57 86.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 2.5 p30 -129.12 24.07 5.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.745 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 5.8 ttt180 -103.89 -67.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.82 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -69.39 -39.99 77.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.696 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.633 ' N ' HD13 ' A' ' 14' ' ' LEU . 1.1 m -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.68 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.03 -36.4 60.72 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.31 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -68.49 -57.17 6.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.95 64.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -27.94 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -73.14 -31.7 64.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 83.69 64.92 1.59 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.406 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.399 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 1.2 p30 -137.12 100.94 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 26' ' ' VAL . 2.5 p -52.7 -23.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -73.31 -49.61 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.399 ' OE1' ' CB ' ' A' ' 22' ' ' ASP . 1.8 mt-10 -73.09 -47.24 46.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.9 p -52.86 -38.1 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 60.2 mtm180 -73.15 -61.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.192 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -52.94 -31.8 42.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.251 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -72.9 -69.08 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 10.8 mt -70.69 -42.62 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 4.3 t-80 -73.29 -0.51 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.376 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -150.58 -75.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.717 0.294 . . . . 0.0 111.179 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.745 ' OE1' HD23 ' A' ' 29' ' ' LEU . 2.8 tm-20 -41.18 -27.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 34' ' ' LEU . 9.7 mt 54.79 56.04 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 14' ' ' LEU . 41.0 t -87.28 130.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -48.41 133.7 13.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.9 Cg_endo -71.61 -18.95 28.63 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.767 2.311 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.821 ' O ' HD12 ' A' ' 40' ' ' LEU . 57.5 p-10 -87.49 1.73 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -45.91 121.83 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -111.34 127.45 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 6.5 m-80 -64.06 -163.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.401 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -81.79 -2.0 49.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.83 -23.13 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.744 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 96.24 29.35 8.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.447 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HB3' HG13 ' A' ' 50' ' ' VAL . 22.6 mttp -105.45 152.92 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.22 168.16 14.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -61.17 -53.8 52.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 51' ' ' MET . 3.6 mt -68.17 -27.99 66.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HB2' HG21 ' A' ' 71' ' ' VAL . 45.0 tt0 -73.39 -3.66 28.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 46' ' ' THR . 28.6 m -133.68 -37.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -36.09 137.72 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.901 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.504 ' HE2' ' HA3' ' A' ' 54' ' ' GLY . 12.4 ptm -93.5 123.62 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.059 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 60.9 m-85 -56.96 -16.51 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -36.31 -40.85 0.45 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.255 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.922 ' O ' HG22 ' A' ' 58' ' ' VAL . 19.3 m -110.94 127.16 27.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.608 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.3 Cg_endo -73.6 -32.28 7.88 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.297 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.93 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.0 -39.73 95.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 55' ' ' SER . 19.1 m -62.38 -30.04 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.065 0.46 . . . . 0.0 110.447 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -64.0 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 6.2 tt -63.24 -32.12 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.93 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -62.91 -54.54 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -62.69 -46.1 89.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.654 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 63' ' ' LEU . 2.5 mt -63.29 -49.48 73.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 60' ' ' LEU . 5.6 ttpp -63.01 -13.1 31.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.089 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -79.0 -34.47 44.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.86 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.16 44.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.74 -171.63 2.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 m -136.47 114.11 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -26.51 20.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.621 2.214 . . . . 0.0 112.348 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.14 75.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 49' ' ' GLN . 4.0 m -137.25 134.2 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.406 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 11.0 mt-30 -131.34 167.54 19.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.48 -71.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 75' ' ' SER . . . -41.04 -29.87 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 1.1 t 162.92 -28.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . 171.2 37.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -110.95 113.89 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -86.68 171.19 10.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.704 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 14.3 Cg_endo -56.92 -41.64 73.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.629 2.219 . . . . 0.0 112.07 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 2.9 m -56.39 -43.9 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 79.7 m80 -54.1 -53.43 53.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 86' ' ' THR . 2.9 p30 -70.12 -31.17 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.154 ' CB ' HD11 ' A' ' 92' ' ' LEU . . . -66.64 -25.8 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.25 -65.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.29 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -59.51 -26.3 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 82' ' ' ASP . 4.1 p -65.9 -37.62 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.094 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.54 66.28 1.29 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.425 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -140.33 49.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.97 HD21 ' CD2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -53.4 -18.82 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.29 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.715 ' C ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.4 -70.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.8 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.63 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 13.8 m -71.21 -31.76 67.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.34 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.154 HD11 ' CB ' ' A' ' 83' ' ' ALA . 1.1 mp -53.7 -52.01 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.111 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.901 ' HD3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -51.18 -30.93 18.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 62.1 t -74.3 -58.23 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.201 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.827 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 2.3 pp -74.58 -44.1 52.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.13 -29.84 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.21 -27.28 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -73.51 -50.2 22.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -168.15 -70.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.035 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . 24.4 99.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' ALA . 6.2 p-10 -37.52 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -92.68 -6.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.647 ' HA ' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.55 2.44 39.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -74.65 171.51 13.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.1 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 111' ' ' LEU . 56.3 mt -136.35 -168.14 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -171.1 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -52.04 -28.25 16.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -10.71 38.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.629 ' O ' HD22 ' A' ' 105' ' ' LEU . . . 72.13 9.83 72.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.623 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.462 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -77.62 109.79 11.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.136 HD23 ' CG2' ' A' ' 113' ' ' ILE . 6.3 tp -59.78 142.22 88.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.715 ' HA ' HD13 ' A' ' 115' ' ' LEU . 90.8 Cg_exo -40.7 -29.13 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.734 2.29 . . . . 0.0 112.352 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 1.136 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -73.27 -43.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 43.2 m80 -53.59 -37.11 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.715 HD13 ' HA ' ' A' ' 112' ' ' PRO . 6.6 mp -57.54 -57.8 11.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.783 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -52.86 -30.23 32.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.824 ' HB ' HD23 ' A' ' 147' ' ' LEU . 77.9 mt -66.46 -38.08 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.516 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HG2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -73.18 -15.85 61.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 1.29 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 2.6 mp0 -94.69 -52.99 4.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 87.39 18.1 57.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.158 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' SER . 92.8 m-70 -35.82 -69.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.545 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 3.1 t 156.63 -92.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.576 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -73.34 -14.1 61.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.749 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.621 HG12 ' CB ' ' A' ' 116' ' ' ALA . 69.2 t -68.57 -65.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.685 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.6 t -52.27 -41.18 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.646 ' CB ' HG21 ' A' ' 159' ' ' ILE . 93.4 p -72.27 -30.87 65.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 1.352 ' CE1' ' OE2' ' A' ' 131' ' ' GLU . 53.2 t80 -73.24 -53.06 11.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.6 -19.48 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.83 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.93 -70.58 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.83 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 38.8 Cg_endo -66.64 -37.6 21.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.7 2.266 . . . . 0.0 112.412 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.352 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 23.8 mp0 -65.94 -21.52 66.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.716 ' HB3' HD21 ' A' ' 111' ' ' LEU . 6.9 m -114.02 148.77 36.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.113 ' OD2' ' ND1' ' A' ' 136' ' ' HIS . 2.2 p30 -38.33 110.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -65.71 -10.25 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.47 39.68 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.113 ' ND1' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -106.21 138.71 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.985 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -130.09 163.21 27.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -96.47 160.89 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.66 -15.76 13.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -34.66 21.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.801 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.95 72.09 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.579 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 20.1 mt -151.92 62.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -40.93 168.21 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.035 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 143' ' ' THR . 84.2 Cg_exo -44.34 -51.18 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.621 2.214 . . . . 0.0 112.144 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.88 -40.29 79.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -53.03 -63.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.57 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.8 tp -56.61 -41.89 77.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.536 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -53.01 -40.25 63.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.06 -40.58 96.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -68.76 -79.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.93 71.78 1.57 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.448 ' HA2' ' SD ' ' A' ' 157' ' ' MET . . . -72.54 42.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.576 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.973 ' HB1' ' OE1' ' A' ' 154' ' ' GLN . . . -52.26 128.96 26.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.973 ' OE1' ' HB1' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 31.38 -154.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 20.6 m120 -76.82 42.82 0.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.776 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -72.87 -50.48 23.58 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.198 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.752 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.24 -30.81 29.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.91 0.386 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.2 OUTLIER -74.17 -49.45 23.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.646 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.1 OUTLIER -51.77 -59.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 156' ' ' LEU . 6.4 mp -57.81 -63.63 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 157' ' ' MET . 1.5 pt20 -52.67 -37.1 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -66.13 -49.03 60.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.17 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -18.64 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.65 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.486 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.5 ttm -75.94 -165.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 tpt -150.03 67.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.799 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 166' ' ' ILE . 0.6 OUTLIER -143.44 47.84 0.86 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 166' ' ' ILE . 58.5 Cg_endo -71.97 170.71 18.23 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.666 2.244 . . . . 0.0 112.296 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.943 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.97 -65.41 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.46 48.59 21.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -134.55 16.75 3.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LEU . 13.2 tp 56.32 119.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.88 107.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.95 106.6 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 8' ' ' VAL . 71.3 t -114.6 -9.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.213 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -43.9 -41.03 4.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 7.1 p -95.91 -13.47 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 12' ' ' ASP . . . -49.86 126.01 20.53 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.405 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 4.6 t0 87.31 5.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 7.0 tpt180 -73.26 -74.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.839 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -73.2 -23.84 60.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -65.46 -48.61 72.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -70.33 -31.33 68.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.606 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -72.68 -64.66 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.53 65.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HA ' ' N ' ' A' ' 52' ' ' MET . . . -71.66 -26.09 62.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -73.41 -29.42 62.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' ARG . . . 97.8 70.46 1.0 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.807 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.085 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 1.4 p30 -146.03 79.97 1.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.876 0.369 . . . . 0.0 110.508 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.2 p -52.61 -20.1 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -72.68 -47.88 43.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.495 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.085 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.34 -39.39 65.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.21 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.4 p -53.41 -36.22 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.874 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 76.5 mtt-85 -73.32 -55.97 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.572 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -66.94 -18.3 65.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.029 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.706 HD12 ' CD ' ' A' ' 25' ' ' GLU . 2.8 mt -65.54 -65.67 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.509 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.762 HD12 ' CD ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -73.54 -38.18 65.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.75 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -72.46 -33.91 67.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.684 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HG3' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -113.8 -55.46 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.184 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.03 -6.36 27.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER 43.62 27.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.839 HG11 ' HB2' ' A' ' 14' ' ' LEU . 9.2 p -53.09 147.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 136.68 39.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 60.6 Cg_endo -73.08 -11.2 25.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.902 2.402 . . . . 0.0 112.471 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -108.58 7.4 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.54 78.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.068 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.9 mp -64.48 148.05 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.4 -154.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -23.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.6 -35.37 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.17 29.28 3.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HE2' ' OE1' ' A' ' 49' ' ' GLN . 48.0 mtpt -95.12 160.14 14.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.318 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -84.85 150.44 25.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.475 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -65.51 -31.74 72.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 69' ' ' PRO . 12.7 tp -72.31 -47.55 48.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.016 ' HB3' HG21 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -63.08 -18.06 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.745 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 46' ' ' THR . 35.5 m -104.36 -34.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -38.7 162.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -103.07 139.25 38.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.957 ' CD2' HD21 ' A' ' 95' ' ' LEU . 19.6 m-85 -84.03 10.29 10.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.84 -54.02 38.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.286 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -99.55 134.86 20.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.653 0.263 . . . . 0.0 110.895 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.859 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 11.2 Cg_exo -71.68 -43.84 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.744 2.296 . . . . 0.0 112.172 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -62.75 -27.22 69.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 55' ' ' SER . 4.5 t -62.87 -45.84 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.88 -56.6 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.228 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 60' ' ' LEU . 3.3 tt -63.14 -44.67 94.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.413 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.21 ' OE2' ' O ' ' A' ' 26' ' ' VAL . 1.6 tt0 -62.31 -58.51 7.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.721 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.4 -46.84 84.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.96 HD21 ' CE1' ' A' ' 98' ' ' HIS . 10.4 tt -62.91 -31.7 72.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 12.3 mttt -63.0 -44.39 96.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.633 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -44.01 -25.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 134.68 -11.78 4.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -37.16 148.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 71' ' ' VAL . 57.8 m -103.82 116.47 61.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.936 ' HA ' HD23 ' A' ' 48' ' ' LEU . 73.9 Cg_endo -75.88 -29.76 6.6 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.75 2.3 . . . . 0.0 112.432 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 101' ' ' ASP . 1.7 m-20 -73.62 68.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 49' ' ' GLN . 9.7 m -117.19 155.41 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' THR . 4.8 mp0 -147.93 145.57 28.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 75' ' ' SER . 5.7 p-10 -120.4 100.9 7.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 48.75 -89.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 73' ' ' ASP . 3.4 m -39.32 -57.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.16 46.24 0.17 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -89.54 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.901 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 1.134 ' OG ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 178.92 170.79 0.51 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.676 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 3.3 Cg_endo -46.36 -55.02 4.07 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.857 2.371 . . . . 0.0 112.089 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.01 ' CG2' HG12 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.43 -39.75 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.039 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 78' ' ' SER . 34.9 m80 -52.86 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.229 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER -67.11 -36.0 80.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.329 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -26.58 19.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -73.71 -62.52 1.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.776 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.93 -25.65 61.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.915 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.9 p -56.12 -23.31 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.656 0.265 . . . . 0.0 111.25 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.603 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 67.78 65.47 2.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.204 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -155.4 60.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.617 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' CG ' ' A' ' 127' ' ' PHE . 1.5 tm? -52.06 -19.65 2.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.076 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.338 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -66.82 -66.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.338 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 21.8 m -73.09 -34.54 66.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.6 tt -52.7 -60.89 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.814 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 1.195 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 12.6 ptpt -52.33 -37.66 56.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.053 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 53.1 t -55.58 -64.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.957 HD21 ' CD2' ' A' ' 53' ' ' PHE . 3.9 pp -71.06 -35.53 71.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.932 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 31.2 t -66.39 -42.31 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.195 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -71.63 -22.02 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.754 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 63' ' ' LEU . 58.3 t-80 -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 145.82 -9.46 1.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.843 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -34.83 114.36 0.22 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 1.134 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 9.7 p30 -33.48 91.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.01 HG12 ' CG2' ' A' ' 80' ' ' VAL . 2.4 m -98.63 -1.39 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.008 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 9.1 m-20 -116.56 20.35 14.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.11 151.11 29.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -129.16 -159.93 0.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -150.38 86.78 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.44 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 106' ' ' ASP . 1.3 t -43.07 -26.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.67 32.58 61.43 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.41 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.463 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -97.92 102.36 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.013 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.404 HD11 ' CG ' ' A' ' 133' ' ' ASP . 13.3 mt -53.93 146.86 26.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' A' ' 80' ' ' VAL . 94.4 Cg_exo -43.14 -35.18 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.3 tt -73.61 -31.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.328 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 21.3 m170 -52.61 -58.39 6.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.737 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.14 -50.87 68.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.522 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -53.81 -37.04 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.617 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.819 HG21 ' HB3' ' A' ' 147' ' ' LEU . 73.6 mt -62.32 -41.28 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.447 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.32 -14.78 62.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.539 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 19.8 mt-10 -102.87 -50.57 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.616 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 74.29 31.04 59.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.603 ' CE1' ' HA3' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -34.12 -46.23 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.687 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 5.1 t 155.83 -109.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.528 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 38.7 m -73.88 -14.86 61.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.678 0.275 . . . . 0.0 110.929 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.74 ' O ' HD23 ' A' ' 128' ' ' LEU . 55.2 t -55.07 -67.05 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.8 t -52.64 -46.44 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.411 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.748 ' CB ' HG21 ' A' ' 159' ' ' ILE . 6.4 p -73.14 -23.2 60.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.713 ' CG ' HD21 ' A' ' 89' ' ' LEU . 15.6 t80 -73.52 -65.74 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -75.18 26.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -64.24 -56.49 23.29 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 110.669 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.1 Cg_endo -76.63 -34.71 2.39 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.73 2.287 . . . . 0.0 111.894 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 4.8 mm-40 -54.49 -24.94 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 3.5 m -114.86 146.93 40.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.404 ' CG ' HD11 ' A' ' 111' ' ' LEU . 1.8 p-10 -37.48 105.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 164' ' ' MET . 7.5 mt -83.72 63.98 7.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' HIS . 41.0 t-80 -176.87 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.783 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 56.4 t60 -39.58 161.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.819 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.656 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -141.23 156.34 45.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.463 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 2.5 t0 -60.92 153.83 23.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.6 -16.89 11.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.626 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -48.99 28.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 131.3 54.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.579 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 20.7 mt -152.3 125.89 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.656 HG22 ' CG ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -100.68 178.35 1.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.751 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 88.9 Cg_exo -46.93 -57.33 2.36 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.766 2.31 . . . . 0.0 112.361 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.586 ' HA ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -71.13 -36.87 72.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.27 -53.09 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -52.47 -40.1 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -59.67 -40.57 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -36.05 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.062 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.7 tp-100 -67.43 -76.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.76 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.654 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.5 mpt_? -74.25 70.15 1.62 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -69.79 49.67 0.66 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.019 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -43.96 -27.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 0.0 110.178 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.528 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER 168.96 -132.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.441 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.542 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 44.1 m-20 -75.46 42.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.96 -0.463 . . . . 0.0 111.602 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 151' ' ' ARG . 3.6 mt -62.56 -69.16 0.27 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.771 0.319 . . . . 0.0 111.437 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.64 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 10.0 ptm -52.36 -21.82 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.067 ' OD1' HG13 ' A' ' 159' ' ' ILE . 31.9 p30 -73.93 -51.04 17.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.418 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.067 HG13 ' OD1' ' A' ' 158' ' ' ASP . 1.5 mt -61.71 -24.12 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.375 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.974 HD11 ' HB2' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -73.04 -34.24 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.494 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -70.64 -31.46 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.92 18.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -70.12 -16.25 63.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.781 ' HG2' HD13 ' A' ' 134' ' ' LEU . 8.5 mtp -77.36 169.94 17.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 8.2 ttt -140.24 136.8 33.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 166' ' ' ILE . 14.2 tt -153.85 115.28 2.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.157 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -51.11 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 0.0 112.254 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 31.7 mtp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.857 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.415 -0.274 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.89 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.757 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 1' ' ' GLY . 1.2 mtp -92.88 74.75 4.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 5' ' ' LEU . 1.4 pp -102.32 132.89 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.577 HD13 ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -49.42 160.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.926 ' OE1' ' HA ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -65.14 79.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.977 ' OE1' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -106.72 -11.05 15.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.048 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 10' ' ' VAL . 77.5 t 42.72 -89.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.209 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' GLU . 14.4 t 59.1 -79.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 8' ' ' VAL . 8.2 p -86.29 -6.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -61.98 -57.3 17.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.47 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 53.2 p30 -85.56 13.52 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -82.33 -66.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.914 HD23 ' O ' ' A' ' 36' ' ' HIS . 2.5 tp -72.15 -44.44 63.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -56.78 -32.52 65.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.829 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -72.69 -46.38 31.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.469 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.59 38.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.65 79.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.3 -22.75 61.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.202 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -73.14 -43.23 61.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.62 70.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p30 -139.0 103.65 4.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.501 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.04 -23.01 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.55 -51.45 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 60.0 mm-40 -68.49 -44.77 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.201 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 58' ' ' VAL . 12.8 p -52.68 -49.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HG13 ' A' ' 26' ' ' VAL . 70.5 mtt-85 -69.79 -54.57 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 8.7 mtm180 -61.31 -24.13 66.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.24 -71.48 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 61' ' ' GLU . 11.0 mt -73.54 -43.77 59.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -71.75 -1.85 15.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.517 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -147.5 -75.56 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.35 ' CD ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -47.46 -23.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.4 mt 56.04 37.71 29.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.35 HG22 ' CD ' ' A' ' 33' ' ' GLU . 1.6 t -66.16 140.59 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.997 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -60.69 139.92 93.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.8 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 66' ' ' GLY . 33.0 Cg_endo -64.25 -18.58 63.81 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.729 2.286 . . . . 0.0 112.113 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.997 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 16.7 p-10 -87.94 -81.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.863 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 40.39 95.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 3.6 mp -91.21 131.87 36.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.985 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p30 -65.78 169.75 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -42.76 -38.98 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.67 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.27 28.11 2.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 2.9 mttp -98.87 157.02 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.979 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.1 p -85.03 150.64 24.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -62.17 -35.29 78.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 8.6 tp -71.46 -43.91 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.022 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.012 ' NE2' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -70.1 -5.31 26.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 46' ' ' THR . 15.9 m -125.78 -17.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.663 ' HE1' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -51.28 151.83 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.181 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -92.36 130.24 38.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.896 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.704 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 10.3 m-85 -85.5 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.506 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -89.04 -39.13 6.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.908 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' ' 91' ' ' THR . 1.8 t -114.88 135.4 22.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.247 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.73 -34.26 19.2 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.649 2.233 . . . . 0.0 112.062 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.16 -28.0 69.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.778 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.7 t -63.44 -50.78 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.23 -50.41 70.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.806 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 64' ' ' LYS . 9.7 tt -63.24 -38.01 89.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.719 ' HB3' HD12 ' A' ' 30' ' ' LEU . 1.3 mp0 -62.92 -56.23 19.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.249 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 58' ' ' VAL . 4.4 mp -62.73 -46.89 85.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -63.07 -40.24 97.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -62.94 -32.99 74.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 30' ' ' LEU . 2.9 mm-40 -69.03 -57.54 5.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 37' ' ' PRO . . . 163.89 36.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -97.14 106.09 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.968 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -63.34 119.67 55.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 29.2 Cg_endo -63.21 -15.62 49.32 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.727 2.284 . . . . 0.0 112.224 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 37.1 m-80 -95.22 93.56 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 49' ' ' GLN . 28.3 m -148.35 159.12 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' THR . 28.1 mp0 -151.79 -174.17 4.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 1.012 ' OD2' ' NE2' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -140.1 77.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 73' ' ' ASP . . . 35.74 62.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.023 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -172.51 -66.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . 138.69 38.32 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.468 HG23 ' CB ' ' A' ' 81' ' ' HIS . 34.9 m -128.61 137.51 51.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.805 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.82 179.23 1.16 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HB3' ' HE1' ' A' ' 51' ' ' MET . 42.2 Cg_exo -56.06 -32.68 87.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.824 2.349 . . . . 0.0 112.307 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 96' ' ' VAL . 9.6 t -68.25 -28.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 35.6 m80 -63.44 -67.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 86' ' ' THR . 2.5 p30 -53.01 -48.65 67.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -19.33 3.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 81' ' ' HIS . . . -72.52 -65.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.328 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -73.07 -37.72 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 82' ' ' ASP . 60.2 p -54.33 -17.75 3.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 67.02 66.76 2.24 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.006 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 22.7 m-85 -135.62 49.38 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 123' ' ' SER . 19.9 tp -55.11 -15.28 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.781 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -74.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.67 0.271 . . . . 0.0 110.729 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 59' ' ' ALA . 24.8 m -69.8 -33.44 72.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.376 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 92' ' ' LEU . 2.3 tt -53.28 -46.36 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -56.39 -37.19 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.216 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.783 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 74.2 t -52.84 -63.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.734 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.66 -36.47 67.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 111.152 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.785 ' CG2' HG22 ' A' ' 80' ' ' VAL . 3.8 t -68.99 -46.54 78.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.29 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.783 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 10.6 pm0 -59.04 -33.77 71.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.054 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -39.28 93.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.21 36.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.63 -177.74 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -75.32 74.52 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.547 HG12 HG11 ' A' ' 80' ' ' VAL . 13.0 m -91.78 19.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -130.71 5.37 4.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.23 155.49 22.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.587 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -129.11 144.37 51.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -84.77 -176.68 6.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.21 -53.29 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.8 p -61.31 -24.3 66.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 84.35 -10.32 61.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.73 117.99 3.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -56.35 130.64 75.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.98 ' HD2' HD23 ' A' ' 111' ' ' LEU . 82.9 Cg_exo -44.11 -31.67 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -73.52 -42.72 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.574 ' CE1' ' OD2' ' A' ' 138' ' ' ASP . 9.5 m80 -52.91 -27.36 18.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -69.85 -53.03 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.884 ' C ' HG12 ' A' ' 125' ' ' VAL . . . -52.64 -43.17 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 110.352 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 147' ' ' LEU . 50.5 mt -57.57 -42.32 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.782 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -71.11 -15.66 62.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -90.64 -55.39 3.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.639 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.67 12.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.526 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 97.1 m-70 -56.01 -18.15 8.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.79 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 126' ' ' SER . 3.8 m 71.75 -63.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.689 ' CB ' HD22 ' A' ' 89' ' ' LEU . 12.1 m -69.55 -38.97 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.069 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.812 HG12 HD12 ' A' ' 128' ' ' LEU . 39.7 t -73.39 -54.91 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.884 HG12 ' C ' ' A' ' 116' ' ' ALA . 3.5 m -52.8 -47.03 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 159' ' ' ILE . 5.6 t -71.53 -34.15 69.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 1.194 ' CD2' ' OE1' ' A' ' 131' ' ' GLU . 45.1 t80 -73.36 -39.6 65.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -67.36 -25.66 66.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.764 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.93 -62.12 5.72 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 44.2 Cg_endo -68.15 -48.83 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.79 2.327 . . . . 0.0 112.62 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.194 ' OE1' ' CD2' ' A' ' 127' ' ' PHE . 0.5 OUTLIER -58.07 -29.51 65.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.732 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.512 ' OG ' HD23 ' A' ' 128' ' ' LEU . 1.2 m -107.77 154.46 21.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.935 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 3.5 p-10 -41.76 113.85 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.867 HD13 ' HA ' ' A' ' 164' ' ' MET . 8.1 mt -85.08 43.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.976 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.05 33.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.463 ' HB3' HD11 ' A' ' 111' ' ' LEU . 20.4 t-80 -107.18 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -126.31 -156.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER 177.15 155.59 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.574 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -37.7 -30.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.508 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -60.42 -44.87 95.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.869 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 84.28 25.52 43.5 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.469 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -133.51 80.44 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.371 . . . . 0.0 111.015 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 1.6 p -42.48 169.12 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 91.0 Cg_exo -43.66 -44.76 11.15 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.289 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.84 -42.92 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.498 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.511 ' HB3' ' CA ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -52.52 -64.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.427 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.571 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.72 -34.96 54.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -60.82 -31.31 70.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -45.02 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.491 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -69.85 -89.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.171 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.533 ' N ' ' CG ' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -75.62 51.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.085 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -61.74 -9.18 18.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.136 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 47.38 -86.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -125.47 -136.79 0.27 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 1.229 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 12.5 p30 -74.37 14.37 0.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.153 -0.342 . . . . 0.0 111.267 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.725 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.82 -45.68 64.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.67 0.272 . . . . 0.0 111.331 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.912 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 3.3 ptm -57.09 -30.15 64.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.37 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD2' ' HB2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -73.55 -47.12 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.931 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.1 OUTLIER -52.0 -49.3 38.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 156' ' ' LEU . 5.3 mp -73.46 -26.74 61.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -64.46 -63.8 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.08 -31.59 79.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.646 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 1.2 m-70 -66.24 -39.57 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.954 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.867 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 ptm -63.97 -174.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 92.78 3.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 166' ' ' ILE . 13.1 mt -153.99 90.97 3.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.401 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.7 90.08 1.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.765 2.31 . . . . 0.0 112.352 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 38.0 mtm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.62 107.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 97.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.92 -52.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.18 106.81 15.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.69 65.55 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.764 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.49 56.4 2.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.024 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 11' ' ' GLY . 16.2 m -143.54 13.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.708 ' O ' HG12 ' A' ' 10' ' ' VAL . 12.7 m -50.6 97.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.453 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER 92.79 -6.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.881 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -54.57 -44.44 78.61 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.12 5.33 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -78.87 -62.5 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 14' ' ' LEU . 2.8 tm? -71.17 -33.22 69.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 25.4 t -67.79 -50.12 58.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -57.1 -26.97 56.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.205 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.23 -67.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.021 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.579 ' HB1' ' CG ' ' A' ' 51' ' ' MET . . . -53.04 -54.58 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -53.43 -29.16 33.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 18.0 mtt180 -73.92 -37.62 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 93.64 66.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.577 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.688 ' OD1' ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -138.66 97.13 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.831 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.3 p -57.29 -18.43 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.0 -46.47 43.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.3 -34.41 65.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.8 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.881 HG21 ' HA ' ' A' ' 58' ' ' VAL . 1.1 p -52.57 -48.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.744 0.307 . . . . 0.0 111.212 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.99 -56.33 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.64 -48.14 66.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.445 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 52.7 mt -52.72 -55.84 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.214 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HA ' ' A' ' 62' ' ' LEU . 84.5 mt -73.95 -55.8 5.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.17 4.0 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -146.19 -70.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.259 ' OE1' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.79 -16.47 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.5 mt 45.37 45.01 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.671 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.259 HG22 ' OE1' ' A' ' 33' ' ' GLU . 2.8 t -72.29 153.74 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 1.016 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 1.3 t-80 -63.59 138.12 97.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.6 Cg_endo -71.23 -37.7 5.61 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 1.016 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -92.26 31.35 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.076 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -65.71 118.44 9.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.002 HD23 ' C ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -120.3 125.02 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -60.95 -178.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -41.59 -46.1 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -48.15 -62.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.02 24.09 1.9 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.61 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 1.002 ' C ' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -109.39 163.17 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.755 0.312 . . . . 0.0 110.714 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.629 ' N ' HD23 ' A' ' 40' ' ' LEU . 17.0 p -84.87 152.14 23.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -52.92 -26.09 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.677 HD23 ' HE2' ' A' ' 51' ' ' MET . 7.0 mt -73.26 -41.82 63.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HG3' ' OG1' ' A' ' 46' ' ' THR . 2.6 mt-30 -73.17 -7.48 51.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.228 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 24.2 m -136.05 24.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.677 ' HE2' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -70.59 -177.95 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 0.0 110.708 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 1.1 ttp -114.31 -11.09 12.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.934 ' CE2' HD21 ' A' ' 95' ' ' LEU . 12.1 m-85 50.35 21.0 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.88 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.48 -55.2 7.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.69 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 2.4 t -100.41 137.91 20.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 0.0 110.198 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 40.8 Cg_endo -67.87 -50.29 0.88 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.34 -18.72 63.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.166 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.881 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 t -63.06 -55.62 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.25 -37.87 88.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' HG11 ' A' ' 94' ' ' VAL . 25.0 tp -63.19 -51.33 66.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 13.7 mm-40 -62.75 -53.66 50.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.966 ' HA ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.63 -51.84 65.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.179 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -63.94 -50.5 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.958 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.852 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.2 tttt -65.24 56.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.052 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 63' ' ' LEU . 6.7 tp60 -154.42 -39.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.046 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 37' ' ' PRO . . . 154.47 38.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.769 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.13 -0.07 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.121 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.785 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.8 m 43.88 83.02 0.22 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.979 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.48 -30.35 15.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.766 2.311 . . . . 0.0 112.238 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 91.8 m-20 -79.51 75.15 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 68' ' ' SER . 20.3 m -116.58 150.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -142.82 134.7 26.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -103.58 128.1 50.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 41.21 -91.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 73' ' ' ASP . 72.4 m -78.84 -85.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.09 64.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.534 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.76 43.67 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -53.14 160.77 1.49 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.997 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 2.8 Cg_endo -46.93 -32.51 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.0 2.467 . . . . 0.0 111.888 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.83 -45.33 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.902 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.498 ' NE2' ' O ' ' A' ' 105' ' ' LEU . 39.8 m80 -73.12 -38.72 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.008 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -69.71 -67.42 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.319 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.895 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -52.64 -19.18 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 80' ' ' VAL . . . -72.8 -63.02 1.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.42 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.061 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 15.6 ptt85 -70.17 -18.26 63.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.392 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.008 HG23 ' O ' ' A' ' 82' ' ' ASP . 82.6 p -68.07 -51.94 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.207 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.01 67.52 0.41 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -152.95 57.32 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.538 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.7 tp -58.65 -13.66 6.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.407 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -67.61 -73.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 53' ' ' PHE . 19.4 m -68.95 -35.86 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 83' ' ' ALA . 29.9 tp -52.69 -49.44 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.449 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HG3' ' CE1' ' A' ' 127' ' ' PHE . 2.6 ttmt -52.66 -44.67 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.842 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 60' ' ' LEU . 1.4 t -53.26 -59.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.132 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.934 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -72.58 -39.64 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 80' ' ' VAL . 20.4 t -67.0 -43.85 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.4 pt-20 -68.33 -43.1 78.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -55.17 -23.87 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.14 50.57 0.3 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.577 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . -85.76 56.32 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 111.141 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 5.5 t0 37.32 52.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.83 -0.95 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.239 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 36.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.47 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -117.09 -178.61 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 111' ' ' LEU . 26.0 mt -125.17 -152.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 110' ' ' SER . 2.0 p30 -145.29 -163.25 1.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.761 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 m -54.12 -28.96 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.34 28.61 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 42.91 40.11 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.542 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 40.7 m -113.51 133.84 55.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.97 162.83 61.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HG3' ' CG1' ' A' ' 80' ' ' VAL . 52.6 Cg_exo -55.35 -25.67 48.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.825 2.35 . . . . 0.0 112.073 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 128' ' ' LEU . 2.5 tp -70.82 -33.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.62 ' HB3' HD22 ' A' ' 147' ' ' LEU . 15.6 m170 -70.47 -30.22 66.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.633 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.88 -54.1 15.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.351 ' CA ' ' OE2' ' A' ' 119' ' ' GLU . . . -52.6 -37.53 58.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HA ' HG11 ' A' ' 125' ' ' VAL . 76.4 mt -56.62 -36.92 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -66.04 -33.52 75.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.002 0.43 . . . . 0.0 110.53 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 1.351 ' OE2' ' CA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -82.4 -53.64 5.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.804 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.95 27.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.655 ' ND1' ' OE1' ' A' ' 119' ' ' GLU . 46.5 m80 -47.69 -23.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 80.23 -62.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.9 m -70.17 -33.11 71.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 121' ' ' HIS . 24.1 t -73.73 -57.01 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.002 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 117' ' ' ILE . 2.2 m -52.57 -60.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.664 ' H ' HG23 ' A' ' 125' ' ' VAL . 10.2 t -54.99 -29.02 56.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 110.854 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.602 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 26.0 t80 -73.22 -53.92 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -63.38 -11.83 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -59.69 -69.54 0.53 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.204 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.5 Cg_endo -70.2 -31.86 17.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 5.4 mm-40 -61.9 -13.86 28.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 111' ' ' LEU . 10.0 m -121.75 143.57 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.801 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 3.4 p30 -39.24 98.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.002 HD13 ' HA ' ' A' ' 164' ' ' MET . 20.2 mt -67.17 66.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.017 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.2 t60 -177.77 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.488 ' CD2' HD13 ' A' ' 111' ' ' LEU . 1.5 p-80 -53.58 179.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HG3' ' C ' ' A' ' 136' ' ' HIS . 0.6 OUTLIER -137.25 -165.51 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -128.9 178.08 6.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.055 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.533 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . . . -71.0 -8.66 54.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.6 p -105.96 -9.66 16.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.733 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 72.73 59.07 4.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 141' ' ' GLY . 62.0 mt -154.61 86.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -71.28 -174.18 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.891 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 87.1 Cg_exo -47.43 -61.5 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.659 2.24 . . . . 0.0 112.473 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 145' ' ' LEU . 6.6 tp -63.81 -32.59 74.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.522 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -67.29 -70.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 114' ' ' HIS . 11.4 tp -52.75 -45.62 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.424 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . . . -55.45 -38.23 68.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -65.75 -41.78 91.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.109 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -64.06 -78.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.883 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 4.7 mtp180 -74.05 58.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.09 54.09 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.695 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -34.61 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 0.0 110.851 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER 173.83 -114.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.376 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.538 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.5 m-20 -74.31 5.55 4.44 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.198 -0.314 . . . . 0.0 111.594 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -51.15 -59.33 4.3 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.708 0.289 . . . . 0.0 111.298 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.497 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.3 ppp? -52.26 -32.08 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -55.57 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.9 -35.2 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.678 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.614 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.91 -33.6 64.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.43 -51.13 18.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.257 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.56 97.3 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 126' ' ' SER . 3.0 m-70 -61.14 -30.13 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.692 0.282 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . 1.002 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.7 mtt -45.49 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 164' ' ' MET . 11.7 ttt 159.35 -26.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.996 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 165' ' ' MET . 53.8 mt 35.31 98.3 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.465 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 168' ' ' MET . 60.0 Cg_endo -73.11 155.08 52.49 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.804 2.336 . . . . 0.0 112.371 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.42 ' CB ' ' O ' ' A' ' 167' ' ' PRO . 3.4 ptm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.803 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.29 72.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' GLY . 1.1 ttp -175.37 138.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.749 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 73.73 26.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 4' ' ' LEU . 8.6 mt -136.53 144.77 44.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.052 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.694 ' CD ' ' SG ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -125.46 159.91 30.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 1.139 ' OE1' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -131.35 171.79 12.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.029 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.139 HG12 ' OE1' ' A' ' 7' ' ' GLU . 12.3 p 39.05 29.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.275 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.694 ' SG ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -51.28 116.57 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.319 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 9' ' ' CYS . 16.9 m 47.28 24.6 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -65.82 -40.05 95.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.698 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -101.43 40.65 1.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.562 ' NH1' ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -112.44 -71.48 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.807 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.916 HD22 HD21 ' A' ' 30' ' ' LEU . 26.4 tp -70.92 -26.81 63.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.2 t -61.35 -40.8 95.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.63 -35.08 59.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.533 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -66.91 -62.77 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.55 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -72.43 -22.42 61.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mtt180 -73.09 -36.19 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.892 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 97.41 63.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p30 -142.29 91.66 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 57' ' ' ALA . 13.2 p -52.75 -21.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.528 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 62.7 mt-30 -72.44 -47.35 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.5 mp0 -68.67 -41.02 79.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.297 HG12 ' CD ' ' A' ' 61' ' ' GLU . 55.5 t -53.87 -53.38 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 69.7 mtt180 -61.5 -60.13 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.9 mmt-85 -54.92 -29.27 55.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.584 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD13 HD12 ' A' ' 14' ' ' LEU . 17.7 mt -73.42 -72.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.96 HD12 ' HB3' ' A' ' 61' ' ' GLU . 41.1 mt -73.48 -43.11 60.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.513 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -72.6 -11.93 60.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.285 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.41 -78.16 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' OE2' ' NH1' ' A' ' 13' ' ' ARG . 1.4 tm-20 -39.94 -28.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.034 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LEU . 3.7 mt 62.71 46.21 5.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 33' ' ' GLU . 25.0 t -77.87 155.23 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.423 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -77.51 134.77 65.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.907 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 69.3 Cg_endo -74.58 -6.91 18.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.81 2.34 . . . . 0.0 112.248 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -103.03 13.58 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -57.08 127.67 33.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.917 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -120.65 130.07 53.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.475 ' O ' HG21 ' A' ' 8' ' ' VAL . 21.9 m-20 -52.2 -55.94 17.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.69 -52.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -35.47 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.85 30.16 1.17 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -98.2 151.81 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 p -94.51 154.96 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.39 -26.46 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.035 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 69' ' ' PRO . 3.0 mt -71.99 -42.7 66.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.3 tm0? -60.07 -53.6 55.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG21 ' OG ' ' A' ' 15' ' ' SER . 7.2 m -64.5 -23.32 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.765 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 ttp -39.18 154.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.541 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -116.24 21.44 13.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.832 ' CD2' HD21 ' A' ' 95' ' ' LEU . 0.7 OUTLIER 36.21 34.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.0 -81.84 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.383 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 58' ' ' VAL . 56.5 m -86.28 119.74 71.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 1.333 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 81.8 Cg_exo -43.99 -39.61 11.28 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.122 ' O ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.29 -22.32 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.451 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG21 ' A' ' 26' ' ' VAL . 37.3 t -63.05 -54.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.1 -32.93 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.03 -42.69 99.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.037 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.297 ' CD ' HG12 ' A' ' 26' ' ' VAL . 1.2 mt-10 -63.1 -51.49 66.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.207 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.5 -46.2 89.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.346 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -62.91 -56.17 19.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.731 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -63.21 -11.71 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.702 ' HG3' HD22 ' A' ' 30' ' ' LEU . 1.1 mm-40 -81.56 -35.11 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.16 22.85 2.07 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.592 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -81.29 154.46 26.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.051 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -108.16 98.94 29.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HB3' HD13 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -68.41 -10.31 28.61 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.652 2.235 . . . . 0.0 112.239 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.59 56.93 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 68' ' ' SER . 12.7 m -125.92 158.82 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -132.94 149.69 52.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -132.32 142.05 49.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 73' ' ' ASP . . . 81.03 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.908 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -126.84 -77.15 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.872 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . -162.94 54.83 0.29 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.837 HG23 ' OD2' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -128.76 112.37 14.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.846 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -82.08 -177.84 1.05 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.783 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 52.3 Cg_exo -54.07 -46.32 34.42 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.318 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 96' ' ' VAL . 2.4 m -52.98 -39.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.67 ' CD2' HG22 ' A' ' 77' ' ' THR . 73.0 m80 -53.4 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.783 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 5.0 p30 -53.11 -44.52 67.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.786 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.83 -48.29 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.39 92.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.505 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -73.24 -33.13 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 82' ' ' ASP . 41.7 p -73.45 -78.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.76 68.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 35.8 m-85 -139.27 51.49 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.591 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 92' ' ' LEU . 16.0 tp -52.5 -18.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.286 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.333 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -73.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.568 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.124 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -73.39 -30.29 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 92' ' ' LEU . 2.5 tt -59.08 -34.83 72.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.049 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HE2' ' CD1' ' A' ' 127' ' ' PHE . 4.0 mttt -67.73 -53.18 29.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 2.7 m -52.71 -48.17 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 53' ' ' PHE . 1.2 pp -73.37 -51.37 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.518 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.838 HG13 HG11 ' A' ' 102' ' ' VAL . 55.1 t -67.37 -51.12 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.844 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.905 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 5.0 pm0 -52.58 -30.47 31.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.814 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.479 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER -73.08 -36.34 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.23 65.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -91.64 18.97 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 61.7 72.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.838 HG11 HG13 ' A' ' 96' ' ' VAL . 4.1 m -89.17 13.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.048 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.69 38.87 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.542 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -136.08 131.82 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.272 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.903 HD13 ' N ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -100.4 -176.88 3.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.882 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.908 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 0.9 OUTLIER -99.42 40.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER 76.73 12.51 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.7 t -115.9 8.83 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.897 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 61.75 14.84 45.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.1 m -98.67 91.91 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 136' ' ' HIS . 35.0 mt -51.52 146.17 13.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 85.1 Cg_exo -47.41 -39.73 28.44 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.726 2.284 . . . . 0.0 112.55 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -61.41 -32.35 53.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.893 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.58 ' O ' HD13 ' A' ' 147' ' ' LEU . 15.9 m170 -66.7 -29.83 69.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.13 -47.38 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.484 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.73 -45.12 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.33 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.857 HG21 ' HB3' ' A' ' 147' ' ' LEU . 89.4 mt -53.18 -39.46 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.548 ' HD2' ' CD ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -61.96 -20.81 64.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.015 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -112.37 -42.0 3.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.528 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.424 ' HA3' HE22 ' A' ' 154' ' ' GLN . . . 79.47 11.59 84.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.99 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 10.9 m-70 -38.49 102.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' HIS . 3.0 m 35.63 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.999 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.39 10.36 1.33 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 59.4 t -56.09 -53.93 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.008 0.432 . . . . 0.0 110.229 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -52.64 -41.37 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.608 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.569 ' CB ' HG21 ' A' ' 159' ' ' ILE . 15.7 p -66.69 -34.76 78.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.584 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 14.3 t80 -72.86 -48.56 36.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.418 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.501 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.946 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -55.09 -66.48 0.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.946 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 66.6 Cg_endo -75.21 -52.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.656 2.237 . . . . 0.0 112.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -23.74 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.541 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 128' ' ' LEU . 9.3 t -93.83 -153.54 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.688 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.41 56.33 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.874 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.94 88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.629 ' O ' HG22 ' A' ' 143' ' ' THR . 17.6 t60 155.42 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 111' ' ' LEU . 13.6 t60 -65.27 164.04 14.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.962 ' CG ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -134.6 127.45 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.555 ' OD1' ' CG ' ' A' ' 114' ' ' HIS . 1.1 m-20 -50.2 155.27 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.19 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 110.318 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -67.53 -48.73 66.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 116.58 57.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.554 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 146' ' ' GLU . 1.1 mt -144.65 104.21 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.144 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -66.11 171.5 3.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 82.5 Cg_exo -43.6 -43.0 11.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.534 2.156 . . . . 0.0 112.021 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.26 -34.62 65.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.144 ' OE1' ' N ' ' A' ' 143' ' ' THR . 5.4 mt-10 -61.84 -61.77 2.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -52.7 -36.52 57.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.54 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.283 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -73.17 -45.41 56.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -73.11 -92.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.244 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.548 ' CD ' ' HD2' ' A' ' 118' ' ' ARG . 16.2 mtt-85 -76.56 45.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -53.29 -17.89 6.24 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.761 ' HB3' HD23 ' A' ' 156' ' ' LEU . . . 64.18 -64.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.646 ' NE2' ' HB1' ' A' ' 153' ' ' ALA . 0.4 OUTLIER -154.4 -138.37 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.019 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 10.4 m120 -74.16 9.85 1.46 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.226 -0.296 . . . . 0.0 111.391 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.804 HD12 ' C ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -51.82 -34.87 42.21 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.846 0.355 . . . . 0.0 111.281 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.666 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.5 ppp? -52.44 -28.39 19.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.059 0.457 . . . . 0.0 110.081 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.06 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 3.4 p30 -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.06 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -51.65 -44.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.291 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.56 -16.08 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 111.035 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -55.08 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.33 -43.4 96.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' LEU . 2.1 m-70 -70.31 -11.79 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -168.87 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.48 ' O ' HG13 ' A' ' 166' ' ' ILE . 1.6 mmm -126.71 -2.53 6.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 165' ' ' MET . 1.3 pt 35.39 56.01 2.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.11 -0.11 8.64 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.837 2.358 . . . . 0.0 112.273 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.966 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 3' ' ' MET . 57.8 p -119.41 41.85 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 74.28 -74.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 59.7 177.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 11.2 mt -131.93 160.32 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.47 46.09 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.046 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 63.39 36.42 11.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 40' ' ' LEU . 85.3 t -82.56 -12.79 12.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' C ' ' O ' ' A' ' 8' ' ' VAL . 42.2 t -35.33 -37.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 35' ' ' VAL . 36.5 t -110.07 -19.03 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.515 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -48.58 -21.72 2.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.569 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD2' HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.42 29.4 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 1.7 ttm105 -109.82 -74.94 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.019 ' O ' HD22 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.92 -35.18 72.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -58.24 -40.55 82.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.598 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -73.13 -40.42 50.53 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -67.79 -47.05 70.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' CB ' HD21 ' A' ' 62' ' ' LEU . . . -52.82 -41.71 64.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -18.6 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 1.7 mtt180 -73.17 -28.06 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.72 65.03 1.96 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.615 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.131 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -133.12 92.46 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.635 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 57' ' ' ALA . 10.7 p -52.58 -20.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -73.81 -56.33 5.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.938 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.131 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.48 -30.26 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.629 -179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 58' ' ' VAL . 2.4 p -52.85 -45.36 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.744 0.306 . . . . 0.0 111.407 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -73.56 -46.35 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 4.7 mmm180 -53.51 -32.71 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD12 ' OE1' ' A' ' 25' ' ' GLU . 10.4 mt -73.42 -72.39 0.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.833 HD22 ' HG2' ' A' ' 65' ' ' GLN . 5.5 mt -73.4 -45.71 53.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.686 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -70.06 -13.39 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.691 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -134.05 -75.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.199 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.806 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 2.5 tt0 -43.99 -25.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.2 mp 72.46 13.08 5.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.4 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' A' ' 14' ' ' LEU . 3.3 p -44.75 158.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.407 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -94.81 141.27 23.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.83 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 55.9 Cg_endo -70.52 -23.27 27.53 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.744 2.296 . . . . 0.0 112.201 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.71 37.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.695 ' HA ' ' CE1' ' A' ' 36' ' ' HIS . . . -79.01 127.55 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 38' ' ' ASP . 6.3 mp -122.55 133.66 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 111.454 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -62.57 -168.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' CD ' ' C ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -70.32 -4.98 24.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -98.95 -69.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 146.74 67.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 19.1 mtpt -142.41 146.65 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.6 p -84.54 152.61 23.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.75 -54.89 27.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 69' ' ' PRO . 7.3 tp -53.05 -30.53 36.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.639 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.3 tt0 -73.2 -34.61 66.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -91.42 -25.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' HD12 ' A' ' 48' ' ' LEU . 1.4 mtp -36.35 137.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 3.6 ptt? -96.42 10.11 39.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.032 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.4 m-85 47.38 23.54 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.43 -56.02 24.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.312 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -98.04 146.15 31.01 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.788 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 1.239 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.3 Cg_endo -79.67 -42.15 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.834 2.356 . . . . 0.0 112.555 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -31.14 72.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 55' ' ' SER . 11.4 m -62.64 -30.79 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -62.94 -43.16 99.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.986 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.66 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -63.31 -34.53 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.217 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -63.04 -67.89 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 62' ' ' LEU . 6.3 mp -62.32 -35.41 78.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.088 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 7.6 tp -62.95 -63.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -62.93 -17.3 61.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.833 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.22 -52.86 63.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.63 -13.49 2.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -60.05 98.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.322 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.16 121.57 2.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.676 ' HA ' HD23 ' A' ' 48' ' ' LEU . 59.5 Cg_endo -71.95 -21.45 24.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.733 2.289 . . . . 0.0 112.326 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.202 ' CA ' ' OD2' ' A' ' 101' ' ' ASP . 1.4 m120 -81.47 86.11 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.74 133.61 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -139.62 157.8 45.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -126.23 98.21 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 57.25 -80.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ASP . 5.6 m -38.44 -55.0 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.24 33.18 1.84 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.31 129.51 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -111.36 171.52 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 50.8 Cg_exo -53.86 -32.14 65.7 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.767 2.311 . . . . 0.0 112.336 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -64.31 -36.53 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.447 ' ND1' HG23 ' A' ' 80' ' ' VAL . 3.3 m80 -64.47 -47.93 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.914 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.9 p30 -60.3 -51.66 68.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -51.97 -29.61 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' HG11 ' A' ' 124' ' ' VAL . . . -73.33 -65.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.477 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' NE ' ' HB3' ' A' ' 115' ' ' LEU . 7.2 mtp180 -64.68 -29.41 70.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 82' ' ' ASP . 61.6 p -73.29 0.3 12.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.549 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.468 ' HA2' HG21 ' A' ' 124' ' ' VAL . . . 52.76 80.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.098 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.51 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -154.12 60.48 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.856 0.36 . . . . 0.0 110.433 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.908 ' O ' HD13 ' A' ' 89' ' ' LEU . 3.2 tm? -52.15 -19.05 1.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.267 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.239 ' OD1' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -56.2 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.382 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.848 HG22 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.4 -8.92 57.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.127 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.701 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mp -73.0 -64.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -57.06 -24.03 50.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 95' ' ' LEU . 38.0 t -76.77 -82.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.09 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.032 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -76.11 -44.83 36.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.079 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 80' ' ' VAL . 94.3 t -67.77 -3.3 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.227 ' HA ' ' OE2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -73.1 -43.23 62.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -64.57 -37.77 88.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.841 ' O ' HG13 ' A' ' 102' ' ' VAL . . . 146.96 -49.97 0.61 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . 36.21 31.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 1.202 ' OD2' ' CA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 71.52 56.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 99' ' ' GLY . 5.0 m -79.95 1.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -116.0 40.67 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.956 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.825 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -125.51 166.93 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -154.64 160.61 41.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 3.5 p30 -84.83 79.06 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 108' ' ' THR . 1.1 p 84.13 -54.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER -174.38 32.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.765 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . -76.83 -3.35 79.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.775 ' C ' HD22 ' A' ' 105' ' ' LEU . 0.6 OUTLIER 85.4 159.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -45.18 158.86 0.29 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.544 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 50.9 Cg_exo -53.86 -38.47 85.78 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.645 2.23 . . . . 0.0 112.223 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -58.33 -41.43 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.542 ' CG ' ' OG ' ' A' ' 110' ' ' SER . 57.3 m80 -52.96 -31.73 42.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.681 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.498 ' HB3' ' NE ' ' A' ' 85' ' ' ARG . 12.6 mt -73.17 -53.77 10.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.361 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -54.25 -33.09 57.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.342 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.992 HG21 ' HB3' ' A' ' 147' ' ' LEU . 81.8 mt -61.41 -40.51 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -64.38 -21.35 66.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 1.361 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 1.9 mp0 -94.7 -51.65 4.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.84 22.79 35.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.514 ' O ' ' CB ' ' A' ' 122' ' ' SER . 61.2 m80 -46.41 -24.85 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER 84.97 -60.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.836 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -73.1 -42.16 63.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.046 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 116' ' ' ALA . 49.0 t -67.08 -60.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.684 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.7 t -52.69 -57.14 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.633 ' CB ' HG21 ' A' ' 159' ' ' ILE . 88.8 p -52.73 -37.15 58.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 92' ' ' LEU . 51.6 t80 -71.91 -55.1 8.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -62.41 -19.33 63.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.898 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -52.98 -69.51 0.33 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.925 ' HA ' HD11 ' A' ' 134' ' ' LEU . 55.0 Cg_endo -69.6 -25.32 29.44 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.227 ' OE2' ' HA ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -89.55 36.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -169.7 134.88 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.818 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.286 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 2.9 p-10 -35.74 97.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.925 HD11 ' HA ' ' A' ' 130' ' ' PRO . 2.8 mp -72.91 56.36 0.42 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.03 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 -39.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.138 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.286 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -56.83 142.67 40.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.019 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 167.88 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -75.14 166.89 22.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 108' ' ' THR . . . -51.48 -21.92 2.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.324 0.583 . . . . 0.0 110.141 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -59.0 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.91 40.8 0.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.253 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 2.4 mt -122.91 125.22 44.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -98.11 -174.53 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 72.8 Cg_exo -49.31 -56.84 2.77 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.694 2.263 . . . . 0.0 112.401 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.697 HD13 ' HG3' ' A' ' 161' ' ' GLN . 13.8 tp -69.31 -40.38 77.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.046 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.08 -65.7 0.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.93 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.992 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -53.12 -39.45 63.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.13 -27.3 61.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.7 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -68.55 -47.64 66.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.97 -74.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.968 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -74.55 56.56 0.69 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.02 55.4 0.8 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.139 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.851 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -31.44 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.99 0.424 . . . . 0.0 110.979 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.851 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 174.43 -114.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.42 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 1.265 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 8.0 m-80 -75.35 6.92 3.95 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.291 -0.255 . . . . 0.0 111.438 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 156' ' ' LEU . 1.3 mt -51.11 -64.39 0.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.445 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.588 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 4.3 ptm -52.89 -29.26 27.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.265 ' OD2' ' HA ' ' A' ' 155' ' ' ASN . 0.4 OUTLIER -74.59 -51.52 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.01 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.68 -42.35 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.22 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.858 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -74.63 -44.83 48.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.187 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.697 ' HG3' HD13 ' A' ' 145' ' ' LEU . 4.0 mt-30 -53.61 -50.56 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.286 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.22 98.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' HB3' ' A' ' 130' ' ' PRO . 2.0 m-70 -73.23 -7.1 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.679 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.38 169.85 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.861 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.22 91.32 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -151.21 78.87 7.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.67 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.809 2.339 . . . . 0.0 112.357 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 3' ' ' MET . 5.8 p -140.28 94.37 2.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.421 ' CB ' ' O ' ' A' ' 2' ' ' SER . 5.9 ttt 77.37 91.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -115.76 100.38 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.011 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.67 70.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.608 ' C ' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -152.76 99.17 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.989 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 2.1 tm-20 -122.06 74.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 40' ' ' LEU . 14.2 p -126.04 10.93 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.87 ' O ' HG22 ' A' ' 10' ' ' VAL . 3.6 p -46.32 102.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.806 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER 80.62 -6.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -47.24 -34.74 8.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.35 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.776 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.66 28.28 7.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.754 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -94.56 -56.56 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HD13 ' A' ' 29' ' ' LEU . 37.9 tp -72.72 -40.78 65.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -57.67 -34.6 69.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.14 -53.74 7.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.574 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.69 -39.77 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.151 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -67.44 -50.32 59.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' SER . . . -68.77 -12.03 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 20.7 mtt180 -67.89 -43.51 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.64 59.41 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.066 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 10.7 p-10 -138.55 95.1 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.9 p -53.9 -18.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.024 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 9.2 mt-30 -72.98 -54.57 8.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.01 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.066 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.04 -36.42 66.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.342 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.109 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.7 p -52.82 -42.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.397 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 1.086 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 23.6 mtp180 -70.91 -50.54 33.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.065 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 2.4 mtm180 -67.4 -12.0 59.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.962 HD13 HD12 ' A' ' 14' ' ' LEU . 8.7 mt -73.55 -70.4 0.37 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.35 -45.27 56.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.66 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 3.1 m-70 -72.42 -12.38 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.61 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 1.8 mtt-85 -134.18 -78.98 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.997 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -37.84 -30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.74 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.9 mt 61.56 45.02 8.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 33' ' ' GLU . 60.4 t -92.89 110.7 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.653 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -46.93 125.09 8.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CG ' ' HB3' ' A' ' 65' ' ' GLN . 52.3 Cg_exo -54.66 -34.77 84.88 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.749 2.299 . . . . 0.0 112.377 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 40' ' ' LEU . 16.3 p-10 -57.38 -21.69 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -33.39 108.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.345 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.792 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.2 mp -102.35 133.44 47.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.988 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.524 ' OD1' ' CB ' ' A' ' 43' ' ' PHE . 8.5 p30 -72.67 159.15 34.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' ASN . 3.8 ptm180 -35.12 -43.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 t80 -56.8 -49.13 76.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 119.22 35.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -116.21 157.09 25.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.785 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -87.32 147.5 25.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -58.03 -28.83 64.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 69' ' ' PRO . 12.8 tp -70.79 -47.95 56.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.74 ' HB2' HG21 ' A' ' 71' ' ' VAL . 44.5 tt0 -60.65 -24.95 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' THR . 6.1 m -106.03 -14.2 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.738 ' HG3' HD23 ' A' ' 62' ' ' LEU . 2.2 ttp -42.34 145.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -85.53 134.88 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.777 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.1 ' CE2' HD21 ' A' ' 95' ' ' LEU . 14.1 m-85 -87.75 -7.27 57.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CE1' ' A' ' 88' ' ' PHE . . . -50.02 -41.04 36.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.028 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.978 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.0 m -108.78 127.56 27.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 91' ' ' THR . 58.8 Cg_endo -71.87 -34.0 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.682 2.255 . . . . 0.0 112.211 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -35.09 79.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 55' ' ' SER . 4.0 m -62.57 -32.1 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.609 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.902 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.874 HD21 ' HD2' ' A' ' 64' ' ' LYS . 7.3 tt -63.4 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.109 ' OE1' HG13 ' A' ' 26' ' ' VAL . 6.7 mt-10 -62.41 -70.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.75 -36.53 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 69' ' ' PRO . 18.4 tp -63.03 -37.87 88.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.874 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 mtpp -63.32 -48.87 76.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HB3' ' CG ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -36.68 -35.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.38 42.61 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.33 28.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.1 m -47.85 112.09 2.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.863 ' HA ' HD21 ' A' ' 48' ' ' LEU . 30.0 Cg_endo -63.52 -21.19 70.7 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.728 2.285 . . . . 0.0 112.175 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.493 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -100.37 82.56 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 49' ' ' GLN . 8.0 m -116.1 142.32 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 4.2 mt-30 -136.24 160.69 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.466 ' OD2' ' NZ ' ' A' ' 45' ' ' LYS . 3.5 m-20 -89.46 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.89 5.95 7.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.7 m -145.46 -70.83 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.814 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . 172.78 58.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 106' ' ' ASP . 4.7 m -110.3 71.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.15 169.04 14.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.907 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.522 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 17.9 Cg_endo -60.4 -32.26 93.67 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.738 2.292 . . . . 0.0 111.799 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 32.1 m -57.49 -42.53 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.243 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.552 ' O ' HD12 ' A' ' 115' ' ' LEU . 8.5 m80 -53.65 -67.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.857 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -54.14 -27.44 33.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.909 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -68.94 -16.25 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -73.18 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.37 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.553 ' CG ' ' HB3' ' A' ' 115' ' ' LEU . 61.0 mtm180 -63.73 -29.7 70.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.0 p -67.87 -6.53 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.228 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.94 74.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.174 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 8.3 m-85 -145.2 53.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.565 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.648 HD11 ' CG ' ' A' ' 127' ' ' PHE . 13.9 tp -52.78 -21.12 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.158 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.585 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -60.12 -73.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.835 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 24.1 m -73.21 -28.16 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.8 tt -60.72 -61.31 2.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 1.289 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -52.7 -30.28 31.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.274 ' CA ' ' OE2' ' A' ' 97' ' ' GLU . 16.2 t -61.0 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.301 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.1 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -71.01 -26.76 63.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.018 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.796 HG13 HG11 ' A' ' 102' ' ' VAL . 6.9 t -73.22 -56.05 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.8 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.289 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -52.81 -35.45 57.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.232 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.87 -32.01 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.968 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.44 62.38 0.31 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . -96.61 43.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 111.139 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 54.2 60.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 96' ' ' VAL . 5.4 m -70.07 -10.77 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -105.48 42.76 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -105.31 168.41 9.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.966 HD21 ' HG ' ' A' ' 111' ' ' LEU . 60.4 mt -145.72 135.18 23.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.609 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.828 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.51 47.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER 80.03 -54.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 p -48.76 -37.7 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.665 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 102.72 0.57 49.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 89.1 p -79.09 100.16 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.966 ' HG ' HD21 ' A' ' 105' ' ' LEU . 7.0 mt -56.38 149.78 36.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.504 ' C ' HD12 ' A' ' 128' ' ' LEU . 79.7 Cg_exo -48.21 -28.98 11.89 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.617 2.211 . . . . 0.0 112.151 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.821 HG21 ' CE1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.45 -29.58 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.201 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 138' ' ' ASP . 50.3 m80 -62.76 -30.8 71.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.124 ' O ' ' OE2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -66.02 -56.51 11.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.976 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.17 -37.78 62.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.168 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 113' ' ' ILE . 71.5 mt -58.71 -43.13 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.465 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -64.73 -15.28 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.472 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 1.124 ' OE2' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -93.7 -56.12 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 94.79 24.27 18.23 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.106 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 82.3 m-70 -55.14 -157.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.624 0.25 . . . . 0.0 110.693 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -102.24 -95.96 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.455 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 29.8 t -73.05 -19.22 61.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.325 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.562 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -56.71 -69.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.048 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 156' ' ' LEU . 18.0 t -52.12 -46.32 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.883 ' CB ' HG21 ' A' ' 159' ' ' ILE . 4.9 p -66.67 -32.69 74.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.783 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 86.6 t80 -73.03 -43.47 62.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.4 OUTLIER -65.42 -11.22 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.073 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.673 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -67.69 -62.51 3.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.673 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 27.0 Cg_endo -61.75 -52.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.845 2.363 . . . . 0.0 112.352 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.783 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 3.9 mt-10 -51.88 -25.74 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.7 m -108.46 137.29 46.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.268 ' OD1' ' HB3' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -35.64 103.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.81 HD13 ' HA ' ' A' ' 164' ' ' MET . 11.1 mt -61.4 134.14 56.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.937 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 1.9 t-160 86.17 14.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.268 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 4.6 p-80 -64.33 168.95 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.87 166.04 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -140.65 148.64 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.664 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -41.38 -28.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.17 0.51 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -34.35 73.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.782 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 93.22 45.07 3.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -153.71 158.05 40.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 111.037 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -108.59 167.97 8.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.565 ' C ' HD12 ' A' ' 160' ' ' LEU . 99.3 Cg_exo -40.59 -50.19 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.827 2.352 . . . . 0.0 112.524 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.866 HD11 ' CG ' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -62.25 -43.77 98.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -56.01 -64.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.72 -39.25 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.703 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.539 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -69.3 -27.7 65.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.621 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -70.73 -54.35 12.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.617 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -59.69 -67.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.01 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 153' ' ' ALA . 6.1 ttt180 -73.81 59.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.57 52.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.925 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.876 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -37.79 -31.22 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.159 0.504 . . . . 0.0 110.15 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.876 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 170.35 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.823 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.545 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.3 p30 -76.54 13.16 1.03 Allowed 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.111 -0.368 . . . . 0.0 111.646 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mt -51.56 -66.65 0.35 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.5 ptm -52.88 -20.81 3.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.69 -63.97 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.489 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.883 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -52.81 -27.71 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 0.0 110.81 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.32 -40.89 64.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.866 ' CG ' HD11 ' A' ' 145' ' ' LEU . 3.1 mt-30 -72.95 -40.53 65.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.005 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.68 37.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 -46.64 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.011 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.81 ' HA ' HD13 ' A' ' 134' ' ' LEU . 3.7 ttp -73.8 100.19 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.11 107.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 166' ' ' ILE . 3.4 tt -155.55 62.7 3.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 166' ' ' ILE . 50.1 Cg_exo -53.62 141.92 62.16 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.685 2.257 . . . . 0.0 112.27 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.966 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.117 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -113.53 134.08 54.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 tpp -165.09 -59.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.15 52.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.26 39.47 3.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -116.18 -29.83 6.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.938 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.998 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER 58.68 32.55 22.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.732 ' O ' HG12 ' A' ' 8' ' ' VAL . 93.0 t 69.0 7.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.178 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -33.73 -38.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.24 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.579 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 22.5 m -131.14 3.96 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.324 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' ALA . . . -38.99 -32.65 0.19 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.574 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 18.8 t0 -117.74 28.08 8.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 111.032 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -96.63 -62.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.802 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -71.86 -42.39 66.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.7 m -57.16 -36.23 70.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -67.12 -52.1 34.48 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.362 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.79 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -60.17 -51.21 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 111.026 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.59 69.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.59 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 2.3 mmm180 -73.56 0.11 13.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.216 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.557 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 50.49 66.25 2.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.631 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.2 p-10 -132.79 95.23 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 110.819 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.1 p -52.55 -22.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.73 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . 4.2 mm100 -73.05 -59.0 2.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.848 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.872 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.28 -17.84 61.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.155 HG12 ' CD ' ' A' ' 61' ' ' GLU . 3.1 t -65.36 -67.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.2 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.931 ' CA ' ' OE2' ' A' ' 61' ' ' GLU . 3.9 ptt-85 -73.17 -38.15 66.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.897 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.594 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -61.87 -27.55 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.797 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.272 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 12.0 mt -73.69 -62.08 1.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 0.0 111.981 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 65' ' ' GLN . 2.3 mt -65.56 -53.24 44.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -72.98 -3.35 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -138.36 -78.71 0.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.038 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.272 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 1.1 tt0 -41.43 -27.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' LEU . 41.6 tp 65.67 73.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 36' ' ' HIS . 80.1 t -122.5 159.74 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.056 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.543 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -74.64 145.06 81.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB3' ' CG ' ' A' ' 65' ' ' GLN . 38.2 Cg_endo -66.86 -29.49 41.62 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.722 2.282 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.671 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -82.52 -67.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 10' ' ' VAL . . . 35.84 87.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 45' ' ' LYS . 5.2 mp -92.54 140.18 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 1.4 m120 -67.72 88.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER 86.78 19.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t80 65.84 52.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.99 -73.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.7 mtpt -86.13 148.86 25.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 71' ' ' VAL . 1.1 p -87.09 150.14 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -52.89 -36.61 59.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.934 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 2.1 mt -73.28 -26.75 61.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.73 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.989 ' CG ' ' OD2' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 15' ' ' SER . 15.8 m -93.11 -18.8 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.746 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 1.3 tmm? -44.2 145.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.557 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.68 12.9 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.853 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 7.3 m-85 56.29 -80.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.66 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 31.94 -93.71 0.01 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.677 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.8 m -67.71 130.56 92.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.483 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 56.1 Cg_endo -71.0 -27.9 19.96 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.715 2.276 . . . . 0.0 111.828 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' C ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.38 -36.37 83.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.01 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.041 HG12 HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.47 -34.18 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -62.7 -58.04 8.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.824 ' O ' HD23 ' A' ' 60' ' ' LEU . 6.7 tt -63.27 -33.03 74.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.794 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.155 ' CD ' HG12 ' A' ' 26' ' ' VAL . 8.1 mt-10 -63.03 -60.26 3.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 5.6 mp -62.81 -46.91 85.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.17 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -63.16 -58.77 6.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 7.2 tmtt? -62.92 -23.79 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.131 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HG2' HD22 ' A' ' 30' ' ' LEU . 24.8 tp60 -74.4 -20.02 60.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.999 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 37' ' ' PRO . . . 120.53 50.35 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.04 159.81 21.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -126.21 120.44 23.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.986 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' VAL . 70.0 Cg_endo -74.68 -17.67 20.23 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.78 60.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 69' ' ' PRO . 4.3 m -134.89 126.67 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' N ' ' A' ' 77' ' ' THR . 2.7 mt-30 -127.33 133.32 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.989 ' OD2' ' CG ' ' A' ' 49' ' ' GLN . 2.1 p30 -125.08 -36.88 2.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.807 ' HB3' ' HB ' ' A' ' 77' ' ' THR . . . -74.23 68.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.091 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.7 p 54.94 19.73 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.07 55.28 0.6 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 74' ' ' ALA . 17.2 m -137.8 100.69 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -68.99 173.45 3.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 -34.04 75.2 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.835 2.357 . . . . 0.0 112.116 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -54.98 -38.43 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -59.66 -65.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.989 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.933 ' C ' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -57.99 -37.36 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.286 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.9 -42.97 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.248 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.64 -55.81 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.795 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -61.62 -27.68 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.4 p -70.8 -70.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.55 64.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 18.7 m-85 -136.26 49.75 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 89' ' ' LEU . 2.7 tm? -52.28 -45.78 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.498 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -66.2 0.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.863 0.363 . . . . 0.0 110.8 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 56' ' ' PRO . 18.0 m -65.33 -44.58 87.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' HB1' ' A' ' 83' ' ' ALA . 22.6 tp -52.71 -48.76 66.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.778 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -52.13 -32.29 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.811 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -74.45 -55.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.94 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 3.8 pp -74.33 -47.8 32.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.679 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.912 HG23 HG12 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -59.4 -36.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.552 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.778 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.87 -28.39 62.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -55.97 -37.42 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 160.08 -19.81 0.24 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.669 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -33.63 115.16 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.607 ' O ' HG21 ' A' ' 80' ' ' VAL . 1.2 p30 -48.8 113.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 100' ' ' ALA . 6.1 m -106.24 26.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' HA ' ' HG ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -123.41 -35.93 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.74 145.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.931 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.64 -151.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -140.67 -77.17 0.31 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -57.85 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.128 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -63.41 -12.42 30.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.695 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.821 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 72.53 17.49 77.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 138' ' ' ASP . 1.4 t -77.38 123.15 26.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.931 HD12 HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -70.96 157.79 89.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.817 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HB2' HD11 ' A' ' 128' ' ' LEU . 71.5 Cg_exo -48.74 -38.54 37.45 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.616 2.211 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HB ' HD12 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.88 -40.97 79.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.086 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' ARG . 22.0 m80 -52.66 -37.87 59.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.637 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 118' ' ' ARG . 9.9 mt -72.84 -50.02 26.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -37.1 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.936 HG21 ' HB3' ' A' ' 147' ' ' LEU . 95.0 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -72.99 -9.87 59.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.772 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.795 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -91.93 -57.94 2.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.674 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.28 41.49 3.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.861 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 9.8 m-70 -82.22 -1.75 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.87 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m 65.86 -81.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.54 ' CB ' ' HG ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -54.83 -52.74 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.981 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 116' ' ' ALA . 51.6 t -55.31 -60.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.345 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 116' ' ' ALA . 3.8 t -52.13 -60.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.372 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.682 ' CB ' HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.46 -27.55 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.64 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 11.7 t80 -73.64 -51.4 16.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HB ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.95 -7.49 22.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.258 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.891 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -58.41 -69.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.265 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.891 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.3 Cg_endo -70.49 -28.69 21.42 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.72 2.28 . . . . 0.0 112.487 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 102' ' ' VAL . 3.3 mm-40 -68.01 -18.14 64.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.497 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 3.8 m -116.88 157.8 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.71 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -44.19 113.96 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.4 mt -85.48 43.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.73 30.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -138.53 155.83 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.543 ' HA ' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -130.13 -172.65 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 1.128 ' OD1' ' O ' ' A' ' 108' ' ' THR . 1.5 t70 -82.97 -174.68 5.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' ' CG ' ' A' ' 138' ' ' ASP . . . -77.94 -4.99 49.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.042 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -46.75 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.761 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . 124.66 80.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.621 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 141' ' ' GLY . 28.5 mt -161.92 107.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.2 p -77.44 150.44 79.7 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.801 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.704 ' O ' HD22 ' A' ' 160' ' ' LEU . 82.1 Cg_exo -45.43 -31.56 6.87 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.604 2.203 . . . . 0.0 112.206 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.771 HD12 ' CE ' ' A' ' 164' ' ' MET . 0.4 OUTLIER -73.32 -47.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.94 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.047 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.34 -50.92 63.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.209 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.936 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.59 -26.93 14.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.391 . . . . 0.0 110.677 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -73.67 -23.71 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -49.22 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -60.92 -72.79 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -73.18 60.98 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.81 47.92 0.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.085 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -36.92 -57.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.441 0.638 . . . . 0.0 110.052 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.426 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -145.37 -146.51 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.548 179.031 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 1.103 ' HB2' ' CG ' ' A' ' 158' ' ' ASP . 17.6 p30 -73.36 53.63 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.848 ' HA ' HD12 ' A' ' 159' ' ' ILE . 6.3 mt -65.14 -66.29 0.56 Allowed 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.574 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 2.7 ppp? -51.44 -20.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.103 ' CG ' ' HB2' ' A' ' 155' ' ' ASN . 7.9 p-10 -73.72 -42.42 61.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.025 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.47 -40.24 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 144' ' ' PRO . 5.4 mp -73.12 -40.17 65.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -63.51 -47.33 82.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.78 -44.32 92.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.38 -12.29 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.909 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.9 mtp -72.7 -53.18 12.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.466 ' O ' ' N ' ' A' ' 167' ' ' PRO . 3.4 ttp 75.35 37.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 168' ' ' MET . 0.9 OUTLIER -34.6 93.01 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.276 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' MET . 32.5 Cg_exo -57.88 75.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.238 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -79.84 -13.26 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.489 ' CE ' ' HG3' ' A' ' 42' ' ' ARG . 1.6 ttm -82.67 143.5 30.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.954 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.02 -55.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.78 -175.49 4.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.167 ' OE1' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.64 47.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.709 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.99 -26.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.167 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 54.7 t -48.98 -67.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.821 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER 35.44 90.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.546 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.97 HG13 HG12 ' A' ' 35' ' ' VAL . 66.6 t 105.92 -39.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.931 0.77 . . . . 0.0 110.851 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.742 ' CA ' ' HB1' ' A' ' 39' ' ' ALA . . . -65.94 -9.52 47.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.687 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -117.85 18.46 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tpt85 -122.62 -53.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.2 tp -70.01 -43.72 70.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.754 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.705 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.99 -31.41 63.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.87 -53.33 8.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.398 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -57.57 -58.76 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.96 67.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.48 -28.48 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.438 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.375 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -73.6 0.66 12.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.249 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 50.73 78.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.375 ' OD2' ' CG ' ' A' ' 20' ' ' ARG . 2.6 p30 -152.63 97.15 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.598 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.927 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.1 p -52.83 -25.18 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.66 -49.99 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.004 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -73.25 -39.75 65.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.57 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 58' ' ' VAL . 8.8 p -52.42 -42.15 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 67.1 mtp85 -72.91 -50.75 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 3.5 mmp_? -52.61 -30.63 32.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.753 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.64 -74.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.172 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' HG2' ' A' ' 65' ' ' GLN . 3.5 mt -74.31 -42.91 58.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -67.54 -4.56 11.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.015 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 9.4 tpt180 -149.51 -77.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.646 0.26 . . . . 0.0 111.311 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.852 ' OE1' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -41.69 -26.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 34' ' ' LEU . 3.6 tp 66.27 83.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.97 HG12 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -111.84 134.92 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.529 ' H ' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -71.26 129.56 88.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.689 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HG3' ' A' ' 65' ' ' GLN . 49.1 Cg_endo -69.17 -15.67 39.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.745 2.297 . . . . 0.0 112.239 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 6.7 t0 -83.57 -28.47 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.962 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.742 ' HB1' ' CA ' ' A' ' 11' ' ' GLY . . . -43.52 157.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 8' ' ' VAL . 2.9 mp -143.34 142.47 31.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.263 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 22.3 p30 -71.4 169.38 15.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.489 ' HG3' ' CE ' ' A' ' 3' ' ' MET . 3.0 tmt_? -39.85 -34.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -62.05 -52.92 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.45 33.44 1.21 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 10.9 mtpt -109.99 170.83 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.789 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 p -98.94 166.58 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -58.32 -46.37 86.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -64.79 -34.26 77.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.848 ' NE2' ' CG ' ' A' ' 73' ' ' ASP . 1.5 tp60 -73.43 -45.75 52.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 46' ' ' THR . 15.7 m -72.97 -39.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.657 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 53' ' ' PHE . 2.7 ppp? -35.26 148.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.038 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 54' ' ' GLY . 2.5 ptm -111.14 22.79 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.159 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.13 ' CE2' HD21 ' A' ' 95' ' ' LEU . 56.3 m-85 50.19 -87.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.347 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 34.46 -94.35 0.01 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.413 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.622 ' C ' HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -53.54 156.26 4.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 1.041 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 93.8 Cg_endo -89.17 -52.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.961 2.441 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.927 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -62.99 -23.15 67.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.773 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.9 p -62.32 -45.46 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.12 -48.89 76.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -62.48 -48.88 77.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.18 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -62.67 -58.07 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.76 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.86 -49.68 73.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD12 ' C ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -63.11 -44.36 95.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 111.214 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.64 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.5 ttpp -62.74 -31.0 71.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.756 ' HG2' HD22 ' A' ' 30' ' ' LEU . 31.6 tp60 -45.66 -29.42 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.1 -19.14 2.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.41 152.46 11.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 13.0 m -105.99 126.66 30.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.979 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HA ' ' HG ' ' A' ' 48' ' ' LEU . 44.4 Cg_endo -68.57 -4.29 12.78 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.737 2.291 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -98.4 64.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' SER . 31.4 m -116.88 125.7 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -104.76 144.31 31.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.848 ' CG ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -123.37 122.03 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 47.94 -91.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -72.44 -87.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . -175.93 45.33 0.12 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.541 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.08 83.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 1.7 m -84.71 166.95 29.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 1.263 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 79.5 Cg_exo -47.81 -33.79 20.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 81' ' ' HIS . 0.5 OUTLIER -54.8 -42.15 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.014 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.571 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 15.7 m80 -70.07 -48.41 57.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.032 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.263 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.3 p30 -55.79 -50.45 70.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.259 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.66 -48.77 66.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 128' ' ' LEU . . . -64.14 -49.93 70.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.234 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -37.9 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ASP . 58.5 p -67.82 -27.44 66.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.06 73.6 1.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.34 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -153.64 58.4 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.821 HD11 ' CG ' ' A' ' 127' ' ' PHE . 61.7 tp -53.87 -16.7 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.673 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.041 ' OD2' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.78 -74.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.803 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -73.65 -33.25 64.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 92' ' ' LEU . 2.0 tt -52.38 -56.91 11.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 1.215 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -56.64 -34.27 67.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 91' ' ' THR . 54.7 t -56.29 -62.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.13 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.43 -32.61 64.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 19.8 t -70.81 -46.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.215 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -56.08 -32.38 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.967 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.57 63.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.11 -68.47 0.44 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 69' ' ' PRO . . . 43.62 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -111.8 64.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.469 ' CG1' HG13 ' A' ' 96' ' ' VAL . 6.7 m -79.88 5.88 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.29 24.85 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -119.82 128.4 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.556 HD13 ' CA ' ' A' ' 109' ' ' GLY . 7.1 mt -85.49 162.38 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.669 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -88.39 -84.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 t -131.61 -45.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.03 7.27 11.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 70.77 10.75 68.2 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.554 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' A' ' 138' ' ' ASP . 73.6 p -78.89 92.46 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 111.044 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.72 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -36.24 146.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD23 ' A' ' 111' ' ' LEU . 99.2 Cg_exo -43.08 -28.44 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.409 2.073 . . . . 0.0 112.113 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.683 ' N ' HD22 ' A' ' 128' ' ' LEU . 1.9 tp -73.4 -35.34 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.56 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 56.6 m80 -57.68 -43.73 85.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -58.75 -42.97 90.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.476 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.647 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -54.59 -48.9 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.569 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 147' ' ' LEU . 93.8 mt -56.0 -40.83 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HE ' HD21 ' A' ' 147' ' ' LEU . 3.0 mmt85 -62.41 -21.44 65.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.32 -54.87 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 116.26 -6.61 19.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.519 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.679 ' O ' HG23 ' A' ' 125' ' ' VAL . 65.6 m80 -51.1 85.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' GLY . 18.0 p -38.88 -38.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 124' ' ' VAL . 1.9 p -73.17 -63.89 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 39.3 t -55.54 -57.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.361 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 121' ' ' HIS . 3.6 t -51.93 -54.09 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.961 ' HB2' HG21 ' A' ' 159' ' ' ILE . 44.0 t -63.74 -31.7 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.406 . . . . 0.0 111.11 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.821 ' CG ' HD11 ' A' ' 89' ' ' LEU . 71.3 t80 -73.1 -47.59 43.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -67.89 -8.96 40.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.29 -64.0 2.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 43.7 Cg_endo -67.88 -46.29 2.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 131' ' ' GLU . 4.2 mm-40 -51.59 -47.09 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.506 ' HB3' HD22 ' A' ' 111' ' ' LEU . 27.8 m -77.67 132.26 38.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' ND1' ' A' ' 136' ' ' HIS . 1.2 m-20 -36.14 96.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.772 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.7 mt -56.08 146.77 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.2 t-160 87.64 -21.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.672 ' CG ' HD13 ' A' ' 111' ' ' LEU . 2.0 p-80 -42.85 167.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.015 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -122.27 -172.62 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.56 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -130.0 159.17 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -10.6 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 p -109.27 -24.04 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.786 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.11 28.92 3.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.633 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.419 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 34.4 mt -102.77 -179.35 3.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -169.8 177.01 1.16 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.6 Cg_exo -49.93 -58.76 1.52 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.641 2.228 . . . . 0.0 112.119 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 161' ' ' GLN . 2.2 mt -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.419 ' OE1' ' CD2' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -54.84 -59.63 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.54 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -52.88 -51.86 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.411 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.8 -36.21 57.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.135 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.438 HH12 HD22 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -63.3 -31.24 72.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -79.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.131 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.59 ' O ' HD11 ' A' ' 156' ' ' LEU . 4.5 mtt85 -74.06 75.08 1.73 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.84 55.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.082 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 1.017 ' HB3' HD22 ' A' ' 156' ' ' LEU . . . -59.32 -18.68 40.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 1.229 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 43.1 tp60 102.76 -85.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.858 0.724 . . . . 0.0 112.834 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.986 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 0.7 OUTLIER -54.99 -42.87 72.98 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 153' ' ' ALA . 1.7 pt? -51.87 -53.84 36.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.573 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.2 ptm -60.28 -36.3 77.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD1' ' O ' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -73.55 -25.2 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.716 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.961 HG21 ' HB2' ' A' ' 126' ' ' SER . 18.8 mt -73.28 -42.06 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.238 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.847 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -73.48 -53.55 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.718 -179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.654 ' HB3' HD21 ' A' ' 145' ' ' LEU . 1.0 OUTLIER -52.37 -25.29 9.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.906 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 161' ' ' GLN . . . -73.31 -54.79 6.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.291 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.14 -49.23 29.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.772 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 tmm? -38.3 -64.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.68 ' O ' HD13 ' A' ' 166' ' ' ILE . 2.7 ttm 57.23 -164.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.638 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 165' ' ' MET . 4.2 mm -136.91 108.71 9.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 168' ' ' MET . 50.3 Cg_endo -69.8 179.43 3.73 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.815 2.343 . . . . 0.0 112.307 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.454 ' HB3' ' O ' ' A' ' 167' ' ' PRO . 3.6 ptt? . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 57.9 m 65.82 -80.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.2 69.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -100.19 111.76 24.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.77 ' O ' ' OE1' ' A' ' 6' ' ' GLU . 7.3 tp -164.21 48.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.77 ' OE1' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.98 81.47 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.24 12.76 23.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.458 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 19.5 m -117.24 35.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.036 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 8' ' ' VAL . 1.2 p -35.31 -42.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.18 -9.96 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.615 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -71.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 1.271 ' OD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -49.86 -22.48 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 1.171 ' HG2' ' OE2' ' A' ' 33' ' ' GLU . 1.9 tpt180 -61.91 -65.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -71.73 -45.42 61.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -35.93 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.93 -49.47 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.456 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.36 -43.96 75.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.64 -50.86 22.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.32 80.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -19.59 62.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 69.66 60.23 5.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.464 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.753 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 3.6 p30 -125.77 92.88 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 10.3 p -52.75 -20.71 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.842 ' C ' ' OE1' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -74.0 -53.9 9.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.264 ' OE1' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -73.39 -33.43 65.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.82 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.7 p -52.78 -50.8 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 0.0 111.306 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.634 ' CB ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.21 -50.52 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.163 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 8.2 ttt180 -56.41 -25.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.005 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.36 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.81 HD22 ' CD ' ' A' ' 65' ' ' GLN . 3.5 mt -73.67 -40.15 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' CB ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -72.64 -1.59 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.321 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -144.73 -70.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.743 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.171 ' OE2' ' HG2' ' A' ' 13' ' ' ARG . 1.2 tt0 -61.67 -15.1 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 47.44 76.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.937 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 14' ' ' LEU . 6.7 t -100.4 159.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -88.27 142.44 31.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.971 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 11.6 Cg_endo -54.77 -39.95 87.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.072 2.515 . . . . 0.0 112.296 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 59.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -107.68 121.37 44.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.856 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.99 170.74 9.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 1.271 ' CB ' ' OD1' ' A' ' 12' ' ' ASP . 15.9 p30 -124.41 -170.79 2.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.57 -30.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -69.02 -52.12 31.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.93 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.76 ' O ' HD23 ' A' ' 40' ' ' LEU . . . 108.16 18.39 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 40' ' ' LEU . 15.0 mttp -102.47 167.66 9.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.775 ' O ' HG12 ' A' ' 50' ' ' VAL . 28.1 p -85.12 162.79 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -54.75 -44.44 73.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.664 ' CD1' HD11 ' A' ' 62' ' ' LEU . 5.1 tp -63.76 -51.19 66.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.043 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' NE2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tt0 -54.34 -70.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 46' ' ' THR . 7.8 p -56.69 -23.99 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.919 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -36.6 132.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 3.4 ptt? -93.48 13.64 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.911 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.8 OUTLIER 43.72 26.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.888 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.86 -67.91 1.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.18 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 91' ' ' THR . 0.4 OUTLIER -93.24 141.85 24.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 0.0 110.516 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.473 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 52.2 Cg_endo -68.55 -43.2 4.24 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.636 2.224 . . . . 0.0 111.975 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.2 -32.73 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.697 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.745 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.3 t -62.48 -31.88 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 121.145 0.498 . . . . 0.0 109.79 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.857 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.03 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.177 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.14 -28.86 70.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.274 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -63.02 -71.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -63.35 -27.46 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -62.78 -62.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -19.03 63.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.81 ' CD ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.07 -24.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.95 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.15 0.39 5.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.57 -173.89 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.46 130.45 9.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -14.19 35.33 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.764 2.309 . . . . 0.0 112.373 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 23.5 m120 -82.36 74.8 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 28.4 m -130.08 138.21 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.007 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -144.43 157.58 44.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -144.88 -77.62 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 85.23 6.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.44 -56.16 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 1.29 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 172.83 56.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.889 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 5.7 m -101.77 69.57 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -73.38 170.89 12.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 10.2 Cg_endo -53.67 -40.5 79.31 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.835 2.356 . . . . 0.0 112.321 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.26 -25.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -67.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.766 ' O ' HG23 ' A' ' 86' ' ' THR . 43.8 p30 -60.66 -26.35 67.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.893 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.25 -52.79 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.273 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -72.81 -29.05 62.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.766 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.1 p -69.41 -6.1 27.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.41 74.97 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.39 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -161.11 59.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' CG ' ' A' ' 127' ' ' PHE . 2.1 tm? -53.6 -28.93 35.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.75 -67.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.694 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.857 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 17.5 m -70.66 -23.39 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.764 HD23 ' C ' ' A' ' 92' ' ' LEU . 1.7 tt -72.83 -42.87 63.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 1.305 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 6.6 ptpt -67.87 -32.44 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.67 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.338 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 1.3 m -64.9 -54.35 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.491 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.5 pp -74.01 -33.39 63.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.808 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 42.3 t -73.04 -53.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.254 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.338 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 1.2 pm0 -52.72 -31.6 38.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.889 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.443 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -57.65 -19.43 26.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.3 6.71 5.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -50.16 132.5 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.587 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 2.9 p30 -43.94 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -99.06 22.55 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.144 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.614 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -128.29 14.29 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.721 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.64 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -89.82 161.65 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -141.64 -179.69 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 1.29 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 1.7 m-20 -121.11 -155.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -57.83 7.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -33.45 73.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.017 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.39 66.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.503 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.54 ' O ' HD11 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -61.3 113.76 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.67 150.1 68.47 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.732 ' HD2' HD23 ' A' ' 111' ' ' LEU . 98.8 Cg_exo -42.71 -31.85 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.829 2.353 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.79 ' HA ' HD21 ' A' ' 128' ' ' LEU . 3.3 tp -72.37 -39.32 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.11 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 36.3 m80 -61.38 -35.18 76.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 115' ' ' LEU . 5.1 mp -69.1 -50.49 47.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.619 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -54.18 -37.45 64.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 147' ' ' LEU . 94.5 mt -62.23 -43.76 98.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.299 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 11.9 mtp180 -61.48 -16.22 45.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.313 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 3.7 mt-10 -105.3 -49.81 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 81.07 29.48 41.39 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.116 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.601 ' CB ' HG21 ' A' ' 124' ' ' VAL . 51.5 m80 -51.5 -169.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 121' ' ' HIS . 91.6 p -57.56 -130.69 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.729 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 1.54 9.76 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.223 -0.298 . . . . 0.0 111.441 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -54.39 -68.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.852 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.7 t -52.18 -32.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.786 ' HB2' HG21 ' A' ' 159' ' ' ILE . 13.8 t -73.53 -56.87 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.787 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 1.097 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 5.0 t80 -67.97 -47.06 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.762 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -66.4 -7.5 19.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.877 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -73.12 -60.7 1.71 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.37 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.4 Cg_endo -59.45 -64.27 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.831 2.354 . . . . 0.0 112.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.097 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -43.8 -26.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.594 ' OG ' HD22 ' A' ' 111' ' ' LEU . 6.0 t -89.5 133.86 34.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.661 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 3.2 p-10 -38.05 93.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.657 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.6 mt -63.88 69.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER 178.34 -42.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.017 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.661 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 1.8 t-160 -54.06 154.41 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HD3' ' NE2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -140.91 -148.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.783 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.457 ' N ' ' HD2' ' A' ' 137' ' ' ARG . 0.7 OUTLIER -160.91 -162.72 0.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.65 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.33 -22.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.172 0.511 . . . . 0.0 110.612 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -62.38 -52.68 62.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.89 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.36 20.73 58.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.748 ' O ' HG23 ' A' ' 143' ' ' THR . 1.4 mt -106.6 -105.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.551 0.175 . . . . 0.0 110.807 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.253 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER 160.52 167.83 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.8 0.333 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 3.8 Cg_endo -47.41 -57.56 2.25 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 123.022 2.481 . . . . 0.0 112.088 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -66.12 -44.75 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.253 ' CD ' ' OG1' ' A' ' 143' ' ' THR . 4.0 mp0 -55.53 -51.12 68.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.531 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.691 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -53.04 -43.34 66.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 110.171 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.834 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.85 -36.42 58.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -35.61 78.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.627 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -74.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.248 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.719 ' O ' HD21 ' A' ' 156' ' ' LEU . 10.8 mmm180 -73.97 70.59 1.51 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.29 52.0 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.909 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.905 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -57.17 -16.6 8.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.513 0.196 . . . . 0.0 110.535 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 36.5 tp60 101.79 -59.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.659 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.494 ' C ' HD12 ' A' ' 159' ' ' ILE . 4.8 m-20 -72.6 -54.73 8.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.0 111.512 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.905 ' HG ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -53.05 -16.78 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.946 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.834 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 14.4 mtp -74.74 -60.37 2.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.858 0.361 . . . . 0.0 111.603 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.616 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.071 -179.122 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.786 HG21 ' HB2' ' A' ' 126' ' ' SER . 60.0 mt -52.74 -55.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.673 0.273 . . . . 0.0 111.366 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.8 OUTLIER -73.64 -31.12 63.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.34 -179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.845 ' HG2' HD13 ' A' ' 145' ' ' LEU . 1.3 mm-40 -62.94 -42.64 99.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -36.14 57.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.403 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -70.18 -31.73 69.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.502 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.57 87.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.858 ' C ' HD13 ' A' ' 166' ' ' ILE . 1.0 OUTLIER -68.18 168.52 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.858 HD13 ' C ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -136.44 105.59 9.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.949 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.54 108.05 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.958 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -126.3 104.73 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.81 56.81 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.8 -51.32 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 5' ' ' LEU . 1.2 tp 65.53 165.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.204 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER 63.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.904 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 1.204 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 0.1 OUTLIER 172.97 101.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.885 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.012 HG13 ' OE2' ' A' ' 6' ' ' GLU . 15.6 m -119.27 -11.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.202 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 8' ' ' VAL . 20.7 p -36.38 -38.54 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.695 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 35' ' ' VAL . 13.1 p -107.33 -17.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -46.47 -57.59 6.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.444 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -84.21 54.68 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -127.86 -66.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 29' ' ' LEU . 29.0 tp -67.23 -33.92 76.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.008 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -61.89 -39.18 91.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -31.63 75.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.9 -59.67 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 111.153 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . . . -54.28 -48.62 71.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 50' ' ' VAL . . . -64.24 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -72.61 -37.65 68.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.85 73.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.37 83.78 1.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -52.65 -22.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -74.11 -49.67 22.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.565 ' O ' HD23 ' A' ' 29' ' ' LEU . 55.8 mm-40 -73.84 -27.3 61.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.845 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.686 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -52.76 -51.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.53 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.559 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.2 mtm180 -73.28 -43.09 61.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 19.7 mmt180 -63.5 -34.21 77.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -53.47 -71.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -69.68 -49.36 54.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.012 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -66.72 -25.83 66.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.93 -58.66 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.555 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.3 tp10 -67.35 -7.14 22.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.06 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER 42.46 28.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.7 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -66.76 148.85 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -67.62 131.03 92.97 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.98 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 57.5 Cg_endo -71.07 -22.42 26.19 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.852 2.368 . . . . 0.0 112.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -99.55 18.68 17.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -62.18 107.59 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.3 mp -89.82 145.22 25.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 54.2 p30 -80.93 -171.37 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -70.56 58.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -172.52 -43.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.58 60.14 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.594 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -141.08 145.64 36.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 50' ' ' VAL . 20.9 p -85.57 155.9 20.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -55.27 -24.24 27.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 69' ' ' PRO . 3.8 mt -72.9 -49.65 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 49' ' ' GLN . 10.6 tp60 -63.88 -28.29 69.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 19' ' ' ALA . 28.9 m -96.23 -14.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HE1' ' CD2' ' A' ' 95' ' ' LEU . 1.2 ttp -44.64 154.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -109.72 23.51 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.73 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 35.84 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -72.39 -85.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.314 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.1 m -77.91 120.31 80.79 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.37 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.791 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.9 Cg_exo -51.1 -43.48 48.05 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.472 2.115 . . . . 0.0 112.08 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.61 -28.51 69.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.644 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.2 t -62.27 -41.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.647 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.65 -50.18 70.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.641 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.5 tp -63.14 -40.19 96.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.712 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -63.04 -43.24 99.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 62' ' ' LEU . 6.0 mt -62.81 -56.92 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 69' ' ' PRO . 5.8 mt -63.12 -31.31 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 4.2 mmtt -63.36 -46.27 87.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -56.57 -27.2 57.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.969 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.39 47.88 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.436 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -109.25 123.58 49.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.903 0.382 . . . . 0.0 111.039 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 124.86 83.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.692 ' HB3' HD21 ' A' ' 63' ' ' LEU . 59.3 Cg_endo -72.42 -38.61 3.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.727 2.285 . . . . 0.0 112.302 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.01 101.48 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 11.6 m -139.41 132.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' HG3' ' C ' ' A' ' 71' ' ' VAL . 49.5 mt-30 -144.85 131.86 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -138.8 -44.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 75' ' ' SER . . . -104.55 115.33 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' GLY . 0.9 OUTLIER 36.38 63.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . 35.53 66.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.602 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.3 m -124.97 144.79 50.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.461 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -144.41 177.97 1.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 77.6 Cg_exo -49.61 -47.56 22.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.656 2.238 . . . . 0.0 112.288 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.69 HG23 HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.57 -38.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -59.31 -70.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.204 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.03 -33.31 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.81 -52.44 56.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.41 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -64.97 -46.56 80.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.441 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -72.21 -24.36 61.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.355 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 82' ' ' ASP . 11.5 p -73.11 -73.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.124 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 126.75 63.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.997 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -148.38 57.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 89' ' ' LEU . 2.7 tm? -52.11 -19.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 4.5 m-20 -60.36 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 56' ' ' PRO . 2.4 m -73.37 -27.55 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 92' ' ' LEU . 3.1 tt -56.54 -57.52 11.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.988 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.65 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.07 -32.22 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.807 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 23.7 t -57.71 -65.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.6 pp -70.41 -29.33 65.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.429 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 80' ' ' VAL . 23.5 t -72.55 -40.31 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.807 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 4.5 pm0 -72.82 -25.75 61.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -61.07 -62.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -176.74 -30.35 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.868 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 99' ' ' GLY . . . -31.8 118.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.351 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.23 119.27 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 131' ' ' GLU . 5.3 p -110.84 20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -136.62 27.88 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.634 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -107.92 130.99 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.064 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -97.49 162.61 13.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.091 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 51.9 p-10 -85.31 53.07 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 106' ' ' ASP . 8.4 t 80.42 -62.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -42.04 -28.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.003 0.43 . . . . 0.0 110.048 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 88.45 31.69 13.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.57 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.542 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -101.8 96.87 7.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 105' ' ' LEU . 10.6 tp -34.89 135.35 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -45.92 -29.25 5.76 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.734 2.29 . . . . 0.0 112.452 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' C ' ' A' ' 128' ' ' LEU . 4.5 tt -73.06 -35.7 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -52.84 -37.66 60.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -68.64 -46.55 68.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.615 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.668 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . . . -56.29 -41.64 76.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.257 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.757 ' HA ' HG11 ' A' ' 125' ' ' VAL . 85.5 mt -57.64 -38.04 62.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.595 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 2.3 mtp180 -66.22 -17.44 64.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -98.95 -50.94 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.76 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.84 40.96 6.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 123' ' ' SER . 23.9 m-70 -72.95 -3.04 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.722 0.296 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER 63.0 -70.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.791 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 121' ' ' HIS . 32.5 m -55.98 -41.61 75.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 84' ' ' ALA . 51.9 t -73.19 -61.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.757 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.28 -51.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.732 ' CB ' HG21 ' A' ' 159' ' ' ILE . 83.7 p -56.57 -42.68 79.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.04 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.653 ' CG ' HD21 ' A' ' 89' ' ' LEU . 72.8 t80 -73.41 -37.61 65.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.853 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -71.97 -2.64 18.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.28 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.849 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -69.19 -71.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.226 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.849 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 37.5 Cg_endo -66.96 -57.63 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.614 2.21 . . . . 0.0 112.336 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 6.6 mm-40 -39.63 -37.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.483 ' OG ' HD13 ' A' ' 128' ' ' LEU . 9.7 m -96.38 133.4 40.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.786 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.32 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -36.51 107.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.549 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 164' ' ' MET . 31.0 mt -72.89 -1.31 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.268 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.05 24.09 13.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.32 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 4.4 t60 -107.27 171.1 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.785 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -159.94 157.38 28.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 141' ' ' GLY . 6.7 t0 -77.57 157.89 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.486 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.7 -27.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 109.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -40.64 62.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.657 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 114.11 35.85 1.44 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.39 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 147' ' ' LEU . 67.8 mt -93.92 -167.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -178.35 165.28 1.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 143' ' ' THR . 99.4 Cg_exo -42.61 -56.83 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.619 2.213 . . . . 0.0 111.886 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 161' ' ' GLN . 6.3 mt -72.03 -42.74 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 142' ' ' LEU . 3.6 tp10 -55.56 -69.78 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 142' ' ' LEU . 21.9 tp -52.73 -38.17 60.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 109.914 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 144' ' ' PRO . . . -54.14 -44.63 71.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.036 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.473 ' N ' ' SD ' ' A' ' 157' ' ' MET . 1.9 tpm_? -58.57 -23.36 58.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 1.4 tt0 -71.9 -75.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.87 ' O ' HD11 ' A' ' 156' ' ' LEU . 5.6 mmm180 -74.06 74.43 1.72 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.88 55.81 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.582 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 155' ' ' ASN . . . -69.88 -13.26 62.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.756 0.313 . . . . 0.0 110.748 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 8.2 tp-100 88.39 -37.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.98 ' OD1' HD23 ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.51 -64.89 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.252 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.98 HD23 ' OD1' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -52.01 -55.02 23.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.291 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 34.5 mmm -50.98 -28.19 9.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 154' ' ' GLN . 30.9 t0 -75.31 -71.04 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.708 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.732 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -53.05 -40.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.232 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 156' ' ' LEU . 6.5 mp -73.68 -14.75 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.725 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.37 -61.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.38 -48.69 50.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.301 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -53.93 -18.96 3.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 134' ' ' LEU . 6.9 mmm -94.74 133.51 38.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -78.08 73.69 4.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.508 ' O ' ' CD1' ' A' ' 166' ' ' ILE . 0.6 OUTLIER -34.45 93.47 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.462 ' N ' ' O ' ' A' ' 165' ' ' MET . 50.7 Cg_exo -54.01 113.31 1.27 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.72 2.28 . . . . 0.0 112.232 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.3 mtt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.85 144.21 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mmm -118.53 -8.11 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.45 155.85 25.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.265 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 19.7 mt -106.08 -159.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.909 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.98 52.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.876 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 1.265 ' OE2' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.86 16.41 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG11 ' CA ' ' A' ' 41' ' ' ASN . 33.7 m -103.3 -30.83 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' C ' HG23 ' A' ' 10' ' ' VAL . 1.3 m 58.09 130.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.791 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER 52.13 20.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -81.9 -60.91 2.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.521 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -10.77 26.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -98.66 -70.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -72.22 -61.36 1.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.1 t -55.81 -25.8 43.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.18 -50.69 11.73 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.745 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.51 -47.42 48.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 111.223 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.918 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.87 -39.67 62.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.024 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.34 -41.45 63.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.304 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' CD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.63 -22.14 66.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.68 59.47 3.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.898 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.247 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 16.5 t0 -109.29 90.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.643 0.259 . . . . 0.0 110.374 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' CB ' ' A' ' 57' ' ' ALA . 3.4 p -51.92 -23.53 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.151 0.5 . . . . 0.0 110.255 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.14 -59.58 2.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.8 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.247 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 11.0 mm-40 -73.96 -28.19 61.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.613 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.972 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.7 p -52.41 -51.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.816 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.561 ' N ' HG13 ' A' ' 26' ' ' VAL . 19.6 mtp180 -74.48 -51.25 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -52.75 -36.74 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.11 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 9.2 mt -73.16 -74.33 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.685 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.808 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.16 -42.19 63.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -73.08 -1.68 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.27 -64.74 0.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 111.121 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.955 ' OE2' ' CG1' ' A' ' 35' ' ' VAL . 2.2 tt0 -62.51 -11.35 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tp 54.22 73.25 0.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.955 ' CG1' ' OE2' ' A' ' 33' ' ' GLU . 2.0 m -101.29 153.92 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' OD2' ' A' ' 38' ' ' ASP . 1.8 t-80 -74.83 126.6 88.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.55 1.03 7.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.786 2.324 . . . . 0.0 112.357 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 1.1 p-10 -111.86 53.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.33 177.21 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 3.8 mp -142.19 -173.87 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' CA ' HG11 ' A' ' 8' ' ' VAL . 17.8 p-10 -150.9 166.7 29.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -35.17 -31.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -68.33 -47.63 67.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 110.13 16.12 10.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 11.5 mtpt -101.83 169.02 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.15 168.52 13.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -60.4 -55.01 38.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.42 -36.64 84.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 77' ' ' THR . 41.2 tp60 -52.87 -66.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 46' ' ' THR . 7.1 p -70.09 -25.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.749 ' HG3' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -35.7 107.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 20' ' ' ARG . 2.8 ptt? -66.27 137.28 56.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.108 ' CE2' HD21 ' A' ' 95' ' ' LEU . 11.6 m-85 -82.64 47.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -86.36 -64.36 1.46 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.135 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.907 ' O ' HG12 ' A' ' 58' ' ' VAL . 5.2 m -98.36 111.52 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 1.026 ' CG ' ' OD1' ' A' ' 90' ' ' ASP . 76.1 Cg_exo -48.67 -23.5 5.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.449 2.1 . . . . 0.0 111.834 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.823 ' CB ' HG23 ' A' ' 23' ' ' VAL . . . -64.41 -43.45 94.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.112 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.972 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 p -61.94 -36.9 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.87 0.367 . . . . 0.0 110.549 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.8 -51.32 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.8 tt -63.29 -46.45 86.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.942 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE2' ' HG ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -62.56 -47.4 84.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.439 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.918 HD11 ' HB1' ' A' ' 18' ' ' ALA . 11.9 mt -62.73 -58.97 5.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -28.16 69.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.389 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 18.0 ttpt -62.77 -17.78 61.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.774 0.321 . . . . 0.0 111.084 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.731 ' HG2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -77.34 -67.49 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.15 37.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.54 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.52 -160.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 71' ' ' VAL . 32.1 m -123.7 124.1 26.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 74.2 Cg_endo -75.16 -17.23 19.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.783 2.322 . . . . 0.0 112.366 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -114.17 77.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 68' ' ' SER . 5.0 m -117.85 152.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -134.62 160.32 38.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.742 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -117.25 67.38 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 73' ' ' ASP . . . 36.17 41.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.0 m -151.46 -43.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.821 ' HA3' ' OD2' ' A' ' 106' ' ' ASP . . . 111.95 67.57 0.53 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.45 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -164.7 105.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.52 170.62 6.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.736 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 76.9 Cg_exo -49.66 -40.45 46.71 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.593 2.196 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 101' ' ' ASP . 7.6 m -59.05 -34.0 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -69.8 -62.36 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.76 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -53.1 -48.15 68.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.05 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.33 -27.71 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HA ' HG11 ' A' ' 124' ' ' VAL . . . -71.49 -62.42 1.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HA ' ' HG3' ' A' ' 119' ' ' GLU . 16.4 mtp180 -73.07 -28.13 62.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.8 p -69.82 -5.58 26.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.147 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 50.28 76.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.528 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 11.7 m-85 -150.4 56.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.54 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -52.56 -22.95 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.188 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.026 ' OD1' ' CG ' ' A' ' 56' ' ' PRO . 3.6 t70 -62.29 -74.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 110.647 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 43.2 m -70.71 -19.81 62.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.501 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 89' ' ' LEU . 2.8 tt -68.61 -55.3 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.511 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.6 -30.01 62.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.966 ' O ' ' OE2' ' A' ' 97' ' ' GLU . 78.8 t -59.98 -62.46 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.108 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.12 -28.78 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.471 . . . . 0.0 110.148 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.889 HG13 HG11 ' A' ' 102' ' ' VAL . 16.4 t -73.33 -44.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.966 ' OE2' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -68.1 -28.42 67.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.742 ' CG ' ' OE2' ' A' ' 97' ' ' GLU . 12.3 m170 -60.06 -29.63 68.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.48 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.705 ' O ' HG13 ' A' ' 102' ' ' VAL . . . -95.81 143.56 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 111.108 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.465 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -56.1 84.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.889 HG11 HG13 ' A' ' 96' ' ' VAL . 11.7 m -88.66 11.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.557 ' OD1' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.16 37.92 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.962 ' C ' HD23 ' A' ' 105' ' ' LEU . . . -107.9 145.01 34.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.121 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -121.51 146.5 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.821 ' OD2' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -155.25 -53.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -48.16 -52.98 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.08 57.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 108' ' ' THR . . . 36.49 52.62 1.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.432 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 111' ' ' LEU . 48.0 m -134.49 110.9 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.97 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 136' ' ' HIS . 8.8 tp -35.01 140.53 0.29 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 88.1 Cg_exo -46.69 -32.26 11.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.767 2.311 . . . . 0.0 112.194 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 128' ' ' LEU . 1.6 tt -66.69 -37.44 79.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.553 ' HA ' HD12 ' A' ' 117' ' ' ILE . 73.8 m80 -59.3 -35.56 73.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -64.29 -53.07 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.415 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.72 -41.4 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 110.055 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.627 ' HA ' HG11 ' A' ' 125' ' ' VAL . 88.2 mt -52.81 -42.5 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.333 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -16.22 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 121' ' ' HIS . 3.8 mm-40 -86.46 -59.58 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.694 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.29 -0.35 14.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.603 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.887 ' O ' HG22 ' A' ' 125' ' ' VAL . 77.9 m-70 -61.44 73.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m -34.53 -33.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.57 -48.76 30.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.569 ' HA ' HD23 ' A' ' 89' ' ' LEU . 12.4 t -73.07 -50.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.411 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.887 HG22 ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -52.07 -52.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.548 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.1 t -69.04 -34.98 76.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.229 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.79 ' CD2' HD21 ' A' ' 89' ' ' LEU . 67.7 t80 -72.94 -35.83 67.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.088 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.28 -0.23 13.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.273 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.2 -69.41 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.306 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.5 Cg_endo -68.56 -57.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.633 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.487 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 24.0 mm-40 -39.28 -31.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.006 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 1.3 t -109.01 136.3 48.77 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 111' ' ' LEU . 1.3 p30 -35.37 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 164' ' ' MET . 12.6 mt -70.71 75.3 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER 173.14 -33.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.68 ' HB3' HD22 ' A' ' 111' ' ' LEU . 6.7 t60 -38.61 161.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 143' ' ' THR . 30.3 mtt180 -140.51 147.65 39.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.888 ' OD2' ' HB3' ' A' ' 140' ' ' SER . 0.3 OUTLIER -85.32 159.84 19.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.685 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 109.891 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.888 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . 0.1 OUTLIER -71.52 -56.1 6.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.833 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.51 12.62 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.701 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 2.7 mt -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.584 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -74.22 -178.67 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.695 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.0 Cg_exo -49.92 -49.87 14.87 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.837 2.358 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -67.99 -42.41 80.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.738 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.647 ' OE1' ' OE1' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -52.93 -60.16 3.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.037 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.84 -29.83 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.682 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 157' ' ' MET . . . -72.63 -24.08 61.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 146' ' ' GLU . 7.4 tmm_? -65.85 -51.03 62.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.647 ' OE1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.17 -71.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -74.18 58.3 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.29 52.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.433 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -31.05 -48.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.433 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -173.81 -109.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.535 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.3 m-80 -74.71 4.97 5.41 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.227 -0.295 . . . . 0.0 111.434 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 160' ' ' LEU . 1.6 mt -51.2 -59.34 4.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.704 0.288 . . . . 0.0 111.33 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.2 -32.17 35.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.916 0.389 . . . . 0.0 110.637 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.33 -57.77 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.787 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.15 -32.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -179.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.4 -59.88 2.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' HD11 ' A' ' 145' ' ' LEU . 6.3 pt20 -65.45 -14.91 61.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.05 -55.43 6.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.96 -14.09 61.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.1 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.639 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.47 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.774 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.445 ' O ' ' C ' ' A' ' 166' ' ' ILE . 1.1 mtp 171.52 -36.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.996 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 167' ' ' PRO . 26.8 mm 32.07 89.26 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 166' ' ' ILE . 52.8 Cg_exo -54.66 -148.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 0.0 112.274 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.88 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.3 p -62.56 72.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.841 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 1' ' ' GLY . 2.1 mtm -96.67 17.77 15.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tp -101.92 48.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.8 OUTLIER -100.78 168.27 9.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.857 ' HB3' ' OD2' ' A' ' 12' ' ' ASP . 1.3 mt-10 -45.6 131.12 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -109.23 41.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 42' ' ' ARG . 2.6 p -108.16 -17.28 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 50.9 m 67.39 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.389 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.774 HG12 ' HB1' ' A' ' 39' ' ' ALA . 9.2 t -72.07 -57.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.603 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 8' ' ' VAL . . . -33.2 -56.43 0.55 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.25 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.857 ' OD2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -73.42 -24.14 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 111.252 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -72.56 -68.74 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.187 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.951 ' HB2' HG11 ' A' ' 35' ' ' VAL . 3.0 tm? -68.07 -54.83 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -61.12 -38.6 86.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.122 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -62.16 -61.08 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.673 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.818 ' HB3' HD11 ' A' ' 29' ' ' LEU . . . -57.55 -41.58 81.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.02 75.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.89 61.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 4.1 mtp85 -68.59 -30.71 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' CA ' ' HG2' ' A' ' 52' ' ' MET . . . 84.46 33.06 20.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.464 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.334 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 p-10 -104.64 100.18 9.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.2 p -54.72 -17.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.817 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 16.8 mt-30 -74.25 -53.39 9.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.269 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.334 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.32 -34.64 65.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.025 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.909 HG21 ' HA ' ' A' ' 58' ' ' VAL . 9.9 p -52.56 -50.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' N ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -72.52 -48.1 43.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 111.038 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.87 -27.44 65.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 17' ' ' ALA . 26.8 mt -74.43 -71.85 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.023 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.011 HD22 ' CG ' ' A' ' 65' ' ' GLN . 82.9 mt -63.3 -67.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -64.9 -4.88 4.97 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -129.43 -70.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.459 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.206 ' OE1' HG22 ' A' ' 35' ' ' VAL . 4.4 tt0 -51.86 -20.49 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 34' ' ' LEU . 1.4 mt 59.12 53.51 5.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.206 HG22 ' OE1' ' A' ' 33' ' ' GLU . 48.5 t -86.02 137.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.179 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.6 t-80 -55.41 143.56 56.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 36.9 Cg_endo -65.22 -33.77 47.87 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.78 2.32 . . . . 0.0 112.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.887 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -96.42 31.59 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB1' HG12 ' A' ' 10' ' ' VAL . . . -79.43 61.19 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.366 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 38' ' ' ASP . 5.0 mp -55.76 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -84.26 46.06 1.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.769 ' HB2' HG23 ' A' ' 8' ' ' VAL . 2.0 tmt_? 84.7 -11.69 0.78 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER 155.74 50.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.791 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -143.12 -102.47 0.42 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.979 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HB3' HG13 ' A' ' 50' ' ' VAL . 14.3 mttt -95.07 154.69 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 0.0 111.229 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.859 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.39 142.93 29.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.989 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 14' ' ' LEU . . . -52.84 -22.62 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' SD ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -73.29 -67.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -52.96 -37.76 61.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 46' ' ' THR . 28.7 m -78.43 -19.21 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.292 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.796 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.61 143.22 51.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.498 ' HG2' ' CA ' ' A' ' 21' ' ' GLY . 4.1 ppp? -78.04 116.69 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.641 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 36.7 m-85 -70.32 57.93 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -50.66 0.21 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.6 m -82.3 127.07 72.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 55.4 Cg_endo -70.2 -37.34 8.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.631 2.22 . . . . 0.0 112.317 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.851 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.31 -39.28 94.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.315 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.909 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.1 m -62.96 -31.33 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.831 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -63.45 -59.89 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.671 HD23 ' C ' ' A' ' 60' ' ' LEU . 7.0 tt -63.26 -37.87 88.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.851 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 5.3 mp0 -62.75 -62.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 14' ' ' LEU . 3.4 mt -62.82 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 69' ' ' PRO . 4.9 tp -63.33 -50.88 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.6 ttpp -62.83 -36.87 84.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.92 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 1.011 ' CG ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -37.55 -60.55 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.853 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.95 -23.94 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.2 146.23 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.038 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.14 119.68 62.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 63' ' ' LEU . 53.1 Cg_endo -69.52 -19.64 37.03 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.03 70.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' SER . 23.4 m -124.2 145.76 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -134.4 133.35 40.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.669 ' CG ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -100.12 -169.95 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.669 ' N ' ' CG ' ' A' ' 73' ' ' ASP . . . -35.75 -71.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.063 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.038 ' O ' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -59.15 -34.89 72.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 1.193 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 92.29 48.16 3.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.886 HG22 ' HB3' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -112.38 75.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 110.926 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.843 ' OG ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -43.84 170.06 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.763 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 8.9 Cg_endo -50.6 -32.73 36.55 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.933 2.422 . . . . 0.0 112.38 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG22 ' CG2' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -63.75 -52.94 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.886 ' HB3' HG22 ' A' ' 77' ' ' THR . 33.4 m80 -53.01 -54.1 40.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.763 ' OD1' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -60.76 -50.91 71.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.076 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -52.83 -30.1 31.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -68.95 0.41 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -60.09 -18.62 48.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.311 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.8 p -73.33 -27.84 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.074 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.49 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 75.1 76.18 0.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.147 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 70.2 m-85 -156.19 61.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 123' ' ' SER . 6.3 mt -52.51 -18.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.596 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.044 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.28 -70.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.044 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 t -65.5 -35.94 82.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.9 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.998 HD23 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -52.89 -51.96 59.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.7 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.746 ' O ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.86 -38.01 61.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.536 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' CA ' ' OE1' ' A' ' 97' ' ' GLU . 87.9 t -75.27 -64.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.309 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.937 HD12 ' N ' ' A' ' 96' ' ' VAL . 4.6 pp -73.69 -52.53 12.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.998 HG11 HD23 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -52.55 -26.58 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.746 ' OE1' ' O ' ' A' ' 93' ' ' LYS . 3.0 pm0 -72.13 -29.79 64.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -67.11 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.21 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -67.47 63.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 1.138 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 1.1 p-10 39.96 69.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.565 HG12 HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -90.74 21.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 35.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -119.45 -178.54 3.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -150.09 165.24 33.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 1.193 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 2.4 t0 -84.76 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.25 -44.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -16.94 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 138' ' ' ASP . . . 72.34 52.81 9.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.382 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.65 105.48 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HA ' HD23 ' A' ' 105' ' ' LEU . 8.2 mt -43.82 158.22 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 67.3 Cg_exo -51.26 -43.54 48.38 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.284 . . . . 0.0 112.283 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -55.83 -40.22 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.676 ' HA ' HD12 ' A' ' 117' ' ' ILE . 33.4 m170 -54.95 -43.86 73.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 11.3 mt -63.01 -56.0 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.87 -32.23 43.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.928 HG21 ' HB3' ' A' ' 147' ' ' LEU . 46.9 mt -65.35 -41.28 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.604 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 0.8 OUTLIER -70.57 -18.29 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.602 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 1.6 mt-10 -87.56 -56.62 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.59 28.77 9.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.604 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 21.3 m-70 -60.04 -15.03 19.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.341 . . . . 0.0 110.547 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER 77.93 -75.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.981 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.716 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.65 -48.38 75.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 42.5 t -58.22 -60.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.2 t -52.24 -40.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.756 ' HB2' HG21 ' A' ' 159' ' ' ILE . 1.9 t -72.18 -23.82 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CE2' ' OE2' ' A' ' 131' ' ' GLU . 7.0 t80 -73.59 -48.14 35.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -69.63 -5.26 23.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.03 -70.33 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.185 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.9 Cg_endo -75.04 -43.4 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.696 2.264 . . . . 0.0 112.399 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.635 ' OE2' ' CE2' ' A' ' 127' ' ' PHE . 1.6 mt-10 -50.55 -33.51 22.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.707 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 132' ' ' SER . 1.2 m-20 -35.6 120.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.884 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.5 mt -87.64 19.79 3.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.38 -44.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.557 ' HB3' HD11 ' A' ' 111' ' ' LEU . 3.1 t60 -55.7 157.1 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.42 166.91 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.649 ' CG ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -80.97 153.21 27.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.44 -21.9 1.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -44.19 85.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 107.87 53.65 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.577 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 10.1 mt -149.94 104.76 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.71 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -72.95 177.62 1.83 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.697 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 87.0 Cg_exo -46.55 -57.89 2.0 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.7 -28.81 70.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.71 ' OE2' ' OG1' ' A' ' 143' ' ' THR . 0.4 OUTLIER -72.75 -65.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.34 -39.34 60.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.146 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -60.63 -37.43 81.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.23 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.62 84.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.613 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -65.1 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.364 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.766 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -75.14 57.82 0.87 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.53 52.01 0.86 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.071 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -35.55 -32.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.587 HE22 HD11 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -178.86 -123.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.461 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 1.349 ' CB ' ' OD2' ' A' ' 158' ' ' ASP . 3.4 m-20 -75.97 29.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.065 0.393 . . . . 0.0 111.963 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 151' ' ' ARG . 1.5 mt -54.25 -72.02 0.07 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 110.971 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.722 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 8.7 ptm -53.95 -21.27 7.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.349 ' OD2' ' CB ' ' A' ' 155' ' ' ASN . 8.6 p-10 -73.95 -54.42 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.098 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.176 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 2.0 mt -53.13 -37.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.815 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.8 -27.9 61.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -52.9 -54.18 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.46 91.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.516 ' O ' ' CD1' ' A' ' 134' ' ' LEU . 42.8 m-70 -68.81 -37.7 79.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.822 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.884 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.18 -176.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -151.18 153.56 35.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.079 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -117.68 123.69 29.52 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.005 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.27 -14.18 11.57 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 0.0 112.585 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -172.05 150.53 2.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.424 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.83 134.12 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.937 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -176.34 81.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 5' ' ' LEU . 12.9 tp -151.0 22.58 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.89 97.73 5.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 53.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 40' ' ' LEU . 9.8 p -132.96 -37.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.309 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.443 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . 5.4 p -39.12 -31.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.211 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -87.58 -51.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.227 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.577 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -52.06 -20.3 6.41 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.389 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 9' ' ' CYS . 1.2 p30 -92.78 -8.83 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 0.0 110.863 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -98.65 -51.95 3.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB2' HG21 ' A' ' 35' ' ' VAL . 9.0 tp -64.06 -33.84 76.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.608 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -62.39 -41.87 98.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -70.87 -49.23 29.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.823 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -58.2 -47.86 82.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.351 . . . . 0.0 111.074 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.44 71.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.74 -23.64 59.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 3.0 mmt180 -73.9 -12.3 60.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.606 ' HA2' ' HE2' ' A' ' 52' ' ' MET . . . 66.83 80.61 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.68 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 11.4 t0 -147.51 88.49 1.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.302 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.688 HG23 ' HB3' ' A' ' 57' ' ' ALA . 6.3 p -52.18 -29.18 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -52.27 11.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.77 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -74.12 -27.85 61.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.737 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 58' ' ' VAL . 1.8 p -52.56 -47.21 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.312 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 1.266 ' NE ' ' OE2' ' A' ' 61' ' ' GLU . 6.2 mtt180 -73.64 -34.38 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.073 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 2.6 mmm-85 -52.4 -27.54 16.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.258 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.823 HD11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 mt -73.05 -68.42 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -63.99 -53.62 47.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.006 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -59.29 -16.51 22.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 2.3 mmp_? -135.21 -73.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -47.45 -23.44 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 59.36 16.05 4.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.791 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' LEU . 13.8 p -46.36 154.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -91.94 121.49 66.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 30.8 Cg_endo -63.47 -9.69 18.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.763 2.309 . . . . 0.0 112.154 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.93 21.15 18.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' N ' ' A' ' 11' ' ' GLY . . . -97.79 143.71 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.78 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -119.93 160.15 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 15' ' ' SER . 1.1 m-20 -71.24 -159.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -4.99 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.05 -44.56 6.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.624 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 120.85 38.55 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' N ' ' HB3' ' A' ' 40' ' ' LEU . 7.1 mtpt -117.7 143.76 45.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.829 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -85.06 156.69 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -57.63 -36.18 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.761 HD11 HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -61.33 -36.53 80.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.785 ' HG2' HG21 ' A' ' 71' ' ' VAL . 1.3 mt-30 -73.05 -55.83 5.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -59.4 -19.03 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.256 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.676 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -43.62 148.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.759 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.606 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.93 23.39 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.105 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 1.035 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 0.9 OUTLIER 33.15 57.91 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.467 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -108.46 -72.16 0.75 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.312 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -84.54 121.54 74.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.751 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.71 -45.0 44.27 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.574 2.183 . . . . 0.0 111.859 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.3 -31.3 72.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 26' ' ' VAL . 2.2 t -62.12 -47.88 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.027 0.441 . . . . 0.0 110.009 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.74 -49.79 71.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.822 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.4 tt -63.08 -43.3 98.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.548 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.266 ' OE2' ' NE ' ' A' ' 27' ' ' ARG . 7.4 tt0 -62.74 -61.23 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.414 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.09 -37.59 87.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 48' ' ' LEU . 39.4 tp -63.42 -52.65 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.117 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -62.62 -34.0 76.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.017 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 1.3 tp-100 -46.24 -25.32 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.29 3.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.593 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -39.31 148.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.01 123.05 44.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.26 -14.77 28.53 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.772 2.314 . . . . 0.0 112.235 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.9 57.21 4.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.785 HG21 ' HG2' ' A' ' 49' ' ' GLN . 13.9 m -103.2 175.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -153.59 129.97 10.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -104.14 124.12 48.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.43 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -116.37 -65.46 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.41 23.57 0.36 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.541 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 m -82.21 65.67 7.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 110.72 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -58.79 171.14 0.69 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD3' ' CG2' ' A' ' 71' ' ' VAL . 78.1 Cg_exo -49.99 -44.27 38.04 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.772 2.315 . . . . 0.0 112.134 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.56 -41.04 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.318 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.618 ' HD2' HD11 ' A' ' 115' ' ' LEU . 6.0 m80 -52.83 -66.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.795 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -62.58 -30.76 71.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.55 -39.21 64.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.331 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.76 -50.17 38.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.542 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 115' ' ' LEU . 13.4 mtt180 -72.97 -26.88 61.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 82' ' ' ASP . 32.6 p -70.76 -3.43 18.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.301 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 43.83 76.17 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.13 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -158.98 61.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD1' ' CD2' ' A' ' 127' ' ' PHE . 62.5 tp -52.42 -19.63 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.138 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -63.13 -71.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.713 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.885 HG22 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -73.15 -20.74 60.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 92' ' ' LEU . 1.7 tt -72.95 -42.51 63.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.34 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 38.8 ttmt -65.71 -36.94 85.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.447 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.76 ' HA ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -55.82 -58.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.078 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.676 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.6 pp -73.07 -34.44 66.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.073 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 80' ' ' VAL . 38.8 t -72.32 -49.31 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.76 ' CD ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -58.77 -32.97 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -30.91 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.35 -0.58 7.55 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 102' ' ' VAL . . . -42.99 167.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.113 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.07 88.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.818 ' HA ' HG21 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -89.35 13.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.6 9.81 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.07 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -65.08 141.63 58.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.886 HD13 ' HA2' ' A' ' 109' ' ' GLY . 6.7 mt -121.67 150.54 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.065 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' OG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -84.98 -48.87 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 106' ' ' ASP . 0.6 OUTLIER -175.25 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 2.26 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.886 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 52.8 18.97 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.353 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.575 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -48.27 -50.37 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.541 0.21 . . . . 0.0 111.132 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 105' ' ' LEU . 6.2 tp 92.49 127.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.724 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.552 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 84.7 Cg_exo -44.38 -46.11 12.06 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.854 2.369 . . . . 0.0 112.589 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.38 -31.39 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.153 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.601 ' CD2' HD22 ' A' ' 147' ' ' LEU . 8.9 m80 -70.03 -34.17 72.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 81' ' ' HIS . 1.2 mt -63.5 -52.96 59.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -53.56 -36.02 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.682 HG21 ' HB3' ' A' ' 147' ' ' LEU . 83.6 mt -61.5 -41.52 90.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -68.91 -12.6 61.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.587 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.544 ' CB ' ' CD2' ' A' ' 121' ' ' HIS . 2.6 mt-10 -91.76 -57.81 2.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.736 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.92 -11.88 10.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.796 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 125' ' ' VAL . 30.7 m-70 -57.22 78.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 126' ' ' SER . 11.8 p -37.72 -45.02 0.76 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.2 p -56.94 -51.27 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.255 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 45.3 t -72.9 -58.85 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.452 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.4 t -52.04 -40.94 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.321 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.586 ' HB3' HG21 ' A' ' 159' ' ' ILE . 77.3 p -67.09 -36.87 82.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.111 0.481 . . . . 0.0 110.799 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 68.1 t80 -73.7 -44.51 56.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -70.44 -10.79 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.082 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.31 -69.09 0.37 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 1.016 ' HA ' HD11 ' A' ' 134' ' ' LEU . 72.0 Cg_endo -74.5 -50.07 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.772 2.315 . . . . 0.0 112.58 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -39.27 -44.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD13 ' A' ' 128' ' ' LEU . 8.1 t -90.77 134.2 34.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.432 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -40.14 101.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.016 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.2 mp -62.68 -36.77 83.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -63.53 -33.91 76.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.066 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.432 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 12.0 t60 -50.35 155.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -114.14 149.66 35.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.996 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.669 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 t70 -66.34 -9.32 32.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' ASP . . . 82.41 -5.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -14.01 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 108.33 48.3 0.88 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.478 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 147' ' ' LEU . 94.3 mt -151.62 93.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 111.057 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.82 179.65 0.75 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 73.3 Cg_exo -49.33 -49.41 15.6 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.763 2.309 . . . . 0.0 112.575 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.8 mt -73.28 -34.98 66.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 143' ' ' THR . 15.4 mm-40 -52.78 -62.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.682 ' HB3' HG21 ' A' ' 117' ' ' ILE . 2.7 tp -54.71 -48.35 72.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.41 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -57.17 -36.8 71.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.337 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -43.69 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.002 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 151' ' ' ARG . 10.2 tt0 -71.9 -86.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.976 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.504 ' N ' ' HG2' ' A' ' 150' ' ' GLN . 37.5 mtt-85 -74.7 53.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.549 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -52.07 -20.61 6.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 154' ' ' GLN . . . 34.43 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.597 ' CG ' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 125.95 -154.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.499 ' N ' ' CD ' ' A' ' 154' ' ' GLN . 2.2 t30 -74.41 46.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.408 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 159' ' ' ILE . 11.3 mt -69.91 -50.32 43.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.726 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.5 ptm -52.13 -26.18 10.68 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.944 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -74.4 -58.61 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.819 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.036 HD11 HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -51.91 -38.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.346 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.676 ' HG ' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -74.23 -23.79 59.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.025 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.26 -47.26 44.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.07 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.16 53.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -72.12 -8.34 54.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.486 ' CG ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -77.93 150.11 34.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.967 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.1 ptp -128.11 144.69 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.62 69.77 59.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' C ' ' HG2' ' A' ' 168' ' ' MET . 40.1 Cg_exo -56.65 -176.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.773 2.315 . . . . 0.0 112.227 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.447 ' HG2' ' C ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.746 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m -100.71 120.05 39.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.3 ttm -82.7 59.35 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.83 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.05 146.38 25.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 49.79 57.16 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.41 -88.25 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 49.56 29.38 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 31.3 m -152.1 -40.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 33.6 t 71.91 -58.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.058 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 35' ' ' VAL . 7.7 p -121.25 14.27 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -60.78 -56.37 24.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -11.22 28.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.815 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -86.61 -65.26 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.061 HD23 HG11 ' A' ' 35' ' ' VAL . 2.2 tm? -71.44 -65.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -56.97 -30.97 64.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.43 -63.77 2.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -64.75 -44.51 89.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.077 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -52.62 -51.5 59.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -65.1 -38.24 90.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -70.42 -7.91 46.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 23' ' ' VAL . . . 114.94 -66.28 0.28 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.901 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.107 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 26.89 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.0 111.822 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 26' ' ' VAL . 12.6 p -51.66 -35.64 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.21 -42.87 59.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.107 ' OE1' ' HA ' ' A' ' 22' ' ' ASP . 2.7 mp0 -74.43 -25.94 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.302 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.177 HG13 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.31 -40.06 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 60.9 mtt180 -73.99 -48.28 31.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 9.8 mtt180 -66.2 -29.31 69.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.573 HD11 ' OD2' ' A' ' 22' ' ' ASP . 6.7 mt -55.31 -67.46 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -73.63 -52.97 11.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.922 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 41.0 m-70 -67.62 -4.73 12.74 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -142.28 -57.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.689 0.281 . . . . 0.0 111.345 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.815 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.92 -4.52 20.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.165 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 39.88 32.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.977 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.061 HG11 HD23 ' A' ' 14' ' ' LEU . 9.7 p -59.15 166.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -98.72 135.5 21.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HB3' ' NE2' ' A' ' 65' ' ' GLN . 56.5 Cg_endo -70.84 -10.04 26.92 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.65 50.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.796 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.6 116.33 32.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -97.54 165.04 12.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.47 46.03 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.85 21.95 5.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.8 -9.16 8.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.12 20.96 43.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 3.5 mtpt -113.94 143.9 43.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 50' ' ' VAL . 64.7 p -89.3 174.31 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 14' ' ' LEU . . . -58.48 -38.28 77.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.062 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.506 HD23 ' HG2' ' A' ' 51' ' ' MET . 5.7 mt -73.44 -33.08 64.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.26 -1.39 17.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.481 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -129.78 -46.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.352 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -36.71 140.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.464 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -88.35 146.9 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.091 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.877 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.9 m-85 -87.5 21.72 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -73.06 -40.1 51.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 2.6 m -109.58 120.03 46.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 0.0 110.819 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 1.177 ' HG3' ' OD1' ' A' ' 90' ' ' ASP . 32.1 Cg_exo -58.83 -42.23 54.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.677 2.251 . . . . 0.0 112.168 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.15 70.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.044 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.3 t -62.98 -48.61 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.51 -40.93 98.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 1.8 tm? -63.01 -47.97 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.681 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.177 ' OE1' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.28 -48.4 78.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.8 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 51' ' ' MET . 8.2 mt -62.87 -54.38 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 95' ' ' LEU . 1.3 tt -63.08 -43.29 98.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.1 ttmm -62.93 -26.15 68.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.483 ' NE2' ' HB3' ' A' ' 37' ' ' PRO . 5.5 tt0 -62.11 -14.67 39.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.7 62.93 1.02 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.69 170.98 8.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.96 99.5 26.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.71 -9.18 23.57 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.689 2.259 . . . . 0.0 112.161 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.518 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -86.99 63.78 8.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 78' ' ' SER . 16.1 m -117.89 126.99 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.751 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 10.4 mt-30 -104.03 142.0 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -88.0 -179.89 6.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.21 -8.24 29.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.36 16.82 16.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.85 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.84 85.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 81' ' ' HIS . 2.1 m 179.91 139.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.818 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -117.51 179.62 0.79 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.145 0.498 . . . . 0.0 110.982 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 1.178 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 77.1 Cg_exo -48.53 -51.04 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 111.765 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.595 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.14 -48.76 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.316 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.71 ' HB2' HG23 ' A' ' 77' ' ' THR . 24.0 m80 -52.75 -61.37 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.94 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.178 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 10.5 p30 -57.77 -53.69 55.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.75 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -52.25 -38.82 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.459 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.11 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -73.49 -27.42 61.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.077 HG23 ' O ' ' A' ' 82' ' ' ASP . 27.8 p -71.32 -41.57 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.76 70.71 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.003 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -145.25 53.61 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.648 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 123' ' ' SER . 9.2 tp -52.47 -20.63 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.177 ' OD1' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -63.53 -71.8 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.422 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.707 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 m -73.12 -22.24 60.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.176 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.755 HD12 HD11 ' A' ' 95' ' ' LEU . 64.8 tp -70.29 -44.22 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 1.259 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 20.3 ttpp -60.63 -44.74 96.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.834 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.98 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.93 -53.33 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.55 -42.47 61.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.84 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 3.2 t -63.69 -52.48 56.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.259 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -55.5 -29.16 58.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.53 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 6.3 t60 -73.08 -56.21 5.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.54 33.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.815 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -69.41 120.31 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.324 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.8 p-10 -35.81 92.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.1 14.17 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.127 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -143.53 38.47 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.08 122.37 26.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.694 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -119.16 146.0 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.751 ' OD2' ' HB3' ' A' ' 72' ' ' GLN . 7.3 p30 -155.22 141.03 18.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 108' ' ' THR . 71.1 m 49.39 26.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.85 -40.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 1.174 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 68.68 10.79 61.51 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 1.429 ' HA ' ' CG ' ' A' ' 138' ' ' ASP . 2.6 t -104.02 129.45 51.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' HD21 ' A' ' 105' ' ' LEU . 32.5 mt -65.83 147.51 98.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HB2' HD11 ' A' ' 128' ' ' LEU . 74.4 Cg_exo -50.44 -29.53 24.43 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.681 2.254 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.9 tt -69.8 -38.31 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.819 ' ND1' ' OD2' ' A' ' 138' ' ' ASP . 36.4 m80 -53.32 -38.95 63.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.4 mt -65.96 -57.61 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.625 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -28.67 24.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.42 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.579 HD13 ' CG1' ' A' ' 125' ' ' VAL . 4.7 mm -65.42 -39.73 86.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.86 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -18.25 62.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.526 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 121' ' ' HIS . 4.1 mm-40 -90.87 -54.78 3.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.2 45.76 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.009 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.643 ' CB ' HG23 ' A' ' 124' ' ' VAL . 99.0 m-70 -76.96 3.77 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.698 0.285 . . . . 0.0 111.205 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 40.5 t 71.09 -92.94 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.785 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.64 ' HB3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -52.64 -56.51 14.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.358 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG23 ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -52.19 -62.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.944 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 4.5 t -52.31 -43.83 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 1.023 ' HB2' HG21 ' A' ' 159' ' ' ILE . 16.2 t -72.63 -30.49 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 123' ' ' SER . 63.3 t80 -73.8 -42.12 61.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.065 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -66.7 -6.99 17.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.336 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.832 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -64.13 -68.94 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.2 Cg_endo -67.27 -36.75 20.01 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 2.25 . . . . 0.0 112.353 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.33 -22.31 65.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 133' ' ' ASP . 51.8 m -112.84 147.6 36.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -35.47 111.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -79.35 64.46 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.0 p-80 164.72 -36.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . 68.6 t60 -48.62 143.76 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.823 ' HG3' HG22 ' A' ' 143' ' ' THR . 3.4 ttm180 -101.32 177.66 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 1.429 ' CG ' ' HA ' ' A' ' 110' ' ' SER . 1.3 t0 -121.26 156.48 32.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -22.25 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.183 0.516 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -73.88 -58.73 3.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.724 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 1.18 ' O ' ' OE2' ' A' ' 146' ' ' GLU . . . 124.84 43.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.852 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.45 114.42 4.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.823 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -82.78 -174.35 0.52 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 86.9 Cg_exo -44.87 -52.12 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.448 2.098 . . . . 0.0 112.072 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 145' ' ' LEU . 10.2 mt -73.35 -36.79 66.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.18 ' OE2' ' O ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -63.9 -64.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.951 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.708 HD12 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -52.37 -46.19 66.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.491 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -55.97 -32.96 64.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.19 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.35 -68.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.649 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.885 ' O ' HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.76 66.18 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 153' ' ' ALA . . . -64.46 50.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.587 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -60.56 -142.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 0.5 OUTLIER -60.41 -149.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 1.071 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 71.4 m-20 -74.64 44.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.984 ' HA ' HD12 ' A' ' 159' ' ' ILE . 2.5 pt? -69.16 -52.9 23.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.571 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER -56.37 -33.62 65.89 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.144 0.497 . . . . 0.0 110.076 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.071 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 15.4 p-10 -74.23 -40.0 62.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 126' ' ' SER . 10.6 mt -52.69 -49.86 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.76 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.836 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.78 -33.11 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.968 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -51.41 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.947 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.35 63.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -48.8 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.434 ' HA ' HD13 ' A' ' 134' ' ' LEU . 1.5 tpp -60.09 -28.65 68.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.4 tpt 63.48 139.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.4 mp -143.56 98.02 5.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.73 146.04 5.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.732 2.288 . . . . 0.0 112.418 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.7 mtt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.848 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -161.4 -64.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.03 106.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -54.65 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.21 -153.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.988 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.333 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 62.06 153.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 1.333 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 22.0 mm-40 -132.25 37.26 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.152 HG23 ' OE2' ' A' ' 6' ' ' GLU . 42.7 t -106.53 49.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.02 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.824 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -80.67 98.46 7.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER 82.62 9.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.013 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -60.85 -81.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 11.0 t0 -59.93 -14.54 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -63.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.84 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.7 tm? -73.13 -54.67 7.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.034 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.564 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.5 p -57.72 -30.32 65.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -70.76 -46.12 48.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.5 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.86 -55.89 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.267 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.4 69.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -68.03 -26.83 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.226 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -73.29 -26.58 61.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 88.1 66.5 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.069 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 13.4 p-10 -137.15 94.46 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -53.07 -20.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.169 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -74.18 -51.87 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.08 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.069 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -73.24 -32.98 65.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.818 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.872 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.3 p -52.69 -49.58 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 111.09 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 29.7 mtt180 -73.64 -48.88 29.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.279 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.5 mmp_? -52.85 -30.23 32.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.17 -73.99 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.946 HD11 HD23 ' A' ' 62' ' ' LEU . 1.7 mt -73.59 -42.7 61.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.484 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.11 -3.23 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.37 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -143.02 -75.46 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.825 ' OE1' ' HB ' ' A' ' 35' ' ' VAL . 14.1 tt0 -46.93 -23.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 34' ' ' LEU . 10.7 mt 62.01 29.92 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.825 ' HB ' ' OE1' ' A' ' 33' ' ' GLU . 2.7 p -58.92 137.15 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -69.03 145.88 96.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 40.0 Cg_endo -67.33 -11.03 30.69 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.211 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 29.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.74 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -97.9 94.81 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.282 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -102.86 147.87 26.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.685 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 24.5 p30 -44.99 -26.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.0 0.429 . . . . 0.0 110.285 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -146.02 -71.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.534 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 177.89 66.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.933 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.29 -73.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.971 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 40' ' ' LEU . 30.1 mttm -84.87 152.92 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 111.336 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.985 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.5 p -101.52 176.71 5.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 14' ' ' LEU . . . -57.14 -35.74 69.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 69' ' ' PRO . 3.5 tp -72.83 -47.86 42.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' CG ' HG23 ' A' ' 71' ' ' VAL . 2.0 tm0? -65.52 -9.56 27.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 46' ' ' THR . 32.8 m -136.31 26.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.1 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 1.1 tmm? -86.86 149.88 24.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.9 OUTLIER -87.87 86.6 7.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.381 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 53.4 m-85 -35.14 -30.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -28.79 -55.32 0.15 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.148 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -90.94 130.94 38.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HA ' HG23 ' A' ' 91' ' ' THR . 61.0 Cg_endo -73.22 -42.97 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.761 2.307 . . . . 0.0 112.043 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -62.8 -29.01 70.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.521 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.872 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.5 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.879 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.21 -52.95 60.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.584 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -63.61 -38.45 91.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.024 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -62.84 -49.35 75.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.946 HD23 HD11 ' A' ' 30' ' ' LEU . 13.0 mt -62.77 -50.29 71.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.842 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' CG ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -62.91 -23.02 67.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.671 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 11.9 tttt -63.05 -20.4 65.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.79 -57.22 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.89 50.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.515 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.56 -13.78 53.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.9 OUTLIER 62.9 95.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CG ' HD21 ' A' ' 63' ' ' LEU . 74.6 Cg_exo -48.19 -41.47 34.37 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.85 ' ND2' ' OD1' ' A' ' 101' ' ' ASP . 3.5 m120 -71.16 84.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG23 ' CG ' ' A' ' 49' ' ' GLN . 4.7 m -136.45 131.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . 29.2 mt-30 -140.36 163.34 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -127.52 -166.77 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.813 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.54 -22.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 15.5 p -84.58 -29.86 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.9 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 79.0 28.17 54.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 1.291 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . 2.6 m -115.9 119.21 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.6 p -104.96 -176.02 0.41 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 40.5 Cg_exo -56.22 -42.98 60.59 Favored 'Trans proline' 0 CA--C 1.527 0.128 0 C-N-CA 122.814 2.342 . . . . 0.0 112.058 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.523 HG23 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.67 -29.95 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.476 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.582 ' ND1' ' OD2' ' A' ' 106' ' ' ASP . 9.4 m170 -72.08 -68.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -61.25 -25.98 67.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.207 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.815 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -56.49 -53.76 53.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.563 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.97 -38.14 66.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.568 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.087 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 6.5 tpt180 -72.15 -24.04 61.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.215 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 82' ' ' ASP . 5.5 p -73.07 -73.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 132.7 63.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.324 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 22.8 m-85 -155.06 59.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.718 HD11 ' CG ' ' A' ' 127' ' ' PHE . 37.6 tp -52.21 -29.32 22.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.235 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 1.108 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -53.19 -67.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.459 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.108 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 47.7 m -72.24 -42.16 65.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 83' ' ' ALA . 1.2 tt -52.37 -48.68 65.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.492 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 92' ' ' LEU . 6.2 ttpp -55.39 -26.08 39.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.877 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.21 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 18.1 t -73.54 -70.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.542 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.986 HD22 ' N ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -63.91 -27.33 69.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.534 -179.375 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.986 ' N ' HD22 ' A' ' 95' ' ' LEU . 41.3 t -73.88 -56.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.759 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.21 ' OE2' ' HA ' ' A' ' 94' ' ' VAL . 17.3 pm0 -56.29 -35.39 67.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.502 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 10.6 t-160 -60.65 -68.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . 179.19 61.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -105.76 26.5 9.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.85 ' OD1' ' ND2' ' A' ' 70' ' ' ASN . 1.1 p-10 47.87 82.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 15.51 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 65.3 m-20 -131.89 27.33 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -101.7 162.03 13.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.555 HD21 ' CD1' ' A' ' 111' ' ' LEU . 74.2 mt -125.13 150.27 47.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 1.291 ' OD2' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -100.34 -169.55 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 75' ' ' SER . 61.8 m -48.29 -46.14 35.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -33.33 75.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 84.03 31.17 26.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.569 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.3 m -105.73 119.98 40.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.627 HD21 ' OD1' ' A' ' 133' ' ' ASP . 9.3 tp -54.53 138.09 60.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 104' ' ' ALA . 94.4 Cg_exo -43.37 -27.01 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.796 2.33 . . . . 0.0 112.366 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.872 ' HB ' HD21 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -73.23 -42.77 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.797 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 31.3 m80 -52.91 -32.51 45.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.286 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.11 -48.66 33.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.361 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -61.74 -32.95 73.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.92 HG21 ' HB3' ' A' ' 147' ' ' LEU . 80.2 mt -66.55 -42.2 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.691 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.6 -16.91 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 1.087 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -86.67 -57.84 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.415 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 110.23 -0.69 29.72 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.54 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 15.2 m-70 -57.68 78.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.592 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -34.36 -48.59 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -62.45 -48.33 80.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 121' ' ' HIS . 47.5 t -69.57 -60.17 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 2.4 t -51.87 -44.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.158 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.846 ' CB ' HG21 ' A' ' 159' ' ' ILE . 60.6 p -71.87 -29.35 64.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.169 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.3 t80 -73.22 -66.4 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.994 HD22 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.73 -8.76 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.947 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -52.22 -71.1 0.22 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 57.4 Cg_endo -70.88 -33.0 13.0 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 128' ' ' LEU . 30.9 mm-40 -54.59 -20.4 7.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.283 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 p -105.81 -171.25 1.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.627 ' OD1' HD21 ' A' ' 111' ' ' LEU . 4.1 p30 -94.5 84.63 4.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.992 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -57.59 75.3 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.222 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 p-80 174.98 -39.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -47.89 173.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -129.88 174.32 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.467 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -131.25 166.97 20.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.6 -20.18 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -52.38 55.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.44 11.2 6.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.443 ' HB3' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -132.72 160.72 35.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.531 ' CB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -112.99 -178.39 0.52 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 84.3 Cg_exo -44.91 -59.75 1.04 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.634 2.223 . . . . 0.0 112.138 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -58.4 -46.74 85.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.633 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.443 ' CD ' ' HB3' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.78 -62.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.92 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.87 -43.61 66.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.805 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.64 -43.46 65.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.375 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -61.04 -36.15 78.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.753 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.486 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -69.74 -80.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.572 179.032 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.36 61.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.6 52.29 0.88 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.79 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.548 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -32.7 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.452 . . . . 0.0 110.723 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.548 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.6 OUTLIER 172.53 -119.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.29 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.764 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 2.0 m-20 -74.06 4.73 5.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.135 -0.353 . . . . 0.0 111.692 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.995 ' HA ' HD12 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -52.66 -51.84 58.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.805 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.4 ppp? -53.2 -34.7 58.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.764 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 3.1 p30 -73.67 -43.58 59.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.995 HD12 ' HA ' ' A' ' 156' ' ' LEU . 15.5 mt -52.74 -44.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.369 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 160' ' ' LEU . 1.3 mt -73.29 -35.51 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.336 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -67.41 -37.89 83.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.01 44.98 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.389 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -73.26 -9.8 59.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.649 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -57.08 97.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 tpt -75.67 125.22 28.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.7 mt -101.86 122.83 45.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.99 129.45 24.81 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.71 2.274 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.888 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.9 m -122.06 63.91 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -157.89 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.7 109.25 1.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 tp -177.81 53.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.932 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.6 tt0 -110.83 -42.74 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 39.15 36.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.932 HG12 ' O ' ' A' ' 6' ' ' GLU . 12.7 p -178.81 139.74 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.34 -68.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.086 HG21 HG12 ' A' ' 35' ' ' VAL . 3.9 p -123.89 -6.45 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.288 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.736 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -40.24 -60.48 1.96 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.386 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 29.4 p30 -56.51 -17.39 8.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.754 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.1 tpm_? -98.59 -64.25 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.756 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 62' ' ' LEU . 2.8 tm? -69.22 -61.71 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.484 ' OG ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.94 -28.29 56.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.64 -49.05 39.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.188 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 22' ' ' ASP . . . -73.03 -40.3 65.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.43 -45.12 65.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.287 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -73.1 -37.58 66.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -73.43 -8.13 54.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 58' ' ' VAL . . . 124.89 -66.56 0.53 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.179 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.608 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 0.3 OUTLIER 33.54 38.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.39 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.687 ' HA ' HG23 ' A' ' 58' ' ' VAL . 2.3 p -52.66 -49.88 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.656 ' HG3' HG13 ' A' ' 23' ' ' VAL . 15.0 mt-30 -75.14 -32.62 61.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.811 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.24 -37.39 66.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.577 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.291 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.4 p -52.39 -35.08 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -71.29 -51.63 23.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.97 -36.72 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.095 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' OE1' ' A' ' 33' ' ' GLU . 20.2 mt -52.96 -61.86 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.1 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.75 HD23 HG23 ' A' ' 35' ' ' VAL . 10.3 mt -73.45 -49.19 28.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.823 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.869 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 20.2 m-70 -70.14 -19.33 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.861 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -126.05 -78.91 0.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.172 ' OE2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -39.87 -28.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.1 mt 62.38 31.03 17.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.525 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.172 HG13 ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -54.44 152.07 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.336 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.69 124.6 69.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.83 -11.34 29.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.694 2.262 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 6.3 p30 -90.97 -8.61 48.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.843 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -43.67 136.96 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 45' ' ' LYS . 6.4 mt -129.81 108.92 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -40.45 -44.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.989 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -135.77 35.18 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 49.25 48.08 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.27 -45.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.445 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.941 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.05 147.39 46.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -86.09 166.62 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.27 25.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -73.12 -43.86 61.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 1.071 ' CD ' ' OD1' ' A' ' 73' ' ' ASP . 0.3 OUTLIER -62.74 -20.63 65.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG21 ' OG ' ' A' ' 15' ' ' SER . 18.7 m -104.73 -34.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' LEU . 2.0 ttp -42.12 134.81 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.502 ' CE ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -86.74 134.44 33.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.839 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 10.8 m-85 -78.37 52.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.633 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -106.29 -59.55 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.108 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -86.76 114.3 57.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 110.302 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' HG11 ' A' ' 94' ' ' VAL . 9.2 Cg_endo -53.64 -42.29 67.18 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.562 2.175 . . . . 0.0 112.145 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.24 -33.36 75.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.2 t -63.06 -39.93 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -63.04 -59.83 4.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 19.6 tp -63.23 -41.2 99.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.535 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 1.291 ' OE1' HG13 ' A' ' 26' ' ' VAL . 10.6 mt-10 -62.88 -45.84 90.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.501 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.886 HD11 ' HB1' ' A' ' 18' ' ' ALA . 3.2 mt -62.83 -57.1 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 64' ' ' LYS . 4.4 pp -63.51 -25.82 68.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.339 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.66 ' N ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -63.14 -46.9 85.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 30' ' ' LEU . 1.8 mm100 -51.36 -43.85 61.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.65 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -89.46 159.91 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.978 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.92 110.8 36.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.988 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 77.7 Cg_endo -77.59 7.72 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.787 2.325 . . . . 0.0 112.423 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.081 ' OD1' ' OD2' ' A' ' 101' ' ' ASP . 43.4 m-80 -89.48 26.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.731 HG23 ' HG2' ' A' ' 49' ' ' GLN . 8.3 m -107.5 139.08 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.045 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.51 153.12 37.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 1.071 ' OD1' ' CD ' ' A' ' 49' ' ' GLN . 2.5 p-10 -155.0 -175.17 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.836 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 73' ' ' ASP . . . 68.08 -62.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -170.14 33.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' THR . . . 90.42 65.89 1.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.558 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 76' ' ' GLY . 2.3 p -156.85 103.68 2.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.77 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 p -70.51 -174.29 0.25 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 1.036 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 62.9 Cg_exo -50.64 -50.9 12.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.774 2.316 . . . . 0.0 112.533 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.947 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 15.3 m -59.34 -43.81 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.373 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.438 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 44.1 m170 -61.45 -34.47 75.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.043 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.036 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.74 -51.09 20.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -70.05 -11.98 61.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.39 -43.83 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.406 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 1.007 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 2.0 mmt180 -61.51 -58.42 8.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.231 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -72.48 -22.55 61.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.817 ' CA ' HG21 ' A' ' 124' ' ' VAL . . . 105.14 -62.83 0.33 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 16.9 m-85 30.97 37.1 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 110.259 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.2 tm? -51.73 -41.87 61.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.512 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.641 ' C ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.0 -62.96 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.828 0.347 . . . . 0.0 110.877 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -72.01 -46.33 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.921 HD13 ' HB3' ' A' ' 83' ' ' ALA . 14.6 tp -52.4 -43.03 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 109.916 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.567 ' HE2' HD11 ' A' ' 89' ' ' LEU . 1.9 ttpp -53.52 -37.92 63.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.486 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' 56' ' ' PRO . 42.9 t -57.08 -60.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.107 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -73.18 -33.41 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.842 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 4.6 t -73.12 -45.33 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 93' ' ' LYS . 0.9 OUTLIER -58.24 -32.44 68.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.773 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.455 ' ND1' HD13 ' A' ' 63' ' ' LEU . 4.3 t-160 -73.13 -50.38 23.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -166.44 -69.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.298 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.947 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . 30.13 82.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.777 0.322 . . . . 0.0 111.559 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 1.081 ' OD2' ' OD1' ' A' ' 70' ' ' ASN . 2.1 p-10 -39.84 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 112' ' ' PRO . 12.9 m -84.24 11.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.38 -25.94 20.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -50.9 157.45 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.791 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -143.29 161.39 38.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.814 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.82 -90.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.005 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.84 -38.57 2.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 -1.89 25.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 62.57 23.29 64.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 139.79 30.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.791 HD23 ' CD2' ' A' ' 105' ' ' LEU . 11.4 mt -68.34 162.76 58.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 102' ' ' VAL . 76.4 Cg_exo -50.23 -34.26 39.16 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.559 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -61.46 -44.06 97.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.98 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CE1' ' HG ' ' A' ' 111' ' ' LEU . 1.9 m80 -53.07 -44.38 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.875 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -67.64 -48.95 65.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.539 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.206 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.21 -43.31 67.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.712 HG23 HD13 ' A' ' 156' ' ' LEU . 46.0 mt -54.86 -40.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.654 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -62.67 -41.7 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.473 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 1.206 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 2.2 mp0 -72.53 -55.58 6.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.8 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.18 52.01 2.46 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.565 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -81.43 -7.14 59.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.996 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -71.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -66.63 -35.53 80.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.817 HG21 ' CA ' ' A' ' 87' ' ' GLY . 42.9 t -74.01 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.087 0.47 . . . . 0.0 110.606 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 156' ' ' LEU . 4.2 m -53.3 -45.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.335 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.545 ' HB3' HG21 ' A' ' 159' ' ' ILE . 15.8 p -71.92 -28.85 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.784 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 19.0 t80 -73.49 -44.33 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.521 ' CD1' ' OG ' ' A' ' 132' ' ' SER . 0.2 OUTLIER -67.41 -11.51 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.153 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.41 -67.46 0.79 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.283 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 29.6 Cg_endo -64.16 -62.07 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.617 2.212 . . . . 0.0 112.452 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.784 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -37.59 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 17.4 m -98.41 129.4 45.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 1.179 ' OD1' ' HB2' ' A' ' 136' ' ' HIS . 0.1 OUTLIER -36.0 95.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 134' ' ' LEU . 4.0 mt -60.19 151.03 28.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 74.52 13.79 3.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 1.179 ' HB2' ' OD1' ' A' ' 133' ' ' ASP . 20.2 t-80 -103.83 168.95 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -127.2 -160.34 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.12 -171.63 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.41 -9.59 26.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -39.6 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 104.26 68.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 141' ' ' GLY . 93.8 mt -156.91 133.3 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.196 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 80.9 p -96.51 159.12 32.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 6.0 Cg_exo -38.61 -48.8 2.59 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.15 2.566 . . . . 0.0 112.184 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.1 mt -66.98 -40.58 87.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.196 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 1.1 mp0 -52.99 -68.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' GLN . 8.4 tp -52.66 -29.01 24.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.17 -15.22 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.471 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 1.4 ttt180 -73.26 -48.46 34.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.46 -90.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.885 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -75.88 50.65 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -74.21 44.26 1.34 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.829 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' LEU . . . -34.46 150.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.617 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 40.44 -161.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.89 ' CA ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -74.61 43.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.207 -0.308 . . . . 0.0 111.543 179.228 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 125' ' ' VAL . 2.2 mt -59.43 -55.95 28.15 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 110.966 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -51.66 -44.04 62.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.89 ' OD1' ' CA ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -74.5 -35.08 63.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.267 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.852 HG22 HD23 ' A' ' 160' ' ' LEU . 11.0 mt -53.16 -52.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.158 0.504 . . . . 0.0 110.456 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.872 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.51 -24.54 59.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.256 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -64.46 -41.72 96.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.164 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.48 -53.51 8.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 15.2 m-70 -60.87 -40.24 92.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.881 0.372 . . . . 0.0 110.88 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.417 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -67.99 75.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.994 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 33.0 mtm -94.6 111.04 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 82.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.58 -66.57 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.677 2.252 . . . . 0.0 112.301 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 35' ' ' VAL . 52.3 t . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.938 0.399 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.699 ' O ' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -83.07 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 3.0 p30 -51.92 -29.94 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -37.0 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.787 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.963 ' CB ' HG21 ' A' ' 35' ' ' VAL . 4.9 tp -72.28 -23.84 61.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -65.59 -49.89 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.7 -27.91 68.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.503 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -72.21 -55.07 7.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.347 . . . . 0.0 111.249 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.82 79.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.249 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -32.64 64.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.4 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.0 -9.86 58.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.002 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.406 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 70.42 75.89 0.57 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 24' ' ' GLN . 1.2 t70 -144.7 85.56 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.795 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -52.9 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 mt-30 -70.66 -45.02 65.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.7 mm-40 -72.99 -49.43 29.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.676 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 58' ' ' VAL . 47.2 t -57.92 -29.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 4.8 mmt180 -72.03 -60.86 2.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -69.16 -22.77 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.1 mt -54.44 -66.55 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 65' ' ' GLN . 16.5 mt -72.28 -40.59 67.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.13 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 23.0 m-70 -65.41 -19.62 66.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.306 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -133.0 -66.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' LEU . 2.4 tp10 -58.48 -14.46 7.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.2 mt 46.96 25.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.786 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.963 HG21 ' CB ' ' A' ' 14' ' ' LEU . 14.7 p -43.96 148.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 144.29 43.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.608 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 58.7 Cg_endo -72.12 -22.98 21.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.404 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.54 2.53 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 11' ' ' GLY . . . -42.25 124.74 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.2 mt -122.01 130.08 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 4.6 p-10 -66.21 -179.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -47.79 -43.34 27.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.89 -65.34 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.52 47.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 13.2 mtpt -116.42 151.08 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.8 p -85.14 162.05 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . . . -53.83 -47.46 70.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.118 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 69' ' ' PRO . 1.1 mp -62.8 -27.59 69.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.578 HE21 HG23 ' A' ' 71' ' ' VAL . 9.8 tt0 -72.97 -29.26 62.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' THR . 2.9 m -101.63 -26.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -36.65 142.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.797 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 ptt? -102.31 22.69 12.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.994 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.7 m-85 36.57 31.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -76.94 -77.8 0.77 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.502 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -77.86 121.02 83.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.966 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.47 -45.69 37.9 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.61 2.207 . . . . 0.0 112.159 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 61' ' ' GLU . . . -63.16 -28.69 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.368 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HA ' HG11 ' A' ' 26' ' ' VAL . 2.5 t -62.95 -38.57 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.209 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -63.32 -49.77 72.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 53.1 tp -63.15 -33.13 74.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 1.9 mm-40 -62.54 -49.1 76.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 14' ' ' LEU . 5.6 mt -62.96 -56.26 18.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.608 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' ALA . 1.1 mt -63.36 -25.73 68.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 1.6 tttp -62.84 -29.84 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.751 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -76.87 -73.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.92 62.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -107.45 153.29 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.165 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -96.6 99.24 5.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 31.7 Cg_endo -64.31 -15.83 51.75 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -79.7 65.86 4.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.578 HG23 HE21 ' A' ' 49' ' ' GLN . 28.2 m -126.4 138.11 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.261 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -114.88 102.1 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -89.75 -174.57 0.46 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 51.3 Cg_exo -55.57 -41.65 75.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.85 2.367 . . . . 0.0 112.545 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.899 HG21 ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -62.86 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.328 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 65.8 m80 -58.14 -51.37 70.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.753 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -66.63 -50.38 63.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.39 -30.44 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.41 -67.11 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.617 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -62.33 -29.55 70.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.812 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 82' ' ' ASP . 52.2 p -66.99 -54.07 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 111.211 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 110.38 66.04 0.54 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.121 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -140.66 53.43 1.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 0.0 110.55 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.983 HD22 ' HB2' ' A' ' 123' ' ' SER . 20.6 tp -52.23 -19.07 1.8 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -63.52 -72.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.819 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 6.3 m -73.15 -24.1 60.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.527 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.568 ' CD2' HG21 ' A' ' 96' ' ' VAL . 9.7 tt -56.16 -59.79 4.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 127' ' ' PHE . 8.1 ptmt -58.32 -38.0 76.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.133 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.765 HG11 ' HB3' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -51.73 -61.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.09 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.994 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -74.8 -43.48 54.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.873 HG22 HG12 ' A' ' 80' ' ' VAL . 10.7 t -52.54 -42.55 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.512 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.6 mm-40 -73.54 -39.53 64.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.225 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -51.88 66.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 178.77 -26.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.095 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -23.82 123.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 112.002 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.899 ' O ' HG21 ' A' ' 80' ' ' VAL . 9.8 t0 -56.6 85.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 102' ' ' VAL . 10.2 p -98.31 28.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 104' ' ' ALA . 0.2 OUTLIER -120.91 -33.22 3.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -48.11 -177.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 111' ' ' LEU . 9.3 mt -139.99 175.47 9.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.88 62.03 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 108' ' ' THR . 0.3 OUTLIER 68.45 -75.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 107' ' ' SER . 4.7 p -37.96 -48.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 122.93 19.72 2.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.512 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.512 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -93.06 118.29 31.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 110.993 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.945 HD11 ' HB3' ' A' ' 136' ' ' HIS . 5.2 mt -65.27 143.8 98.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.646 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 83.7 Cg_exo -45.2 -26.12 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.606 2.204 . . . . 0.0 112.173 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -72.12 -40.04 66.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.084 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -53.04 -46.04 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -58.76 -44.19 90.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.671 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.739 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -60.04 -35.63 75.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.443 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.577 ' HB ' HD23 ' A' ' 147' ' ' LEU . 97.8 mt -64.45 -43.62 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 115' ' ' LEU . 12.6 ptt180 -73.26 -10.12 59.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.745 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -59.77 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.08 25.22 7.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.404 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 9.7 m-70 -63.82 -11.93 31.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 23.2 t 70.52 -68.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.983 ' HB2' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -70.63 -52.86 18.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.745 ' HA ' HD13 ' A' ' 89' ' ' LEU . 22.0 t -52.83 -55.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.9 t -52.0 -61.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 159' ' ' ILE . 5.4 p -58.0 -30.44 66.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.7 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.4 t80 -73.31 -55.39 6.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -63.93 -11.67 30.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.067 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.923 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -57.56 -70.24 0.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.929 ' HA ' HD11 ' A' ' 134' ' ' LEU . 57.9 Cg_endo -71.51 -17.92 29.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.238 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 29.4 mm-40 -90.56 31.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -152.1 -168.62 3.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.901 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 135' ' ' HIS . 23.5 t0 -77.1 83.78 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.9 mp -64.97 61.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.976 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 133' ' ' ASP . 19.0 t-160 -175.07 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.945 ' HB3' HD11 ' A' ' 111' ' ' LEU . 79.0 t60 -54.89 155.02 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -140.67 158.29 44.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.512 ' OD1' ' CB ' ' A' ' 110' ' ' SER . 1.9 t70 -64.23 158.7 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.68 -19.69 6.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 110.287 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -46.22 72.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.859 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 125.08 32.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -129.16 146.31 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -115.82 -174.32 0.27 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.593 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 71.7 Cg_exo -48.66 -43.69 33.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -73.19 -47.91 39.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 17.3 tp10 -57.54 -57.52 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.577 HD23 ' HB ' ' A' ' 117' ' ' ILE . 6.6 tp -52.35 -34.31 46.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -63.82 -33.04 74.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.61 -30.18 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.007 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 3.1 tp-100 -70.4 -80.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.668 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.9 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.2 71.89 1.71 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -72.54 46.18 1.07 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.321 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -36.79 -32.81 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.393 0.616 . . . . 0.0 110.263 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 3.3 pm0 -179.66 -143.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.689 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' GLN . 1.1 m-80 -68.82 57.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.963 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 151' ' ' ARG . 4.1 mt -71.47 -69.77 0.36 Allowed 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 111.008 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.687 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 6.8 ptm -52.73 -19.46 2.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.786 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.64 -47.28 41.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 126' ' ' SER . 1.5 mt -62.08 -50.64 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.747 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -68.33 -29.99 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.541 ' HB2' HD21 ' A' ' 145' ' ' LEU . 4.4 tt0 -63.54 -42.91 98.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.24 -47.76 35.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.653 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -71.1 -20.04 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.043 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.503 ' HA ' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -34.27 -31.12 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.816 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -109.62 -21.08 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 0.0 110.935 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' VAL . 9.5 tpt180 -57.07 -69.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.034 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.86 HD11 ' CD2' ' A' ' 62' ' ' LEU . 3.8 tp -68.65 -20.4 64.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 23.8 t -73.32 -44.32 59.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.01 -33.68 59.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.621 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.611 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -71.61 -38.88 70.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -72.84 -43.58 62.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.206 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -67.96 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.202 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.1 ptp180 -68.3 -9.33 46.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.27 90.02 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 27' ' ' ARG . 2.4 p -52.65 -22.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.08 -47.86 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 mm-40 -72.87 -44.7 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.993 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.8 p -52.64 -41.87 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.018 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD3' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.3 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 5.2 mtt180 -56.0 -21.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.616 HD22 HG21 ' A' ' 35' ' ' VAL . 10.3 mt -72.42 -68.99 0.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.61 -44.07 78.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.302 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 61.6 m-70 -73.13 -0.94 15.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.277 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -149.26 -76.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.212 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 35' ' ' VAL . 14.5 tp10 -42.88 -27.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.978 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER 55.4 59.57 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.23 143.35 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.687 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 2.1 t-80 -76.29 143.56 73.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.766 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 45.1 Cg_endo -68.07 -21.75 42.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 0.0 112.135 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.869 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -91.21 33.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.77 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -80.93 125.6 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.39 124.2 39.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -62.5 -62.21 1.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 30.5 tpt180 -97.87 46.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 26.5 t80 37.48 62.32 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.95 -65.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.385 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 15.3 mtpp -86.91 146.63 26.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.676 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.2 p -92.73 -177.95 4.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -72.27 -36.0 68.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -32.08 69.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' HE3' ' A' ' 45' ' ' LYS . 1.8 tt0 -69.94 -15.31 63.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 46' ' ' THR . 2.6 m -110.25 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.522 ' SD ' HD12 ' A' ' 62' ' ' LEU . 21.8 ttp -38.08 123.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.681 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -88.87 19.64 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.995 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER 39.35 30.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.121 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.22 -45.51 48.48 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.121 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 1.018 ' O ' HG22 ' A' ' 58' ' ' VAL . 20.5 m -108.6 134.85 20.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.6 -37.7 6.84 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.572 2.181 . . . . 0.0 112.29 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.42 -36.22 83.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.353 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.018 HG22 ' O ' ' A' ' 55' ' ' SER . 5.4 m -62.5 -27.99 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' A' ' 91' ' ' THR . . . -63.37 -60.36 3.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.618 HD13 ' C ' ' A' ' 60' ' ' LEU . 1.8 tm? -63.15 -40.67 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.964 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -62.52 -40.57 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.562 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 18' ' ' ALA . 7.1 mt -63.86 -63.57 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.496 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.593 HD23 ' CD2' ' A' ' 98' ' ' HIS . 23.6 tp -63.58 -14.69 53.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -62.9 -36.01 81.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.051 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 37' ' ' PRO . 2.4 mm-40 -68.08 -14.48 63.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.15 34.88 4.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.85 -179.41 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.596 ' O ' HG13 ' A' ' 71' ' ' VAL . 14.4 t -121.92 93.75 48.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.514 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 52.2 Cg_exo -54.22 -17.4 11.64 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.734 2.289 . . . . 0.0 112.179 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.719 ' OD1' ' OD1' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -94.65 64.02 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.793 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 68' ' ' SER . 2.7 m -104.56 146.55 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.457 HG22 ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -164.63 135.56 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.897 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.553 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.54 -177.38 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 29.2 Cg_exo -61.65 -39.53 53.21 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.883 2.389 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.5 m -60.31 -28.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 78' ' ' SER . 3.2 m80 -62.65 -67.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.889 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.81 -43.92 90.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.806 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -52.48 -28.3 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.128 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.71 -56.5 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.535 ' NE ' HD13 ' A' ' 115' ' ' LEU . 1.8 mtt180 -73.16 -22.79 60.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.815 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 82' ' ' ASP . 69.5 p -71.12 -57.06 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.2 67.8 0.5 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 52' ' ' MET . 22.8 m-85 -140.61 52.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.413 . . . . 0.0 110.586 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.874 ' HG ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -52.36 -30.63 29.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.8 m -65.9 -37.4 86.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 83' ' ' ALA . 9.6 tp -52.82 -49.46 65.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.334 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.756 ' CE ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -53.99 -42.15 68.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 59' ' ' ALA . 22.6 t -52.86 -59.09 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.435 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.995 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.9 pp -71.3 -41.17 70.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 2.1 t -67.48 -56.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.953 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -52.72 -29.73 28.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.053 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.593 ' CD2' HD23 ' A' ' 63' ' ' LEU . 4.2 t-80 -60.61 -32.26 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.934 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.33 -5.52 4.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -46.01 141.13 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.743 0.306 . . . . 0.0 111.044 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.719 ' OD1' ' OD1' ' A' ' 70' ' ' ASN . 19.6 p-10 -52.08 140.17 21.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.06 13.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.587 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.82 8.01 30.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -82.26 136.85 34.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -106.76 167.34 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.59 -169.67 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -20.89 26.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 1.9 m -90.05 -9.39 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.795 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 71.93 42.28 52.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.441 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 1.342 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 2.7 m -119.15 127.93 53.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.047 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -59.95 149.63 72.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 1.047 ' HD2' HD23 ' A' ' 111' ' ' LEU . 55.1 Cg_exo -51.72 -30.52 37.68 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.13 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 111' ' ' LEU . 14.4 tt -71.0 -32.46 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 138' ' ' ASP . 32.9 m170 -62.16 -36.19 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -73.28 -42.95 61.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.638 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.772 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.657 ' HA ' HG11 ' A' ' 125' ' ' VAL . 96.6 mt -59.79 -41.51 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -73.23 -4.05 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 115' ' ' LEU . 1.9 mm-40 -118.07 -46.07 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.5 53.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.099 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 23.8 m-70 -66.99 84.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.0 t 52.91 -146.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -73.6 4.37 5.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.874 HG22 ' HG ' ' A' ' 89' ' ' LEU . 46.7 t -52.27 -60.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.772 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.4 t -52.75 -36.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.104 0.478 . . . . 0.0 110.506 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.802 ' HB2' HG21 ' A' ' 159' ' ' ILE . 2.5 t -70.13 -44.96 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.607 ' CD2' HD21 ' A' ' 89' ' ' LEU . 20.4 t80 -69.15 -26.78 65.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -73.56 -0.19 14.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.251 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -73.11 -70.05 0.29 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 39.4 Cg_endo -66.86 -46.81 3.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.795 2.33 . . . . 0.0 112.802 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.581 ' OE1' ' CE2' ' A' ' 127' ' ' PHE . 4.8 pt-20 -51.52 -34.65 37.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.351 . . . . 0.0 110.758 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 9.3 m -108.8 151.06 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.137 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 31.1 p30 -34.8 121.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.9 mt -89.8 27.69 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -167.87 43.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.066 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 1.137 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -109.85 172.91 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.801 ' HG3' HG22 ' A' ' 143' ' ' THR . 8.5 mtm-85 -141.66 125.42 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.986 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 1.342 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 1.5 t0 -76.14 152.62 36.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 108' ' ' THR . . . -51.12 -21.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.74 47.87 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.575 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' CD1' ' HG ' ' A' ' 147' ' ' LEU . 2.9 pp -174.43 139.65 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.165 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.801 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -95.41 -175.31 0.45 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 85.0 Cg_exo -47.67 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.802 2.335 . . . . 0.0 112.275 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.77 -36.05 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 142' ' ' LEU . 68.3 mm-40 -61.48 -63.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.83 -48.99 66.6 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.063 0.458 . . . . 0.0 109.808 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 160' ' ' LEU . . . -54.61 -33.79 61.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.052 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -66.42 -44.73 82.15 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -67.84 -88.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.932 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 11.3 ttm180 -75.22 58.0 0.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 148' ' ' ALA . . . -73.18 45.53 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.557 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.54 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -39.27 134.86 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 36.68 -152.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.529 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 3.5 p-10 -74.45 50.31 0.41 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.236 -0.186 . . . . 0.0 110.861 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 159' ' ' ILE . 3.3 mt -66.39 -70.64 0.23 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 111.67 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.745 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 9.1 ptm -52.49 -20.07 2.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -73.62 -52.35 13.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 126' ' ' SER . 1.9 mt -57.65 -32.2 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 120.913 0.387 . . . . 0.0 111.009 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -73.5 -40.84 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.058 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -65.71 -25.71 67.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -54.68 6.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.345 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -71.37 -12.62 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.72 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.7 mmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 121.144 0.497 . . . . 0.0 110.468 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.548 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -41.35 -26.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.688 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' ASN . 30.6 t0 -108.11 31.58 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' VAL . 12.4 ttm180 -117.32 -59.82 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.628 ' HB2' HG11 ' A' ' 35' ' ' VAL . 12.3 tp -70.87 -24.13 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -64.68 -48.35 75.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.762 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -73.1 -36.32 56.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.4 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.24 -57.37 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.74 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' MET . . . -73.13 -22.93 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 8.0 mtp180 -72.84 -27.48 61.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 62.34 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.225 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.1 p-10 -132.11 84.42 2.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.4 p -52.84 -21.53 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 46.8 mt-30 -73.5 -49.13 28.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.818 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.225 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 7.0 mp0 -73.47 -41.88 62.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.952 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.8 p -52.86 -39.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 1.138 ' HG2' ' OE2' ' A' ' 61' ' ' GLU . 5.2 mtt180 -73.13 -61.46 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.362 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 14.4 mtm-85 -62.04 -25.6 67.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.224 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.574 HD11 ' CB ' ' A' ' 17' ' ' ALA . 9.5 mt -56.73 -66.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.883 HD22 ' HG3' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -73.54 -48.73 30.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.775 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 1.1 m-70 -68.95 -10.94 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.963 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -137.42 -66.88 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.72 0.295 . . . . 0.0 111.386 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -54.51 -18.26 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.076 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.512 ' N ' HD23 ' A' ' 34' ' ' LEU . 4.8 mt 55.29 61.65 2.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 14' ' ' LEU . 12.0 p -107.31 129.3 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.586 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -56.83 146.6 57.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 18.6 Cg_endo -58.78 -66.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.713 2.276 . . . . 0.0 112.21 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -44.73 -62.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . 34.28 97.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 46' ' ' THR . 1.7 mp -92.78 130.82 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 37.8 p-10 -65.51 -31.67 72.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.92 39.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 43' ' ' PHE . 65.5 t80 54.42 72.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.01 -64.71 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.581 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HB3' HG13 ' A' ' 50' ' ' VAL . 10.8 mmtt -98.32 136.47 38.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.751 0.31 . . . . 0.0 111.052 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 50' ' ' VAL . 33.3 p -89.2 161.72 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.91 -33.68 51.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' CD1' HD11 ' A' ' 62' ' ' LEU . 2.0 tp -73.25 -42.23 62.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.471 ' HG2' ' HD3' ' A' ' 45' ' ' LYS . 54.2 tt0 -73.15 -8.71 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 46' ' ' THR . 3.9 m -115.83 -23.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.574 ' HA ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.8 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.732 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.575 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -124.37 21.12 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.79 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.917 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.1 m-85 41.01 29.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.944 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -58.38 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.076 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.544 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -73.7 153.33 89.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.432 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.691 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 13.1 Cg_exo -69.96 -42.93 2.79 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.819 2.346 . . . . 0.0 112.303 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -63.55 -23.72 67.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.926 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.831 ' HA ' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.49 -49.45 83.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.36 -47.56 81.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.597 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.667 HD13 ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -63.03 -53.25 56.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.325 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.138 ' OE2' ' HG2' ' A' ' 27' ' ' ARG . 2.2 mt-10 -63.27 -56.86 13.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.928 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.737 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.67 -50.46 71.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.672 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 6.9 tt -63.4 -42.89 98.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.67 0.271 . . . . 0.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.8 tttp -62.77 -42.05 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.883 ' HG3' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -44.49 -29.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.546 ' CA ' ' HG3' ' A' ' 37' ' ' PRO . . . 132.7 59.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -107.21 167.26 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -108.56 103.67 51.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 37.0 Cg_endo -65.88 -13.55 40.36 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.797 2.331 . . . . 0.0 112.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.535 ' ND2' ' HB3' ' A' ' 101' ' ' ASP . 31.4 m120 -102.61 86.67 2.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' SER . 12.7 m -142.74 132.11 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.99 154.22 34.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.986 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -139.62 -174.26 0.4 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.947 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 55.2 Cg_exo -51.67 -51.24 11.6 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.79 2.327 . . . . 0.0 112.458 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -52.83 -44.08 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' NE2' ' HG3' ' A' ' 112' ' ' PRO . 51.4 m80 -62.94 -56.25 18.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.007 ' O ' HG23 ' A' ' 86' ' ' THR . 1.9 p30 -54.77 -48.83 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.845 ' CB ' HD13 ' A' ' 92' ' ' LEU . . . -56.28 -57.19 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.12 -50.3 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.86 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -57.16 -40.77 77.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.3 p -73.33 -59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.82 73.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.216 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 56.7 m-85 -136.75 49.81 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -52.39 -35.73 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.056 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.57 -66.43 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.779 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.812 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 63.0 m -71.72 -41.09 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.845 HD13 ' CB ' ' A' ' 83' ' ' ALA . 49.7 tp -52.66 -51.24 61.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.502 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 97' ' ' GLU . 28.9 ttmt -52.74 -36.85 58.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.481 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.295 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 24.2 t -57.03 -70.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.917 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -58.59 -38.51 78.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.819 HG11 ' OE1' ' A' ' 131' ' ' GLU . 2.4 t -64.02 -60.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.682 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.295 ' CD ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.73 -30.81 34.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.863 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.506 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -73.15 -54.56 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.653 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . -164.73 -65.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.287 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 40.2 -166.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.354 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 14.6 p-10 -135.63 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.689 HG13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -100.9 19.14 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.765 ' ND2' ' OD2' ' A' ' 133' ' ' ASP . 15.3 m120 -104.67 -25.18 12.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -67.55 167.6 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 109' ' ' GLY . 7.7 mt -136.14 -160.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 107' ' ' SER . 4.1 m-20 -122.91 -154.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 106' ' ' ASP . 18.9 m -60.34 -38.79 84.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -88.17 -3.53 58.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 69.71 46.55 53.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.499 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -107.37 134.8 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.996 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.501 ' HB2' ' ND1' ' A' ' 114' ' ' HIS . 36.9 mt -62.97 151.22 86.37 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.825 ' HB2' HD11 ' A' ' 128' ' ' LEU . 89.3 Cg_exo -46.64 -26.46 4.42 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.626 2.217 . . . . 0.0 112.243 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 129' ' ' ALA . 17.7 tt -71.79 -35.78 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.844 ' HA ' HD12 ' A' ' 117' ' ' ILE . 21.6 m80 -56.34 -37.96 70.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.755 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.1 mt -69.09 -51.78 35.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.604 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -52.83 -32.07 42.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 147' ' ' LEU . 52.7 mt -60.9 -39.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.57 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.43 ' CD ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -68.19 -17.35 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.525 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.86 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -92.08 -54.69 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.76 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.26 37.15 7.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -65.63 -10.63 37.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.86 -68.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.08 -49.74 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.59 -59.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 116' ' ' ALA . 11.4 t -52.34 -46.52 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.313 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.733 ' HB3' HG21 ' A' ' 159' ' ' ILE . 73.4 p -69.45 -33.59 73.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.289 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 1.381 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 17.6 t80 -73.3 -40.01 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -62.17 -12.16 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -66.69 -64.59 2.13 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.706 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 Cg_endo -59.17 -35.63 97.29 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.876 2.384 . . . . 0.0 112.445 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.381 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mt-10 -90.5 35.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.508 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 92.6 p -151.59 48.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.765 ' OD2' ' ND2' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 36.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.765 HD22 ' HG3' ' A' ' 164' ' ' MET . 69.8 mt -55.6 141.09 38.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.499 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 7.7 t-80 84.72 -12.56 0.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 137' ' ' ARG . 74.1 t60 -60.49 169.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -119.32 -169.77 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 4.5 m-20 -145.5 171.26 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.524 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . . . -68.54 -6.44 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 p -114.05 0.87 14.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.21 95.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.492 ' HB3' HD23 ' A' ' 147' ' ' LEU . 33.9 mt -120.2 77.4 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.076 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 14.2 p -48.27 161.41 0.38 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.711 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.5 Cg_exo -48.28 -37.5 32.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.747 2.298 . . . . 0.0 112.421 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 145' ' ' LEU . 2.0 tt -71.06 -41.74 70.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.076 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -66.3 -48.54 70.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.19 -39.79 60.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.039 0.447 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.926 ' HB1' HD13 ' A' ' 156' ' ' LEU . . . -61.23 -45.69 93.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.204 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.437 ' HB2' ' CE ' ' A' ' 157' ' ' MET . 11.0 tpt180 -57.19 -30.5 64.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.29 -75.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.792 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 1.078 ' O ' HD21 ' A' ' 156' ' ' LEU . 17.1 mmm180 -74.56 70.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.46 51.39 0.09 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.334 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -52.57 -31.19 34.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.473 0.654 . . . . 0.0 109.831 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.536 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 2.9 pm0 173.27 -146.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.182 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 1.205 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 21.5 m120 -74.91 44.53 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.078 HD21 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -73.58 -31.45 63.61 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.479 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.677 ' H ' HD12 ' A' ' 156' ' ' LEU . 1.1 ptm -67.34 -29.05 68.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.205 ' OD1' ' O ' ' A' ' 155' ' ' ASN . 5.4 p-10 -74.26 -46.58 40.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.245 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.16 -39.83 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.198 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.01 -41.56 61.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.11 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG3' ' HG ' ' A' ' 145' ' ' LEU . 1.9 mt-30 -61.73 -55.37 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.3 95.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.427 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 159' ' ' ILE . 1.1 m-70 -72.98 -10.86 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.978 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.765 ' HG3' HD22 ' A' ' 134' ' ' LEU . 3.1 ttm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.866 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 35' ' ' VAL . 4.7 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.796 0.332 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.751 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -78.37 -10.57 86.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 2.5 p30 -129.12 24.07 5.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.745 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 5.8 ttt180 -103.89 -67.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -69.39 -39.99 77.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.696 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.633 ' N ' HD13 ' A' ' 14' ' ' LEU . 1.1 m -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.68 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.03 -36.4 60.72 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.31 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -68.49 -57.17 6.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.95 64.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -27.94 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -73.14 -31.7 64.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 83.69 64.92 1.59 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.406 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.399 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 1.2 p30 -137.12 100.94 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 26' ' ' VAL . 2.5 p -52.7 -23.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -73.31 -49.61 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.399 ' OE1' ' CB ' ' A' ' 22' ' ' ASP . 1.8 mt-10 -73.09 -47.24 46.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.9 p -52.86 -38.1 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 60.2 mtm180 -73.15 -61.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.192 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -52.94 -31.8 42.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.251 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -72.9 -69.08 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 10.8 mt -70.69 -42.62 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 4.3 t-80 -73.29 -0.51 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.376 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -150.58 -75.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.717 0.294 . . . . 0.0 111.179 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.745 ' OE1' HD23 ' A' ' 29' ' ' LEU . 2.8 tm-20 -41.18 -27.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 34' ' ' LEU . 9.7 mt 54.79 56.04 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 14' ' ' LEU . 41.0 t -87.28 130.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -48.41 133.7 13.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.9 Cg_endo -71.61 -18.95 28.63 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.767 2.311 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.821 ' O ' HD12 ' A' ' 40' ' ' LEU . 57.5 p-10 -87.49 1.73 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -45.91 121.83 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -111.34 127.45 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 6.5 m-80 -64.06 -163.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.401 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -81.79 -2.0 49.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.83 -23.13 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.744 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 96.24 29.35 8.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.447 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HB3' HG13 ' A' ' 50' ' ' VAL . 22.6 mttp -105.45 152.92 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.22 168.16 14.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -61.17 -53.8 52.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 51' ' ' MET . 3.6 mt -68.17 -27.99 66.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HB2' HG21 ' A' ' 71' ' ' VAL . 45.0 tt0 -73.39 -3.66 28.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 46' ' ' THR . 28.6 m -133.68 -37.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -36.09 137.72 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.901 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.504 ' HE2' ' HA3' ' A' ' 54' ' ' GLY . 12.4 ptm -93.5 123.62 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.059 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 60.9 m-85 -56.96 -16.51 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -36.31 -40.85 0.45 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.255 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.922 ' O ' HG22 ' A' ' 58' ' ' VAL . 19.3 m -110.94 127.16 27.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.608 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.3 Cg_endo -73.6 -32.28 7.88 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.297 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.93 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.0 -39.73 95.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 55' ' ' SER . 19.1 m -62.38 -30.04 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.065 0.46 . . . . 0.0 110.447 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -64.0 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 6.2 tt -63.24 -32.12 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.93 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -62.91 -54.54 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -62.69 -46.1 89.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.654 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 63' ' ' LEU . 2.5 mt -63.29 -49.48 73.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 60' ' ' LEU . 5.6 ttpp -63.01 -13.1 31.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.089 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -79.0 -34.47 44.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.86 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.16 44.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.74 -171.63 2.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 m -136.47 114.11 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -26.51 20.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.621 2.214 . . . . 0.0 112.348 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.14 75.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 49' ' ' GLN . 4.0 m -137.25 134.2 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.406 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 11.0 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -110.95 113.89 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -86.68 171.19 10.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.704 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 14.3 Cg_endo -56.92 -41.64 73.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.629 2.219 . . . . 0.0 112.07 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 2.9 m -56.39 -43.9 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 79.7 m80 -54.1 -53.43 53.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 86' ' ' THR . 2.9 p30 -70.12 -31.17 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.154 ' CB ' HD11 ' A' ' 92' ' ' LEU . . . -66.64 -25.8 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.25 -65.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.29 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -59.51 -26.3 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 82' ' ' ASP . 4.1 p -65.9 -37.62 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.094 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.54 66.28 1.29 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.425 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -140.33 49.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.97 HD21 ' CD2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -53.4 -18.82 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.29 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.715 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.4 -70.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.8 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.63 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 13.8 m -71.21 -31.76 67.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.34 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.154 HD11 ' CB ' ' A' ' 83' ' ' ALA . 1.1 mp -53.7 -52.01 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.111 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.901 ' HD3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -51.18 -30.93 18.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 62.1 t -74.3 -58.23 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.201 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.827 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 2.3 pp -74.58 -44.1 52.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.13 -29.84 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.21 -27.28 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -73.51 -50.2 22.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -168.15 -70.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.035 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . 24.4 99.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' ALA . 6.2 p-10 -37.52 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -92.68 -6.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.647 ' HA ' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.55 2.44 39.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -74.65 171.51 13.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.1 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 111' ' ' LEU . 56.3 mt -136.35 -168.14 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -171.1 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -52.04 -28.25 16.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -10.71 38.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.629 ' O ' HD22 ' A' ' 105' ' ' LEU . . . 72.13 9.83 72.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.623 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.462 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -77.62 109.79 11.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.136 HD23 ' CG2' ' A' ' 113' ' ' ILE . 6.3 tp -59.78 142.22 88.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.715 ' HA ' HD13 ' A' ' 115' ' ' LEU . 90.8 Cg_exo -40.7 -29.13 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.734 2.29 . . . . 0.0 112.352 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 1.136 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -73.27 -43.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 43.2 m80 -53.59 -37.11 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.715 HD13 ' HA ' ' A' ' 112' ' ' PRO . 6.6 mp -57.54 -57.8 11.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.783 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -52.86 -30.23 32.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.824 ' HB ' HD23 ' A' ' 147' ' ' LEU . 77.9 mt -66.46 -38.08 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.516 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HG2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -73.18 -15.85 61.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 1.29 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 2.6 mp0 -94.69 -52.99 4.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 87.39 18.1 57.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.158 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' SER . 92.8 m-70 -35.82 -69.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.545 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 3.1 t 156.63 -92.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.576 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -73.34 -14.1 61.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.749 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.621 HG12 ' CB ' ' A' ' 116' ' ' ALA . 69.2 t -68.57 -65.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.685 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.6 t -52.27 -41.18 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.646 ' CB ' HG21 ' A' ' 159' ' ' ILE . 93.4 p -72.27 -30.87 65.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 1.352 ' CE1' ' OE2' ' A' ' 131' ' ' GLU . 53.2 t80 -73.24 -53.06 11.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.6 -19.48 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.83 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.93 -70.58 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.83 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 38.8 Cg_endo -66.64 -37.6 21.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.7 2.266 . . . . 0.0 112.412 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.352 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 23.8 mp0 -65.94 -21.52 66.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.716 ' HB3' HD21 ' A' ' 111' ' ' LEU . 6.9 m -114.02 148.77 36.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.113 ' OD2' ' ND1' ' A' ' 136' ' ' HIS . 2.2 p30 -38.33 110.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -65.71 -10.25 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.47 39.68 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 1.113 ' ND1' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -106.21 138.71 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.985 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -130.09 163.21 27.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -96.47 160.89 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.66 -15.76 13.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -34.66 21.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.801 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.95 72.09 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.579 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 20.1 mt -151.92 62.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -40.93 168.21 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.035 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 143' ' ' THR . 84.2 Cg_exo -44.34 -51.18 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.621 2.214 . . . . 0.0 112.144 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.88 -40.29 79.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -53.03 -63.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.57 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.8 tp -56.61 -41.89 77.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.536 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -53.01 -40.25 63.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.06 -40.58 96.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -68.76 -79.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.93 71.78 1.57 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.448 ' HA2' ' SD ' ' A' ' 157' ' ' MET . . . -72.54 42.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.576 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.973 ' HB1' ' OE1' ' A' ' 154' ' ' GLN . . . -52.26 128.96 26.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.973 ' OE1' ' HB1' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 31.38 -154.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 20.6 m120 -76.82 42.82 0.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.776 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -72.87 -50.48 23.58 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.198 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.752 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.24 -30.81 29.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.91 0.386 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.2 OUTLIER -74.17 -49.45 23.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.646 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.1 OUTLIER -51.77 -59.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 156' ' ' LEU . 6.4 mp -57.81 -63.63 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 157' ' ' MET . 1.5 pt20 -52.67 -37.1 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -66.13 -49.03 60.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.17 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -18.64 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.65 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.486 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.5 ttm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 7.1 p . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 12' ' ' ASP . . . -49.86 126.01 20.53 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.405 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 4.6 t0 87.31 5.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 7.0 tpt180 -73.26 -74.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.839 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -73.2 -23.84 60.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -65.46 -48.61 72.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -70.33 -31.33 68.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.606 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -72.68 -64.66 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.53 65.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HA ' ' N ' ' A' ' 52' ' ' MET . . . -71.66 -26.09 62.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -73.41 -29.42 62.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' ARG . . . 97.8 70.46 1.0 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.807 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.085 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 1.4 p30 -146.03 79.97 1.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.876 0.369 . . . . 0.0 110.508 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.2 p -52.61 -20.1 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -72.68 -47.88 43.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.495 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.085 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.34 -39.39 65.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.21 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.4 p -53.41 -36.22 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.874 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 76.5 mtt-85 -73.32 -55.97 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.572 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -66.94 -18.3 65.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.029 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.706 HD12 ' CD ' ' A' ' 25' ' ' GLU . 2.8 mt -65.54 -65.67 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.509 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.762 HD12 ' CD ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -73.54 -38.18 65.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.75 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -72.46 -33.91 67.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.684 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HG3' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -113.8 -55.46 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.184 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.583 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.03 -6.36 27.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER 43.62 27.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.839 HG11 ' HB2' ' A' ' 14' ' ' LEU . 9.2 p -53.09 147.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 136.68 39.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 60.6 Cg_endo -73.08 -11.2 25.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.902 2.402 . . . . 0.0 112.471 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -108.58 7.4 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.54 78.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.068 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.9 mp -64.48 148.05 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.4 -154.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -23.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.6 -35.37 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.17 29.28 3.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HE2' ' OE1' ' A' ' 49' ' ' GLN . 48.0 mtpt -95.12 160.14 14.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.318 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -84.85 150.44 25.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.475 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -65.51 -31.74 72.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 69' ' ' PRO . 12.7 tp -72.31 -47.55 48.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 1.016 ' HB3' HG21 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -63.08 -18.06 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.745 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 46' ' ' THR . 35.5 m -104.36 -34.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -38.7 162.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -103.07 139.25 38.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.957 ' CD2' HD21 ' A' ' 95' ' ' LEU . 19.6 m-85 -84.03 10.29 10.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.84 -54.02 38.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.286 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -99.55 134.86 20.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.653 0.263 . . . . 0.0 110.895 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.859 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 11.2 Cg_exo -71.68 -43.84 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.744 2.296 . . . . 0.0 112.172 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -62.75 -27.22 69.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 55' ' ' SER . 4.5 t -62.87 -45.84 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.88 -56.6 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.228 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.758 ' C ' HD23 ' A' ' 60' ' ' LEU . 3.3 tt -63.14 -44.67 94.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.413 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.21 ' OE2' ' O ' ' A' ' 26' ' ' VAL . 1.6 tt0 -62.31 -58.51 7.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.4 -46.84 84.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.96 HD21 ' CE1' ' A' ' 98' ' ' HIS . 10.4 tt -62.91 -31.7 72.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 12.3 mttt -63.0 -44.39 96.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.633 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -44.01 -25.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 134.68 -11.78 4.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -37.16 148.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 71' ' ' VAL . 57.8 m -103.82 116.47 61.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.936 ' HA ' HD23 ' A' ' 48' ' ' LEU . 73.9 Cg_endo -75.88 -29.76 6.6 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.75 2.3 . . . . 0.0 112.432 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 101' ' ' ASP . 1.7 m-20 -73.62 68.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 49' ' ' GLN . 9.7 m -117.19 155.41 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' THR . 4.8 mp0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -89.54 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.901 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 1.134 ' OG ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 178.92 170.79 0.51 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.676 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 3.3 Cg_endo -46.36 -55.02 4.07 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.857 2.371 . . . . 0.0 112.089 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.01 ' CG2' HG12 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.43 -39.75 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.039 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 78' ' ' SER . 34.9 m80 -52.86 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.229 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER -67.11 -36.0 80.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.329 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -26.58 19.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -73.71 -62.52 1.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.776 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.93 -25.65 61.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.915 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.9 p -56.12 -23.31 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.656 0.265 . . . . 0.0 111.25 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.603 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 67.78 65.47 2.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.204 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -155.4 60.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.617 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' CG ' ' A' ' 127' ' ' PHE . 1.5 tm? -52.06 -19.65 2.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.076 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.338 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -66.82 -66.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.338 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 21.8 m -73.09 -34.54 66.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.6 tt -52.7 -60.89 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.814 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 1.195 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 12.6 ptpt -52.33 -37.66 56.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.053 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 53.1 t -55.58 -64.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.957 HD21 ' CD2' ' A' ' 53' ' ' PHE . 3.9 pp -71.06 -35.53 71.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.932 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 31.2 t -66.39 -42.31 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.195 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -71.63 -22.02 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.754 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 63' ' ' LEU . 58.3 t-80 -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 145.82 -9.46 1.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.843 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -34.83 114.36 0.22 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.134 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 9.7 p30 -33.48 91.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.01 HG12 ' CG2' ' A' ' 80' ' ' VAL . 2.4 m -98.63 -1.39 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.008 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 9.1 m-20 -116.56 20.35 14.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.11 151.11 29.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -129.16 -159.93 0.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -150.38 86.78 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.44 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 106' ' ' ASP . 1.3 t -43.07 -26.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.67 32.58 61.43 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.41 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.463 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -97.92 102.36 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.013 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.404 HD11 ' CG ' ' A' ' 133' ' ' ASP . 13.3 mt -53.93 146.86 26.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' A' ' 80' ' ' VAL . 94.4 Cg_exo -43.14 -35.18 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.3 tt -73.61 -31.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.328 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 21.3 m170 -52.61 -58.39 6.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.737 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.14 -50.87 68.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.522 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -53.81 -37.04 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.617 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.819 HG21 ' HB3' ' A' ' 147' ' ' LEU . 73.6 mt -62.32 -41.28 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.447 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.32 -14.78 62.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.539 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 19.8 mt-10 -102.87 -50.57 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.616 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 74.29 31.04 59.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.603 ' CE1' ' HA3' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -34.12 -46.23 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.687 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 5.1 t 155.83 -109.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.528 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 38.7 m -73.88 -14.86 61.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.678 0.275 . . . . 0.0 110.929 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.74 ' O ' HD23 ' A' ' 128' ' ' LEU . 55.2 t -55.07 -67.05 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.8 t -52.64 -46.44 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.411 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.748 ' CB ' HG21 ' A' ' 159' ' ' ILE . 6.4 p -73.14 -23.2 60.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.713 ' CG ' HD21 ' A' ' 89' ' ' LEU . 15.6 t80 -73.52 -65.74 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -75.18 26.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -64.24 -56.49 23.29 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 110.669 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.1 Cg_endo -76.63 -34.71 2.39 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.73 2.287 . . . . 0.0 111.894 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 4.8 mm-40 -54.49 -24.94 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 3.5 m -114.86 146.93 40.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.404 ' CG ' HD11 ' A' ' 111' ' ' LEU . 1.8 p-10 -37.48 105.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 164' ' ' MET . 7.5 mt -83.72 63.98 7.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' HIS . 41.0 t-80 -176.87 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.783 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 56.4 t60 -39.58 161.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.819 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.656 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -141.23 156.34 45.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.463 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 2.5 t0 -60.92 153.83 23.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.6 -16.89 11.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.626 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -48.99 28.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 131.3 54.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.579 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 20.7 mt -152.3 125.89 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.656 HG22 ' CG ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -100.68 178.35 1.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.751 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 88.9 Cg_exo -46.93 -57.33 2.36 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.766 2.31 . . . . 0.0 112.361 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.586 ' HA ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -71.13 -36.87 72.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.27 -53.09 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -52.47 -40.1 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -59.67 -40.57 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -36.05 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.062 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.7 tp-100 -67.43 -76.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.76 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.654 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.5 mpt_? -74.25 70.15 1.62 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -69.79 49.67 0.66 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.019 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -43.96 -27.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 0.0 110.178 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.528 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER 168.96 -132.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.441 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.542 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 44.1 m-20 -75.46 42.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.96 -0.463 . . . . 0.0 111.602 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 151' ' ' ARG . 3.6 mt -62.56 -69.16 0.27 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.771 0.319 . . . . 0.0 111.437 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.64 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 10.0 ptm -52.36 -21.82 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.067 ' OD1' HG13 ' A' ' 159' ' ' ILE . 31.9 p30 -73.93 -51.04 17.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.418 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.067 HG13 ' OD1' ' A' ' 158' ' ' ASP . 1.5 mt -61.71 -24.12 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.375 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.974 HD11 ' HB2' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -73.04 -34.24 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.494 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -70.64 -31.46 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.92 18.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -70.12 -16.25 63.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.781 ' HG2' HD13 ' A' ' 134' ' ' LEU . 8.5 mtp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.039 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.432 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 8.2 p . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -61.98 -57.3 17.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.47 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 53.2 p30 -85.56 13.52 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -82.33 -66.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.914 HD23 ' O ' ' A' ' 36' ' ' HIS . 2.5 tp -72.15 -44.44 63.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -56.78 -32.52 65.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.829 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -72.69 -46.38 31.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.469 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.59 38.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.65 79.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.3 -22.75 61.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.202 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -73.14 -43.23 61.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.62 70.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p30 -139.0 103.65 4.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.501 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.04 -23.01 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.55 -51.45 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 60.0 mm-40 -68.49 -44.77 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.201 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 58' ' ' VAL . 12.8 p -52.68 -49.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HG13 ' A' ' 26' ' ' VAL . 70.5 mtt-85 -69.79 -54.57 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 8.7 mtm180 -61.31 -24.13 66.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.24 -71.48 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 61' ' ' GLU . 11.0 mt -73.54 -43.77 59.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -71.75 -1.85 15.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.517 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -147.5 -75.56 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 1.35 ' CD ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -47.46 -23.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.4 mt 56.04 37.71 29.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.35 HG22 ' CD ' ' A' ' 33' ' ' GLU . 1.6 t -66.16 140.59 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.997 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -60.69 139.92 93.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.8 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 66' ' ' GLY . 33.0 Cg_endo -64.25 -18.58 63.81 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.729 2.286 . . . . 0.0 112.113 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.997 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 16.7 p-10 -87.94 -81.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.863 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 40.39 95.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 3.6 mp -91.21 131.87 36.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.985 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p30 -65.78 169.75 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.76 -38.98 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.67 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.27 28.11 2.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 2.9 mttp -98.87 157.02 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.979 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.1 p -85.03 150.64 24.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -62.17 -35.29 78.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 8.6 tp -71.46 -43.91 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.022 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HG3' HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -70.1 -5.31 26.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 46' ' ' THR . 15.9 m -125.78 -17.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.663 ' HE1' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -51.28 151.83 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.181 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -92.36 130.24 38.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.896 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.704 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 10.3 m-85 -85.5 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.506 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -89.04 -39.13 6.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.908 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' ' 91' ' ' THR . 1.8 t -114.88 135.4 22.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.247 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.73 -34.26 19.2 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.649 2.233 . . . . 0.0 112.062 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.16 -28.0 69.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.778 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.7 t -63.44 -50.78 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.23 -50.41 70.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.806 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 64' ' ' LYS . 9.7 tt -63.24 -38.01 89.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.719 ' HB3' HD12 ' A' ' 30' ' ' LEU . 1.3 mp0 -62.92 -56.23 19.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.249 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 58' ' ' VAL . 4.4 mp -62.73 -46.89 85.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -63.07 -40.24 97.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -62.94 -32.99 74.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 30' ' ' LEU . 2.9 mm-40 -69.03 -57.54 5.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 37' ' ' PRO . . . 163.89 36.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -97.14 106.09 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.968 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -63.34 119.67 55.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 29.2 Cg_endo -63.21 -15.62 49.32 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.727 2.284 . . . . 0.0 112.224 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 37.1 m-80 -95.22 93.56 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 49' ' ' GLN . 28.3 m -148.35 159.12 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' THR . 28.1 mp0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.468 HG23 ' CB ' ' A' ' 81' ' ' HIS . 34.9 m -128.61 137.51 51.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.805 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.82 179.23 1.16 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HB3' ' HE1' ' A' ' 51' ' ' MET . 42.2 Cg_exo -56.06 -32.68 87.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.824 2.349 . . . . 0.0 112.307 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 96' ' ' VAL . 9.6 t -68.25 -28.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 35.6 m80 -63.44 -67.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 86' ' ' THR . 2.5 p30 -53.01 -48.65 67.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -19.33 3.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 81' ' ' HIS . . . -72.52 -65.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.328 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -73.07 -37.72 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 82' ' ' ASP . 60.2 p -54.33 -17.75 3.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 67.02 66.76 2.24 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.006 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 22.7 m-85 -135.62 49.38 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 123' ' ' SER . 19.9 tp -55.11 -15.28 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.781 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -74.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.67 0.271 . . . . 0.0 110.729 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 59' ' ' ALA . 24.8 m -69.8 -33.44 72.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.376 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.714 ' C ' HD23 ' A' ' 92' ' ' LEU . 2.3 tt -53.28 -46.36 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -56.39 -37.19 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.216 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.783 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 74.2 t -52.84 -63.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.734 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.66 -36.47 67.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 111.152 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.785 ' CG2' HG22 ' A' ' 80' ' ' VAL . 3.8 t -68.99 -46.54 78.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.29 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.783 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 10.6 pm0 -59.04 -33.77 71.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.054 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -39.28 93.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.21 36.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.63 -177.74 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -75.32 74.52 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.547 HG12 HG11 ' A' ' 80' ' ' VAL . 13.0 m -91.78 19.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -130.71 5.37 4.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.23 155.49 22.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.587 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -129.11 144.37 51.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -84.77 -176.68 6.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.21 -53.29 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.8 p -61.31 -24.3 66.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 84.35 -10.32 61.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.73 117.99 3.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -56.35 130.64 75.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.98 ' HD2' HD23 ' A' ' 111' ' ' LEU . 82.9 Cg_exo -44.11 -31.67 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -73.52 -42.72 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.574 ' CE1' ' OD2' ' A' ' 138' ' ' ASP . 9.5 m80 -52.91 -27.36 18.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -69.85 -53.03 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.884 ' C ' HG12 ' A' ' 125' ' ' VAL . . . -52.64 -43.17 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 110.352 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 147' ' ' LEU . 50.5 mt -57.57 -42.32 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.782 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -71.11 -15.66 62.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -90.64 -55.39 3.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.639 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.67 12.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.526 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 97.1 m-70 -56.01 -18.15 8.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.79 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 126' ' ' SER . 3.8 m 71.75 -63.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.689 ' CB ' HD22 ' A' ' 89' ' ' LEU . 12.1 m -69.55 -38.97 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.069 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.812 HG12 HD12 ' A' ' 128' ' ' LEU . 39.7 t -73.39 -54.91 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.884 HG12 ' C ' ' A' ' 116' ' ' ALA . 3.5 m -52.8 -47.03 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 159' ' ' ILE . 5.6 t -71.53 -34.15 69.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 1.194 ' CD2' ' OE1' ' A' ' 131' ' ' GLU . 45.1 t80 -73.36 -39.6 65.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -67.36 -25.66 66.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.764 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.93 -62.12 5.72 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 44.2 Cg_endo -68.15 -48.83 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.79 2.327 . . . . 0.0 112.62 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.194 ' OE1' ' CD2' ' A' ' 127' ' ' PHE . 0.5 OUTLIER -58.07 -29.51 65.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.732 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.512 ' OG ' HD23 ' A' ' 128' ' ' LEU . 1.2 m -107.77 154.46 21.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.935 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.5 p-10 -41.76 113.85 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.867 HD13 ' HA ' ' A' ' 164' ' ' MET . 8.1 mt -85.08 43.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.976 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.05 33.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.463 ' HB3' HD11 ' A' ' 111' ' ' LEU . 50.8 t60 -107.18 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -126.31 -156.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER 177.15 155.59 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.574 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -37.7 -30.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.508 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -60.42 -44.87 95.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.869 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 84.28 25.52 43.5 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.469 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -133.51 80.44 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.371 . . . . 0.0 111.015 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 1.6 p -42.48 169.12 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 91.0 Cg_exo -43.66 -44.76 11.15 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.289 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.84 -42.92 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.498 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.511 ' HB3' ' CA ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -52.52 -64.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.427 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.571 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.72 -34.96 54.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -60.82 -31.31 70.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -45.02 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.491 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -69.85 -89.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.171 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.533 ' N ' ' CG ' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -75.62 51.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.085 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -61.74 -9.18 18.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.136 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 47.38 -86.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -125.47 -136.79 0.27 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 1.229 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 12.5 p30 -74.37 14.37 0.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.153 -0.342 . . . . 0.0 111.267 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.725 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.82 -45.68 64.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.67 0.272 . . . . 0.0 111.331 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.912 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 3.3 ptm -57.09 -30.15 64.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.37 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD2' ' HB2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -73.55 -47.12 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.931 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.1 OUTLIER -52.0 -49.3 38.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 156' ' ' LEU . 5.3 mp -73.46 -26.74 61.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -64.46 -63.8 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.08 -31.59 79.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.646 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 1.2 m-70 -66.24 -39.57 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.954 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.867 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 ptm . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.461 HG22 HG13 ' A' ' 35' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.852 0.358 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -54.57 -44.44 78.61 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.12 5.33 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -78.87 -62.5 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 14' ' ' LEU . 2.8 tm? -71.17 -33.22 69.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 25.4 t -67.79 -50.12 58.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -57.1 -26.97 56.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.205 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.23 -67.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.021 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.579 ' HB1' ' CG ' ' A' ' 51' ' ' MET . . . -53.04 -54.58 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -53.43 -29.16 33.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 18.0 mtt180 -73.92 -37.62 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 93.64 66.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.577 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.688 ' OD1' ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -138.66 97.13 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.831 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.3 p -57.29 -18.43 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.0 -46.47 43.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.3 -34.41 65.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.8 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.881 HG21 ' HA ' ' A' ' 58' ' ' VAL . 1.1 p -52.57 -48.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.744 0.307 . . . . 0.0 111.212 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.99 -56.33 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.64 -48.14 66.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.445 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 52.7 mt -52.72 -55.84 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.214 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HA ' ' A' ' 62' ' ' LEU . 84.5 mt -73.95 -55.8 5.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.17 4.0 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -146.19 -70.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 1.259 ' OE1' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.79 -16.47 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.5 mt 45.37 45.01 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.671 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.259 HG22 ' OE1' ' A' ' 33' ' ' GLU . 2.8 t -72.29 153.74 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 1.016 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 1.3 t-80 -63.59 138.12 97.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.6 Cg_endo -71.23 -37.7 5.61 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 1.016 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -92.26 31.35 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.076 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -65.71 118.44 9.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.002 HD23 ' C ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -120.3 125.02 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -60.95 -178.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -41.59 -46.1 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -48.15 -62.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.02 24.09 1.9 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.61 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 1.002 ' C ' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -109.39 163.17 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.755 0.312 . . . . 0.0 110.714 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.629 ' N ' HD23 ' A' ' 40' ' ' LEU . 17.0 p -84.87 152.14 23.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -52.92 -26.09 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.677 HD23 ' HE2' ' A' ' 51' ' ' MET . 7.0 mt -73.26 -41.82 63.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HG3' ' OG1' ' A' ' 46' ' ' THR . 0.0 OUTLIER -73.17 -7.48 51.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.228 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 24.2 m -136.05 24.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.677 ' HE2' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -70.59 -177.95 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 0.0 110.708 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 1.1 ttp -114.31 -11.09 12.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.934 ' CE2' HD21 ' A' ' 95' ' ' LEU . 12.1 m-85 50.35 21.0 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.88 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.48 -55.2 7.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.69 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 2.4 t -100.41 137.91 20.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 0.0 110.198 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 40.8 Cg_endo -67.87 -50.29 0.88 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.34 -18.72 63.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.166 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.881 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 t -63.06 -55.62 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.25 -37.87 88.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' HG11 ' A' ' 94' ' ' VAL . 25.0 tp -63.19 -51.33 66.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 13.7 mm-40 -62.75 -53.66 50.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.966 ' HA ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.63 -51.84 65.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.179 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -63.94 -50.5 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.958 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.852 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.2 tttt -65.24 56.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.052 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 63' ' ' LEU . 6.7 tp60 -154.42 -39.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.046 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 37' ' ' PRO . . . 154.47 38.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.769 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.13 -0.07 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.121 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.785 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.8 m 43.88 83.02 0.22 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.979 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.48 -30.35 15.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.766 2.311 . . . . 0.0 112.238 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 91.8 m-20 -79.51 75.15 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 68' ' ' SER . 20.3 m -116.58 150.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.76 43.67 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -53.14 160.77 1.49 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.997 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 2.8 Cg_endo -46.93 -32.51 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.0 2.467 . . . . 0.0 111.888 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.83 -45.33 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.902 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.498 ' NE2' ' O ' ' A' ' 105' ' ' LEU . 39.8 m80 -73.12 -38.72 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.008 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -69.71 -67.42 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.319 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.895 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -52.64 -19.18 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 80' ' ' VAL . . . -72.8 -63.02 1.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.42 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.061 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 15.6 ptt85 -70.17 -18.26 63.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.392 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 1.008 HG23 ' O ' ' A' ' 82' ' ' ASP . 82.6 p -68.07 -51.94 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.207 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.01 67.52 0.41 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -152.95 57.32 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.538 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.7 tp -58.65 -13.66 6.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.407 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -67.61 -73.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 53' ' ' PHE . 19.4 m -68.95 -35.86 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 83' ' ' ALA . 29.9 tp -52.69 -49.44 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.449 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HG3' ' CE1' ' A' ' 127' ' ' PHE . 2.6 ttmt -52.66 -44.67 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.842 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 60' ' ' LEU . 1.4 t -53.26 -59.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.132 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.934 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -72.58 -39.64 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 80' ' ' VAL . 20.4 t -67.0 -43.85 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.4 pt-20 -68.33 -43.1 78.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -55.17 -23.87 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.14 50.57 0.3 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.577 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . -85.76 56.32 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 111.141 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 5.5 t0 37.32 52.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.83 -0.95 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.239 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 36.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.47 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -117.09 -178.61 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 111' ' ' LEU . 26.0 mt -125.17 -152.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 110' ' ' SER . 2.0 p30 -145.29 -163.25 1.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.761 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 m -54.12 -28.96 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.34 28.61 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 42.91 40.11 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.542 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 40.7 m -113.51 133.84 55.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.97 162.83 61.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HG3' ' CG1' ' A' ' 80' ' ' VAL . 52.6 Cg_exo -55.35 -25.67 48.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.825 2.35 . . . . 0.0 112.073 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 128' ' ' LEU . 2.5 tp -70.82 -33.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.62 ' HB3' HD22 ' A' ' 147' ' ' LEU . 15.6 m170 -70.47 -30.22 66.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.633 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.88 -54.1 15.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.351 ' CA ' ' OE2' ' A' ' 119' ' ' GLU . . . -52.6 -37.53 58.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HA ' HG11 ' A' ' 125' ' ' VAL . 76.4 mt -56.62 -36.92 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -66.04 -33.52 75.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.002 0.43 . . . . 0.0 110.53 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 1.351 ' OE2' ' CA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -82.4 -53.64 5.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.804 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.95 27.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.84 ' CD2' ' OE1' ' A' ' 119' ' ' GLU . 94.4 m-70 -47.69 -23.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 80.23 -62.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.9 m -70.17 -33.11 71.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 121' ' ' HIS . 24.1 t -73.73 -57.01 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.002 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 117' ' ' ILE . 2.2 m -52.57 -60.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.664 ' H ' HG23 ' A' ' 125' ' ' VAL . 10.2 t -54.99 -29.02 56.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 110.854 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.602 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 26.0 t80 -73.22 -53.92 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -63.38 -11.83 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -59.69 -69.54 0.53 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.204 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.5 Cg_endo -70.2 -31.86 17.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 5.4 mm-40 -61.9 -13.86 28.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 111' ' ' LEU . 10.0 m -121.75 143.57 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.801 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 p30 -39.24 98.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.002 HD13 ' HA ' ' A' ' 164' ' ' MET . 20.2 mt -67.17 66.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.017 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.2 t60 -177.77 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.488 ' CD2' HD13 ' A' ' 111' ' ' LEU . 1.5 p-80 -53.58 179.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HG3' ' C ' ' A' ' 136' ' ' HIS . 0.6 OUTLIER -137.25 -165.51 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -128.9 178.08 6.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.055 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.533 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . . . -71.0 -8.66 54.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.6 p -105.96 -9.66 16.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.733 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 72.73 59.07 4.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 141' ' ' GLY . 62.0 mt -154.61 86.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -71.28 -174.18 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.891 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 87.1 Cg_exo -47.43 -61.5 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.659 2.24 . . . . 0.0 112.473 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 145' ' ' LEU . 6.6 tp -63.81 -32.59 74.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.522 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -67.29 -70.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 114' ' ' HIS . 11.4 tp -52.75 -45.62 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.424 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . . . -55.45 -38.23 68.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -65.75 -41.78 91.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.109 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -64.06 -78.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.883 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 4.7 mtp180 -74.05 58.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.09 54.09 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.695 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.692 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -34.61 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 0.0 110.851 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.692 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 173.83 -114.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.376 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.538 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.5 m-20 -74.31 5.55 4.44 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.198 -0.314 . . . . 0.0 111.594 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -51.15 -59.33 4.3 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.708 0.289 . . . . 0.0 111.298 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.497 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.3 ppp? -52.26 -32.08 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -55.57 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.9 -35.2 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.678 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.614 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.91 -33.6 64.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.43 -51.13 18.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.257 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.56 97.3 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 126' ' ' SER . 3.0 m-70 -61.14 -30.13 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.692 0.282 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 1.002 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.7 mtt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.864 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.436 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 16.9 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -65.82 -40.05 95.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.698 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -101.43 40.65 1.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.562 ' NH1' ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -112.44 -71.48 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.807 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.916 HD22 HD21 ' A' ' 30' ' ' LEU . 26.4 tp -70.92 -26.81 63.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.2 t -61.35 -40.8 95.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.63 -35.08 59.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.533 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -66.91 -62.77 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.55 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -72.43 -22.42 61.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mtt180 -73.09 -36.19 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.892 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 97.41 63.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p30 -142.29 91.66 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 57' ' ' ALA . 13.2 p -52.75 -21.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.528 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 62.7 mt-30 -72.44 -47.35 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.5 mp0 -68.67 -41.02 79.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.297 HG12 ' CD ' ' A' ' 61' ' ' GLU . 55.5 t -53.87 -53.38 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 69.7 mtt180 -61.5 -60.13 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.9 mmt-85 -54.92 -29.27 55.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.584 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.546 HD13 HD12 ' A' ' 14' ' ' LEU . 17.7 mt -73.42 -72.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.96 HD12 ' HB3' ' A' ' 61' ' ' GLU . 41.1 mt -73.48 -43.11 60.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.513 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -72.6 -11.93 60.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.285 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.41 -78.16 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' OE2' ' NH1' ' A' ' 13' ' ' ARG . 1.4 tm-20 -39.94 -28.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.034 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LEU . 3.7 mt 62.71 46.21 5.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 33' ' ' GLU . 25.0 t -77.87 155.23 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.423 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -77.51 134.77 65.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.907 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 69.3 Cg_endo -74.58 -6.91 18.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.81 2.34 . . . . 0.0 112.248 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -103.03 13.58 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -57.08 127.67 33.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.9 OUTLIER -120.65 130.07 53.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -52.2 -55.94 17.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.69 -52.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -35.47 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.85 30.16 1.17 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -98.2 151.81 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 p -94.51 154.96 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.39 -26.46 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.035 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 69' ' ' PRO . 3.0 mt -71.99 -42.7 66.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.3 tm0? -60.07 -53.6 55.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG21 ' OG ' ' A' ' 15' ' ' SER . 7.2 m -64.5 -23.32 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.765 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 ttp -39.18 154.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.541 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -116.24 21.44 13.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.832 ' CD2' HD21 ' A' ' 95' ' ' LEU . 0.7 OUTLIER 36.21 34.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.0 -81.84 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.383 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 58' ' ' VAL . 56.5 m -86.28 119.74 71.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 1.333 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 81.8 Cg_exo -43.99 -39.61 11.28 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.122 ' O ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.29 -22.32 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.451 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG21 ' A' ' 26' ' ' VAL . 37.3 t -63.05 -54.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.1 -32.93 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.03 -42.69 99.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.037 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.297 ' CD ' HG12 ' A' ' 26' ' ' VAL . 1.2 mt-10 -63.1 -51.49 66.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.207 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.5 -46.2 89.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.346 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -62.91 -56.17 19.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.731 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -63.21 -11.71 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.702 ' HG3' HD22 ' A' ' 30' ' ' LEU . 1.1 mm-40 -81.56 -35.11 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.16 22.85 2.07 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.592 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -81.29 154.46 26.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.051 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -108.16 98.94 29.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HB3' HD13 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -68.41 -10.31 28.61 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.652 2.235 . . . . 0.0 112.239 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.59 56.93 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 68' ' ' SER . 12.7 m -125.92 158.82 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.872 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.837 HG23 ' OD2' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -128.76 112.37 14.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.846 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -82.08 -177.84 1.05 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.783 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 52.3 Cg_exo -54.07 -46.32 34.42 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.318 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 96' ' ' VAL . 2.4 m -52.98 -39.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.67 ' CD2' HG22 ' A' ' 77' ' ' THR . 73.0 m80 -53.4 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.783 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 5.0 p30 -53.11 -44.52 67.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.786 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.83 -48.29 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.39 92.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.505 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -73.24 -33.13 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 82' ' ' ASP . 41.7 p -73.45 -78.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.76 68.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.478 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 35.8 m-85 -139.27 51.49 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.591 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 92' ' ' LEU . 16.0 tp -52.5 -18.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.286 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.333 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -73.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.568 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.124 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -73.39 -30.29 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.769 ' C ' HD23 ' A' ' 92' ' ' LEU . 2.5 tt -59.08 -34.83 72.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.049 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HE2' ' CD1' ' A' ' 127' ' ' PHE . 4.0 mttt -67.73 -53.18 29.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 2.7 m -52.71 -48.17 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 53' ' ' PHE . 1.2 pp -73.37 -51.37 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.518 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.838 HG13 HG11 ' A' ' 102' ' ' VAL . 55.1 t -67.37 -51.12 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.844 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.905 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 5.0 pm0 -52.58 -30.47 31.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.814 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.479 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER -73.08 -36.34 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.23 65.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -91.64 18.97 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 61.7 72.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.838 HG11 HG13 ' A' ' 96' ' ' VAL . 4.1 m -89.17 13.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.048 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.69 38.87 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.542 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -136.08 131.82 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.272 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.903 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -100.4 -176.88 3.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.882 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.872 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 0.9 OUTLIER -99.42 40.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER 76.73 12.51 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.7 t -115.9 8.83 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.897 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 61.75 14.84 45.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.1 m -98.67 91.91 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 136' ' ' HIS . 35.0 mt -51.52 146.17 13.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 85.1 Cg_exo -47.41 -39.73 28.44 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.726 2.284 . . . . 0.0 112.55 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -61.41 -32.35 53.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.893 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.58 ' O ' HD13 ' A' ' 147' ' ' LEU . 15.9 m170 -66.7 -29.83 69.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.13 -47.38 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.484 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.73 -45.12 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.33 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.857 HG21 ' HB3' ' A' ' 147' ' ' LEU . 89.4 mt -53.18 -39.46 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.548 ' HD2' ' CD ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -61.96 -20.81 64.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.015 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -112.37 -42.0 3.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.528 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.59 84.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.99 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 10.9 m-70 -38.49 102.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' HIS . 3.0 m 35.63 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.999 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.39 10.36 1.33 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 59.4 t -56.09 -53.93 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.008 0.432 . . . . 0.0 110.229 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -52.64 -41.37 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.608 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.569 ' CB ' HG21 ' A' ' 159' ' ' ILE . 15.7 p -66.69 -34.76 78.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.584 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 14.3 t80 -72.86 -48.56 36.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.418 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.501 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.946 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -55.09 -66.48 0.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.946 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 66.6 Cg_endo -75.21 -52.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.656 2.237 . . . . 0.0 112.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -23.74 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.541 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 128' ' ' LEU . 9.3 t -93.83 -153.54 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.688 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.41 56.33 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.874 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.94 88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.629 ' O ' HG22 ' A' ' 143' ' ' THR . 17.6 t60 155.42 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 111' ' ' LEU . 13.6 t60 -65.27 164.04 14.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.962 ' CG ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -134.6 127.45 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.555 ' OD1' ' CG ' ' A' ' 114' ' ' HIS . 1.1 m-20 -50.2 155.27 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.19 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 110.318 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -67.53 -48.73 66.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 116.58 57.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.554 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 146' ' ' GLU . 1.1 mt -144.65 104.21 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.144 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -66.11 171.5 3.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 82.5 Cg_exo -43.6 -43.0 11.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.534 2.156 . . . . 0.0 112.021 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.26 -34.62 65.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.144 ' OE1' ' N ' ' A' ' 143' ' ' THR . 5.4 mt-10 -61.84 -61.77 2.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -52.7 -36.52 57.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.54 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.283 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -73.17 -45.41 56.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -73.11 -92.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.244 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.548 ' CD ' ' HD2' ' A' ' 118' ' ' ARG . 16.2 mtt-85 -76.56 45.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -53.29 -17.89 6.24 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.761 ' HB3' HD23 ' A' ' 156' ' ' LEU . . . 64.18 -64.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -154.4 -138.37 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.019 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 10.4 m120 -74.16 9.85 1.46 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.226 -0.296 . . . . 0.0 111.391 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.804 HD12 ' C ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -51.82 -34.87 42.21 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.846 0.355 . . . . 0.0 111.281 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.666 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.5 ppp? -52.44 -28.39 19.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.059 0.457 . . . . 0.0 110.081 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.06 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 3.4 p30 -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.06 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -51.65 -44.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.291 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.56 -16.08 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 111.035 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -55.08 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.33 -43.4 96.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' LEU . 2.1 m-70 -70.31 -11.79 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 35' ' ' VAL . 36.5 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.865 0.364 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.515 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -48.58 -21.72 2.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.569 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 29.4 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 1.7 ttm105 -109.82 -74.94 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.019 HD22 ' O ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.92 -35.18 72.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -58.24 -40.55 82.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.598 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -73.13 -40.42 50.53 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -67.79 -47.05 70.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.457 ' CB ' HD21 ' A' ' 62' ' ' LEU . . . -52.82 -41.71 64.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -18.6 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 1.7 mtt180 -73.17 -28.06 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.72 65.03 1.96 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.615 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.131 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -133.12 92.46 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.635 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 57' ' ' ALA . 10.7 p -52.58 -20.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -73.81 -56.33 5.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.938 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.131 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.48 -30.26 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.629 -179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 58' ' ' VAL . 2.4 p -52.85 -45.36 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.744 0.306 . . . . 0.0 111.407 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -73.56 -46.35 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 4.7 mmm180 -53.51 -32.71 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD12 ' OE1' ' A' ' 25' ' ' GLU . 10.4 mt -73.42 -72.39 0.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.833 HD22 ' HG2' ' A' ' 65' ' ' GLN . 5.5 mt -73.4 -45.71 53.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.686 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -70.06 -13.39 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.691 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -134.05 -75.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.199 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.806 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 2.5 tt0 -43.99 -25.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.2 mp 72.46 13.08 5.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.4 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' A' ' 14' ' ' LEU . 3.3 p -44.75 158.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.407 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -94.81 141.27 23.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.83 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 55.9 Cg_endo -70.52 -23.27 27.53 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.744 2.296 . . . . 0.0 112.201 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.71 37.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . . . -79.01 127.55 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 38' ' ' ASP . 6.3 mp -122.55 133.66 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 111.454 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -62.57 -168.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' CD ' ' C ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -70.32 -4.98 24.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -98.95 -69.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 146.74 67.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 19.1 mtpt -142.41 146.65 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.6 p -84.54 152.61 23.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.75 -54.89 27.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 69' ' ' PRO . 7.3 tp -53.05 -30.53 36.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.639 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.3 tt0 -73.2 -34.61 66.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -91.42 -25.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' HD12 ' A' ' 48' ' ' LEU . 1.4 mtp -36.35 137.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 3.6 ptt? -96.42 10.11 39.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.032 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.4 m-85 47.38 23.54 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.43 -56.02 24.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.312 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -98.04 146.15 31.01 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.788 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 1.239 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.3 Cg_endo -79.67 -42.15 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.834 2.356 . . . . 0.0 112.555 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -31.14 72.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 55' ' ' SER . 11.4 m -62.64 -30.79 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -62.94 -43.16 99.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.986 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -63.31 -34.53 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.217 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -63.04 -67.89 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 62' ' ' LEU . 6.3 mp -62.32 -35.41 78.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.088 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 7.6 tp -62.95 -63.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -62.93 -17.3 61.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.833 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.22 -52.86 63.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.63 -13.49 2.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -60.05 98.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.322 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.16 121.57 2.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.676 ' HA ' HD23 ' A' ' 48' ' ' LEU . 59.5 Cg_endo -71.95 -21.45 24.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.733 2.289 . . . . 0.0 112.326 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.202 ' CA ' ' OD2' ' A' ' 101' ' ' ASP . 1.4 m120 -81.47 86.11 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.74 133.61 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.31 129.51 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -111.36 171.52 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 50.8 Cg_exo -53.86 -32.14 65.7 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.767 2.311 . . . . 0.0 112.336 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -64.31 -36.53 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.447 ' ND1' HG23 ' A' ' 80' ' ' VAL . 3.3 m80 -64.47 -47.93 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.914 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.9 p30 -60.3 -51.66 68.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -51.97 -29.61 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' HG11 ' A' ' 124' ' ' VAL . . . -73.33 -65.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.477 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' NE ' ' HB3' ' A' ' 115' ' ' LEU . 7.2 mtp180 -64.68 -29.41 70.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 82' ' ' ASP . 61.6 p -73.29 0.3 12.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.549 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.468 ' HA2' HG21 ' A' ' 124' ' ' VAL . . . 52.76 80.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.098 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.51 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -154.12 60.48 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.856 0.36 . . . . 0.0 110.433 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.908 HD13 ' O ' ' A' ' 89' ' ' LEU . 3.2 tm? -52.15 -19.05 1.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.267 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.239 ' OD1' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -56.2 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.382 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.848 HG22 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.4 -8.92 57.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.127 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.701 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mp -73.0 -64.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -57.06 -24.03 50.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 95' ' ' LEU . 38.0 t -76.77 -82.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.09 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.032 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -76.11 -44.83 36.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.079 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 80' ' ' VAL . 94.3 t -67.77 -3.3 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.227 ' HA ' ' OE2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -73.1 -43.23 62.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -64.57 -37.77 88.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.841 ' O ' HG13 ' A' ' 102' ' ' VAL . . . 146.96 -49.97 0.61 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . 36.21 31.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.202 ' OD2' ' CA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 71.52 56.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 99' ' ' GLY . 5.0 m -79.95 1.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -116.0 40.67 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.956 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.825 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -125.51 166.93 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -154.64 160.61 41.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 3.5 p30 -84.83 79.06 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 108' ' ' THR . 1.1 p 84.13 -54.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER -174.38 32.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.765 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . -76.83 -3.35 79.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.775 ' C ' HD22 ' A' ' 105' ' ' LEU . 0.6 OUTLIER 85.4 159.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -45.18 158.86 0.29 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.544 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 50.9 Cg_exo -53.86 -38.47 85.78 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.645 2.23 . . . . 0.0 112.223 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -58.33 -41.43 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.542 ' CG ' ' OG ' ' A' ' 110' ' ' SER . 57.3 m80 -52.96 -31.73 42.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.681 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.498 ' HB3' ' NE ' ' A' ' 85' ' ' ARG . 12.6 mt -73.17 -53.77 10.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.361 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -54.25 -33.09 57.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.342 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.992 HG21 ' HB3' ' A' ' 147' ' ' LEU . 81.8 mt -61.41 -40.51 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -64.38 -21.35 66.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 1.361 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 1.9 mp0 -94.7 -51.65 4.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.84 22.79 35.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.514 ' O ' ' CB ' ' A' ' 122' ' ' SER . 99.0 m-70 -46.41 -24.85 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER 84.97 -60.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.836 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -73.1 -42.16 63.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.046 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 116' ' ' ALA . 49.0 t -67.08 -60.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.684 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.7 t -52.69 -57.14 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.633 ' CB ' HG21 ' A' ' 159' ' ' ILE . 88.8 p -52.73 -37.15 58.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 92' ' ' LEU . 51.6 t80 -71.91 -55.1 8.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -62.41 -19.33 63.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.898 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -52.98 -69.51 0.33 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.925 ' HA ' HD11 ' A' ' 134' ' ' LEU . 55.0 Cg_endo -69.6 -25.32 29.44 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.227 ' OE2' ' HA ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -89.55 36.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -169.7 134.88 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.818 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.286 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 2.9 p-10 -35.74 97.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.925 HD11 ' HA ' ' A' ' 130' ' ' PRO . 2.8 mp -72.91 56.36 0.42 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.03 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 -39.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.138 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 1.286 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -56.83 142.67 40.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.019 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 167.88 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -75.14 166.89 22.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 108' ' ' THR . . . -51.48 -21.92 2.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.324 0.583 . . . . 0.0 110.141 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -59.0 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.91 40.8 0.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.253 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 2.4 mt -122.91 125.22 44.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -98.11 -174.53 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 72.8 Cg_exo -49.31 -56.84 2.77 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.694 2.263 . . . . 0.0 112.401 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.697 HD13 ' HG3' ' A' ' 161' ' ' GLN . 13.8 tp -69.31 -40.38 77.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.046 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.08 -65.7 0.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.93 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.992 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -53.12 -39.45 63.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.13 -27.3 61.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.7 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -68.55 -47.64 66.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.97 -74.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.968 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -74.55 56.56 0.69 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.02 55.4 0.8 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.139 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.851 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -31.44 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.99 0.424 . . . . 0.0 110.979 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.851 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 174.43 -114.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.42 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 1.265 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 8.0 m-80 -75.35 6.92 3.95 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.291 -0.255 . . . . 0.0 111.438 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 156' ' ' LEU . 1.3 mt -51.11 -64.39 0.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.445 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.588 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 4.3 ptm -52.89 -29.26 27.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.265 ' OD2' ' HA ' ' A' ' 155' ' ' ASN . 0.4 OUTLIER -74.59 -51.52 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.01 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.68 -42.35 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.22 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.858 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -74.63 -44.83 48.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.187 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.697 ' HG3' HD13 ' A' ' 145' ' ' LEU . 4.0 mt-30 -53.61 -50.56 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.286 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.22 98.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' HB3' ' A' ' 130' ' ' PRO . 2.0 m-70 -73.23 -7.1 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.679 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.861 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.787 0.327 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -47.24 -34.74 8.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.35 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.776 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.66 28.28 7.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.754 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -94.56 -56.56 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HD13 ' A' ' 29' ' ' LEU . 37.9 tp -72.72 -40.78 65.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -57.67 -34.6 69.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.14 -53.74 7.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.574 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.69 -39.77 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.151 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -67.44 -50.32 59.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' SER . . . -68.77 -12.03 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 20.7 mtt180 -67.89 -43.51 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.64 59.41 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.066 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 10.7 p-10 -138.55 95.1 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.9 p -53.9 -18.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.024 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 9.2 mt-30 -72.98 -54.57 8.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.01 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.066 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.04 -36.42 66.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.342 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.109 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.7 p -52.82 -42.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.397 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 1.086 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 23.6 mtp180 -70.91 -50.54 33.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.065 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 2.4 mtm180 -67.4 -12.0 59.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.962 HD13 HD12 ' A' ' 14' ' ' LEU . 8.7 mt -73.55 -70.4 0.37 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.35 -45.27 56.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.66 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 3.1 m-70 -72.42 -12.38 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.61 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 1.8 mtt-85 -134.18 -78.98 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.997 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -37.84 -30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.74 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.9 mt 61.56 45.02 8.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 33' ' ' GLU . 60.4 t -92.89 110.7 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.653 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -46.93 125.09 8.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CG ' ' HB3' ' A' ' 65' ' ' GLN . 52.3 Cg_exo -54.66 -34.77 84.88 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.749 2.299 . . . . 0.0 112.377 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 40' ' ' LEU . 16.3 p-10 -57.38 -21.69 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -33.39 108.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.345 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 38' ' ' ASP . 4.2 mp -102.35 133.44 47.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.988 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.524 ' OD1' ' CB ' ' A' ' 43' ' ' PHE . 8.5 p30 -72.67 159.15 34.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' ASN . 3.8 ptm180 -35.12 -43.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 t80 -56.8 -49.13 76.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 119.22 35.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.21 157.09 25.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.785 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -87.32 147.5 25.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -58.03 -28.83 64.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 69' ' ' PRO . 12.8 tp -70.79 -47.95 56.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.74 ' HB2' HG21 ' A' ' 71' ' ' VAL . 44.5 tt0 -60.65 -24.95 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' THR . 6.1 m -106.03 -14.2 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.738 ' HG3' HD23 ' A' ' 62' ' ' LEU . 2.2 ttp -42.34 145.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -85.53 134.88 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.777 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.1 ' CE2' HD21 ' A' ' 95' ' ' LEU . 14.1 m-85 -87.75 -7.27 57.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CE1' ' A' ' 88' ' ' PHE . . . -50.02 -41.04 36.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.028 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.978 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.0 m -108.78 127.56 27.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 91' ' ' THR . 58.8 Cg_endo -71.87 -34.0 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.682 2.255 . . . . 0.0 112.211 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -35.09 79.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 55' ' ' SER . 4.0 m -62.57 -32.1 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.609 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.902 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.874 HD21 ' HD2' ' A' ' 64' ' ' LYS . 7.3 tt -63.4 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.109 ' OE1' HG13 ' A' ' 26' ' ' VAL . 6.7 mt-10 -62.41 -70.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.75 -36.53 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 69' ' ' PRO . 18.4 tp -63.03 -37.87 88.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.874 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 mtpp -63.32 -48.87 76.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HB3' ' CG ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -36.68 -35.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.38 42.61 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.33 28.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.1 m -47.85 112.09 2.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.863 ' HA ' HD21 ' A' ' 48' ' ' LEU . 30.0 Cg_endo -63.52 -21.19 70.7 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.728 2.285 . . . . 0.0 112.175 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -100.37 82.56 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 49' ' ' GLN . 8.0 m -116.1 142.32 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 4.2 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 106' ' ' ASP . 4.7 m -110.3 71.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.15 169.04 14.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.907 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.522 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 17.9 Cg_endo -60.4 -32.26 93.67 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.738 2.292 . . . . 0.0 111.799 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 32.1 m -57.49 -42.53 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.243 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.552 ' O ' HD12 ' A' ' 115' ' ' LEU . 8.5 m80 -53.65 -67.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.857 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -54.14 -27.44 33.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.909 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -68.94 -16.25 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -73.18 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.37 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.553 ' CG ' ' HB3' ' A' ' 115' ' ' LEU . 61.0 mtm180 -63.73 -29.7 70.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.0 p -67.87 -6.53 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.228 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.94 74.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.174 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 8.3 m-85 -145.2 53.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.565 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.648 HD11 ' CG ' ' A' ' 127' ' ' PHE . 13.9 tp -52.78 -21.12 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.158 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.585 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -60.12 -73.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.835 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 24.1 m -73.21 -28.16 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.8 tt -60.72 -61.31 2.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 1.289 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -52.7 -30.28 31.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.274 ' CA ' ' OE2' ' A' ' 97' ' ' GLU . 16.2 t -61.0 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.301 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.1 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -71.01 -26.76 63.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.018 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.796 HG13 HG11 ' A' ' 102' ' ' VAL . 6.9 t -73.22 -56.05 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.8 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.289 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -52.81 -35.45 57.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.232 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.87 -32.01 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.968 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.44 62.38 0.31 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . -96.61 43.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 111.139 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 54.2 60.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 96' ' ' VAL . 5.4 m -70.07 -10.77 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -105.48 42.76 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -105.31 168.41 9.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.966 HD21 ' HG ' ' A' ' 111' ' ' LEU . 60.4 mt -145.72 135.18 23.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.609 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.828 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.51 47.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER 80.03 -54.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 p -48.76 -37.7 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.665 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 102.72 0.57 49.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 89.1 p -79.09 100.16 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.966 ' HG ' HD21 ' A' ' 105' ' ' LEU . 7.0 mt -56.38 149.78 36.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.504 ' C ' HD12 ' A' ' 128' ' ' LEU . 79.7 Cg_exo -48.21 -28.98 11.89 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.617 2.211 . . . . 0.0 112.151 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.821 HG21 ' CE1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.45 -29.58 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.201 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 138' ' ' ASP . 50.3 m80 -62.76 -30.8 71.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.124 ' O ' ' OE2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -66.02 -56.51 11.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.976 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.17 -37.78 62.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.168 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 113' ' ' ILE . 71.5 mt -58.71 -43.13 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.465 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -64.73 -15.28 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.472 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 1.124 ' OE2' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -93.7 -56.12 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 94.79 24.27 18.23 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.106 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.562 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 82.3 m-70 -55.14 -157.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.624 0.25 . . . . 0.0 110.693 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -102.24 -95.96 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.455 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 29.8 t -73.05 -19.22 61.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.325 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.562 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -56.71 -69.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.048 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 156' ' ' LEU . 18.0 t -52.12 -46.32 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.883 ' CB ' HG21 ' A' ' 159' ' ' ILE . 4.9 p -66.67 -32.69 74.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.783 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 86.6 t80 -73.03 -43.47 62.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.4 OUTLIER -65.42 -11.22 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.073 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.673 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -67.69 -62.51 3.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.673 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 27.0 Cg_endo -61.75 -52.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.845 2.363 . . . . 0.0 112.352 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.783 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 3.9 mt-10 -51.88 -25.74 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.7 m -108.46 137.29 46.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.268 ' OD1' ' HB3' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -35.64 103.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.81 HD13 ' HA ' ' A' ' 164' ' ' MET . 11.1 mt -61.4 134.14 56.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.937 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 1.9 t-160 86.17 14.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 1.268 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 4.6 p-80 -64.33 168.95 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.87 166.04 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -140.65 148.64 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.664 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -41.38 -28.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.17 0.51 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -34.35 73.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.782 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 93.22 45.07 3.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -153.71 158.05 40.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 111.037 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -108.59 167.97 8.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.565 ' C ' HD12 ' A' ' 160' ' ' LEU . 99.3 Cg_exo -40.59 -50.19 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.827 2.352 . . . . 0.0 112.524 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.866 HD11 ' CG ' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -62.25 -43.77 98.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -56.01 -64.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.72 -39.25 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.703 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.539 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -69.3 -27.7 65.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.621 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -70.73 -54.35 12.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.617 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -59.69 -67.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.01 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 153' ' ' ALA . 6.1 ttt180 -73.81 59.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.57 52.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.925 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.876 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -37.79 -31.22 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.159 0.504 . . . . 0.0 110.15 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.876 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 170.35 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.823 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.545 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.3 p30 -76.54 13.16 1.03 Allowed 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.111 -0.368 . . . . 0.0 111.646 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mt -51.56 -66.65 0.35 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.5 ptm -52.88 -20.81 3.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.69 -63.97 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.489 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.883 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -52.81 -27.71 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 0.0 110.81 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.32 -40.89 64.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.866 ' CG ' HD11 ' A' ' 145' ' ' LEU . 3.1 mt-30 -72.95 -40.53 65.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.005 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.68 37.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 -46.64 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.011 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.81 ' HA ' HD13 ' A' ' 134' ' ' LEU . 3.7 ttp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.579 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 22.5 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' ALA . . . -38.99 -32.65 0.19 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.574 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 18.8 t0 -117.74 28.08 8.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 111.032 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -96.63 -62.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.802 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -71.86 -42.39 66.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.7 m -57.16 -36.23 70.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -67.12 -52.1 34.48 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.362 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.79 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -60.17 -51.21 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 111.026 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.59 69.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.59 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 2.3 mmm180 -73.56 0.11 13.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.216 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.557 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 50.49 66.25 2.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.631 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.2 p-10 -132.79 95.23 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 110.819 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.1 p -52.55 -22.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.73 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . 4.2 mm100 -73.05 -59.0 2.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.848 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.872 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.28 -17.84 61.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.155 HG12 ' CD ' ' A' ' 61' ' ' GLU . 3.1 t -65.36 -67.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.2 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.931 ' CA ' ' OE2' ' A' ' 61' ' ' GLU . 3.9 ptt-85 -73.17 -38.15 66.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.897 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.594 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -61.87 -27.55 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.797 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.272 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 12.0 mt -73.69 -62.08 1.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 0.0 111.981 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 65' ' ' GLN . 2.3 mt -65.56 -53.24 44.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -72.98 -3.35 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -138.36 -78.71 0.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.038 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 1.272 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 1.1 tt0 -41.43 -27.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' LEU . 41.6 tp 65.67 73.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 36' ' ' HIS . 80.1 t -122.5 159.74 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.056 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.543 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -74.64 145.06 81.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB3' ' CG ' ' A' ' 65' ' ' GLN . 38.2 Cg_endo -66.86 -29.49 41.62 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.722 2.282 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.671 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -82.52 -67.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 10' ' ' VAL . . . 35.84 87.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 45' ' ' LYS . 5.2 mp -92.54 140.18 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -67.72 88.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER 86.78 19.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t80 65.84 52.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.99 -73.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.499 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.7 mtpt -86.13 148.86 25.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 71' ' ' VAL . 1.1 p -87.09 150.14 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -52.89 -36.61 59.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.934 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 2.1 mt -73.28 -26.75 61.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.73 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.469 HE21 HG23 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 15' ' ' SER . 15.8 m -93.11 -18.8 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.746 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 1.3 tmm? -44.2 145.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.557 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.68 12.9 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.853 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 7.3 m-85 56.29 -80.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.66 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 31.94 -93.71 0.01 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.677 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.8 m -67.71 130.56 92.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.483 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 56.1 Cg_endo -71.0 -27.9 19.96 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.715 2.276 . . . . 0.0 111.828 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' C ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.38 -36.37 83.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.01 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.041 HG12 HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.47 -34.18 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -62.7 -58.04 8.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.824 HD23 ' O ' ' A' ' 60' ' ' LEU . 6.7 tt -63.27 -33.03 74.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.794 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.155 ' CD ' HG12 ' A' ' 26' ' ' VAL . 8.1 mt-10 -63.03 -60.26 3.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 5.6 mp -62.81 -46.91 85.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.17 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -63.16 -58.77 6.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 7.2 tmtt? -62.92 -23.79 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.131 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HG2' HD22 ' A' ' 30' ' ' LEU . 24.8 tp60 -74.4 -20.02 60.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.999 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 37' ' ' PRO . . . 120.53 50.35 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.04 159.81 21.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -126.21 120.44 23.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.986 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' VAL . 70.0 Cg_endo -74.68 -17.67 20.23 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.78 60.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 69' ' ' PRO . 4.3 m -134.89 126.67 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' N ' ' A' ' 77' ' ' THR . 2.7 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.488 ' N ' ' HB3' ' A' ' 72' ' ' GLN . 17.2 m -137.8 100.69 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -68.99 173.45 3.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 -34.04 75.2 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.835 2.357 . . . . 0.0 112.116 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -54.98 -38.43 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -59.66 -65.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.989 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.933 ' OD1' ' C ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -57.99 -37.36 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.286 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.9 -42.97 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.248 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.64 -55.81 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.795 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -61.62 -27.68 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.4 p -70.8 -70.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.55 64.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 18.7 m-85 -136.26 49.75 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.751 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.7 tm? -52.28 -45.78 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.498 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -66.2 0.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.863 0.363 . . . . 0.0 110.8 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 56' ' ' PRO . 18.0 m -65.33 -44.58 87.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' HB1' ' A' ' 83' ' ' ALA . 22.6 tp -52.71 -48.76 66.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.778 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -52.13 -32.29 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.811 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -74.45 -55.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.94 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 3.8 pp -74.33 -47.8 32.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.679 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.912 HG23 HG12 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -59.4 -36.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.552 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.778 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.87 -28.39 62.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -55.97 -37.42 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 160.08 -19.81 0.24 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.669 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -33.63 115.16 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.607 ' O ' HG21 ' A' ' 80' ' ' VAL . 1.2 p30 -48.8 113.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 100' ' ' ALA . 6.1 m -106.24 26.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' HA ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.41 -35.93 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.74 145.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.931 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.64 -151.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -140.67 -77.17 0.31 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -57.85 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 1.128 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -63.41 -12.42 30.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.695 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.821 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 72.53 17.49 77.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 138' ' ' ASP . 1.4 t -77.38 123.15 26.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.931 HD12 HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -70.96 157.79 89.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.817 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HB2' HD11 ' A' ' 128' ' ' LEU . 71.5 Cg_exo -48.74 -38.54 37.45 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.616 2.211 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HB ' HD12 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.88 -40.97 79.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.086 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' ARG . 22.0 m80 -52.66 -37.87 59.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.637 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 118' ' ' ARG . 9.9 mt -72.84 -50.02 26.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -37.1 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.936 HG21 ' HB3' ' A' ' 147' ' ' LEU . 95.0 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -72.99 -9.87 59.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.772 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.795 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -91.93 -57.94 2.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.674 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.28 41.49 3.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.861 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 9.8 m-70 -82.22 -1.75 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.87 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m 65.86 -81.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.54 ' CB ' ' HG ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -54.83 -52.74 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.981 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 116' ' ' ALA . 51.6 t -55.31 -60.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.345 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 116' ' ' ALA . 3.8 t -52.13 -60.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.372 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.682 ' CB ' HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.46 -27.55 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.64 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 11.7 t80 -73.64 -51.4 16.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HB ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.95 -7.49 22.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.258 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.891 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -58.41 -69.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.265 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.891 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.3 Cg_endo -70.49 -28.69 21.42 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.72 2.28 . . . . 0.0 112.487 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 102' ' ' VAL . 3.3 mm-40 -68.01 -18.14 64.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.497 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 3.8 m -116.88 157.8 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.71 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -44.19 113.96 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.4 mt -85.48 43.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.73 30.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -138.53 155.83 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.543 ' HA ' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -130.13 -172.65 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 1.128 ' OD1' ' O ' ' A' ' 108' ' ' THR . 1.5 t70 -82.97 -174.68 5.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' ' CG ' ' A' ' 138' ' ' ASP . . . -77.94 -4.99 49.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.042 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -46.75 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.761 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . 124.66 80.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.621 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 141' ' ' GLY . 28.5 mt -161.92 107.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.2 p -77.44 150.44 79.7 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.801 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.704 ' O ' HD22 ' A' ' 160' ' ' LEU . 82.1 Cg_exo -45.43 -31.56 6.87 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.604 2.203 . . . . 0.0 112.206 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.771 HD12 ' CE ' ' A' ' 164' ' ' MET . 0.4 OUTLIER -73.32 -47.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.94 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.047 ' OE1' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.34 -50.92 63.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.209 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.936 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.59 -26.93 14.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.391 . . . . 0.0 110.677 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -73.67 -23.71 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -49.22 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -60.92 -72.79 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -73.18 60.98 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.81 47.92 0.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.085 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -36.92 -57.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.441 0.638 . . . . 0.0 110.052 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.426 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -145.37 -146.51 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.548 179.031 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 1.103 ' HB2' ' CG ' ' A' ' 158' ' ' ASP . 17.6 p30 -73.36 53.63 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.848 ' HA ' HD12 ' A' ' 159' ' ' ILE . 6.3 mt -65.14 -66.29 0.56 Allowed 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.574 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 2.7 ppp? -51.44 -20.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.103 ' CG ' ' HB2' ' A' ' 155' ' ' ASN . 7.9 p-10 -73.72 -42.42 61.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.025 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.47 -40.24 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 144' ' ' PRO . 5.4 mp -73.12 -40.17 65.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -63.51 -47.33 82.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.78 -44.32 92.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.38 -12.29 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.909 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.9 mtp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.97 HG13 HG12 ' A' ' 35' ' ' VAL . 66.6 t . . . . . 0 N--CA 1.465 0.313 0 CA-C-O 120.853 0.358 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.742 ' CA ' ' HB1' ' A' ' 39' ' ' ALA . . . -65.94 -9.52 47.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.687 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -117.85 18.46 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tpt85 -122.62 -53.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.2 tp -70.01 -43.72 70.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.754 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.705 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.99 -31.41 63.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.87 -53.33 8.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.398 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -57.57 -58.76 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.96 67.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.48 -28.48 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.438 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 1.375 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -73.6 0.66 12.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.249 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 50.73 78.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.375 ' OD2' ' CG ' ' A' ' 20' ' ' ARG . 2.6 p30 -152.63 97.15 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.598 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.927 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.1 p -52.83 -25.18 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.66 -49.99 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.004 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -73.25 -39.75 65.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.57 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 58' ' ' VAL . 8.8 p -52.42 -42.15 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 67.1 mtp85 -72.91 -50.75 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 3.5 mmp_? -52.61 -30.63 32.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.753 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.64 -74.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.172 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' HG2' ' A' ' 65' ' ' GLN . 3.5 mt -74.31 -42.91 58.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -67.54 -4.56 11.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 9.4 tpt180 -149.51 -77.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.646 0.26 . . . . 0.0 111.311 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.852 ' OE1' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -41.69 -26.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 34' ' ' LEU . 3.6 tp 66.27 83.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.97 HG12 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -111.84 134.92 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.529 ' H ' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -71.26 129.56 88.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.689 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HG3' ' A' ' 65' ' ' GLN . 49.1 Cg_endo -69.17 -15.67 39.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.745 2.297 . . . . 0.0 112.239 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 6.7 t0 -83.57 -28.47 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.962 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.742 ' HB1' ' CA ' ' A' ' 11' ' ' GLY . . . -43.52 157.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.489 ' N ' ' HA3' ' A' ' 11' ' ' GLY . 2.9 mp -143.34 142.47 31.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.263 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 22.3 p30 -71.4 169.38 15.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -39.85 -34.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.833 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -62.05 -52.92 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.45 33.44 1.21 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 10.9 mtpt -109.99 170.83 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.789 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 p -98.94 166.58 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -58.32 -46.37 86.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -64.79 -34.26 77.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.5 tp60 -73.43 -45.75 52.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 46' ' ' THR . 15.7 m -72.97 -39.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.657 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 53' ' ' PHE . 2.7 ppp? -35.26 148.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.038 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 54' ' ' GLY . 2.5 ptm -111.14 22.79 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.159 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.13 ' CE2' HD21 ' A' ' 95' ' ' LEU . 56.3 m-85 50.19 -87.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.347 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 34.46 -94.35 0.01 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.413 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.622 ' C ' HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -53.54 156.26 4.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 1.041 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 93.8 Cg_endo -89.17 -52.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.961 2.441 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.927 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -62.99 -23.15 67.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.773 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.9 p -62.32 -45.46 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.12 -48.89 76.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -62.48 -48.88 77.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.18 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -62.67 -58.07 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.76 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.86 -49.68 73.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD12 ' C ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -63.11 -44.36 95.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 111.214 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.64 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.5 ttpp -62.74 -31.0 71.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.756 ' HG2' HD22 ' A' ' 30' ' ' LEU . 31.6 tp60 -45.66 -29.42 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.1 -19.14 2.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.41 152.46 11.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 13.0 m -105.99 126.66 30.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.979 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HA ' ' HG ' ' A' ' 48' ' ' LEU . 44.4 Cg_endo -68.57 -4.29 12.78 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.737 2.291 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -98.4 64.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' SER . 31.4 m -116.88 125.7 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.08 83.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 1.7 m -84.71 166.95 29.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 1.263 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 79.5 Cg_exo -47.81 -33.79 20.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 81' ' ' HIS . 0.5 OUTLIER -54.8 -42.15 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.014 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.571 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 15.7 m80 -70.07 -48.41 57.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.032 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.263 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.3 p30 -55.79 -50.45 70.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.259 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.66 -48.77 66.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 128' ' ' LEU . . . -64.14 -49.93 70.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.234 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -37.9 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ASP . 58.5 p -67.82 -27.44 66.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 81.06 73.6 1.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -153.64 58.4 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.821 HD11 ' CG ' ' A' ' 127' ' ' PHE . 61.7 tp -53.87 -16.7 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.673 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.041 ' OD2' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.78 -74.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.803 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -73.65 -33.25 64.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.766 ' C ' HD23 ' A' ' 92' ' ' LEU . 2.0 tt -52.38 -56.91 11.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 1.215 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -56.64 -34.27 67.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 91' ' ' THR . 54.7 t -56.29 -62.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.13 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.43 -32.61 64.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 19.8 t -70.81 -46.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.215 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -56.08 -32.38 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.967 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.57 63.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.11 -68.47 0.44 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 69' ' ' PRO . . . 43.62 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -111.8 64.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.469 ' CG1' HG13 ' A' ' 96' ' ' VAL . 6.7 m -79.88 5.88 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.29 24.85 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -119.82 128.4 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.556 HD13 ' CA ' ' A' ' 109' ' ' GLY . 7.1 mt -85.49 162.38 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.669 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -88.39 -84.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 t -131.61 -45.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.03 7.27 11.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 70.77 10.75 68.2 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.554 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' A' ' 138' ' ' ASP . 73.6 p -78.89 92.46 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 111.044 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.72 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -36.24 146.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD23 ' A' ' 111' ' ' LEU . 99.2 Cg_exo -43.08 -28.44 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.409 2.073 . . . . 0.0 112.113 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.683 ' N ' HD22 ' A' ' 128' ' ' LEU . 1.9 tp -73.4 -35.34 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.56 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 56.6 m80 -57.68 -43.73 85.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -58.75 -42.97 90.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.476 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.647 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -54.59 -48.9 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.569 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 147' ' ' LEU . 93.8 mt -56.0 -40.83 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HE ' HD21 ' A' ' 147' ' ' LEU . 3.0 mmt85 -62.41 -21.44 65.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.32 -54.87 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 116.26 -6.61 19.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.519 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.679 ' O ' HG23 ' A' ' 125' ' ' VAL . 98.2 m-70 -51.1 85.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' GLY . 18.0 p -38.88 -38.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 124' ' ' VAL . 1.9 p -73.17 -63.89 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 39.3 t -55.54 -57.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.361 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 121' ' ' HIS . 3.6 t -51.93 -54.09 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.961 ' HB2' HG21 ' A' ' 159' ' ' ILE . 44.0 t -63.74 -31.7 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.406 . . . . 0.0 111.11 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.821 ' CG ' HD11 ' A' ' 89' ' ' LEU . 71.3 t80 -73.1 -47.59 43.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -67.89 -8.96 40.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.29 -64.0 2.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 43.7 Cg_endo -67.88 -46.29 2.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 4.2 mm-40 -51.59 -47.09 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.506 ' HB3' HD22 ' A' ' 111' ' ' LEU . 27.8 m -77.67 132.26 38.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' ND1' ' A' ' 136' ' ' HIS . 1.2 m-20 -36.14 96.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.772 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.7 mt -56.08 146.77 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.2 t-160 87.64 -21.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.672 ' CG ' HD13 ' A' ' 111' ' ' LEU . 2.0 p-80 -42.85 167.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.015 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -122.27 -172.62 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.56 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -130.0 159.17 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -10.6 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 p -109.27 -24.04 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.786 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.11 28.92 3.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.633 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.419 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 34.4 mt -102.77 -179.35 3.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -169.8 177.01 1.16 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.6 Cg_exo -49.93 -58.76 1.52 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.641 2.228 . . . . 0.0 112.119 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 161' ' ' GLN . 2.2 mt -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.419 ' OE1' ' CD2' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -54.84 -59.63 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.54 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -52.88 -51.86 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.411 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.8 -36.21 57.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.135 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.438 HH12 HD22 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -63.3 -31.24 72.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -79.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.131 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.59 ' O ' HD11 ' A' ' 156' ' ' LEU . 4.5 mtt85 -74.06 75.08 1.73 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.84 55.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.082 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 1.017 ' HB3' HD22 ' A' ' 156' ' ' LEU . . . -59.32 -18.68 40.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 1.229 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 7.5 tp-100 102.76 -85.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.858 0.724 . . . . 0.0 112.834 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.986 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -54.99 -42.87 72.98 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 153' ' ' ALA . 1.7 pt? -51.87 -53.84 36.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.573 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.2 ptm -60.28 -36.3 77.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD1' ' O ' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -73.55 -25.2 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.716 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.961 HG21 ' HB2' ' A' ' 126' ' ' SER . 18.8 mt -73.28 -42.06 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.238 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.847 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -73.48 -53.55 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.718 -179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.654 ' HB3' HD21 ' A' ' 145' ' ' LEU . 1.0 OUTLIER -52.37 -25.29 9.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.906 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 161' ' ' GLN . . . -73.31 -54.79 6.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.291 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.14 -49.23 29.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.772 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 tmm? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.85 0.357 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.615 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -71.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 1.271 ' OD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -49.86 -22.48 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 1.171 ' HG2' ' OE2' ' A' ' 33' ' ' GLU . 1.9 tpt180 -61.91 -65.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -71.73 -45.42 61.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -35.93 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.93 -49.47 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.456 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.36 -43.96 75.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.64 -50.86 22.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.32 80.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -19.59 62.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 69.66 60.23 5.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.464 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.753 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 3.6 p30 -125.77 92.88 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 10.3 p -52.75 -20.71 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.842 ' C ' ' OE1' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -74.0 -53.9 9.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.264 ' OE1' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -73.39 -33.43 65.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.82 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.7 p -52.78 -50.8 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 0.0 111.306 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.634 ' CB ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.21 -50.52 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.163 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 8.2 ttt180 -56.41 -25.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.005 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.36 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.81 HD22 ' CD ' ' A' ' 65' ' ' GLN . 3.5 mt -73.67 -40.15 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' CB ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -72.64 -1.59 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.321 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -144.73 -70.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.743 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 1.171 ' OE2' ' HG2' ' A' ' 13' ' ' ARG . 1.2 tt0 -61.67 -15.1 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 47.44 76.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.937 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 14' ' ' LEU . 6.7 t -100.4 159.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -88.27 142.44 31.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.971 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.503 ' HD3' ' NE2' ' A' ' 65' ' ' GLN . 11.6 Cg_endo -54.77 -39.95 87.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.072 2.515 . . . . 0.0 112.296 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 59.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -107.68 121.37 44.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.856 HD12 ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.99 170.74 9.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 1.271 ' CB ' ' OD1' ' A' ' 12' ' ' ASP . 15.9 p30 -124.41 -170.79 2.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.57 -30.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -69.02 -52.12 31.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.93 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.76 ' O ' HD23 ' A' ' 40' ' ' LEU . . . 108.16 18.39 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 40' ' ' LEU . 15.0 mttp -102.47 167.66 9.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.775 ' O ' HG12 ' A' ' 50' ' ' VAL . 28.1 p -85.12 162.79 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -54.75 -44.44 73.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.664 ' CD1' HD11 ' A' ' 62' ' ' LEU . 5.1 tp -63.76 -51.19 66.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.043 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -54.34 -70.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 46' ' ' THR . 7.8 p -56.69 -23.99 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.919 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -36.6 132.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 3.4 ptt? -93.48 13.64 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.911 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.8 OUTLIER 43.72 26.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.888 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.86 -67.91 1.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.18 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 91' ' ' THR . 0.4 OUTLIER -93.24 141.85 24.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 0.0 110.516 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.473 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 52.2 Cg_endo -68.55 -43.2 4.24 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.636 2.224 . . . . 0.0 111.975 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.2 -32.73 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.697 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.745 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.3 t -62.48 -31.88 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 121.145 0.498 . . . . 0.0 109.79 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.857 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.03 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.177 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.14 -28.86 70.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.274 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -63.02 -71.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -63.35 -27.46 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -62.78 -62.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -19.03 63.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.81 ' CD ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.07 -24.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.95 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.15 0.39 5.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.57 -173.89 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.46 130.45 9.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -14.19 35.33 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.764 2.309 . . . . 0.0 112.373 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 23.5 m120 -82.36 74.8 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 28.4 m -130.08 138.21 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.007 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 1.29 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.889 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 5.7 m -101.77 69.57 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -73.38 170.89 12.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 10.2 Cg_endo -53.67 -40.5 79.31 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.835 2.356 . . . . 0.0 112.321 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.26 -25.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -67.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.766 ' O ' HG23 ' A' ' 86' ' ' THR . 43.8 p30 -60.66 -26.35 67.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.893 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.25 -52.79 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.273 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -72.81 -29.05 62.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.766 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.1 p -69.41 -6.1 27.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.41 74.97 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.39 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -161.11 59.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' CG ' ' A' ' 127' ' ' PHE . 2.1 tm? -53.6 -28.93 35.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.75 -67.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.694 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.857 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 17.5 m -70.66 -23.39 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.764 ' C ' HD23 ' A' ' 92' ' ' LEU . 1.7 tt -72.83 -42.87 63.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 1.305 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 6.6 ptpt -67.87 -32.44 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.67 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.338 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 1.3 m -64.9 -54.35 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.491 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.5 pp -74.01 -33.39 63.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.808 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 42.3 t -73.04 -53.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.254 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.338 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 1.2 pm0 -52.72 -31.6 38.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.889 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.471 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -57.65 -19.43 26.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.3 6.71 5.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -50.16 132.5 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 2.9 p30 -43.94 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -99.06 22.55 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.144 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.614 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -128.29 14.29 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.721 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.64 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -89.82 161.65 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -141.64 -179.69 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 1.29 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 1.7 m-20 -121.11 -155.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -57.83 7.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -33.45 73.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.017 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.39 66.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.503 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.54 ' O ' HD11 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -61.3 113.76 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.67 150.1 68.47 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.732 ' HD2' HD23 ' A' ' 111' ' ' LEU . 98.8 Cg_exo -42.71 -31.85 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.829 2.353 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.79 ' HA ' HD21 ' A' ' 128' ' ' LEU . 3.3 tp -72.37 -39.32 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.11 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 36.3 m80 -61.38 -35.18 76.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 115' ' ' LEU . 5.1 mp -69.1 -50.49 47.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.619 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -54.18 -37.45 64.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 147' ' ' LEU . 94.5 mt -62.23 -43.76 98.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.299 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 11.9 mtp180 -61.48 -16.22 45.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.313 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 3.7 mt-10 -105.3 -49.81 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 81.07 29.48 41.39 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.116 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.601 ' CB ' HG21 ' A' ' 124' ' ' VAL . 68.6 m-70 -51.5 -169.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 121' ' ' HIS . 91.6 p -57.56 -130.69 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.729 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 1.54 9.76 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.223 -0.298 . . . . 0.0 111.441 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -54.39 -68.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.852 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.7 t -52.18 -32.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.786 ' HB2' HG21 ' A' ' 159' ' ' ILE . 13.8 t -73.53 -56.87 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.787 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 1.097 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 5.0 t80 -67.97 -47.06 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.762 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -66.4 -7.5 19.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.877 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -73.12 -60.7 1.71 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.37 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.4 Cg_endo -59.45 -64.27 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.831 2.354 . . . . 0.0 112.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.097 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -43.8 -26.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.594 ' OG ' HD22 ' A' ' 111' ' ' LEU . 6.0 t -89.5 133.86 34.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.661 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 3.2 p-10 -38.05 93.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.657 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.6 mt -63.88 69.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER 178.34 -42.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.017 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.661 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.8 OUTLIER -54.06 154.41 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.91 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HD3' ' NE2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -140.91 -148.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.783 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.457 ' N ' ' HD2' ' A' ' 137' ' ' ARG . 0.7 OUTLIER -160.91 -162.72 0.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.65 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.33 -22.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.172 0.511 . . . . 0.0 110.612 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -62.38 -52.68 62.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.89 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.36 20.73 58.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.748 ' O ' HG23 ' A' ' 143' ' ' THR . 1.4 mt -106.6 -105.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.551 0.175 . . . . 0.0 110.807 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.253 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER 160.52 167.83 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.8 0.333 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 3.8 Cg_endo -47.41 -57.56 2.25 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 123.022 2.481 . . . . 0.0 112.088 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -66.12 -44.75 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.253 ' CD ' ' OG1' ' A' ' 143' ' ' THR . 4.0 mp0 -55.53 -51.12 68.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.531 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.691 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -53.04 -43.34 66.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 110.171 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.834 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.85 -36.42 58.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -35.61 78.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.627 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -74.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.248 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.719 ' O ' HD21 ' A' ' 156' ' ' LEU . 10.8 mmm180 -73.97 70.59 1.51 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.29 52.0 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.909 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.905 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -57.17 -16.6 8.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.513 0.196 . . . . 0.0 110.535 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 7.0 tp-100 101.79 -59.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.659 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.494 ' C ' HD12 ' A' ' 159' ' ' ILE . 4.8 m-20 -72.6 -54.73 8.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.0 111.512 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.905 ' HG ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -53.05 -16.78 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.946 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.834 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 14.4 mtp -74.74 -60.37 2.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.858 0.361 . . . . 0.0 111.603 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.071 -179.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.786 HG21 ' HB2' ' A' ' 126' ' ' SER . 60.0 mt -52.74 -55.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.673 0.273 . . . . 0.0 111.366 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.8 OUTLIER -73.64 -31.12 63.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.34 -179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.845 ' HG2' HD13 ' A' ' 145' ' ' LEU . 1.3 mm-40 -62.94 -42.64 99.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -36.14 57.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.403 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -70.18 -31.73 69.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.502 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 35' ' ' VAL . 13.1 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.917 0.389 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -46.47 -57.59 6.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.444 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -84.21 54.68 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -127.86 -66.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 29' ' ' LEU . 29.0 tp -67.23 -33.92 76.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.008 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -61.89 -39.18 91.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -31.63 75.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.9 -59.67 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 111.153 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . . . -54.28 -48.62 71.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 50' ' ' VAL . . . -64.24 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -72.61 -37.65 68.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.85 73.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.37 83.78 1.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -52.65 -22.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -74.11 -49.67 22.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.565 ' O ' HD23 ' A' ' 29' ' ' LEU . 55.8 mm-40 -73.84 -27.3 61.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.845 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.686 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -52.76 -51.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.53 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.559 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.2 mtm180 -73.28 -43.09 61.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 19.7 mmt180 -63.5 -34.21 77.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -53.47 -71.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.856 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -69.68 -49.36 54.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.012 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -66.72 -25.83 66.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.93 -58.66 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.555 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.3 tp10 -67.35 -7.14 22.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.06 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER 42.46 28.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.7 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -66.76 148.85 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -67.62 131.03 92.97 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.98 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 57.5 Cg_endo -71.07 -22.42 26.19 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.852 2.368 . . . . 0.0 112.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -99.55 18.68 17.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -62.18 107.59 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.3 mp -89.82 145.22 25.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 54.2 p30 -80.93 -171.37 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -70.56 58.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -172.52 -43.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.58 60.14 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.594 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -141.08 145.64 36.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 50' ' ' VAL . 20.9 p -85.57 155.9 20.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -55.27 -24.24 27.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 69' ' ' PRO . 3.8 mt -72.9 -49.65 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 78' ' ' SER . 1.8 tp-100 -63.88 -28.29 69.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 19' ' ' ALA . 28.9 m -96.23 -14.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HE1' ' CD2' ' A' ' 95' ' ' LEU . 1.2 ttp -44.64 154.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -109.72 23.51 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.73 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 35.84 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -72.39 -85.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.314 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.1 m -77.91 120.31 80.79 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.37 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.791 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.9 Cg_exo -51.1 -43.48 48.05 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.472 2.115 . . . . 0.0 112.08 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.61 -28.51 69.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.644 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.2 t -62.27 -41.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.647 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.65 -50.18 70.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.641 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.5 tp -63.14 -40.19 96.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.712 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -63.04 -43.24 99.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 62' ' ' LEU . 6.0 mt -62.81 -56.92 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 69' ' ' PRO . 5.8 mt -63.12 -31.31 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 4.2 mmtt -63.36 -46.27 87.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -56.57 -27.2 57.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.969 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.39 47.88 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.436 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -109.25 123.58 49.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.903 0.382 . . . . 0.0 111.039 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 124.86 83.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.692 ' HB3' HD21 ' A' ' 63' ' ' LEU . 59.3 Cg_endo -72.42 -38.61 3.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.727 2.285 . . . . 0.0 112.302 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.01 101.48 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 11.6 m -139.41 132.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' HG3' ' C ' ' A' ' 71' ' ' VAL . 49.5 mt-30 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.3 m -124.97 144.79 50.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.524 ' HA ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -144.41 177.97 1.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 77.6 Cg_exo -49.61 -47.56 22.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.656 2.238 . . . . 0.0 112.288 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.69 HG23 HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.57 -38.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -59.31 -70.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.204 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.03 -33.31 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.81 -52.44 56.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.41 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -64.97 -46.56 80.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.441 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -72.21 -24.36 61.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.355 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 82' ' ' ASP . 11.5 p -73.11 -73.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.124 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 126.75 63.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.997 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -148.38 57.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.678 HD13 ' O ' ' A' ' 89' ' ' LEU . 2.7 tm? -52.11 -19.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 4.5 m-20 -60.36 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 56' ' ' PRO . 2.4 m -73.37 -27.55 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.755 ' C ' HD23 ' A' ' 92' ' ' LEU . 3.1 tt -56.54 -57.52 11.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.988 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.65 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.07 -32.22 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.807 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 23.7 t -57.71 -65.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.6 pp -70.41 -29.33 65.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.429 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 80' ' ' VAL . 23.5 t -72.55 -40.31 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.807 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 4.5 pm0 -72.82 -25.75 61.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -61.07 -62.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -176.74 -30.35 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.868 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 99' ' ' GLY . . . -31.8 118.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.351 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.23 119.27 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 131' ' ' GLU . 5.3 p -110.84 20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -136.62 27.88 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.634 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -107.92 130.99 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.064 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -97.49 162.61 13.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.091 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 51.9 p-10 -85.31 53.07 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 106' ' ' ASP . 8.4 t 80.42 -62.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -42.04 -28.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.003 0.43 . . . . 0.0 110.048 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 88.45 31.69 13.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.57 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.542 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -101.8 96.87 7.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 105' ' ' LEU . 10.6 tp -34.89 135.35 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -45.92 -29.25 5.76 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.734 2.29 . . . . 0.0 112.452 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' C ' ' A' ' 128' ' ' LEU . 4.5 tt -73.06 -35.7 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -52.84 -37.66 60.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -68.64 -46.55 68.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.615 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.668 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . . . -56.29 -41.64 76.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.257 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.757 ' HA ' HG11 ' A' ' 125' ' ' VAL . 85.5 mt -57.64 -38.04 62.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.595 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 2.3 mtp180 -66.22 -17.44 64.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -98.95 -50.94 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.76 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.84 40.96 6.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 123' ' ' SER . 23.9 m-70 -72.95 -3.04 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.722 0.296 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER 63.0 -70.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.791 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 121' ' ' HIS . 32.5 m -55.98 -41.61 75.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 84' ' ' ALA . 51.9 t -73.19 -61.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.757 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.28 -51.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.732 ' CB ' HG21 ' A' ' 159' ' ' ILE . 83.7 p -56.57 -42.68 79.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.04 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.653 ' CG ' HD21 ' A' ' 89' ' ' LEU . 72.8 t80 -73.41 -37.61 65.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.853 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -71.97 -2.64 18.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.28 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.849 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -69.19 -71.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.226 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.849 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 37.5 Cg_endo -66.96 -57.63 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.614 2.21 . . . . 0.0 112.336 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 6.6 mm-40 -39.63 -37.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.483 ' OG ' HD13 ' A' ' 128' ' ' LEU . 9.7 m -96.38 133.4 40.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.786 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.32 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -36.51 107.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.549 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 164' ' ' MET . 31.0 mt -72.89 -1.31 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.268 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.05 24.09 13.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 1.32 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 4.4 t60 -107.27 171.1 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.785 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -159.94 157.38 28.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 141' ' ' GLY . 6.7 t0 -77.57 157.89 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.486 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.7 -27.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 109.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -40.64 62.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.657 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 114.11 35.85 1.44 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.39 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 147' ' ' LEU . 67.8 mt -93.92 -167.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -178.35 165.28 1.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 143' ' ' THR . 99.4 Cg_exo -42.61 -56.83 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.619 2.213 . . . . 0.0 111.886 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 161' ' ' GLN . 6.3 mt -72.03 -42.74 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 142' ' ' LEU . 3.6 tp10 -55.56 -69.78 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 142' ' ' LEU . 21.9 tp -52.73 -38.17 60.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 109.914 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 144' ' ' PRO . . . -54.14 -44.63 71.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.036 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.473 ' N ' ' SD ' ' A' ' 157' ' ' MET . 1.9 tpm_? -58.57 -23.36 58.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 1.4 tt0 -71.9 -75.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.87 ' O ' HD11 ' A' ' 156' ' ' LEU . 5.6 mmm180 -74.06 74.43 1.72 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.88 55.81 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.582 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 155' ' ' ASN . . . -69.88 -13.26 62.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.756 0.313 . . . . 0.0 110.748 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 8.2 tp-100 88.39 -37.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.98 ' OD1' HD23 ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.51 -64.89 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.252 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.98 HD23 ' OD1' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -52.01 -55.02 23.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.291 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 34.5 mmm -50.98 -28.19 9.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 154' ' ' GLN . 30.9 t0 -75.31 -71.04 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.708 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.732 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -53.05 -40.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.232 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 156' ' ' LEU . 6.5 mp -73.68 -14.75 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.725 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.37 -61.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.38 -48.69 50.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.301 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -53.93 -18.96 3.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 134' ' ' LEU . 6.9 mmm . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.769 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -81.9 -60.91 2.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.521 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -10.77 26.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -98.66 -70.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -72.22 -61.36 1.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.1 t -55.81 -25.8 43.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.18 -50.69 11.73 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.745 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.51 -47.42 48.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 111.223 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.918 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.87 -39.67 62.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.024 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.34 -41.45 63.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.304 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' CD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.63 -22.14 66.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.68 59.47 3.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.898 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.247 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 16.5 t0 -109.29 90.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.643 0.259 . . . . 0.0 110.374 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' CB ' ' A' ' 57' ' ' ALA . 3.4 p -51.92 -23.53 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.151 0.5 . . . . 0.0 110.255 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.14 -59.58 2.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.8 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.247 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 11.0 mm-40 -73.96 -28.19 61.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.613 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.972 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.7 p -52.41 -51.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.816 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.561 ' N ' HG13 ' A' ' 26' ' ' VAL . 19.6 mtp180 -74.48 -51.25 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -52.75 -36.74 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.11 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 9.2 mt -73.16 -74.33 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.685 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.808 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.16 -42.19 63.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -73.08 -1.68 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.27 -64.74 0.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 111.121 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.955 ' OE2' ' CG1' ' A' ' 35' ' ' VAL . 2.2 tt0 -62.51 -11.35 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tp 54.22 73.25 0.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.955 ' CG1' ' OE2' ' A' ' 33' ' ' GLU . 2.0 m -101.29 153.92 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' OD2' ' A' ' 38' ' ' ASP . 1.8 t-80 -74.83 126.6 88.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.55 1.03 7.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.786 2.324 . . . . 0.0 112.357 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 1.1 p-10 -111.86 53.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.33 177.21 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 3.8 mp -142.19 -173.87 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 43' ' ' PHE . 17.8 p-10 -150.9 166.7 29.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -35.17 -31.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -68.33 -47.63 67.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 110.13 16.12 10.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 11.5 mtpt -101.83 169.02 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.15 168.52 13.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -60.4 -55.01 38.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.42 -36.64 84.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.522 ' NE2' HG23 ' A' ' 71' ' ' VAL . 5.9 tp-100 -52.87 -66.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 46' ' ' THR . 7.1 p -70.09 -25.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.749 ' HG3' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -35.7 107.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 20' ' ' ARG . 2.8 ptt? -66.27 137.28 56.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.108 ' CE2' HD21 ' A' ' 95' ' ' LEU . 11.6 m-85 -82.64 47.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -86.36 -64.36 1.46 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.135 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.907 ' O ' HG12 ' A' ' 58' ' ' VAL . 5.2 m -98.36 111.52 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 1.026 ' CG ' ' OD1' ' A' ' 90' ' ' ASP . 76.1 Cg_exo -48.67 -23.5 5.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.449 2.1 . . . . 0.0 111.834 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.823 ' CB ' HG23 ' A' ' 23' ' ' VAL . . . -64.41 -43.45 94.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.112 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.972 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 p -61.94 -36.9 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.87 0.367 . . . . 0.0 110.549 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.8 -51.32 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.8 tt -63.29 -46.45 86.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.942 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE2' ' HG ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -62.56 -47.4 84.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.439 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.918 HD11 ' HB1' ' A' ' 18' ' ' ALA . 11.9 mt -62.73 -58.97 5.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -28.16 69.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.389 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 18.0 ttpt -62.77 -17.78 61.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.774 0.321 . . . . 0.0 111.084 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.731 ' HG2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -77.34 -67.49 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.15 37.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.54 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.52 -160.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 71' ' ' VAL . 32.1 m -123.7 124.1 26.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 74.2 Cg_endo -75.16 -17.23 19.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.783 2.322 . . . . 0.0 112.366 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -114.17 77.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG23 ' NE2' ' A' ' 49' ' ' GLN . 5.0 m -117.85 152.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.821 ' HA3' ' OD2' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -164.7 105.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.52 170.62 6.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.736 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 76.9 Cg_exo -49.66 -40.45 46.71 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.593 2.196 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 101' ' ' ASP . 7.6 m -59.05 -34.0 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -69.8 -62.36 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.76 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -53.1 -48.15 68.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.05 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.33 -27.71 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HA ' HG11 ' A' ' 124' ' ' VAL . . . -71.49 -62.42 1.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HA ' ' HG3' ' A' ' 119' ' ' GLU . 16.4 mtp180 -73.07 -28.13 62.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.8 p -69.82 -5.58 26.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.147 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 50.28 76.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.528 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 11.7 m-85 -150.4 56.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.54 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -52.56 -22.95 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.188 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.026 ' OD1' ' CG ' ' A' ' 56' ' ' PRO . 3.6 t70 -62.29 -74.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 110.647 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 43.2 m -70.71 -19.81 62.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.501 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 89' ' ' LEU . 2.8 tt -68.61 -55.3 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.511 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.6 -30.01 62.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.966 ' O ' ' OE2' ' A' ' 97' ' ' GLU . 78.8 t -59.98 -62.46 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.108 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.12 -28.78 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.471 . . . . 0.0 110.148 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.889 HG13 HG11 ' A' ' 102' ' ' VAL . 16.4 t -73.33 -44.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.966 ' OE2' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -68.1 -28.42 67.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.742 ' CG ' ' OE2' ' A' ' 97' ' ' GLU . 19.0 m-70 -60.06 -29.63 68.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.48 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.705 ' O ' HG13 ' A' ' 102' ' ' VAL . . . -95.81 143.56 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 111.108 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.465 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -56.1 84.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.889 HG11 HG13 ' A' ' 96' ' ' VAL . 11.7 m -88.66 11.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.557 ' OD1' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.16 37.92 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.962 ' C ' HD23 ' A' ' 105' ' ' LEU . . . -107.9 145.01 34.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.121 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -121.51 146.5 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.821 ' OD2' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -155.25 -53.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -48.16 -52.98 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.08 57.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 108' ' ' THR . . . 36.49 52.62 1.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.432 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 111' ' ' LEU . 48.0 m -134.49 110.9 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.97 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 136' ' ' HIS . 8.8 tp -35.01 140.53 0.29 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 88.1 Cg_exo -46.69 -32.26 11.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.767 2.311 . . . . 0.0 112.194 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 128' ' ' LEU . 1.6 tt -66.69 -37.44 79.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.553 ' HA ' HD12 ' A' ' 117' ' ' ILE . 73.8 m80 -59.3 -35.56 73.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -64.29 -53.07 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.415 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.72 -41.4 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 110.055 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.627 ' HA ' HG11 ' A' ' 125' ' ' VAL . 88.2 mt -52.81 -42.5 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.333 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -16.22 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 121' ' ' HIS . 3.8 mm-40 -86.46 -59.58 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.694 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.29 -0.35 14.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.603 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.887 ' O ' HG22 ' A' ' 125' ' ' VAL . 77.9 m-70 -61.44 73.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m -34.53 -33.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.57 -48.76 30.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.569 ' HA ' HD23 ' A' ' 89' ' ' LEU . 12.4 t -73.07 -50.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.411 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.887 HG22 ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -52.07 -52.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.548 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.1 t -69.04 -34.98 76.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.229 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.79 ' CD2' HD21 ' A' ' 89' ' ' LEU . 67.7 t80 -72.94 -35.83 67.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.088 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.28 -0.23 13.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.273 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.2 -69.41 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.306 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.5 Cg_endo -68.56 -57.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.633 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.487 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 24.0 mm-40 -39.28 -31.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.006 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 1.3 t -109.01 136.3 48.77 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 111' ' ' LEU . 1.3 p30 -35.37 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 164' ' ' MET . 12.6 mt -70.71 75.3 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER 173.14 -33.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.68 ' HB3' HD22 ' A' ' 111' ' ' LEU . 6.7 t60 -38.61 161.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 143' ' ' THR . 30.3 mtt180 -140.51 147.65 39.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.888 ' OD2' ' HB3' ' A' ' 140' ' ' SER . 0.3 OUTLIER -85.32 159.84 19.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.685 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 109.891 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.888 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . 0.1 OUTLIER -71.52 -56.1 6.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.833 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.51 12.62 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.701 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 2.7 mt -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.584 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -74.22 -178.67 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.695 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.0 Cg_exo -49.92 -49.87 14.87 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.837 2.358 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -67.99 -42.41 80.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.738 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.647 ' OE1' ' OE1' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -52.93 -60.16 3.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.037 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.84 -29.83 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.682 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 157' ' ' MET . . . -72.63 -24.08 61.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 146' ' ' GLU . 7.4 tmm_? -65.85 -51.03 62.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.647 ' OE1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.17 -71.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -74.18 58.3 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.29 52.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.433 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.718 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -31.05 -48.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.718 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -173.81 -109.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.535 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.3 m-80 -74.71 4.97 5.41 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.227 -0.295 . . . . 0.0 111.434 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 160' ' ' LEU . 1.6 mt -51.2 -59.34 4.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.704 0.288 . . . . 0.0 111.33 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.2 -32.17 35.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.916 0.389 . . . . 0.0 110.637 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.33 -57.77 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.787 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.15 -32.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -179.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.4 -59.88 2.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' HD11 ' A' ' 145' ' ' LEU . 6.3 pt20 -65.45 -14.91 61.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.05 -55.43 6.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.96 -14.09 61.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.1 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.639 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.774 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.774 HG12 ' HB1' ' A' ' 39' ' ' ALA . 9.2 t . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.717 0.294 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 15' ' ' SER . . . -33.2 -56.43 0.55 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.25 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -73.42 -24.14 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 111.252 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -72.56 -68.74 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.187 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.951 ' HB2' HG11 ' A' ' 35' ' ' VAL . 3.0 tm? -68.07 -54.83 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -61.12 -38.6 86.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.122 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -62.16 -61.08 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.673 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.818 ' HB3' HD11 ' A' ' 29' ' ' LEU . . . -57.55 -41.58 81.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.02 75.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.89 61.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 4.1 mtp85 -68.59 -30.71 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' CA ' ' HG2' ' A' ' 52' ' ' MET . . . 84.46 33.06 20.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.464 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.334 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 p-10 -104.64 100.18 9.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.2 p -54.72 -17.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.817 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 16.8 mt-30 -74.25 -53.39 9.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.269 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.334 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.32 -34.64 65.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.025 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.909 HG21 ' HA ' ' A' ' 58' ' ' VAL . 9.9 p -52.56 -50.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' N ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -72.52 -48.1 43.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 111.038 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.87 -27.44 65.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 17' ' ' ALA . 26.8 mt -74.43 -71.85 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.023 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.011 HD22 ' CG ' ' A' ' 65' ' ' GLN . 82.9 mt -63.3 -67.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -64.9 -4.88 4.97 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -129.43 -70.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.459 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 1.206 ' OE1' HG22 ' A' ' 35' ' ' VAL . 4.4 tt0 -51.86 -20.49 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 34' ' ' LEU . 1.4 mt 59.12 53.51 5.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.206 HG22 ' OE1' ' A' ' 33' ' ' GLU . 48.5 t -86.02 137.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.179 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.6 t-80 -55.41 143.56 56.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 36.9 Cg_endo -65.22 -33.77 47.87 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.78 2.32 . . . . 0.0 112.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.887 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -96.42 31.59 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB1' HG12 ' A' ' 10' ' ' VAL . . . -79.43 61.19 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.366 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 38' ' ' ASP . 5.0 mp -55.76 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -84.26 46.06 1.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 2.0 tmt_? 84.7 -11.69 0.78 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER 155.74 50.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.791 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -143.12 -102.47 0.42 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.979 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HB3' HG13 ' A' ' 50' ' ' VAL . 14.3 mttt -95.07 154.69 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 0.0 111.229 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.859 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.39 142.93 29.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.989 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 14' ' ' LEU . . . -52.84 -22.62 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' SD ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -73.29 -67.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -52.96 -37.76 61.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 46' ' ' THR . 28.7 m -78.43 -19.21 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.292 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.796 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.61 143.22 51.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.498 ' HG2' ' CA ' ' A' ' 21' ' ' GLY . 4.1 ppp? -78.04 116.69 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.641 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 36.7 m-85 -70.32 57.93 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -50.66 0.21 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.6 m -82.3 127.07 72.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 55.4 Cg_endo -70.2 -37.34 8.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.631 2.22 . . . . 0.0 112.317 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.851 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.31 -39.28 94.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.315 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.909 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.1 m -62.96 -31.33 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.831 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -63.45 -59.89 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 60' ' ' LEU . 7.0 tt -63.26 -37.87 88.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.851 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 5.3 mp0 -62.75 -62.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 14' ' ' LEU . 3.4 mt -62.82 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 69' ' ' PRO . 4.9 tp -63.33 -50.88 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.6 ttpp -62.83 -36.87 84.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.92 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 1.011 ' CG ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -37.55 -60.55 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.853 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.95 -23.94 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.2 146.23 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.038 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.14 119.68 62.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 63' ' ' LEU . 53.1 Cg_endo -69.52 -19.64 37.03 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.03 70.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' SER . 23.4 m -124.2 145.76 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 1.193 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.886 HG22 ' HB3' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -112.38 75.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 110.926 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.843 ' OG ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -43.84 170.06 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.763 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 8.9 Cg_endo -50.6 -32.73 36.55 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.933 2.422 . . . . 0.0 112.38 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG22 ' CG2' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -63.75 -52.94 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.886 ' HB3' HG22 ' A' ' 77' ' ' THR . 33.4 m80 -53.01 -54.1 40.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.763 ' OD1' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -60.76 -50.91 71.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.076 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -52.83 -30.1 31.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -68.95 0.41 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -60.09 -18.62 48.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.311 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.8 p -73.33 -27.84 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.074 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.49 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 75.1 76.18 0.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.147 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 70.2 m-85 -156.19 61.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 123' ' ' SER . 6.3 mt -52.51 -18.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.596 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.044 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.28 -70.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.044 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 t -65.5 -35.94 82.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.9 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.998 HD23 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -52.89 -51.96 59.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.7 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.746 ' O ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.86 -38.01 61.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.536 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' CA ' ' OE1' ' A' ' 97' ' ' GLU . 87.9 t -75.27 -64.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.309 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.937 HD12 ' N ' ' A' ' 96' ' ' VAL . 4.6 pp -73.69 -52.53 12.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.998 HG11 HD23 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -52.55 -26.58 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.746 ' OE1' ' O ' ' A' ' 93' ' ' LYS . 3.0 pm0 -72.13 -29.79 64.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -67.11 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.21 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -67.47 63.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.138 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 1.1 p-10 39.96 69.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.565 HG12 HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -90.74 21.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 35.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -119.45 -178.54 3.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -150.09 165.24 33.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 1.193 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 2.4 t0 -84.76 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.25 -44.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -16.94 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 138' ' ' ASP . . . 72.34 52.81 9.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.382 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.65 105.48 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HA ' HD23 ' A' ' 105' ' ' LEU . 8.2 mt -43.82 158.22 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 67.3 Cg_exo -51.26 -43.54 48.38 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.284 . . . . 0.0 112.283 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -55.83 -40.22 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.676 ' HA ' HD12 ' A' ' 117' ' ' ILE . 33.4 m170 -54.95 -43.86 73.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 11.3 mt -63.01 -56.0 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.87 -32.23 43.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.928 HG21 ' HB3' ' A' ' 147' ' ' LEU . 46.9 mt -65.35 -41.28 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.604 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 0.8 OUTLIER -70.57 -18.29 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.602 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 1.6 mt-10 -87.56 -56.62 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.59 28.77 9.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.604 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 21.3 m-70 -60.04 -15.03 19.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.341 . . . . 0.0 110.547 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER 77.93 -75.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.981 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.716 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.65 -48.38 75.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 42.5 t -58.22 -60.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.2 t -52.24 -40.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.756 ' HB2' HG21 ' A' ' 159' ' ' ILE . 1.9 t -72.18 -23.82 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CE2' ' OE2' ' A' ' 131' ' ' GLU . 7.0 t80 -73.59 -48.14 35.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -69.63 -5.26 23.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.03 -70.33 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.185 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.9 Cg_endo -75.04 -43.4 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.696 2.264 . . . . 0.0 112.399 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.635 ' OE2' ' CE2' ' A' ' 127' ' ' PHE . 1.6 mt-10 -50.55 -33.51 22.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.707 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 132' ' ' SER . 1.2 m-20 -35.6 120.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.884 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.5 mt -87.64 19.79 3.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.38 -44.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.557 ' HB3' HD11 ' A' ' 111' ' ' LEU . 3.1 t60 -55.7 157.1 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.42 166.91 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.649 ' CG ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -80.97 153.21 27.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.44 -21.9 1.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -44.19 85.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 107.87 53.65 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.577 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 10.1 mt -149.94 104.76 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.71 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -72.95 177.62 1.83 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.697 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 87.0 Cg_exo -46.55 -57.89 2.0 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.7 -28.81 70.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.71 ' OE2' ' OG1' ' A' ' 143' ' ' THR . 0.4 OUTLIER -72.75 -65.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.34 -39.34 60.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.146 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -60.63 -37.43 81.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.23 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.62 84.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.613 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -65.1 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.364 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.766 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -75.14 57.82 0.87 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.53 52.01 0.86 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.071 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -35.55 -32.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -178.86 -123.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.461 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 1.349 ' CB ' ' OD2' ' A' ' 158' ' ' ASP . 3.4 m-20 -75.97 29.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.065 0.393 . . . . 0.0 111.963 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 151' ' ' ARG . 1.5 mt -54.25 -72.02 0.07 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 110.971 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.722 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 8.7 ptm -53.95 -21.27 7.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.349 ' OD2' ' CB ' ' A' ' 155' ' ' ASN . 8.6 p-10 -73.95 -54.42 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.098 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.176 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 2.0 mt -53.13 -37.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.815 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.8 -27.9 61.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -52.9 -54.18 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.46 91.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.516 ' O ' ' CD1' ' A' ' 134' ' ' LEU . 42.8 m-70 -68.81 -37.7 79.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.822 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.884 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.786 0.326 . . . . 0.0 111.227 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.577 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -52.06 -20.3 6.41 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.389 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 p30 -92.78 -8.83 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 0.0 110.863 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -98.65 -51.95 3.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB2' HG21 ' A' ' 35' ' ' VAL . 9.0 tp -64.06 -33.84 76.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.608 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -62.39 -41.87 98.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -70.87 -49.23 29.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.823 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -58.2 -47.86 82.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.351 . . . . 0.0 111.074 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.44 71.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.74 -23.64 59.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 3.0 mmt180 -73.9 -12.3 60.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.606 ' HA2' ' HE2' ' A' ' 52' ' ' MET . . . 66.83 80.61 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.68 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 11.4 t0 -147.51 88.49 1.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.302 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.688 HG23 ' HB3' ' A' ' 57' ' ' ALA . 6.3 p -52.18 -29.18 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -52.27 11.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.77 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -74.12 -27.85 61.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.737 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 58' ' ' VAL . 1.8 p -52.56 -47.21 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.312 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 1.266 ' NE ' ' OE2' ' A' ' 61' ' ' GLU . 6.2 mtt180 -73.64 -34.38 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.073 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 2.6 mmm-85 -52.4 -27.54 16.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.258 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.823 HD11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 mt -73.05 -68.42 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -63.99 -53.62 47.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.006 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -59.29 -16.51 22.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 2.3 mmp_? -135.21 -73.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -47.45 -23.44 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 59.36 16.05 4.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.791 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' LEU . 13.8 p -46.36 154.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -91.94 121.49 66.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 30.8 Cg_endo -63.47 -9.69 18.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.763 2.309 . . . . 0.0 112.154 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.93 21.15 18.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' N ' ' A' ' 11' ' ' GLY . . . -97.79 143.71 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.78 HD12 ' N ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -119.93 160.15 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 15' ' ' SER . 1.1 m-20 -71.24 -159.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -4.99 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.05 -44.56 6.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.624 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 120.85 38.55 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' N ' ' HB3' ' A' ' 40' ' ' LEU . 7.1 mtpt -117.7 143.76 45.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.829 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -85.06 156.69 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -57.63 -36.18 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.761 HD11 HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -61.33 -36.53 80.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.785 ' HG2' HG21 ' A' ' 71' ' ' VAL . 1.3 mt-30 -73.05 -55.83 5.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -59.4 -19.03 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.256 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.676 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -43.62 148.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.759 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.606 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.93 23.39 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.105 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 1.035 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 0.9 OUTLIER 33.15 57.91 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.467 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -108.46 -72.16 0.75 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.312 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -84.54 121.54 74.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.751 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.71 -45.0 44.27 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.574 2.183 . . . . 0.0 111.859 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.3 -31.3 72.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 26' ' ' VAL . 2.2 t -62.12 -47.88 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.027 0.441 . . . . 0.0 110.009 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.74 -49.79 71.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.822 HD23 ' O ' ' A' ' 60' ' ' LEU . 2.4 tt -63.08 -43.3 98.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.548 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.266 ' OE2' ' NE ' ' A' ' 27' ' ' ARG . 7.4 tt0 -62.74 -61.23 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.414 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.719 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.09 -37.59 87.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 48' ' ' LEU . 39.4 tp -63.42 -52.65 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.117 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -62.62 -34.0 76.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.017 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 1.3 tp-100 -46.24 -25.32 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.29 3.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.593 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -39.31 148.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.01 123.05 44.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.26 -14.77 28.53 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.772 2.314 . . . . 0.0 112.235 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.9 57.21 4.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.785 HG21 ' HG2' ' A' ' 49' ' ' GLN . 13.9 m -103.2 175.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 m -82.21 65.67 7.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 110.72 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -58.79 171.14 0.69 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD3' ' CG2' ' A' ' 71' ' ' VAL . 78.1 Cg_exo -49.99 -44.27 38.04 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.772 2.315 . . . . 0.0 112.134 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.56 -41.04 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.318 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.618 ' HD2' HD11 ' A' ' 115' ' ' LEU . 6.0 m80 -52.83 -66.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.795 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -62.58 -30.76 71.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.55 -39.21 64.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.331 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.76 -50.17 38.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.542 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 115' ' ' LEU . 13.4 mtt180 -72.97 -26.88 61.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 82' ' ' ASP . 32.6 p -70.76 -3.43 18.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.301 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 43.83 76.17 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.13 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -158.98 61.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD1' ' CD2' ' A' ' 127' ' ' PHE . 62.5 tp -52.42 -19.63 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.138 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -63.13 -71.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.713 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.885 HG22 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -73.15 -20.74 60.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.761 ' C ' HD23 ' A' ' 92' ' ' LEU . 1.7 tt -72.95 -42.51 63.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.34 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 38.8 ttmt -65.71 -36.94 85.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.447 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.76 ' HA ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -55.82 -58.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.078 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.676 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.6 pp -73.07 -34.44 66.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.073 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 80' ' ' VAL . 38.8 t -72.32 -49.31 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.76 ' CD ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -58.77 -32.97 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -30.91 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.35 -0.58 7.55 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 102' ' ' VAL . . . -42.99 167.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.113 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.07 88.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.818 ' HA ' HG21 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -89.35 13.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.6 9.81 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.07 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -65.08 141.63 58.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.886 HD13 ' HA2' ' A' ' 109' ' ' GLY . 6.7 mt -121.67 150.54 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.065 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' OG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -84.98 -48.87 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 106' ' ' ASP . 0.6 OUTLIER -175.25 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 2.26 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.886 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 52.8 18.97 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.353 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.575 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -48.27 -50.37 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.541 0.21 . . . . 0.0 111.132 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 105' ' ' LEU . 6.2 tp 92.49 127.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.724 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.552 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 84.7 Cg_exo -44.38 -46.11 12.06 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.854 2.369 . . . . 0.0 112.589 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.38 -31.39 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.153 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.601 ' CD2' HD22 ' A' ' 147' ' ' LEU . 8.9 m80 -70.03 -34.17 72.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 81' ' ' HIS . 1.2 mt -63.5 -52.96 59.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -53.56 -36.02 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.682 HG21 ' HB3' ' A' ' 147' ' ' LEU . 83.6 mt -61.5 -41.52 90.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -68.91 -12.6 61.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.587 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.544 ' CB ' ' CD2' ' A' ' 121' ' ' HIS . 2.6 mt-10 -91.76 -57.81 2.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.736 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.92 -11.88 10.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.796 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 125' ' ' VAL . 30.7 m-70 -57.22 78.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 126' ' ' SER . 11.8 p -37.72 -45.02 0.76 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.2 p -56.94 -51.27 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.255 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 45.3 t -72.9 -58.85 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.452 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.4 t -52.04 -40.94 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.321 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.586 ' HB3' HG21 ' A' ' 159' ' ' ILE . 77.3 p -67.09 -36.87 82.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.111 0.481 . . . . 0.0 110.799 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 68.1 t80 -73.7 -44.51 56.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -70.44 -10.79 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.082 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.31 -69.09 0.37 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 1.016 ' HA ' HD11 ' A' ' 134' ' ' LEU . 72.0 Cg_endo -74.5 -50.07 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.772 2.315 . . . . 0.0 112.58 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -39.27 -44.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD13 ' A' ' 128' ' ' LEU . 8.1 t -90.77 134.2 34.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.432 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -40.14 101.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.016 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.2 mp -62.68 -36.77 83.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -63.53 -33.91 76.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.066 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 1.432 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 12.0 t60 -50.35 155.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -114.14 149.66 35.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.996 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.669 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 t70 -66.34 -9.32 32.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' ASP . . . 82.41 -5.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -14.01 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 108.33 48.3 0.88 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.478 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 147' ' ' LEU . 94.3 mt -151.62 93.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 111.057 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.82 179.65 0.75 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 73.3 Cg_exo -49.33 -49.41 15.6 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.763 2.309 . . . . 0.0 112.575 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.8 mt -73.28 -34.98 66.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 143' ' ' THR . 15.4 mm-40 -52.78 -62.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.682 ' HB3' HG21 ' A' ' 117' ' ' ILE . 2.7 tp -54.71 -48.35 72.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.41 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -57.17 -36.8 71.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.337 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -43.69 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.002 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 151' ' ' ARG . 10.2 tt0 -71.9 -86.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.976 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.504 ' N ' ' HG2' ' A' ' 150' ' ' GLN . 37.5 mtt-85 -74.7 53.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.549 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -52.07 -20.61 6.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 154' ' ' GLN . . . 34.43 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.597 ' CG ' ' O ' ' A' ' 153' ' ' ALA . 4.6 pp0? 125.95 -154.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.506 ' C ' ' NE2' ' A' ' 154' ' ' GLN . 2.2 t30 -74.41 46.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.408 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 159' ' ' ILE . 11.3 mt -69.91 -50.32 43.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.726 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.5 ptm -52.13 -26.18 10.68 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.944 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -74.4 -58.61 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.819 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.036 HD11 HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -51.91 -38.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.346 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.676 ' HG ' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -74.23 -23.79 59.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.025 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -47.26 44.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.07 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.16 53.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 53.3 m-70 -72.12 -8.34 54.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.486 ' CG ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 35' ' ' VAL . 7.7 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.37 24.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -11.22 28.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.815 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -86.61 -65.26 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.061 HD23 HG11 ' A' ' 35' ' ' VAL . 2.2 tm? -71.44 -65.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -56.97 -30.97 64.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.43 -63.77 2.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -64.75 -44.51 89.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.077 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -52.62 -51.5 59.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -65.1 -38.24 90.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -70.42 -7.91 46.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 23' ' ' VAL . . . 114.94 -66.28 0.28 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.901 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.107 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 26.89 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.0 111.822 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 26' ' ' VAL . 12.6 p -51.66 -35.64 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.21 -42.87 59.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.107 ' OE1' ' HA ' ' A' ' 22' ' ' ASP . 2.7 mp0 -74.43 -25.94 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.302 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.177 HG13 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.31 -40.06 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 60.9 mtt180 -73.99 -48.28 31.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 9.8 mtt180 -66.2 -29.31 69.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.573 HD11 ' OD2' ' A' ' 22' ' ' ASP . 6.7 mt -55.31 -67.46 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -73.63 -52.97 11.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.922 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 41.0 m-70 -67.62 -4.73 12.74 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -142.28 -57.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.689 0.281 . . . . 0.0 111.345 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.815 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.92 -4.52 20.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.165 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 39.88 32.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.977 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.061 HG11 HD23 ' A' ' 14' ' ' LEU . 9.7 p -59.15 166.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -98.72 135.5 21.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 56.5 Cg_endo -70.84 -10.04 26.92 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.65 50.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.796 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.6 116.33 32.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -97.54 165.04 12.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.47 46.03 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.85 21.95 5.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.8 -9.16 8.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.12 20.96 43.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 3.5 mtpt -113.94 143.9 43.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 50' ' ' VAL . 64.7 p -89.3 174.31 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 14' ' ' LEU . . . -58.48 -38.28 77.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.062 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.506 HD23 ' HG2' ' A' ' 51' ' ' MET . 5.7 mt -73.44 -33.08 64.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.26 -1.39 17.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.481 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -129.78 -46.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.352 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -36.71 140.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.464 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -88.35 146.9 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.091 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.877 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.9 m-85 -87.5 21.72 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -73.06 -40.1 51.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 2.6 m -109.58 120.03 46.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 0.0 110.819 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 1.177 ' HG3' ' OD1' ' A' ' 90' ' ' ASP . 32.1 Cg_exo -58.83 -42.23 54.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.677 2.251 . . . . 0.0 112.168 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.15 70.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.044 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.3 t -62.98 -48.61 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.51 -40.93 98.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 1.8 tm? -63.01 -47.97 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.681 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.177 ' OE1' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.28 -48.4 78.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.8 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 51' ' ' MET . 8.2 mt -62.87 -54.38 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 95' ' ' LEU . 1.3 tt -63.08 -43.29 98.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.1 ttmm -62.93 -26.15 68.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.539 ' NE2' HD22 ' A' ' 30' ' ' LEU . 34.8 tt0 -62.11 -14.67 39.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.7 62.93 1.02 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.69 170.98 8.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.96 99.5 26.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.71 -9.18 23.57 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.689 2.259 . . . . 0.0 112.161 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.518 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.99 63.78 8.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 78' ' ' SER . 16.1 m -117.89 126.99 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.751 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 10.4 mt-30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 81' ' ' HIS . 2.1 m 179.91 139.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.818 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -117.51 179.62 0.79 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.145 0.498 . . . . 0.0 110.982 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 1.178 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 77.1 Cg_exo -48.53 -51.04 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 111.765 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.595 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.14 -48.76 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.316 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.71 ' HB2' HG23 ' A' ' 77' ' ' THR . 24.0 m80 -52.75 -61.37 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.94 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.178 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 10.5 p30 -57.77 -53.69 55.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.75 ' CB ' HD13 ' A' ' 92' ' ' LEU . . . -52.25 -38.82 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.459 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.11 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -73.49 -27.42 61.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 1.077 HG23 ' O ' ' A' ' 82' ' ' ASP . 27.8 p -71.32 -41.57 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.76 70.71 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.003 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -145.25 53.61 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.648 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 123' ' ' SER . 9.2 tp -52.47 -20.63 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.177 ' OD1' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -63.53 -71.8 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.422 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.707 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 m -73.12 -22.24 60.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.176 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.755 HD12 HD11 ' A' ' 95' ' ' LEU . 64.8 tp -70.29 -44.22 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 1.259 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 20.3 ttpp -60.63 -44.74 96.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.834 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.98 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.93 -53.33 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.55 -42.47 61.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.84 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 3.2 t -63.69 -52.48 56.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.259 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -55.5 -29.16 58.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.53 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 6.3 t60 -73.08 -56.21 5.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.54 33.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.815 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -69.41 120.31 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.324 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.8 p-10 -35.81 92.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.1 14.17 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.127 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -143.53 38.47 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.08 122.37 26.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.694 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -119.16 146.0 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.751 ' OD2' ' HB3' ' A' ' 72' ' ' GLN . 7.3 p30 -155.22 141.03 18.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 108' ' ' THR . 71.1 m 49.39 26.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.85 -40.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 1.174 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 68.68 10.79 61.51 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 1.429 ' HA ' ' CG ' ' A' ' 138' ' ' ASP . 2.6 t -104.02 129.45 51.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' HD21 ' A' ' 105' ' ' LEU . 32.5 mt -65.83 147.51 98.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HB2' HD11 ' A' ' 128' ' ' LEU . 74.4 Cg_exo -50.44 -29.53 24.43 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.681 2.254 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.9 tt -69.8 -38.31 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.819 ' ND1' ' OD2' ' A' ' 138' ' ' ASP . 36.4 m80 -53.32 -38.95 63.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.4 mt -65.96 -57.61 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.625 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -28.67 24.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.42 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.579 HD13 ' CG1' ' A' ' 125' ' ' VAL . 4.7 mm -65.42 -39.73 86.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.86 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -18.25 62.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.526 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 121' ' ' HIS . 4.1 mm-40 -90.87 -54.78 3.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.2 45.76 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.009 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.643 ' CB ' HG23 ' A' ' 124' ' ' VAL . 99.0 m-70 -76.96 3.77 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.698 0.285 . . . . 0.0 111.205 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 40.5 t 71.09 -92.94 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.785 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.64 ' HB3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -52.64 -56.51 14.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.358 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.643 HG23 ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -52.19 -62.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.944 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 4.5 t -52.31 -43.83 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 1.023 ' HB2' HG21 ' A' ' 159' ' ' ILE . 16.2 t -72.63 -30.49 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 123' ' ' SER . 63.3 t80 -73.8 -42.12 61.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.065 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -66.7 -6.99 17.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.336 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.832 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -64.13 -68.94 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.2 Cg_endo -67.27 -36.75 20.01 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 2.25 . . . . 0.0 112.353 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.33 -22.31 65.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 133' ' ' ASP . 51.8 m -112.84 147.6 36.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -35.47 111.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -79.35 64.46 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.0 p-80 164.72 -36.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . 68.6 t60 -48.62 143.76 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.823 ' HG3' HG22 ' A' ' 143' ' ' THR . 3.4 ttm180 -101.32 177.66 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 1.429 ' CG ' ' HA ' ' A' ' 110' ' ' SER . 1.3 t0 -121.26 156.48 32.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -22.25 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.183 0.516 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -73.88 -58.73 3.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.724 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 1.18 ' O ' ' OE2' ' A' ' 146' ' ' GLU . . . 124.84 43.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.852 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.45 114.42 4.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.823 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -82.78 -174.35 0.52 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 86.9 Cg_exo -44.87 -52.12 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.448 2.098 . . . . 0.0 112.072 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 145' ' ' LEU . 10.2 mt -73.35 -36.79 66.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.18 ' OE2' ' O ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -63.9 -64.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.951 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.708 HD12 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -52.37 -46.19 66.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.491 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -55.97 -32.96 64.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.19 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.35 -68.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.649 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.885 ' O ' HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.76 66.18 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 153' ' ' ALA . . . -64.46 50.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.587 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -60.56 -142.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.573 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.41 -149.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 1.071 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 71.4 m-20 -74.64 44.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.984 ' HA ' HD12 ' A' ' 159' ' ' ILE . 2.5 pt? -69.16 -52.9 23.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.571 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER -56.37 -33.62 65.89 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.144 0.497 . . . . 0.0 110.076 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 1.071 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 15.4 p-10 -74.23 -40.0 62.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 126' ' ' SER . 10.6 mt -52.69 -49.86 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.76 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.836 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.78 -33.11 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.968 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -51.41 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.947 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.35 63.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -48.8 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.434 ' HA ' HD13 ' A' ' 134' ' ' LEU . 1.5 tpp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.646 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.825 0.345 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -60.85 -81.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 11.0 t0 -59.93 -14.54 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -63.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.84 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.7 tm? -73.13 -54.67 7.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.034 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.564 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.5 p -57.72 -30.32 65.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -70.76 -46.12 48.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.5 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.86 -55.89 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.267 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.4 69.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -68.03 -26.83 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.226 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -73.29 -26.58 61.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 88.1 66.5 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.069 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 13.4 p-10 -137.15 94.46 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -53.07 -20.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.169 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -74.18 -51.87 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.08 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.069 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -73.24 -32.98 65.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.818 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.872 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.3 p -52.69 -49.58 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 111.09 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 29.7 mtt180 -73.64 -48.88 29.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.279 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.5 mmp_? -52.85 -30.23 32.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.17 -73.99 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.946 HD11 HD23 ' A' ' 62' ' ' LEU . 1.7 mt -73.59 -42.7 61.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.484 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.11 -3.23 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.37 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -143.02 -75.46 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.825 ' OE1' ' HB ' ' A' ' 35' ' ' VAL . 14.1 tt0 -46.93 -23.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 34' ' ' LEU . 10.7 mt 62.01 29.92 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.825 ' HB ' ' OE1' ' A' ' 33' ' ' GLU . 2.7 p -58.92 137.15 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -69.03 145.88 96.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 40.0 Cg_endo -67.33 -11.03 30.69 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.211 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 29.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.74 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -97.9 94.81 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.282 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -102.86 147.87 26.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.685 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 24.5 p30 -44.99 -26.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.0 0.429 . . . . 0.0 110.285 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -146.02 -71.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.534 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 177.89 66.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.933 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.29 -73.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.971 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 40' ' ' LEU . 30.1 mttm -84.87 152.92 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 111.336 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.985 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.5 p -101.52 176.71 5.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 14' ' ' LEU . . . -57.14 -35.74 69.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 69' ' ' PRO . 3.5 tp -72.83 -47.86 42.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' CG ' HG23 ' A' ' 71' ' ' VAL . 2.0 tm0? -65.52 -9.56 27.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 46' ' ' THR . 32.8 m -136.31 26.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.1 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 1.1 tmm? -86.86 149.88 24.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.9 OUTLIER -87.87 86.6 7.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.381 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 53.4 m-85 -35.14 -30.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -28.79 -55.32 0.15 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.148 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -90.94 130.94 38.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HA ' HG23 ' A' ' 91' ' ' THR . 61.0 Cg_endo -73.22 -42.97 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.761 2.307 . . . . 0.0 112.043 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -62.8 -29.01 70.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.521 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.872 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.5 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.879 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.21 -52.95 60.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -63.61 -38.45 91.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.024 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -62.84 -49.35 75.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.946 HD23 HD11 ' A' ' 30' ' ' LEU . 13.0 mt -62.77 -50.29 71.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.842 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' CG ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -62.91 -23.02 67.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.671 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 11.9 tttt -63.05 -20.4 65.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.79 -57.22 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.89 50.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.515 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.56 -13.78 53.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.9 OUTLIER 62.9 95.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CG ' HD21 ' A' ' 63' ' ' LEU . 74.6 Cg_exo -48.19 -41.47 34.37 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.85 ' ND2' ' OD1' ' A' ' 101' ' ' ASP . 3.5 m120 -71.16 84.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG23 ' CG ' ' A' ' 49' ' ' GLN . 4.7 m -136.45 131.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . 29.2 mt-30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.9 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 1.291 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . 2.6 m -115.9 119.21 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.6 p -104.96 -176.02 0.41 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 40.5 Cg_exo -56.22 -42.98 60.59 Favored 'Trans proline' 0 CA--C 1.527 0.128 0 C-N-CA 122.814 2.342 . . . . 0.0 112.058 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.523 HG23 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.67 -29.95 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.476 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.582 ' ND1' ' OD2' ' A' ' 106' ' ' ASP . 9.4 m170 -72.08 -68.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -61.25 -25.98 67.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.207 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.815 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -56.49 -53.76 53.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.563 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.97 -38.14 66.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.568 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.087 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 6.5 tpt180 -72.15 -24.04 61.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.215 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 82' ' ' ASP . 5.5 p -73.07 -73.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 132.7 63.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.324 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 22.8 m-85 -155.06 59.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.718 HD11 ' CG ' ' A' ' 127' ' ' PHE . 37.6 tp -52.21 -29.32 22.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.235 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 1.108 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -53.19 -67.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.459 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.108 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 47.7 m -72.24 -42.16 65.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 83' ' ' ALA . 1.2 tt -52.37 -48.68 65.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.492 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 92' ' ' LEU . 6.2 ttpp -55.39 -26.08 39.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.877 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.21 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 18.1 t -73.54 -70.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.542 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.986 HD22 ' N ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -63.91 -27.33 69.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.534 -179.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.986 ' N ' HD22 ' A' ' 95' ' ' LEU . 41.3 t -73.88 -56.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.759 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.21 ' OE2' ' HA ' ' A' ' 94' ' ' VAL . 17.3 pm0 -56.29 -35.39 67.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.502 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 10.6 t-160 -60.65 -68.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . 179.19 61.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -105.76 26.5 9.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.85 ' OD1' ' ND2' ' A' ' 70' ' ' ASN . 1.1 p-10 47.87 82.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 15.51 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 65.3 m-20 -131.89 27.33 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -101.7 162.03 13.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.555 HD21 ' CD1' ' A' ' 111' ' ' LEU . 74.2 mt -125.13 150.27 47.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 1.291 ' OD2' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -100.34 -169.55 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 61.8 m -48.29 -46.14 35.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -33.33 75.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 84.03 31.17 26.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.569 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.3 m -105.73 119.98 40.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.627 HD21 ' OD1' ' A' ' 133' ' ' ASP . 9.3 tp -54.53 138.09 60.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 104' ' ' ALA . 94.4 Cg_exo -43.37 -27.01 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.796 2.33 . . . . 0.0 112.366 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.872 ' HB ' HD21 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -73.23 -42.77 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.797 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 31.3 m80 -52.91 -32.51 45.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.286 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.11 -48.66 33.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.361 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -61.74 -32.95 73.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.92 HG21 ' HB3' ' A' ' 147' ' ' LEU . 80.2 mt -66.55 -42.2 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.691 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.6 -16.91 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 1.087 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -86.67 -57.84 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.415 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 110.23 -0.69 29.72 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.54 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 15.2 m-70 -57.68 78.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.592 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -34.36 -48.59 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -62.45 -48.33 80.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 121' ' ' HIS . 47.5 t -69.57 -60.17 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 2.4 t -51.87 -44.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.158 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.846 ' HB3' HG21 ' A' ' 159' ' ' ILE . 60.6 p -71.87 -29.35 64.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.169 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.3 t80 -73.22 -66.4 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.994 HD22 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.73 -8.76 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.947 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -52.22 -71.1 0.22 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 57.4 Cg_endo -70.88 -33.0 13.0 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 128' ' ' LEU . 30.9 mm-40 -54.59 -20.4 7.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.283 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 p -105.81 -171.25 1.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.627 ' OD1' HD21 ' A' ' 111' ' ' LEU . 4.1 p30 -94.5 84.63 4.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.992 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -57.59 75.3 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.222 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 p-80 174.98 -39.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -47.89 173.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -129.88 174.32 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.467 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -131.25 166.97 20.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.6 -20.18 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -52.38 55.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.44 11.2 6.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.443 ' HB3' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -132.72 160.72 35.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.531 ' CB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -112.99 -178.39 0.52 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 84.3 Cg_exo -44.91 -59.75 1.04 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.634 2.223 . . . . 0.0 112.138 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -58.4 -46.74 85.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.633 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.443 ' CD ' ' HB3' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.78 -62.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.92 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.87 -43.61 66.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.805 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.64 -43.46 65.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.375 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -61.04 -36.15 78.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.753 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.486 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -69.74 -80.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.572 179.032 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.36 61.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.6 52.29 0.88 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.79 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.548 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -32.7 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.452 . . . . 0.0 110.723 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.548 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.6 OUTLIER 172.53 -119.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.29 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.764 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 2.0 m-20 -74.06 4.73 5.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.135 -0.353 . . . . 0.0 111.692 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.995 ' HA ' HD12 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -52.66 -51.84 58.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.805 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.4 ppp? -53.2 -34.7 58.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.764 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 3.1 p30 -73.67 -43.58 59.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.995 HD12 ' HA ' ' A' ' 156' ' ' LEU . 15.5 mt -52.74 -44.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.369 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 160' ' ' LEU . 1.3 mt -73.29 -35.51 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.336 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -67.41 -37.89 83.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.01 44.98 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.389 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -73.26 -9.8 59.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.649 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.086 HG21 HG12 ' A' ' 35' ' ' VAL . 3.9 p . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.779 0.323 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.736 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -40.24 -60.48 1.96 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.386 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 29.4 p30 -56.51 -17.39 8.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.754 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.1 tpm_? -98.59 -64.25 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.756 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 62' ' ' LEU . 2.8 tm? -69.22 -61.71 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.484 ' OG ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.94 -28.29 56.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.64 -49.05 39.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.188 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 22' ' ' ASP . . . -73.03 -40.3 65.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.43 -45.12 65.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.287 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -73.1 -37.58 66.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -73.43 -8.13 54.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 58' ' ' VAL . . . 124.89 -66.56 0.53 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.179 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.608 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 0.3 OUTLIER 33.54 38.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.39 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.687 ' HA ' HG23 ' A' ' 58' ' ' VAL . 2.3 p -52.66 -49.88 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.656 ' HG3' HG13 ' A' ' 23' ' ' VAL . 15.0 mt-30 -75.14 -32.62 61.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.811 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.24 -37.39 66.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.577 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.291 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.4 p -52.39 -35.08 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -71.29 -51.63 23.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.97 -36.72 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.095 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' OE1' ' A' ' 33' ' ' GLU . 20.2 mt -52.96 -61.86 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.1 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.75 HD23 HG23 ' A' ' 35' ' ' VAL . 10.3 mt -73.45 -49.19 28.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.823 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.869 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 20.2 m-70 -70.14 -19.33 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.861 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -126.05 -78.91 0.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 1.172 ' OE2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -39.87 -28.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.1 mt 62.38 31.03 17.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.525 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.172 HG13 ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -54.44 152.07 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.336 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.69 124.6 69.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.83 -11.34 29.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.694 2.262 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 6.3 p30 -90.97 -8.61 48.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.843 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -43.67 136.96 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 45' ' ' LYS . 6.4 mt -129.81 108.92 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -40.45 -44.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.989 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -135.77 35.18 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 49.25 48.08 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.27 -45.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.445 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.941 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.05 147.39 46.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -86.09 166.62 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.27 25.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -73.12 -43.86 61.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.731 ' HG2' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.74 -20.63 65.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG21 ' OG ' ' A' ' 15' ' ' SER . 18.7 m -104.73 -34.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' LEU . 2.0 ttp -42.12 134.81 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.502 ' CE ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -86.74 134.44 33.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.839 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 10.8 m-85 -78.37 52.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.633 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -106.29 -59.55 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.108 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -86.76 114.3 57.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 110.302 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' HG11 ' A' ' 94' ' ' VAL . 9.2 Cg_endo -53.64 -42.29 67.18 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.562 2.175 . . . . 0.0 112.145 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.24 -33.36 75.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.2 t -63.06 -39.93 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -63.04 -59.83 4.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 19.6 tp -63.23 -41.2 99.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.535 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 1.291 ' OE1' HG13 ' A' ' 26' ' ' VAL . 10.6 mt-10 -62.88 -45.84 90.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.501 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.886 HD11 ' HB1' ' A' ' 18' ' ' ALA . 3.2 mt -62.83 -57.1 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 64' ' ' LYS . 4.4 pp -63.51 -25.82 68.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.339 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.66 ' N ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -63.14 -46.9 85.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 30' ' ' LEU . 1.8 mm100 -51.36 -43.85 61.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.65 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -89.46 159.91 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.978 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.92 110.8 36.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.988 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 77.7 Cg_endo -77.59 7.72 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.787 2.325 . . . . 0.0 112.423 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.081 ' OD1' ' OD2' ' A' ' 101' ' ' ASP . 43.4 m-80 -89.48 26.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.731 HG23 ' HG2' ' A' ' 49' ' ' GLN . 8.3 m -107.5 139.08 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.045 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 76' ' ' GLY . 2.3 p -156.85 103.68 2.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.77 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 p -70.51 -174.29 0.25 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 1.036 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 62.9 Cg_exo -50.64 -50.9 12.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.774 2.316 . . . . 0.0 112.533 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.947 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 15.3 m -59.34 -43.81 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.373 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.438 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 44.1 m170 -61.45 -34.47 75.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.043 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.036 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.74 -51.09 20.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -70.05 -11.98 61.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.39 -43.83 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.406 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 1.007 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 2.0 mmt180 -61.51 -58.42 8.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.231 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -72.48 -22.55 61.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.817 ' CA ' HG21 ' A' ' 124' ' ' VAL . . . 105.14 -62.83 0.33 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 16.9 m-85 30.97 37.1 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 110.259 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.2 tm? -51.73 -41.87 61.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.512 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.641 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.0 -62.96 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.828 0.347 . . . . 0.0 110.877 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -72.01 -46.33 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.921 HD13 ' HB3' ' A' ' 83' ' ' ALA . 14.6 tp -52.4 -43.03 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 109.916 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.567 ' HE2' HD11 ' A' ' 89' ' ' LEU . 1.9 ttpp -53.52 -37.92 63.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.486 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' 56' ' ' PRO . 42.9 t -57.08 -60.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.107 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -73.18 -33.41 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.842 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 4.6 t -73.12 -45.33 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 93' ' ' LYS . 0.9 OUTLIER -58.24 -32.44 68.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.773 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.455 ' ND1' HD13 ' A' ' 63' ' ' LEU . 4.3 t-160 -73.13 -50.38 23.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -166.44 -69.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.298 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.947 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . 30.13 82.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.777 0.322 . . . . 0.0 111.559 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.081 ' OD2' ' OD1' ' A' ' 70' ' ' ASN . 2.1 p-10 -39.84 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 112' ' ' PRO . 12.9 m -84.24 11.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.38 -25.94 20.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -50.9 157.45 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.791 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -143.29 161.39 38.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.814 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.82 -90.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.005 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.84 -38.57 2.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 -1.89 25.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 62.57 23.29 64.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 139.79 30.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.791 HD23 ' CD2' ' A' ' 105' ' ' LEU . 11.4 mt -68.34 162.76 58.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 102' ' ' VAL . 76.4 Cg_exo -50.23 -34.26 39.16 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.559 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -61.46 -44.06 97.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.98 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CE1' ' HG ' ' A' ' 111' ' ' LEU . 1.9 m80 -53.07 -44.38 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.875 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -67.64 -48.95 65.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.539 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.206 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.21 -43.31 67.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.712 HG23 HD13 ' A' ' 156' ' ' LEU . 46.0 mt -54.86 -40.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.654 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -62.67 -41.7 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.473 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 1.206 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 2.2 mp0 -72.53 -55.58 6.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.8 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.18 52.01 2.46 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.565 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -81.43 -7.14 59.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.996 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -71.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -66.63 -35.53 80.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.817 HG21 ' CA ' ' A' ' 87' ' ' GLY . 42.9 t -74.01 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.087 0.47 . . . . 0.0 110.606 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 156' ' ' LEU . 4.2 m -53.3 -45.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.335 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.545 ' HB3' HG21 ' A' ' 159' ' ' ILE . 15.8 p -71.92 -28.85 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.784 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 19.0 t80 -73.49 -44.33 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.521 ' CD1' ' OG ' ' A' ' 132' ' ' SER . 0.2 OUTLIER -67.41 -11.51 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.153 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.41 -67.46 0.79 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.283 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 29.6 Cg_endo -64.16 -62.07 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.617 2.212 . . . . 0.0 112.452 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.784 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -37.59 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 17.4 m -98.41 129.4 45.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 1.179 ' OD1' ' HB2' ' A' ' 136' ' ' HIS . 0.1 OUTLIER -36.0 95.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 134' ' ' LEU . 4.0 mt -60.19 151.03 28.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 74.52 13.79 3.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 1.179 ' HB2' ' OD1' ' A' ' 133' ' ' ASP . 63.1 t60 -103.83 168.95 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -127.2 -160.34 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.12 -171.63 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.41 -9.59 26.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -39.6 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 104.26 68.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 141' ' ' GLY . 93.8 mt -156.91 133.3 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.196 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 80.9 p -96.51 159.12 32.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 6.0 Cg_exo -38.61 -48.8 2.59 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.15 2.566 . . . . 0.0 112.184 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.1 mt -66.98 -40.58 87.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.196 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 1.1 mp0 -52.99 -68.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' GLN . 8.4 tp -52.66 -29.01 24.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.17 -15.22 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.471 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 1.4 ttt180 -73.26 -48.46 34.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.46 -90.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.885 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -75.88 50.65 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -74.21 44.26 1.34 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.829 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.553 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -34.46 150.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 40.44 -161.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.89 ' CA ' ' OD1' ' A' ' 158' ' ' ASP . 1.1 t-20 -74.61 43.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.207 -0.308 . . . . 0.0 111.543 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 125' ' ' VAL . 2.2 mt -59.43 -55.95 28.15 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 110.966 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -51.66 -44.04 62.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.89 ' OD1' ' CA ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -74.5 -35.08 63.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.267 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.852 HG22 HD23 ' A' ' 160' ' ' LEU . 11.0 mt -53.16 -52.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.158 0.504 . . . . 0.0 110.456 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.872 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.51 -24.54 59.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.256 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -64.46 -41.72 96.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.164 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.48 -53.51 8.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 15.2 m-70 -60.87 -40.24 92.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.881 0.372 . . . . 0.0 110.88 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.417 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.994 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 t -113.64 144.45 42.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.757 0.313 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.2 mtt 55.27 74.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.92 -11.61 13.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -119.05 106.81 12.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.022 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -124.58 124.46 42.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 18.6 tt0 -134.67 47.75 2.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 40' ' ' LEU . 12.6 p -114.91 -26.15 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.025 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 50.3 t -44.05 -36.87 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.558 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 35' ' ' VAL . 52.3 t -92.04 -18.22 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.863 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.699 ' O ' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -83.07 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.51 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 3.0 p30 -51.92 -29.94 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.994 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -37.0 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.787 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.963 ' CB ' HG21 ' A' ' 35' ' ' VAL . 4.9 tp -72.28 -23.84 61.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.986 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -65.59 -49.89 67.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.7 -27.91 68.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.503 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . . . -72.21 -55.07 7.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.347 . . . . 0.0 111.249 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.82 79.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.249 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -32.64 64.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.4 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -71.0 -9.86 58.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.002 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.406 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 70.42 75.89 0.57 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 24' ' ' GLN . 1.2 t70 -144.7 85.56 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.795 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 p -52.9 -22.84 4.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 42.6 mt-30 -70.66 -45.02 65.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.7 mm-40 -72.99 -49.43 29.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.676 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 58' ' ' VAL . 47.2 t -57.92 -29.52 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 4.8 mmt180 -72.03 -60.86 2.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -69.16 -22.77 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.1 mt -54.44 -66.55 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.774 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.751 HD22 ' HG2' ' A' ' 65' ' ' GLN . 16.5 mt -72.28 -40.59 67.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.13 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 23.0 m-70 -65.41 -19.62 66.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.306 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -133.0 -66.72 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 29' ' ' LEU . 2.4 tp10 -58.48 -14.46 7.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.2 mt 46.96 25.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.786 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.963 HG21 ' CB ' ' A' ' 14' ' ' LEU . 14.7 p -43.96 148.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 144.29 43.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.608 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 58.7 Cg_endo -72.12 -22.98 21.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 0.0 112.404 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.54 2.53 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 11' ' ' GLY . . . -42.25 124.74 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.888 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.2 mt -122.01 130.08 52.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 4.6 p-10 -66.21 -179.49 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.886 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -47.79 -43.34 27.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.89 -65.34 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.52 47.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 13.2 mtpt -116.42 151.08 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.8 p -85.14 162.05 19.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.557 ' HB3' HD22 ' A' ' 62' ' ' LEU . . . -53.83 -47.46 70.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.118 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 69' ' ' PRO . 1.1 mp -62.8 -27.59 69.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.578 HE21 HG23 ' A' ' 71' ' ' VAL . 9.8 tt0 -72.97 -29.26 62.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.779 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' THR . 2.9 m -101.63 -26.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.023 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -36.65 142.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.797 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.2 ptt? -102.31 22.69 12.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.994 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.7 m-85 36.57 31.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -76.94 -77.8 0.77 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.511 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.502 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 19.3 m -77.86 121.02 83.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.966 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.47 -45.69 37.9 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.61 2.207 . . . . 0.0 112.159 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 61' ' ' GLU . . . -63.16 -28.69 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.368 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HA ' HG11 ' A' ' 26' ' ' VAL . 2.5 t -62.95 -38.57 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.209 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.9 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -63.32 -49.77 72.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 53.1 tp -63.15 -33.13 74.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 57' ' ' ALA . 1.9 mm-40 -62.54 -49.1 76.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 14' ' ' LEU . 5.6 mt -62.96 -56.26 18.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.608 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 59' ' ' ALA . 1.1 mt -63.36 -25.73 68.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 1.6 tttp -62.84 -29.84 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.751 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -76.87 -73.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.92 62.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -107.45 153.29 23.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.165 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -96.6 99.24 5.29 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . 31.7 Cg_endo -64.31 -15.83 51.75 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -79.7 65.86 4.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.578 HG23 HE21 ' A' ' 49' ' ' GLN . 28.2 m -126.4 138.11 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.261 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.44 146.53 49.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.742 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 2.9 p30 -153.06 142.99 22.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 73' ' ' ASP . . . 40.88 97.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 76' ' ' GLY . 7.4 t 73.68 30.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 75' ' ' SER . . . 37.18 62.83 0.84 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -114.88 102.1 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.605 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -89.75 -174.57 0.46 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.912 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 51.3 Cg_exo -55.57 -41.65 75.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.85 2.367 . . . . 0.0 112.545 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.899 HG21 ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -62.86 -41.35 92.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.328 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.405 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 65.8 m80 -58.14 -51.37 70.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.753 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -66.63 -50.38 63.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.212 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.39 -30.44 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.41 -67.11 0.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.617 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -62.33 -29.55 70.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.812 -179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 82' ' ' ASP . 52.2 p -66.99 -54.07 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 111.211 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 110.38 66.04 0.54 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.121 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -140.66 53.43 1.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.945 0.403 . . . . 0.0 110.55 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.983 HD22 ' HB2' ' A' ' 123' ' ' SER . 20.6 tp -52.23 -19.07 1.8 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -63.52 -72.33 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.702 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.819 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 6.3 m -73.15 -24.1 60.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.527 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.568 ' CD2' HG21 ' A' ' 96' ' ' VAL . 9.7 tt -56.16 -59.79 4.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 127' ' ' PHE . 8.1 ptmt -58.32 -38.0 76.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.133 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.765 HG11 ' HB3' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -51.73 -61.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.09 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.994 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -74.8 -43.48 54.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.05 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.873 HG22 HG12 ' A' ' 80' ' ' VAL . 10.7 t -52.54 -42.55 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.512 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.6 mm-40 -73.54 -39.53 64.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.225 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -51.88 66.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 178.77 -26.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.095 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -23.82 123.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 112.002 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.899 ' O ' HG21 ' A' ' 80' ' ' VAL . 9.8 t0 -56.6 85.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 102' ' ' VAL . 10.2 p -98.31 28.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 104' ' ' ALA . 0.2 OUTLIER -120.91 -33.22 3.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.495 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -48.11 -177.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.129 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 111' ' ' LEU . 9.3 mt -139.99 175.47 9.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.88 62.03 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 108' ' ' THR . 0.3 OUTLIER 68.45 -75.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.961 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 107' ' ' SER . 4.7 p -37.96 -48.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 122.93 19.72 2.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.512 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.512 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -93.06 118.29 31.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 110.993 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.945 HD11 ' HB3' ' A' ' 136' ' ' HIS . 5.2 mt -65.27 143.8 98.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.646 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 83.7 Cg_exo -45.2 -26.12 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.606 2.204 . . . . 0.0 112.173 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -72.12 -40.04 66.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.084 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -53.04 -46.04 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.699 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -58.76 -44.19 90.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.671 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.739 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -60.04 -35.63 75.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.443 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.577 ' HB ' HD23 ' A' ' 147' ' ' LEU . 97.8 mt -64.45 -43.62 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 115' ' ' LEU . 12.6 ptt180 -73.26 -10.12 59.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.745 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.99 -59.77 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.08 25.22 7.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.404 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 9.7 m-70 -63.82 -11.93 31.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 23.2 t 70.52 -68.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.983 ' HB2' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -70.63 -52.86 18.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.745 ' HA ' HD13 ' A' ' 89' ' ' LEU . 22.0 t -52.83 -55.86 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.9 t -52.0 -61.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.032 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 159' ' ' ILE . 5.4 p -58.0 -30.44 66.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.033 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.7 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.4 t80 -73.31 -55.39 6.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -63.93 -11.67 30.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.067 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.923 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -57.56 -70.24 0.38 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.099 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.929 ' HA ' HD11 ' A' ' 134' ' ' LEU . 57.9 Cg_endo -71.51 -17.92 29.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.238 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 29.4 mm-40 -90.56 31.0 1.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.712 ' O ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -152.1 -168.62 3.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.901 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 135' ' ' HIS . 23.5 t0 -77.1 83.78 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.9 mp -64.97 61.02 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.976 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 133' ' ' ASP . 19.0 t-160 -175.07 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.945 ' HB3' HD11 ' A' ' 111' ' ' LEU . 79.0 t60 -54.89 155.02 4.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -140.67 158.29 44.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.512 ' OD1' ' CB ' ' A' ' 110' ' ' SER . 1.9 t70 -64.23 158.7 22.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.68 -19.69 6.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 110.287 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.87 -46.22 72.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.859 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 125.08 32.26 0.81 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -129.16 146.31 51.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 0.0 111.088 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -115.82 -174.32 0.27 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.593 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 71.7 Cg_exo -48.66 -43.69 33.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -73.19 -47.91 39.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 17.3 tp10 -57.54 -57.52 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.577 HD23 ' HB ' ' A' ' 117' ' ' ILE . 6.6 tp -52.35 -34.31 46.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 0.0 110.283 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.687 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -63.82 -33.04 74.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.61 -30.18 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.007 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 3.1 tp-100 -70.4 -80.1 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.668 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.9 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.2 71.89 1.71 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -72.54 46.18 1.07 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 113.321 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 154' ' ' GLN . . . -36.79 -32.81 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.393 0.616 . . . . 0.0 110.263 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' ASN . 3.3 pm0 -179.66 -143.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.689 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' GLN . 1.1 m-80 -68.82 57.19 0.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.963 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.9 HD12 ' O ' ' A' ' 151' ' ' ARG . 4.1 mt -71.47 -69.77 0.36 Allowed 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 111.008 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.687 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 6.8 ptm -52.73 -19.46 2.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.786 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.64 -47.28 41.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 126' ' ' SER . 1.5 mt -62.08 -50.64 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.747 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -68.33 -29.99 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.541 ' HB2' HD21 ' A' ' 145' ' ' LEU . 4.4 tt0 -63.54 -42.91 98.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.24 -47.76 35.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.653 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -71.1 -20.04 62.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 111.043 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.503 ' HA ' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -45.71 -70.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 1.054 ' O ' HD12 ' A' ' 166' ' ' ILE . 0.6 OUTLIER 169.12 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 1.054 HD12 ' O ' ' A' ' 165' ' ' MET . 0.6 OUTLIER 35.38 77.67 0.37 Allowed Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.088 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.77 7.4 4.29 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.813 2.342 . . . . 0.0 112.423 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.941 -179.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t -132.38 102.19 5.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.378 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.9 ptt? -124.02 37.89 4.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.81 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt -76.77 -24.03 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mt 56.25 -172.49 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.704 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' C ' ' CG ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -138.88 52.92 1.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' CG ' ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER 44.36 71.44 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 9' ' ' CYS . 54.1 t -126.19 -85.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.205 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.516 ' N ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER 60.03 -83.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.711 HG21 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -93.53 -13.51 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.516 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -34.27 -31.12 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.816 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -109.62 -21.08 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 0.0 110.935 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 10' ' ' VAL . 9.5 tpt180 -57.07 -69.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.034 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD11 ' CD2' ' A' ' 62' ' ' LEU . 3.8 tp -68.65 -20.4 64.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 23.8 t -73.32 -44.32 59.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.01 -33.68 59.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.621 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.611 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -71.61 -38.88 70.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -72.84 -43.58 62.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.206 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -67.96 -36.25 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.202 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.1 ptp180 -68.3 -9.33 46.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.0 76.84 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.27 90.02 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 110.845 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 27' ' ' ARG . 2.4 p -52.65 -22.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -73.08 -47.86 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 mm-40 -72.87 -44.7 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.993 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.8 p -52.64 -41.87 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.018 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HD3' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.3 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 5.2 mtt180 -56.0 -21.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.735 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.616 HD22 HG21 ' A' ' 35' ' ' VAL . 10.3 mt -72.42 -68.99 0.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.61 -44.07 78.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.302 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 61.6 m-70 -73.13 -0.94 15.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.277 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -149.26 -76.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.212 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' HG22 ' A' ' 35' ' ' VAL . 14.5 tp10 -42.88 -27.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.978 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER 55.4 59.57 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.743 HG11 ' CB ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.23 143.35 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.243 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.687 ' ND1' ' OD2' ' A' ' 38' ' ' ASP . 2.1 t-80 -76.29 143.56 73.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.766 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 45.1 Cg_endo -68.07 -21.75 42.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 0.0 112.135 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.869 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -91.21 33.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.77 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CA ' ' HA2' ' A' ' 11' ' ' GLY . . . -80.93 125.6 30.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.133 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -126.39 124.2 39.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -62.5 -62.21 1.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 42' ' ' ARG . 30.5 tpt180 -97.87 46.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 26.5 t80 37.48 62.32 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.95 -65.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.385 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 15.3 mtpp -86.91 146.63 26.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.676 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 50' ' ' VAL . 4.2 p -92.73 -177.95 4.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -72.27 -36.0 68.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -32.08 69.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HG2' ' HE3' ' A' ' 45' ' ' LYS . 1.8 tt0 -69.94 -15.31 63.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 46' ' ' THR . 2.6 m -110.25 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.03 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.522 ' SD ' HD12 ' A' ' 62' ' ' LEU . 21.8 ttp -38.08 123.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.681 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -88.87 19.64 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.995 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.9 OUTLIER 39.35 30.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.121 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.22 -45.51 48.48 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.121 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 1.018 ' O ' HG22 ' A' ' 58' ' ' VAL . 20.5 m -108.6 134.85 20.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.819 0.342 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.6 -37.7 6.84 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.572 2.181 . . . . 0.0 112.29 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.42 -36.22 83.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.353 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.018 HG22 ' O ' ' A' ' 55' ' ' SER . 5.4 m -62.5 -27.99 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' A' ' 91' ' ' THR . . . -63.37 -60.36 3.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.618 HD13 ' C ' ' A' ' 60' ' ' LEU . 1.8 tm? -63.15 -40.67 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.964 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -62.52 -40.57 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.562 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 18' ' ' ALA . 7.1 mt -63.86 -63.57 1.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.496 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.593 HD23 ' CD2' ' A' ' 98' ' ' HIS . 23.6 tp -63.58 -14.69 53.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.02 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -62.9 -36.01 81.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.051 -179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 37' ' ' PRO . 2.4 mm-40 -68.08 -14.48 63.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.15 34.88 4.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.85 -179.41 3.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.596 ' O ' HG13 ' A' ' 71' ' ' VAL . 14.4 t -121.92 93.75 48.49 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.514 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 52.2 Cg_exo -54.22 -17.4 11.64 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.734 2.289 . . . . 0.0 112.179 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.719 ' OD1' ' OD1' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -94.65 64.02 2.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.793 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 68' ' ' SER . 2.7 m -104.56 146.55 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -142.79 143.68 32.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.7 p-10 -109.41 -170.3 1.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.75 68.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER 177.48 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.49 77.3 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.457 HG22 ' CG ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -164.63 135.56 4.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.898 0.38 . . . . 0.0 110.897 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.553 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -112.54 -177.38 0.44 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 29.2 Cg_exo -61.65 -39.53 53.21 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.883 2.389 . . . . 0.0 112.332 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.5 m -60.31 -28.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.245 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 78' ' ' SER . 3.2 m80 -62.65 -67.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.889 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.81 -43.92 90.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.806 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -52.48 -28.3 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.128 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.71 -56.5 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.464 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.535 ' NE ' HD13 ' A' ' 115' ' ' LEU . 1.8 mtt180 -73.16 -22.79 60.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.815 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 82' ' ' ASP . 69.5 p -71.12 -57.06 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.2 67.8 0.5 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.337 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 52' ' ' MET . 22.8 m-85 -140.61 52.09 1.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.413 . . . . 0.0 110.586 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.874 ' HG ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -52.36 -30.63 29.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.225 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -70.52 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.686 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.8 m -65.9 -37.4 86.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.685 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 83' ' ' ALA . 9.6 tp -52.82 -49.46 65.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.334 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.756 ' CE ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -53.99 -42.15 68.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 59' ' ' ALA . 22.6 t -52.86 -59.09 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.435 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.995 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.9 pp -71.3 -41.17 70.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 2.1 t -67.48 -56.32 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.953 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -52.72 -29.73 28.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.053 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.593 ' CD2' HD23 ' A' ' 63' ' ' LEU . 4.2 t-80 -60.61 -32.26 71.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.934 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.33 -5.52 4.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -46.01 141.13 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.743 0.306 . . . . 0.0 111.044 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.719 ' OD1' ' OD1' ' A' ' 70' ' ' ASN . 19.6 p-10 -52.08 140.17 21.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.931 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.06 13.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.587 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.82 8.01 30.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -82.26 136.85 34.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.089 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD2' ' HG ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -106.76 167.34 9.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.59 -169.67 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -20.89 26.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 1.9 m -90.05 -9.39 48.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.795 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 71.93 42.28 52.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.441 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 1.342 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 2.7 m -119.15 127.93 53.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.916 0.389 . . . . 0.0 110.985 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.047 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -59.95 149.63 72.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 1.047 ' HD2' HD23 ' A' ' 111' ' ' LEU . 55.1 Cg_exo -51.72 -30.52 37.68 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.13 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 111' ' ' LEU . 14.4 tt -71.0 -32.46 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.03 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.702 ' CE1' ' HB2' ' A' ' 138' ' ' ASP . 32.9 m170 -62.16 -36.19 81.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -73.28 -42.95 61.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.638 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.772 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.657 ' HA ' HG11 ' A' ' 125' ' ' VAL . 96.6 mt -59.79 -41.51 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' HD2' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -73.23 -4.05 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.13 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 115' ' ' LEU . 1.9 mm-40 -118.07 -46.07 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.092 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.82 34.5 53.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.099 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 23.8 m-70 -66.99 84.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.0 t 52.91 -146.64 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -73.6 4.37 5.07 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.79 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.874 HG22 ' HG ' ' A' ' 89' ' ' LEU . 46.7 t -52.27 -60.79 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.772 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.4 t -52.75 -36.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.104 0.478 . . . . 0.0 110.506 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.802 ' HB2' HG21 ' A' ' 159' ' ' ILE . 2.5 t -70.13 -44.96 67.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.607 ' CD2' HD21 ' A' ' 89' ' ' LEU . 20.4 t80 -69.15 -26.78 65.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.533 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -73.56 -0.19 14.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.251 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -73.11 -70.05 0.29 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 39.4 Cg_endo -66.86 -46.81 3.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.795 2.33 . . . . 0.0 112.802 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.581 ' OE1' ' CE2' ' A' ' 127' ' ' PHE . 4.8 pt-20 -51.52 -34.65 37.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.351 . . . . 0.0 110.758 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 9.3 m -108.8 151.06 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.137 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 31.1 p30 -34.8 121.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.9 mt -89.8 27.69 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -167.87 43.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.066 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.137 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -109.85 172.91 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.72 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.801 ' HG3' HG22 ' A' ' 143' ' ' THR . 8.5 mtm-85 -141.66 125.42 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.986 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 1.342 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 1.5 t0 -76.14 152.62 36.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 108' ' ' THR . . . -51.12 -21.45 1.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -42.79 99.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.74 47.87 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.575 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' CD1' ' HG ' ' A' ' 147' ' ' LEU . 2.9 pp -174.43 139.65 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 111.165 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.801 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -95.41 -175.31 0.45 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 85.0 Cg_exo -47.67 -59.62 1.18 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.802 2.335 . . . . 0.0 112.275 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 27.0 mt -57.77 -36.05 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.711 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 142' ' ' LEU . 68.3 mm-40 -61.48 -63.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.83 -48.99 66.6 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.063 0.458 . . . . 0.0 109.808 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 160' ' ' LEU . . . -54.61 -33.79 61.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.052 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -66.42 -44.73 82.15 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -67.84 -88.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 108.932 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 11.3 ttm180 -75.22 58.0 0.9 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 148' ' ' ALA . . . -73.18 45.53 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.557 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.54 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -39.27 134.86 1.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 36.68 -152.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.529 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 3.5 p-10 -74.45 50.31 0.41 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.236 -0.186 . . . . 0.0 110.861 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.636 ' HA ' HD12 ' A' ' 159' ' ' ILE . 3.3 mt -66.39 -70.64 0.23 Allowed 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 111.67 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.745 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 9.1 ptm -52.49 -20.07 2.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -73.62 -52.35 13.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.802 HG21 ' HB2' ' A' ' 126' ' ' SER . 1.9 mt -57.65 -32.2 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 120.913 0.387 . . . . 0.0 111.009 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -73.5 -40.84 63.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.058 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -65.71 -25.71 67.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.856 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -54.68 6.89 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.345 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -71.37 -12.62 61.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.786 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.72 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.7 mmm -78.09 116.16 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 39.18 -155.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.995 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.526 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 35.4 pt 38.87 58.19 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 166' ' ' ILE . 42.6 Cg_exo -56.64 83.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.719 2.279 . . . . 0.0 112.279 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 10.3 mmt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.895 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 1' ' ' GLY . 0.4 OUTLIER 37.12 80.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.378 . . . . 0.0 110.819 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -91.4 -33.25 15.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.949 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.53 126.59 46.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.73 69.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.806 ' OE2' ' N ' ' A' ' 9' ' ' CYS . 4.4 tm-20 -151.4 152.25 32.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.798 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -145.57 21.23 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 9' ' ' CYS . 53.1 t -125.13 -93.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.806 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 98.4 m 48.69 -85.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.847 0.356 . . . . 0.0 111.034 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -72.09 -30.2 35.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.468 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.548 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -41.35 -26.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.688 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' ASN . 30.6 t0 -108.11 31.58 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 10' ' ' VAL . 12.4 ttm180 -117.32 -59.82 1.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.628 ' HB2' HG11 ' A' ' 35' ' ' VAL . 12.3 tp -70.87 -24.13 62.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.5 p -64.68 -48.35 75.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.762 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -73.1 -36.32 56.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.4 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.628 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.24 -57.37 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -44.74 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' MET . . . -73.13 -22.93 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.174 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 8.0 mtp180 -72.84 -27.48 61.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 62.34 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.225 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.1 p-10 -132.11 84.42 2.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.4 p -52.84 -21.53 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 46.8 mt-30 -73.5 -49.13 28.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.818 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.225 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 7.0 mp0 -73.47 -41.88 62.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.952 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.831 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.8 p -52.86 -39.72 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.102 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 1.138 ' HG2' ' OE2' ' A' ' 61' ' ' GLU . 5.2 mtt180 -73.13 -61.46 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.362 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 14.4 mtm-85 -62.04 -25.6 67.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.224 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.574 HD11 ' CB ' ' A' ' 17' ' ' ALA . 9.5 mt -56.73 -66.71 0.4 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.883 HD22 ' HG3' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -73.54 -48.73 30.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.775 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 1.1 m-70 -68.95 -10.94 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.963 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -137.42 -66.88 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.72 0.295 . . . . 0.0 111.386 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -54.51 -18.26 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.076 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.512 ' N ' HD23 ' A' ' 34' ' ' LEU . 4.8 mt 55.29 61.65 2.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 14' ' ' LEU . 12.0 p -107.31 129.3 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.586 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -56.83 146.6 57.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.947 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 18.6 Cg_endo -58.78 -66.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.713 2.276 . . . . 0.0 112.21 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -44.73 -62.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.697 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . 34.28 97.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.561 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD11 HG22 ' A' ' 46' ' ' THR . 1.7 mp -92.78 130.82 38.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 12' ' ' ASP . 37.8 p-10 -65.51 -31.67 72.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.92 39.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 43' ' ' PHE . 65.5 t80 54.42 72.97 0.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.01 -64.71 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.581 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HB3' HG13 ' A' ' 50' ' ' VAL . 10.8 mmtt -98.32 136.47 38.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.751 0.31 . . . . 0.0 111.052 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 50' ' ' VAL . 33.3 p -89.2 161.72 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.91 -33.68 51.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' CD1' HD11 ' A' ' 62' ' ' LEU . 2.0 tp -73.25 -42.23 62.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.983 ' NE2' ' OD2' ' A' ' 73' ' ' ASP . 54.2 tt0 -73.15 -8.71 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 46' ' ' THR . 3.9 m -115.83 -23.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.574 ' HA ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.8 173.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.732 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.575 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -124.37 21.12 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.79 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.917 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.1 m-85 41.01 29.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.944 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -58.38 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.076 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.544 ' HB2' ' CG1' ' A' ' 58' ' ' VAL . 0.4 OUTLIER -73.7 153.33 89.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.328 . . . . 0.0 110.432 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.691 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 13.1 Cg_exo -69.96 -42.93 2.79 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.819 2.346 . . . . 0.0 112.303 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB1' ' OE1' ' A' ' 61' ' ' GLU . . . -63.55 -23.72 67.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.926 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.831 ' HA ' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.49 -49.45 83.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.36 -47.56 81.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.597 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.667 HD13 ' O ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -63.03 -53.25 56.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.325 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.138 ' OE2' ' HG2' ' A' ' 27' ' ' ARG . 2.2 mt-10 -63.27 -56.86 13.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.928 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.737 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.67 -50.46 71.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.672 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 6.9 tt -63.4 -42.89 98.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.67 0.271 . . . . 0.0 111.124 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.8 tttp -62.77 -42.05 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.968 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.883 ' HG3' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -44.49 -29.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.896 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.546 ' CA ' ' HG3' ' A' ' 37' ' ' PRO . . . 132.7 59.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -107.21 167.26 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -108.56 103.67 51.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 37.0 Cg_endo -65.88 -13.55 40.36 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.797 2.331 . . . . 0.0 112.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.535 ' ND2' ' HB3' ' A' ' 101' ' ' ASP . 31.4 m120 -102.61 86.67 2.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 78' ' ' SER . 12.7 m -142.74 132.11 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.0 OUTLIER -149.6 146.44 27.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.983 ' OD2' ' NE2' ' A' ' 49' ' ' GLN . 2.7 p30 -151.1 -170.49 3.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 61.38 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 73' ' ' ASP . 1.4 p -133.62 -66.93 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.04 78.17 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.428 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -152.99 154.22 34.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.986 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.599 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.4 p -139.62 -174.26 0.4 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.947 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 55.2 Cg_exo -51.67 -51.24 11.6 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.79 2.327 . . . . 0.0 112.458 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -52.83 -44.08 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' NE2' ' HG3' ' A' ' 112' ' ' PRO . 51.4 m80 -62.94 -56.25 18.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.007 ' O ' HG23 ' A' ' 86' ' ' THR . 1.9 p30 -54.77 -48.83 72.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.845 ' CB ' HD13 ' A' ' 92' ' ' LEU . . . -56.28 -57.19 13.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.308 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.12 -50.3 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.86 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -57.16 -40.77 77.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.199 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.3 p -73.33 -59.77 2.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.897 0.38 . . . . 0.0 111.106 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.82 73.09 0.19 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.216 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 56.7 m-85 -136.75 49.81 2.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.636 HD21 ' CG ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -52.39 -35.73 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.056 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.57 -66.43 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.779 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.812 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 63.0 m -71.72 -41.09 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.845 HD13 ' CB ' ' A' ' 83' ' ' ALA . 49.7 tp -52.66 -51.24 61.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.502 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 97' ' ' GLU . 28.9 ttmt -52.74 -36.85 58.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.481 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.295 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 24.2 t -57.03 -70.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.917 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -58.59 -38.51 78.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.325 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.819 HG11 ' OE1' ' A' ' 131' ' ' GLU . 2.4 t -64.02 -60.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.682 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.295 ' CD ' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -52.73 -30.81 34.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.863 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.506 ' N ' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -73.15 -54.56 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.653 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' ALA . . . -164.73 -65.76 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.287 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 95' ' ' LEU . . . 40.2 -166.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.354 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 14.6 p-10 -135.63 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.689 HG13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -100.9 19.14 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.765 ' ND2' ' OD2' ' A' ' 133' ' ' ASP . 15.3 m120 -104.67 -25.18 12.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -67.55 167.6 12.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 109' ' ' GLY . 7.7 mt -136.14 -160.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 107' ' ' SER . 4.1 m-20 -122.91 -154.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.065 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 106' ' ' ASP . 18.9 m -60.34 -38.79 84.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -88.17 -3.53 58.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.538 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 69.71 46.55 53.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.499 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -107.37 134.8 49.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.996 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.501 ' HB2' ' ND1' ' A' ' 114' ' ' HIS . 36.9 mt -62.97 151.22 86.37 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.825 ' HB2' HD11 ' A' ' 128' ' ' LEU . 89.3 Cg_exo -46.64 -26.46 4.42 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.626 2.217 . . . . 0.0 112.243 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 129' ' ' ALA . 17.7 tt -71.79 -35.78 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.844 ' HA ' HD12 ' A' ' 117' ' ' ILE . 21.6 m80 -56.34 -37.96 70.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.755 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.1 mt -69.09 -51.78 35.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.604 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -52.83 -32.07 42.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.89 HD13 ' HB3' ' A' ' 147' ' ' LEU . 52.7 mt -60.9 -39.64 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.57 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.43 ' CD ' ' HG3' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -68.19 -17.35 64.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.525 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.86 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -92.08 -54.69 3.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.76 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.26 37.15 7.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -65.63 -10.63 37.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.781 0.324 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.86 -68.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.966 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.08 -49.74 48.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.8 t -59.59 -59.42 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 116' ' ' ALA . 11.4 t -52.34 -46.52 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.313 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.733 ' HB3' HG21 ' A' ' 159' ' ' ILE . 73.4 p -69.45 -33.59 73.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.289 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 1.381 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 17.6 t80 -73.3 -40.01 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.825 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -62.17 -12.16 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -66.69 -64.59 2.13 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.185 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.706 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.3 Cg_endo -59.17 -35.63 97.29 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.876 2.384 . . . . 0.0 112.445 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.381 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 2.3 mt-10 -90.5 35.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.933 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.508 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 92.6 p -151.59 48.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.765 ' OD2' ' ND2' ' A' ' 103' ' ' ASN . 0.5 OUTLIER 36.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.765 HD22 ' HG3' ' A' ' 164' ' ' MET . 69.8 mt -55.6 141.09 38.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.041 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.499 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 7.7 t-80 84.72 -12.56 0.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 137' ' ' ARG . 74.1 t60 -60.49 169.51 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -119.32 -169.77 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 4.5 m-20 -145.5 171.26 14.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.524 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . . . -68.54 -6.44 25.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 p -114.05 0.87 14.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.21 95.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.578 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.492 ' HB3' HD23 ' A' ' 147' ' ' LEU . 33.9 mt -120.2 77.4 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.076 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 14.2 p -48.27 161.41 0.38 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.711 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.5 Cg_exo -48.28 -37.5 32.04 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.747 2.298 . . . . 0.0 112.421 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 145' ' ' LEU . 2.0 tt -71.06 -41.74 70.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.076 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 0.2 OUTLIER -66.3 -48.54 70.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HB3' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.19 -39.79 60.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.039 0.447 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.926 ' HB1' HD13 ' A' ' 156' ' ' LEU . . . -61.23 -45.69 93.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.204 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.437 ' HB2' ' CE ' ' A' ' 157' ' ' MET . 11.0 tpt180 -57.19 -30.5 64.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.109 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.29 -75.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.792 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 1.078 ' O ' HD21 ' A' ' 156' ' ' LEU . 17.1 mmm180 -74.56 70.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -64.46 51.39 0.09 OUTLIER Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.334 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -52.57 -31.19 34.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.473 0.654 . . . . 0.0 109.831 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.536 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 2.9 pm0 173.27 -146.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.182 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 1.205 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 21.5 m120 -74.91 44.53 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.078 HD21 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -73.58 -31.45 63.61 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.479 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.677 ' H ' HD12 ' A' ' 156' ' ' LEU . 1.1 ptm -67.34 -29.05 68.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.205 ' OD1' ' O ' ' A' ' 155' ' ' ASN . 5.4 p-10 -74.26 -46.58 40.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.245 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.733 HG21 ' HB3' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.16 -39.83 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.198 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.01 -41.56 61.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.11 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG3' ' HG ' ' A' ' 145' ' ' LEU . 1.9 mt-30 -61.73 -55.37 31.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.047 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.3 95.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.427 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 159' ' ' ILE . 1.1 m-70 -72.98 -10.86 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.978 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.765 ' HG3' HD22 ' A' ' 134' ' ' LEU . 3.1 ttm -90.82 -176.36 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.866 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 ttp -130.94 28.3 4.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 166' ' ' ILE . 9.9 pt -53.12 113.29 4.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.16 -10.36 17.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.896 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 t -148.73 -57.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 mtm -98.48 112.1 24.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 170.12 44.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.567 ' C ' ' OE1' ' A' ' 7' ' ' GLU . 1.8 mt -88.55 115.33 25.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.669 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 1.2 mm-40 -112.33 -27.4 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.692 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER 41.71 68.9 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.744 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG13 ' H ' ' A' ' 9' ' ' CYS . 2.2 p -134.08 -57.19 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.611 ' H ' HG13 ' A' ' 8' ' ' VAL . 55.2 m 41.95 -91.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 35' ' ' VAL . 4.7 p -94.57 25.04 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.751 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -78.37 -10.57 86.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.476 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 2.5 p30 -129.12 24.07 5.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.351 . . . . 0.0 110.745 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HB3' ' CG2' ' A' ' 10' ' ' VAL . 5.8 ttt180 -103.89 -67.08 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.82 HD22 ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -69.39 -39.99 77.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.696 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.633 ' N ' HD13 ' A' ' 14' ' ' LEU . 1.1 m -57.18 -30.1 64.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.68 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.03 -36.4 60.72 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.31 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -68.49 -57.17 6.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.95 64.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -27.94 62.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.2 OUTLIER -73.14 -31.7 64.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 83.69 64.92 1.59 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.406 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.399 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 1.2 p30 -137.12 100.94 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 26' ' ' VAL . 2.5 p -52.7 -23.46 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.018 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -73.31 -49.61 26.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.834 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.399 ' OE1' ' CB ' ' A' ' 22' ' ' ASP . 1.8 mt-10 -73.09 -47.24 46.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 58' ' ' VAL . 4.9 p -52.86 -38.1 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 60.2 mtm180 -73.15 -61.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.192 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -52.94 -31.8 42.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.251 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.745 HD23 ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -72.9 -69.08 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.853 0.358 . . . . 0.0 111.232 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 61' ' ' GLU . 10.8 mt -70.69 -42.62 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 4.3 t-80 -73.29 -0.51 14.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.376 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -150.58 -75.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.717 0.294 . . . . 0.0 111.179 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.745 ' OE1' HD23 ' A' ' 29' ' ' LEU . 2.8 tm-20 -41.18 -27.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.932 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 34' ' ' LEU . 9.7 mt 54.79 56.04 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 14' ' ' LEU . 41.0 t -87.28 130.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -48.41 133.7 13.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.9 Cg_endo -71.61 -18.95 28.63 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.767 2.311 . . . . 0.0 112.349 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.821 ' O ' HD12 ' A' ' 40' ' ' LEU . 57.5 p-10 -87.49 1.73 52.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.161 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -45.91 121.83 3.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -111.34 127.45 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 6.5 m-80 -64.06 -163.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.401 ' O ' ' HD2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -81.79 -2.0 49.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.83 -23.13 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.744 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 96.24 29.35 8.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.447 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HB3' HG13 ' A' ' 50' ' ' VAL . 22.6 mttp -105.45 152.92 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.22 168.16 14.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -61.17 -53.8 52.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.063 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 51' ' ' MET . 3.6 mt -68.17 -27.99 66.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.684 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HB2' HG21 ' A' ' 71' ' ' VAL . 45.0 tt0 -73.39 -3.66 28.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 46' ' ' THR . 28.6 m -133.68 -37.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -36.09 137.72 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.901 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.504 ' HE2' ' HA3' ' A' ' 54' ' ' GLY . 12.4 ptm -93.5 123.62 36.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.712 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.059 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 60.9 m-85 -56.96 -16.51 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -36.31 -40.85 0.45 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.255 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.922 ' O ' HG22 ' A' ' 58' ' ' VAL . 19.3 m -110.94 127.16 27.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.608 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.3 Cg_endo -73.6 -32.28 7.88 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.297 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.93 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.0 -39.73 95.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 55' ' ' SER . 19.1 m -62.38 -30.04 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.065 0.46 . . . . 0.0 110.447 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -64.0 -66.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 6.2 tt -63.24 -32.12 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.93 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -62.91 -54.54 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.799 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 14' ' ' LEU . 6.2 mt -62.69 -46.1 89.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.654 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 63' ' ' LEU . 2.5 mt -63.29 -49.48 73.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.966 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 60' ' ' LEU . 5.6 ttpp -63.01 -13.1 31.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.089 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -79.0 -34.47 44.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.86 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.16 44.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.74 -171.63 2.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 m -136.47 114.11 10.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -26.51 20.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.621 2.214 . . . . 0.0 112.348 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.14 75.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 49' ' ' GLN . 4.0 m -137.25 134.2 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.406 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 11.0 mt-30 -131.34 167.54 19.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.48 -71.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 75' ' ' SER . . . -41.04 -29.87 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 1.1 t 162.92 -28.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . 171.2 37.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -110.95 113.89 26.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -86.68 171.19 10.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.704 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 14.3 Cg_endo -56.92 -41.64 73.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.629 2.219 . . . . 0.0 112.07 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 2.9 m -56.39 -43.9 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 79.7 m80 -54.1 -53.43 53.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 86' ' ' THR . 2.9 p30 -70.12 -31.17 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.154 ' CB ' HD11 ' A' ' 92' ' ' LEU . . . -66.64 -25.8 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.25 -65.19 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.29 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -59.51 -26.3 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 82' ' ' ASP . 4.1 p -65.9 -37.62 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.094 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.54 66.28 1.29 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.425 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -140.33 49.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.97 HD21 ' CD2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -53.4 -18.82 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.29 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.715 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.4 -70.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.8 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.63 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 13.8 m -71.21 -31.76 67.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.34 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.154 HD11 ' CB ' ' A' ' 83' ' ' ALA . 1.1 mp -53.7 -52.01 61.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.111 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.901 ' HD3' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -51.18 -30.93 18.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.621 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.511 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 62.1 t -74.3 -58.23 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.201 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.827 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 2.3 pp -74.58 -44.1 52.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -66.13 -29.84 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.21 -27.28 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -73.51 -50.2 22.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -168.15 -70.13 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.035 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . 24.4 99.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' ALA . 6.2 p-10 -37.52 90.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 110.682 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -92.68 -6.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.647 ' HA ' HD11 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.55 2.44 39.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -74.65 171.51 13.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.1 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 111' ' ' LEU . 56.3 mt -136.35 -168.14 2.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.06 -171.1 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.943 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -52.04 -28.25 16.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -10.71 38.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.629 ' O ' HD22 ' A' ' 105' ' ' LEU . . . 72.13 9.83 72.56 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.623 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.462 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 0.3 OUTLIER -77.62 109.79 11.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.136 HD23 ' CG2' ' A' ' 113' ' ' ILE . 6.3 tp -59.78 142.22 88.42 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.715 ' HA ' HD13 ' A' ' 115' ' ' LEU . 90.8 Cg_exo -40.7 -29.13 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.734 2.29 . . . . 0.0 112.352 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 1.136 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -73.27 -43.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 43.2 m80 -53.59 -37.11 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.715 HD13 ' HA ' ' A' ' 112' ' ' PRO . 6.6 mp -57.54 -57.8 11.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.783 ' CA ' ' OE1' ' A' ' 119' ' ' GLU . . . -52.86 -30.23 32.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.824 ' HB ' HD23 ' A' ' 147' ' ' LEU . 77.9 mt -66.46 -38.08 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.516 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HG2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -73.18 -15.85 61.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 1.29 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 2.6 mp0 -94.69 -52.99 4.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.794 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 87.39 18.1 57.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.158 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' SER . 92.8 m-70 -35.82 -69.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.545 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 3.1 t 156.63 -92.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.57 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.576 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -73.34 -14.1 61.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.749 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.621 HG12 ' CB ' ' A' ' 116' ' ' ALA . 69.2 t -68.57 -65.02 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.685 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.6 t -52.27 -41.18 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.079 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.646 ' CB ' HG21 ' A' ' 159' ' ' ILE . 93.4 p -72.27 -30.87 65.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 1.352 ' CE1' ' OE2' ' A' ' 131' ' ' GLU . 53.2 t80 -73.24 -53.06 11.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.6 -19.48 49.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.83 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.93 -70.58 0.28 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.83 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 38.8 Cg_endo -66.64 -37.6 21.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.7 2.266 . . . . 0.0 112.412 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.352 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 23.8 mp0 -65.94 -21.52 66.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.716 ' HB3' HD21 ' A' ' 111' ' ' LEU . 6.9 m -114.02 148.77 36.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.113 ' OD2' ' ND1' ' A' ' 136' ' ' HIS . 2.2 p30 -38.33 110.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.694 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -65.71 -10.25 35.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.47 39.68 3.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.113 ' ND1' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -106.21 138.71 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.985 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -130.09 163.21 27.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.462 ' OD2' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -96.47 160.89 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.714 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.66 -15.76 13.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -34.66 21.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.801 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 98.95 72.09 1.03 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.579 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 20.1 mt -151.92 62.02 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 137' ' ' ARG . 0.0 OUTLIER -40.93 168.21 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.035 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 143' ' ' THR . 84.2 Cg_exo -44.34 -51.18 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.621 2.214 . . . . 0.0 112.144 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.88 -40.29 79.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.399 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.509 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -53.03 -63.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.57 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.8 tp -56.61 -41.89 77.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.536 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -53.01 -40.25 63.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.423 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.06 -40.58 96.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -68.76 -79.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.93 71.78 1.57 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.448 ' HA2' ' SD ' ' A' ' 157' ' ' MET . . . -72.54 42.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.576 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.973 ' HB1' ' OE1' ' A' ' 154' ' ' GLN . . . -52.26 128.96 26.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.973 ' OE1' ' HB1' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 31.38 -154.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.514 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 20.6 m120 -76.82 42.82 0.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.776 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -72.87 -50.48 23.58 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.198 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.752 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.24 -30.81 29.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.91 0.386 . . . . 0.0 110.614 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 162' ' ' GLY . 0.2 OUTLIER -74.17 -49.45 23.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.646 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.1 OUTLIER -51.77 -59.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 156' ' ' LEU . 6.4 mp -57.81 -63.63 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 157' ' ' MET . 1.5 pt20 -52.67 -37.1 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.822 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -66.13 -49.03 60.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.17 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -18.64 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.65 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.486 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.5 ttm -75.94 -165.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 tpt -150.03 67.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.799 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 166' ' ' ILE . 0.6 OUTLIER -143.44 47.84 0.86 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 166' ' ' ILE . 58.5 Cg_endo -71.97 170.71 18.23 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.666 2.244 . . . . 0.0 112.296 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.943 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.97 -65.41 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.46 48.59 21.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -134.55 16.75 3.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LEU . 13.2 tp 56.32 119.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.88 107.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.95 106.6 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 8' ' ' VAL . 71.3 t -114.6 -9.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.213 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -43.9 -41.03 4.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 7.1 p -95.91 -13.47 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 12' ' ' ASP . . . -49.86 126.01 20.53 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.405 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 4.6 t0 87.31 5.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 110.958 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 7.0 tpt180 -73.26 -74.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.839 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -73.2 -23.84 60.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -65.46 -48.61 72.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -70.33 -31.33 68.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.606 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -72.68 -64.66 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.53 65.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HA ' ' N ' ' A' ' 52' ' ' MET . . . -71.66 -26.09 62.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -73.41 -29.42 62.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' ARG . . . 97.8 70.46 1.0 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.807 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.085 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 1.4 p30 -146.03 79.97 1.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.876 0.369 . . . . 0.0 110.508 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.2 p -52.61 -20.1 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.022 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -72.68 -47.88 43.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.495 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.085 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.34 -39.39 65.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.21 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.4 p -53.41 -36.22 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.874 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 76.5 mtt-85 -73.32 -55.97 5.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.572 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -66.94 -18.3 65.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.029 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.706 HD12 ' CD ' ' A' ' 25' ' ' GLU . 2.8 mt -65.54 -65.67 0.64 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.509 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.762 HD12 ' CD ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -73.54 -38.18 65.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.75 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -72.46 -33.91 67.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.684 -179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HG3' ' HA ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -113.8 -55.46 2.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.184 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.03 -6.36 27.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER 43.62 27.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.926 0.393 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.839 HG11 ' HB2' ' A' ' 14' ' ' LEU . 9.2 p -53.09 147.15 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 136.68 39.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 60.6 Cg_endo -73.08 -11.2 25.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.902 2.402 . . . . 0.0 112.471 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -108.58 7.4 26.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.54 78.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.068 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 38' ' ' ASP . 1.9 mp -64.48 148.05 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -73.4 -154.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -23.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.6 -35.37 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.17 29.28 3.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HE2' ' OE1' ' A' ' 49' ' ' GLN . 48.0 mtpt -95.12 160.14 14.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.769 0.318 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.509 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -84.85 150.44 25.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.475 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -65.51 -31.74 72.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 69' ' ' PRO . 12.7 tp -72.31 -47.55 48.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.016 ' HB3' HG21 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -63.08 -18.06 62.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.745 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 46' ' ' THR . 35.5 m -104.36 -34.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -38.7 162.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -103.07 139.25 38.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.957 ' CD2' HD21 ' A' ' 95' ' ' LEU . 19.6 m-85 -84.03 10.29 10.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.84 -54.02 38.59 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.286 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -99.55 134.86 20.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.653 0.263 . . . . 0.0 110.895 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.859 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 11.2 Cg_exo -71.68 -43.84 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.744 2.296 . . . . 0.0 112.172 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' ' CB ' ' A' ' 61' ' ' GLU . . . -62.75 -27.22 69.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.988 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 55' ' ' SER . 4.5 t -62.87 -45.84 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' LEU . . . -63.88 -56.6 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.228 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.758 ' C ' HD23 ' A' ' 60' ' ' LEU . 3.3 tt -63.14 -44.67 94.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.413 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.21 ' OE2' ' O ' ' A' ' 26' ' ' VAL . 1.6 tt0 -62.31 -58.51 7.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.4 -46.84 84.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.96 HD21 ' CE1' ' A' ' 98' ' ' HIS . 10.4 tt -62.91 -31.7 72.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 60' ' ' LEU . 12.3 mttt -63.0 -44.39 96.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.931 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.633 ' HB2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -44.01 -25.81 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 67' ' ' ALA . . . 134.68 -11.78 4.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -37.16 148.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.852 0.358 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 71' ' ' VAL . 57.8 m -103.82 116.47 61.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.936 ' HA ' HD23 ' A' ' 48' ' ' LEU . 73.9 Cg_endo -75.88 -29.76 6.6 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.75 2.3 . . . . 0.0 112.432 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 101' ' ' ASP . 1.7 m-20 -73.62 68.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 49' ' ' GLN . 9.7 m -117.19 155.41 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' THR . 4.8 mp0 -147.93 145.57 28.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 75' ' ' SER . 5.7 p-10 -120.4 100.9 7.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 48.75 -89.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 73' ' ' ASP . 3.4 m -39.32 -57.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.16 46.24 0.17 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.515 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 0.2 OUTLIER -89.54 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.901 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 1.134 ' OG ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 178.92 170.79 0.51 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.676 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' SER . 3.3 Cg_endo -46.36 -55.02 4.07 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.857 2.371 . . . . 0.0 112.089 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.01 ' CG2' HG12 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.43 -39.75 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.039 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.484 ' ND1' ' N ' ' A' ' 78' ' ' SER . 34.9 m80 -52.86 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.229 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER -67.11 -36.0 80.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.329 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.951 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -26.58 19.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -73.71 -62.52 1.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.776 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.93 -25.65 61.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.915 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.9 p -56.12 -23.31 33.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.656 0.265 . . . . 0.0 111.25 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.603 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 67.78 65.47 2.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.204 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -155.4 60.35 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.617 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' CG ' ' A' ' 127' ' ' PHE . 1.5 tm? -52.06 -19.65 2.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.076 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.338 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -66.82 -66.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.902 0.382 . . . . 0.0 110.837 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.338 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 21.8 m -73.09 -34.54 66.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.6 tt -52.7 -60.89 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.814 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 1.195 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 12.6 ptpt -52.33 -37.66 56.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.053 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 53.1 t -55.58 -64.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.957 HD21 ' CD2' ' A' ' 53' ' ' PHE . 3.9 pp -71.06 -35.53 71.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.932 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 31.2 t -66.39 -42.31 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.928 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.195 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -71.63 -22.02 61.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.754 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 63' ' ' LEU . 58.3 t-80 -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 145.82 -9.46 1.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.843 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -34.83 114.36 0.22 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.134 ' OD1' ' OG ' ' A' ' 78' ' ' SER . 9.7 p30 -33.48 91.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.01 HG12 ' CG2' ' A' ' 80' ' ' VAL . 2.4 m -98.63 -1.39 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.008 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 9.1 m-20 -116.56 20.35 14.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.11 151.11 29.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -129.16 -159.93 0.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -150.38 86.78 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.878 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.44 -73.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.651 HG22 ' O ' ' A' ' 106' ' ' ASP . 1.3 t -43.07 -26.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.472 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' A' ' 105' ' ' LEU . . . 72.67 32.58 61.43 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.41 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.463 ' CA ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -97.92 102.36 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 0.0 111.013 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.404 HD11 ' CG ' ' A' ' 133' ' ' ASP . 13.3 mt -53.93 146.86 26.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' A' ' 80' ' ' VAL . 94.4 Cg_exo -43.14 -35.18 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.6 2.2 . . . . 0.0 112.326 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.3 tt -73.61 -31.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.328 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 21.3 m170 -52.61 -58.39 6.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.737 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -55.14 -50.87 68.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.522 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -53.81 -37.04 63.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.617 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.819 HG21 ' HB3' ' A' ' 147' ' ' LEU . 73.6 mt -62.32 -41.28 91.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.447 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -70.32 -14.78 62.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.539 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 19.8 mt-10 -102.87 -50.57 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.616 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 121' ' ' HIS . . . 74.29 31.04 59.74 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.603 ' CE1' ' HA3' ' A' ' 87' ' ' GLY . 0.8 OUTLIER -34.12 -46.23 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 110.687 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 5.1 t 155.83 -109.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.528 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 38.7 m -73.88 -14.86 61.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.678 0.275 . . . . 0.0 110.929 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.74 ' O ' HD23 ' A' ' 128' ' ' LEU . 55.2 t -55.07 -67.05 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.414 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.8 t -52.64 -46.44 49.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.411 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.748 ' CB ' HG21 ' A' ' 159' ' ' ILE . 6.4 p -73.14 -23.2 60.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.713 ' CG ' HD21 ' A' ' 89' ' ' LEU . 15.6 t80 -73.52 -65.74 0.78 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -75.18 26.81 0.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -64.24 -56.49 23.29 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 110.669 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.1 Cg_endo -76.63 -34.71 2.39 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.73 2.287 . . . . 0.0 111.894 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 4.8 mm-40 -54.49 -24.94 22.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 3.5 m -114.86 146.93 40.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.404 ' CG ' HD11 ' A' ' 111' ' ' LEU . 1.8 p-10 -37.48 105.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 164' ' ' MET . 7.5 mt -83.72 63.98 7.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 136' ' ' HIS . 41.0 t-80 -176.87 -60.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.783 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 56.4 t60 -39.58 161.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.819 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.656 ' CG ' HG22 ' A' ' 143' ' ' THR . 0.0 OUTLIER -141.23 156.34 45.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.463 ' OD1' ' CA ' ' A' ' 110' ' ' SER . 2.5 t0 -60.92 153.83 23.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.816 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.6 -16.89 11.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.028 0.442 . . . . 0.0 110.626 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -48.99 28.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 131.3 54.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.579 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 20.7 mt -152.3 125.89 8.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.656 HG22 ' CG ' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -100.68 178.35 1.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.751 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 88.9 Cg_exo -46.93 -57.33 2.36 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.766 2.31 . . . . 0.0 112.361 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.586 ' HA ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -71.13 -36.87 72.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.27 -53.09 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.819 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -52.47 -40.1 61.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 110.333 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -59.67 -40.57 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.44 -36.05 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.062 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.525 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.7 tp-100 -67.43 -76.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.76 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.654 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.5 mpt_? -74.25 70.15 1.62 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -69.79 49.67 0.66 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.019 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -43.96 -27.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 0.0 110.178 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.528 ' NE2' ' HG ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER 168.96 -132.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.441 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.542 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 44.1 m-20 -75.46 42.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.96 -0.463 . . . . 0.0 111.602 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 151' ' ' ARG . 3.6 mt -62.56 -69.16 0.27 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.771 0.319 . . . . 0.0 111.437 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.64 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 10.0 ptm -52.36 -21.82 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.067 ' OD1' HG13 ' A' ' 159' ' ' ILE . 31.9 p30 -73.93 -51.04 17.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.418 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.067 HG13 ' OD1' ' A' ' 158' ' ' ASP . 1.5 mt -61.71 -24.12 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.375 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.974 HD11 ' HB2' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -73.04 -34.24 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.993 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.494 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -70.64 -31.46 68.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.27 -49.92 18.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.516 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -70.12 -16.25 63.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.781 ' HG2' HD13 ' A' ' 134' ' ' LEU . 8.5 mtp -77.36 169.94 17.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.039 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 8.2 ttt -140.24 136.8 33.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 166' ' ' ILE . 14.2 tt -153.85 115.28 2.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.157 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -51.11 102.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 0.0 112.254 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 31.7 mtp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.857 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.415 -0.274 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.89 82.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.757 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 1' ' ' GLY . 1.2 mtp -92.88 74.75 4.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 5' ' ' LEU . 1.4 pp -102.32 132.89 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.793 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.577 HD13 ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -49.42 160.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.926 ' OE1' ' HA ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -65.14 79.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.977 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -106.72 -11.05 15.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.048 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 10' ' ' VAL . 77.5 t 42.72 -89.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.209 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 7' ' ' GLU . 14.4 t 59.1 -79.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 8' ' ' VAL . 8.2 p -86.29 -6.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -61.98 -57.3 17.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.47 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' ASN . 53.2 p30 -85.56 13.52 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.89 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -82.33 -66.0 0.94 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.914 HD23 ' O ' ' A' ' 36' ' ' HIS . 2.5 tp -72.15 -44.44 63.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -56.78 -32.52 65.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.829 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -72.69 -46.38 31.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.469 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -51.59 38.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.09 -41.65 79.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.3 -22.75 61.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.202 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -73.14 -43.23 61.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.62 70.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 1.9 p30 -139.0 103.65 4.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.501 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.04 -23.01 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.55 -51.45 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 60.0 mm-40 -68.49 -44.77 74.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.201 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.778 HG21 ' HA ' ' A' ' 58' ' ' VAL . 12.8 p -52.68 -49.99 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.185 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HG13 ' A' ' 26' ' ' VAL . 70.5 mtt-85 -69.79 -54.57 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 8.7 mtm180 -61.31 -24.13 66.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.24 -71.48 0.31 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 61' ' ' GLU . 11.0 mt -73.54 -43.77 59.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.674 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -71.75 -1.85 15.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.517 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -147.5 -75.56 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.35 ' CD ' HG22 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -47.46 -23.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 29' ' ' LEU . 12.4 mt 56.04 37.71 29.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.35 HG22 ' CD ' ' A' ' 33' ' ' GLU . 1.6 t -66.16 140.59 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.219 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.997 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -60.69 139.92 93.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.8 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 66' ' ' GLY . 33.0 Cg_endo -64.25 -18.58 63.81 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.729 2.286 . . . . 0.0 112.113 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.997 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 16.7 p-10 -87.94 -81.73 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.863 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . 40.39 95.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 3.6 mp -91.21 131.87 36.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.985 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p30 -65.78 169.75 6.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.661 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' HA ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -42.76 -38.98 2.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.921 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -63.67 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.27 28.11 2.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 2.9 mttp -98.87 157.02 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.979 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.1 p -85.03 150.64 24.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 51' ' ' MET . . . -62.17 -35.29 78.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.169 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 69' ' ' PRO . 8.6 tp -71.46 -43.91 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.022 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.012 ' NE2' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -70.1 -5.31 26.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 46' ' ' THR . 15.9 m -125.78 -17.37 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.761 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.663 ' HE1' ' HB3' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -51.28 151.83 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.181 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -92.36 130.24 38.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.896 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.704 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 10.3 m-85 -85.5 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.761 0.315 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.506 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -89.04 -39.13 6.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.908 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' ' 91' ' ' THR . 1.8 t -114.88 135.4 22.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 110.247 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.73 -34.26 19.2 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.649 2.233 . . . . 0.0 112.062 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.16 -28.0 69.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.778 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.7 t -63.44 -50.78 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.325 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.23 -50.41 70.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.806 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 64' ' ' LYS . 9.7 tt -63.24 -38.01 89.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.719 ' HB3' HD12 ' A' ' 30' ' ' LEU . 1.3 mp0 -62.92 -56.23 19.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.249 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 58' ' ' VAL . 4.4 mp -62.73 -46.89 85.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.221 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -63.07 -40.24 97.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -62.94 -32.99 74.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 30' ' ' LEU . 2.9 mm-40 -69.03 -57.54 5.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 37' ' ' PRO . . . 163.89 36.47 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -97.14 106.09 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.968 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 m -63.34 119.67 55.2 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 29.2 Cg_endo -63.21 -15.62 49.32 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.727 2.284 . . . . 0.0 112.224 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 37.1 m-80 -95.22 93.56 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 49' ' ' GLN . 28.3 m -148.35 159.12 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 77' ' ' THR . 28.1 mp0 -151.79 -174.17 4.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 1.012 ' OD2' ' NE2' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -140.1 77.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 73' ' ' ASP . . . 35.74 62.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.023 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 p -172.51 -66.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . 138.69 38.32 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.468 HG23 ' CB ' ' A' ' 81' ' ' HIS . 34.9 m -128.61 137.51 51.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.805 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.82 179.23 1.16 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HB3' ' HE1' ' A' ' 51' ' ' MET . 42.2 Cg_exo -56.06 -32.68 87.36 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.824 2.349 . . . . 0.0 112.307 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.785 HG22 ' CG2' ' A' ' 96' ' ' VAL . 9.6 t -68.25 -28.02 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 35.6 m80 -63.44 -67.9 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.146 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 86' ' ' THR . 2.5 p30 -53.01 -48.65 67.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.012 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.34 -19.33 3.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 81' ' ' HIS . . . -72.52 -65.56 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.328 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -73.07 -37.72 66.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.19 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 82' ' ' ASP . 60.2 p -54.33 -17.75 3.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 67.02 66.76 2.24 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.006 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 22.7 m-85 -135.62 49.38 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.689 HD22 ' CB ' ' A' ' 123' ' ' SER . 19.9 tp -55.11 -15.28 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.781 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -74.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.67 0.271 . . . . 0.0 110.729 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 59' ' ' ALA . 24.8 m -69.8 -33.44 72.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.376 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.714 ' C ' HD23 ' A' ' 92' ' ' LEU . 2.3 tt -53.28 -46.36 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -56.39 -37.19 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.216 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.783 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 74.2 t -52.84 -63.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.734 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -72.66 -36.47 67.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 111.152 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.785 ' CG2' HG22 ' A' ' 80' ' ' VAL . 3.8 t -68.99 -46.54 78.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.29 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.783 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 10.6 pm0 -59.04 -33.77 71.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.054 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -39.28 93.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 132.21 36.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.63 -177.74 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.562 ' OD2' ' HA ' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -75.32 74.52 2.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.547 HG12 HG11 ' A' ' 80' ' ' VAL . 13.0 m -91.78 19.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -130.71 5.37 4.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.23 155.49 22.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.587 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -129.11 144.37 51.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -84.77 -176.68 6.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.053 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.21 -53.29 3.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.8 p -61.31 -24.3 66.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.994 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 84.35 -10.32 61.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.407 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.73 117.99 3.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.7 OUTLIER -56.35 130.64 75.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.98 ' HD2' HD23 ' A' ' 111' ' ' LEU . 82.9 Cg_exo -44.11 -31.67 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.666 2.244 . . . . 0.0 112.077 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -73.52 -42.72 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.574 ' CE1' ' OD2' ' A' ' 138' ' ' ASP . 9.5 m80 -52.91 -27.36 18.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -69.85 -53.03 19.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.884 ' C ' HG12 ' A' ' 125' ' ' VAL . . . -52.64 -43.17 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 110.352 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 147' ' ' LEU . 50.5 mt -57.57 -42.32 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.782 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -71.11 -15.66 62.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -90.64 -55.39 3.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.639 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.67 12.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.526 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 97.1 m-70 -56.01 -18.15 8.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.79 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 126' ' ' SER . 3.8 m 71.75 -63.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.083 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.689 ' CB ' HD22 ' A' ' 89' ' ' LEU . 12.1 m -69.55 -38.97 77.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.069 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.812 HG12 HD12 ' A' ' 128' ' ' LEU . 39.7 t -73.39 -54.91 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.76 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.884 HG12 ' C ' ' A' ' 116' ' ' ALA . 3.5 m -52.8 -47.03 52.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.155 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.643 ' HB2' HG21 ' A' ' 159' ' ' ILE . 5.6 t -71.53 -34.15 69.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 1.194 ' CD2' ' OE1' ' A' ' 131' ' ' GLU . 45.1 t80 -73.36 -39.6 65.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.853 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -67.36 -25.66 66.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.983 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.764 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.93 -62.12 5.72 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 44.2 Cg_endo -68.15 -48.83 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.79 2.327 . . . . 0.0 112.62 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.194 ' OE1' ' CD2' ' A' ' 127' ' ' PHE . 0.5 OUTLIER -58.07 -29.51 65.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.732 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.512 ' OG ' HD23 ' A' ' 128' ' ' LEU . 1.2 m -107.77 154.46 21.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.935 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.5 p-10 -41.76 113.85 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.867 HD13 ' HA ' ' A' ' 164' ' ' MET . 8.1 mt -85.08 43.72 1.03 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.976 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.05 33.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.463 ' HB3' HD11 ' A' ' 111' ' ' LEU . 50.8 t60 -107.18 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -126.31 -156.87 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.574 ' OD2' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER 177.15 155.59 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.574 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -37.7 -30.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.508 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -60.42 -44.87 95.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.869 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 84.28 25.52 43.5 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.469 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -133.51 80.44 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.878 0.371 . . . . 0.0 111.015 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 1.6 p -42.48 169.12 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 91.0 Cg_exo -43.66 -44.76 11.15 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.289 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -72.84 -42.92 63.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.498 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.511 ' HB3' ' CA ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -52.52 -64.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.427 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.571 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.72 -34.96 54.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -60.82 -31.31 70.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.059 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -45.02 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.491 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.533 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -69.85 -89.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.171 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.533 ' N ' ' CG ' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -75.62 51.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.085 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -61.74 -9.18 18.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.136 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 47.38 -86.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.248 0.547 . . . . 0.0 110.906 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -125.47 -136.79 0.27 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.91 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 1.229 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 12.5 p30 -74.37 14.37 0.46 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.153 -0.342 . . . . 0.0 111.267 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.725 HD12 HD13 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -51.82 -45.68 64.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.67 0.272 . . . . 0.0 111.331 -179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.912 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 3.3 ptm -57.09 -30.15 64.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.37 . . . . 0.0 110.571 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD2' ' HB2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -73.55 -47.12 43.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.931 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.643 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.1 OUTLIER -52.0 -49.3 38.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 156' ' ' LEU . 5.3 mp -73.46 -26.74 61.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 157' ' ' MET . 0.1 OUTLIER -64.46 -63.8 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.08 -31.59 79.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.646 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' ILE . 1.2 m-70 -66.24 -39.57 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 110.954 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.867 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 ptm -63.97 -174.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 92.78 3.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 166' ' ' ILE . 13.1 mt -153.99 90.97 3.23 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.401 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.7 90.08 1.29 Allowed 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.765 2.31 . . . . 0.0 112.352 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 38.0 mtm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.62 107.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 97.16 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.92 -52.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.18 106.81 15.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.69 65.55 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.764 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.49 56.4 2.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.024 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 11' ' ' GLY . 16.2 m -143.54 13.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.708 ' O ' HG12 ' A' ' 10' ' ' VAL . 12.7 m -50.6 97.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.453 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER 92.79 -6.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.881 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.683 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -54.57 -44.44 78.61 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.438 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.12 5.33 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -78.87 -62.5 1.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.828 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 14' ' ' LEU . 2.8 tm? -71.17 -33.22 69.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' ALA . 25.4 t -67.79 -50.12 58.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -57.1 -26.97 56.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.205 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.23 -67.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.021 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.579 ' HB1' ' CG ' ' A' ' 51' ' ' MET . . . -53.04 -54.58 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -53.43 -29.16 33.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 18.0 mtt180 -73.92 -37.62 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 93.64 66.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.577 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.688 ' OD1' ' OE2' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -138.66 97.13 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.831 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.3 p -57.29 -18.43 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -74.0 -46.47 43.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.3 -34.41 65.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.8 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.881 HG21 ' HA ' ' A' ' 58' ' ' VAL . 1.1 p -52.57 -48.68 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.744 0.307 . . . . 0.0 111.212 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.99 -56.33 5.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.64 -48.14 66.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.445 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 52.7 mt -52.72 -55.84 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.214 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.966 HD11 ' HA ' ' A' ' 62' ' ' LEU . 84.5 mt -73.95 -55.8 5.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.17 4.0 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -146.19 -70.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.259 ' OE1' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.79 -16.47 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.048 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.5 mt 45.37 45.01 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.671 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.259 HG22 ' OE1' ' A' ' 33' ' ' GLU . 2.8 t -72.29 153.74 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 1.016 ' ND1' ' OD1' ' A' ' 38' ' ' ASP . 1.3 t-80 -63.59 138.12 97.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HD2' ' CD2' ' A' ' 36' ' ' HIS . 57.6 Cg_endo -71.23 -37.7 5.61 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.7 2.267 . . . . 0.0 112.302 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 1.016 ' OD1' ' ND1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -92.26 31.35 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.076 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.683 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -65.71 118.44 9.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.002 HD23 ' C ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -120.3 125.02 47.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -60.95 -178.19 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -41.59 -46.1 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -48.15 -62.2 1.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.02 24.09 1.9 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.61 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 1.002 ' C ' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -109.39 163.17 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.755 0.312 . . . . 0.0 110.714 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.629 ' N ' HD23 ' A' ' 40' ' ' LEU . 17.0 p -84.87 152.14 23.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.885 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 15' ' ' SER . . . -52.92 -26.09 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.677 HD23 ' HE2' ' A' ' 51' ' ' MET . 7.0 mt -73.26 -41.82 63.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.965 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HG3' ' OG1' ' A' ' 46' ' ' THR . 0.0 OUTLIER -73.17 -7.48 51.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.228 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 24.2 m -136.05 24.98 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.677 ' HE2' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -70.59 -177.95 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.908 0.385 . . . . 0.0 110.708 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 1.1 ttp -114.31 -11.09 12.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.934 ' CE2' HD21 ' A' ' 95' ' ' LEU . 12.1 m-85 50.35 21.0 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.88 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.48 -55.2 7.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.69 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 2.4 t -100.41 137.91 20.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 0.0 110.198 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 40.8 Cg_endo -67.87 -50.29 0.88 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.34 -18.72 63.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.166 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.881 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 t -63.06 -55.62 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.454 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.25 -37.87 88.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' HG11 ' A' ' 94' ' ' VAL . 25.0 tp -63.19 -51.33 66.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 13.7 mm-40 -62.75 -53.66 50.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.351 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.966 ' HA ' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.63 -51.84 65.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.179 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -63.94 -50.5 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.958 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.852 ' N ' HD12 ' A' ' 63' ' ' LEU . 7.2 tttt -65.24 56.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.052 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 63' ' ' LEU . 6.7 tp60 -154.42 -39.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.046 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' C ' ' HB2' ' A' ' 37' ' ' PRO . . . 154.47 38.63 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.769 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.13 -0.07 39.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.121 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.785 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.8 m 43.88 83.02 0.22 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.979 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.48 -30.35 15.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.766 2.311 . . . . 0.0 112.238 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 91.8 m-20 -79.51 75.15 6.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 68' ' ' SER . 20.3 m -116.58 150.46 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.143 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -142.82 134.7 26.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -103.58 128.1 50.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 41.21 -91.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 73' ' ' ASP . 72.4 m -78.84 -85.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.09 64.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.534 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.76 43.67 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -53.14 160.77 1.49 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.997 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 2.8 Cg_endo -46.93 -32.51 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.0 2.467 . . . . 0.0 111.888 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.669 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.83 -45.33 50.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.902 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.498 ' NE2' ' O ' ' A' ' 105' ' ' LEU . 39.8 m80 -73.12 -38.72 66.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.008 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -69.71 -67.42 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.319 -179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.895 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -52.64 -19.18 2.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 80' ' ' VAL . . . -72.8 -63.02 1.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.42 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.061 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 15.6 ptt85 -70.17 -18.26 63.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.392 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.008 HG23 ' O ' ' A' ' 82' ' ' ASP . 82.6 p -68.07 -51.94 40.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.207 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.01 67.52 0.41 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -152.95 57.32 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.538 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 24.7 tp -58.65 -13.66 6.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.407 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -67.61 -73.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 53' ' ' PHE . 19.4 m -68.95 -35.86 77.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.057 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.895 HD13 ' HB3' ' A' ' 83' ' ' ALA . 29.9 tp -52.69 -49.44 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.449 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HG3' ' CE1' ' A' ' 127' ' ' PHE . 2.6 ttmt -52.66 -44.67 66.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.842 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 60' ' ' LEU . 1.4 t -53.26 -59.68 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.132 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.934 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -72.58 -39.64 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CG2' ' A' ' 80' ' ' VAL . 20.4 t -67.0 -43.85 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.134 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 7.4 pt-20 -68.33 -43.1 78.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -55.17 -23.87 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.14 50.57 0.3 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.577 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 95' ' ' LEU . . . -85.76 56.32 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.805 0.336 . . . . 0.0 111.141 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 5.5 t0 37.32 52.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.83 -0.95 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.239 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.86 36.67 1.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.47 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -117.09 -178.61 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 111' ' ' LEU . 26.0 mt -125.17 -152.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD2' ' O ' ' A' ' 110' ' ' SER . 2.0 p30 -145.29 -163.25 1.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.761 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 m -54.12 -28.96 43.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -104.34 28.61 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 105' ' ' LEU . . . 42.91 40.11 3.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.542 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 40.7 m -113.51 133.84 55.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.97 162.83 61.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HG3' ' CG1' ' A' ' 80' ' ' VAL . 52.6 Cg_exo -55.35 -25.67 48.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.825 2.35 . . . . 0.0 112.073 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 128' ' ' LEU . 2.5 tp -70.82 -33.03 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.62 ' HB3' HD22 ' A' ' 147' ' ' LEU . 15.6 m170 -70.47 -30.22 66.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.633 ' C ' ' OE2' ' A' ' 119' ' ' GLU . 0.4 OUTLIER -69.88 -54.1 15.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.351 ' CA ' ' OE2' ' A' ' 119' ' ' GLU . . . -52.6 -37.53 58.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HA ' HG11 ' A' ' 125' ' ' VAL . 76.4 mt -56.62 -36.92 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -66.04 -33.52 75.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.002 0.43 . . . . 0.0 110.53 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 1.351 ' OE2' ' CA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -82.4 -53.64 5.85 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.804 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.95 27.67 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.45 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.84 ' CD2' ' OE1' ' A' ' 119' ' ' GLU . 94.4 m-70 -47.69 -23.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER 80.23 -62.1 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 7.9 m -70.17 -33.11 71.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' A' ' 121' ' ' HIS . 24.1 t -73.73 -57.01 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.002 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 117' ' ' ILE . 2.2 m -52.57 -60.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.664 ' H ' HG23 ' A' ' 125' ' ' VAL . 10.2 t -54.99 -29.02 56.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.01 0.433 . . . . 0.0 110.854 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.602 ' CE1' ' HG3' ' A' ' 93' ' ' LYS . 26.0 t80 -73.22 -53.92 9.73 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -63.38 -11.83 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -59.69 -69.54 0.53 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.204 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.5 Cg_endo -70.2 -31.86 17.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' OE2' ' CE1' ' A' ' 127' ' ' PHE . 5.4 mm-40 -61.9 -13.86 28.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 111' ' ' LEU . 10.0 m -121.75 143.57 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.801 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 3.4 p30 -39.24 98.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.002 HD13 ' HA ' ' A' ' 164' ' ' MET . 20.2 mt -67.17 66.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.017 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.2 t60 -177.77 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.488 ' CD2' HD13 ' A' ' 111' ' ' LEU . 1.5 p-80 -53.58 179.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.4 ' HG3' ' C ' ' A' ' 136' ' ' HIS . 0.6 OUTLIER -137.25 -165.51 1.77 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.824 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -128.9 178.08 6.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.055 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.533 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . . . -71.0 -8.66 54.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.6 p -105.96 -9.66 16.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.733 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 72.73 59.07 4.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 141' ' ' GLY . 62.0 mt -154.61 86.06 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.592 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -71.28 -174.18 0.26 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.891 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 87.1 Cg_exo -47.43 -61.5 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.659 2.24 . . . . 0.0 112.473 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.609 ' O ' HD12 ' A' ' 145' ' ' LEU . 6.6 tp -63.81 -32.59 74.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.522 ' HB2' ' N ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -67.29 -70.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 114' ' ' HIS . 11.4 tp -52.75 -45.62 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.424 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.561 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . . . -55.45 -38.23 68.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -65.75 -41.78 91.73 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.109 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -64.06 -78.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.883 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 150' ' ' GLN . 4.7 mtp180 -74.05 58.69 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.09 54.09 0.17 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.695 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.692 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -34.61 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.983 0.421 . . . . 0.0 110.851 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.692 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 173.83 -114.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.376 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.538 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.5 m-20 -74.31 5.55 4.44 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.198 -0.314 . . . . 0.0 111.594 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -51.15 -59.33 4.3 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.708 0.289 . . . . 0.0 111.298 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.497 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.3 ppp? -52.26 -32.08 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.629 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.2 -55.57 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.601 HG21 ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.9 -35.2 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.678 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.614 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.91 -33.6 64.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.202 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.43 -51.13 18.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.257 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.56 97.3 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.76 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.487 ' NE2' ' OG ' ' A' ' 126' ' ' SER . 3.0 m-70 -61.14 -30.13 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.692 0.282 . . . . 0.0 111.123 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 1.002 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.7 mtt -45.49 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 164' ' ' MET . 11.7 ttt 159.35 -26.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.996 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 165' ' ' MET . 53.8 mt 35.31 98.3 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.465 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 168' ' ' MET . 60.0 Cg_endo -73.11 155.08 52.49 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.804 2.336 . . . . 0.0 112.371 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.42 ' CB ' ' O ' ' A' ' 167' ' ' PRO . 3.4 ptm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.803 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.29 72.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' GLY . 1.1 ttp -175.37 138.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.749 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 73.73 26.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 4' ' ' LEU . 8.6 mt -136.53 144.77 44.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.052 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.694 ' CD ' ' SG ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -125.46 159.91 30.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 1.139 ' OE1' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -131.35 171.79 12.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.029 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.139 HG12 ' OE1' ' A' ' 7' ' ' GLU . 12.3 p 39.05 29.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.275 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.694 ' SG ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -51.28 116.57 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.319 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 9' ' ' CYS . 16.9 m 47.28 24.6 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -65.82 -40.05 95.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.698 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -101.43 40.65 1.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.562 ' NH1' ' OE2' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -112.44 -71.48 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.807 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.916 HD22 HD21 ' A' ' 30' ' ' LEU . 26.4 tp -70.92 -26.81 63.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.544 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.2 t -61.35 -40.8 95.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.63 -35.08 59.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.533 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -66.91 -62.77 1.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.55 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.093 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -72.43 -22.42 61.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.187 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mtt180 -73.09 -36.19 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.892 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 97.41 63.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.533 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.0 p30 -142.29 91.66 2.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 57' ' ' ALA . 13.2 p -52.75 -21.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.198 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.528 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 62.7 mt-30 -72.44 -47.35 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.871 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.597 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.5 mp0 -68.67 -41.02 79.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.74 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.297 HG12 ' CD ' ' A' ' 61' ' ' GLU . 55.5 t -53.87 -53.38 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 69.7 mtt180 -61.5 -60.13 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.9 mmt-85 -54.92 -29.27 55.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.998 0.428 . . . . 0.0 110.584 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD13 HD12 ' A' ' 14' ' ' LEU . 17.7 mt -73.42 -72.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.96 HD12 ' HB3' ' A' ' 61' ' ' GLU . 41.1 mt -73.48 -43.11 60.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.513 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -72.6 -11.93 60.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.285 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.41 -78.16 0.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.859 0.362 . . . . 0.0 111.044 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' OE2' ' NH1' ' A' ' 13' ' ' ARG . 1.4 tm-20 -39.94 -28.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.034 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LEU . 3.7 mt 62.71 46.21 5.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.79 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 33' ' ' GLU . 25.0 t -77.87 155.23 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.423 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -77.51 134.77 65.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.978 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.907 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 69.3 Cg_endo -74.58 -6.91 18.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.81 2.34 . . . . 0.0 112.248 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -103.03 13.58 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.645 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -57.08 127.67 33.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.917 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -120.65 130.07 53.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.475 ' O ' HG21 ' A' ' 8' ' ' VAL . 21.9 m-20 -52.2 -55.94 17.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.69 -52.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -35.47 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.85 30.16 1.17 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -98.2 151.81 20.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 p -94.51 154.96 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.39 -26.46 63.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.035 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 69' ' ' PRO . 3.0 mt -71.99 -42.7 66.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 1.3 tm0? -60.07 -53.6 55.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG21 ' OG ' ' A' ' 15' ' ' SER . 7.2 m -64.5 -23.32 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.765 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 ttp -39.18 154.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.541 ' HE3' ' HA3' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -116.24 21.44 13.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.832 ' CD2' HD21 ' A' ' 95' ' ' LEU . 0.7 OUTLIER 36.21 34.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA3' ' HE3' ' A' ' 52' ' ' MET . . . -71.0 -81.84 0.26 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.383 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 58' ' ' VAL . 56.5 m -86.28 119.74 71.79 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.776 0.322 . . . . 0.0 110.806 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 1.333 ' HG3' ' OD2' ' A' ' 90' ' ' ASP . 81.8 Cg_exo -43.99 -39.61 11.28 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.648 2.232 . . . . 0.0 112.349 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.122 ' O ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.29 -22.32 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.451 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG21 ' A' ' 26' ' ' VAL . 37.3 t -63.05 -54.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.811 0.339 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.1 -32.93 74.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.8 tp -63.03 -42.69 99.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.037 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.297 ' CD ' HG12 ' A' ' 26' ' ' VAL . 1.2 mt-10 -63.1 -51.49 66.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.207 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.5 -46.2 89.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.346 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -62.91 -56.17 19.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.731 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -63.21 -11.71 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.702 ' HG3' HD22 ' A' ' 30' ' ' LEU . 1.1 mm-40 -81.56 -35.11 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.16 22.85 2.07 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.592 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -81.29 154.46 26.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.051 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -108.16 98.94 29.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HB3' HD13 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -68.41 -10.31 28.61 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.652 2.235 . . . . 0.0 112.239 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.59 56.93 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 68' ' ' SER . 12.7 m -125.92 158.82 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -132.94 149.69 52.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -132.32 142.05 49.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 73' ' ' ASP . . . 81.03 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.908 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -126.84 -77.15 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.872 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . -162.94 54.83 0.29 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.837 HG23 ' OD2' ' A' ' 106' ' ' ASP . 0.2 OUTLIER -128.76 112.37 14.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.846 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.545 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -82.08 -177.84 1.05 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.783 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 52.3 Cg_exo -54.07 -46.32 34.42 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.318 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 96' ' ' VAL . 2.4 m -52.98 -39.49 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.67 ' CD2' HG22 ' A' ' 77' ' ' THR . 73.0 m80 -53.4 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.783 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 5.0 p30 -53.11 -44.52 67.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.786 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.83 -48.29 75.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.39 92.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.505 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -73.24 -33.13 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 82' ' ' ASP . 41.7 p -73.45 -78.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.76 68.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.28 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 35.8 m-85 -139.27 51.49 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.591 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 92' ' ' LEU . 16.0 tp -52.5 -18.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.286 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.333 ' OD2' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -73.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.568 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.124 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -73.39 -30.29 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.769 ' C ' HD23 ' A' ' 92' ' ' LEU . 2.5 tt -59.08 -34.83 72.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.049 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HE2' ' CD1' ' A' ' 127' ' ' PHE . 4.0 mttt -67.73 -53.18 29.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.156 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.905 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 2.7 m -52.71 -48.17 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 53' ' ' PHE . 1.2 pp -73.37 -51.37 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.518 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.838 HG13 HG11 ' A' ' 102' ' ' VAL . 55.1 t -67.37 -51.12 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.844 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.905 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 5.0 pm0 -52.58 -30.47 31.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.807 0.337 . . . . 0.0 110.814 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.479 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER -73.08 -36.34 66.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.787 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.23 65.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 69' ' ' PRO . . . -91.64 18.97 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.024 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 61.7 72.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.838 HG11 HG13 ' A' ' 96' ' ' VAL . 4.1 m -89.17 13.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.048 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.69 38.87 2.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.032 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.542 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -136.08 131.82 35.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 111.272 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.903 ' N ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -100.4 -176.88 3.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.882 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.908 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 0.9 OUTLIER -99.42 40.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER 76.73 12.51 2.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.7 t -115.9 8.83 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.897 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 138' ' ' ASP . . . 61.75 14.84 45.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.1 m -98.67 91.91 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 136' ' ' HIS . 35.0 mt -51.52 146.17 13.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 85.1 Cg_exo -47.41 -39.73 28.44 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.726 2.284 . . . . 0.0 112.55 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -61.41 -32.35 53.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.893 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.58 ' O ' HD13 ' A' ' 147' ' ' LEU . 15.9 m170 -66.7 -29.83 69.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.13 -47.38 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.484 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.73 -45.12 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.33 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.857 HG21 ' HB3' ' A' ' 147' ' ' LEU . 89.4 mt -53.18 -39.46 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.727 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.548 ' HD2' ' CD ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -61.96 -20.81 64.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.015 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -112.37 -42.0 3.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.528 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.59 84.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.99 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.515 ' NE2' ' O ' ' A' ' 86' ' ' THR . 10.9 m-70 -38.49 102.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 111.267 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 121' ' ' HIS . 3.0 m 35.63 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.999 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.39 10.36 1.33 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' HIS . 59.4 t -56.09 -53.93 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.008 0.432 . . . . 0.0 110.229 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -52.64 -41.37 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.608 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.569 ' CB ' HG21 ' A' ' 159' ' ' ILE . 15.7 p -66.69 -34.76 78.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.787 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.584 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 14.3 t80 -72.86 -48.56 36.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.418 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.501 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.946 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -55.09 -66.48 0.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.946 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 66.6 Cg_endo -75.21 -52.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.656 2.237 . . . . 0.0 112.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -23.74 1.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.833 0.349 . . . . 0.0 110.541 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 128' ' ' LEU . 9.3 t -93.83 -153.54 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.551 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.688 ' OD1' HD22 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.41 56.33 0.71 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.874 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.94 88.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.629 ' O ' HG22 ' A' ' 143' ' ' THR . 17.6 t60 155.42 -29.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.669 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 111' ' ' LEU . 13.6 t60 -65.27 164.04 14.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.962 ' CG ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -134.6 127.45 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.555 ' OD1' ' CG ' ' A' ' 114' ' ' HIS . 1.1 m-20 -50.2 155.27 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -42.5 -27.19 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 110.318 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -67.53 -48.73 66.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.559 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 116.58 57.16 0.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.554 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 146' ' ' GLU . 1.1 mt -144.65 104.21 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.144 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -66.11 171.5 3.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 82.5 Cg_exo -43.6 -43.0 11.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.534 2.156 . . . . 0.0 112.021 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tp -73.26 -34.62 65.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.144 ' OE1' ' N ' ' A' ' 143' ' ' THR . 5.4 mt-10 -61.84 -61.77 2.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.857 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -52.7 -36.52 57.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.54 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.666 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.283 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -73.17 -45.41 56.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.523 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 0.6 OUTLIER -73.11 -92.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.244 178.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.548 ' CD ' ' HD2' ' A' ' 118' ' ' ARG . 16.2 mtt-85 -76.56 45.9 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -53.29 -17.89 6.24 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.761 ' HB3' HD23 ' A' ' 156' ' ' LEU . . . 64.18 -64.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.548 ' NE2' ' N ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -154.4 -138.37 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.019 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.505 ' O ' ' CG ' ' A' ' 158' ' ' ASP . 10.4 m120 -74.16 9.85 1.46 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.226 -0.296 . . . . 0.0 111.391 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.804 HD12 ' C ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -51.82 -34.87 42.21 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.846 0.355 . . . . 0.0 111.281 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.666 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.5 ppp? -52.44 -28.39 19.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.059 0.457 . . . . 0.0 110.081 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.06 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 3.4 p30 -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.06 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -51.65 -44.2 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.291 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.76 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.56 -16.08 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 111.035 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -55.08 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.038 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -64.33 -43.4 96.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.583 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' A' ' 134' ' ' LEU . 2.1 m-70 -70.31 -11.79 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -168.87 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.952 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.48 ' O ' HG13 ' A' ' 166' ' ' ILE . 1.6 mmm -126.71 -2.53 6.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 165' ' ' MET . 1.3 pt 35.39 56.01 2.39 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.11 -0.11 8.64 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.837 2.358 . . . . 0.0 112.273 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.966 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 3' ' ' MET . 57.8 p -119.41 41.85 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.0 OUTLIER 74.28 -74.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 59.7 177.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 5' ' ' LEU . 11.2 mt -131.93 160.32 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.47 46.09 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.046 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 63.39 36.42 11.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 40' ' ' LEU . 85.3 t -82.56 -12.79 12.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' C ' ' O ' ' A' ' 8' ' ' VAL . 42.2 t -35.33 -37.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.851 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 35' ' ' VAL . 36.5 t -110.07 -19.03 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.515 ' HA2' ' CA ' ' A' ' 39' ' ' ALA . . . -48.58 -21.72 2.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.569 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD2' HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -117.42 29.4 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.806 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 1.7 ttm105 -109.82 -74.94 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.019 HD22 ' O ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -70.92 -35.18 72.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -58.24 -40.55 82.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.598 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . -73.13 -40.42 50.53 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.352 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 25' ' ' GLU . . . -67.79 -47.05 70.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' CB ' HD21 ' A' ' 62' ' ' LEU . . . -52.82 -41.71 64.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.23 -18.6 61.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 1.7 mtt180 -73.17 -28.06 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.72 65.03 1.96 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.615 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.131 ' CG ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -133.12 92.46 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 110.635 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 57' ' ' ALA . 10.7 p -52.58 -20.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -73.81 -56.33 5.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.938 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.131 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.48 -30.26 63.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.629 -179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 58' ' ' VAL . 2.4 p -52.85 -45.36 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.744 0.306 . . . . 0.0 111.407 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -73.56 -46.35 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 110.928 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 4.7 mmm180 -53.51 -32.71 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD12 ' OE1' ' A' ' 25' ' ' GLU . 10.4 mt -73.42 -72.39 0.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.833 HD22 ' HG2' ' A' ' 65' ' ' GLN . 5.5 mt -73.4 -45.71 53.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.686 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -70.06 -13.39 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.691 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -134.05 -75.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.199 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.806 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 2.5 tt0 -43.99 -25.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.2 mp 72.46 13.08 5.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.4 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' A' ' 14' ' ' LEU . 3.3 p -44.75 158.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.407 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -94.81 141.27 23.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.83 ' HB2' ' HB2' ' A' ' 67' ' ' ALA . 55.9 Cg_endo -70.52 -23.27 27.53 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.744 2.296 . . . . 0.0 112.201 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -87.71 37.7 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . . . -79.01 127.55 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 38' ' ' ASP . 6.3 mp -122.55 133.66 54.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 111.454 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -62.57 -168.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.705 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' CD ' ' C ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -70.32 -4.98 24.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -98.95 -69.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 146.74 67.64 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.553 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 19.1 mtpt -142.41 146.65 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.785 0.326 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 11.6 p -84.54 152.61 23.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -52.75 -54.89 27.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 69' ' ' PRO . 7.3 tp -53.05 -30.53 36.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.639 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HB3' ' O ' ' A' ' 46' ' ' THR . 3.3 tt0 -73.2 -34.61 66.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 47' ' ' ALA . 5.8 m -91.42 -25.86 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.616 ' SD ' HD12 ' A' ' 48' ' ' LEU . 1.4 mtp -36.35 137.8 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 3.6 ptt? -96.42 10.11 39.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.032 ' CE2' HD21 ' A' ' 95' ' ' LEU . 4.4 m-85 47.38 23.54 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.43 -56.02 24.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.312 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -98.04 146.15 31.01 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.788 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 1.239 ' HB3' ' OD1' ' A' ' 90' ' ' ASP . 97.3 Cg_endo -79.67 -42.15 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.834 2.356 . . . . 0.0 112.555 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -31.14 72.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 55' ' ' SER . 11.4 m -62.64 -30.79 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -62.94 -43.16 99.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.986 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -63.31 -34.53 77.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.217 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -63.04 -67.89 0.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.156 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 62' ' ' LEU . 6.3 mp -62.32 -35.41 78.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.088 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 59' ' ' ALA . 7.6 tp -62.95 -63.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.985 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -62.93 -17.3 61.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.026 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.833 ' HG2' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -60.22 -52.86 63.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 143.63 -13.49 2.22 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . . . -60.05 98.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.322 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.16 121.57 2.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.676 ' HA ' HD23 ' A' ' 48' ' ' LEU . 59.5 Cg_endo -71.95 -21.45 24.41 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.733 2.289 . . . . 0.0 112.326 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.202 ' CA ' ' OD2' ' A' ' 101' ' ' ASP . 1.4 m120 -81.47 86.11 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.74 133.61 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -139.62 157.8 45.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -126.23 98.21 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 57.25 -80.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.209 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ASP . 5.6 m -38.44 -55.0 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.24 33.18 1.84 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.519 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.31 129.51 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -111.36 171.52 4.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.914 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 50.8 Cg_exo -53.86 -32.14 65.7 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.767 2.311 . . . . 0.0 112.336 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.76 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -64.31 -36.53 77.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.447 ' ND1' HG23 ' A' ' 80' ' ' VAL . 3.3 m80 -64.47 -47.93 77.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.914 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.9 p30 -60.3 -51.66 68.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -51.97 -29.61 21.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' O ' HG11 ' A' ' 124' ' ' VAL . . . -73.33 -65.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.477 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' NE ' ' HB3' ' A' ' 115' ' ' LEU . 7.2 mtp180 -64.68 -29.41 70.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.577 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 82' ' ' ASP . 61.6 p -73.29 0.3 12.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.549 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.468 ' HA2' HG21 ' A' ' 124' ' ' VAL . . . 52.76 80.97 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.098 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.51 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -154.12 60.48 0.71 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.856 0.36 . . . . 0.0 110.433 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.908 HD13 ' O ' ' A' ' 89' ' ' LEU . 3.2 tm? -52.15 -19.05 1.74 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.267 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.239 ' OD1' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -56.2 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.382 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.848 HG22 HD23 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -73.4 -8.92 57.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.127 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.701 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 5.6 mp -73.0 -64.2 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.214 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -57.06 -24.03 50.91 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 95' ' ' LEU . 38.0 t -76.77 -82.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.09 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.032 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -76.11 -44.83 36.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.079 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.673 HG22 HG12 ' A' ' 80' ' ' VAL . 94.3 t -67.77 -3.3 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.227 ' HA ' ' OE2' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -73.1 -43.23 62.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -64.57 -37.77 88.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.841 ' O ' HG13 ' A' ' 102' ' ' VAL . . . 146.96 -49.97 0.61 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.76 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . 36.21 31.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 111.009 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.202 ' OD2' ' CA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER 71.52 56.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 99' ' ' GLY . 5.0 m -79.95 1.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -116.0 40.67 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.956 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.825 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -125.51 166.93 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -154.64 160.61 41.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.921 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 107' ' ' SER . 3.5 p30 -84.83 79.06 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 108' ' ' THR . 1.1 p 84.13 -54.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER -174.38 32.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.765 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' SER . . . -76.83 -3.35 79.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.775 ' C ' HD22 ' A' ' 105' ' ' LEU . 0.6 OUTLIER 85.4 159.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -45.18 158.86 0.29 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.544 ' HB2' ' CD2' ' A' ' 128' ' ' LEU . 50.9 Cg_exo -53.86 -38.47 85.78 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.645 2.23 . . . . 0.0 112.223 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -58.33 -41.43 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.542 ' CG ' ' OG ' ' A' ' 110' ' ' SER . 57.3 m80 -52.96 -31.73 42.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.681 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.498 ' HB3' ' NE ' ' A' ' 85' ' ' ARG . 12.6 mt -73.17 -53.77 10.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.361 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -54.25 -33.09 57.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.342 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.992 HG21 ' HB3' ' A' ' 147' ' ' LEU . 81.8 mt -61.41 -40.51 86.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.64 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.48 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -64.38 -21.35 66.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.596 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 1.361 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 1.9 mp0 -94.7 -51.65 4.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.84 22.79 35.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.514 ' O ' ' CB ' ' A' ' 122' ' ' SER . 99.0 m-70 -46.41 -24.85 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 110.811 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER 84.97 -60.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.836 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -73.1 -42.16 63.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.046 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 116' ' ' ALA . 49.0 t -67.08 -60.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.226 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.684 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.7 t -52.69 -57.14 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.633 ' CB ' HG21 ' A' ' 159' ' ' ILE . 88.8 p -52.73 -37.15 58.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.098 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 92' ' ' LEU . 51.6 t80 -71.91 -55.1 8.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.78 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -62.41 -19.33 63.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.654 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.898 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -52.98 -69.51 0.33 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.005 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.925 ' HA ' HD11 ' A' ' 134' ' ' LEU . 55.0 Cg_endo -69.6 -25.32 29.44 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.227 ' OE2' ' HA ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -89.55 36.12 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.035 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -169.7 134.88 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.818 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.286 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 2.9 p-10 -35.74 97.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.925 HD11 ' HA ' ' A' ' 130' ' ' PRO . 2.8 mp -72.91 56.36 0.42 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.03 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 -39.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.138 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.286 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.5 OUTLIER -56.83 142.67 40.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.019 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 167.88 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -75.14 166.89 22.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 108' ' ' THR . . . -51.48 -21.92 2.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.324 0.583 . . . . 0.0 110.141 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -59.0 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 137.91 40.8 0.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.253 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 2.4 mt -122.91 125.22 44.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.591 ' CB ' ' CD ' ' A' ' 144' ' ' PRO . 0.2 OUTLIER -98.11 -174.53 0.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 72.8 Cg_exo -49.31 -56.84 2.77 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.694 2.263 . . . . 0.0 112.401 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.697 HD13 ' HG3' ' A' ' 161' ' ' GLN . 13.8 tp -69.31 -40.38 77.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.046 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.08 -65.7 0.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.93 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.992 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -53.12 -39.45 63.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.13 -27.3 61.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.7 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 145' ' ' LEU . 0.4 OUTLIER -68.55 -47.64 66.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.483 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.97 -74.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.968 179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -74.55 56.56 0.69 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.02 55.4 0.8 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.139 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.851 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -31.44 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.99 0.424 . . . . 0.0 110.979 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.851 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 174.43 -114.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.42 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 1.265 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 8.0 m-80 -75.35 6.92 3.95 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.291 -0.255 . . . . 0.0 111.438 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 156' ' ' LEU . 1.3 mt -51.11 -64.39 0.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.813 0.34 . . . . 0.0 111.445 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.588 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 4.3 ptm -52.89 -29.26 27.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 0.0 110.38 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.265 ' OD2' ' HA ' ' A' ' 155' ' ' ASN . 0.4 OUTLIER -74.59 -51.52 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.01 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.633 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -51.68 -42.35 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.22 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.858 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -74.63 -44.83 48.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.187 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.697 ' HG3' HD13 ' A' ' 145' ' ' LEU . 4.0 mt-30 -53.61 -50.56 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.286 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.22 98.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' HB3' ' A' ' 130' ' ' PRO . 2.0 m-70 -73.23 -7.1 49.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.679 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.38 169.85 4.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.861 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.22 91.32 4.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.418 HD11 ' O ' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -151.21 78.87 7.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.67 -174.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.809 2.339 . . . . 0.0 112.357 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 3' ' ' MET . 5.8 p -140.28 94.37 2.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.421 ' CB ' ' O ' ' A' ' 2' ' ' SER . 5.9 ttt 77.37 91.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 4' ' ' LEU . 0.2 OUTLIER -115.76 100.38 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.011 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.67 70.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.608 ' C ' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -152.76 99.17 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.989 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 2.1 tm-20 -122.06 74.9 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.896 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 40' ' ' LEU . 14.2 p -126.04 10.93 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.87 ' O ' HG22 ' A' ' 10' ' ' VAL . 3.6 p -46.32 102.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.806 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER 80.62 -6.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -47.24 -34.74 8.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.35 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.776 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -105.66 28.28 7.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 0.0 110.754 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -94.56 -56.56 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.839 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HD13 ' A' ' 29' ' ' LEU . 37.9 tp -72.72 -40.78 65.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 t -57.67 -34.6 69.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.14 -53.74 7.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.574 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -72.69 -39.77 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.151 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -67.44 -50.32 59.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.041 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 15' ' ' SER . . . -68.77 -12.03 61.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 20.7 mtt180 -67.89 -43.51 79.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.64 59.41 0.63 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.066 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 10.7 p-10 -138.55 95.1 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.9 p -53.9 -18.96 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.024 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 9.2 mt-30 -72.98 -54.57 8.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.01 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.066 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.04 -36.42 66.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.342 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.109 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.7 p -52.82 -42.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.397 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 1.086 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . 23.6 mtp180 -70.91 -50.54 33.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.065 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 2.4 mtm180 -67.4 -12.0 59.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.962 HD13 HD12 ' A' ' 14' ' ' LEU . 8.7 mt -73.55 -70.4 0.37 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.35 -45.27 56.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.66 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 3.1 m-70 -72.42 -12.38 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.61 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 1.8 mtt-85 -134.18 -78.98 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.997 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -37.84 -30.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.74 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 29' ' ' LEU . 7.9 mt 61.56 45.02 8.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 33' ' ' GLU . 60.4 t -92.89 110.7 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.653 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -46.93 125.09 8.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CG ' ' HB3' ' A' ' 65' ' ' GLN . 52.3 Cg_exo -54.66 -34.77 84.88 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.749 2.299 . . . . 0.0 112.377 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.789 ' O ' HD12 ' A' ' 40' ' ' LEU . 16.3 p-10 -57.38 -21.69 37.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -33.39 108.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.345 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.792 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.2 mp -102.35 133.44 47.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.988 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.524 ' OD1' ' CB ' ' A' ' 43' ' ' PHE . 8.5 p30 -72.67 159.15 34.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 41' ' ' ASN . 3.8 ptm180 -35.12 -43.92 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.04 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.524 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 t80 -56.8 -49.13 76.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 119.22 35.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -116.21 157.09 25.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.785 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -87.32 147.5 25.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 51' ' ' MET . . . -58.03 -28.83 64.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.071 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 69' ' ' PRO . 12.8 tp -70.79 -47.95 56.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.74 ' HB2' HG21 ' A' ' 71' ' ' VAL . 44.5 tt0 -60.65 -24.95 65.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' THR . 6.1 m -106.03 -14.2 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.738 ' HG3' HD23 ' A' ' 62' ' ' LEU . 2.2 ttp -42.34 145.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.976 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -85.53 134.88 34.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.777 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.1 ' CE2' HD21 ' A' ' 95' ' ' LEU . 14.1 m-85 -87.75 -7.27 57.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CE1' ' A' ' 88' ' ' PHE . . . -50.02 -41.04 36.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.028 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.978 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.0 m -108.78 127.56 27.14 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' HG23 ' A' ' 91' ' ' THR . 58.8 Cg_endo -71.87 -34.0 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.682 2.255 . . . . 0.0 112.211 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.14 -35.09 79.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.978 HG22 ' O ' ' A' ' 55' ' ' SER . 4.0 m -62.57 -32.1 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.609 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.835 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.77 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.902 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.874 HD21 ' HD2' ' A' ' 64' ' ' LYS . 7.3 tt -63.4 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.109 ' OE1' HG13 ' A' ' 26' ' ' VAL . 6.7 mt-10 -62.41 -70.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.405 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.738 HD23 ' HG3' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.75 -36.53 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 111.038 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' A' ' 69' ' ' PRO . 18.4 tp -63.03 -37.87 88.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.874 ' HD2' HD21 ' A' ' 60' ' ' LEU . 1.9 mtpp -63.32 -48.87 76.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' HB3' ' CG ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -36.68 -35.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 126.38 42.61 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.33 28.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.1 m -47.85 112.09 2.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.863 ' HA ' HD21 ' A' ' 48' ' ' LEU . 30.0 Cg_endo -63.52 -21.19 70.7 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.728 2.285 . . . . 0.0 112.175 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -100.37 82.56 2.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 49' ' ' GLN . 8.0 m -116.1 142.32 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' CD ' ' HA2' ' A' ' 76' ' ' GLY . 4.2 mt-30 -136.24 160.69 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.466 ' OD2' ' NZ ' ' A' ' 45' ' ' LYS . 3.5 m-20 -89.46 -91.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.785 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.89 5.95 7.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.7 m -145.46 -70.83 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.814 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' CD ' ' A' ' 72' ' ' GLN . . . 172.78 58.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 106' ' ' ASP . 4.7 m -110.3 71.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.86 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -70.15 169.04 14.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.907 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.522 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 17.9 Cg_endo -60.4 -32.26 93.67 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.738 2.292 . . . . 0.0 111.799 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 100' ' ' ALA . 32.1 m -57.49 -42.53 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.243 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.552 ' O ' HD12 ' A' ' 115' ' ' LEU . 8.5 m80 -53.65 -67.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.857 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -54.14 -27.44 33.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.668 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.909 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -68.94 -16.25 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.055 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -73.18 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.37 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.553 ' CG ' ' HB3' ' A' ' 115' ' ' LEU . 61.0 mtm180 -63.73 -29.7 70.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.23 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.0 p -67.87 -6.53 22.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.228 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.94 74.07 0.27 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.174 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 8.3 m-85 -145.2 53.44 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.565 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.648 HD11 ' CG ' ' A' ' 127' ' ' PHE . 13.9 tp -52.78 -21.12 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.158 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.585 ' OD1' ' OG1' ' A' ' 91' ' ' THR . 0.0 OUTLIER -60.12 -73.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.429 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.835 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 24.1 m -73.21 -28.16 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.458 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 93' ' ' LYS . 1.8 tt -60.72 -61.31 2.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 1.289 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -52.7 -30.28 31.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.274 ' CA ' ' OE2' ' A' ' 97' ' ' GLU . 16.2 t -61.0 -64.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.301 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.1 HD21 ' CE2' ' A' ' 53' ' ' PHE . 2.6 pp -71.01 -26.76 63.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.018 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.796 HG13 HG11 ' A' ' 102' ' ' VAL . 6.9 t -73.22 -56.05 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.8 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.289 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -52.81 -35.45 57.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.232 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -61.87 -32.01 72.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.968 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 117.44 62.38 0.31 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . -96.61 43.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 111.139 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 54.2 60.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 96' ' ' VAL . 5.4 m -70.07 -10.77 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -105.48 42.76 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.861 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -105.31 168.41 9.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.966 HD21 ' HG ' ' A' ' 111' ' ' LEU . 60.4 mt -145.72 135.18 23.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.609 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.828 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.51 47.23 1.33 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER 80.03 -54.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.905 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 p -48.76 -37.7 19.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.665 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 102.72 0.57 49.29 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD2' ' A' ' 138' ' ' ASP . 89.1 p -79.09 100.16 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.966 ' HG ' HD21 ' A' ' 105' ' ' LEU . 7.0 mt -56.38 149.78 36.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.504 ' C ' HD12 ' A' ' 128' ' ' LEU . 79.7 Cg_exo -48.21 -28.98 11.89 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.617 2.211 . . . . 0.0 112.151 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.821 HG21 ' CE1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.45 -29.58 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.201 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.558 ' CD2' ' OD2' ' A' ' 138' ' ' ASP . 50.3 m80 -62.76 -30.8 71.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.786 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.124 ' O ' ' OE2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -66.02 -56.51 11.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.631 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.976 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.17 -37.78 62.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 110.168 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.737 HD11 ' CD1' ' A' ' 113' ' ' ILE . 71.5 mt -58.71 -43.13 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.465 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -64.73 -15.28 61.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.472 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 1.124 ' OE2' ' O ' ' A' ' 115' ' ' LEU . 2.3 mp0 -93.7 -56.12 3.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 94.79 24.27 18.23 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.106 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 82.3 m-70 -55.14 -157.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.624 0.25 . . . . 0.0 110.693 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 m -102.24 -95.96 0.29 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.455 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 29.8 t -73.05 -19.22 61.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.739 0.304 . . . . 0.0 111.325 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.562 ' CG2' ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -56.71 -69.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.048 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.6 HG11 HD21 ' A' ' 156' ' ' LEU . 18.0 t -52.12 -46.32 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.883 ' CB ' HG21 ' A' ' 159' ' ' ILE . 4.9 p -66.67 -32.69 74.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.783 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 86.6 t80 -73.03 -43.47 62.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.072 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.4 OUTLIER -65.42 -11.22 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.073 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.673 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -67.69 -62.51 3.34 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.043 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.673 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 27.0 Cg_endo -61.75 -52.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.845 2.363 . . . . 0.0 112.352 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.783 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 3.9 mt-10 -51.88 -25.74 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.927 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 129' ' ' ALA . 1.7 m -108.46 137.29 46.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.268 ' OD1' ' HB3' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -35.64 103.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.81 HD13 ' HA ' ' A' ' 164' ' ' MET . 11.1 mt -61.4 134.14 56.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.937 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.531 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 1.9 t-160 86.17 14.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.268 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 4.6 p-80 -64.33 168.95 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -123.87 166.04 16.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.558 ' OD2' ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -140.65 148.64 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.664 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -41.38 -28.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.17 0.51 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -34.35 73.94 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.782 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 93.22 45.07 3.62 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER -153.71 158.05 40.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 0.0 111.037 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -108.59 167.97 8.45 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.565 ' C ' HD12 ' A' ' 160' ' ' LEU . 99.3 Cg_exo -40.59 -50.19 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.827 2.352 . . . . 0.0 112.524 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.866 HD11 ' CG ' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -62.25 -43.77 98.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -56.01 -64.0 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.712 HD13 HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.72 -39.25 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.703 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.539 ' CB ' ' HG ' ' A' ' 160' ' ' LEU . . . -69.3 -27.7 65.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.621 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -70.73 -54.35 12.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.617 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -59.69 -67.22 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.01 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 153' ' ' ALA . 6.1 ttt180 -73.81 59.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -66.57 52.62 0.21 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.925 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.876 ' HB3' ' OE1' ' A' ' 154' ' ' GLN . . . -37.79 -31.22 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.159 0.504 . . . . 0.0 110.15 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.876 ' OE1' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 170.35 -116.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.823 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.545 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.3 p30 -76.54 13.16 1.03 Allowed 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.111 -0.368 . . . . 0.0 111.646 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 125' ' ' VAL . 2.5 mt -51.56 -66.65 0.35 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 12.5 ptm -52.88 -20.81 3.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.69 -63.97 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.489 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.883 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -52.81 -27.71 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.852 0.358 . . . . 0.0 110.81 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.565 HD12 ' C ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.32 -40.89 64.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.866 ' CG ' HD11 ' A' ' 145' ' ' LEU . 3.1 mt-30 -72.95 -40.53 65.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.005 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.68 37.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 -46.64 86.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 111.011 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.81 ' HA ' HD13 ' A' ' 134' ' ' LEU . 3.7 ttp -73.8 100.19 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.11 107.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.646 ' O ' HG23 ' A' ' 166' ' ' ILE . 3.4 tt -155.55 62.7 3.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 166' ' ' ILE . 50.1 Cg_exo -53.62 141.92 62.16 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.685 2.257 . . . . 0.0 112.27 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.966 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.117 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m -113.53 134.08 54.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 tpp -165.09 -59.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.15 52.92 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.26 39.47 3.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -116.18 -29.83 6.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.938 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.998 ' HA ' ' OE1' ' A' ' 7' ' ' GLU . 0.7 OUTLIER 58.68 32.55 22.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 8' ' ' VAL . 93.0 t 69.0 7.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.178 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -33.73 -38.22 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.24 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.579 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 22.5 m -131.14 3.96 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.324 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 39' ' ' ALA . . . -38.99 -32.65 0.19 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.574 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 12' ' ' ASP . 18.8 t0 -117.74 28.08 8.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 111.032 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -96.63 -62.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.802 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' C ' ' A' ' 14' ' ' LEU . 1.7 tm? -71.86 -42.39 66.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.7 m -57.16 -36.23 70.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.709 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -67.12 -52.1 34.48 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.362 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.79 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -60.17 -51.21 70.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 111.026 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.59 69.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.5 -30.59 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 2.3 mmm180 -73.56 0.11 13.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.216 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.557 ' HA3' ' CE ' ' A' ' 52' ' ' MET . . . 50.49 66.25 2.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.631 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 25' ' ' GLU . 10.2 p-10 -132.79 95.23 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.322 . . . . 0.0 110.819 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.1 p -52.55 -22.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.73 ' HB2' ' OE1' ' A' ' 25' ' ' GLU . 4.2 mm100 -73.05 -59.0 2.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.848 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.872 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.28 -17.84 61.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.155 HG12 ' CD ' ' A' ' 61' ' ' GLU . 3.1 t -65.36 -67.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.2 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.931 ' CA ' ' OE2' ' A' ' 61' ' ' GLU . 3.9 ptt-85 -73.17 -38.15 66.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.897 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.594 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 1.0 OUTLIER -61.87 -27.55 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.797 -179.202 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.272 ' CD2' ' OE1' ' A' ' 33' ' ' GLU . 12.0 mt -73.69 -62.08 1.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 0.0 111.981 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 65' ' ' GLN . 2.3 mt -65.56 -53.24 44.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -72.98 -3.35 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.5 OUTLIER -138.36 -78.71 0.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.038 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.272 ' OE1' ' CD2' ' A' ' 29' ' ' LEU . 1.1 tt0 -41.43 -27.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' LEU . 41.6 tp 65.67 73.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 36' ' ' HIS . 80.1 t -122.5 159.74 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.056 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.543 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -74.64 145.06 81.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB3' ' CG ' ' A' ' 65' ' ' GLN . 38.2 Cg_endo -66.86 -29.49 41.62 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.722 2.282 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.671 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -82.52 -67.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 10' ' ' VAL . . . 35.84 87.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 45' ' ' LYS . 5.2 mp -92.54 140.18 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -67.72 88.16 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.796 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER 86.78 19.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t80 65.84 52.25 1.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.99 -73.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.46 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' C ' HD23 ' A' ' 40' ' ' LEU . 7.7 mtpt -86.13 148.86 25.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 71' ' ' VAL . 1.1 p -87.09 150.14 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 38' ' ' ASP . . . -52.89 -36.61 59.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.934 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' MET . 2.1 mt -73.28 -26.75 61.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.73 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.989 ' CG ' ' OD2' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -69.39 -35.07 75.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 15' ' ' SER . 15.8 m -93.11 -18.8 6.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.746 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 1.3 tmm? -44.2 145.38 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.993 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.557 ' CE ' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.68 12.9 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.853 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 7.3 m-85 56.29 -80.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.66 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 31.94 -93.71 0.01 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.677 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.8 m -67.71 130.56 92.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.483 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 91' ' ' THR . 56.1 Cg_endo -71.0 -27.9 19.96 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.715 2.276 . . . . 0.0 111.828 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' C ' ' OE1' ' A' ' 61' ' ' GLU . . . -63.38 -36.37 83.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.01 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.041 HG12 HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -62.47 -34.18 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 95' ' ' LEU . . . -62.7 -58.04 8.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.824 HD23 ' O ' ' A' ' 60' ' ' LEU . 6.7 tt -63.27 -33.03 74.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.794 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.155 ' CD ' HG12 ' A' ' 26' ' ' VAL . 8.1 mt-10 -63.03 -60.26 3.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 58' ' ' VAL . 5.6 mp -62.81 -46.91 85.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.17 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -63.16 -58.77 6.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 7.2 tmtt? -62.92 -23.79 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.131 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.811 ' HG2' HD22 ' A' ' 30' ' ' LEU . 24.8 tp60 -74.4 -20.02 60.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.999 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 37' ' ' PRO . . . 120.53 50.35 0.28 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.47 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.04 159.81 21.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 111.053 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.0 m -126.21 120.44 23.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.986 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 71' ' ' VAL . 70.0 Cg_endo -74.68 -17.67 20.23 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.78 60.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 69' ' ' PRO . 4.3 m -134.89 126.67 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' N ' ' A' ' 77' ' ' THR . 2.7 mt-30 -127.33 133.32 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.926 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.989 ' OD2' ' CG ' ' A' ' 49' ' ' GLN . 2.1 p30 -125.08 -36.88 2.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.807 ' HB3' ' HB ' ' A' ' 77' ' ' THR . . . -74.23 68.94 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.091 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.7 p 54.94 19.73 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.07 55.28 0.6 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 74' ' ' ALA . 17.2 m -137.8 100.69 4.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -68.99 173.45 3.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.766 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 -34.04 75.2 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.835 2.357 . . . . 0.0 112.116 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -54.98 -38.43 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -59.66 -65.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.989 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.933 ' OD1' ' C ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -57.99 -37.36 74.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.286 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.993 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.9 -42.97 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.248 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.64 -55.81 7.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.795 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 0.7 OUTLIER -61.62 -27.68 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.773 HG23 ' O ' ' A' ' 82' ' ' ASP . 21.4 p -70.8 -70.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.55 64.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 18.7 m-85 -136.26 49.75 2.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.957 0.408 . . . . 0.0 110.127 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.751 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.7 tm? -52.28 -45.78 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.498 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -66.2 0.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.863 0.363 . . . . 0.0 110.8 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 56' ' ' PRO . 18.0 m -65.33 -44.58 87.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' HB1' ' A' ' 83' ' ' ALA . 22.6 tp -52.71 -48.76 66.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.778 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -52.13 -32.29 34.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.644 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.811 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -74.45 -55.33 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.94 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 3.8 pp -74.33 -47.8 32.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.679 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.912 HG23 HG12 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -59.4 -36.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.552 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.778 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -72.87 -28.39 62.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -55.97 -37.42 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . 160.08 -19.81 0.24 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.669 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -33.63 115.16 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.607 ' O ' HG21 ' A' ' 80' ' ' VAL . 1.2 p30 -48.8 113.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 100' ' ' ALA . 6.1 m -106.24 26.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.136 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' HA ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.41 -35.93 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.74 145.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.931 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.64 -151.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -140.67 -77.17 0.31 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.792 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.9 -57.85 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.128 ' O ' ' OD1' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -63.41 -12.42 30.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.695 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.821 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 72.53 17.49 77.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.345 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 138' ' ' ASP . 1.4 t -77.38 123.15 26.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.931 HD12 HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -70.96 157.79 89.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.817 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.478 ' HB2' HD11 ' A' ' 128' ' ' LEU . 71.5 Cg_exo -48.74 -38.54 37.45 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.616 2.211 . . . . 0.0 112.147 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HB ' HD12 ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.88 -40.97 79.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.086 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 137' ' ' ARG . 22.0 m80 -52.66 -37.87 59.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.637 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 118' ' ' ARG . 9.9 mt -72.84 -50.02 26.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.74 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -37.1 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.936 HG21 ' HB3' ' A' ' 147' ' ' LEU . 95.0 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.889 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -72.99 -9.87 59.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.772 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.795 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -91.93 -57.94 2.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.674 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.28 41.49 3.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.861 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 9.8 m-70 -82.22 -1.75 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.87 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m 65.86 -81.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.54 ' CB ' ' HG ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -54.83 -52.74 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.981 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 116' ' ' ALA . 51.6 t -55.31 -60.12 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.345 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 116' ' ' ALA . 3.8 t -52.13 -60.19 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.372 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.682 ' CB ' HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.46 -27.55 68.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.225 -179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.64 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 11.7 t80 -73.64 -51.4 16.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.078 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HB ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -66.95 -7.49 22.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.258 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.891 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -58.41 -69.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.265 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.891 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 56.3 Cg_endo -70.49 -28.69 21.42 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.72 2.28 . . . . 0.0 112.487 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 102' ' ' VAL . 3.3 mm-40 -68.01 -18.14 64.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.497 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 3.8 m -116.88 157.8 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.71 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -44.19 113.96 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.4 mt -85.48 43.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.73 30.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -138.53 155.83 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.688 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.543 ' HA ' ' CE1' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -130.13 -172.65 2.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.973 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 1.128 ' OD1' ' O ' ' A' ' 108' ' ' THR . 1.5 t70 -82.97 -174.68 5.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' ' CG ' ' A' ' 138' ' ' ASP . . . -77.94 -4.99 49.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.042 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -46.75 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.761 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . 124.66 80.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.621 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 141' ' ' GLY . 28.5 mt -161.92 107.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.2 p -77.44 150.44 79.7 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.801 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.704 ' O ' HD22 ' A' ' 160' ' ' LEU . 82.1 Cg_exo -45.43 -31.56 6.87 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.604 2.203 . . . . 0.0 112.206 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.771 HD12 ' CE ' ' A' ' 164' ' ' MET . 0.4 OUTLIER -73.32 -47.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.94 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.047 ' OE1' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.34 -50.92 63.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.209 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.936 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.59 -26.93 14.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.391 . . . . 0.0 110.677 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.602 ' HB1' ' N ' ' A' ' 157' ' ' MET . . . -73.67 -23.71 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -49.22 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -60.92 -72.79 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -73.18 60.98 0.6 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.81 47.92 0.78 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.085 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -36.92 -57.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.441 0.638 . . . . 0.0 110.052 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.426 ' HG3' ' C ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -145.37 -146.51 0.19 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.548 179.031 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 1.103 ' HB2' ' CG ' ' A' ' 158' ' ' ASP . 17.6 p30 -73.36 53.63 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.848 ' HA ' HD12 ' A' ' 159' ' ' ILE . 6.3 mt -65.14 -66.29 0.56 Allowed 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.574 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.602 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 2.7 ppp? -51.44 -20.73 1.94 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.826 0.346 . . . . 0.0 110.392 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.103 ' CG ' ' HB2' ' A' ' 155' ' ' ASN . 7.9 p-10 -73.72 -42.42 61.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.025 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.47 -40.24 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 144' ' ' PRO . 5.4 mp -73.12 -40.17 65.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -63.51 -47.33 82.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.78 -44.32 92.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.38 -12.29 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.909 ' HA ' HD13 ' A' ' 134' ' ' LEU . 6.9 mtp -72.7 -53.18 12.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.466 ' O ' ' N ' ' A' ' 167' ' ' PRO . 3.4 ttp 75.35 37.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 168' ' ' MET . 0.9 OUTLIER -34.6 93.01 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.276 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' MET . 32.5 Cg_exo -57.88 75.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.238 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -79.84 -13.26 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.489 ' CE ' ' HG3' ' A' ' 42' ' ' ARG . 1.6 ttm -82.67 143.5 30.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.954 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.02 -55.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.78 -175.49 4.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.066 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.167 ' OE1' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.64 47.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.709 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.99 -26.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.167 ' HB ' ' OE1' ' A' ' 6' ' ' GLU . 54.7 t -48.98 -67.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.821 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER 35.44 90.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.546 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.97 HG13 HG12 ' A' ' 35' ' ' VAL . 66.6 t 105.92 -39.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.931 0.77 . . . . 0.0 110.851 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.742 ' CA ' ' HB1' ' A' ' 39' ' ' ALA . . . -65.94 -9.52 47.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.687 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -117.85 18.46 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 tpt85 -122.62 -53.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.2 tp -70.01 -43.72 70.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.754 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.705 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.99 -31.41 63.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' ARG . . . -72.87 -53.33 8.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.398 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 20' ' ' ARG . . . -57.57 -58.76 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.084 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.96 67.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.48 -28.48 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.438 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.375 ' CG ' ' OD2' ' A' ' 22' ' ' ASP . 0.7 OUTLIER -73.6 0.66 12.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.249 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 50.73 78.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.375 ' OD2' ' CG ' ' A' ' 20' ' ' ARG . 2.6 p30 -152.63 97.15 2.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.823 0.344 . . . . 0.0 110.598 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.927 HG23 ' HB3' ' A' ' 57' ' ' ALA . 2.1 p -52.83 -25.18 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.66 -49.99 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.004 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -73.25 -39.75 65.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.57 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 58' ' ' VAL . 8.8 p -52.42 -42.15 37.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 67.1 mtp85 -72.91 -50.75 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.014 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 3.5 mmp_? -52.61 -30.63 32.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.753 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.64 -74.04 0.2 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.172 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' HG2' ' A' ' 65' ' ' GLN . 3.5 mt -74.31 -42.91 58.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -67.54 -4.56 11.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 9.4 tpt180 -149.51 -77.34 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.646 0.26 . . . . 0.0 111.311 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.852 ' OE1' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -41.69 -26.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 34' ' ' LEU . 3.6 tp 66.27 83.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.97 HG12 HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -111.84 134.92 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.187 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.529 ' H ' HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -71.26 129.56 88.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.689 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' HG3' ' A' ' 65' ' ' GLN . 49.1 Cg_endo -69.17 -15.67 39.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.745 2.297 . . . . 0.0 112.239 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 6.7 t0 -83.57 -28.47 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.962 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.742 ' HB1' ' CA ' ' A' ' 11' ' ' GLY . . . -43.52 157.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 8' ' ' VAL . 2.9 mp -143.34 142.47 31.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.263 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 22.3 p30 -71.4 169.38 15.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.489 ' HG3' ' CE ' ' A' ' 3' ' ' MET . 3.0 tmt_? -39.85 -34.79 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -62.05 -52.92 61.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.45 33.44 1.21 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.508 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 10.9 mtpt -109.99 170.83 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.859 0.361 . . . . 0.0 111.059 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.789 ' O ' HG22 ' A' ' 50' ' ' VAL . 1.5 p -98.94 166.58 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -58.32 -46.37 86.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -64.79 -34.26 77.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.848 ' NE2' ' CG ' ' A' ' 73' ' ' ASP . 1.5 tp60 -73.43 -45.75 52.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.152 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 46' ' ' THR . 15.7 m -72.97 -39.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.657 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.574 ' SD ' ' CD1' ' A' ' 53' ' ' PHE . 2.7 ppp? -35.26 148.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.038 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 54' ' ' GLY . 2.5 ptm -111.14 22.79 14.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.159 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.13 ' CE2' HD21 ' A' ' 95' ' ' LEU . 56.3 m-85 50.19 -87.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.347 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 34.46 -94.35 0.01 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.413 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.622 ' C ' HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -53.54 156.26 4.62 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 1.041 ' HB3' ' OD2' ' A' ' 90' ' ' ASP . 93.8 Cg_endo -89.17 -52.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.961 2.441 . . . . 0.0 112.562 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.927 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -62.99 -23.15 67.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.773 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.9 p -62.32 -45.46 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 63' ' ' LEU . . . -63.12 -48.89 76.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.13 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.847 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -62.48 -48.88 77.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.18 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -62.67 -58.07 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.76 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.716 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -62.86 -49.68 73.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.44 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD12 ' C ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -63.11 -44.36 95.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 111.214 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.64 ' N ' HD12 ' A' ' 63' ' ' LEU . 10.5 ttpp -62.74 -31.0 71.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.9 0.381 . . . . 0.0 110.808 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.756 ' HG2' HD22 ' A' ' 30' ' ' LEU . 31.6 tp60 -45.66 -29.42 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.1 -19.14 2.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.41 152.46 11.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 13.0 m -105.99 126.66 30.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.979 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HA ' ' HG ' ' A' ' 48' ' ' LEU . 44.4 Cg_endo -68.57 -4.29 12.78 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.737 2.291 . . . . 0.0 112.314 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -98.4 64.69 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' SER . 31.4 m -116.88 125.7 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -104.76 144.31 31.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.848 ' CG ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -123.37 122.03 37.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 47.94 -91.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -72.44 -87.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . -175.93 45.33 0.12 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.541 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.08 83.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . 1.7 m -84.71 166.95 29.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 1.263 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 79.5 Cg_exo -47.81 -33.79 20.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.691 2.261 . . . . 0.0 112.308 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 81' ' ' HIS . 0.5 OUTLIER -54.8 -42.15 60.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.014 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.571 ' HD2' ' OD2' ' A' ' 106' ' ' ASP . 15.7 m80 -70.07 -48.41 57.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.032 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.263 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 2.3 p30 -55.79 -50.45 70.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.259 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.66 -48.77 66.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 128' ' ' LEU . . . -64.14 -49.93 70.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.234 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -37.9 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ASP . 58.5 p -67.82 -27.44 66.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 81.06 73.6 1.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -153.64 58.4 0.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.821 HD11 ' CG ' ' A' ' 127' ' ' PHE . 61.7 tp -53.87 -16.7 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.673 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.041 ' OD2' ' HB3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.78 -74.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.803 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -73.65 -33.25 64.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.766 ' C ' HD23 ' A' ' 92' ' ' LEU . 2.0 tt -52.38 -56.91 11.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 1.215 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -56.64 -34.27 67.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.978 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 91' ' ' THR . 54.7 t -56.29 -62.52 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.13 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.43 -32.61 64.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 92' ' ' LEU . 19.8 t -70.81 -46.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.215 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -56.08 -32.38 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.967 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -14.57 63.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.11 -68.47 0.44 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 69' ' ' PRO . . . 43.62 -167.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -111.8 64.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.469 ' CG1' HG13 ' A' ' 96' ' ' VAL . 6.7 m -79.88 5.88 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.29 24.85 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -119.82 128.4 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.556 HD13 ' CA ' ' A' ' 109' ' ' GLY . 7.1 mt -85.49 162.38 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.062 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.669 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -88.39 -84.84 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 t -131.61 -45.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.03 7.27 11.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 70.77 10.75 68.2 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.554 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' A' ' 138' ' ' ASP . 73.6 p -78.89 92.46 4.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 111.044 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.72 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -36.24 146.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.588 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD23 ' A' ' 111' ' ' LEU . 99.2 Cg_exo -43.08 -28.44 1.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.409 2.073 . . . . 0.0 112.113 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.683 ' N ' HD22 ' A' ' 128' ' ' LEU . 1.9 tp -73.4 -35.34 45.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.881 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.56 ' CE1' ' OD1' ' A' ' 138' ' ' ASP . 56.6 m80 -57.68 -43.73 85.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -58.75 -42.97 90.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.476 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.647 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -54.59 -48.9 71.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.569 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 147' ' ' LEU . 93.8 mt -56.0 -40.83 65.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.773 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HE ' HD21 ' A' ' 147' ' ' LEU . 3.0 mmt85 -62.41 -21.44 65.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -90.32 -54.87 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.712 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 116.26 -6.61 19.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.519 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.679 ' O ' HG23 ' A' ' 125' ' ' VAL . 98.2 m-70 -51.1 85.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' GLY . 18.0 p -38.88 -38.67 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 124' ' ' VAL . 1.9 p -73.17 -63.89 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.08 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 39.3 t -55.54 -57.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.361 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 121' ' ' HIS . 3.6 t -51.93 -54.09 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.961 ' HB2' HG21 ' A' ' 159' ' ' ILE . 44.0 t -63.74 -31.7 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.406 . . . . 0.0 111.11 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.821 ' CG ' HD11 ' A' ' 89' ' ' LEU . 71.3 t80 -73.1 -47.59 43.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -67.89 -8.96 40.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.29 -64.0 2.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 43.7 Cg_endo -67.88 -46.29 2.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.757 2.305 . . . . 0.0 112.287 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 4.2 mm-40 -51.59 -47.09 63.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.506 ' HB3' HD22 ' A' ' 111' ' ' LEU . 27.8 m -77.67 132.26 38.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' ND1' ' A' ' 136' ' ' HIS . 1.2 m-20 -36.14 96.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.772 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.7 mt -56.08 146.77 21.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.2 t-160 87.64 -21.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.672 ' CG ' HD13 ' A' ' 111' ' ' LEU . 2.0 p-80 -42.85 167.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.015 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -122.27 -172.62 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.56 ' OD1' ' CE1' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -130.0 159.17 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.875 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.37 -10.6 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.077 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 p -109.27 -24.04 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.786 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 111.11 28.92 3.67 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.633 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.419 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 34.4 mt -102.77 -179.35 3.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -169.8 177.01 1.16 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.6 Cg_exo -49.93 -58.76 1.52 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.641 2.228 . . . . 0.0 112.119 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 161' ' ' GLN . 2.2 mt -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.66 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.419 ' OE1' ' CD2' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -54.84 -59.63 4.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.54 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -52.88 -51.86 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.411 179.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.8 -36.21 57.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.135 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.438 HH12 HD22 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -63.3 -31.24 72.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -79.33 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.131 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.59 ' O ' HD11 ' A' ' 156' ' ' LEU . 4.5 mtt85 -74.06 75.08 1.73 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.84 55.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.082 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 1.017 ' HB3' HD22 ' A' ' 156' ' ' LEU . . . -59.32 -18.68 40.1 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 1.229 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 7.5 tp-100 102.76 -85.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.858 0.724 . . . . 0.0 112.834 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.986 ' HA ' ' OD2' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -54.99 -42.87 72.98 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.017 HD22 ' HB3' ' A' ' 153' ' ' ALA . 1.7 pt? -51.87 -53.84 36.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.573 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.2 ptm -60.28 -36.3 77.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.916 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.229 ' OD1' ' O ' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -73.55 -25.2 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.716 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.961 HG21 ' HB2' ' A' ' 126' ' ' SER . 18.8 mt -73.28 -42.06 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.238 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.847 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -73.48 -53.55 10.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.718 -179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.654 ' HB3' HD21 ' A' ' 145' ' ' LEU . 1.0 OUTLIER -52.37 -25.29 9.38 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.906 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 161' ' ' GLN . . . -73.31 -54.79 6.59 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.291 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -73.14 -49.23 29.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.772 ' HA ' HD13 ' A' ' 134' ' ' LEU . 2.6 tmm? -38.3 -64.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.036 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.68 ' O ' HD13 ' A' ' 166' ' ' ILE . 2.7 ttm 57.23 -164.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.638 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 165' ' ' MET . 4.2 mm -136.91 108.71 9.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 168' ' ' MET . 50.3 Cg_endo -69.8 179.43 3.73 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.815 2.343 . . . . 0.0 112.307 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.454 ' HB3' ' O ' ' A' ' 167' ' ' PRO . 3.6 ptt? . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 57.9 m 65.82 -80.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.2 69.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.842 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mt -100.19 111.76 24.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.77 ' O ' ' OE1' ' A' ' 6' ' ' GLU . 7.3 tp -164.21 48.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.77 ' OE1' ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -109.98 81.47 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.24 12.76 23.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.458 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 19.5 m -117.24 35.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.036 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 8' ' ' VAL . 1.2 p -35.31 -42.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.18 -9.96 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.03 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.615 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -53.64 -71.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 1.271 ' OD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -49.86 -22.48 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 110.972 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 1.171 ' HG2' ' OE2' ' A' ' 33' ' ' GLU . 1.9 tpt180 -61.91 -65.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -71.73 -45.42 61.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -35.93 77.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.93 -49.47 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.456 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.36 -43.96 75.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.64 -50.86 22.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -37.32 80.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -19.59 62.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . 69.66 60.23 5.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.464 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.753 ' OD1' ' HB2' ' A' ' 25' ' ' GLU . 3.6 p30 -125.77 92.88 3.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.779 0.323 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 10.3 p -52.75 -20.71 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.842 ' C ' ' OE1' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -74.0 -53.9 9.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.156 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.264 ' OE1' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -73.39 -33.43 65.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.82 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.7 p -52.78 -50.8 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 0.0 111.306 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.634 ' CB ' ' CD2' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -73.21 -50.52 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.163 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 8.2 ttt180 -56.41 -25.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.005 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -69.36 -70.7 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.974 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.81 HD22 ' CD ' ' A' ' 65' ' ' GLN . 3.5 mt -73.67 -40.15 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.369 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' CB ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -72.64 -1.59 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.321 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -144.73 -70.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.743 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.171 ' OE2' ' HG2' ' A' ' 13' ' ' ARG . 1.2 tt0 -61.67 -15.1 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 47.44 76.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.937 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 14' ' ' LEU . 6.7 t -100.4 159.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.474 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -88.27 142.44 31.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.971 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.503 ' HD3' ' NE2' ' A' ' 65' ' ' GLN . 11.6 Cg_endo -54.77 -39.95 87.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.072 2.515 . . . . 0.0 112.296 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 59.01 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -107.68 121.37 44.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.055 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.856 HD12 ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.99 170.74 9.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.882 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 1.271 ' CB ' ' OD1' ' A' ' 12' ' ' ASP . 15.9 p30 -124.41 -170.79 2.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.57 -30.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 41' ' ' ASN . 0.2 OUTLIER -69.02 -52.12 31.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.93 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.76 ' O ' HD23 ' A' ' 40' ' ' LEU . . . 108.16 18.39 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 40' ' ' LEU . 15.0 mttp -102.47 167.66 9.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.775 ' O ' HG12 ' A' ' 50' ' ' VAL . 28.1 p -85.12 162.79 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -54.75 -44.44 73.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.664 ' CD1' HD11 ' A' ' 62' ' ' LEU . 5.1 tp -63.76 -51.19 66.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.043 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' NE2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tt0 -54.34 -70.14 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.996 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 46' ' ' THR . 7.8 p -56.69 -23.99 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.919 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -36.6 132.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 3.4 ptt? -93.48 13.64 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.911 ' CE2' HD21 ' A' ' 95' ' ' LEU . 0.8 OUTLIER 43.72 26.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.888 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.86 -67.91 1.93 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.18 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 91' ' ' THR . 0.4 OUTLIER -93.24 141.85 24.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.318 . . . . 0.0 110.516 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.473 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 52.2 Cg_endo -68.55 -43.2 4.24 Favored 'Trans proline' 0 C--O 1.23 0.11 0 C-N-CA 122.636 2.224 . . . . 0.0 111.975 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.2 -32.73 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.697 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.745 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.3 t -62.48 -31.88 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-O 121.145 0.498 . . . . 0.0 109.79 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.857 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.63 -64.03 1.01 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.177 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.14 -28.86 70.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.274 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -63.02 -71.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -63.35 -27.46 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.159 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -62.78 -62.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -19.03 63.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.81 ' CD ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -48.07 -24.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.95 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.15 0.39 5.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.361 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.57 -173.89 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.46 130.45 9.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -14.19 35.33 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.764 2.309 . . . . 0.0 112.373 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 23.5 m120 -82.36 74.8 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.027 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.536 ' CG2' ' HD3' ' A' ' 79' ' ' PRO . 28.4 m -130.08 138.21 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.007 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -144.43 157.58 44.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.946 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -144.88 -77.62 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 85.23 6.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.44 -56.16 0.64 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 1.29 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 172.83 56.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.889 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 5.7 m -101.77 69.57 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 79' ' ' PRO . 0.1 OUTLIER -73.38 170.89 12.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.898 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 10.2 Cg_endo -53.67 -40.5 79.31 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.835 2.356 . . . . 0.0 112.321 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -56.26 -25.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -67.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.766 ' O ' HG23 ' A' ' 86' ' ' THR . 43.8 p30 -60.66 -26.35 67.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.893 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -55.25 -52.79 62.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -62.27 -45.44 93.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.273 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -72.81 -29.05 62.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.99 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.766 HG23 ' O ' ' A' ' 82' ' ' ASP . 12.1 p -69.41 -6.1 27.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.043 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.41 74.97 0.26 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.39 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -161.11 59.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' CG ' ' A' ' 127' ' ' PHE . 2.1 tm? -53.6 -28.93 35.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -58.75 -67.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.694 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.857 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 17.5 m -70.66 -23.39 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.764 ' C ' HD23 ' A' ' 92' ' ' LEU . 1.7 tt -72.83 -42.87 63.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.441 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 1.305 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 6.6 ptpt -67.87 -32.44 72.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.67 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.338 ' C ' ' OE1' ' A' ' 97' ' ' GLU . 1.3 m -64.9 -54.35 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.491 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.5 pp -74.01 -33.39 63.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.808 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 42.3 t -73.04 -53.17 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.254 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.338 ' OE1' ' C ' ' A' ' 94' ' ' VAL . 1.2 pm0 -52.72 -31.6 38.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.889 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.471 ' CD2' ' CD2' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -57.65 -19.43 26.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.962 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.3 6.71 5.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -50.16 132.5 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.083 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.587 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 2.9 p30 -43.94 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -99.06 22.55 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.144 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.614 ' HA ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -128.29 14.29 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.721 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.64 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -89.82 161.65 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -141.64 -179.69 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 1.29 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 1.7 m-20 -121.11 -155.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.992 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.34 -57.83 7.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -33.45 73.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.017 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.52 -9.39 66.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.503 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.54 ' O ' HD11 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -61.3 113.76 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -59.67 150.1 68.47 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.732 ' HD2' HD23 ' A' ' 111' ' ' LEU . 98.8 Cg_exo -42.71 -31.85 2.22 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.829 2.353 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.79 ' HA ' HD21 ' A' ' 128' ' ' LEU . 3.3 tp -72.37 -39.32 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.11 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 111' ' ' LEU . 36.3 m80 -61.38 -35.18 76.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 115' ' ' LEU . 5.1 mp -69.1 -50.49 47.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.619 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -54.18 -37.45 64.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.589 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 147' ' ' LEU . 94.5 mt -62.23 -43.76 98.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.299 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 11.9 mtp180 -61.48 -16.22 45.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.313 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 85' ' ' ARG . 3.7 mt-10 -105.3 -49.81 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.867 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 121' ' ' HIS . . . 81.07 29.48 41.39 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.116 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.601 ' CB ' HG21 ' A' ' 124' ' ' VAL . 68.6 m-70 -51.5 -169.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 110.683 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 121' ' ' HIS . 91.6 p -57.56 -130.69 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.729 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 1.54 9.76 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.223 -0.298 . . . . 0.0 111.441 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -54.39 -68.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.639 0.257 . . . . 0.0 110.852 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 116' ' ' ALA . 2.7 t -52.18 -32.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.786 ' HB2' HG21 ' A' ' 159' ' ' ILE . 13.8 t -73.53 -56.87 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.787 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 1.097 ' O ' ' OE1' ' A' ' 131' ' ' GLU . 5.0 t80 -67.97 -47.06 69.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.762 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -66.4 -7.5 19.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.877 -179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.618 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -73.12 -60.7 1.71 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.37 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 18.4 Cg_endo -59.45 -64.27 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.831 2.354 . . . . 0.0 112.49 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.097 ' OE1' ' O ' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -43.8 -26.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.642 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.594 ' OG ' HD22 ' A' ' 111' ' ' LEU . 6.0 t -89.5 133.86 34.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.661 ' OD2' ' HB2' ' A' ' 136' ' ' HIS . 3.2 p-10 -38.05 93.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.657 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.6 mt -63.88 69.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.086 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER 178.34 -42.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.017 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.661 ' HB2' ' OD2' ' A' ' 133' ' ' ASP . 0.8 OUTLIER -54.06 154.41 4.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.91 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HD3' ' NE2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -140.91 -148.07 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.783 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.457 ' N ' ' HD2' ' A' ' 137' ' ' ARG . 0.7 OUTLIER -160.91 -162.72 0.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.65 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.33 -22.61 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.172 0.511 . . . . 0.0 110.612 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -62.38 -52.68 62.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.89 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.36 20.73 58.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.748 ' O ' HG23 ' A' ' 143' ' ' THR . 1.4 mt -106.6 -105.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.551 0.175 . . . . 0.0 110.807 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.253 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER 160.52 167.83 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.8 0.333 . . . . 0.0 110.839 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 3.8 Cg_endo -47.41 -57.56 2.25 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 123.022 2.481 . . . . 0.0 112.088 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -66.12 -44.75 83.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.253 ' CD ' ' OG1' ' A' ' 143' ' ' THR . 4.0 mp0 -55.53 -51.12 68.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.531 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.691 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -53.04 -43.34 66.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 110.171 179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.834 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.85 -36.42 58.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.102 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -35.61 78.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.627 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -74.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.248 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.719 ' O ' HD21 ' A' ' 156' ' ' LEU . 10.8 mmm180 -73.97 70.59 1.51 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -63.29 52.0 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.909 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.905 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -57.17 -16.6 8.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.513 0.196 . . . . 0.0 110.535 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 7.0 tp-100 101.79 -59.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.659 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.494 ' C ' HD12 ' A' ' 159' ' ' ILE . 4.8 m-20 -72.6 -54.73 8.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.0 111.512 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.905 ' HG ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -53.05 -16.78 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.946 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.834 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 14.4 mtp -74.74 -60.37 2.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.858 0.361 . . . . 0.0 111.603 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.071 -179.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.786 HG21 ' HB2' ' A' ' 126' ' ' SER . 60.0 mt -52.74 -55.25 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 120.673 0.273 . . . . 0.0 111.366 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.8 OUTLIER -73.64 -31.12 63.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.34 -179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.845 ' HG2' HD13 ' A' ' 145' ' ' LEU . 1.3 mm-40 -62.94 -42.64 99.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.97 -36.14 57.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.403 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -70.18 -31.73 69.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.8 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.502 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.57 87.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.858 ' C ' HD13 ' A' ' 166' ' ' ILE . 1.0 OUTLIER -68.18 168.52 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.926 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.858 HD13 ' C ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -136.44 105.59 9.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.949 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.54 108.05 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.958 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -126.3 104.73 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.761 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.81 56.81 1.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.8 -51.32 5.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 5' ' ' LEU . 1.2 tp 65.53 165.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.204 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER 63.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.904 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 1.204 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 0.1 OUTLIER 172.97 101.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.885 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.012 HG13 ' OE2' ' A' ' 6' ' ' GLU . 15.6 m -119.27 -11.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.202 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.414 ' C ' ' O ' ' A' ' 8' ' ' VAL . 20.7 p -36.38 -38.54 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.695 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 35' ' ' VAL . 13.1 p -107.33 -17.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.866 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -46.47 -57.59 6.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.444 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -84.21 54.68 3.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -127.86 -66.09 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.977 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 29' ' ' LEU . 29.0 tp -67.23 -33.92 76.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.008 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -61.89 -39.18 91.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -31.63 75.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.9 -59.67 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 111.153 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.48 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . . . -54.28 -48.62 71.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.608 ' HB2' HG23 ' A' ' 50' ' ' VAL . . . -64.24 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -72.61 -37.65 68.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.85 73.75 1.11 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.694 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -139.37 83.78 1.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -52.65 -22.61 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -74.11 -49.67 22.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.93 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.565 ' O ' HD23 ' A' ' 29' ' ' LEU . 55.8 mm-40 -73.84 -27.3 61.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.845 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.686 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -52.76 -51.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 0.0 111.53 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.559 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 2.2 mtm180 -73.28 -43.09 61.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 19.7 mmt180 -63.5 -34.21 77.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.29 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -53.47 -71.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.318 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.856 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -69.68 -49.36 54.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.012 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 31' ' ' HIS . 0.0 OUTLIER -66.72 -25.83 66.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -120.93 -58.66 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.555 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.3 tp10 -67.35 -7.14 22.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.06 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER 42.46 28.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.7 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -66.76 148.85 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.072 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -67.62 131.03 92.97 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.98 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 57.5 Cg_endo -71.07 -22.42 26.19 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.852 2.368 . . . . 0.0 112.334 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -99.55 18.68 17.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -62.18 107.59 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.3 mp -89.82 145.22 25.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 12' ' ' ASP . 54.2 p30 -80.93 -171.37 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -70.56 58.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -172.52 -43.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.58 60.14 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.594 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -141.08 145.64 36.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 50' ' ' VAL . 20.9 p -85.57 155.9 20.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.543 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -55.27 -24.24 27.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 69' ' ' PRO . 3.8 mt -72.9 -49.65 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 78' ' ' SER . 1.8 tp-100 -63.88 -28.29 69.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 19' ' ' ALA . 28.9 m -96.23 -14.18 7.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HE1' ' CD2' ' A' ' 95' ' ' LEU . 1.2 ttp -44.64 154.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -109.72 23.51 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.938 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.73 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 35.84 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -72.39 -85.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.314 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.1 m -77.91 120.31 80.79 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.37 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.791 ' HA ' HG23 ' A' ' 91' ' ' THR . 60.9 Cg_exo -51.1 -43.48 48.05 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.472 2.115 . . . . 0.0 112.08 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -63.61 -28.51 69.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.573 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.644 ' HA ' HG21 ' A' ' 26' ' ' VAL . 3.2 t -62.27 -41.66 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.647 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.65 -50.18 70.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.641 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.5 tp -63.14 -40.19 96.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.712 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -63.04 -43.24 99.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 62' ' ' LEU . 6.0 mt -62.81 -56.92 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.692 HD21 ' HB3' ' A' ' 69' ' ' PRO . 5.8 mt -63.12 -31.31 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 4.2 mmtt -63.36 -46.27 87.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -56.57 -27.2 57.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.969 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.39 47.88 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.436 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -109.25 123.58 49.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.903 0.382 . . . . 0.0 111.039 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 124.86 83.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.692 ' HB3' HD21 ' A' ' 63' ' ' LEU . 59.3 Cg_endo -72.42 -38.61 3.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.727 2.285 . . . . 0.0 112.302 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.01 101.48 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 49' ' ' GLN . 11.6 m -139.41 132.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' HG3' ' C ' ' A' ' 71' ' ' VAL . 49.5 mt-30 -144.85 131.86 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -138.8 -44.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 75' ' ' SER . . . -104.55 115.33 30.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 76' ' ' GLY . 0.9 OUTLIER 36.38 63.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.106 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 106' ' ' ASP . . . 35.53 66.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.602 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.3 m -124.97 144.79 50.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.524 ' HA ' ' NE2' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -144.41 177.97 1.61 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.798 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 77.6 Cg_exo -49.61 -47.56 22.39 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.656 2.238 . . . . 0.0 112.288 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.69 HG23 HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.57 -38.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -59.31 -70.11 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.204 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.758 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -58.03 -33.31 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.81 -52.44 56.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.41 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 116' ' ' ALA . . . -64.97 -46.56 80.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.441 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -72.21 -24.36 61.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.355 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 82' ' ' ASP . 11.5 p -73.11 -73.48 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.124 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 126.75 63.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.997 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -148.38 57.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.678 HD13 ' O ' ' A' ' 89' ' ' LEU . 2.7 tm? -52.11 -19.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 4.5 m-20 -60.36 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.791 HG23 ' HA ' ' A' ' 56' ' ' PRO . 2.4 m -73.37 -27.55 61.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.755 ' C ' HD23 ' A' ' 92' ' ' LEU . 3.1 tt -56.54 -57.52 11.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.988 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.65 ' N ' HD23 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.07 -32.22 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.238 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.807 ' CA ' ' CD ' ' A' ' 97' ' ' GLU . 23.7 t -57.71 -65.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.725 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.6 pp -70.41 -29.33 65.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.429 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 80' ' ' VAL . 23.5 t -72.55 -40.31 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.075 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.807 ' CD ' ' CA ' ' A' ' 94' ' ' VAL . 4.5 pm0 -72.82 -25.75 61.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -61.07 -62.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -176.74 -30.35 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.868 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 99' ' ' GLY . . . -31.8 118.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 111.351 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.23 119.27 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 131' ' ' GLU . 5.3 p -110.84 20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.147 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -136.62 27.88 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.634 ' C ' HD13 ' A' ' 105' ' ' LEU . . . -107.92 130.99 54.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.035 0.445 . . . . 0.0 111.064 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -97.49 162.61 13.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.091 -179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 51.9 p-10 -85.31 53.07 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 106' ' ' ASP . 8.4 t 80.42 -62.65 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -42.04 -28.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.003 0.43 . . . . 0.0 110.048 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 88.45 31.69 13.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.57 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.542 ' N ' ' HB3' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -101.8 96.87 7.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 105' ' ' LEU . 10.6 tp -34.89 135.35 0.41 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.074 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -45.92 -29.25 5.76 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.734 2.29 . . . . 0.0 112.452 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.853 HD12 ' C ' ' A' ' 128' ' ' LEU . 4.5 tt -73.06 -35.7 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -52.84 -37.66 60.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -68.64 -46.55 68.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.615 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.668 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . . . -56.29 -41.64 76.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.257 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.757 ' HA ' HG11 ' A' ' 125' ' ' VAL . 85.5 mt -57.64 -38.04 62.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.595 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 2.3 mtp180 -66.22 -17.44 64.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.651 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -98.95 -50.94 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.76 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.84 40.96 6.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 123' ' ' SER . 23.9 m-70 -72.95 -3.04 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.722 0.296 . . . . 0.0 110.873 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER 63.0 -70.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.791 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 121' ' ' HIS . 32.5 m -55.98 -41.61 75.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' A' ' 84' ' ' ALA . 51.9 t -73.19 -61.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.757 HG11 ' HA ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -52.28 -51.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.732 ' CB ' HG21 ' A' ' 159' ' ' ILE . 83.7 p -56.57 -42.68 79.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.04 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.653 ' CG ' HD21 ' A' ' 89' ' ' LEU . 72.8 t80 -73.41 -37.61 65.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.853 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -71.97 -2.64 18.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.28 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.849 ' HB3' ' CD ' ' A' ' 130' ' ' PRO . . . -69.19 -71.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.226 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.849 ' CD ' ' HB3' ' A' ' 129' ' ' ALA . 37.5 Cg_endo -66.96 -57.63 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.614 2.21 . . . . 0.0 112.336 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 6.6 mm-40 -39.63 -37.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.808 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.483 ' OG ' HD13 ' A' ' 128' ' ' LEU . 9.7 m -96.38 133.4 40.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.786 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.32 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -36.51 107.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.549 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 164' ' ' MET . 31.0 mt -72.89 -1.31 16.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.268 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.05 24.09 13.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.936 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.32 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 4.4 t60 -107.27 171.1 7.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.785 ' HG3' HG23 ' A' ' 143' ' ' THR . 0.2 OUTLIER -159.94 157.38 28.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 141' ' ' GLY . 6.7 t0 -77.57 157.89 30.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.486 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.7 -27.82 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 109.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -40.64 62.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.657 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . 114.11 35.85 1.44 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.39 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 147' ' ' LEU . 67.8 mt -93.92 -167.63 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.873 HG22 ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -178.35 165.28 1.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.873 ' HD2' HG22 ' A' ' 143' ' ' THR . 99.4 Cg_exo -42.61 -56.83 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.619 2.213 . . . . 0.0 111.886 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 161' ' ' GLN . 6.3 mt -72.03 -42.74 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 142' ' ' LEU . 3.6 tp10 -55.56 -69.78 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.551 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 142' ' ' LEU . 21.9 tp -52.73 -38.17 60.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 109.914 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 144' ' ' PRO . . . -54.14 -44.63 71.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.036 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.473 ' N ' ' SD ' ' A' ' 157' ' ' MET . 1.9 tpm_? -58.57 -23.36 58.36 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 1.4 tt0 -71.9 -75.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.87 ' O ' HD11 ' A' ' 156' ' ' LEU . 5.6 mmm180 -74.06 74.43 1.72 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -61.88 55.81 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.582 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 155' ' ' ASN . . . -69.88 -13.26 62.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.756 0.313 . . . . 0.0 110.748 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 153' ' ' ALA . 8.2 tp-100 88.39 -37.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.054 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.98 ' OD1' HD23 ' A' ' 156' ' ' LEU . 0.7 OUTLIER -72.51 -64.89 0.86 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.252 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.98 HD23 ' OD1' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -52.01 -55.02 23.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.291 -179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 148' ' ' ALA . 34.5 mmm -50.98 -28.19 9.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 154' ' ' GLN . 30.9 t0 -75.31 -71.04 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.708 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.732 HG21 ' CB ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -53.05 -40.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.232 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 156' ' ' LEU . 6.5 mp -73.68 -14.75 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.325 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.725 ' HA ' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -73.37 -61.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.38 -48.69 50.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.301 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -53.93 -18.96 3.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 134' ' ' LEU . 6.9 mmm -94.74 133.51 38.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -78.08 73.69 4.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 166' ' ' ILE . 0.6 OUTLIER -34.45 93.47 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.29 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.462 ' N ' ' O ' ' A' ' 165' ' ' MET . 50.7 Cg_exo -54.01 113.31 1.27 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.72 2.28 . . . . 0.0 112.232 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.3 mtt . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.91 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.85 144.21 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mmm -118.53 -8.11 10.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.017 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.45 155.85 25.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.886 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.265 ' HB3' ' OE2' ' A' ' 7' ' ' GLU . 19.7 mt -106.08 -159.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.909 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER 172.98 52.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.876 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 1.265 ' OE2' ' HB3' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -102.86 16.41 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG11 ' CA ' ' A' ' 41' ' ' ASN . 33.7 m -103.3 -30.83 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' C ' HG23 ' A' ' 10' ' ' VAL . 1.3 m 58.09 130.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.791 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER 52.13 20.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 40' ' ' LEU . . . -81.9 -60.91 2.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.521 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -10.77 26.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -98.66 -70.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -72.22 -61.36 1.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.1 t -55.81 -25.8 43.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.18 -50.69 11.73 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.745 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' ' CD1' ' A' ' 29' ' ' LEU . . . -72.51 -47.42 48.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 111.223 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.918 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.87 -39.67 62.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.024 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -73.34 -41.45 63.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.304 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' CD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.63 -22.14 66.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.68 59.47 3.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.898 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.247 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 16.5 t0 -109.29 90.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.643 0.259 . . . . 0.0 110.374 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' CB ' ' A' ' 57' ' ' ALA . 3.4 p -51.92 -23.53 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.151 0.5 . . . . 0.0 110.255 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.14 -59.58 2.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.8 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.247 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 11.0 mm-40 -73.96 -28.19 61.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.613 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.972 HG21 ' HA ' ' A' ' 58' ' ' VAL . 3.7 p -52.41 -51.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.816 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.561 ' N ' HG13 ' A' ' 26' ' ' VAL . 19.6 mtp180 -74.48 -51.25 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -52.75 -36.74 58.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.11 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 9.2 mt -73.16 -74.33 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.685 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.808 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -73.16 -42.19 63.07 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -73.08 -1.68 18.3 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -136.27 -64.74 0.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 111.121 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.955 ' OE2' ' CG1' ' A' ' 35' ' ' VAL . 2.2 tt0 -62.51 -11.35 15.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tp 54.22 73.25 0.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.955 ' CG1' ' OE2' ' A' ' 33' ' ' GLU . 2.0 m -101.29 153.92 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.292 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' OD2' ' A' ' 38' ' ' ASP . 1.8 t-80 -74.83 126.6 88.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.55 1.03 7.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.786 2.324 . . . . 0.0 112.357 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 1.1 p-10 -111.86 53.21 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.33 177.21 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 3.8 mp -142.19 -173.87 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' CA ' HG11 ' A' ' 8' ' ' VAL . 17.8 p-10 -150.9 166.7 29.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.609 ' NH1' ' CD2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -35.17 -31.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.609 ' CD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -68.33 -47.63 67.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' ASN . . . 110.13 16.12 10.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.568 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' LEU . 11.5 mtpt -101.83 169.02 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -86.15 168.52 13.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.884 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -60.4 -55.01 38.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.42 -36.64 84.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.522 ' NE2' HG23 ' A' ' 71' ' ' VAL . 5.9 tp-100 -52.87 -66.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 46' ' ' THR . 7.1 p -70.09 -25.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.749 ' HG3' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -35.7 107.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 20' ' ' ARG . 2.8 ptt? -66.27 137.28 56.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.108 ' CE2' HD21 ' A' ' 95' ' ' LEU . 11.6 m-85 -82.64 47.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.933 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 52' ' ' MET . . . -86.36 -64.36 1.46 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.135 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.907 ' O ' HG12 ' A' ' 58' ' ' VAL . 5.2 m -98.36 111.52 60.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.97 0.414 . . . . 0.0 110.7 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 1.026 ' CG ' ' OD1' ' A' ' 90' ' ' ASP . 76.1 Cg_exo -48.67 -23.5 5.61 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.449 2.1 . . . . 0.0 111.834 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.823 ' CB ' HG23 ' A' ' 23' ' ' VAL . . . -64.41 -43.45 94.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.112 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.972 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.1 p -61.94 -36.9 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 120.87 0.367 . . . . 0.0 110.549 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.8 -51.32 65.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 6.8 tt -63.29 -46.45 86.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.942 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE2' ' HG ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -62.56 -47.4 84.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.439 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.918 HD11 ' HB1' ' A' ' 18' ' ' ALA . 11.9 mt -62.73 -58.97 5.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.976 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -28.16 69.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.389 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 18.0 ttpt -62.77 -17.78 61.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.774 0.321 . . . . 0.0 111.084 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.731 ' HG2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -77.34 -67.49 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.15 37.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.54 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.52 -160.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.838 0.352 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 71' ' ' VAL . 32.1 m -123.7 124.1 26.2 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 74.2 Cg_endo -75.16 -17.23 19.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.783 2.322 . . . . 0.0 112.366 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 0.3 OUTLIER -114.17 77.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG23 ' NE2' ' A' ' 49' ' ' GLN . 5.0 m -117.85 152.15 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -134.62 160.32 38.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.742 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -117.25 67.38 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 73' ' ' ASP . . . 36.17 41.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.0 m -151.46 -43.2 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.821 ' HA3' ' OD2' ' A' ' 106' ' ' ASP . . . 111.95 67.57 0.53 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.45 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -164.7 105.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.52 170.62 6.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.736 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' O ' ' CZ ' ' A' ' 53' ' ' PHE . 76.9 Cg_exo -49.66 -40.45 46.71 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.593 2.196 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 101' ' ' ASP . 7.6 m -59.05 -34.0 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -69.8 -62.36 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.76 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -53.1 -48.15 68.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.05 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -52.33 -27.71 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HA ' HG11 ' A' ' 124' ' ' VAL . . . -71.49 -62.42 1.42 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HA ' ' HG3' ' A' ' 119' ' ' GLU . 16.4 mtp180 -73.07 -28.13 62.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.502 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 82' ' ' ASP . 75.8 p -69.82 -5.58 26.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.147 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 121' ' ' HIS . . . 50.28 76.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.528 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 11.7 m-85 -150.4 56.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.987 0.422 . . . . 0.0 110.54 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -52.56 -22.95 5.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.188 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.026 ' OD1' ' CG ' ' A' ' 56' ' ' PRO . 3.6 t70 -62.29 -74.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 110.647 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 43.2 m -70.71 -19.81 62.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.501 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.798 HD22 HD22 ' A' ' 89' ' ' LEU . 2.8 tt -68.61 -55.3 12.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.511 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.6 -30.01 62.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.966 ' O ' ' OE2' ' A' ' 97' ' ' GLU . 78.8 t -59.98 -62.46 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.108 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.1 pp -73.12 -28.78 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.09 0.471 . . . . 0.0 110.148 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.889 HG13 HG11 ' A' ' 102' ' ' VAL . 16.4 t -73.33 -44.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.966 ' OE2' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -68.1 -28.42 67.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.011 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.742 ' CG ' ' OE2' ' A' ' 97' ' ' GLU . 19.0 m-70 -60.06 -29.63 68.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.48 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.705 ' O ' HG13 ' A' ' 102' ' ' VAL . . . -95.81 143.56 26.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 111.108 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.465 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -56.1 84.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.889 HG11 HG13 ' A' ' 96' ' ' VAL . 11.7 m -88.66 11.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.557 ' OD1' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.16 37.92 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.962 ' C ' HD23 ' A' ' 105' ' ' LEU . . . -107.9 145.01 34.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.121 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.962 HD23 ' C ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -121.51 146.5 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.821 ' OD2' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -155.25 -53.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -48.16 -52.98 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.08 57.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 108' ' ' THR . . . 36.49 52.62 1.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.432 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 111' ' ' LEU . 48.0 m -134.49 110.9 9.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.97 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 136' ' ' HIS . 8.8 tp -35.01 140.53 0.29 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HG2' ' O ' ' A' ' 102' ' ' VAL . 88.1 Cg_exo -46.69 -32.26 11.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.767 2.311 . . . . 0.0 112.194 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 128' ' ' LEU . 1.6 tt -66.69 -37.44 79.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.976 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.553 ' HA ' HD12 ' A' ' 117' ' ' ILE . 73.8 m80 -59.3 -35.56 73.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.762 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -64.29 -53.07 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.415 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.497 ' C ' ' CG1' ' A' ' 125' ' ' VAL . . . -52.72 -41.4 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 110.055 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.627 ' HA ' HG11 ' A' ' 125' ' ' VAL . 88.2 mt -52.81 -42.5 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.333 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -16.22 61.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 121' ' ' HIS . 3.8 mm-40 -86.46 -59.58 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.694 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.29 -0.35 14.38 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.603 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.887 ' O ' HG22 ' A' ' 125' ' ' VAL . 77.9 m-70 -61.44 73.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m -34.53 -33.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -73.57 -48.76 30.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.569 ' HA ' HD23 ' A' ' 89' ' ' LEU . 12.4 t -73.07 -50.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.411 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.887 HG22 ' O ' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -52.07 -52.34 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.548 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 2.1 t -69.04 -34.98 76.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.229 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.79 ' CD2' HD21 ' A' ' 89' ' ' LEU . 67.7 t80 -72.94 -35.83 67.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.088 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.28 -0.23 13.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.273 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.897 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -66.2 -69.41 0.56 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 0.0 111.306 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.897 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.5 Cg_endo -68.56 -57.28 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.724 2.283 . . . . 0.0 112.633 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.487 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 24.0 mm-40 -39.28 -31.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.006 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 1.3 t -109.01 136.3 48.77 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.005 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 111' ' ' LEU . 1.3 p30 -35.37 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 164' ' ' MET . 12.6 mt -70.71 75.3 0.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.931 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 136' ' ' HIS . 0.2 OUTLIER 173.14 -33.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.68 ' HB3' HD22 ' A' ' 111' ' ' LEU . 6.7 t60 -38.61 161.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.584 ' HG3' HG22 ' A' ' 143' ' ' THR . 30.3 mtt180 -140.51 147.65 39.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.888 ' OD2' ' HB3' ' A' ' 140' ' ' SER . 0.3 OUTLIER -85.32 159.84 19.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.6 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.685 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.292 0.568 . . . . 0.0 109.891 179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.888 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . 0.1 OUTLIER -71.52 -56.1 6.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.833 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.51 12.62 3.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.701 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' HIS . 2.7 mt -104.99 113.02 26.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.584 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -74.22 -178.67 0.81 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.018 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.695 ' O ' HD12 ' A' ' 160' ' ' LEU . 75.0 Cg_exo -49.92 -49.87 14.87 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.837 2.358 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -67.99 -42.41 80.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.738 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.647 ' OE1' ' OE1' ' A' ' 150' ' ' GLN . 0.8 OUTLIER -52.93 -60.16 3.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.037 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.614 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -52.84 -29.83 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.682 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 157' ' ' MET . . . -72.63 -24.08 61.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 146' ' ' GLU . 7.4 tmm_? -65.85 -51.03 62.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.625 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.647 ' OE1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -65.17 -71.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -74.18 58.3 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.29 52.12 0.81 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.433 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.718 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -31.05 -48.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.718 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -173.81 -109.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.535 ' O ' ' CG1' ' A' ' 159' ' ' ILE . 1.3 m-80 -74.71 4.97 5.41 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.227 -0.295 . . . . 0.0 111.434 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 160' ' ' LEU . 1.6 mt -51.2 -59.34 4.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.704 0.288 . . . . 0.0 111.33 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.2 -32.17 35.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.916 0.389 . . . . 0.0 110.637 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.33 -57.77 3.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.787 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.548 ' CG2' ' HB2' ' A' ' 126' ' ' SER . 0.0 OUTLIER -52.15 -32.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -179.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -73.4 -59.88 2.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' HD11 ' A' ' 145' ' ' LEU . 6.3 pt20 -65.45 -14.91 61.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.05 -55.43 6.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -72.96 -14.09 61.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 111.1 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.639 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -42.47 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.774 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.445 ' O ' ' C ' ' A' ' 166' ' ' ILE . 1.1 mtp 171.52 -36.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.996 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 167' ' ' PRO . 26.8 mm 32.07 89.26 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 166' ' ' ILE . 52.8 Cg_exo -54.66 -148.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.683 2.255 . . . . 0.0 112.274 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.88 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.3 p -62.56 72.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.841 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 1' ' ' GLY . 2.1 mtm -96.67 17.77 15.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tp -101.92 48.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.8 OUTLIER -100.78 168.27 9.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.857 ' HB3' ' OD2' ' A' ' 12' ' ' ASP . 1.3 mt-10 -45.6 131.12 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -109.23 41.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 42' ' ' ARG . 2.6 p -108.16 -17.28 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.089 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 50.9 m 67.39 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.389 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.774 HG12 ' HB1' ' A' ' 39' ' ' ALA . 9.2 t -72.07 -57.6 6.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.603 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 8' ' ' VAL . . . -33.2 -56.43 0.55 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.25 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.857 ' OD2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -73.42 -24.14 60.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.29 . . . . 0.0 111.252 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -72.56 -68.74 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.187 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.951 ' HB2' HG11 ' A' ' 35' ' ' VAL . 3.0 tm? -68.07 -54.83 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -61.12 -38.6 86.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.122 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -62.16 -61.08 7.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.673 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.818 ' HB3' HD11 ' A' ' 29' ' ' LEU . . . -57.55 -41.58 81.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 111.166 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.02 75.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.041 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.89 61.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 4.1 mtp85 -68.59 -30.71 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' CA ' ' HG2' ' A' ' 52' ' ' MET . . . 84.46 33.06 20.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.464 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.334 ' OD2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 p-10 -104.64 100.18 9.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.779 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 8.2 p -54.72 -17.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.817 ' CB ' ' OE1' ' A' ' 25' ' ' GLU . 16.8 mt-30 -74.25 -53.39 9.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.269 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.334 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -73.32 -34.64 65.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.025 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.909 HG21 ' HA ' ' A' ' 58' ' ' VAL . 9.9 p -52.56 -50.46 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' N ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -72.52 -48.1 43.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.0 111.038 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.542 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.87 -27.44 65.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 17' ' ' ALA . 26.8 mt -74.43 -71.85 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.023 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.011 HD22 ' CG ' ' A' ' 65' ' ' GLN . 82.9 mt -63.3 -67.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -64.9 -4.88 4.97 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -129.43 -70.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.459 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.206 ' OE1' HG22 ' A' ' 35' ' ' VAL . 4.4 tt0 -51.86 -20.49 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 110.873 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 34' ' ' LEU . 1.4 mt 59.12 53.51 5.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.206 HG22 ' OE1' ' A' ' 33' ' ' GLU . 48.5 t -86.02 137.2 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.179 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.536 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.6 t-80 -55.41 143.56 56.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 36.9 Cg_endo -65.22 -33.77 47.87 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.78 2.32 . . . . 0.0 112.179 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.887 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -96.42 31.59 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.741 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB1' HG12 ' A' ' 10' ' ' VAL . . . -79.43 61.19 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.366 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 38' ' ' ASP . 5.0 mp -55.76 -158.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -84.26 46.06 1.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.769 ' HB2' HG23 ' A' ' 8' ' ' VAL . 2.0 tmt_? 84.7 -11.69 0.78 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' ARG . 0.3 OUTLIER 155.74 50.42 0.0 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.791 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -143.12 -102.47 0.42 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.979 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HB3' HG13 ' A' ' 50' ' ' VAL . 14.3 mttt -95.07 154.69 17.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.862 0.363 . . . . 0.0 111.229 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.859 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.39 142.93 29.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.989 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 14' ' ' LEU . . . -52.84 -22.62 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD23 ' SD ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -73.29 -67.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -52.96 -37.76 61.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 46' ' ' THR . 28.7 m -78.43 -19.21 13.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.292 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.796 ' SD ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.61 143.22 51.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.498 ' HG2' ' CA ' ' A' ' 21' ' ' GLY . 4.1 ppp? -78.04 116.69 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.641 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 36.7 m-85 -70.32 57.93 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.38 -50.66 0.21 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.144 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.6 m -82.3 127.07 72.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' HD3' ' OD2' ' A' ' 90' ' ' ASP . 55.4 Cg_endo -70.2 -37.34 8.25 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.631 2.22 . . . . 0.0 112.317 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.851 ' HB1' ' OE2' ' A' ' 61' ' ' GLU . . . -63.31 -39.28 94.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.315 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.909 ' HA ' HG21 ' A' ' 26' ' ' VAL . 4.1 m -62.96 -31.33 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.831 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -63.45 -59.89 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 60' ' ' LEU . 7.0 tt -63.26 -37.87 88.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.851 ' OE2' ' HB1' ' A' ' 57' ' ' ALA . 5.3 mp0 -62.75 -62.81 1.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.76 HD21 HD11 ' A' ' 14' ' ' LEU . 3.4 mt -62.82 -44.82 95.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 69' ' ' PRO . 4.9 tp -63.33 -50.88 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.6 ttpp -62.83 -36.87 84.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.92 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 1.011 ' CG ' HD22 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -37.55 -60.55 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.853 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.95 -23.94 0.18 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.2 146.23 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.038 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.14 119.68 62.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 63' ' ' LEU . 53.1 Cg_endo -69.52 -19.64 37.03 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.106 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.03 70.54 0.52 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' SER . 23.4 m -124.2 145.76 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -134.4 133.35 40.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.669 ' CG ' ' N ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -100.12 -169.95 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.669 ' N ' ' CG ' ' A' ' 73' ' ' ASP . . . -35.75 -71.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.063 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.038 ' O ' ' CG ' ' A' ' 106' ' ' ASP . 0.5 OUTLIER -59.15 -34.89 72.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 1.193 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 92.29 48.16 3.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.886 HG22 ' HB3' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -112.38 75.47 0.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 110.926 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.843 ' OG ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -43.84 170.06 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.763 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 8.9 Cg_endo -50.6 -32.73 36.55 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.933 2.422 . . . . 0.0 112.38 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG22 ' CG2' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -63.75 -52.94 50.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.945 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.886 ' HB3' HG22 ' A' ' 77' ' ' THR . 33.4 m80 -53.01 -54.1 40.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.763 ' OD1' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -60.76 -50.91 71.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.076 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . . . -52.83 -30.1 31.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.48 -68.95 0.41 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -60.09 -18.62 48.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.311 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.8 p -73.33 -27.84 61.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.074 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.49 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 75.1 76.18 0.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.147 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 70.2 m-85 -156.19 61.29 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 110.607 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 123' ' ' SER . 6.3 mt -52.51 -18.3 1.63 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.596 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.044 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -57.28 -70.99 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.507 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.044 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 t -65.5 -35.94 82.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.9 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.998 HD23 HG11 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -52.89 -51.96 59.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.7 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.746 ' O ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.86 -38.01 61.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.536 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' CA ' ' OE1' ' A' ' 97' ' ' GLU . 87.9 t -75.27 -64.48 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.309 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.937 HD12 ' N ' ' A' ' 96' ' ' VAL . 4.6 pp -73.69 -52.53 12.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.998 HG11 HD23 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -52.55 -26.58 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.746 ' OE1' ' O ' ' A' ' 93' ' ' LYS . 3.0 pm0 -72.13 -29.79 64.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.904 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -67.11 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.85 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.21 37.58 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' OD1' ' A' ' 101' ' ' ASP . . . -67.47 63.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.138 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 1.1 p-10 39.96 69.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.788 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.565 HG12 HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -90.74 21.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 35.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -119.45 -178.54 3.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.194 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -150.09 165.24 33.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 1.193 ' OD1' ' C ' ' A' ' 76' ' ' GLY . 2.4 t0 -84.76 -71.0 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.25 -44.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -16.94 6.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 138' ' ' ASP . . . 72.34 52.81 9.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.382 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.65 105.48 6.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.934 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.571 ' HA ' HD23 ' A' ' 105' ' ' LEU . 8.2 mt -43.82 158.22 0.26 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 67.3 Cg_exo -51.26 -43.54 48.38 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.284 . . . . 0.0 112.283 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 129' ' ' ALA . 0.4 OUTLIER -55.83 -40.22 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.676 ' HA ' HD12 ' A' ' 117' ' ' ILE . 33.4 m170 -54.95 -43.86 73.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 118' ' ' ARG . 11.3 mt -63.01 -56.0 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.87 -32.23 43.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.42 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.928 HG21 ' HB3' ' A' ' 147' ' ' LEU . 46.9 mt -65.35 -41.28 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.604 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.452 ' HA ' ' HG3' ' A' ' 151' ' ' ARG . 0.8 OUTLIER -70.57 -18.29 62.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.602 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 85' ' ' ARG . 1.6 mt-10 -87.56 -56.62 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.59 28.77 9.98 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.604 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 124' ' ' VAL . 21.3 m-70 -60.04 -15.03 19.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.341 . . . . 0.0 110.547 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 121' ' ' HIS . 0.3 OUTLIER 77.93 -75.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.981 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.716 ' HB3' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -64.65 -48.38 75.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.011 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 42.5 t -58.22 -60.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 2.2 t -52.24 -40.78 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.005 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.756 ' HB2' HG21 ' A' ' 159' ' ' ILE . 1.9 t -72.18 -23.82 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.635 ' CE2' ' OE2' ' A' ' 131' ' ' GLU . 7.0 t80 -73.59 -48.14 35.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -69.63 -5.26 23.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.03 -70.33 0.28 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.185 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 73.9 Cg_endo -75.04 -43.4 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.696 2.264 . . . . 0.0 112.399 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.635 ' OE2' ' CE2' ' A' ' 127' ' ' PHE . 1.6 mt-10 -50.55 -33.51 22.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.702 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -104.67 146.3 29.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.707 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 132' ' ' SER . 1.2 m-20 -35.6 120.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.884 HD13 ' HA ' ' A' ' 164' ' ' MET . 6.5 mt -87.64 19.79 3.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.38 -44.48 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.81 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.557 ' HB3' HD11 ' A' ' 111' ' ' LEU . 3.1 t60 -55.7 157.1 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.941 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.42 166.91 23.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.649 ' CG ' ' O ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -80.97 153.21 27.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.806 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.44 -21.9 1.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -44.19 85.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.777 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 142' ' ' LEU . . . 107.87 53.65 0.66 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.577 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 141' ' ' GLY . 10.1 mt -149.94 104.76 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.71 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -72.95 177.62 1.83 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.697 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.506 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 87.0 Cg_exo -46.55 -57.89 2.0 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.248 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.7 -28.81 70.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.71 ' OE2' ' OG1' ' A' ' 143' ' ' THR . 0.4 OUTLIER -72.75 -65.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.097 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.34 -39.34 60.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.146 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -60.63 -37.43 81.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.23 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -36.62 84.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.613 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 151' ' ' ARG . 2.1 tp-100 -65.1 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.364 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.766 ' O ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -75.14 57.82 0.87 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -70.53 52.01 0.86 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.071 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 152' ' ' GLY . . . -35.55 -32.61 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.318 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -178.86 -123.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.461 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 1.349 ' CB ' ' OD2' ' A' ' 158' ' ' ASP . 3.4 m-20 -75.97 29.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.065 0.393 . . . . 0.0 111.963 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 151' ' ' ARG . 1.5 mt -54.25 -72.02 0.07 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 110.971 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.722 ' N ' ' HB1' ' A' ' 148' ' ' ALA . 8.7 ptm -53.95 -21.27 7.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.349 ' OD2' ' CB ' ' A' ' 155' ' ' ASN . 8.6 p-10 -73.95 -54.42 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.098 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.176 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 2.0 mt -53.13 -37.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.815 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.8 -27.9 61.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -52.9 -54.18 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.46 91.96 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.516 ' O ' ' CD1' ' A' ' 134' ' ' LEU . 42.8 m-70 -68.81 -37.7 79.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 0.0 110.822 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.884 ' HA ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.18 -176.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -151.18 153.56 35.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.079 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -117.68 123.69 29.52 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.005 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.27 -14.18 11.57 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.866 2.377 . . . . 0.0 112.585 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.878 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -172.05 150.53 2.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.424 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.83 134.12 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.937 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -176.34 81.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 5' ' ' LEU . 12.9 tp -151.0 22.58 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.89 97.73 5.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 53.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 40' ' ' LEU . 9.8 p -132.96 -37.34 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.309 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.443 ' HA ' ' OD2' ' A' ' 12' ' ' ASP . 5.4 p -39.12 -31.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.211 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.498 HG12 HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -87.58 -51.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.227 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.577 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -52.06 -20.3 6.41 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.389 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 9' ' ' CYS . 1.2 p30 -92.78 -8.83 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.839 0.352 . . . . 0.0 110.863 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -98.65 -51.95 3.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB2' HG21 ' A' ' 35' ' ' VAL . 9.0 tp -64.06 -33.84 76.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.608 ' CB ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -62.39 -41.87 98.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 20' ' ' ARG . . . -70.87 -49.23 29.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.436 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.823 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -58.2 -47.86 82.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.351 . . . . 0.0 111.074 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.91 -43.44 71.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 52' ' ' MET . . . -73.74 -23.64 59.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 3.0 mmt180 -73.9 -12.3 60.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.606 ' HA2' ' HE2' ' A' ' 52' ' ' MET . . . 66.83 80.61 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.68 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 11.4 t0 -147.51 88.49 1.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.302 . . . . 0.0 110.676 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.688 HG23 ' HB3' ' A' ' 57' ' ' ALA . 6.3 p -52.18 -29.18 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -52.27 11.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.77 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -74.12 -27.85 61.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.737 -179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.883 ' HB ' HG22 ' A' ' 58' ' ' VAL . 1.8 p -52.56 -47.21 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.312 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 1.266 ' NE ' ' OE2' ' A' ' 61' ' ' GLU . 6.2 mtt180 -73.64 -34.38 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 111.073 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 2.6 mmm-85 -52.4 -27.54 16.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.258 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.823 HD11 ' CB ' ' A' ' 17' ' ' ALA . 1.4 mt -73.05 -68.42 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -63.99 -53.62 47.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.006 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -59.29 -16.51 22.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 2.3 mmp_? -135.21 -73.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -47.45 -23.44 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER 59.36 16.05 4.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.791 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' LEU . 13.8 p -46.36 154.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -91.94 121.49 66.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 30.8 Cg_endo -63.47 -9.69 18.92 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.763 2.309 . . . . 0.0 112.154 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -106.93 21.15 18.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' N ' ' A' ' 11' ' ' GLY . . . -97.79 143.71 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.78 HD12 ' N ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -119.93 160.15 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 15' ' ' SER . 1.1 m-20 -71.24 -159.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -4.99 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.821 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.05 -44.56 6.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.624 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 120.85 38.55 0.65 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' N ' ' HB3' ' A' ' 40' ' ' LEU . 7.1 mtpt -117.7 143.76 45.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.829 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -85.06 156.69 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . . . -57.63 -36.18 71.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.761 HD11 HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -61.33 -36.53 80.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.815 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.785 ' HG2' HG21 ' A' ' 71' ' ' VAL . 1.3 mt-30 -73.05 -55.83 5.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -59.4 -19.03 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.256 -179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.676 ' HE1' HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -43.62 148.36 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.759 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.606 ' HE2' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -108.93 23.39 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.105 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 1.035 ' CE2' ' HB2' ' A' ' 83' ' ' ALA . 0.9 OUTLIER 33.15 57.91 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.467 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -108.46 -72.16 0.75 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.312 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -84.54 121.54 74.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.751 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.71 -45.0 44.27 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.574 2.183 . . . . 0.0 111.859 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB3' HG23 ' A' ' 23' ' ' VAL . . . -63.3 -31.3 72.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 ' HB ' ' A' ' 26' ' ' VAL . 2.2 t -62.12 -47.88 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.027 0.441 . . . . 0.0 110.009 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.885 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.74 -49.79 71.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.822 HD23 ' O ' ' A' ' 60' ' ' LEU . 2.4 tt -63.08 -43.3 98.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.548 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.266 ' OE2' ' NE ' ' A' ' 27' ' ' ARG . 7.4 tt0 -62.74 -61.23 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.414 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.719 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -63.09 -37.59 87.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.079 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 48' ' ' LEU . 39.4 tp -63.42 -52.65 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.117 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -62.62 -34.0 76.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.017 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.482 ' HG2' ' HG ' ' A' ' 30' ' ' LEU . 1.3 tp-100 -46.24 -25.32 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.29 3.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.593 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -39.31 148.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -102.01 123.05 44.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.26 -14.77 28.53 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.772 2.314 . . . . 0.0 112.235 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -88.9 57.21 4.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.785 HG21 ' HG2' ' A' ' 49' ' ' GLN . 13.9 m -103.2 175.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.057 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -153.59 129.97 10.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -104.14 124.12 48.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.833 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.43 -77.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -116.37 -65.46 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.41 23.57 0.36 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.541 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.0 m -82.21 65.67 7.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.81 0.338 . . . . 0.0 110.72 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -58.79 171.14 0.69 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD3' ' CG2' ' A' ' 71' ' ' VAL . 78.1 Cg_exo -49.99 -44.27 38.04 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.772 2.315 . . . . 0.0 112.134 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -52.56 -41.04 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.318 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.618 ' HD2' HD11 ' A' ' 115' ' ' LEU . 6.0 m80 -52.83 -66.59 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.795 ' O ' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -62.58 -30.76 71.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.035 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -53.55 -39.21 64.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.331 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.76 -50.17 38.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.542 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.553 ' NE ' HD13 ' A' ' 115' ' ' LEU . 13.4 mtt180 -72.97 -26.88 61.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.322 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 82' ' ' ASP . 32.6 p -70.76 -3.43 18.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.301 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 43.83 76.17 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.13 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -158.98 61.57 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.625 ' CD1' ' CD2' ' A' ' 127' ' ' PHE . 62.5 tp -52.42 -19.63 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.138 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -63.13 -71.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.713 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.885 HG22 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -73.15 -20.74 60.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.603 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.761 ' C ' HD23 ' A' ' 92' ' ' LEU . 1.7 tt -72.95 -42.51 63.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.34 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 127' ' ' PHE . 38.8 ttmt -65.71 -36.94 85.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.447 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.76 ' HA ' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -55.82 -58.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.078 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.676 HD22 ' HE1' ' A' ' 51' ' ' MET . 1.6 pp -73.07 -34.44 66.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.073 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 80' ' ' VAL . 38.8 t -72.32 -49.31 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.76 ' CD ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -58.77 -32.97 69.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -30.91 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 126.35 -0.58 7.55 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.467 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 102' ' ' VAL . . . -42.99 167.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.113 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.07 88.55 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.815 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.818 ' HA ' HG21 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -89.35 13.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.6 9.81 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.07 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -65.08 141.63 58.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.886 HD13 ' HA2' ' A' ' 109' ' ' GLY . 6.7 mt -121.67 150.54 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.065 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' OG ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -84.98 -48.87 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.866 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 106' ' ' ASP . 0.6 OUTLIER -175.25 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.94 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 2.26 42.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.886 ' HA2' HD13 ' A' ' 105' ' ' LEU . . . 52.8 18.97 6.2 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.353 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.575 ' O ' ' CG ' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -48.27 -50.37 30.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.541 0.21 . . . . 0.0 111.132 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 105' ' ' LEU . 6.2 tp 92.49 127.81 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.724 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.552 ' CG ' ' CG1' ' A' ' 80' ' ' VAL . 84.7 Cg_exo -44.38 -46.11 12.06 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.854 2.369 . . . . 0.0 112.589 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -63.38 -31.39 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.153 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.601 ' CD2' HD22 ' A' ' 147' ' ' LEU . 8.9 m80 -70.03 -34.17 72.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 81' ' ' HIS . 1.2 mt -63.5 -52.96 59.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' C ' HG22 ' A' ' 125' ' ' VAL . . . -53.56 -36.02 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.682 HG21 ' HB3' ' A' ' 147' ' ' LEU . 83.6 mt -61.5 -41.52 90.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.626 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -68.91 -12.6 61.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.587 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.544 ' CB ' ' CD2' ' A' ' 121' ' ' HIS . 2.6 mt-10 -91.76 -57.81 2.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.736 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 119.92 -11.88 10.86 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.796 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 125' ' ' VAL . 30.7 m-70 -57.22 78.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.828 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 126' ' ' SER . 11.8 p -37.72 -45.02 0.76 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.2 p -56.94 -51.27 69.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.255 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 121' ' ' HIS . 45.3 t -72.9 -58.85 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.452 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' C ' ' A' ' 116' ' ' ALA . 2.4 t -52.04 -40.94 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.773 0.321 . . . . 0.0 111.238 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.586 ' HB3' HG21 ' A' ' 159' ' ' ILE . 77.3 p -67.09 -36.87 82.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.111 0.481 . . . . 0.0 110.799 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 68.1 t80 -73.7 -44.51 56.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -70.44 -10.79 60.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.082 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -53.31 -69.09 0.37 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.089 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 1.016 ' HA ' HD11 ' A' ' 134' ' ' LEU . 72.0 Cg_endo -74.5 -50.07 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.772 2.315 . . . . 0.0 112.58 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -39.27 -44.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD13 ' A' ' 128' ' ' LEU . 8.1 t -90.77 134.2 34.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.432 ' CG ' ' HB2' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -40.14 101.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.836 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.016 HD11 ' HA ' ' A' ' 130' ' ' PRO . 5.2 mp -62.68 -36.77 83.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.011 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -63.53 -33.91 76.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.066 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.432 ' HB2' ' CG ' ' A' ' 133' ' ' ASP . 12.0 t60 -50.35 155.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.882 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -114.14 149.66 35.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.996 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.669 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 t70 -66.34 -9.32 32.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' ASP . . . 82.41 -5.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.38 -14.01 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.607 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 108.33 48.3 0.88 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.478 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 147' ' ' LEU . 94.3 mt -151.62 93.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.682 0.277 . . . . 0.0 111.057 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.536 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.82 179.65 0.75 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 73.3 Cg_exo -49.33 -49.41 15.6 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.763 2.309 . . . . 0.0 112.575 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.8 mt -73.28 -34.98 66.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 143' ' ' THR . 15.4 mm-40 -52.78 -62.14 1.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.682 ' HB3' HG21 ' A' ' 117' ' ' ILE . 2.7 tp -54.71 -48.35 72.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.41 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -57.17 -36.8 71.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.337 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -43.69 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.002 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 151' ' ' ARG . 10.2 tt0 -71.9 -86.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.976 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.504 ' N ' ' HG2' ' A' ' 150' ' ' GLN . 37.5 mtt-85 -74.7 53.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.549 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 154' ' ' GLN . . . -52.07 -20.61 6.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 154' ' ' GLN . . . 34.43 30.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.582 -0.155 . . . . 0.0 110.582 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.597 ' CG ' ' O ' ' A' ' 153' ' ' ALA . 4.6 pp0? 125.95 -154.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.506 ' C ' ' NE2' ' A' ' 154' ' ' GLN . 2.2 t30 -74.41 46.11 0.25 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.408 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.036 HD23 HD11 ' A' ' 159' ' ' ILE . 11.3 mt -69.91 -50.32 43.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.185 0.517 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.726 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 10.5 ptm -52.13 -26.18 10.68 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.944 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -74.4 -58.61 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.819 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.036 HD11 HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -51.91 -38.27 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.346 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.676 ' HG ' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -74.23 -23.79 59.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.025 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -47.26 44.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.07 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.16 53.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 53.3 m-70 -72.12 -8.34 54.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.486 ' CG ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -77.93 150.11 34.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.967 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.1 ptp -128.11 144.69 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.62 69.77 59.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' C ' ' HG2' ' A' ' 168' ' ' MET . 40.1 Cg_exo -56.65 -176.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.773 2.315 . . . . 0.0 112.227 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.447 ' HG2' ' C ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.746 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m -100.71 120.05 39.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.3 ttm -82.7 59.35 4.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.83 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.05 146.38 25.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 49.79 57.16 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.873 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.41 -88.25 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 49.56 29.38 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 31.3 m -152.1 -40.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.004 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 33.6 t 71.91 -58.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.058 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 35' ' ' VAL . 7.7 p -121.25 14.27 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -60.78 -56.37 24.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -11.22 28.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.815 ' HD2' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -86.61 -65.26 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.824 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.061 HD23 HG11 ' A' ' 35' ' ' VAL . 2.2 tm? -71.44 -65.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -56.97 -30.97 64.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.43 -63.77 2.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -64.75 -44.51 89.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 111.077 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 14' ' ' LEU . . . -52.62 -51.5 59.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 51' ' ' MET . . . -65.1 -38.24 90.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -70.42 -7.91 46.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.814 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 23' ' ' VAL . . . 114.94 -66.28 0.28 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.901 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.107 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 0.3 OUTLIER 26.89 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.0 111.822 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 26' ' ' VAL . 12.6 p -51.66 -35.64 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.21 -42.87 59.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.34 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.107 ' OE1' ' HA ' ' A' ' 22' ' ' ASP . 2.7 mp0 -74.43 -25.94 59.76 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.302 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.177 HG13 ' OE1' ' A' ' 61' ' ' GLU . 1.8 p -52.31 -40.06 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 60.9 mtt180 -73.99 -48.28 31.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 9.8 mtt180 -66.2 -29.31 69.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.573 HD11 ' OD2' ' A' ' 22' ' ' ASP . 6.7 mt -55.31 -67.46 0.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -73.63 -52.97 11.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.922 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 27' ' ' ARG . 41.0 m-70 -67.62 -4.73 12.74 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -142.28 -57.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.689 0.281 . . . . 0.0 111.345 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.815 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.92 -4.52 20.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.165 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER 39.88 32.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.977 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.061 HG11 HD23 ' A' ' 14' ' ' LEU . 9.7 p -59.15 166.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.519 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -98.72 135.5 21.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . 56.5 Cg_endo -70.84 -10.04 26.92 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.65 50.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.796 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.6 116.33 32.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -97.54 165.04 12.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -109.47 46.03 1.03 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.85 21.95 5.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HB3' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -121.8 -9.16 8.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.12 20.96 43.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 3.5 mtpt -113.94 143.9 43.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 50' ' ' VAL . 64.7 p -89.3 174.31 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 14' ' ' LEU . . . -58.48 -38.28 77.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.062 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.506 HD23 ' HG2' ' A' ' 51' ' ' MET . 5.7 mt -73.44 -33.08 64.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.26 -1.39 17.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.481 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -129.78 -46.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.352 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.732 ' HE3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -36.71 140.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.464 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -88.35 146.9 25.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.091 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.877 ' CE2' HD21 ' A' ' 95' ' ' LEU . 1.9 m-85 -87.5 21.72 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -73.06 -40.1 51.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 23' ' ' VAL . 2.6 m -109.58 120.03 46.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 0.0 110.819 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 1.177 ' HG3' ' OD1' ' A' ' 90' ' ' ASP . 32.1 Cg_exo -58.83 -42.23 54.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.677 2.251 . . . . 0.0 112.168 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.15 70.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.044 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.3 t -62.98 -48.61 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG22 ' A' ' 91' ' ' THR . . . -63.51 -40.93 98.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LYS . 1.8 tm? -63.01 -47.97 80.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.681 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.177 ' OE1' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.28 -48.4 78.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.8 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 51' ' ' MET . 8.2 mt -62.87 -54.38 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 95' ' ' LEU . 1.3 tt -63.08 -43.29 98.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' LEU . 6.1 ttmm -62.93 -26.15 68.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.539 ' NE2' HD22 ' A' ' 30' ' ' LEU . 34.8 tt0 -62.11 -14.67 39.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.7 62.93 1.02 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.566 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -120.69 170.98 8.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.96 99.5 26.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.71 -9.18 23.57 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.689 2.259 . . . . 0.0 112.161 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.518 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.99 63.78 8.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 78' ' ' SER . 16.1 m -117.89 126.99 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.751 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 10.4 mt-30 -104.03 142.0 35.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -88.0 -179.89 6.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.21 -8.24 29.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.36 16.82 16.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.85 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.84 85.15 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 81' ' ' HIS . 2.1 m 179.91 139.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.824 0.345 . . . . 0.0 110.818 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.523 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -117.51 179.62 0.79 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.145 0.498 . . . . 0.0 110.982 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 1.178 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 77.1 Cg_exo -48.53 -51.04 10.98 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.731 2.287 . . . . 0.0 111.765 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.595 ' CG2' HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.14 -48.76 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.316 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.71 ' HB2' HG23 ' A' ' 77' ' ' THR . 24.0 m80 -52.75 -61.37 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.94 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.178 ' OD1' ' O ' ' A' ' 79' ' ' PRO . 10.5 p30 -57.77 -53.69 55.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.75 ' CB ' HD13 ' A' ' 92' ' ' LEU . . . -52.25 -38.82 59.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.459 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.11 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -73.49 -27.42 61.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.077 HG23 ' O ' ' A' ' 82' ' ' ASP . 27.8 p -71.32 -41.57 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.76 70.71 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.003 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -145.25 53.61 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.648 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 123' ' ' SER . 9.2 tp -52.47 -20.63 3.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.177 ' OD1' ' HG3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -63.53 -71.8 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.422 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.707 HG22 ' HB2' ' A' ' 59' ' ' ALA . 6.5 m -73.12 -22.24 60.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.176 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.755 HD12 HD11 ' A' ' 95' ' ' LEU . 64.8 tp -70.29 -44.22 68.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 1.259 ' O ' ' CD ' ' A' ' 97' ' ' GLU . 20.3 ttpp -60.63 -44.74 96.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.834 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.98 ' HA ' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -52.93 -53.33 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.535 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 53' ' ' PHE . 1.2 pp -73.55 -42.47 61.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.837 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.84 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 3.2 t -63.69 -52.48 56.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.259 ' CD ' ' O ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -55.5 -29.16 58.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.53 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 6.3 t60 -73.08 -56.21 5.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.961 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.54 33.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.815 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -69.41 120.31 15.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.324 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.572 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 1.8 p-10 -35.81 92.31 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -107.1 14.17 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.127 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -143.53 38.47 1.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.08 122.37 26.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.694 HD21 ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -119.16 146.0 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.638 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.751 ' OD2' ' HB3' ' A' ' 72' ' ' GLN . 7.3 p30 -155.22 141.03 18.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 108' ' ' THR . 71.1 m 49.39 26.56 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.683 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -163.85 -40.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 1.174 ' O ' ' OD1' ' A' ' 138' ' ' ASP . . . 68.68 10.79 61.51 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.467 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 1.429 ' HA ' ' CG ' ' A' ' 138' ' ' ASP . 2.6 t -104.02 129.45 51.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.852 0.358 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.694 ' HG ' HD21 ' A' ' 105' ' ' LEU . 32.5 mt -65.83 147.51 98.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HB2' HD11 ' A' ' 128' ' ' LEU . 74.4 Cg_exo -50.44 -29.53 24.43 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.681 2.254 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 129' ' ' ALA . 2.9 tt -69.8 -38.31 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.819 ' ND1' ' OD2' ' A' ' 138' ' ' ASP . 36.4 m80 -53.32 -38.95 63.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.4 mt -65.96 -57.61 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.625 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 125' ' ' VAL . . . -52.95 -28.67 24.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.42 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.579 HD13 ' CG1' ' A' ' 125' ' ' VAL . 4.7 mm -65.42 -39.73 86.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.86 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -18.25 62.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.526 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 121' ' ' HIS . 4.1 mm-40 -90.87 -54.78 3.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.2 45.76 5.23 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.009 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.643 ' CB ' HG23 ' A' ' 124' ' ' VAL . 99.0 m-70 -76.96 3.77 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.698 0.285 . . . . 0.0 111.205 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 40.5 t 71.09 -92.94 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.785 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.64 ' HB3' HD22 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -52.64 -56.51 14.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.358 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG23 ' CB ' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -52.19 -62.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.944 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 116' ' ' ALA . 4.5 t -52.31 -43.83 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 1.023 ' HB2' HG21 ' A' ' 159' ' ' ILE . 16.2 t -72.63 -30.49 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.36 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 123' ' ' SER . 63.3 t80 -73.8 -42.12 61.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.065 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -66.7 -6.99 17.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.336 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.832 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -64.13 -68.94 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.832 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 41.2 Cg_endo -67.27 -36.75 20.01 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 2.25 . . . . 0.0 112.353 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.33 -22.31 65.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 133' ' ' ASP . 51.8 m -112.84 147.6 36.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -35.47 111.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 134' ' ' LEU . 5.8 mt -79.35 64.46 4.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 134' ' ' LEU . 6.0 p-80 164.72 -36.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.021 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . 68.6 t60 -48.62 143.76 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.823 ' HG3' HG22 ' A' ' 143' ' ' THR . 3.4 ttm180 -101.32 177.66 4.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 1.429 ' CG ' ' HA ' ' A' ' 110' ' ' SER . 1.3 t0 -121.26 156.48 32.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.89 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.74 -22.25 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.183 0.516 . . . . 0.0 110.37 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -73.88 -58.73 3.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.724 179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 1.18 ' O ' ' OE2' ' A' ' 146' ' ' GLU . . . 124.84 43.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.852 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.45 114.42 4.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.823 HG22 ' HG3' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -82.78 -174.35 0.52 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 143' ' ' THR . 86.9 Cg_exo -44.87 -52.12 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.448 2.098 . . . . 0.0 112.072 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 145' ' ' LEU . 10.2 mt -73.35 -36.79 66.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.18 ' OE2' ' O ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -63.9 -64.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.951 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.708 HD12 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -52.37 -46.19 66.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.491 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -55.97 -32.96 64.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.307 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.19 83.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.041 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -59.35 -68.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.649 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.885 ' O ' HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -73.76 66.18 1.08 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 153' ' ' ALA . . . -64.46 50.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.587 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 151' ' ' ARG . . . -60.56 -142.37 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.573 ' NE2' ' HB3' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -60.41 -149.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 1.071 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 71.4 m-20 -74.64 44.27 0.21 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.984 ' HA ' HD12 ' A' ' 159' ' ' ILE . 2.5 pt? -69.16 -52.9 23.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.661 0.267 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.571 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER -56.37 -33.62 65.89 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.144 0.497 . . . . 0.0 110.076 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.071 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 15.4 p-10 -74.23 -40.0 62.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.082 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 126' ' ' SER . 10.6 mt -52.69 -49.86 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.76 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.836 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -73.78 -33.11 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.968 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -51.41 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.947 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.35 63.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -48.8 80.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.434 ' HA ' HD13 ' A' ' 134' ' ' LEU . 1.5 tpp -60.09 -28.65 68.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.4 tpt 63.48 139.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.4 mp -143.56 98.02 5.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.057 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.73 146.04 5.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.732 2.288 . . . . 0.0 112.418 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.7 mtt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.848 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -161.4 -64.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.03 106.73 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 -54.65 2.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.21 -153.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.988 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.333 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER 62.06 153.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 1.333 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 22.0 mm-40 -132.25 37.26 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.152 HG23 ' OE2' ' A' ' 6' ' ' GLU . 42.7 t -106.53 49.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.02 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.824 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -80.67 98.46 7.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.681 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.824 HG12 ' O ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER 82.62 9.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.013 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB1' ' A' ' 39' ' ' ALA . . . -60.85 -81.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 11.0 t0 -59.93 -14.54 16.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -63.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.692 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.84 ' HA ' HD12 ' A' ' 29' ' ' LEU . 1.7 tm? -73.13 -54.67 7.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.034 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.564 ' N ' HD13 ' A' ' 14' ' ' LEU . 5.5 p -57.72 -30.32 65.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 12' ' ' ASP . . . -70.76 -46.12 48.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.5 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' O ' ' OD1' ' A' ' 22' ' ' ASP . . . -61.86 -55.89 25.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.267 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.4 69.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.182 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -68.03 -26.83 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.226 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' O ' ' SD ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -73.29 -26.58 61.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . 88.1 66.5 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.596 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.069 ' CB ' ' OE2' ' A' ' 25' ' ' GLU . 13.4 p-10 -137.15 94.46 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.842 0.353 . . . . 0.0 110.958 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 26' ' ' VAL . 7.3 p -53.07 -20.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.169 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -74.18 -51.87 14.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.08 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.069 ' OE2' ' CB ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -73.24 -32.98 65.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.818 -179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.872 HG21 ' HA ' ' A' ' 58' ' ' VAL . 2.3 p -52.69 -49.58 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 111.09 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 31' ' ' HIS . 29.7 mtt180 -73.64 -48.88 29.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.279 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 1.5 mmp_? -52.85 -30.23 32.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.96 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -73.17 -73.99 0.19 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.946 HD11 HD23 ' A' ' 62' ' ' LEU . 1.7 mt -73.59 -42.7 61.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.484 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -73.11 -3.23 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.37 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -143.02 -75.46 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 0.0 111.047 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.825 ' OE1' ' HB ' ' A' ' 35' ' ' VAL . 14.1 tt0 -46.93 -23.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 34' ' ' LEU . 10.7 mt 62.01 29.92 17.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.825 ' HB ' ' OE1' ' A' ' 33' ' ' GLU . 2.7 p -58.92 137.15 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -69.03 145.88 96.85 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 36' ' ' HIS . 40.0 Cg_endo -67.33 -11.03 30.69 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.768 2.312 . . . . 0.0 112.211 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 29.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.74 ' C ' HD13 ' A' ' 40' ' ' LEU . . . -97.9 94.81 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.282 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -102.86 147.87 26.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.685 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 24.5 p30 -44.99 -26.17 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.0 0.429 . . . . 0.0 110.285 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' HG22 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -146.02 -71.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.534 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 177.89 66.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.933 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.29 -73.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.971 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 40' ' ' LEU . 30.1 mttm -84.87 152.92 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 111.336 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.985 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.5 p -101.52 176.71 5.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.695 ' HB2' ' CD1' ' A' ' 14' ' ' LEU . . . -57.14 -35.74 69.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 69' ' ' PRO . 3.5 tp -72.83 -47.86 42.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' CG ' HG23 ' A' ' 71' ' ' VAL . 2.0 tm0? -65.52 -9.56 27.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 46' ' ' THR . 32.8 m -136.31 26.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.1 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 1.1 tmm? -86.86 149.88 24.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.501 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.9 OUTLIER -87.87 86.6 7.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.381 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 83' ' ' ALA . 53.4 m-85 -35.14 -30.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -28.79 -55.32 0.15 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.148 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -90.94 130.94 38.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.919 0.39 . . . . 0.0 110.963 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HA ' HG23 ' A' ' 91' ' ' THR . 61.0 Cg_endo -73.22 -42.97 0.8 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.761 2.307 . . . . 0.0 112.043 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -62.8 -29.01 70.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.521 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.872 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.5 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.879 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB2' ' CG2' ' A' ' 91' ' ' THR . . . -63.21 -52.95 60.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -63.61 -38.45 91.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.024 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -62.84 -49.35 75.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.946 HD23 HD11 ' A' ' 30' ' ' LEU . 13.0 mt -62.77 -50.29 71.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.842 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' CG ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -62.91 -23.02 67.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.671 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 11.9 tttt -63.05 -20.4 65.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.79 -57.22 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 135.89 50.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.515 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.56 -13.78 53.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 71' ' ' VAL . 0.9 OUTLIER 62.9 95.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CG ' HD21 ' A' ' 63' ' ' LEU . 74.6 Cg_exo -48.19 -41.47 34.37 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.85 ' ND2' ' OD1' ' A' ' 101' ' ' ASP . 3.5 m120 -71.16 84.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG23 ' CG ' ' A' ' 49' ' ' GLN . 4.7 m -136.45 131.98 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . 29.2 mt-30 -140.36 163.34 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.841 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -127.52 -166.77 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.813 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.54 -22.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 15.5 p -84.58 -29.86 25.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.9 ' C ' ' OD1' ' A' ' 106' ' ' ASP . . . 79.0 28.17 54.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.588 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 1.291 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . 2.6 m -115.9 119.21 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 0.0 110.864 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.586 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.6 p -104.96 -176.02 0.41 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 78' ' ' SER . 40.5 Cg_exo -56.22 -42.98 60.59 Favored 'Trans proline' 0 CA--C 1.527 0.128 0 C-N-CA 122.814 2.342 . . . . 0.0 112.058 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.523 HG23 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.67 -29.95 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.476 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.582 ' ND1' ' OD2' ' A' ' 106' ' ' ASP . 9.4 m170 -72.08 -68.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -61.25 -25.98 67.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.207 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.815 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -56.49 -53.76 53.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.563 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.97 -38.14 66.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.568 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.087 ' HD2' ' OE1' ' A' ' 119' ' ' GLU . 6.5 tpt180 -72.15 -24.04 61.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.215 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 82' ' ' ASP . 5.5 p -73.07 -73.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.125 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 88' ' ' PHE . . . 132.7 63.67 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.324 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 22.8 m-85 -155.06 59.27 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.718 HD11 ' CG ' ' A' ' 127' ' ' PHE . 37.6 tp -52.21 -29.32 22.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.235 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 1.108 ' OD1' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -53.19 -67.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.459 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.108 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 47.7 m -72.24 -42.16 65.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.135 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 83' ' ' ALA . 1.2 tt -52.37 -48.68 65.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.492 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.62 ' N ' HD23 ' A' ' 92' ' ' LEU . 6.2 ttpp -55.39 -26.08 39.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.877 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.21 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 18.1 t -73.54 -70.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.542 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.986 HD22 ' N ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -63.91 -27.33 69.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.534 -179.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.986 ' N ' HD22 ' A' ' 95' ' ' LEU . 41.3 t -73.88 -56.14 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.812 0.339 . . . . 0.0 110.759 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.21 ' OE2' ' HA ' ' A' ' 94' ' ' VAL . 17.3 pm0 -56.29 -35.39 67.44 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.502 ' N ' ' HG2' ' A' ' 97' ' ' GLU . 10.6 t-160 -60.65 -68.83 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . 179.19 61.68 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.469 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . . . -105.76 26.5 9.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.85 ' OD1' ' ND2' ' A' ' 70' ' ' ASN . 1.1 p-10 47.87 82.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 15.51 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.982 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 132' ' ' SER . 65.3 m-20 -131.89 27.33 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -101.7 162.03 13.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.077 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.555 HD21 ' CD1' ' A' ' 111' ' ' LEU . 74.2 mt -125.13 150.27 47.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 1.291 ' OD2' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -100.34 -169.55 1.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 75' ' ' SER . 61.8 m -48.29 -46.14 35.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -33.33 75.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 105' ' ' LEU . . . 84.03 31.17 26.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.569 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.3 m -105.73 119.98 40.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.627 HD21 ' OD1' ' A' ' 133' ' ' ASP . 9.3 tp -54.53 138.09 60.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 104' ' ' ALA . 94.4 Cg_exo -43.37 -27.01 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.796 2.33 . . . . 0.0 112.366 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.872 ' HB ' HD21 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -73.23 -42.77 58.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.797 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 142' ' ' LEU . 31.3 m80 -52.91 -32.51 45.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.286 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -73.11 -48.66 33.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.361 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB1' HG22 ' A' ' 125' ' ' VAL . . . -61.74 -32.95 73.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.92 HG21 ' HB3' ' A' ' 147' ' ' LEU . 80.2 mt -66.55 -42.2 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.691 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' HA ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -72.6 -16.91 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.992 0.425 . . . . 0.0 110.334 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 1.087 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -86.67 -57.84 2.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.415 179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 110.23 -0.69 29.72 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.54 ' CB ' ' HB ' ' A' ' 124' ' ' VAL . 15.2 m-70 -57.68 78.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.743 0.306 . . . . 0.0 110.592 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -34.36 -48.59 0.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.962 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -62.45 -48.33 80.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.54 ' HB ' ' CB ' ' A' ' 121' ' ' HIS . 47.5 t -69.57 -60.17 2.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.464 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 2.4 t -51.87 -44.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.158 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.846 ' HB3' HG21 ' A' ' 159' ' ' ILE . 60.6 p -71.87 -29.35 64.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.169 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CG ' HD11 ' A' ' 89' ' ' LEU . 27.3 t80 -73.22 -66.4 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.887 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.994 HD22 ' O ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -65.73 -8.76 22.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.962 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.947 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -52.22 -71.1 0.22 Allowed Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 57.4 Cg_endo -70.88 -33.0 13.0 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 128' ' ' LEU . 30.9 mm-40 -54.59 -20.4 7.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.283 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 8.8 p -105.81 -171.25 1.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.627 ' OD1' HD21 ' A' ' 111' ' ' LEU . 4.1 p30 -94.5 84.63 4.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.992 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 164' ' ' MET . 0.2 OUTLIER -57.59 75.3 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.222 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 p-80 174.98 -39.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -47.89 173.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -129.88 174.32 9.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.467 ' HB2' ' CE1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -131.25 166.97 20.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.6 -20.18 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.09 -52.38 55.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.941 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 120.44 11.2 6.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.443 ' HB3' ' CD ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -132.72 160.72 35.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.761 0.315 . . . . 0.0 111.075 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.531 ' CB ' ' HD2' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -112.99 -178.39 0.52 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 143' ' ' THR . 84.3 Cg_exo -44.91 -59.75 1.04 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.634 2.223 . . . . 0.0 112.138 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.638 HD21 ' HG2' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -58.4 -46.74 85.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.633 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.443 ' CD ' ' HB3' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -52.78 -62.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.92 ' HB3' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -52.87 -43.61 66.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.805 ' HB1' ' HA ' ' A' ' 157' ' ' MET . . . -52.64 -43.46 65.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.375 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -61.04 -36.15 78.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.753 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.486 ' CG ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -69.74 -80.21 0.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.572 179.032 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.36 61.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -70.6 52.29 0.88 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.79 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.548 ' HB3' HE21 ' A' ' 154' ' ' GLN . . . -32.7 -38.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.048 0.452 . . . . 0.0 110.723 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.548 HE21 ' HB3' ' A' ' 153' ' ' ALA . 0.6 OUTLIER 172.53 -119.91 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.29 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.764 ' HB3' ' OD2' ' A' ' 158' ' ' ASP . 2.0 m-20 -74.06 4.73 5.1 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.135 -0.353 . . . . 0.0 111.692 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.995 ' HA ' HD12 ' A' ' 159' ' ' ILE . 0.1 OUTLIER -52.66 -51.84 58.38 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.74 0.305 . . . . 0.0 111.002 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.805 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . 2.4 ppp? -53.2 -34.7 58.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.764 ' OD2' ' HB3' ' A' ' 155' ' ' ASN . 3.1 p30 -73.67 -43.58 59.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.17 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.995 HD12 ' HA ' ' A' ' 156' ' ' LEU . 15.5 mt -52.74 -44.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.369 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 160' ' ' LEU . 1.3 mt -73.29 -35.51 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.336 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -67.41 -37.89 83.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -67.78 -50.01 44.98 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.389 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -73.26 -9.8 59.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 111.103 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.649 ' HA ' HD22 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -57.08 97.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 tpt -75.67 125.22 28.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.7 mt -101.86 122.83 45.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.99 129.45 24.81 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.71 2.274 . . . . 0.0 112.464 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.888 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.9 m -122.06 63.91 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.783 0.325 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -157.89 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.7 109.25 1.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.1 tp -177.81 53.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.932 ' O ' HG12 ' A' ' 8' ' ' VAL . 1.6 tt0 -110.83 -42.74 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 39.15 36.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.932 HG12 ' O ' ' A' ' 6' ' ' GLU . 12.7 p -178.81 139.74 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.032 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.34 -68.04 0.73 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.086 HG21 HG12 ' A' ' 35' ' ' VAL . 3.9 p -123.89 -6.45 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.288 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.736 ' N ' ' HB1' ' A' ' 39' ' ' ALA . . . -40.24 -60.48 1.96 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.386 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 29.4 p30 -56.51 -17.39 8.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.754 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HB3' HG22 ' A' ' 10' ' ' VAL . 3.1 tpm_? -98.59 -64.25 1.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.756 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.695 HD11 HD21 ' A' ' 62' ' ' LEU . 2.8 tm? -69.22 -61.71 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.484 ' OG ' HG21 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.94 -28.29 56.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.753 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.64 -49.05 39.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.188 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 22' ' ' ASP . . . -73.03 -40.3 65.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.207 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -52.43 -45.12 65.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.287 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -73.1 -37.58 66.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.178 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -73.43 -8.13 54.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 58' ' ' VAL . . . 124.89 -66.56 0.53 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.179 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.608 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 0.3 OUTLIER 33.54 38.21 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.39 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.687 ' HA ' HG23 ' A' ' 58' ' ' VAL . 2.3 p -52.66 -49.88 43.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.656 ' HG3' HG13 ' A' ' 23' ' ' VAL . 15.0 mt-30 -75.14 -32.62 61.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.811 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . 0.3 OUTLIER -73.24 -37.39 66.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.577 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.291 HG13 ' OE1' ' A' ' 61' ' ' GLU . 2.4 p -52.39 -35.08 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 110.956 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -71.29 -51.63 23.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.886 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.97 -36.72 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.095 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' OE1' ' A' ' 33' ' ' GLU . 20.2 mt -52.96 -61.86 2.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.1 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.75 HD23 HG23 ' A' ' 35' ' ' VAL . 10.3 mt -73.45 -49.19 28.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.823 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.869 ' NE2' ' OE2' ' A' ' 61' ' ' GLU . 20.2 m-70 -70.14 -19.33 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.861 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' ARG . 0.1 OUTLIER -126.05 -78.91 0.6 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 111.202 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.172 ' OE2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -39.87 -28.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.1 mt 62.38 31.03 17.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.525 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.172 HG13 ' OE2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -54.44 152.07 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.336 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.69 124.6 69.09 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.83 -11.34 29.29 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.694 2.262 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 6.3 p30 -90.97 -8.61 48.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.843 ' HB2' HG12 ' A' ' 10' ' ' VAL . . . -43.67 136.96 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 45' ' ' LYS . 6.4 mt -129.81 108.92 10.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -40.45 -44.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.989 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -135.77 35.18 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HA ' ' CB ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 49.25 48.08 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.749 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.27 -45.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.445 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.941 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.05 147.39 46.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -86.09 166.62 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.27 25.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -73.12 -43.86 61.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 1.071 ' CD ' ' OD1' ' A' ' 73' ' ' ASP . 0.3 OUTLIER -62.74 -20.63 65.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.769 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG21 ' OG ' ' A' ' 15' ' ' SER . 18.7 m -104.73 -34.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.674 ' HG3' HD12 ' A' ' 62' ' ' LEU . 2.0 ttp -42.12 134.81 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.502 ' CE ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -86.74 134.44 33.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.842 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.839 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 10.8 m-85 -78.37 52.46 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.633 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' SD ' ' A' ' 52' ' ' MET . . . -106.29 -59.55 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.108 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -86.76 114.3 57.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 110.302 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' HG11 ' A' ' 94' ' ' VAL . 9.2 Cg_endo -53.64 -42.29 67.18 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.562 2.175 . . . . 0.0 112.145 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . -63.24 -33.36 75.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.722 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.2 t -63.06 -39.93 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -63.04 -59.83 4.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HB2' ' CG1' ' A' ' 94' ' ' VAL . 19.6 tp -63.23 -41.2 99.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.535 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 1.291 ' OE1' HG13 ' A' ' 26' ' ' VAL . 10.6 mt-10 -62.88 -45.84 90.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.501 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.886 HD11 ' HB1' ' A' ' 18' ' ' ALA . 3.2 mt -62.83 -57.1 12.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 64' ' ' LYS . 4.4 pp -63.51 -25.82 68.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.339 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.66 ' N ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -63.14 -46.9 85.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 30' ' ' LEU . 1.8 mm100 -51.36 -43.85 61.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.65 38.58 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 63' ' ' LEU . . . -89.46 159.91 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.978 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.92 110.8 36.24 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.988 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' O ' ' HD2' ' A' ' 79' ' ' PRO . 77.7 Cg_endo -77.59 7.72 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.787 2.325 . . . . 0.0 112.423 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.081 ' OD1' ' OD2' ' A' ' 101' ' ' ASP . 43.4 m-80 -89.48 26.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.731 HG23 ' HG2' ' A' ' 49' ' ' GLN . 8.3 m -107.5 139.08 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.045 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.51 153.12 37.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 1.071 ' OD1' ' CD ' ' A' ' 49' ' ' GLN . 2.5 p-10 -155.0 -175.17 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.836 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 73' ' ' ASP . . . 68.08 -62.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -170.14 33.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.965 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' THR . . . 90.42 65.89 1.2 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.558 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 76' ' ' GLY . 2.3 p -156.85 103.68 2.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.77 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.611 ' CB ' ' CD ' ' A' ' 79' ' ' PRO . 1.2 p -70.51 -174.29 0.25 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 1.036 ' HA ' ' OD2' ' A' ' 82' ' ' ASP . 62.9 Cg_exo -50.64 -50.9 12.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.774 2.316 . . . . 0.0 112.533 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.947 ' CG1' ' HB1' ' A' ' 100' ' ' ALA . 15.3 m -59.34 -43.81 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.373 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.438 ' CD2' ' HG3' ' A' ' 112' ' ' PRO . 44.1 m170 -61.45 -34.47 75.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.043 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.036 ' OD2' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -72.74 -51.09 20.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.921 ' HB3' HD13 ' A' ' 92' ' ' LEU . . . -70.05 -11.98 61.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.39 -43.83 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.406 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 1.007 ' HA ' ' OE2' ' A' ' 119' ' ' GLU . 2.0 mmt180 -61.51 -58.42 8.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.231 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -72.48 -22.55 61.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.817 ' CA ' HG21 ' A' ' 124' ' ' VAL . . . 105.14 -62.83 0.33 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 53' ' ' PHE . 16.9 m-85 30.97 37.1 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 110.259 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.2 tm? -51.73 -41.87 61.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.512 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.641 ' OD1' ' C ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.0 -62.96 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.828 0.347 . . . . 0.0 110.877 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -72.01 -46.33 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.921 HD13 ' HB3' ' A' ' 83' ' ' ALA . 14.6 tp -52.4 -43.03 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.064 0.459 . . . . 0.0 109.916 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.567 ' HE2' HD11 ' A' ' 89' ' ' LEU . 1.9 ttpp -53.52 -37.92 63.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.486 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' 56' ' ' PRO . 42.9 t -57.08 -60.36 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.107 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -73.18 -33.41 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.086 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.842 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 4.6 t -73.12 -45.33 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 93' ' ' LYS . 0.9 OUTLIER -58.24 -32.44 68.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.773 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.455 ' ND1' HD13 ' A' ' 63' ' ' LEU . 4.3 t-160 -73.13 -50.38 23.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.682 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 100' ' ' ALA . . . -166.44 -69.99 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.298 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.947 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . 30.13 82.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.777 0.322 . . . . 0.0 111.559 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.081 ' OD2' ' OD1' ' A' ' 70' ' ' ASN . 2.1 p-10 -39.84 96.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 112' ' ' PRO . 12.9 m -84.24 11.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.38 -25.94 20.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 105' ' ' LEU . . . -50.9 157.45 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.791 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -143.29 161.39 38.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.814 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -84.82 -90.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.005 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.84 -38.57 2.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 -1.89 25.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.081 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.659 ' CA ' HD13 ' A' ' 105' ' ' LEU . . . 62.57 23.29 64.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 139.79 30.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.791 HD23 ' CD2' ' A' ' 105' ' ' LEU . 11.4 mt -68.34 162.76 58.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 102' ' ' VAL . 76.4 Cg_exo -50.23 -34.26 39.16 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.559 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.8 OUTLIER -61.46 -44.06 97.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.98 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.572 ' CE1' ' HG ' ' A' ' 111' ' ' LEU . 1.9 m80 -53.07 -44.38 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.703 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.875 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -67.64 -48.95 65.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.539 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.206 ' HA ' ' OE1' ' A' ' 119' ' ' GLU . . . -53.21 -43.31 67.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.712 HG23 HD13 ' A' ' 156' ' ' LEU . 46.0 mt -54.86 -40.05 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.654 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -62.67 -41.7 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.473 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 1.206 ' OE1' ' HA ' ' A' ' 116' ' ' ALA . 2.2 mp0 -72.53 -55.58 6.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.8 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.18 52.01 2.46 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.678 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.565 ' HB3' HG23 ' A' ' 124' ' ' VAL . 0.5 OUTLIER -81.43 -7.14 59.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.743 0.306 . . . . 0.0 110.996 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 70.26 -71.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.073 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -66.63 -35.53 80.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.817 HG21 ' CA ' ' A' ' 87' ' ' GLY . 42.9 t -74.01 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.087 0.47 . . . . 0.0 110.606 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 1.044 HG21 HD21 ' A' ' 156' ' ' LEU . 4.2 m -53.3 -45.05 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.335 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.545 ' HB3' HG21 ' A' ' 159' ' ' ILE . 15.8 p -71.92 -28.85 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.784 ' CD1' ' OE2' ' A' ' 131' ' ' GLU . 19.0 t80 -73.49 -44.33 58.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.834 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.521 ' CD1' ' OG ' ' A' ' 132' ' ' SER . 0.2 OUTLIER -67.41 -11.51 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.153 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 130' ' ' PRO . . . -56.41 -67.46 0.79 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.283 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 129' ' ' ALA . 29.6 Cg_endo -64.16 -62.07 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.617 2.212 . . . . 0.0 112.452 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.784 ' OE2' ' CD1' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -37.59 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.942 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 128' ' ' LEU . 17.4 m -98.41 129.4 45.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 1.179 ' OD1' ' HB2' ' A' ' 136' ' ' HIS . 0.1 OUTLIER -36.0 95.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 134' ' ' LEU . 4.0 mt -60.19 151.03 28.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 74.52 13.79 3.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 1.179 ' HB2' ' OD1' ' A' ' 133' ' ' ASP . 63.1 t60 -103.83 168.95 8.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.9 mtm-85 -127.2 -160.34 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.12 -171.63 3.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.767 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.41 -9.59 26.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -39.6 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.81 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.413 ' O ' HD23 ' A' ' 142' ' ' LEU . . . 104.26 68.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 141' ' ' GLY . 93.8 mt -156.91 133.3 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.889 0.376 . . . . 0.0 111.075 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.196 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 80.9 p -96.51 159.12 32.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.808 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 143' ' ' THR . 6.0 Cg_exo -38.61 -48.8 2.59 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.15 2.566 . . . . 0.0 112.184 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 145' ' ' LEU . 3.1 mt -66.98 -40.58 87.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.196 ' OE1' ' OG1' ' A' ' 143' ' ' THR . 1.1 mp0 -52.99 -68.77 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.674 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 150' ' ' GLN . 8.4 tp -52.66 -29.01 24.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 160' ' ' LEU . . . -73.17 -15.22 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.471 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 1.4 ttt180 -73.26 -48.46 34.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.46 -90.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.885 179.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -75.88 50.65 0.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 153' ' ' ALA . . . -74.21 44.26 1.34 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.829 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.553 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -34.46 150.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER 40.44 -161.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.89 ' CA ' ' OD1' ' A' ' 158' ' ' ASP . 1.1 t-20 -74.61 43.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.207 -0.308 . . . . 0.0 111.543 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.044 HD21 HG21 ' A' ' 125' ' ' VAL . 2.2 mt -59.43 -55.95 28.15 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.976 0.417 . . . . 0.0 110.966 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.471 ' SD ' ' HA ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -51.66 -44.04 62.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.466 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.89 ' OD1' ' CA ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -74.5 -35.08 63.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.267 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.852 HG22 HD23 ' A' ' 160' ' ' LEU . 11.0 mt -53.16 -52.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 121.158 0.504 . . . . 0.0 110.456 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.872 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -74.51 -24.54 59.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.256 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -64.46 -41.72 96.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.164 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -72.48 -53.51 8.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 159' ' ' ILE . 15.2 m-70 -60.87 -40.24 92.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.881 0.372 . . . . 0.0 110.88 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.417 ' CB ' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -67.99 75.32 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.994 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 33.0 mtm -94.6 111.04 22.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 82.93 26.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.58 -66.57 0.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.677 2.252 . . . . 0.0 112.301 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 stop_ save_